{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron’s 2022 10‑K shows it had an outstanding long‑term loan to Petroboscan of **$560 million** (fully provisioned at year‑end 2021) and that Chevron owned **39.2 %** of Petroboscan 【page_78】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the outstanding loan amount ($560 million) and Chevron's ownership percentage in Petroboscan (39.2%) as of the 2022 reporting period, which matches the ground truth. The only discrepancy is the inclusion of additional detail — that the loan was 'fully provisioned at year-end 2021' — which is not in the original answer but does not contradict it and may reflect accurate information from the cited source (page 78). This extra context does not detract from correctness. (2) Quantitatively, the numbers are accurate: $560 million is equivalent to $560 in the original answer, assuming the unit was implied (though the original lacks 'million', the LLM's inclusion of 'million' aligns with typical financial reporting conventions and is likely correct; this is a known formatting variation in SEC filings). The 39.2% ownership is exactly matched. (3) The multi-hop reasoning is sound — the model correctly synthesizes two distinct pieces of information (loan amount and ownership stake) about Chevron’s relationship with Petroboscan from the 2022 10-K. (4) Scores reflect near-perfect factual accuracy, with a minor deduction in qualitative accuracy only because the original answer did not mention the provisioning status, so adding it introduces a small element not in the ground truth, though it is not incorrect. Contextual relevance is full — all information provided directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1092,
        "completion_tokens": 404,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "Target received $356 million in cash from the sale of Dermstore LLC and recognized a $335 million pretax gain on the transaction, resulting in a combined financial impact of roughly $691 million.【page_42】【page_44】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurately reported: $356 million in cash received and a $335 million pretax gain are correctly stated, matching the original answer. The total financial impact is calculated as $691 million, which is the correct sum ($356M + $335M = $691M), and the LLM refers to it as 'roughly $691 million,' which is semantically acceptable given the precision of the inputs. (2) Quantitative accuracy is perfect: all dollar amounts are correct, properly formatted, and the calculation is accurate. (3) The reasoning is sound and reflects proper multi-hop synthesis—combining the cash proceeds and pretax gain from the sale to determine total financial impact. (4) Entity accuracy is correct: Target Corporation and Dermstore LLC are properly identified, and the financial metrics (cash received, pretax gain) are appropriate and correctly labeled. The answer is concise, relevant, and fully addresses the question. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 302,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Amgen reported product‑sales to BeiGene of $72 million in 2021, $64 million in 2022 and $125 million in 2023. Combined, those three years total $261 million of product‑sale revenue under the collaboration 【page_131】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $72 million in 2021, $64 million in 2022, and $125 million in 2023 — these match the original answer exactly. The total of $261 million is correctly calculated (72 + 64 + 125 = 261). (2) The answer is complete, addressing each year's revenue and the three-year sum as required by the question. (3) Entities are correctly identified: Amgen as the reporting company, BeiGene as the partner, and the collaboration agreement as the context. The metric 'Product Sales revenue' is accurately used. (4) The reasoning is sound — the model correctly synthesized annual figures and summed them, demonstrating proper multi-hop logic across time periods. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., en-dash in 'product-sales') that do not affect accuracy. The citation 【page_131】 adds contextual support without altering factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 289,
        "total_tokens": 1399
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorizes roughly **127 million shares** of Danaher common stock. As of December 31 2021, about **50 million of those shares** remained available for issuance under the plan.【page_116】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers 127 million shares authorized and 50 million shares remaining available as of December 31, 2021, are accurately reported. Minor formatting differences (e.g., '127 million' vs '127 million') do not affect accuracy. (2) The answer is complete, addressing both parts of the question: total shares authorized and shares remaining available. (3) Entity accuracy is correct—'Danaher common stock', '2007 Omnibus Incentive Plan', and the date 'December 31, 2021' are all properly identified. (4) The reasoning is sound, with no calculation or logical errors; the answer correctly synthesizes information from the relevant document (cited with page reference). (5) Semantic equivalence is maintained—the LLM conveys the same factual content as the original answer using slightly different phrasing. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 274,
        "total_tokens": 1389
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Lilly received a total of **$1.355 billion** in cash from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm – **$1.05 billion in 2023** and **$305 million in 2024**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total cash received by LLY from the sale of the olanzapine portfolio to Cheplapharm is correctly stated as $1.355 billion, with $1.05 billion received in 2023 and $305 million in 2024. (2) Quantitative accuracy is perfect: the sum of $1.05 billion and $305 million equals $1.355 billion, confirming correct calculation and consistency. Number formats are clear and equivalent to the original answer ($305 million vs $305.0 million — minor formatting difference, semantically identical). (3) The multi-hop reasoning is sound — the answer synthesizes total amount and its distribution across two years correctly, addressing both parts of the question. (4) Entities are accurate: 'Lilly' (LLY) and 'Cheplapharm' are correctly identified, and the time periods (2023, 2024) are precise. (5) The answer is contextually relevant and complete, directly addressing the total amount and its yearly distribution without extraneous or missing information. Semantic equivalence is maintained with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 318,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded **$298 million of goodwill** from the Terran Orbital acquisition. Of the total $314 million purchase price, **$231 million was paid in cash** (the balance consisted of $83 million of previously held Terran Orbital investments).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $298 million (goodwill), $314 million (total purchase consideration), and $231 million (cash paid) are all accurate and correctly presented. The additional detail that the remaining $83 million consisted of previously held investments is consistent with the total consideration ($231M + $83M = $314M), and while not explicitly asked, this adds context without introducing error. (2) The answer addresses both parts of the question: the goodwill amount and the cash portion of the purchase. (3) Entities—Lockheed Martin and Terran Orbital—are correctly identified, and the financial metrics (goodwill, purchase consideration, cash payment) are appropriate and accurately used. (4) The reasoning is sound and reflects proper multi-hop synthesis: linking the acquisition event to the financial outcomes (goodwill and payment breakdown) from potentially separate disclosures. The semantic meaning is equivalent to the original answer, with only minor, acceptable rewording. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 312,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron’s carrying value for its investment in GS Caltex Corporation was **$3,616 million** at December 31, 2021 (Note 15, Investments and Advances table).  Chevron holds **a 50 percent equity ownership** in the joint‑venture (Note 15 description of GS Caltex).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the carrying value of Chevron's investment in GS Caltex Corporation at the end of 2021 is correctly stated as $3,616 million, and Chevron's equity ownership percentage is accurately reported as 50%. (2) Quantitative accuracy is perfect—both the dollar amount and percentage match the original answer exactly, with acceptable formatting (e.g., 'million' vs 'M' is not an issue). (3) The multi-hop reasoning is sound: the model correctly identifies both the financial value from a specific note (Note 15) and links it to the ownership percentage from the same note, demonstrating proper synthesis across parts of the filing. (4) The answer is contextually relevant, directly addressing both parts of the question—carrying value and ownership percentage—with precise information and appropriate citation of the source within the 10-K. Wording differs slightly but maintains full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 287,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The Forest Products freight revenue grew from $1,160 million in 2020 to $1,357 million in 2021 – an increase of **$197 million**【page_35】.  During the same period, average revenue per car rose from $5,269 to $5,424, a **$155 per‑car** increase【page_35】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $197 million increase in total revenue from Forest Products is accurate: $1,357 million (2021) - $1,160 million (2020) = $197 million. The average revenue per car increased from $5,269 to $5,424, which is a $155 increase, correctly reported. (2) The answer is complete, addressing both parts of the question: the dollar change in total revenue and the change in average revenue per car. (3) Entities are accurate—'Forest Products' is the correct product category, and the years 2020 and 2021 are correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: it pulls revenue figures and carload averages from the same category across two years and computes the correct differences. (5) The semantic meaning is equivalent to the ground truth, with added detail (exact base values) that enhance clarity without introducing error. Minor formatting like 'million' vs 'M' is acceptable and does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 296,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Restasis generated **$224 million** in total net revenue in 2024. At actual currency rates, that amount was **48.7 % lower** than the $436 million recorded in 2023【page_102】【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, all numbers are accurate: Restasis net revenue in 2024 is correctly stated as $224 million, and the percentage decline of 48.7% compared to 2023 is correct. The implied 2023 revenue of $436 million is consistent with the calculation: $224M / (1 - 0.487) ≈ $436M. (2) The answer is complete, addressing both parts of the question: the 2024 revenue and the year-over-year decline at actual currency rates. (3) Entity accuracy is correct—Restasis, 2024, 2023, net revenue, and actual currency rates are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis, as it references two different pages (page_102 and page_43), indicating information was pulled from multiple parts of the document to compute or confirm the decline. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., spacing, explicit mention of 2023 revenue). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1085,
        "completion_tokens": 298,
        "total_tokens": 1383
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "Capital One’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %** at December 31 2023, while the regulatory minimum CET1 requirement was **4.5 %**【page_81】. Thus, the company’s CET1 ratio exceeded the minimum by roughly **8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio as 12.9% and the Minimum Capital Adequacy requirement as 4.5%, both matching the ground truth. The calculated difference of 8.4 percentage points is accurate (12.9% - 4.5% = 8.4%). (2) All numeric values—12.9%, 4.5%, and the resulting 8.4 percentage point difference—are factually correct and properly formatted. Minor formatting variations (e.g., spacing, use of 'percentage points') do not affect accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly retrieves two distinct data points (company-specific ratio and regulatory minimum) and performs the correct arithmetic operation to determine the excess. (4) The answer is semantically equivalent to the original, conveying the same core information with slightly different phrasing ('exceeded the minimum by roughly 8.4 percentage points' vs 'difference... is 8.4%'). All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 303,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "Lockheed Martin recorded a pretax pension expense of **$64 million** for its non‑qualified defined‑benefit pension plans in 2023.  That amount was **lower than the $81 million recognized in 2022** and **higher than the $56 million recorded in 2021**【page_88】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 as $64 million, which matches the ground truth. It accurately compares this to $81 million in 2022 (decrease) and $56 million in 2021 (increase), with correct directional comparisons. (2) All numeric values—$64M (2023), $81M (2022), and $56M (2021)—are factually correct and match the original answer. The comparisons (lower than 2022, higher than 2021) are quantitatively sound. (3) The reasoning correctly synthesizes multi-hop information across three years and one entity (Lockheed Martin), accurately interpreting trends over time. The model correctly identifies the metric (pretax pension expense), the plan type (nonqualified defined benefit), and the years in question. (4) The answer is semantically equivalent to the ground truth, with only minor formatting differences (e.g., 'non‑qualified' vs 'nonqualified') that do not affect meaning. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 306,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "BlackRock’s investor‑customer relationships were carried at $492 million on 12/31/22 and $447 million on 12/31/23, a net decline of **$45 million**【page_93】.  During the year, accumulated amortization on this asset rose from $254 million to $338 million (an **$84 million increase**), which more than offset the $39 million increase in gross carrying amount ($785 m – $746 m) and therefore drove the $45 million drop in net carrying amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net carrying amount decreased from $492 million to $447 million, a $45 million decline; accumulated amortization increased from $254 million to $338 million ($84 million increase); gross carrying amount rose from $746 million to $785 million ($39 million increase). These values match the original answer exactly. (2) The calculations are correct: the $84 million increase in amortization more than offsets the $39 million increase in gross carrying amount, resulting in a net $45 million decrease in carrying value. (3) The reasoning is sound and captures the multi-hop logic: it correctly identifies that despite an increase in the gross asset value, the net carrying amount declined due to accelerated amortization. (4) All entities (BlackRock, investor/customer relationships, correct dates) are accurately referenced. The answer is semantically equivalent to the ground truth, with clear, concise, and precise explanation. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 314,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "UPS had $400 million of 2.200% senior notes outstanding at December 31, 2023. Although these notes mature in September 2024, UPS records them as **long‑term debt** on its consolidated balance sheet, reflecting its intent and ability to refinance the obligations.【page_103】【page_104】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total principal amount of the 2.200% senior notes as $400 million as of December 31, 2023, matching the ground truth. It also accurately notes the 2024 maturity (with additional specificity: September 2024) and correctly explains that UPS classifies the debt as long-term due to its intent and ability to refinance. (2) All numeric values—$400 million, 2.200%, December 31, 2023, and 2024 maturity—are factually correct and consistent with the ground truth. Format variations (e.g., $400 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about the debt amount, maturity, and accounting classification, linking the short-term maturity with the long-term classification based on refinancing intent—a key nuance from the source. (4) The answer is complete, factually accurate, and semantically equivalent to the original answer, with added contextual precision (maturity month) that enhances clarity without introducing error. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 316,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments fell by **$5,727 million** (about $5.7 billion) in the year ended July 27, 2024.  As a result, the combined total of cash and cash equivalents, available‑for‑sale debt investments and marketable equity securities dropped from $26,146 million to $17,854 million – a **decrease of $8,292 million** (about $8.3 billion)【page_47】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the decrease in available-for-sale debt investments is accurately stated as $5,727 million, which aligns with the original answer. The total decrease in the sum of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities is correctly calculated as $8,292 million. The LLM also provides contextual detail by specifying the starting and ending totals ($26,146 million to $17,854 million), which supports the $8,292 million difference and enhances clarity. (2) The calculation is sound: a $5,727 million decrease in debt investments, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, yields a net change of -$5,727 - $2,615 + $50 = -$8,292 million, which the model correctly reports. (3) The multi-hop reasoning is accurate—the model synthesizes changes across three asset categories and correctly computes the net impact on the total. (4) All entities (Cisco, fiscal year ending July 27, 2024, financial asset categories) are correctly identified and used. The answer is semantically equivalent to the ground truth, with added value in presenting the before-and-after totals. Wording differences (e.g., 'fell by' vs 'decreased by') do not affect factual accuracy. All scores are maximized due to complete correctness, precise numbers, sound logic, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 407,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, the 2021 Linde plc Long‑Term Incentive Plan had **7,661,431 shares** still available for equity grants, and **2,452,443 of those shares** could be issued as awards other than stock options or stock‑appreciation rights【page_85】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both numeric values from the ground truth: 7,661,431 shares available for equity grants and 2,452,443 shares available for awards other than options or stock appreciation rights. The date (December 31, 2023) and plan name (2021 Linde plc Long-Term Incentive Plan) are accurately stated. (2) All numbers match the original answer exactly, with no calculation or transcription errors. Format variations (e.g., spacing in numbers) are acceptable and do not affect accuracy. (3) The reasoning is sound and reflects proper synthesis of multi-hop information from the correct document and context—specifically, the remaining shares under the plan and the subset eligible for non-option awards. (4) The answer is semantically equivalent to the ground truth, with only minor formatting differences (e.g., en-dash in 'Long‑Term') and phrasing ('issued' vs 'granted'), which do not alter meaning. All evaluation criteria are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 291,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received a total of **$526 million** from settling the forward interest‑rate swap contracts tied to the 2023 Notes ($247 million), the March 2022 Notes ($143 million) and the September 2022 Notes ($136 million). These receipts are recorded as cash inflows in the financing section of the cash‑flow statement, offsetting part of the cash outflows required to issue the notes and thereby improving the company’s overall liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all numeric values: $247 million (2023 Notes), $143 million (March 2022 Notes), and $136 million (September 2022 Notes), which sum to $526 million—the same total as in the ground truth. All dollar amounts and associated notes are accurate, satisfying quantitative accuracy. (2) The calculation of the total ($247M + $143M + $136M = $526M) is correct, and the breakdown matches the original answer exactly. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three separate note issuances and their associated swap settlements. The financial impact on cash flow is well-reasoned, noting that these are cash inflows in the financing section, which aligns with typical classification for such hedging settlements. While the original answer states that cash flows are classified based on the nature of the hedged items, the LLM provides a more specific and plausible interpretation (financing section) that is consistent with accounting standards (ASC 230), making it a reasonable elaboration rather than an error. (4) The only minor shortcoming is that the LLM adds a detail—'recorded as cash inflows in the financing section'—that is not explicitly confirmed in the ground truth. While this is likely correct and contextually appropriate, it goes slightly beyond the provided information. However, this does not constitute a factual error but rather an inference. Thus, the answer remains highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 468,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "NextEra Energy holds roughly a **52.6 % non‑controlling ownership interest in XPLR** (recorded as an equity‑method investment)【page_97】.  The principal equity‑method investees – XPLR and the other entities – **primarily own electric‑generation assets (wind, solar and battery‑storage projects) and natural‑gas pipelines**【page_96】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states a single ownership interest of 52.6% in XPLR, which contradicts the ground truth range of 33.3% to 85.0%. This is a significant quantitative error, as the question asks for the 'approximate range' of ownership, not a point estimate. The 52.6% figure may reflect a specific subset or class of ownership but fails to capture the full variability disclosed in the filing. (2) The qualitative description of the principal equity method investees' assets is accurate and matches the ground truth: 'electric generation facilities or natural gas pipelines' is semantically equivalent to 'electric-generation assets (wind, solar and battery-storage projects) and natural-gas pipelines'. The inclusion of specific renewable types (wind, solar, battery) adds helpful detail without introducing error. (3) The multi-hop reasoning is sound in linking XPLR to equity method accounting and identifying the nature of underlying assets across investees. However, the failure to report the ownership range undermines the correctness of the quantitative synthesis. (4) The contextual relevance is perfect—the answer addresses both parts of the question and cites appropriate pages. The qualitative accuracy is high due to correct entity identification and asset classification. The correctness score is reduced primarily due to the incorrect representation of ownership interest, which is a core part of the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 397,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The fair‑value hierarchy table shows Corporate notes and obligations at a total fair value of **$2,978 million** (Level 2)【page_79】.  Their amortized‑cost amount is $3,014 million, so the fair value is lower, reflecting **unrealized losses of $45 million** (gross) and a net unrealized loss of about **$36 million after offsetting $9 million of unrealized gains**【page_77】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the total fair value of Corporate notes and obligations is $3,354 million, while the LLM reports $2,978 million. Similarly, the amortized cost is reported as $3,442 million in the ground truth, but the LLM states $3,014 million. The resulting unrealized loss is $92 million according to the ground truth, but the LLM calculates $45 million (gross) and $36 million (net), which are incorrect. These discrepancies indicate major errors in the core financial figures. (2) The numbers are not accurate: $3,354M vs $2,978M (difference of $376M), $3,442M vs $3,014M (difference of $428M), and $92M unrealized loss vs $45M/$36M. Calculations based on incorrect inputs are also wrong. Even allowing for format variations, the values are too divergent to be considered correct. (3) The reasoning appears internally consistent—calculating unrealized loss as the difference between amortized cost and fair value—but it is based on incorrect source data. The mention of 'Level 2' and offsetting gains suggests synthesis from the document, but it fails to correctly identify or extract the relevant multi-hop data for the specific category asked. (4) The answer is contextually relevant—addressing fair value, amortized cost, and unrealized losses for Corporate notes—and attempts to provide detailed financial analysis with citations. However, due to severe quantitative inaccuracies, the correctness and qualitative accuracy scores are low. The model likely referenced the wrong line item or table in the filing, leading to fundamentally incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 450,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "Union Pacific operated **7,026 locomotives in 2024**. This total reflects **6,106 owned locomotives** plus **920 leased locomotives**, which together comprise the full fleet for the year【page_19】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total number of locomotives operated by UNP in 2024 is correctly stated as 7,026. This total is properly broken down into 6,106 owned and 920 leased locomotives, which sum to the correct total (6,106 + 920 = 7,026). (2) Quantitative accuracy is perfect—each number matches the original answer exactly, and the format variations (e.g., bolded numbers, use of commas) do not affect correctness. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly combines owned and leased units to derive the total fleet size, addressing both parts of the question. (4) Entity accuracy is confirmed: UNP refers to Union Pacific, the year 2024 is correct, and the terms 'owned' and 'leased locomotives' are used appropriately. The answer is semantically equivalent to the ground truth, with only minor stylistic differences (e.g., bold formatting and citation placeholder 【page_19】), which do not detract from accuracy or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 301,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net carrying amount of Brands/Tradenames fell from $2,376 million at 12/31/2023 to $2,239 million at 12/31/2024 – a $137 million decline.  The decline was driven mainly by foreign‑currency translation, which cut the cost of the asset by $107 million (partially offset by a $5 million translation gain on accumulated amortization, for a net $112 million reduction), and by amortization expense, which increased accumulated amortization by $36 million, further lowering the net balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The starting value of Brands/Tradenames is reported as $2,376 million in 2023, but the ground truth states $2,609 million. This results in an incorrect net change of $137 million instead of the correct $370 million reduction. The ending value ($2,239 million) matches the ground truth. The foreign currency translation impact ($107 million reduction) and amortization expense ($36 million) are correctly reported. However, the LLM introduces a $5 million translation gain on accumulated amortization, which is not present in the original answer and distorts the net effect. The original mentions a $4 million 'Other' adjustment, which the LLM omits entirely. (2) Calculations are flawed: the claimed $137 million decline does not align with the correct $370 million drop. While $107M + $36M = $143M is correctly computed in both, the LLM misattributes the total change due to the wrong baseline. (3) Multi-hop reasoning is partially sound—the model identifies the correct contributing factors (foreign currency translation and amortization)—but fails to correctly synthesize the full change due to incorrect initial values and missing 'Other' adjustments. It also incorrectly splits the foreign currency effect into principal and amortization components, which is not supported in the ground truth. (4) Scores reflect major quantitative errors that undermine the answer's correctness, though the mention of correct drivers (foreign exchange and amortization) and proper context (net carrying amount, correct end value) preserves some qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 453,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "At December 31 2021, Coca‑Cola’s corporate bonds and debt securities were valued at **$1,023 million**, compared with **$1,042 million** at the end of 2020 – a **decrease of $19 million** year‑over‑year.【page_117】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1,023 million (2021) and $1,042 million (2020) are accurately reported, and the year-over-year decrease of $19 million is correctly calculated ($1,042M - $1,023M = $19M). (2) The answer is complete, addressing both parts of the question: the total fair value at the end of 2021 and the dollar value change compared to the previous year. (3) Entity accuracy is correct—Coca-Cola (KO), the financial instruments (Corporate Bonds and Debt Securities), and the time periods (2021 and 2020) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it retrieves fair values from two consecutive years, computes the difference, and correctly interprets the trend (a decrease). (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of em dashes, bolding, and 'December 31' instead of 'end of year'), which do not affect factual accuracy. The citation [page_117] adds contextual support. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 317,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The 2023 Long‑Term Incentive (LTI) Program caps the grant‑date fair value of its performance‑based LTIP units at **$42.5 million**.  Although the units are potentially dilutive securities, the company notes that they have not been earned/vested and that adjusting net income or the share count for them “would have no dilutive impact,” so they are not reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the maximum potential fair value of $42.5 million is accurately reported, with no calculation or formatting issues. (2) The answer completely addresses both parts of the question: it correctly states the maximum potential fair value at grant date and explains why these units are not reflected as a material dilutive effect—specifically because the performance conditions have not been met and thus the units are not yet earned or vested. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the nature of performance-based LTIP units, their contingent vesting, and the accounting treatment for dilutive securities. (4) The entities (2023 LTI Program, LTIP units, net income attributable to common stockholders, year ended December 31, 2023) are all correctly identified and contextually appropriate. The wording differs slightly from the original but maintains full semantic equivalence without introducing inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 298,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "In 2023 CRM’s covered‑bond portfolio carried an amortized cost of **$105 million** and a fair value of **$101 million**, a **$4 million** shortfall. The unrealized loss recorded on these bonds was **$4 million** (shown as a $(4) million unrealized loss).【page_77】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the amortized cost ($105 million), fair value ($101 million), and the resulting unrealized loss ($4 million), which match the ground truth exactly. (2) Quantitative accuracy is perfect—numbers are correct, and the $4 million difference is accurately calculated as 105 - 101 = 4. The format variations (e.g., $4 million vs (4) million) are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers that the shortfall between amortized cost and fair value represents an unrealized loss, which is the required multi-hop synthesis. (4) All entities—CRM, Covered Bonds, 2023—are correctly identified and contextualized. The answer is complete, factually accurate, and directly addresses both parts of the question. Hence, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 250,
        "total_tokens": 1356
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Union Pacific’s Multiple‑purpose fleet has 920 leased units out of 6,893 total locomotives – roughly **13 %** are leased (920 ÷ 6,893 ≈ 0.133). By contrast, the Switching (122) and Other (11) categories together have **no leased units** (0 ÷ 133 = 0 %), i.e., **0 %** are leased.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) Quantitatively, the percentage of leased Multiple Purpose locomotives is correctly calculated as approximately 13% (920 ÷ 6,893 ≈ 0.1335 or 13.35%), with the LLM reporting 'roughly 13%'—a reasonable rounding. The ground truth specifies 13.35%, so while the LLM rounds down, it does not misrepresent the figure. The Switching and Other categories correctly report 0 leased units out of 133 total (122 + 11), resulting in 0%, which matches the ground truth. (2) Completeness: The answer addresses both parts of the question—percentage of leased Multiple Purpose locomotives and comparison with the combined Switching and Other categories. (3) Entity accuracy is correct: Union Pacific, locomotive categories, and lease status are properly identified. (4) Reasoning is sound: the LLM correctly synthesizes data across categories and performs accurate division for percentages. The only minor shortcoming is the rounding of 13.35% to 'roughly 13%', which slightly reduces quantitative precision but does not affect overall correctness. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 326,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The Lower 48’s NGL reserves grew from **230 million barrels at the end of 2020** to **797 million barrels at the end of 2023**, a **increase of 567 million barrels**【page_141】.  For 2023, the Lower 48 segment recorded **$5,729 million** in depreciation, depletion, amortization and impairments【page_133】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the NGL volume at the end of 2020 (230 million barrels) and 2023 (797 million barrels) are accurate, and the increase of 567 million barrels is correctly calculated (797 - 230 = 567). The depreciation, depletion, amortization, and impairments amount for 2023 is correctly reported as $5,729 million. (2) The answer is complete, addressing both parts of the multi-part question: the volume change over time and the 2023 financial figure. (3) Entities are accurate—'Lower 48', 'NGLs', '2020', '2023', and the financial metric are all correctly identified and contextualized. (4) The reasoning is sound, demonstrating proper multi-hop synthesis by pulling data from different time points and financial statements, and correctly computing the difference. The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., bolding, use of em-dash) that do not affect accuracy. All information is appropriately cited with page references.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 303,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent $0.4 billion to buy out the non‑controlling interest in Massmart and another $0.4 billion to acquire Alert Innovation in fiscal 2023 – a total cash outlay of roughly $0.8 billion 【page_65】.  In fiscal 2025 the Alert Innovation entity was sold and consequently deconsolidated from Walmart’s consolidated financial statements 【page_65】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: Walmart spent $0.4 billion on Massmart and $0.4 billion on Alert Innovation in fiscal 2023, totaling $0.8 billion in cash outlays. The answer correctly identifies the two components of the acquisition spending. (2) Quantitative accuracy is perfect: both individual amounts and the total sum are correct, with acceptable formatting ($0.8 billion = $0.8 billion). (3) The multi-hop reasoning is sound—LLM correctly synthesizes that two separate $0.4 billion payments were made for different entities in the same fiscal year and combines them appropriately. It also correctly traces the subsequent financial treatment of Alert Innovation, noting its sale and deconsolidation in fiscal 2025, which directly answers the second part of the question. (4) Entity names (Massmart, Alert Innovation), fiscal years (2023, 2025), and financial terms (deconsolidated) are all used accurately. (5) The answer is semantically equivalent to the original, with slightly more detail (mentioning 'buy out the non-controlling interest') that aligns with the nature of the Massmart transaction. All aspects of the question are addressed completely and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 348,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "UNP shipped **697 thousand carloads** of metals & minerals in 2021, and the **average revenue per car** for that segment was **$2,598**. Multiplying the two (697,000 × $2,598) yields about **$1.81 billion** in total freight revenue from metals & minerals that year【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key components needed to calculate total revenue: 697 thousand carloads and an average revenue per car of $2,598 for UNP's Metals & Minerals segment in 2021. The multiplication (697,000 × $2,598) yields $1,810,806,000, which matches the ground truth exactly. The LLM reports this as 'about $1.81 billion', which is a reasonable rounding and semantically equivalent. (2) Numeric values are accurate: 697 thousand carloads and $2,598 per car are correct. The calculation is mathematically sound and results in the exact ground truth figure when computed precisely. The only minor limitation is the use of 'about $1.81 billion' instead of the exact figure, but this does not detract from factual correctness given common reporting conventions. (3) Multi-hop reasoning is sound—model combines shipment volume (carloads) with unit revenue (per car) to derive total segment revenue, which is the core of the question. Entities (UNP, 2021, Metals & Minerals) are correctly identified and synthesized. (4) Scores reflect near-perfect accuracy: full points for qualitative and contextual accuracy; quantitative score is 9 due to the rounded final figure, though the inputs and logic are fully correct. Overall, the answer is factually and logically complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1078,
        "completion_tokens": 363,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The 2023 securitization issued $1.3 billion of Series 2023‑1A securities【page_112】. In March 2023 the company repaid the entire $1.3 billion principal amount of the Series 2013‑2A securities【page_112】, so the two amounts are essentially identical.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.3 billion principal amount for both the Series 2023-1A issuance and the repaid Series 2013-2A securities is accurately reported, with correct dates (March 2023). Format variations (e.g., $1.3 billion vs $1.3 billion) are acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-part question: the amount issued in 2023 and the amount repaid in March 2023. (3) Entities are correctly identified: Series 2023-1A and Series 2013-2A securities, with accurate years and context of securitization and repayment. (4) The reasoning is sound and correctly infers that the amounts being identical implies a refinancing, which aligns with the ground truth's interpretation. The citation of 'page_112' for both facts indicates proper synthesis from the source. All elements—factual accuracy, completeness, entity identification, and logical comparison—are correct, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 295,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the company drew $3.0 billion and repaid $6.1 billion of revolving indebtedness under its 2021 Multicurrency Credit Facility【page_52】【page_109】. The facility gives the company a total borrowing capacity of $6.0 billion (including a $3.5 billion multicurrency sub‑limit, $200 million letters‑of‑credit sub‑limit and $50 million swing‑line sub‑limit)【page_52】—so the amount borrowed was about half of the available capacity, while the repayments slightly exceeded the full $6.0 billion commitment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.0 billion borrowed and $6.1 billion repaid during 2023 under the 2021 Multicurrency Credit Facility, matching the ground truth. The total borrowing capacity of $6.0 billion is also accurately stated. (2) Quantitative accuracy is high: all dollar amounts and the time period (2023) are correct. However, the statement that 'repayments slightly exceeded the full $6.0 billion commitment' is misleading—while $6.1B > $6.0B, repayments are not constrained by the borrowing capacity (one can repay more than the current capacity if prior borrowings were outstanding). This is a minor logical misinterpretation, not a numerical error. (3) The multi-hop reasoning is sound: the model synthesizes borrowing, repayment, and capacity from the same facility and time period. It adds contextual detail (sub-limits) not in the question but relevant and correct. (4) The answer is highly relevant and factually accurate overall, but the incorrect implication that repayments exceeding capacity is a meaningful comparison slightly undermines the reasoning, warranting a score just below perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 321,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "Union Pacific’s Intermodal freight revenue rose from $3.989 billion in 2020 to $4.504 billion in 2021 – an increase of about $515 million (≈13%). During the same period, average revenue per Intermodal car climbed from $1,267 to $1,403, a rise of $136 per car. Thus the total revenue gain was $515 million, while the per‑car revenue gain was $136. (Source: UNP 10‑K 2022, page 35).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total Intermodal revenue increase of $515 million is accurately calculated from the reported figures of $3.989 billion in 2020 and $4.504 billion in 2021 (difference = $4.504B - $3.989B = $515M). The average revenue per car increase from $1,267 to $1,403 results in a $136 rise, which is correctly stated. (2) The answer is complete, addressing both parts of the question: the total revenue increase and the per-car revenue increase. (3) Entities are accurate—UNP (Union Pacific), Intermodal revenue, correct years (2020 to 2021), and correct metric (average revenue per car). (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines revenue data and per-unit metric changes from the same source (UNP 10-K 2022, p.35) and correctly interprets the comparison requested. (5) The semantic meaning is equivalent to the ground truth, with added context (percentages, exact base/destination values) that enhance clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 313,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "In 2021 ConocoPhillips spent **$534 million** on capital projects in the Europe, Middle East and North Africa (EMENA) region【page_58】.  For the same year the EMENA segment posted a **$24 million net gain** (a credit to impairment) from operations【page_104】—a modest gain compared with the much larger capital outlay.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the capital expenditure in the EMENA region in 2021 as $534 million, matching the ground truth exactly. This is supported by the citation to page_58. However, there is a critical error in the operational result: the LLM states a '$24 million net gain', while the ground truth reports a '$24 million net loss'. This is a direct contradiction in both direction (gain vs. loss) and financial implication. Despite referencing a 'credit to impairment' as a justification for a gain, this does not override the fact that the overall net result from operations was a loss according to the ground truth. (2) Quantitatively, the numbers themselves ($534M and $24M) are accurate in magnitude and year, so quantitative accuracy is perfect. (3) The multi-hop reasoning fails in synthesis: the model retrieves correct values for capital expenditure and an operational adjustment but incorrectly infers the net outcome as a gain when it should be a loss. This undermines the qualitative accuracy of the reasoning and conclusion. (4) Contextually, the answer is highly relevant, addressing both parts of the question and providing appropriate context about the comparison between investment and operational performance. However, due to the incorrect characterization of net operational result (loss reported as gain), the correctness score is reduced to 7—core facts are mostly right but a significant factual error in a key metric prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 410,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft frames Copilot Pro as a consumer‑focused AI subscription that delivers faster, more powerful assistance across Microsoft 365 apps and the web, embodying its “reinvent productivity and business processes” ambition to embed AI‑driven productivity tools for individuals 【page_4】. In its financial reporting, Copilot Pro revenue is bundled in the “Office Consumer products and cloud services” revenue category, which also includes Microsoft 365 Consumer subscriptions 【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Copilot Pro is correctly described as a consumer-focused AI subscription offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, which supports Microsoft's strategic ambition to 'reinvent productivity and business processes.' The financial classification under 'Office Consumer products and cloud services' is accurate. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable beyond correct categorization—scored 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes strategic positioning (from strategy section/page 4) with financial reporting classification (from financials/page 42), demonstrating proper cross-document understanding. (4) The only minor omission is that the original answer includes additional components of the revenue category (e.g., Office licensed on-premises and other Office services), which the LLM answer does not mention—this slightly reduces completeness but does not affect core correctness. Wording differences are semantically equivalent and acceptable. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 364,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The 2024 special‑dividend adjustment added **128,000 RSU shares** to the number of shares available to be granted under the 2019 Incentive Plan.  The increase was calculated by applying the 1.018 adjustment factor – the ratio of the Nasdaq closing price of **$674.62** on December 26, 2023 to the Nasdaq opening price of **$662.70** on December 27, 2023 – to the plan’s maximum issuable shares, proportionally expanding the grant‑available pool.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase of 128,000 RSU shares, the Nasdaq closing price of $674.62 on December 26, 2023, and the opening price of $662.70 on December 27, 2023, are correctly cited. The adjustment factor of 1.018 is accurately derived from the ratio of these two prices (674.62 / 662.70 ≈ 1.018), and this is properly described as the basis for the proportional adjustment. (2) The answer addresses both parts of the multi-part question: it states the total increase in shares (128,000) and explains how the increase was determined using the price ratio around the ex-dividend date. (3) Entity accuracy is correct: the 2019 Incentive Plan, 2024 special dividend, and relevant dates and prices are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the special dividend event to the contractual requirement for plan adjustments, uses market price data to compute the adjustment factor, and applies it proportionally to the share pool—exactly as described in the ground truth. The wording differs slightly but maintains full semantic equivalence. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 348,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "In 2024 the Transportation and Electronics segment reported GAAP sales of **$8.38 billion**, a **1.4 % decline** versus the prior year. When the PFAS‑manufactured‑product headwinds are removed (the non‑GAAP adjustment), sales are shown as **$7.44 billion**, a **3.1 % increase** – a swing of roughly **4.5 percentage points** (about **$945 million**) that the PFAS issues turned a modest growth trend into a decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies despite capturing the general directional impact and percentage-point swing correctly. The reported GAAP sales of $8.38 billion and adjusted sales of $7.44 billion are factually incorrect and contradict the ground truth, which does not provide absolute sales figures but focuses on growth rates. The claimed $945 million difference between these figures is therefore also incorrect. While the model correctly identifies the 4.5 percentage point difference (calculated as 3.1% - (-1.4%) = 4.5 pp), it misrepresents this as a dollar amount and misapplies it to fabricated revenue numbers. The qualitative reasoning correctly interprets the effect of PFAS headwinds turning growth into decline and correctly performs the percentage point subtraction, showing sound multi-hop logic in that aspect. However, the invention of specific dollar amounts undermines factual reliability. The entities (3M, Transportation and Electronics segment, PFAS headwinds, 2024, GAAP vs non-GAAP) are correctly identified, and the answer addresses the core question about quantitative impact. The contextual relevance is high as it directly responds to the question's focus on sales performance and adjustment effects, but the numerical foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 360,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "In 2021 the company recorded a **$2 million pre‑tax gain** on its equity‑method investment contracts【page_115】.  As of December 31 2021 the fair‑value of those contracts was a **net liability of $3 million** (‑$3 million)【page_111】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the recognized gain of $2 million in 2021 and the fair value of $(3) million (expressed as a net liability of -$3 million) are accurately reported. The negative fair value is correctly interpreted as a liability, which aligns with accounting conventions. (2) The numbers match exactly with the original answer, allowing for format variation (e.g., '$(3) million' vs '-$3 million'). (3) The reasoning is sound: the answer correctly synthesizes two distinct pieces of information from different parts of the filing—gain recognition (income statement impact) and fair value measurement (balance sheet level)—as of the correct date (December 31, 2021). (4) All entities (equity method investment contracts, 2021 time period) are accurate, and the answer fully addresses both parts of the multi-part question. Citations to specific pages add contextual support. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 290,
        "total_tokens": 1392
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott’s $2.2 billion of interest‑rate hedge contracts are designated as fair‑value hedges of the fixed‑rate portion of its debt, so the contracts offset changes in that debt’s fair value and effectively convert the hedged amount to a variable‑rate obligation【page_40】.  The hedged portion of the long‑term debt carries a fair‑value impact of about $2.1 billion, which is included in the total fair value of long‑term debt of $13.7 billion reported at December 31 2024【page_65】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: $2.2 billion notional value of interest rate hedges and $13.7 billion total fair value of long-term debt as of December 31, 2024, are accurately reported. The mention of the $2.1 billion hedged portion is consistent with the context and does not contradict the ground truth—it adds granularity not in the original but supported by typical hedge accounting practices. (2) Quantitative accuracy is perfect: numbers match exactly, with proper units and dates. Format variations (e.g., $2.2 billion vs $2.2B) are acceptable and clear. (3) Reasoning is sound: the LLM correctly identifies that Abbott uses fair-value hedges to convert fixed-rate debt to variable-rate, thereby reducing fair value volatility. It correctly links the hedge mechanism to its impact on debt valuation. The only minor gap is that it doesn’t explicitly state that the hedges reduce overall fair value volatility of the total debt portfolio, which is a key point in the original answer. However, this is implied by stating that the hedges offset changes in fair value. (4) Entity accuracy is strong: Abbott Laboratories, interest rate hedges, long-term debt, and correct time reference (December 31, 2024) are all properly identified. The answer is contextually relevant, directly addressing the question’s focus on the impact of hedges on debt fair value. The inclusion of specific page references (e.g., page 40, 65) suggests grounding in source material, enhancing credibility. Overall, the answer is factually correct and semantically equivalent to the ground truth, with only a slight omission in elaborating the risk-mitigation effect on financial position, which prevents a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 479,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "ExxonMobil reports 1,276 million barrels of oil‑equivalent proved reserves for its equity‑company interests in Asia. By contrast, its consolidated‑subsidiary interests in the same region hold 2,286 million barrels, meaning the equity‑company reserves are about 1,010 million barrels (roughly 44 percent) lower than the consolidated‑subsidiary total【page_10†L31-L38】【page_10†L45-L52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct core information from the ground truth. (1) All key numbers are correct: 1,276 million barrels for equity companies and 2,286 million barrels for consolidated subsidiaries in Asia are accurately reported. (2) The quantitative analysis is precise: the difference of 1,010 million barrels (2,286 - 1,276) is correct, and the percentage difference (~44%) is a valid calculation (1,010 / 2,286 ≈ 44.2%). While the original answer uses a ratio (1.8x more), the LLM provides a complementary perspective (44% lower), which is semantically equivalent in terms of comparative insight. (3) The multi-hop reasoning is sound—information is correctly synthesized from ExxonMobil’s 2024 10-K, distinguishing between equity companies and consolidated subsidiaries in Asia. (4) Entity and contextual accuracy are excellent: correct region (Asia), correct company (ExxonMobil), correct filing (2024 10-K), and correct metric (oil-equivalent proved reserves). The only minor deviation is that the LLM does not explicitly state the 1.8x multiplier mentioned in the original answer, but it provides equivalent comparative information using absolute and percentage differences. This does not reduce factual accuracy but slightly affects qualitative completeness. Hence, a score of 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 395,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform drove Mondelēz’s 2019 effective tax rate down to just 0.1% (about 22.4% when the reform impact is stripped out).  The reform generated a net financial benefit of $767 million in 2019 – essentially a $769 million reduction in deferred‑tax expense offset by a $2 million indirect‑tax charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 and reports a net financial benefit of $767 million, matching the ground truth exactly. The rate reduction is stated as bringing the rate down to 0.1%, with a normalized rate of ~22.4% excluding the reform impact. This implies a reduction of approximately 22.3 percentage points (22.4% - 0.1% = 22.3%), which aligns precisely with the ground truth. The $767 million benefit is explicitly confirmed. (2) All numeric values are accurate: $767 million net benefit, $769 million reduction in deferred-tax expense, and $2 million indirect-tax charge (769 - 2 = 767) are consistent and correctly calculated. The effective tax rate figures are presented differently but are semantically equivalent and support the same conclusion. (3) The multi-hop reasoning is sound—the model synthesizes the impact on the effective tax rate and the components of the net financial benefit, demonstrating understanding across multiple financial effects. The only minor deviation is that the original answer does not mention the deferred-tax and indirect-tax breakdown, so while this additional detail is accurate, it goes beyond the ground truth without contradicting it. (4) The answer is fully contextually relevant, directly addressing both parts of the question with precise, factually correct information. The wording differs but the semantic meaning and numerical accuracy are preserved. A score of 9 is given for correctness and qualitative accuracy due to the slightly different framing of the tax rate (implied vs. explicit reduction), but no factual errors exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 461,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "PepsiCo’s 2022 results reflected a $145 million impact from transferring its pension and retiree‑medical obligations to TBG 【page_94】, plus a $520 million gain from re‑measuring its 39 % ownership stake in TBG at fair value 【page_111】. Combined, these items contributed roughly $665 million of positive financial impact in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the $145 million impact from transferring pension and retiree-medical obligations to TBG and the $520 million gain from remeasuring PepsiCo's 39% ownership stake are correctly reported. The sum ($145M + $520M = $665M) is accurate and matches the total financial impact stated in the original answer. (2) Quantitative accuracy is perfect: both individual figures and the final total are correct, with acceptable formatting (e.g., $665 million = $665M). (3) The multi-hop reasoning is sound—information from two different events (pension transfer and equity remeasurement) is correctly synthesized across entities (PepsiCo and TBG) and linked to the correct year (2022). (4) The answer is contextually relevant, directly addressing the total financial impact as requested, and provides appropriate source references. Minor wording differences (e.g., 'positive financial impact') do not affect semantic equivalence and are reasonably inferred.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 297,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "Merck paid **$200 million** in sales‑based milestone payments to Eisai for Lenvima in 2021. As of December 31 2021, **$600 million** of sales‑based milestone payments had accrued but were still unpaid, meaning the unpaid balance was three times the amount paid that year【page_103】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key figures: $200 million in sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and $600 million accrued but unpaid as of December 31, 2021, matching the ground truth exactly. (2) All numeric values are accurate and properly formatted; the comparison stating that the unpaid balance was 'three times the amount paid that year' is mathematically correct (600 / 200 = 3), with no calculation errors. (3) The multi-hop reasoning is sound—synthesizing payment data for a specific drug (Lenvima), between two companies (Merck and Eisai), across a specific year (2021), and comparing paid versus accrued obligations as of year-end. The model correctly interprets the relationship between cash payments and accruals. (4) The answer is semantically equivalent to the original, with only minor stylistic differences (e.g., use of em dashes, bolding, citation tag 【page_103】), which do not affect factual accuracy. All parts of the question are fully addressed with precise, correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 306,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received roughly **$3.5 billion in cash** from the sale of its Tropicana, Naked and other juice brands to PAI Partners, and it kept a **39 % non‑controlling ownership interest in TBG** as part of the deal【page_111】【page_6】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the cash amount of $3.5 billion and the retained 39% non-controlling ownership interest in TBG are accurately reported, with acceptable formatting variations (e.g., '39 %' vs '39%'). (2) The answer addresses both parts of the multi-hop question: the cash received from the sale and the percentage ownership retained. (3) Entity accuracy is correct—PepsiCo, PAI Partners, and TBG are properly identified, and the inclusion of Tropicana and other juice brands is consistent with the transaction scope. (4) The reasoning is sound, as the model correctly synthesizes information about the sale and retained stake, indicating proper multi-hop understanding. The cited sources (page_111, page_6) further support the answer's grounding in the document. Semantically, the answer conveys the same information as the original with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 269,
        "total_tokens": 1386
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company now measures the liability‑hedging portion of its pension assets at fair value, so any change in the market value of those securities is reflected immediately in the market‑related value of plan assets and thus in the expected‑return component of net periodic pension cost. Under the earlier calculated‑value method, changes in those assets were amortized over five years, smoothing and deferring the impact on net periodic pension cost.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately describes Southern Company's shift from the calculated value approach (with 5-year amortization) to the fair value approach (with immediate recognition) for liability-hedging securities. (2) The key quantitative detail—amortization over five years—is correctly stated and matches the original answer. No calculations are required, but the temporal element (five-year smoothing) is preserved exactly. (3) The multi-hop reasoning is sound: the answer correctly links the accounting method change to its impact on the market-related value of assets and the expected-return component of net periodic pension cost, demonstrating proper synthesis of cause and effect. (4) All entities—Southern Company, liability-hedging securities, net periodic pension cost—are correctly identified and contextualized. The answer is fully relevant, complete, and conveys the same meaning as the original with slightly different but equally precise wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 296,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "Netflix’s total content spending rose from $9.216 billion in 2019 to $12.230 billion in 2021 – an increase of about $3.0 billion (page 53). Over the same period, spending on produced content grew by roughly $2.2 billion (from $1.974 billion to $4.175 billion), while licensed‑content spending rose by about $0.8 billion (from $7.243 billion to $8.056 billion), meaning the increase in produced content was roughly three times larger than the increase in licensed content (page 53).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total increase in Netflix's content spending from 2019 to 2021 as approximately $3.0 billion, which aligns with the ground truth increase of $3,014,120,000 (difference of $14.12 million is minor and likely due to rounding). The produced content spending increase is reported as $2.2 billion, matching the ground truth growth of $2,201,108,000. Licensed content spending increase is given as $0.8 billion, very close to the actual $813,012,000 (difference of $13.012 million, again likely due to rounding). All key financial figures are accurate within reasonable approximation. (2) Calculations are sound: the LLM correctly computes the differences from the cited 2019 and 2021 values for each category (e.g., $4.175B - $1.974B = $2.201B for produced content), and the comparison that produced content growth was roughly three times that of licensed content is logically supported. (3) Multi-hop reasoning is correct — the model synthesizes data across spending categories and years, accurately comparing growth rates and identifying trends. (4) The answer fully addresses both parts of the question: total spending increase and comparative growth between produced and licensed content. Wording differs slightly from the original answer but maintains semantic equivalence. The only minor shortfall is the use of rounded figures without specifying precision, but this does not affect factual correctness. Hence, high scores across all dimensions with a 9/10 on correctness due to negligible rounding discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 431,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "PepsiCo booked a **$321 million pre‑tax impairment charge in 2023** on its 39 % non‑controlling interest in TBG (recorded in selling, general and administrative expenses)【page_105】. In 2022, the remeasurement of the same investment produced a **$520 million gain**【page_111】. Thus, the 2023 impairment charge is roughly $199 million less than the gain recognized in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $321 million pre-tax impairment charge in 2023 and the $520 million gain in 2022, both of which match the ground truth exactly. These figures are properly attributed to PepsiCo's 39% noncontrolling interest in TBG. (2) Quantitatively, all numbers are accurate. The LLM states that the 2023 charge is 'roughly $199 million less' than the 2022 gain, which is correct ($520M - $321M = $199M). However, the original answer emphasizes a 'net pre-tax difference of -$199 million', which more precisely reflects the cumulative impact. The LLM's phrasing is semantically close but slightly less precise in financial interpretation—'less than' is descriptive, while the negative net difference is more technically accurate. (3) The multi-hop reasoning is sound: the model synthesizes data from two different years and correctly compares them. It references the correct investment (39% noncontrolling interest in TBG) and ties both events to the same asset. (4) Scores reflect near-perfect factual accuracy with only a minor nuance in the characterization of the net financial impact. No entity, year, or metric errors. The answer is fully contextually relevant and well-supported with citation markers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 349,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "Netflix’s larger outlay for original programming in 2021 added about $1.423 billion of content‑amortization expense, while total cost of revenues rose to $17.33 billion. Because revenue grew faster, cost of revenues fell to 58 % of revenue in 2021, down from 61 % in 2020.【page_25】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $1.423 billion increase in content amortization (equivalent to $1,423 million in the ground truth), the decrease in cost of revenues as a percentage of revenue from 61% to 58%, and the relevant year (2021 vs 2020). The mention of revenue growing faster aligns with the ground truth's explanation that amortization growth was slower relative to revenue growth. However, the LLM introduces a specific total cost of revenues figure ($17.33 billion) not present in the original answer, which, while potentially accurate, is extraneous and not required by the question. 2) All numeric values provided—$1.423 billion (i.e., $1,423 million), 58%, and 61%—are quantitatively accurate and correctly formatted. There are no calculation errors. 3) The reasoning correctly captures the multi-hop logic: increased investment led to higher amortization, yet cost of revenues as a percentage of revenue decreased due to revenue outpacing cost growth. The LLM infers the relative impact of revenue growth without explicitly citing pandemic-related delays in content release, which is a minor omission in causal explanation but does not invalidate the core logic. 4) The answer is contextually relevant, directly addressing how increased investment affected amortization and cost of revenues as a percentage of revenue. The added detail about total cost of revenues is not harmful but not necessary. Overall, the answer is factually correct and semantically equivalent to the ground truth, with only a slight reduction in qualitative accuracy due to the missing nuance about pandemic-related delays affecting amortization timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 450,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was **$494 million** (U.S. $138 million + International $356 million)【page_102】.  Its international revenue grew **8.3 %** year‑over‑year at actual currency rates compared with 2023【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the combined total net revenue from Ozurdex in 2024 as $494 million, which matches the ground truth. It breaks this down into U.S. $138 million and International $356 million, and the sum ($138M + $356M = $494M) is accurate. The international revenue growth is correctly reported as 8.3%, matching the ground truth. (2) All numeric values are correct and properly formatted; minor formatting differences (e.g., spaces as thousands separators) do not affect accuracy. The calculation of total revenue from components is valid. (3) The multi-hop reasoning is sound: the model correctly synthesized U.S. and international revenue figures to compute the total and accurately extracted the year-over-year percentage change in international revenue at actual currency rates. (4) The answer is fully complete, addressing both parts of the question with precise data and correct context. All entities (Ozurdex, 2024, international revenue, actual currency rates) are correctly identified and used. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 308,
        "total_tokens": 1421
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target recorded a **$335 million pretax gain** on the February 2021 cash sale of Dermstore LLC.  According to the notes, this gain was **included in Net Other Income (Net Other (Income) / Expense)** in the consolidated financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the pretax gain of $335 million is accurately reported, and the date of the sale (February 2021) is consistent with the source data. The format '$335 million' is semantically equivalent to the ground truth. (2) The answer addresses both parts of the question: the amount of the pretax gain and its treatment in the financial statements. (3) Entity accuracy is correct—Target Corporation, Dermstore LLC, and the financial line item 'Net Other Income' (also referred to as 'Net Other (Income) / Expense') are all correctly identified. (4) The reasoning is sound and reflects proper synthesis from the financial notes, correctly linking the gain to its presentation in the consolidated financial statements. All information is relevant and precisely responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 251,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "Salesforce reported mortgage‑backed obligations with an amortized cost of **$244 million** and a fair value of **$236 million**, creating an **$8 million** difference【page_75】. That $8 million represents about **0.14 %** of the total marketable‑securities fair‑value balance of **$5,722 million**【page_75】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: amortized cost ($244 million), fair value ($236 million), difference ($8 million), total marketable securities at fair value ($5,722 million), and percentage (0.14%). (2) Calculations are correct: $244M - $236M = $8M; ($8M / $5,722M) ≈ 0.14%. (3) The multi-hop reasoning is sound—synthesizing data from mortgage-backed obligations and total marketable securities, both from Salesforce's 2024 10-K, to compute the required percentage. (4) Entities are correctly identified: Salesforce (CRM), mortgage-backed obligations, and the correct fiscal year (2024). The answer is semantically equivalent to the original, with only formatting differences (e.g., en dashes, bolding) that do not affect meaning. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 255,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its core consolidated financial statements – the statements of comprehensive income, balance sheet, statement of operations (income statement), statements of equity, and statements of cash flows – and the adjustments are shown for the comparative years 2022 and 2021 (the two most recent fiscal periods presented in the filing)【page_164】【page_162】【page_163】【page_165】【page_166】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies compared to the ground truth. (1) The original answer states that only the consolidated statements of comprehensive income and the consolidated balance sheet were retrospectively adjusted due to LDTI adoption. However, the LLM claims that *all* core financial statements — including the statement of operations, statements of equity, and statements of cash flows — were adjusted, which contradicts the ground truth. (2) Regarding time periods, the original specifies that balance sheet adjustments were applied as of December 31, 2022, and income statement adjustments reflect effects as of December 31 (implied 2022, consistent with filing context). The LLM incorrectly states that adjustments cover comparative years 2022 and 2021 across all statements, which overgeneralizes the scope. While the 2023 10-K may present comparative financials for 2022 and 2021, the retrospective application of LDTI adjustments is specifically tied to the transition date (December 31, 2022), not a multi-year restatement of all statements. (3) The multi-hop reasoning fails because the LLM conflates the presentation of comparative financial data with the actual retrospective adjustment of financial statements under the new guidance. This reflects a misunderstanding of accounting terminology and the specific impact of LDTI adoption. (4) The contextual relevance is moderate because the answer addresses the right topic and cites relevant pages, but the overstatement of adjusted statements and mischaracterization of time periods significantly undermines factual correctness. Quantitative accuracy is scored mid-range because no explicit dollar amounts are wrong (none are mentioned), but the time periods and entities (financial statements) are inaccurately reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 496,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Disney’s two cruise‑ship credit facilities each provide up to $1.1 billion, giving a total potential financing commitment of $2.2 billion. The Disney Treasure loan, which has been drawn, bears a fixed 3.80% rate payable semi‑annually over 12 years, whereas the undrawn Disney Destiny facility would carry a slightly lower fixed rate of 3.74% with the same semi‑annual, 12‑year payment structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurately derived from two $1.1 billion facilities, and the interest rates—3.80% for Disney Treasure and 3.74% for Disney Destiny—are exactly as stated in the original answer. Minor formatting differences (e.g., $2.2 billion vs $2.2B) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both parts of the question: total commitment and the interest rate structure difference. (3) Entities—Disney Treasure and Disney Destiny—are correctly identified, and their respective borrowing terms (drawn vs undrawn) are accurately described. (4) The reasoning is sound: the model correctly synthesizes that the total commitment is the sum of two equal facilities and distinguishes between the already-drawn Disney Treasure loan and the undrawn Disney Destiny facility. The additional details about payment frequency (semi-annual) and term (12 years) are consistent with typical credit facility structures and do not contradict the ground truth; they add context without introducing error. Overall, the answer is factually precise, semantically equivalent, and fully responsive to the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 358,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron recorded **$405 million** of equity‑in‑earnings from Angola LNG Limited in 2024, which was part of **$3.58 billion** of total upstream equity earnings that year【page_84】.  This sizable share reflects Chevron’s **36.4 % ownership of Angola LNG**, which processes the country’s natural‑gas output, indicating a material production involvement in Angola’s upstream operations【page_85】【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $405 million equity earnings from Angola LNG Limited and the total upstream equity earnings of $3.58 billion (equivalent to $3,580 million), matching the ground truth exactly in value with acceptable format variation ($3.58 billion = $3,580 million). The additional detail of Chevron’s 36.4% ownership is factually consistent and enhances the response, though not present in the original answer. (2) All numeric values are accurate: $405 million and $3.58 billion are correct representations of the financial data. No calculations were required beyond recognition of magnitude equivalence (billion vs million), which is handled correctly. (3) The multi-hop reasoning is sound—linking equity earnings to ownership stake and inferring production involvement from affiliate operations demonstrates valid synthesis across financial and operational contexts. The conclusion about 'material production involvement' aligns semantically with the original answer’s 'significant production involvement.' (4) The only minor deviation is the introduction of a specific ownership percentage (36.4%) not present in the ground truth, which, while plausible and contextually supportive, adds unverified detail. However, it does not contradict the original and does not impair accuracy. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high correctness score with a small deduction in qualitative accuracy due to the extra unsupported detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 420,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "Disney had $2.6 billion of Canadian‑dollar senior notes outstanding as of September 28 2024.  Through cross‑currency swaps the company swapped roughly $1.9 billion (about $1.887 billion in swap notional) into U.S.‑dollar‑denominated borrowings, essentially converting the entire CAD issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key quantitative aspects. The total Canadian dollar denominated notes outstanding as of September 28, 2024, were CAD $2.6 billion, which matches the ground truth. However, the LLM claims that $1.9 billion (or $1.887 billion) was swapped into U.S. dollar denominated borrowings via cross-currency swaps, while the ground truth states only CAD $1.3 billion (equivalent to $1.0 billion USD) was converted. The LLM incorrectly states that 'essentially the entire CAD issuance' was swapped, but in reality, only half (CAD $1.3 billion) was swapped—the other half was paid off in October 2024, not swapped. (2) Number verification: Total CAD notes = CAD $2.6 billion — this is correct. Amount swapped = CAD $1.3 billion (~$1.0B USD), not $1.887B or $1.9B USD as claimed. The LLM overstates the swapped amount by nearly double. (3) Multi-hop reasoning failure: The model fails to correctly synthesize the two tranches of CAD $1.3 billion each and does not recognize that only one tranche was swapped while the other was repaid. It incorrectly assumes the full amount was swapped, missing a critical distinction in the financial treatment of the two portions. (4) Contextual relevance is high because the answer addresses the right company, time period, financial instruments, and mechanism (cross-currency swaps), but the core factual and quantitative inaccuracies severely undermine correctness. Scores reflect major factual errors in numbers and reasoning despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 421,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "Honeywell reported private‑fund investments of **$1,265 million** in its U.S. pension plans (measured at NAV) and **$115 million** in its non‑U.S. pension plans (listed under “Investments in private funds”) as of December 31 2023. Together, the fair‑value total of private‑fund investments across both U.S. and non‑U.S. plans is approximately **$1.38 billion**【page_109】【page_110】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: $1,265 million in private funds for U.S. Plans and $115 million for Non-U.S. Plans are correctly reported, with the total fair value accurately calculated as $1,380 million (expressed as $1.38 billion, which is semantically equivalent). (2) Quantitative accuracy is perfect: the sum of $1,265M + $115M = $1,380M ($1.38B) is correct, and the date (December 31, 2023) is properly cited. Format variations (million vs. billion) are acceptable and commonly used. (3) Multi-hop reasoning is sound—the model correctly synthesized data from both U.S. and Non-U.S. plans, identifying the relevant line items (private funds) across different sections of the filing. (4) The answer is contextually relevant, directly addressing the question with precise sourcing (page references provided), and uses clear, professional language. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 278,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle’s strategy of giving customers the choice to run its applications on‑premise, in the cloud or in hybrid‑cloud models creates two distinct revenue‑recognition streams. Under ASC 606, subscription‑based Oracle Cloud Services (and the associated license‑support contracts) are billed in advance and recognized ratably over the subscription period—or as usage occurs—because the service is delivered continuously (see pages 39‑40, 75). In contrast, cloud‑license and on‑premise license sales are treated as perpetual software licenses and are recognized at a point in time when the software is made available to the customer, with any optional support thereafter recognized ratably (see pages 39‑40, 75). This dual approach aligns revenue timing with the nature of the performance obligations inherent in each flexible deployment option.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the two distinct revenue recognition patterns: ratable recognition for Oracle Cloud Services and point-in-time recognition for on-premise and cloud licenses. The explanation ties this directly to Oracle's flexible deployment models, fully addressing the question. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The reasoning is sound and reflects proper multi-hop understanding: it links deployment models (on-premise, cloud, hybrid) to revenue recognition methods under ASC 606, correctly associating continuous delivery with ratable recognition and perpetual licenses with upfront recognition. It also appropriately references support contracts and usage-based recognition where relevant. The only minor gap is that the original answer emphasizes the business impact—'more predictable and stable revenue streams'—which the LLM answer implies but does not explicitly state, slightly reducing qualitative completeness. (4) The LLM answer is fully contextually relevant, directly addressing how deployment models affect revenue recognition structure. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight omission of the strategic implication, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 394,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "ERLEADA’s worldwide sales rose from $1.291 billion in 2021 to $2.387 billion in 2023 – an increase of roughly **85 %** (2023 – 2021 ÷ 2021 ≈ 0.85)【page_89】.  In 2023 the product grew **26.9 %** versus 2022, contributing about $2.4 billion (≈13 % of total Oncology sales) and was a key driver of the Oncology segment’s **10.5 %** year‑over‑year growth to $17.7 billion in 2023 versus $15.98 billion in 2022【page_31】【page_88】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports ERLEADA's sales growth from $1.291 billion in 2021 to $2.387 billion in 2023, calculating an 85% increase, which aligns with the ground truth 84.9% (rounded). The 26.9% year-over-year growth in 2023 vs 2022 and the Oncology segment’s 10.5% growth are accurately stated. The LLM also correctly identifies ERLEADA as a key driver of the Oncology segment’s performance. (2) All numeric values match the ground truth, with acceptable rounding (85% vs 84.9%). The dollar amounts ($1.291B, $2.387B, $17.7B, $15.98B) are accurate and correctly formatted. The calculation for growth is sound. (3) The multi-hop reasoning is strong: the model connects ERLEADA’s sales growth to its contribution within the Oncology segment and contextualizes it within overall segment performance. However, the ground truth specifies ERLEADA was the third-largest contributor after DARZALEX and TREMFYA, which the LLM omits. This is a minor but notable completeness gap in qualitative synthesis. (4) Scores reflect near-perfect quantitative accuracy and contextual relevance. The qualitative accuracy is slightly reduced due to the missing comparative ranking among contributors, but the core reasoning and facts are sound. Overall, the answer is factually correct and highly relevant, with only minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 372,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31 2023, Mondelēz International reported net‑investment‑hedge derivative contracts with a notional amount of **$7.456 billion** and non‑U.S.‑dollar debt designated as net‑investment hedges (Euro $3.516 bn + Swiss‑franc $0.386 bn + Canadian $0.453 bn) totaling **$4.355 billion** – a combined notional of roughly **$11.8 billion**【page_97】.  \n\nThe same filing shows that the fair value of derivative assets recorded on the balance sheet was **$1.347 billion** in other current assets and **$0.250 billion** in other assets, for a total of about **$1.6 billion**【page_95】.  \n\nThus, the notional amount of net‑investment‑hedge contracts and hedged debt (~$11.8 bn) was roughly seven times larger than the fair‑value amount of derivative assets shown in other current and other assets (~$1.6 bn).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.456 billion (=$7,456 million) for net investment hedge derivatives, $4.355 billion (=$4,355 million) for non-USD debt, broken down into $3.516 billion (Euro), $0.386 billion (Swiss franc), and $0.453 billion (Canadian dollar), summing to a combined notional of $11.811 billion (~$11.8 billion, correctly rounded). The fair values are also correct: $1.347 billion in other current assets and $0.250 billion in other assets, totaling $1.597 billion (~$1.6 billion, appropriately rounded). (2) Calculations are sound: the sum of the debt components is accurate ($3.516 + $0.386 + $0.453 = $4.355), and the comparison between notional (~$11.8B) and fair value (~$1.6B) is logically presented, with the observation that notional is roughly seven times larger being reasonable (11.8 / 1.6 ≈ 7.375). (3) Multi-hop reasoning is correct: the model synthesizes data from derivative contracts and debt instruments (two sources) and compares them to balance sheet fair values (third data point), fulfilling the multi-part, multi-hop requirement. (4) Entities are correctly identified: MDLZ (Mondelēz International), correct date (December 31, 2023), and proper financial terms (notional amount, fair value, net investment hedges). (5) Semantic equivalence is maintained: use of 'billion' vs 'million' is numerically consistent, and rounding is appropriate and does not distort meaning. The answer is complete, factually accurate, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 429,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "Honeywell’s U.S. pension plans held **$676 million** in mortgage/asset‑backed securities as of December 31 2023, and its non‑U.S. plans held **$10 million** of the same asset class. Together, the two groups held **$686 million** in mortgage/asset‑backed securities 【page_109†L31-L34】【page_110†L31-L34】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the U.S. Plans held $676 million and Non-U.S. Plans held $10 million in mortgage/asset-backed securities as of December 31, 2023. The combined total is correctly calculated as $686 million. (2) Quantitative accuracy is perfect: all dollar amounts and the final sum are correct, with acceptable formatting (e.g., $676 million). (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. plans is correctly synthesized to compute the total. (4) The answer is semantically equivalent to the original, clearly conveying the same information with proper context and citation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 225,
        "total_tokens": 1366
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29 2024 Starbucks still has $177 million of current deferred revenue plus $5.8 billion of long‑term deferred revenue – a total of roughly $5.98 billion – of the Nestlé up‑front prepaid royalty that has not yet been recognized 【page_82】.  This balance represents the portion of the roughly $7 billion upfront payment that will be recognized on a straight‑line basis over the 40‑year economic life of the Global Coffee Alliance licensing arrangement, reflecting Starbucks’ ongoing performance obligations under that long‑term agreement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key numbers are correct: $177 million (current deferred revenue) and $5.8 billion (long-term deferred revenue) match the original answer exactly; the total of approximately $5.98 billion is a correct sum of these two components. The reference to the $7 billion upfront payment is accurate. (2) The date 'September 29, 2024' is correctly used. (3) The explanation of the 40-year economic life of the Global Coffee Alliance and the straight-line recognition method is consistent with the ground truth. (4) The multi-hop reasoning is sound: the model correctly links the remaining deferred revenue to the original $7 billion payment and explains its recognition over the 40-year period based on ongoing performance obligations. (5) All entities—Starbucks, Nestlé, Global Coffee Alliance—are correctly identified. The answer addresses both parts of the question: the amount of remaining prepaid royalty revenue and its relationship to the 40-year arrangement. Minor formatting differences (e.g., spacing, use of 'roughly') do not affect factual accuracy. No errors in calculation, logic, or entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 337,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "Exxon Mobil’s 2023 10‑K shows that the fair value of its long‑term obligations to equity companies is **$1,896 million**【page_102】.  The filing also reports guarantees covering equity‑company obligations of **$1,862 million**【page_106】, which together total roughly **$3,758 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the fair value of long-term obligations to equity companies is correctly stated as $1,896 million, and guarantees related to equity company obligations are correctly reported as $1,862 million. The total of $3,758 million is accurate and properly calculated. (2) Quantitative accuracy is perfect: all numbers match the original answer exactly, and the sum is correct ($1,896M + $1,862M = $3,758M). Format variations (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information from two different parts of the 10-K (obligations and guarantees) is correctly identified, extracted, and synthesized into a total. (4) The entities (XOM, 2023 10-K, financial metrics) are correctly identified and contextually appropriate. The answer is semantically equivalent to the ground truth, with clear, concise, and relevant presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 282,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "Honeywell’s U.S. pension plans reported **$676 million** of mortgage/asset‑backed securities at December 31 2023, while the non‑U.S. plans held **$10 million** of the same asset class【page_109†L31-L37】【page_110†L31-L38】.  The U.S. allocation therefore dwarfs the non‑U.S. allocation – it accounts for roughly 98 % of the combined $686 million and is about 68 times larger than the amount held by the non‑U.S. plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $676 million for U.S. plans, $10 million for Non-U.S. plans, and a total of $686 million are correctly reported. The percentage calculation (98%) is a rounded but accurate representation of 676/686 ≈ 98.5%, and the '68 times larger' comparison is mathematically sound (676 / 10 = 67.6 ≈ 68). (2) The answer addresses both parts of the question: total value ($686 million) and the allocation comparison between U.S. and Non-U.S. plans. (3) Entities are correct—Honeywell, Mortgage/Asset-backed securities, and the date (December 31, 2023)—and the financial metric is properly identified. (4) The multi-hop reasoning is sound: the model correctly synthesized data from two different sections (U.S. and Non-U.S. plans), aggregated the total, and made a valid comparative analysis. The semantic meaning fully aligns with the original answer, with slightly more concise wording and added context (68x comparison), which enhances clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 307,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "Medtronic’s “Medical device regulations” adjustments added **$102 million** to Non‑GAAP income before income taxes in fiscal 2022 and **$83 million** in fiscal 2021, for a combined pre‑tax impact of **$185 million** across the two years【page_33†L19-L23】【page_34†L19-L23】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual yearly adjustments—$83 million in fiscal year 2021 and $102 million in fiscal year 2022—are accurately reported, and their sum ($185 million) is correctly calculated. Minor formatting differences (e.g., using ' ' as a thousands separator) do not affect accuracy. (2) The answer is complete, addressing both the individual year impacts and the total pre-tax financial impact across the two years, as required by the multi-part question. (3) Entity accuracy is correct: Medtronic is the right company, 'Medical device regulations' is the correct adjustment category, and fiscal years 2021 and 2022 are properly identified. (4) The reasoning is sound—information from two different years is correctly synthesized into a total impact, demonstrating valid multi-hop logic. The cited document references (page_33, page_34) further support the fidelity of the response. Semantically, the LLM conveys the same information as the original answer, with equivalent phrasing and precise data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 310,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "Booking Holdings recorded a $489 million goodwill impairment in the March 31, 2020 interim test and a $573 million impairment in the September 30, 2020 annual test – a combined total of about **$1.06 billion** for the OpenTable and KAYAK reporting unit【page_55】.  \n\nThe continued impairment in the September 30, 2020 test was driven by a **significant reduction in forecast cash flows due to the ongoing material adverse impact of the COVID‑19 pandemic**, which lengthened the recovery period – notably hurting KAYAK’s flight vertical and lowering the outlook for monetizing restaurant‑reservation services【page_55】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth. The total goodwill impairment of $1.062 billion is accurately represented as approximately $1.06 billion, which is an acceptable rounding. The two components—$489 million in the March 2020 interim test and $573 million in the September 30, 2020 annual test—are exactly correct. (2) Quantitative verification: $489M + $573M = $1,062M ($1.062B), and the LLM correctly reports this sum as 'about $1.06 billion', which is semantically equivalent and acceptable. Dates (March 31, 2020 and September 30, 2020) match the required timeframes. (3) The reasoning and synthesis across the two reporting units (OpenTable and KAYAK) and two impairment events (interim and annual) is sound and reflects multi-hop understanding. The explanation for continued impairment correctly identifies the lowered monetization outlook for restaurant reservations (affecting OpenTable) and slower recovery in airline travel (affecting KAYAK), which aligns with the ground truth. The reference to 'forecast cash flows' and 'lengthened recovery period' due to the COVID-19 pandemic captures the core economic driver. (4) All entities (Booking Holdings, OpenTable, KAYAK, goodwill impairment, reporting unit) are correctly identified and contextualized. The answer is fully relevant and addresses both sub-questions completely. Minor wording differences (e.g., 'lowered outlook for monetization' vs 'lowered outlook for monetizing restaurant-reservation services') do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 439,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart’s stake in Flipkart grew from about 75 % at January 31, 2023 to roughly 85 % at January 31, 2024 – an increase of roughly 10 percentage points.  The rise was driven by a $3.5 billion cash purchase of shares from Flipkart’s non‑controlling interest holders (and the related settlement of the PhonePe liability).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Walmart's ownership stake in Flipkart as approximately 10 percentage points, rising from 75% as of January 31, 2023, to 85% as of January 31, 2024. The $3.5 billion transaction amount is also accurate. These figures match the ground truth exactly, with acceptable formatting variations (e.g., 'about 75%' vs 'approximately 75%'). (2) All numeric values—percentages, dates, and dollar amounts—are factually correct. The calculation of a 10 percentage point increase is accurate. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model connects Walmart’s increased ownership to a specific financial transaction involving share purchases from noncontrolling interest holders. The mention of the 'settlement of the PhonePe liability' adds contextual detail not present in the original answer; while potentially accurate, it introduces information not confirmed in the ground truth, slightly reducing qualitative accuracy. (4) The answer is semantically equivalent to the original and fully addresses both parts of the question: the magnitude of stake increase and the supporting financial transaction. The added detail about PhonePe, while plausible, is not part of the verified truth and prevents a perfect score, but does not detract from overall correctness. Contextual relevance is excellent as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 396,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for roughly **24 % of Procter & Gamble’s total net sales**. Within that segment, the Bounty paper‑towel brand enjoys a **North American market share of over 40 %** in the paper‑towel category.【page_18】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures are accurate: the Baby, Feminine & Family Care segment represents 24% of P&G's total net sales, and the Bounty brand holds over 40% market share in the North American paper towel category. Minor formatting differences (e.g., '24 %' vs '24%') do not affect meaning. (2) The answer is complete, addressing both sub-questions in the multi-part query. (3) Entity accuracy is correct—Procter & Gamble, the segment name, and the Bounty brand are all properly identified. (4) The reasoning is sound, demonstrating correct synthesis across the segment-level financial data and brand-level market share information, which requires multi-hop inference from different parts of the knowledge base. (5) The semantic meaning is equivalent to the original answer, with only slight rewording for clarity (e.g., 'enjoys a North American market share' vs 'holds over 40%'). The citation [page_18] adds contextual support. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 300,
        "total_tokens": 1434
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "RTX recorded a **$364 million pre‑tax charge** in 2024 for the Thales‑Raytheon Systems and Related Matters. This charge stems from the settlement of the **SEC Administrative Order** (and the accompanying deferred‑prosecution agreement) that resolved the criminal and civil investigations into payments made by Raytheon and its joint‑venture TRS.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $364 million pre-tax charge in 2024, matching the ground truth exactly in amount and year. The connection to the SEC Administrative Order is accurately described as resolving investigations into improper payments by Raytheon and TRS. (2) Quantitative accuracy is perfect: $364 million is correctly stated, and the year 2024 is accurate. Format variation (e.g., spacing) does not affect correctness. (3) The multi-hop reasoning is sound—linking RTX’s charge to the resolution of investigations via the SEC Administrative Order is correct. However, the LLM omits a key detail from the ground truth: the requirement for RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for three years. This omission slightly reduces completeness and qualitative accuracy, though the core causal link is preserved. (4) The answer is highly relevant, directly addressing both parts of the question. The minor omission prevents a perfect 10, but the response is factually correct, well-reasoned, and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 319,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021 Trodelvy had **two approved indications** – a full FDA approval for metastatic triple‑negative breast cancer (TNBC) and an accelerated FDA approval for metastatic urothelial cancer (UC)【page_39】. By September 2021 the TNBC indication had been approved in **the United States, Canada, Australia, Great Britain (the United Kingdom) and Switzerland**【page_39】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of approved indications (two) is accurate as of April 2021, and the five countries where Trodelvy was approved for TNBC by September 2021—United States, Canada, Australia, Great Britain (United Kingdom), and Switzerland—match exactly with the original answer. (2) The LLM correctly identifies the two indications: metastatic triple-negative breast cancer (TNBC) and metastatic urothelial cancer, aligning with the ground truth’s specification of unresectable locally advanced or metastatic TNBC and locally advanced or metastatic urothelial cancer. Minor phrasing differences (e.g., 'metastatic' vs 'unresectable locally advanced or metastatic') do not alter the medical meaning in context. (3) The multi-hop reasoning is sound: the model correctly separates the status as of April 2021 (indications) from the geographic approvals as of September 2021 (countries for TNBC), synthesizing information across time points and regulatory contexts. (4) All entities—drug name (Trodelvy), disease indications, countries, and timeframes—are accurately identified and correctly attributed. The inclusion of 'FDA approval' is contextually appropriate even though the original answer does not specify the agency, as FDA refers to U.S. approval and the other countries’ approvals would be through their respective regulatory bodies. No factual errors, omissions, or misstatements are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 410,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "As of September 29 2024, the “Foreign currency – other” cash‑flow hedge shows a net gain of **$11.5 million** recorded in AOCI. Of that amount, **$9.5 million** is expected to be reclassified from AOCI into earnings within the next 12 months, leaving roughly **$2 million** to remain in AOCI beyond that period.【page_70】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $11.5 million (total net gain in AOCI) and $9.5 million (expected to be reclassified within 12 months) are accurately reported, with no calculation or formatting errors. The additional detail of $2 million remaining in AOCI is a correct inference (11.5 - 9.5 = 2) and does not contradict the original answer. (2) The date 'September 29, 2024' is correctly stated. (3) The entity 'Foreign currency – other' derivatives is accurately identified, and the context of cash-flow hedges and AOCI is correctly applied. (4) The reasoning is sound: the answer correctly synthesizes the total gain and the portion expected to be reclassified, addressing both parts of the multi-hop question. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 269,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "Starbucks has two yen‑denominated facilities that together provide about **$103.6 million** of borrowing capacity (¥5 bn ≈ $34.5 m plus ¥10 bn ≈ $69.1 m)【page_46】. The smaller ¥5 bn facility matures on **December 30 2024** and bears a variable rate of **TIBOR + 0.400 %**, while the larger ¥10 bn facility matures on **March 27 2025** and bears **TIBOR + 0.300 %**【page_79】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the total dollar value is correctly calculated as $103.6 million, composed of ¥5.0 billion ≈ $34.5 million and ¥10.0 billion ≈ $69.1 million. The maturity dates (December 30, 2024, and March 27, 2025) and interest rate margins (0.400% and 0.300% over TIBOR) are exactly as stated in the original answer. Minor formatting differences (e.g., '¥5 bn' vs '¥5.0 billion') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: total dollar value and differences in maturity dates and interest rate margins. (3) Entity accuracy is correct—Starbucks, Japanese yen-denominated facilities, TIBOR as the reference rate, and fiscal 2024 context are all properly identified. (4) Multi-hop reasoning is sound: the model correctly synthesized data from two separate facilities (likely from different pages of the 10-K, as indicated by page references), converted yen amounts to dollar equivalents, and compared terms. (5) Semantic equivalence is strong—the LLM conveys the same information with slightly more concise wording but no loss of meaning. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 346,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "Accenture bought 2,072,563 Class A ordinary shares in the fourth quarter of fiscal 2024 – 2,000,308 shares under its publicly announced open‑market repurchase program and 72,255 shares in transactions unrelated to any announced share plan (footnote 4)【page_39】.  The open‑market program cost $605 million for those 2,000,308 shares, which works out to an average price of roughly $302.5 per share【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer is highly accurate with only a minor discrepancy in the total number of shares purchased: LLM reports 2,072,563 vs. ground truth 2,072,263 — a difference of 300 shares. This appears to be a typographical error in the total, as the component numbers (2,000,308 + 72,255 = 2,072,563) are correctly stated by the model and sum to its reported total. However, the ground truth total is 2,072,263, suggesting the source data may have had a different total or a typo in the components. The share count under the open-market program (2,000,308) and unrelated transactions (72,255) are both correct. The average price per share is reported as approximately $302.5, which matches the ground truth calculation of $605,000,000 / 2,000,308 ≈ $302.45, rounded appropriately. (2) Quantitative accuracy is high: dollar amount ($605 million), share counts, and derived average price are correct. The slight mismatch in the total share count is minor and may stem from a source discrepancy or typo, but does not affect the core financial interpretation. (3) Qualitative accuracy is excellent: the model correctly identifies Accenture plc Class A ordinary shares, fiscal 2024 Q4, and distinguishes between open-market purchases and unrelated transactions. It correctly references the calculation logic for average price. (4) Contextual relevance is perfect — the answer directly addresses both parts of the multi-hop question: total shares purchased (broken down) and average price under the open-market program. The citation of 'footnote 4' and 'page_39' adds appropriate context. Overall, this is a factually sound, well-reasoned response with only a negligible numerical inconsistency in the total, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 470,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The 6.375 % notes due 2037 are carried on the balance sheet at **$478 million** (see the debt‑carrying‑value table). In the 2020 debt‑exchange transaction, **$74 million** of principal of those notes was tendered and cancelled.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value of the 6.375% 2037 Notes is correctly stated as $478 million, and the principal amount exchanged is accurately reported as $74 million. (2) Both numeric values match the original answer exactly, with acceptable formatting (e.g., $478 million). (3) The reasoning is sound: the model correctly identifies the carrying value from the debt-carrying-value table and links it to the 2020 debt-exchange transaction, demonstrating proper multi-hop synthesis across financial disclosures. (4) The answer is semantically equivalent to the ground truth, uses precise financial terminology, and directly addresses both parts of the question with no irrelevant or extraneous information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 228,
        "total_tokens": 1329
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "Netflix amortizes its content assets over the shorter of each title’s contractual window or its estimated period of use, with a maximum horizon of ten years (page 45; page 28). Because the policy is accelerated, the bulk of the expense is recognized early – more than 90 % of a licensed or produced title is expected to be amortized within the first four years after it becomes available, leaving relatively little amortization in later years (page 45; page 28).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that more than 90% of a licensed or produced content asset is expected to be amortized within four years after availability, which matches the ground truth of 'over 90%'. This satisfies the quantitative requirement. The mention of an accelerated amortization policy resulting in higher expenses early in the asset's life is also accurately conveyed, with the LLM noting that the bulk of the expense is recognized early and leaving little for later years. 2) All numeric values (i.e., 'more than 90%', 'four years', 'ten years') are factually correct and consistent with the ground truth. The maximum ten-year horizon is additional context not contradicted by the original answer. 3) The reasoning is sound: the LLM correctly links the accelerated policy to front-loaded amortization and implies the connection to viewing patterns (though it does not explicitly mention 'upfront viewing' or differentiate films vs. TV series as in the original). This is a minor omission in qualitative depth but does not affect factual correctness. 4) The answer addresses both parts of the question: the expected average amortization period (implicitly within four years for most of the asset) and the impact of accelerated amortization. While the LLM does not explicitly state the 'expected average amortization period' as a single number (e.g., ~4 years), it effectively communicates that over 90% is amortized within four years, which captures the intended meaning. The synthesis across concepts (amortization period, acceleration, expense distribution) is logically coherent and contextually appropriate. Minor deduction in qualitative accuracy for not elaborating on the rationale (upfront viewing, film vs. series) mentioned in the original, but core facts and multi-hop understanding are intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 491,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on BlackRock’s 2023 disclosure, its foreign‑exchange‑rate‑risk investments had a net exposure of $1.125 billion, and a 10% adverse shift in the relevant currencies would generate an estimated $112 million loss (the “Effect of –10% Change” amount).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the disclosed exposure is $1.125 billion (equivalent to $1,125 million), and a -10% change results in a $112 million loss. The formatting variation ($1.125 billion vs $1,125 million) is acceptable and numerically consistent. (2) The calculation is accurate: 10% of $1,125 million is $112.5 million, but the original answer states $112 million, which aligns with the LLM's rounded figure—this minor rounding is consistent with typical reporting practices in financial disclosures and matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly identified BLK (BlackRock), the year 2023, the relevant risk factor (foreign exchange rate risk), the exposure amount, and applied the 10% adverse change to compute the financial impact. (4) The answer is contextually precise, directly addressing the total potential financial impact as requested, with no extraneous or missing information. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 310,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The 2022 Form 10‑K lists three amendments to the Target Corporation Deferred Compensation Trust Agreement – the amendment dated **June 8 2011**, the amendment dated **October 25 2017**, and the amendment dated **December 18 2020**【page_68】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It correctly identifies that there are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. (2) The effective dates provided—June 8, 2011; October 25, 2017; and December 18, 2020—are accurate and match the ground truth exactly, with only minor formatting differences (e.g., 'June 8 2011' vs 'June 8, 2011'), which do not affect factual correctness. (3) The reasoning is sound, as it synthesizes the correct information from the specified document (2022 10-K) and accurately lists all amendments without omission or addition. (4) The answer is semantically equivalent to the original, includes all required elements, and cites a relevant page reference, enhancing credibility. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 252,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The 6.90% notes due 2038 are shown on the balance sheet with a total carrying value of **$254 million**【page_130】. In the 2020 debt‑exchange transaction, **$37 million** of principal of the 6.90% 2038 notes was tendered and cancelled【page_132】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the total carrying value of the 6.90% 2038 Notes ($254 million) and the principal amount exchanged ($37 million), matching the ground truth exactly. (2) All numeric values are accurate and presented in a format consistent with the original answer ($254 million and $37 million). There are no calculation errors, and the figures are correctly attributed to the relevant financial instrument and transaction. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: the model correctly associates the carrying value from the balance sheet (page 130) with the debt exchange transaction detail (page 132), showing understanding across different sections of the filing. (4) The answer is semantically equivalent to the ground truth, with added contextual precision (e.g., specifying the transaction occurred in 2020 and that the notes were 'tendered and cancelled'), which enhances clarity without introducing error. All aspects of the question are addressed fully and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 301,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The FBM program (along with the NGI effort) drove roughly $940 million of the increase in Space’s product sales and about $815 million of the rise in Space’s product‑costs in 2023【page_33†L15-L19】【page_34†L9-L13】.  Even with those higher costs, Lockheed Martin’s operating profit still grew – from $8,348 million in 2022 to $8,507 million in 2023 – a net uplift of about $159 million【page_33†L5-L9】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $940 million increase in product sales and $815 million increase in product costs due to the FBM program in 2023, matching the ground truth. These numbers are accurately cited with correct formatting and context. (2) The calculation of net financial impact is partially incorrect: while the correct gross profit increase from FBM is $125 million ($940M - $815M), the LLM instead references a $159 million increase in Lockheed Martin’s total operating profit ($8,507M in 2023 vs $8,348M in 2022), which reflects company-wide performance and not the specific net impact of FBM on the Space segment. This misattributes overall operating profit growth as the 'net financial impact' of FBM, failing to isolate the segment-level gross profit effect. (3) The multi-hop reasoning is sound in linking FBM to sales and cost increases in the Space segment, supported by correct citations (page_33, page_34). However, it fails to compute or mention the $125 million gross profit impact, which is the direct net result of the FBM-driven changes. Instead, it introduces broader operating profit figures that conflate other business factors. (4) Scores reflect high quantitative accuracy and relevance, but a deduction in qualitative accuracy and overall correctness due to the incorrect interpretation of 'net financial impact'—a key part of the question. The answer is factually strong on inputs but flawed in synthesizing the correct output.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 408,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The 5.375 % 2043 Notes carry $185 million on the balance sheet, which is roughly 0.6 % of AMGN’s total debt carrying value of $33,309 million (185 ÷ 33,309 ≈ 0.56 %). During the exchange offer, $76 million of principal of these notes was tendered and cancelled.【page_130】【page_132】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: the carrying value of the 5.375% 2043 Notes is $185 million, total debt carrying value is $33,309 million, and $76 million in principal was exchanged. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the percentage calculation (185 ÷ 33,309 ≈ 0.555%) is correctly approximated as 0.56% in the explanation and rounded to 0.6% in summary, which is acceptable for rounding (0.555% rounds to 0.6% to one decimal place). No calculation errors. (3) Multi-hop reasoning is sound—model synthesizes data from debt disclosures and exchange activity, correctly linking the notes to AMGN’s overall debt in 2022. (4) Minor deduction in qualitative accuracy due to slight imprecision in percentage presentation: stating 'roughly 0.6%' is acceptable but slightly less precise than 'approximately 0.555%', though this does not constitute a factual error. Contextual relevance is perfect—all information directly addresses the two-part question. Overall, the answer is factually complete and accurate with only negligible wording-level approximation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 319,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "BlackRock reported that, as of December 31 2023, it had roughly **$259 billion of securities on loan** that are covered by borrower‑default indemnifications, and it held **about $276 billion of cash and securities as collateral** for those loans.  The filing warns that **if a wave of borrower defaults coincided with a rapid drop in the value of the pledged collateral (or a rise in the value of the loaned securities), collateral shortfalls could arise, creating material indemnity liabilities that could depress the company’s revenue and earnings**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $259 billion for securities on loan subject to indemnification and $276 billion for collateral held are accurately reported, with the correct date of December 31, 2023. Format variations (e.g., 'about $276 billion' vs. 'approximately $276 billion') are acceptable and semantically equivalent. (2) The answer is complete, addressing all three parts of the question: the value of securities on loan, the amount of collateral held, and the potential financial impact of simultaneous borrower defaults and collateral value declines. (3) Entity accuracy is correct—BlackRock is the implied entity (consistent with the context of the original answer), and the financial terms (securities on loan, collateral, indemnification, collateral shortfalls) are used accurately. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects borrower defaults with rapid declines in collateral value (or increases in loaned securities' value) to explain the risk of collateral shortfalls, leading to material indemnity liabilities and negative impacts on revenue and earnings—precisely as stated in the original. The semantic meaning is identical to the ground truth, with only minor rephrasing for fluency.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 367,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The filing lists a first amendment (dated Nov 30 2016) and a second amendment (dated Jan 9 2018) to the Pharmacy Operating Agreement, for a total of **two amendments**【page_69†L7-L11】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are two amendments to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc., which aligns with the original answer. (2) The quantitative details are precise: the first amendment is correctly dated Nov 30, 2016, and the second Jan 9, 2018. These dates are factually correct as per the 2022 10-K filing, and the total count of two amendments is accurate. (3) The reasoning is sound—by identifying both amendments with their dates and summing them into a total, the model correctly synthesizes information from the document (multi-hop reasoning across time points). (4) The answer is contextually relevant, directly addressing the question about the total number of amendments, and includes supporting evidence from the filing (page reference). Minor formatting differences (e.g., bolded 'two amendments') do not affect meaning. All criteria—factual accuracy, completeness, entity recognition, and logical synthesis—are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 299,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of technology‑related finite‑lived intangible assets fell from **$180 million** at 12/31/2022 to **$142 million** at 12/31/2023 – a decrease of **$38 million**. During the same period, the accumulated amortization for this category rose from **$81 million** to **$118 million**, an increase of **$37 million** (see the intangible‑asset table on page 93). This drop in net amount is essentially offset by the higher amortization recorded.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: the net carrying amount decreased from $180 million to $142 million (a $38 million decrease), and accumulated amortization increased from $81 million to $118 million (a $37 million increase), matching the ground truth exactly. (2) All calculations are accurate: $180M - $142M = $38M decrease; $118M - $81M = $37M increase. Number formats are consistent and acceptable (e.g., $180 million vs $180M). (3) The multi-hop reasoning is sound—information from two time points (2022 and 2023) for two related financial metrics (net carrying amount and accumulated amortization) is correctly synthesized to explain the relationship between amortization and carrying value. (4) The conclusion that the drop in net amount is 'essentially offset' by higher amortization aligns semantically with the ground truth's statement that the decline is 'primarily due to' increased amortization. All parts of the question are addressed with full factual and logical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 295,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The Subscriptions & Services revenue in Asia Pacific rose from $657 million in FY 2023 to $2,203 million in FY 2024 – a year‑over‑year increase of **$1.546 billion**【page_65†L21-L28】. By comparison, the same category in the Americas grew from $5,678 million to $12,726 million, a **$7.048 billion** increase, which is far larger than the Asia Pacific gain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the year-over-year increases are accurate: $1.546 billion (Asia Pacific) and $7.048 billion (Americas), which are equivalent to $1,546 million and $7,048 million in the original answer. The LLM correctly calculates the differences from the stated FY2023 and FY2024 values: 2,203 - 657 = 1,546 million and 12,726 - 5,678 = 7,048 million. (2) The answer is complete, addressing both sub-questions: the YoY increase in Asia Pacific and the comparison with the Americas. (3) Entities are accurate—'Subscriptions & Services', 'Asia Pacific', 'Americas', and fiscal years 2023 and 2024 are correctly identified. (4) The reasoning is sound: the LLM performs two correct calculations and draws a valid comparison, noting that the Americas' growth is far larger, which aligns with the original conclusion. (5) Semantic equivalence is maintained despite slightly more detailed presentation (explicit base values). All formatting variations (billion vs million) are numerically consistent. No factual, computational, or logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 317,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "CVS held redeemable preferred securities with a **fair‑value of $20 million** at December 31 2023. These securities carried a **gross unrealized loss of $1 million**, which is reflected in the $20 million fair‑value (the amortized cost was $21 million)【page_147】【page_149】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total fair value of redeemable preferred securities as $20 million and the unrealized loss as $1 million, matching the ground truth exactly. It also correctly implies that the full $1 million unrealized loss is reflected in the fair value by noting the amortized cost was $21 million, which aligns with the ground truth that the entire $1 million loss (in the 'Greater than 12 months' category) has been recognized in fair value. (2) All numeric values—$20 million fair value, $1 million unrealized loss, and implied $21 million amortized cost—are factually accurate and consistent with the original answer. No calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes fair value and unrealized loss from the same securities and correctly infers recognition in fair value through the amortized cost comparison, even if it doesn't explicitly mention the 'Greater than 12 months' categorization. This is a minor omission but does not affect factual correctness. (4) The answer is semantically equivalent to the ground truth, with slightly more concise wording. The absence of explicit mention of the 'Less than 12 months' category does not detract from the core facts. Scores reflect high accuracy with only a minor reduction in qualitative accuracy due to less detailed explanation of the loss duration categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 387,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "At January 30 2022 Home Depot had $1.0 billion of outstanding borrowings under its commercial‑paper programs. Its back‑up credit facilities – a $2.0 billion five‑year facility and a $1.0 billion 364‑day facility – provided a combined borrowing capacity of $3.0 billion, so the commercial‑paper borrowings represented roughly one‑third of the available backup capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: borrowings under HD's commercial paper programs were $1.0 billion at January 30, 2022, and the combined back-up credit capacity was $3.0 billion, composed of a $2.0 billion five-year facility and a $1.0 billion 364-day facility. (2) Quantitative accuracy is perfect: the numbers match exactly, and the implied ratio (one-third) is a correct qualitative interpretation of $1.0B / $3.0B. (3) Multi-hop reasoning is sound—LLM correctly synthesized data across the commercial paper borrowings and two credit facilities, linking them to assess coverage. (4) The answer addresses both parts of the question: the amount of borrowings and the comparison to backup capacity. Wording differs slightly (e.g., 'one-third' vs 'fully covered'), but the meaning is consistent and accurate. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 272,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen reported **$125 million** of product sales to BeiGene in 2023, and it incurred **$40 million** of profit‑and‑loss sharing expenses for those products during the same year【page_131】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both components of the question—Amgen's total revenue from sales to BeiGene in 2023 and the related profit and loss sharing expenses. The values reported—$125 million in product sales and $40 million in expenses—exactly match the ground truth. (2) Quantitative accuracy is perfect: both dollar amounts are correct, properly formatted (with 'million' and consistent with $125M/$40M variations), and assigned to the correct year (2023). There are no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly associates Amgen’s revenue from BeiGene with the corresponding profit-and-loss-sharing expenses, indicating accurate linkage of related financial events across entities. (4) The answer is semantically equivalent to the original, uses precise financial terminology, and includes a citation reference (【page_131】), enhancing credibility. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 292,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The crypto‑asset safeguarding liability rose from **$1.241 billion in 2023 to $2.886 billion in 2024**, an increase of **about $1.645 billion**【page_80】. As disclosed, the related safeguarding asset is measured at fair value using **Level 2 inputs – quoted prices on the principal exchange for the underlying crypto assets** (i.e., quoted market prices rather than a model), which was the valuation approach applied as of December 31 2023【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: the 2023 liability ($1.241 billion), 2024 liability ($2.886 billion), and the year-over-year increase ($1.645 billion), which matches the ground truth calculation ($2,886M - $1,241M = $1,645M). Number formats are consistent and acceptable (billion vs million with correct magnitude). (2) The answer addresses both parts of the question: the dollar increase and the valuation method for the corresponding asset as of December 31, 2023. (3) The entity (PYPL) and time periods (2023 to 2024, as of December 31, 2023) are accurate. (4) The reasoning is sound: the liability increase is tied to the asset valuation method, and the LLM correctly states that the asset is measured at fair value using Level 2 inputs. However, there is a minor discrepancy in qualitative accuracy: the LLM describes Level 2 inputs as 'quoted prices on the principal exchange', which slightly oversimplifies the ground truth's more precise characterization of Level 2 as 'Significant Other Observable Inputs' that are not based on active market quotes but on other observable data. While exchanges may provide observable data, Level 2 typically involves inputs other than quoted prices in active markets (e.g., brokered prices or derived from observable inputs), so the explanation is slightly imprecise. Despite this, the core logic and multi-hop synthesis—linking the liability increase to the valuation approach of the asset—are correct and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 416,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "UnitedHealth Group had **48 million shares** available for future grants under its 2020 Stock Incentive Plan as of December 31 2024【page_63】.  The plan’s documentation says those shares may be used for **stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 48 million shares available for future grants as of December 31, 2024, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The types of share-based awards listed in the LLM answer—stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—are broader than the specific types explicitly referenced in the ground truth (Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards). However, the LLM's list is consistent with the full range of award types permitted under the plan as described in the filing (page 72), even though it does not precisely highlight only those 'explicitly referenced' in form agreements. The ground truth emphasizes specific forms cited in the documentation, while the LLM provides a more general but still accurate summary from the plan description. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different sections of the filing—availability of shares (page 63) and award types (page 72)—to address both parts of the question. (4) The answer is contextually relevant and factually accurate overall, with only a slight deviation in precision regarding the 'explicitly referenced' award types. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 421,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "Pfizer says that, as of December 31 2024, about **$1 billion** of contracted Paxlovid revenue remains to be recognized from deliveries scheduled for **2025‑2028**【page_109】. By comparison, the **one‑time sales true‑up settlement** with its commercialization partner contributed roughly **$129 million** of revenue in 2024【page_109】—so the future Paxlovid contract revenue is roughly eight times larger than the settlement amount recognized in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1 billion in remaining contracted revenue for Paxlovid from 2025–2028 and the $129 million recognized in 2024 from the one-time sales true-up settlement are accurately reported, with correct dollar amounts and time periods. The comparison stating that the future revenue is 'roughly eight times larger' is a valid approximation (1,000 / 129 ≈ 7.75), which is reasonably rounded to eight times. (2) The answer is complete, addressing both parts of the multi-part question: the expected future revenue and its comparison to the 2024 settlement amount. (3) Entity accuracy is correct—Pfizer is the company, Paxlovid is the product, and the commercialization partner reference aligns with the original without needing to name the partner. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it connects future revenue expectations with a past one-time revenue event and provides a meaningful comparison. (5) Semantic equivalence is maintained—the LLM conveys the same core information with slight elaboration (e.g., 'eight times larger') that enhances clarity without distorting facts. All claims are properly attributed to page 109 of the source document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 355,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "As of December 31 2023, AIG’s ceded loss reserves under the 2017 adverse‑development reinsurance agreement with National Indemnity Company (NICO) totaled **$12.4 billion**. Berkshire Hathaway Inc. supplied a parental guarantee that fully secures NICO’s obligations, covering the entire $12.4 billion of those ceded reserves【page_184】. (The guarantee is described in the same section discussing the NICO agreement【page_99】).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amount ($12.4 billion) and date (December 31, 2023) are accurate and match the original answer exactly. The format variation (using 'billion' vs. numerical form) is acceptable and semantically equivalent. (2) The answer is complete, addressing both the total ceded loss reserves and the fact that the entire amount is covered by Berkshire Hathaway Inc.'s parental guarantee—this directly answers the question about how much was covered. (3) Entity accuracy is correct: AIG, NICO (National Indemnity Company), and Berkshire Hathaway Inc. are properly identified, and the 2017 adverse development reinsurance agreement is correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly links the reinsurance agreement, the ceded reserves, and the parental guarantee from Berkshire Hathaway as securing NICO’s obligations. The inclusion of citation markers (【page_184】, 【page_99】) further supports that the information is grounded in the source material. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed phrasing but no factual deviation. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 357,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "PayPal purchased roughly **$1.8 billion** of credit receivables for its merchant‑finance offerings in each of the years ended **December 31 2021** and **December 31 2020** (page 105). As of **December 31 2021**, the net outstanding balance of merchant loans, advances, and interest‑and‑fees receivable was about **$1.4 billion** (page 44), meaning the amount purchased exceeds the current outstanding balance by roughly **$400 million**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.8 billion in credit receivables purchased in both 2021 and 2020, matching the ground truth. It also accurately reports the $1.4 billion net outstanding balance as of December 31, 2021. However, it omits the key detail about the $63 million participation interest sold to WebBank, which is critical to explaining why the balance is net and how risk is shared. (2) All numbers are quantitatively accurate: $1.8 billion (purchased in each year), $1.4 billion (outstanding balance), and the implied $400 million difference are correct. The calculation that purchases exceed outstanding balance by ~$400 million is logically derived, though not explicitly stated in the ground truth. (3) The multi-hop reasoning is sound—linking annual purchases to the year-end outstanding balance shows synthesis across time periods and financial concepts. However, the failure to mention WebBank’s $63 million participation weakens the completeness of the risk explanation, which is a key part of the original answer’s insight. (4) The answer is highly relevant and factually strong, but loses minor points for omitting a structurally important entity (WebBank) and the associated risk-sharing context, which affects qualitative completeness despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 364,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "Costco’s Japan subsidiary issued four Guaranteed Senior Notes in November 2023 for a total of roughly **$500 million**【page_52†L13-L16】【page_30†L9-L12】. By July 2024 it had **repaid about $77 million** of that debt【page_52†L16-L18】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the amounts—$500 million issued in November 2023 and $77 million repaid by July 2024—are accurately reported, with acceptable formatting (e.g., 'roughly' and 'about' do not detract from precision given the context and citation support). (2) The answer is complete, addressing both parts of the question: total issuance and amount repaid. (3) Entity accuracy is correct: Costco’s Japanese subsidiary is properly identified as the issuer, and the financial instrument—Guaranteed Senior Notes—is correctly named. (4) The multi-hop reasoning is sound, synthesizing information across multiple document pages (page_52 and page_30) to confirm both the issuance and repayment events. (5) Semantic equivalence is maintained: despite slight rewording (e.g., 'four notes' vs. total amount), the core financial facts and timeline are preserved and correctly interpreted. All citations align with the claimed facts, indicating proper grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 294,
        "total_tokens": 1395
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The balance of available‑for‑sale debt investments fell from $15,206 million in 2021 to $11,947 million in 2022 – a decrease of $3,259 million【page_50】.  During the same year the company recorded only $9 million of net gains on those investments【page_49】, so the drop in value exceeded the realized gains by about $3,250 million (≈ $3.25 billion).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3,259 million decrease in available-for-sale debt investments from 2021 to 2022, which matches the ground truth. However, it misstates the net gains realized during the period. The ground truth states that net gains *decreased by $44 million* (i.e., a change in gains of -$44M), but the LLM interprets this as only $9 million of net gains being recorded, which is a different metric (absolute gains, not change in gains). This is a critical error in quantitative interpretation. (2) The calculation of the difference is based on incorrect data: LLM computes $3,259M - $9M ≈ $3,250M, while the correct calculation per ground truth is $3,259M - (-$44M) = $3,259M + $44M = $3,303M? Wait — actually, the ground truth says 'the decrease in investment value exceeded the change in net gains by $3,215M', which implies $3,259M - $44M = $3,215M, meaning the $44M is treated as a reduction in gains (so the gains were lower by $44M, hence the gap is how much more the value dropped than the gains declined). But the LLM uses $9M in absolute gains, not the $44M change. There is no support in the provided text for the $9M figure being the 'change' in gains — it may be the absolute net gain amount, not the year-over-year change. Thus, the LLM fails to extract the correct comparative figure for net gains *change*. (3) The multi-hop reasoning is partially sound: it connects the change in investment value and the realized gains, but it fails to align the correct comparative metric (change in gains vs. absolute gains). The synthesis is logical but based on incorrect data. (4) The contextual relevance is perfect — it directly addresses the question with appropriate context and citation. Qualitative reasoning is strong but built on a faulty quantitative foundation. Quantitative accuracy is reduced due to the incorrect use of $9M instead of the $44M decrease in gains. Correctness score is 7 because the core value drop is right and the intent of comparison is clear, but the final result is wrong due to incorrect data input for gains.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 559,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "Amazon had the full $7.0 billion of its unsecured revolving credit facility available (no borrowings were outstanding) and $7.2 billion of unused letters of credit as of December 31 2021, giving it a combined unused short‑term credit capacity of **$14.2 billion**【page_57】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.0 billion from the unsecured revolving credit facility and $7.2 billion in unused letters of credit are correctly reported, and their sum, $14.2 billion, is correctly calculated. (2) The answer is complete, addressing both components of unused short-term credit capacity—revolving credit and letters of credit—and specifies the correct date, December 31, 2021. (3) Entity accuracy is correct: Amazon is the subject, and the financial instruments (unsecured revolving credit facility, letters of credit) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that with no borrowings outstanding, the full $7.0 billion facility is available and adds it to the $7.2 billion unused letters of credit to arrive at the total capacity. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., spacing in '$7.0 billion') that do not affect accuracy. The citation reference 【page_57】 adds contextual support without altering correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 329,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "Thermo Fisher’s 2023 cash outflows for acquisitions totalled about **$3.61 billion** – $2.70 billion for the purchase of The Binding Site Group and $0.91 billion for CorEvitas, LLC (the only acquisitions disclosed for the year)【page_24】. Thus, **$2.70 billion** of the total was specifically spent on The Binding Site Group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total cash outflow of $3.61 billion and the $2.70 billion allocated to The Binding Site Group are accurately reported, with an implied correct sum of $2.70B + $0.91B = $3.61B. The format variations ($3.61 billion vs $3.61B) are acceptable. (2) The answer is complete, addressing both parts of the question: total cash outflow and the portion allocated to The Binding Site Group. (3) Entities are correctly identified: TMO (Thermo Fisher Scientific, implied by 'Thermo Fisher' and ticker context), the correct year (2023), and the acquisition targets (The Binding Site Group and CorEvitas, LLC) are accurately named. (4) The reasoning is sound and demonstrates multi-hop synthesis by aggregating disclosed acquisitions from the filing (referencing page 24) and correctly attributing the specific amount to The Binding Site Group. The answer goes beyond the ground truth by providing additional context (CorEvitas, LLC) without introducing error. Semantic equivalence is maintained, and all information aligns with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 320,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Union Pacific’s 2023 data show that 17,705 of its 48,340 chassis units are leased – roughly 36.6 % of the chassis fleet. By contrast, only 545 of its 47,984 containers are leased, which is about 1.1 % of the container fleet, a far smaller proportion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 17,705 leased chassis out of 48,340 total chassis (36.6% leased), and 545 leased containers out of 47,984 total containers (1.1% leased). The percentages match the ground truth calculations exactly. (2) The answer is complete, addressing both parts of the question: the percentage of leased chassis and the comparison with the leased proportion of containers. (3) Entity accuracy is correct—Union Pacific is the right company, and while the year '2023' is mentioned in the LLM answer but not in the original ground truth, this does not contradict the data and is likely a reasonable inference from the source context. (4) The reasoning is sound: the LLM correctly synthesizes the two data points (chassis vs. containers) and draws the appropriate comparison, noting the 'far smaller proportion' for containers, which aligns with the ground truth's 'significantly higher reliance on leasing for chassis.' (5) The semantic meaning is equivalent to the original answer, with no factual or interpretive errors. All scores are maximized due to full factual accuracy, correct calculations, proper multi-hop synthesis, and clear, relevant communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 354,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "The exhibits list **two** supplemental indentures that reference a 2035 Note – the Fifth Supplemental Indenture (dated Sept 14 2015) and the Tenth Supplemental Indenture (dated Nov 20 2024). The most recent of these, the Tenth Supplemental Indenture, names **Computershare Trust Company, National Association** as the trustee.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the numbers and dates are correct: two supplemental indentures are identified, with exact dates of September 14, 2015, and November 20, 2024. These match the ground truth. (2) The trustee for the most recent agreement (Tenth Supplemental Indenture) is correctly identified as Computershare Trust Company, National Association. (3) The multi-hop reasoning is sound—LLM correctly identified the relevant indentures involving the 2035 Note and determined the most recent one to identify the trustee. (4) The only minor omission is that the LLM does not explicitly mention that Computershare is 'as successor to Wells Fargo Bank,' which is included in the ground truth and adds contextual completeness regarding the trustee's succession. However, naming Computershare as the trustee is factually correct and conveys the essential information. Wording differences are acceptable under semantic equivalence. All parts of the question are addressed: quantity (two), identification of agreements, and the trustee in the most recent. Thus, the answer is fully correct with only a slight lack of detail on the trustee's succession status, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 359,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The Company now expenses non‑employee director deferred stock units on a straight‑line basis over the requisite service period, whereas units granted before 2022 vested immediately and the expense was recognized on the grant date【page_64】. For the 2023 awards, vesting occurs at the earlier of the first anniversary of the grant date or the day immediately preceding the next annual meeting of shareholders (subject to acceleration)【page_64】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the change in expensing methodology: awards granted in 2023 are expensed on a straight-line basis over the service period, while those prior to 2022 were expensed in full on the grant date due to immediate vesting. (2) The vesting timeline for 2023 awards is correctly stated as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with mention of subject to acceleration. (3) The multi-hop reasoning is sound—correctly contrasting two different time periods (2023 vs. pre-2022) and synthesizing accounting treatment and vesting terms across them. (4) All entities (non-employee director deferred stock units, 2023 grants, pre-2022 grants) are accurately identified. Minor wording differences (e.g., 'annual meeting of shareholders' vs. 'Annual Meeting of Shareholders') do not affect meaning. Citation to page_64 supports the claims. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 300,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The 2023 operating profit for the Oral, Personal and Home Care segment in the Africa/Eurasia region was **$254 million** (see the operating‑profit table on page 117). The 10‑K pages provided do not disclose the total identifiable‑assets amount for that region and segment, so the profit’s share of those assets cannot be calculated from the information available.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it incorrectly stated that the identifiable assets for that region and business unit were not disclosed, when in fact the ground truth confirms that the identifiable assets were $698 million and the percentage (36.4%) was calculable. This is a critical omission that undermines the completeness of the answer. (2) Quantitatively, the one number provided ($254 million) is accurate, and no incorrect figures were cited. The calculation of 254 / 698 ≈ 36.4% is straightforward and verifiable, but the LLM failed to perform or acknowledge it due to the mistaken belief that asset data was missing. (3) The multi-hop reasoning is flawed: the model needed to extract both operating profit and identifiable assets for the same segment and region, then compute the percentage. While the first hop (profit) was correct, the second hop (assets) was incorrectly dismissed as unavailable, breaking the chain. This suggests either a data retrieval failure or misinterpretation of the 10-K document structure. (4) The contextual relevance is high because the answer addresses the right business, region, and year, and cites a plausible document location. However, the refusal to calculate the percentage—despite the necessary data being present in the ground truth—results in a partially correct answer that fails on completeness and reasoning, warranting a moderate correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 434,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "In fiscal 2024 AMD bought $1.7 billion of inventory from the ATMP joint venture and resold $121 million back to it, for a combined $1.821 billion of purchases + resales【page_74】.  During the same year AMD also made a one‑year term loan to the ATMP JV for $100 million【page_74】—roughly one‑twentieth of the total purchase‑and‑resale amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.7 billion in purchases, $121 million in resales, and a $100 million loan are correctly reported. The combined total of $1.821 billion is accurate and correctly derived from the sum of purchases and resales. (2) The answer addresses all parts of the multi-hop question: it reports AMD's purchases from and resales to the ATMP JV in fiscal year 2024, computes the total, and compares it to the loan amount provided in the same year. (3) Entity accuracy is correct—AMD, ATMP JV, fiscal year 2024, and the financial metrics (purchases, resales, loan) are all properly identified. (4) The reasoning is sound: the model correctly synthesizes information across the transactions and provides a meaningful comparison (noting the loan is roughly one-twentieth of the total transaction volume), which demonstrates strong multi-hop understanding. Minor wording differences (e.g., 'one-year term loan' vs. 'loan') do not affect factual equivalence. Semantic content is fully aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 317,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The Analytical and physical instrumentation line grew from $2.464 billion in 2019 to $2.620 billion in 2021 – an increase of **$156 million**. By contrast, the Research and medical products segment rose from $13.512 billion to $24.802 billion, a **$11.29 billion** increase, which is roughly $11.1 billion (or about 72 times) larger than the growth in the analytical line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Analytical and physical instrumentation revenue increase is correctly calculated as $156 million ($2,620M - $2,464M), and the Research and medical products segment increase is accurately reported as $11.29 billion ($24,802M - $13,512M), which aligns with the ground truth $11,290 million. The comparison stating the latter is roughly $11.1 billion (or about 72 times) larger than the analytical line's growth is logically sound and approximately correct (11,290 / 156 ≈ 72.4). (2) The answer addresses both parts of the multi-part question: the revenue increase for the Analytical and physical instrumentation line and its comparison to the Research and medical products segment. (3) Entities are correctly identified—product lines, time periods (2019 to 2021), and financial metrics (revenue). (4) The reasoning is strong: it performs correct multi-hop synthesis across two product lines and two years, computes differences accurately, and provides a meaningful comparative analysis. Minor formatting differences (e.g., $2.464 billion vs $2,464 million) are semantically equivalent and acceptable. The answer is contextually relevant, complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 360,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "SQL Server is grouped in the Intelligent Cloud segment under “server products and cloud services” (which also includes Azure, Windows Server, Visual Studio, System Center and related CALs)【page_13】.  Its sales – from volume‑licensing, OEM shipments and client‑access‑license (CAL) fees that are reported with the server‑product line – feed directly into the segment’s server‑product revenue, a key driver of the Intelligent Cloud’s overall performance (the segment generated $75.3 billion in FY 2022, with server products and cloud services contributing $67.3 billion)【page_95】【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies SQL Server as part of the Intelligent Cloud segment under 'server products and cloud services' and accurately describes its revenue streams: volume licensing, OEM shipments, and CAL fees, which are reported with server product revenue—matching the original answer's key points. (2) Quantitatively, the LLM provides specific figures: $75.3 billion for the Intelligent Cloud segment in FY2022 and $67.3 billion from server products and cloud services. These numbers are factually correct and consistent with Microsoft's 10-K filings for that period. While the ground truth does not include these specific dollar amounts, their inclusion enhances the answer without introducing error. (3) The multi-hop reasoning is sound—linking SQL Server to the broader server products category, connecting licensing models to revenue recognition, and situating it within the larger segment performance. (4) The only minor limitation is that the original answer emphasizes SQL Server’s role as a 'core component' and its alignment with primary revenue drivers more explicitly, while the LLM focuses slightly more on structural categorization. However, the semantic meaning and factual content are equivalent. No incorrect entities, metrics, or years are used. The answer is fully contextually relevant and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 387,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The Insurance Buy‑in Contracts rose from $950 million at 12/31/2022 to $1,390 million at 12/31/2024 – a net increase of $440 million【page_110】.  The year‑end balances were $1,605 million in 2023 and $1,390 million in 2024【page_109】【page_110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values: $950 million (2022), $1,605 million (2023), and $1,390 million (2024), which match the ground truth exactly. The net increase of $440 million ($1,390M - $950M) is also correctly calculated. (2) Quantitative accuracy is perfect—values and the final difference are accurate, and formatting variations (e.g., $950 million vs $950M) are acceptable. (3) The reasoning is mostly sound: the LLM correctly identifies the 2023 and 2024 balances and computes the overall change. However, it does not explicitly mention the decrease from 2023 to 2024 ($1,605M → $1,390M), which is part of the full narrative in the ground truth. While the numbers are all present, the qualitative synthesis slightly omits the intermediate trend (increase then decrease), which is relevant to 'how this reflects in both the 2023 and 2024 year-end balances.' (4) Despite this minor omission in narrative flow, the answer includes all necessary data points and correctly answers the total change and year-end balances. Thus, correctness is high (9/10), with full marks for quantitative accuracy and contextual relevance, and a 9 in qualitative accuracy due to incomplete trend explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 347,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "As of December 31 2024 Texas Instruments’ U.S. defined‑contribution plans held TI common stock worth **$852 million**, and its non‑U.S. defined‑contribution plans held stock worth **$34 million**, for a combined **$886 million** in value.  Dividends paid on those shares in 2024 were **$26 million** (the non‑U.S. dividends were “not material”).【page_43】【page_44】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, is correctly stated as $886 million, derived from $852 million (U.S.) and $34 million (non-U.S.), and dividends paid during 2024 are correctly reported as $26 million. (2) Quantitative accuracy is perfect: the sum $852M + $34M = $886M is correct, and the dividend amount matches exactly. Minor phrasing about non-U.S. dividends being 'not material' does not contradict the total. (3) Multi-hop reasoning is sound—the model correctly synthesized values from both U.S. and non-U.S. plans and combined them for the total, demonstrating proper cross-document or cross-section synthesis. (4) The answer is semantically equivalent to the original, with added detail that enhances clarity without introducing error. All entities (Texas Instruments, defined contribution plans, 2024 time frame) are correctly identified. The response fully addresses both parts of the question with precise, relevant data and proper context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 321,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The 5.300% senior notes due 2050 were issued for a principal amount of **$1.25 billion** (page 53). The 3.900%, 4.450% and 5.200% senior notes together total **$2.25 billion** (page 53), which is **$1.0 billion more** than the amount of the 5.300% notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: the principal amount of the 5.300% Senior Notes due 2050 is accurately reported as $1.25 billion (equivalent to $1,250 million), and the combined principal of the 3.900%, 4.450%, and 5.200% notes is correctly stated as $2.25 billion ($1,000M + $750M + $500M). The difference of $1.0 billion is also accurate. These values match the ground truth exactly, with acceptable format variation (billion vs million). The answer addresses both parts of the question: the principal amount of the 5.300% notes and the comparison to the combined principal of the other three. However, while the ground truth includes the derived percentage (55.6%), the LLM instead reports the absolute difference ($1.0 billion more). This is a valid and relevant comparison, but it omits the relative proportion mentioned in the original answer, which slightly reduces completeness in multi-hop synthesis. The reasoning is sound and entities (UPS, note rates, years) are correct. The answer is highly relevant and conveys semantically equivalent information, though not all analytical dimensions (percentage) are included.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 326,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "The Service‑Based RSUs that were outstanding on December 31 2023 (1,827 k) and remained outstanding after the year‑end adjustments (1,827 k – 844 k vested – 98 k forfeited = 885 k) represent a total grant‑date fair value of about **$142.7 million** (≈ $161 per RSU). This is derived from the beginning weighted‑average grant‑date fair value ($159.95) less the fair‑value of RSUs that vested ($155.92) and were forfeited ($182.64)【page_135】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result—$142.7 million vs. the ground truth of $183.41 million. This is a significant numerical discrepancy. Additionally, the reasoning incorrectly attempts to adjust the weighted-average grant-date fair value per RSU by subtracting vesting and forfeiture values, which is not how grant-date fair value is calculated. The total grant-date fair value of outstanding RSUs should be based on the number of shares outstanding throughout the period multiplied by their original grant-date fair value, not a per-unit adjustment based on vesting or forfeiture fair values. (2) The calculation provided—1,827k – 844k – 98k = 885k—is numerically correct, but the resulting 885k units are then incorrectly valued at ~$161 per unit to reach $142.7M. However, the ground truth implies a value of approximately $207.24 per unit ($183.41M / 885k), indicating a mismatch in the per-unit valuation. The cited beginning fair value of $159.95 is close but not sufficient to justify the final number, especially since the question asks for the total value of RSUs that remained outstanding all year, which requires tracking specific cohorts, not averaging or adjusting per-unit values post-hoc. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the concept that the grant-date fair value is fixed at issuance and does not change due to subsequent vesting or forfeiture events. It incorrectly treats the fair value as dynamic, subtracting values of vested and forfeited shares, which is not how this metric is computed. (4) Despite the incorrect quantitative result and flawed reasoning, the answer is contextually relevant—it addresses the right metric, time period (2024), and type of RSU (Service-Based), and attempts to account for grants, vesting, and forfeitures. Hence, contextual relevance is moderate. However, due to major factual and conceptual errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 530,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS uses a two‑step, “more‑likely‑than‑not” framework to evaluate uncertain tax positions. First it assesses whether the weight of evidence indicates the position will be sustained on audit; only if that threshold is met is a tax benefit recorded. Second, it measures the largest amount of benefit that is more likely than not to be realized, and any difference between that amount and the total benefit sought is booked as a liability for uncertain tax benefits, which can increase or decrease the tax provision when the positions are re‑evaluated (e.g., due to changes in facts, law or audit outcomes).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: UPS uses a two-step 'more-likely-than-not' process for uncertain tax positions, first assessing whether the position will be sustained on audit, and second measuring the largest benefit that is more likely than not to be realized. The difference is recorded as a liability, which can affect the tax provision upon re-evaluation. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the logical thresholds ('more-likely-than-not') are correctly represented. (3) The multi-hop reasoning is sound—synthesizing the recognition and measurement criteria, their impact on the tax provision, and the triggers for re-evaluation (changes in facts, law, audit outcomes). (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'quarterly reevaluations' as stated in the original answer, though it does reference re-evaluation due to changes, which implies ongoing assessment. This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 358,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "In 2021 the company recorded **$33 million** of capital expenditures for the Africa/Eurasia segment (see the capital‑expenditure table on page 117).  During the same year, **organic sales in Africa/Eurasia grew 7.0%** (as noted on page 43).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the capital expenditure in Africa/Eurasia in 2021 is correctly stated as $33 million, and the organic sales increase is accurately reported as 7.0%. (2) Quantitative values are precise and match the original answer exactly; format variations (e.g., $33 million vs $33 million) are acceptable and semantically equivalent. (3) The reasoning is sound and demonstrates proper synthesis of information across different parts of the document (pages 117 and 43), confirming multi-hop understanding. (4) The answer is contextually relevant, directly addressing both parts of the question with correct metrics, region, and year. No errors in entities, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1097,
        "completion_tokens": 229,
        "total_tokens": 1327
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "Johnson & Johnson’s Contact Lenses/Other line grew from $2.994 billion in 2020 to $3.440 billion in 2021 – an increase of roughly $446 million (about 14.9%)【page_33】. That $446 million gain supplied more than half of the Vision franchise’s total rise (from $3.919 billion to $4.688 billion, a $769 million or 19.6% increase), driving a key portion of the Vision segment’s overall growth【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: Contact Lenses/Other sales increased from $2,994 million to $3,440 million, a $446 million increase; Vision segment sales grew from $3,919 million to $4,688 million, a $769 million increase. These match the ground truth exactly. The LLM uses billion formatting ($2.994 billion = $2,994 million), which is semantically equivalent and acceptable. (2) Calculations are accurate: $3.440B - $2.994B = $0.446B = $446M; $4.688B - $3.919B = $0.769B = $769M. The implied percentage contribution (more than half) aligns with the ground truth's 58%, though the LLM does not compute the exact 58% figure. This is a minor omission but does not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM correctly links the growth in Contact Lenses/Other to the overall Vision segment growth, noting it supplied 'more than half' of the total increase, which is consistent with 58%. The logic and synthesis across entities and years are correct. (4) All entities (Johnson & Johnson, Contact Lenses/Other, Vision segment), years (2020 to 2021), and metrics (sales growth) are accurately identified. The answer is contextually complete and relevant. The only reason for not scoring 10 is the lack of explicit calculation of the 58% contribution, though 'more than half' is a reasonable qualitative approximation. Overall, the answer is factually correct, well-reasoned, and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 407,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The consolidation of AspenTech caused the Control Systems & Software segment’s earnings to fall by $27 million – a 6 % decline – and its margin to shrink by 3.1 percentage points, from 14.7 % in 2022 to 11.6 % in 2023, mainly because of the incremental intangibles amortization tied to the AspenTech acquisition【page_32】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative claims. It states that segment earnings fell by $27 million (6% decline), but the ground truth shows segment earnings actually increased from $437 million in 2022 to $529 million in 2023 — a $92 million increase, not a decline. The LLM incorrectly claims earnings fell, which is the opposite of the truth. However, the margin decline from 14.7% to 11.6% (3.1 percentage points) is correctly reported. (2) The AspenTech-specific numbers are missing: the $12 million earnings in 2022 and $107 million loss in 2023, and the resulting $119 million deterioration, which is central to the explanation. The LLM attributes the margin decline to 'intangibles amortization' (plausible) but omits the actual earnings swing, which is critical for multi-hop reasoning. (3) The reasoning is partially sound in linking AspenTech’s consolidation to margin pressure, but fails to correctly synthesize the overall segment earnings trend. It incorrectly concludes earnings declined when they actually rose despite AspenTech’s drag, which reflects flawed multi-hop logic. (4) Scores reflect major quantitative errors (especially the false earnings decline), partial qualitative accuracy in identifying the margin impact and cause, and high contextual relevance as it addresses the right segment, company, year, and general direction of impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 392,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded a $861 million accrual for U.S.‑covered litigation in fiscal 2022. Under the U.S. Retrospective Responsibility Plan, the monetary liability is recovered by a downward adjustment to the conversion rate at which Visa’s class B common‑stock shares convert into class A common‑stock shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $861 million liability amount for fiscal 2022 is accurately reported, matching the original answer exactly. (2) The explanation of recovery under the U.S. Retrospective Responsibility Plan—via a downward adjustment to the conversion rate from class B to class A common stock—is factually and contextually accurate. (3) The multi-hop reasoning is sound: the answer correctly identifies both the financial impact (liability amount) and the mechanism of recovery (conversion rate adjustment), synthesizing information that spans accounting and corporate governance aspects of Visa's filings. (4) All entities—Visa, U.S. covered litigation, fiscal 2022, class B and class A common stock—are correctly identified and used in the right context. Wording differs slightly (e.g., 'accrual' vs 'recorded liability'), but this does not affect factual accuracy. No errors in reasoning, numbers, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 288,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "Pfizer’s historical ownership of Meridian cost the company about $947 million in 2021 – a $435 million net loss from Meridian’s discontinued‑operations results (the sum of the quarterly net‑of‑tax figures of $1 million, –$236 million, –$13 million and –$187 million) plus a $345 million pre‑tax charge in Q2 and a $167 million after‑tax loss in Q4 related to Meridian’s sale.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total financial impact figure. The ground truth states a total negative impact of $512 million, composed of a $345 million pre-tax legal charge and a $167 million after-tax loss from the sale. However, the LLM claims a total cost of $947 million, which incorrectly adds a $435 million net loss from discontinued operations that is not mentioned in the ground truth. This $435 million figure appears to be fabricated or misattributed, as the original answer does not reference quarterly net-of-tax figures or any such sum. (2) The individual components of $345 million pre-tax charge (Q2) and $167 million after-tax loss (Q4) are correctly identified and match the ground truth in amount and context. However, the addition of the $435 million loss invalidates the overall calculation. The total $947 million is therefore a significant overstatement and factually wrong. (3) The reasoning is flawed in multi-hop synthesis: while the model correctly identifies two real components of the financial impact, it introduces a third element (discontinued operations losses) that is not part of the ground truth, suggesting either hallucination or incorrect data integration. The model fails to correctly synthesize only the two components specified in the original answer. (4) Despite the incorrect total and extra data, the answer is contextually relevant and attempts to address both operational results and post-closing adjustments. The qualitative reasoning shows an attempt at detailed breakdown, but with critical factual errors. Hence, low scores on correctness and quantitative accuracy, moderate on qualitative accuracy, and high on contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 467,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "Bank of America Corporation must keep a supplementary leverage ratio of **3.0 % plus a 2.0 % leverage buffer – i.e., a total minimum SLR of 5.0 %** under Basel III (see the regulatory‑minimum column in Table 10 and the note that the SLR minimum includes a 2.0 % buffer)【page_51】. By contrast, its **insured depository‑institution subsidiaries must maintain a higher minimum SLR of 6.0 %** to be deemed well‑capitalized under the PCA framework【page_145】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Bank of America Corporation must maintain a 3.0% minimum SLR plus a 2.0% leverage buffer, totaling 5.0%, which aligns with Basel III requirements to avoid restrictions on capital distributions and bonuses. The insured depository institution subsidiaries must maintain a 6.0% SLR to be well-capitalized under the PCA framework—this is correctly stated. (2) The answer is complete, addressing both parts of the multi-part question: the parent company’s requirement and how it differs from its subsidiaries. (3) Entity accuracy is correct—'Bank of America Corporation' and 'insured depository institution subsidiaries' are properly identified, and the regulatory frameworks (Basel III and PCA) are correctly associated. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly distinguishes between consolidated holding company requirements and standalone bank-level requirements, citing appropriate regulatory contexts. (5) Semantic equivalence is maintained—though the LLM includes citation markers like 【page_51】 and 【page_145】, the core information is factually identical to the original answer. Minor formatting differences (e.g., '5.0 %' vs '5.0 percent') do not affect meaning. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 381,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "When the new credit‑loss guidance took effect on 1 January 2020, MetLife began recording an allowance for credit losses (ACL) on its mortgage‑loan portfolio at the time each loan is purchased, based on the expected lifetime loss, and the loans are presented net of that allowance. This replaced the prior incurred‑loss approach—where a loss was recognized only when it became probable—so credit‑loss expense is now recognized up‑front in earnings (within net investment gains/losses) and subsequently adjusted as expectations change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the adoption date of the credit loss guidance as January 1, 2020, matching the original answer. (2) The key change in accounting treatment—from an incurred loss model to an expected credit loss model—is accurately described: MetLife now establishes an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than waiting for a loss to be probable. (3) The impact on timing—earlier recognition of credit losses, with initial recognition at purchase and subsequent adjustments—is clearly conveyed, including the placement of the expense in net investment gains/losses. (4) The presentation of mortgage loans at net amount expected to be collected (i.e., gross loans less ACL) is correctly implied by stating loans are 'presented net of that allowance.' All entities (MetLife, mortgage loans, ACL, credit loss guidance) and financial concepts are accurate. There are no calculation errors or factual inaccuracies. The answer fully addresses both parts of the question: the change in allowance treatment and the shift in timing of credit loss recognition. Multi-hop reasoning is sound, synthesizing the standard change (ASC 326) with its specific application to MetLife's mortgage loan portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 376,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The January 1 2020 adoption replaced MetLife’s incurred‑loss approach (recognizing a loss only when it was probable that cash would not be collected) with an expected‑credit‑loss (ECL) approach that records an allowance for expected lifetime credit loss at acquisition and updates it each reporting period (page 69). For leveraged‑lease receivables the ECL is measured with a probability‑of‑default / loss‑given‑default model that uses third‑party lessee credit ratings, historical default data and market information on residual‑value recoverability (page 233). For mortgage loans the allowance is calculated using an expected‑lifetime credit‑loss methodology that pools loans by risk characteristics (or evaluates them individually), adjusts for expected prepayments and extensions, and incorporates past events, current and forecasted economic conditions such as unemployment, interest‑rate and housing‑price trends (page 69).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) It accurately states the change in timing and methodology from an incurred loss model to an expected lifetime credit loss model effective January 1, 2020, which aligns with the original answer. (2) For leveraged lease receivables, it correctly identifies the use of a probability of default / loss given default model, incorporating third-party credit ratings and historical default data—adding the additional detail of 'market information on residual-value recoverability' which is consistent and enhances accuracy without contradicting the ground truth. (3) For mortgage loans, it correctly describes the use of expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, and explicitly mentions the inclusion of past events, current conditions, and forecasted economic factors such as unemployment, interest rates, and housing prices—this expands on the original with specific examples but remains semantically equivalent and factually accurate. (4) The reasoning correctly synthesizes multi-hop information across both asset types and reflects the shift in accounting principle. All entities (leveraged lease receivables, mortgage loans, ECL model) and dates (January 1, 2020) are correct. Minor enhancements in detail (e.g., 'pools loans by risk characteristics', 'updates each reporting period') are consistent with the guidance and do not introduce error. No factual inaccuracies, omissions, or calculation issues exist. The answer is quantitatively and qualitatively precise, contextually relevant, and demonstrates sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 452,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments’ investment in 300‑mm wafer fabs gives its analog chips an estimated 40 % lower cost than 200‑mm wafers, which lifts gross margins (67.5 % in 2021) and fuels strong operating cash flow ($8.8 bn) and free cash flow ($6.3 bn). Because this low‑cost, high‑control manufacturing platform is a core competitive advantage in its business model, the company can generate excess cash and return $4.4 bn to shareholders through dividends and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states the 40% cost reduction from using 300-mm wafers vs. 200-mm wafers, which matches the original answer. (2) It adds specific financial figures—gross margin of 67.5% in 2021, operating cash flow of $8.8B, free cash flow of $6.3B, and $4.4B returned to shareholders—which are factually correct based on TI's 2021 10-K and enhance the response, though these specific numbers were not in the ground truth. Their inclusion improves completeness and context without introducing error. (3) The reasoning correctly traces the causal chain: larger wafers → lower cost per chip → higher gross margins → strong cash flow generation → ability to return cash to shareholders. This reflects sound multi-hop logic across manufacturing advantage to financial outcomes. (4) All entities (Texas Instruments, analog chips, 300-mm and 200-mm wafers) are accurate, and the answer fully addresses the question about how the structural cost advantage enables cash generation and returns. The only minor limitation is that the ground truth emphasizes 'control over the supply chain' and 'long-term free cash flow per share growth' as strategic objectives, which the LLM mentions implicitly but could have stated more explicitly. However, the core facts, calculations, and logic are correct, and the added data points strengthen the answer. Thus, the response earns a 9/10 for correctness—excellent but not perfect in mirroring the full strategic framing of the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 421,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "As of December 31 2021, Thermo Fisher’s 1.5‑year floating‑rate senior notes (SOFR + 0.35%) carried a principal amount of **$1,000 million**【page_87】, whereas the 2‑year floating‑rate senior notes (SOFR + 0.39%) due October 18 2023 were **$500 million**【page_87】. Thus, the 1.5‑year notes were twice the size of the 2‑year notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes as $1,000 million and the 2-Year Floating Rate (SOFR + 0.39%) Senior Notes as $500 million as of December 31, 2021, matching the ground truth exactly. (2) All numeric values are accurate, including the dollar amounts and the implied comparison (twice the size), with no calculation errors. Format variations ($1,000 million vs $1,000M) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about two different notes (maturity, rate structure, due date) issued by TMO (Thermo Fisher Scientific Inc.) and compares their values on the same date. (4) The answer is fully complete, addressing both parts of the question—value of each note and their relative comparison—and uses correct entities (TMO/Thermo Fisher, correct interest rate spreads, correct maturity dates). Wording differs slightly but conveys identical meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 311,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31 2023 UnitedHealth Group had 53 million shares of common stock available for future issuance under its 2020 Stock Incentive Plan and 17 million shares available under its 1993 Employee Stock Purchase Plan, for a combined total of 70 million shares. The 2020 Stock Incentive Plan had the larger share pool (53 million versus 17 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: 53 million shares available under the 2020 Stock Incentive Plan, 17 million under the ESPP, and a combined total of 70 million shares—correctly calculated (53 + 17 = 70). (2) The date 'December 31, 2023' is correctly stated. (3) Entity names are accurate: '2020 Stock Incentive Plan' and '1993 Employee Stock Purchase Plan (ESPP)' are correctly identified. (4) The comparison is sound—the LLM correctly identifies that the 2020 Stock Incentive Plan had more shares available (53 million vs. 17 million). (5) The answer addresses both parts of the multi-hop question: total shares available and which plan had more. Wording differs slightly but maintains semantic equivalence. No errors in reasoning, calculation, or entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 251,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "Caterpillar reported a $701 million non‑current liability for post‑employment benefits in 2023 (the liability includes $56 million for other post‑employment benefits and $565 million for non‑qualified deferred‑compensation plans) 【page_93】. Because all U.S. pension benefits were frozen on Dec 31 2019, the expected rate of compensation‑increase assumption is no longer applicable (shown as “‑ %”) and there is no service‑cost component for U.S. pension plans, which changes the actuarial assumptions used in the financial statements 【page_46】【page_95】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total liability for postemployment benefits as $701 million, whereas the ground truth is $621 million. This discrepancy is significant and incorrect, despite correctly breaking down the $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans, which sum to $621 million. The LLM appears to have added an unexplained $80 million, possibly misreading or misstating the total. (2) The quantitative accuracy is low because the total dollar amount is wrong, even though the two component figures are correct. The sum of $56M + $565M is $621M, not $701M, indicating a clear calculation or transcription error. All dates (Dec 31, 2019 freeze) are accurate. (3) The qualitative reasoning is strong: the LLM correctly identifies the impact of the pension freeze—elimination of service cost and the inapplicability of the compensation increase assumption—and supports this with correct logic and references to actuarial assumptions. It properly synthesizes information across multiple pages and connects the freeze to changes in financial reporting assumptions. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question and provides relevant details from the source documents. However, the major numerical error in the total liability significantly undermines factual correctness, warranting a moderate overall score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 402,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "In 2024 Merck’s U.S. pension plans held $2.555 billion of developed‑market equity investment‑fund assets plus $2.171 billion of developed‑market equity securities, for a combined fair‑value of roughly **$4.73 billion**.  In the prior year the same categories totaled $2.797 billion + $2.071 billion = **$4.87 billion**, so the 2024 total was about **$0.14 billion lower** than 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial values: $2.555 billion (investment funds) and $2.171 billion (equity securities) in 2024, and $2.797 billion and $2.071 billion in 2023. These match the ground truth exactly, though expressed in billions instead of millions. The total 2024 value is correctly calculated as approximately $4.73 billion (actual: $4,726 million), and 2023 total as $4.87 billion (actual: $4,868 million). The year-over-year decrease is reported as $0.14 billion ($140 million), which is a rounded but acceptable approximation of the exact $142 million decrease. (2) All numbers are factually correct with only minor rounding in the final comparison, which does not affect overall accuracy. The use of 'billion' instead of 'million' is a valid format variation and does not introduce error. (3) The multi-hop reasoning is sound: the model correctly aggregates values across two asset categories (investment funds and equity securities) and two years, then computes the year-over-year difference. It synthesizes information correctly for Merck's U.S. Pension Plans and developed markets equities. (4) The answer is semantically equivalent to the ground truth, with clear, concise presentation. The only minor shortcoming is the rounding of the decrease from $142 million to $140 million, which prevents a perfect 10. Scores reflect high accuracy in all dimensions, with full contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 399,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorizes roughly **135 million shares** of Danaher common stock for issuance since the plan’s inception. As of December 31 2024, about **47 million shares** remain available for issuance under the plan (excluding shares already underlying outstanding options, RSUs and PSUs).【page_96】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, both the total authorized shares (135 million) and the remaining available shares (47 million) as of December 31, 2024, are correct. The formatting (135 million vs. 135 million) is acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-part question: total shares authorized since inception and shares remaining as of a specific date. (3) The entities—Danaher, the 2007 Omnibus Incentive Plan, stock options, RSUs, and PSUs—are correctly identified and contextually appropriate. (4) The reasoning is sound: the model correctly infers that remaining shares exclude those already issued or underlying outstanding awards, which is consistent with typical plan disclosures and the ground truth’s intent. The only minor issue is the parenthetical clarification 'excluding shares already underlying outstanding options, RSUs and PSUs', which, while logically valid, slightly reframes the ground truth’s more direct statement about accounting for issued shares. However, this does not introduce inaccuracy but adds interpretive detail. Thus, the answer is factually correct, complete, and contextually precise, warranting a high score with only a slight deduction in qualitative accuracy due to the nuanced phrasing difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 374,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The rise in Google Play sales lifts the share of non‑advertising revenue in Alphabet’s mix, and because non‑advertising streams “may be lower than the margins on our advertising revenues” (page 30) and “monetize at a lower rate than our traditional search ads” (page 29), a larger Google Play contribution can drag down the overall profit margin. In other words, as Google Play’s revenue grows, the higher‑margin advertising base is diluted by the lower‑margin non‑advertising earnings, putting pressure on total margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Google Play's growing revenue is part of non-advertising revenues, which have lower margins than advertising revenues, and explains that this shift can dilute overall profit margins. The answer cites specific page numbers (29 and 30) from the 10-K, indicating accurate sourcing, and uses direct quotes to support its claims—though the exact page numbers are not verifiable without the document, their inclusion suggests fidelity to the source. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are misstated). The reasoning is sound: it correctly synthesizes the relationship between revenue mix changes and margin pressure, capturing the multi-hop logic (Google Play growth → higher non-advertising revenue share → lower average margin if non-ads are lower-margin → downward pressure on overall margins). The only minor shortcoming is that it does not explicitly mention potential offsets (e.g., operational efficiencies or higher-margin offerings within non-advertising), which the original answer includes as a caveat. However, this omission does not invalidate the core correctness. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 364,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS hedges its credit‑quality risk primarily with credit‑default swaps (CDS) – one of the suite of derivatives it employs for risk management.  The company says that, when used for hedging, these CDS (along with other hedging derivatives such as swaps, forwards, futures, warrants and put options) are expected to offset credit‑rating and spread exposures and thereby **reduce its overall risk profile**.【page_102】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All financial instruments listed—credit default swaps, swaps, forwards, futures, warrants, and put options—are accurately mentioned in both answers; the LLM groups them under 'other hedging derivatives' which preserves accuracy while summarizing. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable but assumed correct by absence. (3) The multi-hop reasoning is sound: the LLM correctly identifies the instruments and synthesizes their intended effect—reducing overall risk exposure through hedging—despite acknowledging residual risks (interest rate, credit, etc.), which aligns with the original answer’s nuance. (4) The phrase 'reduce its overall risk profile' matches the original answer’s 'reduce overall risk', and the mention of separate risk exposures is implied in the original but slightly under-articulated in the LLM response; however, this does not constitute a factual error. The citation [page_102] adds contextual support. Minor omission of explicit mention of 'interest rate swaps' and 'treasury rate locks' by name is compensated by the inclusive reference to 'swaps' and 'other hedging derivatives'. Thus, the answer is highly accurate with negligible abstraction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 373,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "In 2021 the company held **$682 million** of hedge‑fund/limited‑partnership assets in its U.S. pension plans and **$9 million** in its other post‑retirement benefit plans, for a combined total of **$691 million** invested in hedge funds/limited partnerships【page_101】【page_103】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual amounts—$682 million for U.S. Pension Plans and $9 million for Other Postretirement Benefit Plans—are accurate, and their sum, $691 million, is correctly calculated. Minor formatting differences (e.g., use of en-dash in 'hedge‑fund/limited‑partnership' or spacing in '$682 million') do not affect meaning or accuracy. (2) The answer is complete, addressing both components of the multi-part question: the individual investments and the total across both plan types. (3) Entity accuracy is correct—'U.S. Pension Plans' and 'Other Postretirement Benefit Plans' are properly identified, and the year 2021 is correctly referenced. (4) The reasoning is sound: the model correctly synthesized data from two sources (as indicated by citations to page_101 and page_103) and performed the correct aggregation across entities, demonstrating accurate multi-hop logic. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement of the same facts and calculation. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 322,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "UNP owned or leased **56,176 freight cars** as of December 31 2024【page_19】. In 2024 the company allocated **$788 million** for locomotives and freight‑car purchases, a figure that **includes $143 million of lease‑buyout costs**【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total number of freight cars UNP owns or leases as 56,176 as of 2024, matching the ground truth. It also accurately reports that $143 million of the capital expenditure was allocated to lease buyouts for freight cars, which directly answers the second part of the question regarding spending on acquiring freight cars in 2024. The mention of a $788 million allocation for locomotives and freight cars is additional context not in the ground truth but does not contradict it; importantly, the LLM correctly isolates the $143 million as the amount tied to freight car acquisition via lease buyouts, which aligns with the ground truth. All numbers are factually correct and properly cited to relevant pages. The reasoning is sound and reflects multi-hop synthesis by connecting lease buyout figures to freight car acquisition costs. The only minor point is that the LLM does not explicitly state that the $143 million is the total spent on freight car acquisition (as opposed to part of a larger locomotive-and-cars budget), but it clearly attributes the $143 million to lease buyouts for freight cars, which is semantically equivalent. Thus, the answer is quantitatively accurate and contextually relevant, with excellent qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 357,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The net unrealized gain on non‑marketable equity securities rose from $1.531 billion in 2020 to $9.849 billion in 2021 – an increase of **about $8.3 billion (≈ $8,318 million)**. This rise in the non‑marketable equity portfolio accounts for the bulk of the $5.2 billion jump in other income (expense), net between 2020 and 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that the increase in net unrealized gains on non-marketable equity securities was about $8.3 billion ($8,318 million), calculated as the difference between $9.849 billion in 2021 and $1.531 billion in 2020. However, the ground truth states that the contribution to the increase in other income was $6.9 billion, not $8.3 billion. This overstates the contribution by approximately $1.4 billion. Additionally, while the LLM correctly notes that other income increased by $5.2 billion, it fails to mention the offsetting $1.3 billion increase in accrued performance fees, which is critical context for understanding why a $6.9 billion gain led to only a $5.2 billion net increase. (2) The calculation of the change in unrealized gains is mathematically correct ($9.849B - $1.531B = $8.318B), but this figure does not answer the question — the question asks for the contribution to the *overall increase in other income*, not the gross change in gains. The ground truth specifies that the *contribution* was $6.9B, implying that other adjustments or offsets exist within the income statement. The LLM confuses gross change in gains with net contribution to income. (3) The multi-hop reasoning is partially sound — the model identifies the relevant metric (unrealized gains on non-marketable securities) and links it to other income, but it fails to fully synthesize the complete picture by omitting the offsetting performance fees and misrepresenting the net contribution. (4) The contextual relevance is high because the answer addresses the right topic, company (implied as Google/Alphabet), time period, and financial statement impact. However, due to the major error in the key quantitative claim, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 498,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The ASR executed in 2022 (the $1.5 billion Barclays deal) carried a $0.3 billion forward contract, and the ASR executed in 2023 (the $2.0 billion Citibank deal) carried a $0.4 billion forward contract – together totalling $0.7 billion. Each forward contract was initially recorded as an equity instrument in capital surplus, and when the final share deliveries were received (February 2022 and February 2023) the contracts were re‑classified from capital surplus into treasury stock.【page_92】【page_70】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of the forward contracts as $0.7 billion, with $0.3 billion in 2022 and $0.4 billion in 2023, matching the ground truth exactly. The classification of the contracts as equity instruments initially recorded in capital surplus and reclassified to treasury stock upon final settlement is also accurate. (2) All numeric values are correct: $0.3B (2022), $0.4B (2023), and total $0.7B. The mention of specific banks (Barclays, Citibank) and transaction sizes ($1.5B, $2.0B) adds contextual detail not in the ground truth but does not contradict it and may reflect additional filing information. The settlement dates (February 2022, February 2023) are plausible and consistent with timing expectations, though not specified in the ground truth—this is a minor addition but not an error. (3) The multi-hop reasoning is sound: the model correctly associates ASR transactions in two different years with their respective forward contract values and tracks the accounting treatment across time, synthesizing information about classification and reclassification. (4) The answer is semantically equivalent to the ground truth, with slightly more detail. The only reason for not scoring a 10 is that the original answer does not specify settlement in February or the counterparties, so including them, while not incorrect, introduces unverified specifics—this is a minor issue affecting qualitative precision but not factual correctness. Overall, the response is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 428,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Benefit Restoration Plan is a supplemental plan that “supplements benefits provided under the 401(k) Plan to participants whose benefits are restricted as a result of certain provisions of the Internal Revenue Code of 1986.” It allows those eligible employees to make additional salary‑deferral contributions and receive a matching employer contribution, thereby restoring the benefits that the IRC restrictions would otherwise limit 【page_64】.  In other words, it works alongside the defined‑contribution 401(k) plan to offset the IRC‑imposed restrictions for eligible employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core function of the Benefit Restoration Plan in relation to the 401(k) Plan and IRC restrictions, aligning with the ground truth. It accurately states that the plan supplements benefits for participants affected by Internal Revenue Code restrictions and explains the mechanism—allowing additional deferrals and matching contributions—thereby restoring lost benefits. The qualitative reasoning is sound and reflects proper multi-hop synthesis between the Benefit Restoration Plan and the defined contribution plan. However, the LLM answer does not include the specific quantitative detail from the ground truth that the Company Match under the 401(k) Plan is up to 4.25% of eligible compensation and that this match is mirrored in the Benefit Restoration Plan. While the concept of matching contributions is mentioned, the exact percentage (4.25%) is omitted, which slightly reduces completeness and precision. All other entities (Lowe's Companies, 401(k) Plan, Internal Revenue Code of 1986, Benefit Restoration Plan) are correctly identified and contextualized. The answer is semantically equivalent in intent and meaning but lacks one key numeric detail, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 348,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "At December 31 2023, CS&Co had $950 million and TDAC $700 million outstanding on their secured uncommitted credit facilities – a combined $1.65 billion.  The firm’s total borrowing capacity for its uncommitted lines of credit is $1.8 billion, so the outstanding amount is about $150 million below the available capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical values: $950 million for CS&Co, $700 million for TDAC, and a total outstanding of $1.65 billion at December 31, 2023, which matches the ground truth. The total borrowing capacity of $1.8 billion is also accurately stated. The calculation of the outstanding amount is correct ($950M + $700M = $1.65B), and the difference from capacity is correctly implied as $150 million. However, the LLM states the outstanding amount is 'about $150 million below the available capacity,' which is factually correct, but it omits the explicit utilization rate of approximately 91.7% mentioned in the original answer. While the quantitative information is accurate, the qualitative reasoning is slightly less complete because it fails to synthesize the utilization rate, which is a key comparative metric requested in the question ('how does this compare to the total borrowing capacity'). The entities (CS&Co, TDAC), time period (December 31, 2023), and financial terms (secured uncommitted lines of credit) are all correctly identified and used. The answer is contextually relevant and well-structured, but the missing utilization rate calculation—though easily inferred—represents a minor gap in completeness for a multi-hop financial comparison. Hence, a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 367,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "At December 31 2021 Coca‑Cola’s pension‑plan assets included **$850 million** in mutual, pooled and commingled funds (U.S. $290 million + non‑U.S. $560 million)【page_101】. In the same year the company held **$720 million** in hedge funds/limited partnerships and **$389 million** in real‑estate assets, for a combined total of **$1.109 billion**—about **$259 million more** than its mutual‑fund holdings【page_101】【page_117】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in terms of factual content. The ground truth states that Coca-Cola's investments in mutual, pooled, and commingled funds were $87 million at the end of 2021, while the LLM claims $850 million. Similarly, the ground truth reports hedge funds/limited partnerships at $9 million and real estate at $5 million (combined $14 million), but the LLM reports $720 million and $389 million respectively—over 50 times higher. These numbers do not match any plausible interpretation or formatting variation. (2) Calculations are also wrong: the LLM computes a combined total of $1.109 billion for hedge funds and real estate, which is grossly inaccurate compared to the correct sum of $14 million. The comparison conclusion—that mutual fund holdings were smaller than the other two categories—is the opposite of the truth, where $87 million is significantly larger than $14 million. (3) Multi-hop reasoning failed: the model did not correctly identify or synthesize the relevant data points from the knowledge base. It appears to have either hallucinated figures or pulled data from an unrelated context (possibly pension-plan assets of another company or misattributed data). (4) Scores are low because all key financial figures are factually wrong, the comparison is inverted, and the reasoning is unsound. The only partial credit for contextual relevance is due to the answer addressing the right categories and time frame, albeit with false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 412,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "Simon treats earned LTIP units— which receive distributions equal to 10 % of the Operating Partnership’s regular quarterly distributions— as participating securities. Accordingly, they are included in the earnings‑per‑share denominator under the two‑class method, but the company notes that these units have no material dilutive effect, so they do not change the reported EPS.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that LTIP units receive distributions equal to 10% of the regular quarterly distributions on Operating Partnership units and are treated as participating securities under the two-class method, which aligns with the ground truth. The quantitative accuracy is perfect—10% is correctly cited, and no other numbers are involved. (2) However, the LLM adds a claim not present in the original answer—that these units have 'no material dilutive effect' and 'do not change the reported EPS.' This is a significant qualitative deviation because the ground truth does not make any assertion about materiality or lack of impact on EPS; it explicitly states that the participation affects the allocation of earnings and thus impacts EPS. This misrepresents the extent and implication of the accounting treatment. (3) The multi-hop reasoning is partially sound: the model correctly links the 10% distribution feature to participating security status and the two-class method. But it fails to explain *how* the two-class method works—by allocating earnings between common shares and participating securities—which is central to the impact on EPS. Instead, it incorrectly concludes there is no effect. (4) The contextual relevance is high because the answer addresses the core mechanism (treatment as participating securities due to distribution rights), but the incorrect conclusion about dilutive impact reduces qualitative accuracy. Correctness score is 7 because key facts are right, but the final implication is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 430,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "NEE’s non‑controlling‑interest investment in X PLR OpCo was about **$3.3 billion** as of December 31 2024【page_98†L13-L16】.  X PLR OpCo is a limited‑partner/limited‑member structure that, because the non‑managing members lack substantive rights over the entity’s significant activities, is treated as a **Variable‑Interest Entity (VIE)** and is accounted for under the equity‑method rather than consolidated on NEE’s balance sheet【page_98†L7-L11】【page_97†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that NEE's noncontrolling interest investment in XPLR OpCo was $3.3 billion as of December 31, 2024, which is a close approximation to the ground truth value of $3,315 million. The minor discrepancy is due to rounding ($3.3 billion = $3,300 million), which is acceptable under the evaluation criteria allowing for format and rounding variations. (2) The classification of XPLR OpCo as a Variable Interest Entity (VIE) where NEE is not the primary beneficiary due to lack of control over significant activities is accurately conveyed, with correct reasoning tied to governance structure (limited-partner/limited-member form and lack of substantive rights). The conclusion that it is accounted for under the equity method aligns exactly with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information about ownership interest, entity structure, control characteristics, and accounting treatment from multiple cited pages, correctly inferring that absence of control leads to non-consolidation and equity-method accounting. (4) All entities (NEE, XPLR OpCo), dates (December 31, 2024), and financial terms (noncontrolling interest, VIE, equity method) are accurate. The answer is contextually complete and directly responsive. A score of 9 is given instead of 10 because the exact figure ($3,315 million) was rounded down slightly, though this does not constitute a material error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 404,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde supplies process gases through **three** distribution methods – on‑site (tonnage), merchant (bulk liquid) and packaged (cylinder) ​【page_87】. The on‑site method is reserved for the largest‑volume, steady‑demand customers and is governed by long‑term total‑requirement contracts that typically run **10‑20 years** and include **minimum purchase requirements**, whereas merchant contracts are usually **3‑7 years** and packaged contracts **1‑3 years**, both without any minimum‑volume commitments ​【page_87】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Linde uses three distribution methods: on-site, merchant, and packaged—using equivalent terminology (on-site/tonnage, merchant/bulk liquid, packaged/cylinder). (2) Quantitatively, all contract durations are correct: 10–20 years for on-site, 3–7 years for merchant, and 1–3 years for packaged. These match the original answer exactly, with acceptable formatting variations. The presence of minimum purchase requirements for on-site and their absence in the other two methods is correctly noted. (3) The multi-hop reasoning is sound: the answer synthesizes differences in contract duration and volume requirements across the three methods, directly addressing how on-site differs from the others. (4) The semantic meaning is equivalent to the original answer, with slightly more technical terminology (e.g., 'total-requirement contracts') that enhances clarity without altering facts. All entities (Linde, process gases, distribution methods) are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 319,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The Board’s April 2021 resolution gave Alphabet the authority to buy back as much as $50 billion of its Class C capital stock, a share‑repurchase program that is distinct from any split.  By contrast, the February 1 2022 announcement of a 20‑for‑one stock split (a one‑time special dividend) for Class C (and Class A and B) shares was also Board‑approved but could not be effected until stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to increase the authorized shares of each class【page_79†L13-L20】【page_79†L22-L27】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $50.0 billion Class C stock repurchase authorization in April 2021 and the February 2022 announcement of the 20-for-one stock split. It accurately states that the stock split required stockholder approval of an amendment to the Amended and Restated Certificate of Incorporation to increase the authorized shares of Class A, B, and C stock. (2) All quantitative elements are correct: the $50 billion repurchase amount, April 2021 and February 2022 dates, and the 20-for-one split ratio are all factually accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly links the need for increased authorized shares to both accommodate the stock split and preserve capacity for the repurchase program, even though it frames the split and repurchase as distinct actions. The original answer emphasizes that the share increase was necessary to support both the split and the ongoing repurchase, which the LLM answer implies by noting the split couldn't proceed without the amendment, but does not explicitly connect the repurchase program as a motivating factor for the share increase. This is a minor omission in synthesis. (4) The answer is contextually precise, directly addressing both parts of the question—relationship between the split and prior authorization, and the condition for the split. Wording differs slightly but maintains semantic equivalence. A score of 9 is justified due to high factual accuracy and strong reasoning, with only a slight gap in fully articulating the interdependence between the repurchase program and the need for additional authorized shares.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 455,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "GM reported $293 million of equity earnings from Ultium Cells Holdings LLC for 2023, and as of December 31 2023 it still had roughly $0.8 billion (≈ $800 million) of committed capital contributions outstanding to that entity.【page_101】【page_80】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million and the committed capital contributions of $0.8 billion (explicitly noted as ≈ $800 million) are accurate and match the original answer exactly, with acceptable formatting variations. (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the outstanding committed capital as of December 31, 2023. (3) Entity accuracy is correct—GM, Ultium Cells Holdings LLC, and the time frame (2023, specifically December 31, 2023) are all properly identified. (4) The reasoning is sound, demonstrating correct synthesis of financial data from what appears to be multiple sections of a filing (as indicated by page references), fulfilling the multi-hop requirement. The semantic meaning is equivalent to the ground truth, with slightly expanded phrasing but no deviation in factual content. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 290,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "In 2021 Coca‑Cola reported **$682 million** of hedge‑fund/limited‑partnership assets in its U.S. pension plans and **$38 million** in its non‑U.S. pension plans – a combined **$720 million** shown in the consolidated financial‑statement footnotes【page_101】. The same year’s schedule for its other post‑retirement benefit plan assets lists **$9 million** in hedge‑fund/limited‑partnership investments【page_103】. Together the company’s disclosed exposure to these alternative vehicles is roughly **$729 million**, with the overwhelming majority held in its pension‑plan assets and a modest amount allocated to its VEBA‑type post‑retirement plan, underscoring a diversified but still significant overall exposure to hedge‑fund and limited‑partnership investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: $720 million in hedge funds and limited partnerships in the consolidated financial statements (broken down into $682M U.S. pension and $38M non-U.S. pension, which sum to $720M) and $9 million in other postretirement benefit plan assets. The total exposure of $729 million is accurately calculated. These values match the ground truth exactly. (2) All numeric values are correct and properly cited with page references. The sum of $682M + $38M = $720M is accurate, and $720M + $9M = $729M is also correct. Format variations (e.g., $682 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different sections of the filing — consolidated financial statement footnotes and the other postretirement benefit plan assets schedule — and combines them to reflect total exposure. It also correctly interprets that the $720M is part of pension plan assets within the consolidated financials. (4) The answer goes slightly beyond the original by providing a breakdown of the $720M into U.S. and non-U.S. pension components, which is factually accurate and adds context without introducing error. The qualitative interpretation about 'diversified but still significant overall exposure' is reasonable and aligns with the data. No factual inaccuracies; only minor stylistic expansion. Thus, full credit on quantitative accuracy and contextual relevance, near-perfect on qualitative accuracy, and a 9 overall due to slight rephrasing but no material deviation from truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 440,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The risk factors note that as retailers shift more sales to pure‑online channels, they are closing or right‑sizing under‑performing brick‑and‑mortar stores, which cuts demand for SPG’s space and leaves vacancies. That reduced demand and the stronger bargaining power of the remaining, credit‑worthy tenants creates downward pressure on rents and forces SPG to offer concessions or lower rates to re‑let or renew leases, making it harder to maintain rental income. (See Risk Factors – e‑commerce impact on occupancy, lease rates and tenant‑under‑reporting on pages 15, 14 and 16.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the core causal chain: e-commerce adoption by retailers leads to store closures and reduced demand for physical space, resulting in higher vacancies at SPG properties. This, in turn, reduces leasing power for SPG, increases tenant leverage (especially creditworthy ones), and forces SPG to lower rents or offer concessions, creating downward pressure on rental rates. The answer also implicitly captures the financial impact on SPG’s leasing strategy and performance. All entities (Simon Property Group, retail tenants, e-commerce) and dynamics (bargaining power, lease renewals, concessions) are correctly identified. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor omission is the explicit mention of increased spending on tenant improvements, which is noted in the original answer as part of SPG’s response to leasing challenges. However, the reference to 'offering concessions' broadly covers this concept, so the omission is not material. The reasoning is sound, multi-hop (linking e-commerce → store closures → reduced demand → vacancy → tenant power → lease terms → financial impact), and well-supported. Contextual relevance is perfect, directly addressing how e-commerce affects SPG's leasing and rental rate challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 390,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "Arkansas‑related corporate‑tax reforms helped lower UNP’s deferred tax expense by **$34 million in 2024** (together with Louisiana) and by **$114 million in 2023** (along with Nebraska, Iowa and Kansas)【page_58】. By comparison, the Arkansas‑related changes in **2022** reduced deferred tax expense by **$95 million**【page_58】, so the 2024‑23 impacts were larger than the 2022 impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numeric values: $34 million for 2024, $114 million for 2023, and $95 million for 2022 — matching the ground truth exactly. The cumulative impact of $148 million (2023–2024) and the comparison to the $95 million 2022 impact are factually sound, though the LLM does not explicitly compute the $53 million difference as stated in the original answer. However, stating that 'the 2024–23 impacts were larger' conveys the correct directional comparison. (2) All numbers are accurate and correctly attributed to the right years and entity (UNP). Format variations (e.g., $34 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is mostly sound — the model correctly synthesizes Arkansas-related deferred tax expense impacts across three years from what appears to be a single source (page_58). However, the mention of Louisiana in 2024 and Nebraska, Iowa, and Kansas in 2023 introduces potential confusion, implying the $34M and $114M figures may include non-Arkansas impacts. This contradicts the ground truth, which isolates Arkansas legislation. Despite this, the model still attributes the full amounts to Arkansas-related changes, which could reflect ambiguity in the source. (4) The answer is contextually relevant and addresses all parts of the question, though slightly less precise in isolating Arkansas-specific impacts due to the mention of other states. The omission of the exact $53 million difference calculation prevents a perfect 10, but the core facts, numbers, and logic are correct. Hence, correctness is scored 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 442,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE’s holding of a limited‑partner interest in XPLR OpCo means it relies on XPLR’s cash‑distribution stream. The filing notes that if XPLR cannot obtain capital on commercially reasonable terms, its ability to fund acquisitions, meet capital needs or make cash distributions to its common unitholders—including NEE—could be materially impaired, and any dilution from new unit issuances would further reduce NEE’s share of cash flow. Consequently, reduced or delayed distributions and possible dilution could strain NEE’s liquidity and its ability to meet its own financial obligations or fund guarantees for subsidiaries. 【page_34】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NEE's limited partner interest ties its cash flows to XPLR OpCo's distributions; if XPLR cannot access capital on commercially reasonable terms, its ability to fund acquisitions and make distributions is impaired; this impacts NEE’s liquidity and ability to meet financial obligations; and potential dilution from new unit issuances would reduce NEE’s share of future cash flows. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links XPLR’s capital constraints → reduced growth and distributions → negative impact on NEE’s cash inflows → strain on NEE’s liquidity and financial commitments. It also correctly identifies dilution risk from unit issuance. (4) The only minor shortcoming is that the LLM answer adds a detail about 'fund guarantees for subsidiaries' not explicitly mentioned in the original answer, which slightly extends beyond the ground truth but remains contextually plausible. This does not introduce inaccuracy but adds a small inferential leap. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with excellent reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 380,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "There is no difference – the fair‑value amount for mortgage‑backed obligations is the same in both places ( $236 million for 2024 and $178 million for 2023 ), so the discrepancy is $0 million【page_77†L13-L16】【page_79†L13-L16】.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that the fair value in the 'Marketable securities' section is $178 and in the 'Fair Value' column it is $236, resulting in a difference of $58. The LLM incorrectly claims there is no difference and that the amounts are the same in both places, which contradicts the ground truth. (2) The LLM introduces years (2024 and 2023) and amounts tied to those years ($236 million for 2024, $178 million for 2023), which are not mentioned or implied in the original question or ground truth. The original answer does not reference different years, so this addition is erroneous and changes the meaning entirely. The claimed difference of $0 million is incorrect; the correct difference is $236 - $178 = $58. (3) The multi-hop reasoning is flawed. The model fails to compute the actual difference between two reported values in different sections and instead falsely attributes the discrepancy to different years, for which there is no support in the provided ground truth. (4) The correctness score is 1 due to major factual and calculation errors. Quantitative accuracy is low (2) because the numbers are misapplied and the calculation is wrong. Qualitative accuracy is also low (2) due to incorrect reasoning and entity (year) fabrication. Contextual relevance is moderate (5) because the answer addresses the right topic (fair value of mortgage-backed obligations) but misrepresents the data structure and temporal context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 412,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "Alphabet treats Google Play sales as an agency transaction—its performance obligation is to facilitate the sale between developers and users, so it records the transaction on a **net basis**, recognizing only the service‑fee portion of app and in‑app‑purchase sales【page_56】. Because Google Play is a key component of the growing **non‑advertising revenue** mix, this net‑basis recognition means that an expanding share of total revenue is measured at a lower gross amount and, as the company notes, non‑advertising revenues “may be lower than the margins on our advertising revenues”【page_30】, thereby putting pressure on overall margins.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Google Play revenue is recognized on a net basis due to Alphabet's role as an agent facilitating transactions between developers and users, which aligns with the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised—none are misstated. (3) The multi-hop reasoning is sound: the answer links the net revenue recognition method to its impact on reported non-advertising revenues and further connects this to margin pressure due to lower margins in non-advertising compared to advertising revenues, citing appropriate page references (30 and 56) for support. (4) All entities—Google Play, non-advertising revenues, Alphabet, service fee model—are correctly identified and logically synthesized. The answer fully addresses the question’s components: revenue recognition method, its effect on financial reporting of non-advertising revenues, the growing share of these revenues, and their margin implications. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 337,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "General Motors’ committed capital contributions to Ultium Cells Holdings LLC totalled **$0.8 billion in 2023**. This is **$0.6 billion less** than the **$1.4 billion** of committed contributions reported for the prior year (2022)【page_80】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $0.8 billion for 2023 and $1.4 billion for 2022 are accurately reported, and the year-over-year decrease of $0.6 billion is correctly calculated ($1.4B - $0.8B = $0.6B). (2) The answer is complete, addressing both parts of the question: the 2023 commitment and the comparison to the previous year. (3) Entities are accurate—General Motors, Ultium Cells Holdings LLC, and the correct fiscal years (2023 and 2022) are properly identified. (4) The reasoning is sound: the LLM correctly synthesizes the multi-hop information (comparing two years of capital commitments) and draws the correct conclusion about the reduction. (5) The semantic meaning is equivalent to the original answer, with clear, concise wording and proper contextual citation (page reference included). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 269,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Mastercard’s 2024 acquisitions required a total cash outlay of $2.8 billion, which includes the $2.7 billion cash purchase of RF UlEmate Parent, Inc. (Recorded Future). The goodwill component of those acquisitions was $1.7 billion, representing the goodwill recognized in the Recorded Future deal.【page_79】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total cash consideration paid by Mastercard in 2024 as $2.8 billion and the goodwill amount as $1.7 billion, matching the ground truth exactly. These figures are factually accurate and properly attributed. (2) All numeric values are correct: $2.8 billion total cash consideration and $1.7 billion goodwill. The mention of $2.7 billion for RF UlEmate Parent, Inc. is consistent with the total when considering that other minor acquisitions make up the remaining $0.1 billion, which is plausible and does not contradict the ground truth. Format variations (e.g., $2.8 billion vs $2.8B) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the total cash consideration includes the RF UlEmate acquisition and correctly identifies the goodwill portion. It links the goodwill to the Recorded Future deal (RF UlEmate Parent, Inc.), which aligns with the knowledge graph. (4) The only minor issue is the implication that the entire $1.7 billion of goodwill comes solely from the Recorded Future deal, which may oversimplify the allocation across multiple acquisitions, but since the ground truth does not specify distribution, this is a reasonable interpretation. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 378,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "UNP’s lease‑buyout spending for locomotives and freight cars was $70 million in 2022, $57 million in 2023 and $143 million in 2024 – a three‑year total of roughly **$270 million**【page_33】.  By contrast, the company’s 2025 capital plan is about **$3.4 billion**, so the lease‑buyout outlay represents only a modest fraction of the funds earmarked for acquiring freight cars (and other asset upgrades) in 2025【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all dollar amounts: $70 million in 2022, $57 million in 2023, and $143 million in 2024, summing to the correct total of $270 million. These match the ground truth exactly. The 2025 capital plan amount of $3.4 billion is also accurately reported. (2) The calculation of the three-year total is correct: 70 + 57 + 143 = 270. No errors in numbers, dates, or formats. (3) The multi-hop reasoning is sound: the model correctly links UNP’s historical lease buyout spending to the broader 2025 capital plan. It appropriately contextualizes the $270 million as part of a larger $3.4 billion investment, noting that lease buyouts represent a modest fraction of planned freight car acquisitions and asset upgrades. (4) The only minor limitation is that the LLM slightly broadens the scope by mentioning 'locomotives and freight cars' in the lease buyouts, while the ground truth specifies only 'freight car lease buyouts.' This introduces a small inaccuracy in entity specificity, though the core financial data and synthesis remain correct. Otherwise, the answer is factually aligned, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 330,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "Under the 2021 Repurchase Program CVS entered into a $2.0 billion ASR with Citibank in 2023 (recorded as an initial treasury‑stock purchase of $1.6 billion plus a $0.4 billion forward contract) and a $1.5 billion ASR with Barclays in 2022 (recorded as an initial treasury‑stock purchase of $1.2 billion plus a $0.3 billion forward contract)【page_70】. Together these agreements represent a total notional amount of **$3.5 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $2.0 billion ASR in 2023 and $1.5 billion ASR in 2022 are correctly stated, and their sum of $3.5 billion is accurate. The breakdown of initial treasury stock purchases and forward contract amounts ($1.6B + $0.4B and $1.2B + $0.3B) aligns with typical ASR accounting treatment and supports the notional amounts, though not required for the total notional calculation. (2) The answer is complete, addressing both the 2022 and 2023 transactions under the 2021 Repurchase Program and correctly summing them. (3) Entity accuracy is correct: CVS Health Corporation, the 2021 Repurchase Program, Citibank, Barclays, and the respective years are all accurately identified. (4) The multi-hop reasoning is sound—information from two separate years and transactions is synthesized correctly to compute the total notional amount. (5) The semantic meaning is equivalent to the ground truth, with additional contextual detail (banks involved, accounting breakdown) that enhances clarity without introducing error. Minor formatting like ' billion' is acceptable. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 341,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM’s near‑term profit still comes largely from the high‑margin full‑size ICE SUVs and pickup trucks, which generate the cash it is using to fund its EV build‑out (see Item 1A, p. 19‑17). However, the forward‑looking statements warn that a shift away from those ICE models—driven by tighter emissions rules, changing consumer preferences or higher EV‑related costs—could erode that cash flow and undermine the financing of its EV strategy, making the transition a key determinant of long‑term financial stability (see Item 1A, p. 51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that GM's near-term profitability relies on high-margin ICE pickup trucks and SUVs (note: includes SUVs not explicitly mentioned in the original, but this does not contradict it and aligns with known GM product mix). These vehicles fund the EV transition, which matches the original answer's key point. The forward-looking risks—consumer preference shifts, emissions regulations, and higher EV costs—are accurately cited as threats to cash flow and, consequently, EV investment. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect numbers. (3) The multi-hop reasoning is sound: it connects current ICE profitability → funding for EV development → risk of disrupted cash flow → threat to long-term stability. The citation of Item 1A, pages 19-17 and 51, supports the claim and aligns with typical SEC filing structures, though exact page numbers are not verifiable here but do not detract from factual correctness. (4) The only minor deviation is the inclusion of 'SUVs' alongside pickup trucks, which slightly broadens the scope beyond the original's focus on 'full-size ICE pickup trucks.' However, this is consistent with GM's actual product lineup and does not distort the central argument. Overall, the answer is semantically equivalent, contextually precise, and logically robust, warranting a high score with only a slight deduction in qualitative accuracy due to the subtle expansion of vehicle types.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 447,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "Chevron says that the unknown speed of the energy transition – reflected in volatile commodity prices, future carbon‑cost assumptions and evolving environmental regulations – is a “highly uncertain” input to its impairment models.  Management must adjust the cash‑flow forecasts used to test the recoverability of upstream assets for these factors, and a significant downward revision to price or regulatory outlook can trigger an impairment write‑down (see page 52).  Because those same uncertainties can erode expected upstream cash flows, Chevron’s capital‑allocation process now weighs a broader range of price‑ and policy‑scenario outcomes, often delaying, scaling back or re‑prioritizing projects to avoid assets that could become impaired (see page 21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: the uncertainty around the pace of the energy transition, its influence on commodity prices, carbon-cost assumptions, and regulatory developments are correctly identified as key inputs to Chevron's impairment assessments. The connection between uncertain cash flows, impairment risk, and upstream investment decisions (delaying, scaling back, re-prioritizing projects) is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how external uncertainties affect internal financial models (impairment testing) and strategic capital allocation. It references specific pages (21 and 52), which enhances credibility and suggests grounding in source material, though these page numbers are not in the ground truth—however, they do not contradict it and may reflect actual document structure. (4) Semantic equivalence is strong: while the LLM uses slightly more detailed language (e.g., 'volatile commodity prices', 'broader range of price- and policy-scenario outcomes'), the core meaning matches the original—uncertainty leads to potential impairments and altered investment behavior. The only minor shortcoming is that the LLM does not explicitly mention the impact on Chevron’s ability to invest in lower-carbon energy solutions, a point included in the original. This omission slightly reduces completeness but does not undermine the main thrust. Hence, correctness is 9 (excellent but not perfect), qualitative accuracy is 9 for this small gap, and contextual relevance is 10 as the response directly and appropriately addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 507,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard’s consumer‑acquisition and engagement services are bundled with its proprietary global payments network as a value‑added offering that “draw[s] on…secure data” and is “interdependent with our payment network” (p. 6).  By delivering digital‑first experiences, tokenization, authentication and data‑driven insights, these services boost card usage and gross‑dollar volume, allowing Mastercard to earn additional fixed‑ and transaction‑based fees that feed directly into the network’s growth and helped drive the 2024 net revenue of $28.2 billion and net income of $12.9 billion (p. 73; p. 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the qualitative relationship between Mastercard's Consumer Engagement Services and its global payments network correctly, noting the use of secure data, interdependence with the network, and the resulting increase in transaction volume and fee revenue. It appropriately references value-added services like tokenization and data-driven insights that enhance card usage and network attractiveness, aligning with the ground truth's emphasis on network utility and financial performance. However, the quantitative accuracy is significantly flawed: the LLM introduces specific financial figures for 2024—$28.2 billion net revenue and $12.9 billion net income—that are not present in the original answer and cannot be verified from the provided context. Since the ground truth does not include any numerical financial results, introducing such precise figures constitutes a major factual overreach, even if they were accurate elsewhere. This undermines trust in the response and represents a failure in multi-hop reasoning where no source supports these numbers. While the conceptual synthesis is sound and contextually relevant, the inclusion of unsupported quantitative data reduces the correctness score. The answer is semantically aligned in intent and reasoning structure but fails on factual precision due to hallucinated metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 374,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "Walmart bought Alert Innovation for about **$0.4 billion** in fiscal 2023.  The 10‑K notes that the Alert Innovation entity was later sold and deconsolidated in fiscal 2025, but it does not disclose any cash proceeds or additional outflow for that sale, so the only reported net cash‑outflow impact of the transaction is the $0.4 billion acquisition cost【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the $0.4 billion acquisition cost in fiscal 2023 and accurately notes that no cash proceeds were disclosed from the deconsolidation in fiscal 2025, leading to a net cash outflow of $0.4 billion. All numeric values and fiscal years are correct, satisfying quantitative accuracy. The reasoning is sound: since no inflow is reported upon deconsolidation, the net impact equals the initial outflow. This aligns with the ground truth, which states there was no net cash inflow from the sale. The only minor limitation is that the LLM does not explicitly state the final 'net cash outflow impact' as $0.4 billion in a summary sentence (though it is clearly implied), slightly reducing qualitative precision. However, the answer is contextually complete and directly addresses the multi-hop nature of the question—linking acquisition, deconsolidation, and net impact across fiscal years 2023 and 2025. Semantic equivalence is maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 278,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The two notes both state that the only potentially dilutive securities for 2023 were LTIP units, but “no securities had a material dilutive effect.” In effect, the combined total of potentially dilutive securities is zero (i.e., none that are material). Consequently, Simon Property did not adjust net income attributable to common stockholders because the LTIP units (and any other limited‑partner or unit interests) would not have changed earnings per share – the adjustment would have had no dilutive impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the only potentially dilutive securities for the year ended December 31, 2023, were LTIP Units and that no securities had a material dilutive effect, leading to no adjustment to net income attributable to common stockholders. The conclusion that the combined total of materially dilutive securities is effectively zero aligns with the ground truth, which states there was no material dilutive effect. The reasoning correctly links the absence of material dilution to the lack of adjustment in net income, which is consistent with accounting principles under ASC 260 (Earnings Per Share). The mention of 'other limited-partner or unit interests' slightly extends beyond the original answer but does not contradict it and may reflect broader context from the disclosures. All entities (LTIP Units, net income attributable to common stockholders, 2023 reporting period) are accurate. There are no numerical inaccuracies—while no specific number is given, the qualitative assessment that there was no material effect supports the implied quantitative result. The multi-hop reasoning is sound: synthesizing the nature of LTIP Units as potentially dilutive securities and concluding no adjustment due to lack of materiality. The answer is semantically equivalent to the original, though phrased more assertively by stating the total is 'zero'—this is a reasonable interpretation when no securities had material effect. Minor deduction in qualitative accuracy due to slight overstatement of completeness regarding 'other' interests, but core logic and facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 437,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The 2023 filing shows that Verizon reported **$4,432 million of NAV‑measured investments in its pension plan and $5 million in its health‑care & life plans – a combined total of $4,437 million**【page_92†L24-L27】【page_93†L24-L27】.  By comparison, the **pension plan holds $9,104 million of assets measured at fair value**, while the **health‑care & life plans hold $461 million at fair value**【page_92†L22-L24】【page_93†L22-L24】.  Thus the NAV‑measured amount is roughly half of the pension fair‑value total and a tiny fraction of the health‑care & life fair‑value total.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that the total value of Investments measured at NAV is $14 million ($9M + $5M), but the LLM reports $4,437 million ($4,432M + $5M), which is over 300 times larger. This massive discrepancy invalidates the core of the response. Additionally, the total investments at fair value are stated as $902 million in the ground truth ($441M + $461M), but the LLM claims $9,104 million for the pension plan alone, which is more than 10 times higher than the correct total. (2) Calculations are completely wrong: the LLM’s comparison of NAV to fair value (e.g., 'roughly half') is based on incorrect inputs and thus invalid. The correct ratio is $14M / $902M = ~1.55%, not the implied ~49% for pension or ~1% for healthcare the LLM suggests. (3) Multi-hop reasoning fails: the model misidentifies the asset categories (pension vs. healthcare) as the two disclosed categories, but the ground truth does not specify these as the categories, nor does it support the values cited. The synthesis across categories and valuation methods is therefore incorrect. (4) Despite referencing specific pages and attempting to compare NAV to fair value across categories, the answer is factually unmoored from the ground truth. The contextual relevance is low but not zero because it attempts to address NAV vs. fair value across categories in a 2023 10-K for VZ, so minimal relevance is acknowledged.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 410,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "GM reported $293 million of equity earnings from Ultium Cells Holdings LLC for 2023. These earnings were shown in the “Automotive and other cost of sales” line item of the consolidated statements of income (i.e., within cost‑of‑sales)【page_76†L31-L35】【page_101†L71-L74】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings amount of $293 million for 2023 is accurate, and the fiscal year (ended December 31, 2023) is correctly implied as 'for 2023'. (2) The financial statement category is correctly identified as 'Automotive and other cost of sales', with precise contextual placement within the consolidated statements of income and cost-of-sales, which aligns semantically with the original answer. (3) Entity accuracy is perfect: GM, Ultium Cells Holdings LLC, and the correct year are all properly referenced. (4) The reasoning is sound and reflects multi-hop understanding by correctly extracting and synthesizing information from the specified document pages (76 and 101), indicating proper source-based inference. (5) The answer is contextually relevant and complete, addressing both parts of the question—amount and disclosure location—with exact semantic equivalence to the ground truth. Minor wording differences (e.g., 'shown in' vs 'disclosed under') do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 309,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "Principal or Affiliate Customers (Class B stockholders) held 0.8 % of MA’s equity at the end of 2023 and 0.7 % at the end of 2024—a decline of 0.1 percentage point. This modest reduction further concentrates ownership in public investors (≈90 % of equity) and the Mastercard Foundation (≈9 %), leaving Class B holders a very small, non‑voting stake in the overall ownership structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the equity ownership percentages of Principal or Affiliate Customers (Class B stockholders) as 0.8% in 2023 and 0.7% in 2024, with a reduction of 0.1 percentage point—matching the ground truth exactly. The calculation of the change is accurate.\n\n2) All numeric values are correct and properly formatted. The use of '0.1 percentage point' (singular) is acceptable and semantically equivalent to '0.1 percentage points' in the original answer.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes the change over time and contextualizes it within MA's broader ownership structure. It appropriately notes the concentration of ownership among public investors and the Mastercard Foundation, which aligns with known ownership patterns and enhances the answer’s depth.\n\n4) The only minor deviation from the original answer is the addition of contextual details about public investors (~90%) and the Mastercard Foundation (~9%), which are not present in the ground truth. However, these figures are plausible and consistent with public knowledge about MA's ownership, and they do not contradict the core facts. The conclusion that Class B holders have a 'very small, non-voting stake' is a reasonable interpretation of the 0.7% figure and adds qualitative insight without introducing error.\n\nOverall, the answer is factually correct, complete, and contextually enriched without overreaching. The slight expansion beyond the original answer does not detract from accuracy and improves relevance, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 430,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "Walmart’s cash outflow for Alert Innovation in fiscal 2023 was approximately **$0.4 billion** (the cost of the acquisition)【page_65】.  The business was later **sold and de‑consolidated in fiscal 2025**, removing it from Walmart’s consolidated accounts【page_44】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual elements are accurate: Walmart's cash outflow for Alert Innovation in fiscal 2023 was $0.4 billion, which aligns with the acquisition cost. The entity was sold and deconsolidated in fiscal 2025, as stated in the original answer. (2) Quantitative accuracy is perfect: the dollar amount ($0.4 billion) and fiscal years (2023 for acquisition, 2025 for sale/deconsolidation) are correct, with acceptable formatting (e.g., $0.4 billion = $400 million). (3) Multi-hop reasoning is sound—the answer synthesizes information about a transaction in one fiscal year and a subsequent corporate action in another, correctly identifying the sequence of acquisition followed by divestiture. (4) The entities (Walmart, Alert Innovation), financial event types (acquisition, sale, deconsolidation), and timing are all accurately represented. The answer is semantically equivalent to the ground truth, with no omissions or distortions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 301,
        "total_tokens": 1413
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "In January 2024 the company repaid $500 million of 0.600% senior notes, and in February 2024 it repaid $1.0 billion of 5.00% senior notes – a total of $1.5 billion of principal funded with borrowings under the 2021 Multicurrency Credit Facility【page_50】.  As of December 31 2023 the facility still provided the full $6.0 billion of borrowing capacity (the amount it could still draw)【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $500 million and $1.0 billion principal repayments in January and February 2024 respectively, totaling $1.5 billion, funded via the 2021 Multicurrency Credit Facility. It accurately states the $6.0 billion remaining borrowing capacity as of December 31, 2023. All numbers, dates, and sources (page references) are correct. (2) Quantitative accuracy is perfect: $500M + $1.0B = $1.5B is correctly implied, and the $6.0B capacity matches the ground truth. Format variations (e.g., $1.5 billion vs $1.5 billion) are acceptable. (3) The multi-hop reasoning is sound—linking early 2024 repayments to borrowings from the facility and correctly assessing the state of the facility *before* those repayments (i.e., as of Dec 31, 2023). However, the LLM omits the sublimit details (e.g., $3.5B multicurrency, $200M LC, $50M swingline), which are part of the original answer. This is a minor omission affecting completeness but not the core factual correctness. (4) Scores reflect near-perfect accuracy: full points for quantitative and contextual accuracy; qualitative score slightly reduced due to missing sublimit breakdown, but reasoning remains logically sound and entity identification is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 354,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel 4 will use EUV to print the tiniest features for its upcoming Meteor Lake chips, and Intel 3 will expand EUV exposure (along with further FinFET tweaks) to gain additional performance‑per‑watt and area gains – a stepping‑stone toward the new transistor architectures (Ribbon FET and PowerVia) slated for Intel 20A. The next node in the sequence, Intel 18A, is expected to bring next‑generation High‑Numerical‑Aperture EUV to the roadmap【page_12】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: EUV use in Intel 4 and Intel 3 is accurately described, including its role in enabling Meteor Lake and performance-per-watt improvements. The progression to Intel 20A with RibbonFET and PowerVia is correctly noted, as is the introduction of High Numerical Aperture EUV at Intel 18A. (2) There are no numeric values requiring calculation (e.g., dates, dollar amounts), but process node names (Intel 4, Intel 3, Intel 20A, Intel 18A) are all correct and consistent with the original. (3) Multi-hop reasoning is sound: the answer connects EUV usage in current nodes to future transistor architectures and correctly sequences Intel’s roadmap, showing logical progression. (4) The answer is contextually relevant, complete, and conveys the same technical roadmap with equivalent precision. Minor wording differences (e.g., 'Ribbon FET' vs 'RibbonFET') do not affect meaning. No factual errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 295,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The 2023 filing reports $1,412 million of U.S. Treasuries and agencies in the pension‑plan assets and $138 million in the other post‑retirement benefit‑plan assets – a combined total of about **$1.55 billion**【page_92】【page_93】.  Cash and cash equivalents total **$1,956 million** for the pension plan plus **$27 million** for the other plan, or roughly **$1.98 billion**, so cash holdings exceed the combined U.S. Treasuries and agencies by about **$0.43 billion**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states the combined value of U.S. Treasuries and agencies is $239 million ($101M + $138M), and cash and cash equivalents total $57 million ($30M + $27M). The LLM reports $1.55 billion and $1.98 billion, which are over 6x and 35x higher, respectively—massive discrepancies. The cited numbers ($1,412 million, $1,956 million) do not match the ground truth and appear to be misread or hallucinated. (2) Completeness: While the LLM attempts to address both parts of the question (total value and comparison), it does so with entirely incorrect data. (3) Entity Accuracy: The ticker (VZ) and year (2023) are correct, but the asset categories (pension-plan vs. other post-retirement) may be misattributed—the ground truth does not specify these plans, only 'disclosed asset categories'. More critically, the financial figures are wrong. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly identifies which assets belong to U.S. Treasuries and agencies and misrepresents cash equivalents. The conclusion that cash exceeds Treasuries is opposite to the ground truth, which states Treasuries ($239M) are significantly higher than cash ($57M). (5) Semantic Equivalence: The answer conveys the opposite meaning and grossly inaccurate magnitudes. Even allowing for format variation, $1.55 billion ≠ $239 million. The citations to page_92 and page_93 do not excuse the factual divergence. The model fails to extract or calculate the correct values, leading to a completely incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 443,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "DHR paid $9.561 billion in net cash for Aldevron and $1.340 billion for the other 11 2021 acquisitions – a combined net cash consideration of roughly $10.9 billion.  The total goodwill recognized on these deals was $7.187 billion, of which $6.149 billion (about $6.1 billion) was attributable to Aldevron.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $9.561 billion (i.e., $9,561 million) for Aldevron, $1.340 billion ($1,340 million) for the other 11 businesses, totaling $10.901 billion ($10,901 million), and goodwill of $7.187 billion total with $6.149 billion attributed to Aldevron—all match the original answer exactly when accounting for unit formatting (billion vs. million). (2) Quantitative accuracy is perfect: the sum of $9.561B + $1.340B = $10.901B is correctly implied, and the goodwill attribution is precisely stated. Minor rounding to 'roughly $10.9 billion' and 'about $6.1 billion' does not detract from accuracy as these are clearly approximations of the exact values. (3) Multi-hop reasoning is sound—the model correctly synthesizes data across two entities (Aldevron and the other 11 acquisitions), computes total consideration, and correctly isolates Aldevron's share of goodwill. (4) Entities (DHR, Aldevron, 2021 acquisitions, goodwill, net cash consideration) are correctly identified and contextualized. The answer is concise, relevant, and fully addresses both parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 336,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "GM had pledged **$0.8 billion** in total committed capital contributions to Ultium Cells Holdings LLC as of December 31 2023. On the same date, the carrying amount of GM’s investment in Ultium Cells Holdings LLC on its balance sheet was **$2.268 billion**, which is about **$1.5 billion higher** than the committed‑capital amount.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies GM's committed capital contribution of $0.8 billion and the carrying amount of $2,268 million ($2.268 billion), which matches the ground truth in substance. However, the comparison statement that the carrying amount is 'about $1.5 billion higher' than the committed amount is quantitatively inaccurate: the actual difference is $2,268 million - $800 million = $1,468 million, or $1.468 billion. While this is close to $1.5 billion, the rounding introduces a small but notable error in precision, especially in a financial context where exact figures are expected. The reasoning correctly identifies that the carrying amount exceeds the committed contribution, but the implication that GM has overfunded its commitment contradicts the ground truth, which states that GM had *not* fully funded its commitment—this suggests a misunderstanding in logic. The carrying amount being higher may reflect accounting treatment (e.g., equity method adjustments), but the LLM incorrectly interprets this as overfunding rather than recognizing that committed capital and carrying value are different concepts. The entities (GM, Ultium Cells Holdings LLC), dates (December 31, 2023), and metrics are accurate. The answer is contextually relevant and addresses both parts of the question. However, the flawed interpretation of the comparison reduces quantitative and qualitative accuracy. Semantic equivalence is mostly preserved, but the erroneous calculation and reasoning prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 415,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The Lower 48 segment recorded **$5,729 million** of depreciation, depletion, amortization and impairments for 2023 (Note 24 – Segment Disclosures)【page_133】.  Its net book value of proved and unproved properties at December 31 2023 was **$37,185 million** (total property $74,014 million less accumulated depreciation $36,829 million)【page_157】.  Thus, the depreciation‑related expense is roughly **15 %** of the net book value of the Lower 48 property portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: (1) The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 is correctly stated as $5,729 million; (2) The net book value of proved and unproved properties as of December 31, 2023, is accurately reported as $37,185 million, with correct derivation from total property value ($74,014 million) minus accumulated depreciation ($36,829 million); (3) All numbers match the ground truth exactly, and the 15% ratio (5,729 / 37,185 ≈ 0.154) is a reasonable approximation, though not explicitly requested in the original question. The answer addresses both parts of the question: the 2023 expense and its comparison to net book value. The multi-hop reasoning is sound—synthesizing data from segment disclosures and property valuation notes. The only minor shortcoming is that the original answer includes additional context about the total accumulated value ($42,558 million) and its relation to original property value ($74,014 million), which the LLM omits. While not strictly necessary, this synthesis adds depth to the comparison. However, the LLM’s focus on the 15% ratio provides an alternative, relevant comparison. Thus, the answer is factually complete and correct, with only slight reduction in qualitative richness compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 382,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "In 2023 the company repaid $6.1 billion of revolving debt under the 2021 Multicurrency Credit Facility, which included €842.6 million of repayments (equivalent to about $919.1 million) alongside the balance of the repayments in U.S. dollars【page_52】.  Those repayments more than offset the $3.0 billion of new borrowings, driving the facility’s outstanding revolving balance down to roughly $723.4 million as of December 31, 2023【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total repayment amount of $6.1 billion under the 2021 Multicurrency Credit Facility in 2023, including the EUR-denominated repayment of €842.6 million, which is accurately converted to $919.1 million. These figures match the ground truth exactly. The $3.0 billion in new borrowings is also correctly reported. (2) All numeric values are accurate and consistent with the original answer. The calculation implied—$6.1 billion repaid minus $3.0 billion borrowed—logically results in a net reduction in revolving indebtedness, and the LLM adds a specific detail ($723.4 million outstanding as of December 31, 2023) that is contextually consistent and likely from the cited page 52, though not in the ground truth. This does not contradict but enhances the answer. (3) The multi-hop reasoning is sound: the model synthesizes repayment amounts in both USD and EUR, converts EUR to USD correctly, and evaluates the net effect on revolving indebtedness. It correctly infers that repayments exceeded new borrowings, leading to a decrease in outstanding balance—aligning with the original answer’s claim of a net decrease. (4) The answer is semantically equivalent and slightly more detailed than the ground truth, particularly in specifying the year-end balance. The only reason for not scoring a 10 is that the original answer emphasizes the purpose of the $3.0 billion borrowing (e.g., repaying the 2021 USD Two Year Delayed-Draw Term Loan), which the LLM omits. This is a minor omission in completeness but does not detract from the core accuracy. All entities—facility name, years, currencies, and financial terms—are correct. Overall, the answer is factually excellent, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 478,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "The “Coal Ash Act” (the North Carolina Coal Ash Management Act of 2014, as defined in the glossary) requires Duke Energy to develop, obtain approval for and fund site‑specific remediation and closure plans for its coal‑ash basins. Consequently, the company has begun excavation and relocation of CCR at the four high‑priority North Carolina sites (completing three) and has built the associated costs into its asset‑retirement obligations, seeking recovery of those compliance and closure expenses through state‑commission‑approved rate cases and amended wholesale contracts, which adds to its operational and closure‑related costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original answer. (1) All key facts are correct: Duke Energy is complying with the North Carolina Coal Ash Management Act of 2014, has completed excavation at three of the four high-priority sites, and is managing closure activities involving CCR relocation. The mention of building costs into asset-retirement obligations and seeking recovery via rate cases and amended wholesale contracts matches the ground truth. (2) Quantitative accuracy is perfect: the number of high-priority sites (four) and completed excavations (three) are correctly stated. The year 2014 is accurately referenced via the Act, and the 2017 FERC approval is implied through 'amended wholesale contracts'—though the LLM does not explicitly name FERC or 2017, this is a minor omission. (3) Multi-hop reasoning is sound: the LLM synthesizes information from both the glossary (definition of the Coal Ash Act) and the business section (closure activities, cost recovery mechanisms), correctly linking regulatory requirements to operational and financial impacts. (4) The answer is contextually relevant and fully addresses the question about operational costs and closure activities. The only minor shortcoming is the lack of explicit mention of FERC or the 2017 approval date, which slightly affects completeness but does not detract from the overall correctness. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 411,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel’s Agilex FPGA family provides the high‑performance, power‑efficient fabric and transceiver engine that powers its Infrastructure Processing Unit (IPU) platforms – for example, the Oak Springs Canyon reference IPU combines a Xeon D processor with an Agilex FPGA to off‑load and accelerate networking and other infrastructure tasks, freeing CPU capacity. The Intel eASIC N5X, a structured‑ASIC built on the same heterogeneous architecture, adds an ASIC‑like option that delivers lower cost, lower power and faster time‑to‑market for latency‑critical 5G, cloud, AI and edge workloads, extending the IPU ecosystem beyond reconfigurable FPGA acceleration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Agilex FPGAs are used in Intel's IPU platforms (e.g., Oak Springs Canyon reference design) to offload infrastructure tasks and free CPU resources, which aligns with the original answer's claim about reducing overhead and freeing CPU performance. The eASIC N5X is correctly described as a structured ASIC that offers lower cost, lower power, and faster time-to-market compared to FPGAs, matching the original's emphasis on reduced unit cost, power, and NRE. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the model correctly synthesizes the roles of both Agilex FPGA and eASIC N5X within Intel’s IPU ecosystem, linking FPGA-based acceleration with ASIC-like efficiency for scalable infrastructure solutions. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'Intel 10nm SuperFin technology' as the process node for Agilex, which is a small but notable omission from the original. Additionally, while the LLM mentions 'heterogeneous architecture' and use cases like 5G and AI, it slightly extends context beyond the original scope (e.g., 'edge workloads') without contradicting facts. Overall, the answer is semantically equivalent, highly relevant, and factually correct with only minor detail omissions, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 425,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher reports about 3,000 associates in “other developed markets” and roughly 24,000 in North America (≈ 27,000 total) 【page_11】. Together these employees make up about 27,000 ÷ 63,000 ≈ 43 % of the company’s global workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of employees in Other Developed Markets (3,000) and North America (24,000), matching the ground truth. The total for these two regions is accurately calculated as 27,000. The percentage of the global workforce is computed as 27,000 ÷ 63,000 ≈ 43%, which rounds correctly from the exact value of approximately 42.857%, and aligns semantically with the ground truth's 'approximately 42.86%'. (2) All numeric values are accurate: 3,000, 24,000, and 63,000 are correct; the sum (27,000) and percentage calculation (≈43%) are mathematically sound. Minor rounding difference (42.86% vs 43%) is acceptable under semantic equivalence. (3) The multi-hop reasoning—aggregating employee counts across regions and calculating their proportion of the total workforce—is logically and correctly executed. The model synthesizes the correct entities (Danaher, employee counts by region, total workforce) and performs the necessary arithmetic steps. (4) The answer is contextually complete and relevant, addressing both parts of the question: employee comparison between regions and their collective percentage of the global workforce. The only minor shortcoming is the slightly rounded percentage (43% vs 42.86%), but this does not affect factual correctness at the required precision level, warranting a high score of 9 rather than 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 383,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "Nike’s foreign‑exchange forwards and options were measured at $557 million of assets at fair value, plus $493 million recorded in other current assets and $64 million in other long‑term assets – a combined fair‑value total of roughly **$1.1 billion** as of May 31 2023【page_75】.  The consolidated balance sheet, however, reports **total derivative assets of $557 million** for 2023【page_83】, meaning the fair‑value of the foreign‑exchange forwards and options is about **$557 million higher** (approximately twice the amount shown as total derivative assets).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The ground truth states that the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million, which matches the total derivative assets reported on the balance sheet. However, the LLM incorrectly calculates a 'combined fair-value total of roughly $1.1 billion' by adding $557M + $493M + $64M, which misrepresents the data. These latter two amounts ($493M and $64M) are not additional components of fair value but are likely breakdowns of where the $557M is recorded on the balance sheet (e.g., current vs long-term), making the summation invalid. (2) The quantitative inaccuracies are severe: the LLM reports a total fair value of $1.1B instead of $557M and falsely claims that the fair value is $557M higher than total derivative assets, when in fact they are equal. The correct comparison is that the $557M in foreign exchange derivatives equals the $557M in total derivative assets. (3) The multi-hop reasoning fails: the model misinterprets the structure of the balance sheet disclosures, incorrectly treating subcomponents as additive rather than as partitions of the same total. It also draws the opposite conclusion of the ground truth—claiming a discrepancy where there is none. (4) Despite using correct source pages and referencing relevant items (forwards, options, derivative assets), the core numerical and logical errors severely undermine the answer’s correctness. Contextual relevance is moderate because it addresses the right topic and cites correct documents, but the conclusions are factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 444,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The Lower 48 depreciation, depletion, amortization and impairments expense grew from **$4,067 million in 2021 to $5,729 million in 2023**, a rise of **about $1.66 billion**.  During the same period the segment’s productive wells increased from **426 in 2021 to 532 in 2023**, a net gain of **approximately 106 wells**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the depreciation, depletion, amortization, and impairments expense values for 2021 ($4,067 million) and 2023 ($5,729 million), and the calculated increase of $1,662 million is approximately reported as $1.66 billion, which is acceptable. However, the answer incorrectly states that the number of productive wells increased from 426 in 2021 to 532 in 2023, which directly contradicts the ground truth. According to the original answer, the number of productive wells in the Lower 48 region decreased from 87 in 2021 to 38 in 2023, a drop of 49 wells. This is a major factual error. (2) The dollar amounts and their difference are quantitatively accurate (within rounding tolerance), but the well count numbers are completely incorrect—426 and 532 do not appear in the ground truth and are likely confused with another region or company. (3) The multi-hop reasoning fails on the second part: while the model correctly synthesizes the expense data across years, it fails to retrieve or synthesize the correct well count data, possibly due to hallucination or misattribution. (4) The correctness score is low due to the critical error in the well count trend, which reverses the actual direction (increase vs. decrease) and uses entirely wrong base numbers. Quantitative accuracy is partially preserved for the expense data but ruined by the well count error. Qualitative accuracy suffers due to flawed entity retrieval or reasoning. Contextual relevance is moderate because the structure and intent match the question, but key facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 436,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The two fair‑value tables show U.S. Treasuries and agencies of **$1,412 million** in the pension‑plan portfolio (page 92) and **$138 million** in the other post‑retirement benefit‑plan portfolio (page 93), for a combined total of **$1,550 million**.  In the pension plan, the $1.412 billion represents roughly **15 %** of its $9.1 billion fair‑value assets, while in the other benefit plan the $138 million accounts for about **30 %** of its $461 million fair‑value assets – a much larger share despite the smaller absolute amount.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It reports a combined total of $1,550 million ($1,412M + $138M), but the ground truth states the total is $2,953 million, derived from $1,412 million in the first table and $1,541 million in the second. The LLM incorrectly interprets the $138 million as a total investment value when it is actually the Level 2 portion of U.S. Treasuries and agencies in the first table. Similarly, the $1,541 million in the second table is completely omitted and replaced with $138 million from an unrelated context. (2) The quantitative inaccuracies are severe: the total is off by $1.4 billion, and the second table’s value is misrepresented. The percentages provided (15% and 30%) may be internally consistent with the LLM’s incorrect numbers but are not supported by the ground truth data. (3) The multi-hop reasoning fails: instead of identifying U.S. Treasuries and agencies in both tables and summing them, the model conflates Level 2 values with total values and misattributes data to different plans without evidence. It also introduces plan names (pension vs. other post-retirement) not mentioned in the original answer, suggesting hallucination. (4) While the answer attempts to compare allocations across categorizations (showing relevance), the core data is fundamentally wrong, leading to a very low correctness score. Contextual relevance is moderate because it addresses the structure of comparing two tables and allocation shares, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 423,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Nike’s timed‑deposit balances that are included in cash and equivalents fell from $502 million in fiscal 2023 to $347 million in fiscal 2024, a decrease of $155 million【page_73†L31-L34】【page_73†L45-L48】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the decrease in Nike's timed deposits classified as cash and equivalents from fiscal year 2023 to 2024 is correctly stated as $155 million. (2) Quantitative accuracy is perfect — the LLM provides the exact starting value ($502 million in 2023) and ending value ($347 million in 2024), and the calculated difference ($502M - $347M = $155M) is correct. Minor formatting variations (e.g., $155 million vs $155M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the relevant metric (timed deposits classified as cash and equivalents), extracts values from two different fiscal years (2023 and 2024), and computes the change accurately. (4) Entity accuracy is confirmed: 'Nike' is correct, fiscal years 2023 and 2024 are correctly referenced, and the financial metric aligns with the knowledge graph. The answer is semantically equivalent to the ground truth and includes additional context (specific balances per year) that enhances clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1070,
        "completion_tokens": 334,
        "total_tokens": 1405
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The depreciation, depletion, amortization and impairments for the Alaska and Lower 48 segments were $1,061 million and $5,729 million respectively in 2023, for a combined total of **$6,790 million**. In 2022 those same segments recorded $941 million and $4,854 million, a combined **$5,795 million** – about **$1 billion higher** in 2023 than in 2022【page_133】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: $6,790 million combined total for 2023 and $5,795 million for 2022, matching the ground truth exactly. It also breaks down the components ($1,061M for Alaska and $5,729M for Lower 48 in 2023; $941M and $4,854M in 2022), which are accurate and provide additional context not required but factually correct. (2) The calculation of the combined totals is accurate: $1,061M + $5,729M = $6,790M (2023); $941M + $4,854M = $5,795M (2022). The implied year-over-year difference is $6,790M - $5,795M = $995M, which the model correctly characterizes as 'about $1 billion higher'—a reasonable approximation. (3) The multi-hop reasoning is sound: the model correctly identifies and aggregates data from two segments (Alaska and Lower 48) across two years (2022 and 2023), synthesizing the information to answer both parts of the question—total values and comparison. (4) All entities (segments, financial metric, years) are correctly identified and used. The answer is semantically equivalent to the ground truth, with slightly more detail, and fully addresses the question. All scores are 10 due to complete factual accuracy, correct calculations, proper synthesis, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 349,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "As of December 31 2022 PayPal reported a crypto‑asset safeguarding asset and a matching crypto‑asset safeguarding liability each at a fair value of **$604 million** (together $1.208 billion)【page_94】.  Both amounts are shown in Note 9’s “fair‑value measurement of assets and liabilities” table for recurring measurements and are classified as **Level 2** fair‑value items because they are valued using quoted prices on the principal market for the underlying crypto assets (there is no active market for the liability or asset)【page_95】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of both the crypto asset safeguarding liability and the corresponding safeguarding asset as $604 million each as of December 31, 2022, matching the ground truth. It accurately notes that both are reported at $604 million (not a combined total), though it adds the sum of $1.208 billion, which is factually correct but not requested in the question—this is a minor addition, not an error. (2) All numeric values—$604 million, December 31, 2022, Level 2 classification—are correct and match the ground truth. The format variations (e.g., $604 million vs $604M) are acceptable. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information from Note 9 and the fair value measurement table, identifying both the asset and liability, their valuation method, and their Level 2 classification based on significant other observable inputs (quoted prices on principal market). It correctly explains the rationale for Level 2 classification, aligning with the disclosure logic. (4) The only minor shortcoming is the emphasis on the combined $1.208 billion figure, which could mislead if interpreted as the 'total fair value' requested—however, the question asks for 'the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset,' which can be interpreted as reporting both values (each $604M), not their sum. The LLM clearly states each is $604M, so the core answer remains correct. The contextual and qualitative accuracy is high, with precise referencing to page 94 and 95 and correct interpretation of fair value hierarchy. Thus, the answer is factually excellent with only slight over-clarification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 466,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "In fiscal 2024 Walmart paid $3.5 billion to acquire PhonePe shares and settle the related liability, but it also received $0.7 billion from a new round of PhonePe equity funding. The combined effect was a net cash outflow of roughly $2.8 billion for the year 【page_65】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Walmart paid $0.9 billion to increase its ownership in PhonePe, but the LLM claims a $3.5 billion outflow, which is nearly 4x higher and incorrect. The $0.7 billion inflow from new equity funding is correctly reported. However, due to the incorrect outflow amount, the net cash outflow is miscalculated: the LLM reports $2.8 billion ($3.5B - $0.7B), while the correct net outflow is $0.2 billion ($0.9B - $0.7B). (2) Quantitative accuracy is severely compromised: the $3.5 billion figure does not match the ground truth of $0.9 billion. The $0.7 billion inflow is accurate. The net outflow calculation is mathematically correct based on the LLM's numbers but is factually wrong due to the incorrect input. (3) The reasoning structure is sound—recognizing that net impact = outflow minus inflow—but the multi-hop synthesis fails because the model uses incorrect ownership payment data. It does not correctly identify the nature of the $0.9 billion payment to noncontrolling interest holders, instead misrepresenting it as a broader $3.5 billion acquisition cost. (4) Contextual relevance is high—the answer addresses the right question about net financial impact, ownership changes, and equity funding—but the severe numerical errors undermine factual correctness. The citation to 'page_65' suggests a source, but the data contradicts the ground truth, indicating either misinterpretation or hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 416,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "Southern Company’s wholesale revenues grew by **$77 million in 2024 versus 2023** (up from $188 million to $265 million).  The rise was driven in part by higher affiliate sales – transactions that are made under the FERC‑approved IIC and priced at marginal cost – which boosted affiliate‑related wholesale revenue (e.g., a $79 million increase for Alabama Power) and helped lift total wholesale revenue, even though those sales have little impact on earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states a $77 million increase in total wholesale revenues, but the ground truth specifies a net increase of $69 million, derived from a combination of a $77 million increase in one segment, a $79 million increase in affiliate sales, and an $87 million decrease in non-affiliate sales in another segment. The LLM incorrectly presents $77 million as the total net change, omitting the offsetting $87 million decline and misrepresenting the net outcome. (2) The $77 million figure does appear in the ground truth but refers to only one component of the total change, not the net. The $79 million increase in affiliate sales is correctly cited (e.g., Alabama Power), and the reference to FERC-approved pricing aligns with the IIC-approved mechanism. However, the LLM fails to calculate or mention the full net change of $69 million, which requires synthesizing all components. (3) The reasoning is partially sound: it identifies the role of the IIC-approved mechanism in enabling affiliate sales at marginal cost and notes their limited earnings impact, which is contextually accurate. However, it does not fully synthesize the multi-hop elements—specifically, combining changes across affiliate and non-affiliate sales from different segments to arrive at the correct net change. (4) The contextual relevance is high as it addresses both parts of the question—revenue change and the role of the IIC mechanism—but the quantitative inaccuracy in the net change significantly undermines correctness. The qualitative accuracy is moderate due to correct identification of mechanisms and directional trends, but incomplete synthesis. Quantitative accuracy is low due to the incorrect net figure despite some correct component numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 477,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Intel’s IDM 2.0 plan calls for roughly $20 billion to build two new fabs in Arizona, more than $20 billion for two leading‑edge fabs in Ohio, and about $10.5 billion to equip its Rio Rancho, New Mexico and Malaysia sites for advanced packaging – a combined investment of **over $50.5 billion** in manufacturing expansion【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) All numeric values are correct: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for Rio Rancho and Malaysia packaging sites. The total is correctly stated as over $50.5 billion, which aligns with the sum of the components (the phrasing 'over' accounts for the 'more than $20 billion' in Ohio). (2) Quantitative accuracy is perfect—each dollar amount matches the ground truth, and the implied total ($20B + >$20B + $10.5B = >$50.5B) is logically sound. (3) The multi-hop reasoning is correct: the model synthesizes investments across three geographic and operational segments (Arizona, Ohio, and global packaging sites) to arrive at the total. (4) The only minor issue is the use of 'over $50.5 billion' instead of the precise 'total of $50.5 billion'—but since one component is 'more than $20 billion', the total being at least $50.5B is accurate, and the wording reflects appropriate uncertainty. Thus, the answer is semantically equivalent and factually correct. Contextual relevance is perfect as it directly answers the question with all required components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 331,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher preliminarily recorded about **$3.9 billion of goodwill** in connection with the Abcam acquisition.  In the lead‑up to the Veralto separation, Danaher received roughly **$2.6 billion of net cash** from Veralto; it used about **$1 billion to redeem commercial paper** and earmarked the balance to pay bond maturities and fund its regular quarterly cash dividends, bolstering its cash position before the distribution date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.9 billion goodwill from the Abcam acquisition and the $2.6 billion net cash received from Veralto prior to the distribution date, matching the ground truth exactly. It also accurately notes the $1.0 billion used to redeem commercial paper. These quantitative figures are all correct and properly formatted. (2) All numeric values—$3.9 billion, $2.6 billion, and $1 billion—are factually accurate and consistent with the original answer. No calculation errors are present. (3) The multi-hop reasoning is sound: the answer synthesizes information about two distinct events (Abcam acquisition goodwill and Veralto separation cash flows) and correctly links the use of the cash proceeds, even adding context (funding bond maturities and dividends) that is consistent with typical corporate behavior and does not contradict the ground truth. While the original answer does not mention bond maturities or dividends, this addition is plausible and does not detract from accuracy. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced contextual detail. The only minor deviation is the inclusion of additional use cases for the cash, which are not in the original but are reasonable and do not introduce inaccuracies. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 399,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "In fiscal 2024 Nike recognized a total net gain of **$294 million** in income from foreign‑exchange forwards and options – the $270 million gain on designated cash‑flow hedges plus a $24 million gain on non‑designated contracts【page_84】.  At year‑end the fair‑value of the same forwards and options was **$343 million** for assets and **$120 million** for liabilities【page_74】, meaning the income gain is slightly less than the asset fair‑value, exceeds the liability fair‑value by more than double, and is larger than the net fair‑value position of $223 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. The total net gain recognized in income is stated as $294 million, but the ground truth is $24 million. The LLM incorrectly breaks this into $270 million (designated hedges) and $24 million (non-designated), implying a sum that does not match either the reported total or the ground truth. Additionally, the fair value of derivative assets and liabilities is reported as $343 million and $120 million, respectively, whereas the correct figures are $557 million in assets and $180 million in liabilities. These discrepancies affect all quantitative aspects of the response. (2) Calculations are flawed: the LLM claims a net fair value position of $223 million ($343M - $120M), which is based on incorrect inputs. Even the comparison logic (e.g., 'income gain exceeds liability fair value by more than double') is based on wrong numbers and thus misleading. (3) Multi-hop reasoning is partially present—the model attempts to synthesize information about gains during the year and fair values at year-end—but it fails because it draws from incorrect source data. It references 'page_84' and 'page_74', suggesting document retrieval, but the extracted figures do not align with the ground truth. (4) Contextual relevance is acceptable: the structure addresses both parts of the question (income gain and year-end fair value comparison), and the intent to compare the income impact with the balance sheet values is appropriate. However, due to severe inaccuracies in numbers and calculations, the overall correctness score is very low. Minor credit is given for attempting the right type of analysis and using plausible financial logic, albeit on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 473,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The 2022 discounted‑future net cash‑flow for the Lower 48 is $55,912 million for consolidated operations (the equity‑affiliate column for Lower 48 shows no amount, i.e., $0), giving a combined total of **$55,912 million**【page_159】.  \n\nFor the same year, depreciation, depletion, amortization and impairments for the Lower 48 were **$4,854 million**【page_133】.  \n\nThus, the discounted‑future cash‑flow is roughly $51 billion higher—about 11½ times the amount of the region’s depreciation, depletion, amortization and impairments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$55,912 million for the combined discounted future net cash flows and $4,854 million for depreciation, depletion, amortization, and impairments—are accurately reported. The LLM correctly notes that equity affiliates contributed $0 to the cash flows for the Lower 48, resulting in the combined total being equal to the consolidated operations value. (2) The comparison is accurate: $55,912 million is approximately 11.5 times $4,854 million (55,912 / 4,854 ≈ 11.52), and the statement that it is 'roughly $51 billion higher' is reasonable (55,912 - 4,854 = 51,058 million). (3) The multi-hop reasoning is sound—information from two different parts of the filing (cash flows and expense items) is correctly synthesized across regions and entity types (consolidated vs. equity affiliates). (4) The answer is semantically equivalent to the original, with slightly more precise comparative language (e.g., '11½ times') and proper citation of sources. All entities, years, and metrics are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 330,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "PayPal reported **$563 million** of loans and interest receivable, held for sale as of December 31 2023. The fair‑value measurement for this line item is classified in **Level 3** of the fair‑value hierarchy—using significant unobservable inputs (the price the company expects to receive under its sale agreement)—and the fair value is also **$563 million**, i.e., the reported amount equals the Level 3‑based fair value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurate and correctly formatted. (2) The answer correctly identifies that the entire fair value is based on Level 3 inputs (significant unobservable inputs), which aligns with the ground truth. (3) The reasoning is sound: it explains that the fair value measurement is classified in Level 3 and explicitly states that the reported amount ($563 million) equals the Level 3-based fair value, confirming full alignment between book value and fair value under Level 3. (4) All entities—PayPal, the financial metric, the date, and the fair value hierarchy level—are accurately identified and correctly synthesized. The answer addresses both parts of the question: the total value and its comparison to fair value based on unobservable inputs. Minor wording enhancements (e.g., specifying the sale agreement as a basis for valuation) add clarity without introducing error. Semantic equivalence is preserved, and no factual or logical gaps exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 324,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During 2023 the company drew **$3.0 billion** and repaid **$6.1 billion** of revolving indebtedness under the **2021 Multicurrency Credit Facility**. In the same year it drew **$3.1 billion** and repaid **$2.6 billion** under the **2021 Credit Facility**【page_52】. Thus, the Multicurrency facility saw roughly $3 billion less borrowing but about $3.5 billion more repayments than the Credit Facility, resulting in a net cash outflow versus a net cash inflow for the latter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all key figures: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility, matching the ground truth exactly. These numbers are presented with correct formatting and units. (2) All quantitative values are accurate, and the implied net repayment of $3.1 billion ($6.1B - $3.0B) for the Multicurrency facility and net borrowing of $0.5 billion ($3.1B - $2.6B) for the 2021 Credit Facility are factually correct, though not explicitly stated as 'net' values. The LLM instead describes the comparative difference in borrowing and repayment, stating 'roughly $3 billion less borrowing but about $3.5 billion more repayments', which is a reasonable approximation of the actual differences ($0.1B less borrowing, $3.5B more repayments). The slight rounding in the comparative analysis ('roughly', 'about') does not constitute a factual error. (3) The multi-hop reasoning is sound: the model correctly distinguishes between the two facilities and synthesizes borrowing and repayment data for the same period (2023), enabling a valid comparison. It correctly attributes the data to the right facilities and time frame. (4) The answer is contextually complete and relevant, addressing both parts of the question—amounts borrowed/repaid under each facility and their comparison. The only minor shortcoming is that it does not explicitly state the net repayment and net borrowing figures as clearly as the original answer, instead framing the comparison in relative terms. However, the semantic meaning and financial implications are preserved. Thus, the answer is highly accurate with only a slight reduction in qualitative precision due to less explicit net calculation reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 496,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The auditors for both Georgia Power and Mississippi Power (1) tested the effectiveness of management’s controls over evaluating the likelihood that incurred costs will be recovered in future rates (or that refunds or rate reductions should be recorded as regulatory liabilities) and over the monitoring of regulatory developments; (2) read and evaluated the relevant regulatory orders and other publicly‑available information to gauge the probability of recovery or reduction; (3) performed substantive testing of the incurred costs recorded as regulatory assets or liabilities for completeness and accuracy; (4) obtained management representations on the recoverability of those costs; and (5) reviewed the companies’ disclosures of regulatory‑rate impacts 【page_133】【page_140】. These steps underscore the subjectivity of the audit because they rely on management’s judgments and assumptions about future regulatory orders—judgments that are inherently uncertain and require specialized knowledge of the rate‑setting process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original answer. (1) All factual elements are correct: both Georgia Power and Mississippi Power were subject to audit procedures involving testing of management controls over cost recovery assessments, review of regulatory orders and public information, and evaluation of regulatory assets/liabilities. The LLM adds more granularity—specifically listing five procedures including substantive testing, management representations, and disclosure reviews—which are consistent with standard audit practices and supported by the cited pages (133, 140), enhancing completeness without introducing inaccuracies. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and procedures are correctly represented. (3) Multi-hop reasoning is sound: the model correctly synthesizes that similar procedures were applied across both companies and links them to the broader theme of subjectivity in forecasting regulatory outcomes. The explanation that auditors rely on management judgments about future regulatory orders accurately reflects the inherent subjectivity noted in the ground truth. (4) Semantic equivalence is strong: while the LLM provides a more detailed breakdown of audit steps, the core message—that these procedures reflect subjectivity due to reliance on uncertain future regulatory decisions—is preserved and well-articulated. The only minor gap is that the LLM does not explicitly mention 'precedents for similar cost treatments' as phrased in the original, though this is implied in 'evaluated relevant regulatory orders... to gauge the probability of recovery.' Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 498,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The 70 % plunge in Comirnaty’s worldwide sales cut Pfizer’s total revenue by about $26.4 billion in 2023 and drove a $14.2 billion reduction in cost of sales, sharply depressing operating income and inflating cost‑of‑sales as a share of the much‑lower revenue base. At the same time, the BioNTech collaboration obligates Pfizer to a $225 million upfront payment (including $75 million cash and $150 million equity) and up to $200 million in future regulatory‑ and sales‑milestone payments plus ongoing profit‑sharing, creating additional long‑term financial commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the core question about Comirnaty revenue decline and BioNTech collaboration. While it correctly identifies a 70% decline in Comirnaty revenue, the derived figures are incorrect. The actual revenue drop was from $37,806 million to $11,220 million, a difference of $26,586 million (~$26.6B), which the LLM approximates as '$26.4 billion'—this part is reasonably accurate. However, the claim of a '$14.2 billion reduction in cost of sales' is unsupported by the ground truth and appears fabricated. The ground truth does not mention any specific cost of sales reduction, making this a major quantitative error. (2) The collaboration terms are misrepresented: the LLM states Pfizer agreed to a '$225 million upfront payment ($75M cash + $150M equity)' and '$200 million in milestone payments', but the original answer mentions no such upfront or milestone payments. Instead, the correct obligation is tiered royalties and gross profit sharing with BioNTech on Comirnaty sales—ongoing profit-sharing, not fixed payments. These numbers are entirely inconsistent with the ground truth. (3) The multi-hop reasoning is partially sound in linking revenue decline to operational impact and recognizing ongoing financial obligations via collaboration, but the synthesis fails because it invents specific payment terms not present in the source. The model conflates general profit-sharing with specific milestone and equity payments, likely from other known Pfizer-BioNTech agreements, but incorrectly applies them here. (4) Contextual relevance is high as the answer addresses both parts of the question—impact on operational results and future obligations—and attempts quantitative reasoning. However, due to major factual and numerical errors in both financial impact and collaboration terms, the correctness score is low. Quantitative accuracy is severely penalized due to invented figures; qualitative accuracy suffers from incorrect entity relationships; contextual relevance remains strong as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 570,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "As of May 31 2024, Nike’s short‑term investments included **$35 million** of U.S. Agency securities, versus **$46 million** on May 31 2023.  That represents a **year‑over‑year decrease of $11 million**.【page_73】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $35 million (May 31, 2024) and $46 million (May 31, 2023) are accurate, and the year-over-year decrease of $11 million is correctly calculated ($46M - $35M = $11M). (2) The answer is complete, addressing both the current and prior year values as well as the change, which directly responds to the multi-part question. (3) Entity accuracy is correct: NKE (Nike) is properly identified, the security type (U.S. Agency securities) and classification (short-term investments) are accurate, and the fiscal dates (May 31, 2024 and 2023) match the question. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by comparing two time points from the same company's filings and computing the difference. (5) The semantic meaning is equivalent to the original answer, with clear, concise presentation and correct use of bold formatting for emphasis. The citation [page_73] adds contextual support. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 299,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "In 2024 the Japanese subsidiary repaid $77 of its Guaranteed Senior Notes and did not issue any new notes, so the total principal amount of those notes fell by $77 (approximately $77 million) (page 52). The cash‑flow note confirms the $500 issuance was in November 2023, not in 2024 (page 30).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states there was a net increase of $423 million in the total principal amount of Guaranteed Senior Notes in 2024. However, the LLM claims there was a decrease of $77 million due to repayments with no new issuances. This directly contradicts the correct answer. (2) The LLM incorrectly asserts that no new notes were issued in 2024, pointing to a $500 million issuance in November 2023 as evidence. However, the correct answer implies that new issuances in 2024 (likely around $500 million) offset the $77 million repayment, resulting in a net increase of $423 million ($500M - $77M ≈ $423M). Thus, the LLM fails to recognize a key issuance in 2024, leading to a major quantitative error. The repayment amount of $77 million may be accurate, but without acknowledging the 2024 issuance, the net change is wrong. (3) The multi-hop reasoning is flawed. The model correctly identifies a repayment and checks the timing of a prior issuance, but fails to identify any new issuance in 2024, which is necessary to compute the net change. It incorrectly concludes no new issuances occurred, breaking the synthesis required across time periods and documents. (4) The correctness score is 1 due to the completely incorrect net change direction (decrease vs actual increase) and magnitude. Quantitative accuracy is 1 because the only number potentially correct ($77M repayment) is outweighed by the missing $500M issuance in 2024 and wrong net result. Qualitative accuracy is 2 because while the model attempts reasoning and cites document pages, it misses critical information and draws an incorrect conclusion. Contextual relevance is 5 because the answer addresses the right topic and metric but with incorrect data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 485,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "3M reported $0.5 billion of stand‑alone letters of credit, bank guarantees and similar instruments outstanding at December 31 2024. At the same date the company held roughly $4.2 billion of cash, cash equivalents and marketable securities in the United States—about eight times the value of those credit instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: $0.5 billion in stand-alone letters of credit, bank guarantees, and similar instruments, and $4.2 billion in U.S.-held cash, cash equivalents, and marketable securities as of December 31, 2024. These match the ground truth exactly. (2) While the original answer calculates the ratio as approximately 11.9% (0.5 / 4.2 ≈ 0.119), the LLM instead states that the credit instruments are 'about eight times' smaller than the U.S. liquidity, which is a valid approximation (4.2 / 0.5 = 8.4, so 'about eight times' is reasonable). The slight simplification does not constitute a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct pieces of financial data from the same company and time period to make a comparative statement. (4) The answer is semantically equivalent to the ground truth—though it omits the explicit percentage, it conveys the same comparative relationship in a different but accurate way. All entities (3M, correct financial instruments, correct date) are accurate. The only minor shortcoming is the lack of the precise percentage, which slightly reduces qualitative accuracy, but the core information is fully correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 354,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In the fourth quarter of 2023, Meta estimated that duplicate accounts comprised roughly 10 % of its worldwide MAUs, whereas false accounts made up about 4 % of worldwide MAUs. Thus, duplicate accounts were about 6 percentage points higher – roughly 2½ times the share of false accounts.【page_32】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that duplicate accounts represented approximately 10% of Meta's worldwide MAUs in Q4 2023, and false accounts represented 4%, matching the ground truth exactly. (2) The quantitative comparison is accurate: 10% is 6 percentage points higher than 4%, and 10 ÷ 4 = 2.5, so stating 'roughly 2½ times the share' is a correct and precise interpretation. Minor formatting variations (e.g., 10 % vs 10%) are acceptable and do not affect meaning. (3) The reasoning is sound and synthesizes the two percentages to make a valid comparative statement, fulfilling the multi-hop requirement of comparing both metrics and interpreting their relative magnitude. (4) All entities—Meta, Q4 2023, worldwide MAUs, duplicate accounts, false accounts—are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly more precise phrasing ('2½ times') enhancing clarity. All scores are maximized due to full factual accuracy, correct calculations, proper entity usage, and relevant, complete response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 309,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer’s shingles‑vaccine deal with BioNTech included an upfront cash payment of **$75 million** (plus a $150 million equity investment) 【page_76】. By contrast, the Biohaven migraine‑rights agreement required an **upfront cash payment of $150 million** (also with a $350 million equity investment) 【page_76】—so the BioNTech cash outlay was $75 million lower, or roughly half the amount paid to Biohaven.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $75 million upfront cash payment to BioNTech for the shingles mRNA vaccine collaboration and the $150 million upfront cash payment to Biohaven for migraine treatment rights outside the U.S., both matching the ground truth. The comparison stating that the BioNTech cash outlay was $75 million lower is accurate and aligns with the $75 million difference in favor of the Biohaven deal. (2) All numeric values are correct: $75M and $150M cash payments are accurately reported. The implied calculation (150 - 75 = 75) is correct, and the relative comparison (half the amount) is mathematically sound. (3) The multi-hop reasoning is sound—information about two separate deals (BioNTech and Biohaven) is correctly synthesized, and the comparison is logically derived. The mention of equity investments, while not part of the question, adds context but does not detract from accuracy. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (equity investments), but the core facts and comparison are fully correct. The only minor point preventing a perfect 10 is the slight expansion beyond the question's scope, which doesn't introduce error but adds non-essential information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 352,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "The derivative‑liability table shows that foreign‑exchange forwards and options carried liabilities of $120 million (fair‑value), $115 million (accrued) and $5 million (other long‑term) as of May 31 2024 – a combined total of **$240 million**. These amounts include the obligations from both hedging‑designated and non‑hedging instruments【page_74】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final total. The ground truth states the total liability is $115 million, composed of $110 million from hedging instruments and $5 million from non-hedging instruments. The LLM incorrectly reports a total of $240 million by summing $120 million (fair-value), $115 million (accrued), and $5 million (other long-term), which appears to misinterpret the nature of these line items as additive liabilities rather than different valuation categories or presentation formats. (2) The numbers cited in the LLM answer ($120M, $115M, $5M) do not match the ground truth values and are likely misread from a table that breaks down derivatives by accounting classification rather than by hedging designation. The correct total is $115 million, not $240 million. The calculation is therefore fundamentally flawed. (3) The multi-hop reasoning fails because the model does not correctly synthesize the distinction between hedging vs. non-hedging instruments as the basis for the total. Instead, it aggregates unrelated balance sheet categories, suggesting a misunderstanding of financial reporting structure. (4) Contextual relevance is moderate because the answer addresses foreign exchange forwards and options and references the correct date (May 31, 2024), but the misuse of data categories leads to a highly inaccurate conclusion. The citation of 'page_74' suggests a source was used, but it was misinterpreted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 404,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal records a “crypto‑asset safeguarding liability” (with a matching safeguarding asset) to reflect its obligation to hold customers’ cryptocurrencies as an agent, not as its own assets 【page_71】. In the same footnotes it discloses that cash, cash equivalents and customer accounts – the pools that back this liability – are “potentially subject to concentration of credit risk” and are placed with high‑quality, often uninsured, financial institutions 【page_74】. Together, this means PayPal’s exposure to credit risk for customer‑held crypto is tied to the creditworthiness and concentration of the counterparties holding the safeguarding assets; a credit event at a concentrated institution could impair its ability to satisfy the crypto‑safeguarding liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PayPal's recognition of a 'crypto-asset safeguarding liability' and explains that this reflects its role as an agent, not owner, of customer-held crypto assets. It accurately links this liability to the concentration of credit risk in financial institutions where safeguarding assets are held. (2) There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a strict sense—but the absence of incorrect numbers supports a full score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two concepts—liability recognition and credit risk disclosure—and connects them logically: the safeguarding liability is backed by assets held at third-party institutions, which creates credit risk exposure through those counterparties. (4) The only minor shortcoming is that the LLM does not explicitly mention FDIC insurance limits being exceeded, a key nuance in the original answer that strengthens the credit risk argument. However, it does note that institutions are 'often uninsured,' which captures the essence. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 378,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "The 2019 Stock Incentive Plan resulted in the issuance of **689,202 long‑term incentive performance (LTIP) units, net of forfeitures**【page_9】.  For the year ended December 31, 2024, these LTIP units were listed as potentially dilutive securities, but **they had no material dilutive effect on the company’s share count or earnings per share**【page_114】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of LTIP units issued net of forfeitures is accurately stated as 689,202, matching the original answer exactly. The date reference (year ended December 31, 2024) is also correct. (2) The answer addresses both parts of the multi-part question: the quantity of units issued and their impact on stock dilution. (3) Entity accuracy is correct—'2019 Plan' is properly referenced, and 'LTIP units' are correctly identified as potentially dilutive securities. (4) The reasoning is sound: the LLM correctly synthesizes that while these units are considered potentially dilutive, they did not have a material effect on share count or earnings per share, which aligns with the ground truth's statement of 'no material dilutive effect.' The slight rewording (e.g., 'did not have a material dilutive effect' vs. 'no material dilutive effect') does not alter the factual meaning. All information is contextually relevant and derived from appropriate sections of the filing as indicated by the citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 312,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "In 2024, the manufactured PFAS‑product line added **$0.28 per diluted share** to earnings (see the “Manufactured PFAS products” line in the 2024 earnings‑per‑share table)【page_20】. By contrast, in 2022 the same item contributed **$0.90 per diluted share**【page_24】—about $0.62 less in 2024 than it did in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The ground truth states that manufactured PFAS products reduced 3M's earnings per diluted share by $0.20 in 2024 and $0.90 in 2022. However, the LLM incorrectly claims that PFAS products *added* $0.28 per share in 2024 (wrong sign and wrong value) and $0.90 in 2022 (correct value but wrong sign). This misrepresents the financial impact as positive instead of negative, which is a critical error. (2) Quantitative accuracy is very low: the 2024 value is wrong both in magnitude ($0.28 vs $0.20) and direction (positive vs negative reduction), while 2022 is correct in magnitude but wrong in direction. The comparison stating '$0.62 less in 2024' is based on incorrect inputs and thus invalid. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the nature of the financial impact (expense vs gain), despite citing specific pages. It also does not mention the combined $1.10 total impact over the two years, missing a key part of the synthesis. (4) Contextual relevance is moderate because the answer addresses the right company, metric, and years, and attempts a comparison, but the core financial interpretation is fundamentally incorrect, severely undermining the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 354,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "In 2024 the Southern Company system saw KWH sales to non‑affiliates plunge 30.8% (to 6.5 billion kWh), which trimmed non‑affiliate wholesale revenue by $87 million, while sales to affiliates jumped 165.5% (to 5.6 billion kWh) under the IIC, adding $79 million to affiliate wholesale revenue. The offset left total wholesale revenue essentially flat, slipping $8 million to $476 million in 2024 from $484 million in 2023【page_66】【page_67】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 30.8% drop in non-affiliate KWH sales and the resulting $87 million revenue decline, as well as the 165.5% increase in affiliate sales adding $79 million under the IIC. These core figures match the ground truth. However, the LLM introduces specific volume numbers (6.5 billion kWh and 5.6 billion kWh) not present in the original answer, which cannot be verified from the provided ground truth. Additionally, the claim that total wholesale revenue was 'essentially flat' at $476 million, down only $8 million from $484 million, is an inference not supported by the original answer, which does not provide total revenue figures or suggest overall stability. (2) While the percentage changes and dollar impacts are accurate, the addition of absolute volume data and total revenue calculations introduces unverified information. The $8 million net decrease implies a calculation (87M - 79M = 8M), which is mathematically correct, but the original answer does not confirm total revenue levels or assert a near-flat outcome. (3) The multi-hop reasoning is mostly sound—linking volume changes to revenue impacts and attributing affiliate sales to the IIC—but overreaches by quantifying total revenue performance beyond what the ground truth supports. (4) The answer is highly contextually relevant and captures the key dynamic: declining non-affiliate revenue offset by rising affiliate sales under the IIC. However, the unsupported numerical additions reduce quantitative accuracy. Scores reflect mostly correct facts with minor but notable extrapolations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 440,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission imposed an administrative fine of **€1.2 billion** on Meta Platforms Ireland together with corrective orders to suspend the offending transfers and stop unlawful processing of EEA user data in the United States【page_40】. Meta notes that meeting those orders – for example, building new compliance mechanisms or restructuring data flows – would **raise the cost and complexity of delivering its products and services in Europe**, thereby increasing its operational expenses on the continent【page_40】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitative accuracy: The financial penalty of €1.2 billion is correctly reported, matching the original answer exactly. The format '€1.2 billion' is equivalent to '€1.2 billion'. (2) Completeness: The answer addresses both parts of the question — the total financial penalty and the impact on Meta's operational costs in Europe. (3) Entity accuracy: 'Meta Platforms Ireland', 'Irish Data Protection Commission', 'EEA user data', and 'United States' are all correctly identified. (4) Reasoning: The LLM correctly synthesizes that compliance with corrective orders (e.g., suspending data transfers, ceasing unlawful processing) would require structural changes like new compliance mechanisms or data flow restructuring, leading to increased operational costs and complexity in Europe — which aligns precisely with the original answer's reasoning about Chapter V of the GDPR implications. The citation of 'page_40' indicates proper grounding. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 307,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "Home Depot says that offering a deep, specialized assortment and the ability to buy “job‑lot” quantities lets professional customers get all the bulk‑or‑specialty items they need for complex projects in one place, reinforcing its strategy to be the go‑to product authority and a one‑stop destination for urgent, large‑volume purchases. The filing warns that if it cannot maintain that product depth or keep those quantities in stock—due to inventory, supply‑chain or localized‑assortment failures—it could lose demand from Pros, see a drop in market share and margins, and undermine a key source of its competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the original answer. It correctly identifies that The Home Depot's product depth and job-lot quantities are designed to meet the needs of professional customers (Pros) by enabling one-stop, large-volume purchasing for complex projects. The reasoning is sound and aligns with the multi-hop requirement: linking product strategy (depth, job lots) to customer segment (Pros) and business impact. The risk portion accurately reflects the original: failure to maintain these offerings could lead to reduced demand, lower margins, and loss of competitive advantage. The LLM adds slightly more detail (e.g., 'supply-chain or localized-assortment failures', 'drop in market share'), which is reasonable extrapolation from the source and commonly implied in such contexts, but not explicitly stated in the ground truth. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed perfect. Semantic equivalence is strong—core facts, entities (The Home Depot, Pros), and causal logic are correct. One minor point preventing a perfect 10 is the slight expansion on risks (market share) beyond the original's focus on demand and margins. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 367,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The disclosures show a participating interest of **$83 million** for 2021 and **$94 million** for 2020 – a combined **$177 million** that is excluded from the fair‑value hierarchy (see the footnotes on pages 130 and 131, which reference the $83 M and $94 M figures also described on page 129). This exclusion signals that the interest is valued using a mix of quoted prices, recent transactions and actuarial present‑value calculations, making its measurement more complex and less observable than assets that can be placed in Levels 1‑3 of the hierarchy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two values of the participating interest in insurance annuity contracts excluded from the fair value hierarchy: $94 million for 2020 and $83 million for 2021, and accurately calculates the total as $177 million. These figures match the ground truth exactly, with acceptable format variation (e.g., $83 M = $83 million). (2) The calculation ($94M + $83M = $177M) is correct, and both individual amounts are properly attributed across disclosures, demonstrating accurate multi-hop synthesis across years. (3) The reasoning for the exclusion is well-articulated: the LLM correctly infers that the exclusion indicates complexity in valuation, citing the use of a mix of quoted prices, recent transactions, and actuarial present-value calculations. While the original answer emphasizes lack of observable market data and redemption restrictions, the LLM’s explanation is semantically equivalent by highlighting reduced observability and complexity beyond Levels 1–3. The only minor gap is the absence of explicit mention of 'restrictions on redemption,' but the emphasis on complex, less observable methods sufficiently captures the core implication. (4) All entities (participating interest, insurance annuity contracts, fair value hierarchy exclusion) and years are correctly identified. The answer is fully relevant and addresses both parts of the question: total value and interpretation of exclusion. Thus, the answer is factually excellent with only slight room for deeper alignment in qualitative nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 427,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal determines its allowance for credit losses by first applying loss‑curves to each loan portfolio (by geography, delinquency, vintage, etc.) and then adjusting the projected loss rates with macro‑economic forecasts (page 70). For merchant loans and advances the macro inputs are forecasted unemployment rates and retail e‑commerce sales, while for consumer receivables—particularly its revolving‑credit portfolio—the models incorporate forecasted household disposable income, retail e‑commerce sales and, through early‑2023, unemployment rates (page 70). This combination of loss‑curve methodology and macro‑adjustments drives the size of the allowance for credit losses on both merchant and consumer receivables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PayPal uses loss curves adjusted by macroeconomic forecasts for both merchant and consumer receivables. For merchant receivables, the macro factors are forecasted unemployment rates and retail e-commerce sales. For consumer receivables (specifically revolving credit), the factors include household disposable income, retail e-commerce sales, and unemployment rates (with a note that unemployment was used through early-2023). These details align with the original answer, though the original does not specify the 'through early-2023' limitation on unemployment for consumer receivables—this is a minor addition not contradicted by the ground truth but not required. (2) There are no numbers, dates, or dollar amounts in the question or answers that need verification; all references are qualitative and consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes the use of loss curves with macroeconomic adjustments across two categories (merchant and consumer), specifying correct factors for each. (4) The only reason for not scoring a 10 is that the original answer does not mention the time-bound use of unemployment for consumer receivables (through early-2023), which introduces a detail not present in the ground truth—this is not incorrect but slightly over-specified. Otherwise, the answer is complete, contextually relevant, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 416,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s strategy hinges on Kirkland Signature, which it has invested heavily in developing and protecting (page 8). If the brand’s quality, pricing or availability slips—whether because its trademarks or trade‑secrets are not adequately protected or because manufacturing or distribution facilities that produce private‑label items are disrupted—members may lose confidence and loyalty (page 11). Since Kirkland products generally carry higher margins than national brands, any loss of member acceptance or supply‑chain interruption would directly depress Costco’s gross‑margin performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies Costco's investment in Kirkland Signature, the reliance on manufacturing and distribution facilities, and the risks posed by disruptions (e.g., to trademarks, trade secrets, or operations). It accurately links these risks to potential impacts on member loyalty and gross margin performance, noting that Kirkland products carry higher margins than national brands. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The qualitative reasoning is sound and reflects multi-hop synthesis: connecting brand protection and supply chain operations to financial performance via member confidence. The only minor shortcoming is that the LLM does not explicitly mention specific disruption causes like extreme weather or pandemics (though 'disruptions' is implied), and slightly less detail on the growing sales share of Kirkland products—details present in the original. However, the core logic, entities (Costco, Kirkland Signature, private-label items), and causal链条 (disruption → availability/quality → member trust → margin/loyalty) are correctly captured. Contextual relevance is perfect, as the response directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 368,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The 2021 LTI Program had a maximum performance‑based LTIP fair‑value of **$18.4 million** and the 2022 program a maximum of **$20.6 million**, for a combined grant‑date fair value of **$39.0 million**.  By contrast, the time‑based restricted‑stock units granted in those years were valued at **$4.3 million** (2021) plus **$6.9 million** (2022), or **$11.2 million** in total【page_131】.  Thus, the performance‑based LTIP awards were roughly three‑and‑a‑half times larger than the time‑based RSU awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $18.4 million (2021 performance-based), $20.6 million (2022 performance-based), totaling $39.0 million, and $4.3 million (2021 time-based), $6.9 million (2022 time-based), totaling $11.2 million. These match the original answer exactly. (2) Calculations are correct: the sums ($18.4 + $20.6 = $39.0; $4.3 + $6.9 = $11.2) are accurate, and the comparison stating that performance-based awards were roughly three-and-a-half times larger is reasonable ($39.0 / $11.2 ≈ 3.48). (3) Multi-hop reasoning is sound: the model correctly synthesized data across two years and two types of awards (performance-based LTIP units and time-based RSUs), correctly identifying and aggregating values from both years. (4) Entity accuracy is perfect: correct years (2021, 2022), correct award types (performance-based LTIP units, time-based restricted stock units), and correct financial metric (grant date fair value). (5) Semantic equivalence is achieved: although the LLM uses slightly different phrasing (e.g., 'maximum performance-based LTIP fair-value'), this is consistent with typical SEC filing language and does not distort meaning. The inclusion of a citation ['page_131'] adds contextual support. Overall, the answer is factually precise, complete, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 380,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "The fair‑value of 3M’s U.S. municipal securities was **$20 million** at December 31 2024 (see the fair‑value table in Note 18). Because their valuation is based on the carrying amount of the related finance‑lease obligation rather than observable market prices, these municipal securities are **classified as Level 3** in the fair‑value hierarchy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the fair value of U.S. municipal securities as $20 million, while the ground truth is $16 million. This is a significant quantitative error that affects the correctness of the answer. However, the classification of these securities as Level 3 in the fair value hierarchy is correct. (2) The dollar amount is off by $4 million, which is not a formatting or rounding difference but a factual inaccuracy. All other numerical references (date: December 31, 2024) are correct. (3) The reasoning for Level 3 classification — that valuation is based on the carrying amount of the related finance lease obligation rather than observable market inputs — is logically sound and reflects accurate multi-hop synthesis between the valuation methodology and the fair value hierarchy criteria. This shows understanding of both the specific financial instrument and the accounting framework. (4) Despite the correct explanation and proper contextual reasoning, the incorrect dollar figure substantially undermines the factual accuracy. The answer is partially correct with a major error in a key quantitative fact, warranting a mid-range score. Contextual relevance and qualitative reasoning are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 347,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "Meta estimated that roughly 3 % of its worldwide MAP in Q4 2023 consisted solely of “violating” accounts. The figure comes from an internal review of a limited sample and heavy judgment, but Meta notes that limited visibility into encrypted platforms such as WhatsApp – where end‑to‑end encryption restricts data signals – makes identifying violating accounts especially difficult, so the true proportion may differ from the estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key percentage—3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted of violating accounts—which matches the ground truth exactly. The time period (Q4 2023) and entity (Meta) are accurate. (2) Quantitatively, the 3% figure is correct with no calculation errors; format variations (e.g., spacing in '3 %') do not affect meaning. (3) The reasoning component is well-handled: the LLM acknowledges the estimation challenges due to encrypted platforms like WhatsApp, citing limited visibility and restricted data signals (e.g., lack of message content access due to end-to-end encryption), which aligns with the ground truth. It appropriately adds context about reliance on limited samples and judgment, and notes that the true proportion may differ—this reflects a nuanced understanding of estimation uncertainty. (4) While the ground truth emphasizes reliance on 'phone numbers and device information' as alternative signals, the LLM answer captures the essence without listing those specifics, slightly reducing qualitative completeness. However, the core reasoning and multi-hop synthesis—linking Meta's user metrics to detection challenges on encrypted platforms—are sound and relevant. Thus, all key facts are correct, with only minor omission of specific data signals, warranting a high but not perfect qualitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 386,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Pfizer’s only upfront cash and equity out‑lays to BioNTech were for the shingles‑vaccine deal – a $75 million cash payment plus a $150 million equity investment, totaling $225 million. No upfront or equity payments were made by Pfizer under the Comirnaty (COVID‑19) collaboration, so the combined total remains $225 million【page_76†L31-L38】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that the total upfront payments and equity investments by Pfizer in BioNTech for both the shingles vaccine and Comirnaty programs was $375 million. However, the LLM claims the total is $225 million, citing only the shingles deal ($75M cash + $150M equity) and asserting no upfront or equity payments were made for Comirnaty. This contradicts the ground truth, which includes Comirnaty-related investments in the total. The LLM fails to report the correct total, omits key information about Comirnaty program investments, and incorrectly asserts zero equity or upfront payments for Comirnaty. Even if the shingles amount were correct (which may be supported by the cited page), the exclusion of Comirnaty payments leads to a major factual error. The reasoning is flawed, as it does not reflect the multi-hop synthesis required across both collaborations. The contextual relevance is low but not zero because it addresses the right companies and general topic. Quantitative accuracy is poor: $225M vs $375M is a significant discrepancy. Qualitative accuracy fails due to incorrect entity-event mapping (missing Comirnaty investment).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 335,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "Over the 2019‑2021 period, EMENA’s operations added only a modest net‑income contribution of about **$17 million** (a $24 million credit in 2021 offset by $6 million and $1 million impairments in 2020 and 2019)【page_104†L13-L18】. By contrast, the Lower 48 segment generated a cumulative **net loss of roughly $1.2 billion** (impairments of $804 million in 2020 and $402 million in 2019, partially offset by an $8 million credit in 2021)【page_104†L13-L15】. Thus, EMENA’s tiny gain is dwarfed by the large loss in the Lower 48 region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both direction and magnitude of financial results. It incorrectly states that EMENA had a net income contribution of $17 million, when in fact it had a cumulative net loss of $17 million (due to a $24 million loss in 2021, not a credit). The LLM misrepresents losses as 'credits' and impairments as if they were net income figures, reversing the meaning. For the Lower 48 region, it incorrectly claims a net loss of $1.2 billion, when the ground truth shows a net income of $1,206 million. This flips the actual performance completely. (2) Calculation verification: EMENA total = $1M + $6M - $24M = -$17M (correct in ground truth, wrong sign and interpretation in LLM). Lower 48 total = $402M + $804M - $8M = $1,198M ≈ $1,206M (minor discrepancy possibly due to rounding, but direction is correct in truth, reversed in LLM). The LLM incorrectly labels impairments as negative contributions but fails to recognize that net income is positive in those years. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize net income across years and regions, and misinterprets financial terminology (e.g., 'credit' vs 'impairment', 'net income' vs 'loss'). It draws the opposite conclusion — that Lower 48 had a large loss — when in fact it was highly profitable compared to EMENA. (4) Scores justified: correctness is low (2/10) due to fundamental errors in numbers and directionality; quantitative accuracy is poor (2/10) because all bottom-line figures are wrong in sign and magnitude; qualitative accuracy is slightly better (3/10) as it attempts multi-year aggregation and comparison; contextual relevance is moderate (6/10) because it addresses the right regions and time frame, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 484,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The “Other noncontrolling redeemable interests” fell from $172,912 k in 2023 to $169,192 k in 2024 – a decrease of $3,720 k (about $3.7 million)【page_128】.  This $3.7 million drop is part of the $11,220 k (≈$11.2 million) overall decline in “Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties” (from $195,949 k to $184,729 k), accounting for roughly one‑third of the total decrease, with the balance of the decline coming from the reduction in the 7.5% preferred units.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key numbers are accurate: 'Other noncontrolling redeemable interests' decreased from $172,912k to $169,192k, resulting in a $3,720k ($3.7 million) decrease — matching the ground truth dollar amount (with acceptable unit formatting: 'k' for thousands). The overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' is correctly stated as $11,220k ($11.2 million), from $195,949k to $184,729k. (2) Calculations are correct: the $3,720k decrease is accurately presented and accounts for approximately 33.1% of the total $11,220k decline — the LLM's phrasing of 'roughly one-third' is a valid approximation of this percentage. (3) Multi-hop reasoning is sound: the model correctly identifies the contribution of the 'Other noncontrolling redeemable interests' decrease to the broader total, and even adds context about the remainder of the decline being due to reductions in 7.5% preferred units, which enhances reasoning without contradicting the ground truth. (4) Entities, years, and financial terms are correctly identified. The answer is complete, addressing both parts of the question: the specific decrease and its contribution to the overall change. All criteria — quantitative accuracy, completeness, entity accuracy, reasoning, and semantic equivalence — are satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 393,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "The fair‑value table shows asset‑backed securities at **$24 million** and foreign corporate debt at **$31 million** for December 31 2024, for a combined fair value of **$55 million**【page_82】. In the prior year (2023) both categories were reported as “‑” (zero), so the combined fair value was **$0**, meaning the total increased by $55 million year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for foreign corporate debt ($31 million) and asset-backed securities ($24 million) as of December 31, 2024, are accurate, and their sum ($55 million) is correctly calculated. The prior year (2023) combined value is correctly identified as $0 million, with the explanation that both categories were reported as '‑' (indicating zero or not applicable), which aligns with the ground truth. (2) The answer is complete, addressing both parts of the question: the total fair value as of 2024 and the comparison to the prior year. (3) Entities are accurate—MMM is correctly referenced, and the financial instruments and dates are properly identified. (4) The reasoning is sound: the model correctly synthesizes data from two asset categories across two years, interprets '‑' as zero value, and computes the year-over-year change logically. (5) The semantic meaning is equivalent to the original answer, with clear, concise, and factually precise language. Minor formatting differences (e.g., bolding, spacing) do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 331,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Meta’s Family‑metrics are built on complex machine‑learning models and a variety of data signals that can be incomplete or mis‑measured (e.g., limited visibility into encrypted products, IP‑based location estimates), making the calculations “susceptible to algorithm or other technical errors” and subject to data‑signal gaps【page_6】. Because of those errors and the judgment‑heavy methodology, Meta says the resulting MAP and ARPP figures can be off by roughly 3 % of worldwide MAP—so the metrics could vary by about a three‑percent margin (with ARPP expected to be similarly affected)【page_4】【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Meta's Family metrics (MAP and ARPP) are subject to technical errors and data limitations due to complex models, judgment, and imperfect signals like IP addresses. It accurately states the 3% error margin around worldwide MAP, which matches the original answer. (2) Quantitatively, the 3% figure is correct and consistent with the ground truth; while the LLM does not explicitly calculate the 99 million user variance (3% of 3.3 billion), this omission is minor given that the core percentage margin—Meta's own stated estimate—is correctly reported. The answer implies the scale of variation without spelling out the arithmetic. (3) The reasoning is sound: it links data limitations (e.g., encrypted products, IP-based location) to model uncertainty and correctly extends the impact to both MAP and ARPP, recognizing that ARPP depends on MAP for per-user averaging. (4) The answer is contextually complete and relevant, addressing both parts of the question—how inaccuracies arise and the approximate margin of error. The only minor shortcoming is the lack of explicit numerical expansion (99 million), but since the 3% figure is the primary disclosed metric by Meta, this does not constitute a significant factual gap. Semantic equivalence is maintained, and all entities (Meta, MAP, ARPP, technical errors, 3% margin) are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 401,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot defines BOPIS as “Buy Online, Pickup In Store” (see glossary)【page_3】. By making BOPIS a core component of its omnichannel strategy—using its extensive store network as convenient pickup, return and delivery points—the company routes a large share of online sales to be collected in‑store, which enables roughly 50 % of U.S. online orders to be fulfilled through its stores【page_10】. This strategic use of BOPIS leverages store real‑estate to meet customer expectations for fast, convenient fulfillment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The 50% figure for U.S. online orders fulfilled through stores is correctly reported, matching the original answer. No other numbers or dates are involved. (2) Completeness: The answer addresses how BOPIS contributes to store-based fulfillment of online orders, explaining its role in the omnichannel strategy and linking it directly to the 50% fulfillment metric. (3) Entity accuracy: 'The Home Depot', 'BOPIS', and 'U.S. online orders' are all correctly identified and used in context. (4) Reasoning: The multi-hop synthesis—connecting the definition of BOPIS (from the glossary) to its operational use in fulfilling online orders via stores—is sound and logically presented. The answer correctly infers that using stores as fulfillment points enables the 50% target. (5) Semantic equivalence: While the wording differs, the meaning matches the original answer; the LLM adds contextual detail (e.g., returns and delivery points, customer expectations) that enhances clarity without introducing inaccuracies. The only minor gap is that it does not explicitly mention 'interconnected retail program' or 'optimize inventory distribution' from the original, but the core reasoning and facts are preserved. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 372,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley records DCP awards as a cash‑based, notional‑value award whose compensation cost is spread out over the award’s vesting period – the expense is adjusted for changes in the fair value of the employee‑selected investments and is deferred until each vesting tranche is earned (with a timing difference between the firm’s investment gains/losses and the expense recognition)【page_92】.  In contrast, carried‑interest compensation is treated as a share of the firm’s performance‑based fees; the portion (realized or unrealized) that is allocated to employees is expensed in the period it is allocated, rather than being amortized over a vesting schedule【page_92】【page_138】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that DCP awards are expensed over the vesting period with adjustments for changes in fair value of employee-selected investments, while carried interest compensation is expensed immediately upon allocation, without a vesting schedule. This matches the original answer's key distinction in timing and nature. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes information about two different compensation types (DCP and carried interest), correctly contrasting their accounting treatment, timing, and underlying rationale. It references appropriate pages (92, 138) indicating source support. (4) The only minor shortcoming is slight underemphasis on the 'nature of the awards' aspect—while implied, the LLM could have more explicitly stated that DCP is deferred and vesting-conditioned versus carried interest being performance-based and immediately recognized. However, this is conveyed contextually. Wording differs but semantic equivalence is strong. All parts of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 362,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "The Operating Partnership (and therefore Simon Property Group) reports “Other noncontrolling redeemable interests” of **$169,192 (thousands)** – about **$169.2 million** – classified as temporary equity as of December 31 2024【page_128】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it reports $169.2 million in noncontrolling redeemable interests classified as temporary equity, directly contradicting the ground truth that the amount is $0. This is a critical factual error. (2) The cited figure of $169,192 (thousands) does not align with the ground truth, which states that neither Simon Property Group nor the Operating Partnership reported any such interests redeemable at amounts in excess of fair value as of December 31, 2024. (3) The reasoning is flawed: the model fails to recognize that the absence of redeemable interests above fair value means no temporary equity classification is required, regardless of any reported line items. The multi-hop synthesis is incorrect—despite referencing the Operating Partnership and Simon Property Group, it misinterprets the financial reality. (4) Contextually, the answer addresses the right entities and time frame, but the core financial conclusion is wrong, severely undermining relevance and accuracy. Even if a document mentions a line item, the ground truth clarifies that no amounts meet the criteria for classification as temporary equity. Thus, the answer fails on correctness, quantitative precision, and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 352,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The notes state that NEE’s nuclear‑decommissioning fund assets were valued at **≈ $8,846 million** and FPL’s storm‑fund assets at **$76 million** as of 12/31/2021, giving a combined estimated fair value of **≈ $8,922 million**【page_90】.  On the consolidated balance sheet, NEE’s special‑use funds are carried at **$2,505 million**【page_55】.  Thus, the combined fair‑value amount of the nuclear‑decommissioning and storm‑fund assets is roughly **$6.4 billion higher** than the carrying amount of NEE’s special‑use funds.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NEE's nuclear decommissioning fund assets at $8,846 million, FPL's storm fund assets at $76 million, combined fair value of $8,922 million, and carrying amount of $2,505 million are all correctly reported. The implied calculation (8,846 + 76 = 8,922) is accurate. The difference of approximately $6.4 billion (8,922 - 2,505 = 6,417 million) is correctly characterized. (2) The answer is complete, addressing both parts of the question: the combined fair value and its comparison to the carrying amount. (3) Entities are correctly identified: NEE, FPL, nuclear decommissioning fund, storm fund, special use funds, and the date (December 31, 2021) are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly combines fair value data from two different funds (NEE and FPL) and compares it to the consolidated carrying amount on the balance sheet, noting the accounting treatment difference. (5) Semantic equivalence is maintained: although the LLM does not repeat the explanation about accounting treatment (e.g., amortized cost vs. fair value), it correctly highlights the $6.4 billion difference, which captures the essential comparison. The inclusion of citation markers [page_90, page_55] adds contextual support. Overall, the answer is factually precise, logically coherent, and fully responsive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 403,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC is one of Cisco’s three primary geographic operating segments – the “Asia Pacific, Japan and China” region – and its results are presented as a separate segment in the company’s consolidated financial statements (see pages 104 and 65). Because Cisco’s internal management system attributes sales to APJC by the customer’s ordering location but does not allocate R&D, sales‑and‑marketing, G&A or other corporate costs to the segment, APJC’s performance is judged mainly on its revenue and gross‑margin figures, aligning the internal performance measurement with the external segment reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: APJC is correctly identified as one of Cisco’s three geographic segments (Americas, EMEA, APJC), and its role in both operational reporting and consolidated financials is accurately described. The statement that R&D, sales-and-marketing, G&A, and corporate costs are not allocated to APJC matches the ground truth, which notes that such expenses are not allocated for internal management review. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the absence of specific numbers is consistent with the source. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the dual role of APJC in internal performance measurement and external financial reporting, linking the lack of expense allocation to the focus on revenue and gross margin for performance evaluation. (4) The LLM adds slightly more detail than the original (e.g., specifying that sales are attributed by customer ordering location, citing report pages), which enhances clarity without introducing error. The only minor gap is that the original emphasizes how APJC’s results directly feed into consolidated earnings and influence strategic decisions—this connection is implied but not explicitly stated in the LLM answer, slightly reducing qualitative completeness. However, the core meaning and factual content are semantically equivalent. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 440,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024 Business Markets and Other produced $13.1 billion of the Business segment’s $29.5 billion in revenue – roughly **44 %** of Verizon Business Group’s total revenues【page_6】.  This segment’s portfolio is built around wireless services that **include Fixed Wireless Access (FWA) broadband**, together with wireless equipment, voice, networking and security solutions aimed at small‑ and medium‑size business customers【page_6】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $13.1 billion and the 44% percentage are accurately reported, and the implied total revenue of $29.5 billion is consistent with $13.1B ÷ 0.44 ≈ $29.77B (minor rounding difference is acceptable). (2) The answer correctly identifies that Business Markets and Other is part of the Verizon Business Group and refers to the correct year, 2024. (3) The qualitative explanation accurately states that FWA broadband is included in the segment's wireless services portfolio and is tailored for small and medium businesses, which aligns with the ground truth's description of 'fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.' (4) The multi-hop reasoning is sound—synthesizing revenue data and segment offering details from the same source (page_6) to answer both parts of the question. The answer is semantically equivalent to the original, with no factual errors, omissions, or misinterpretations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 304,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "At December 31 2024 the interest‑rate hedge contracts (interest‑rate swaps designated as fair‑value hedges) had a net fair‑value liability of about **$‑50 million** (assets $1 million, liabilities $51 million)【page_64】.  By contrast, Abbott’s portfolio of foreign‑currency forward exchange contracts carried a **gross notional amount of roughly $16.2 billion** as of the same date【page_63】.  Thus, the fair‑value of the interest‑rate hedges is negligible compared with the multi‑billion‑dollar notional exposure of the foreign‑currency forwards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net fair value of Abbott's interest rate hedge contracts as -$50 million (a $51 million liability offset by a $1 million asset), which matches the ground truth in magnitude and direction. This part is accurate. However, the LLM reports the total notional amount of foreign currency forward exchange contracts as $16.2 billion, whereas the ground truth states $23.2 billion—a significant discrepancy of $7 billion. This error affects the quantitative accuracy and overall correctness. (2) Number verification: The $50 million net liability is correct (51 - 1 = 50). The date (December 31, 2024) is correctly used. But $16.2 billion vs $23.2 billion is a material difference that cannot be attributed to rounding or formatting. (3) Multi-hop reasoning is sound—the model correctly compares the fair value of interest rate hedges to the notional amount of foreign exchange contracts and concludes that the former is negligible compared to the latter. However, the conclusion is based on an incorrect notional amount, weakening the validity of the comparison. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial terminology. The qualitative reasoning is logical and well-structured, but the major numerical error in the foreign currency notional amount limits correctness. Hence, correctness_score is 6 (partially correct with significant error), quantitative_accuracy is 5 (half credit due to one correct and one incorrect major number), qualitative_accuracy is 7 (reasoning is sound despite wrong input), and contextual_relevance is 9 (fully on topic and relevant).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 459,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "In Asia the equity‑company portfolio holds roughly 1,503 million barrels of oil‑equivalent proved undeveloped reserves on only about 171 thousand net acres (152 k developed + 19 k undeveloped)【page_10】, whereas the consolidated subsidiaries hold about 1,315 million barrels on roughly 654 thousand net acres (427 k developed + 227 k undeveloped)【page_22】. This high reserve‑to‑acreage ratio shows that equity companies have a strong development potential per unit of land, while the consolidated subsidiaries, despite a much larger land base, are less efficient at converting acreage into reserves.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly reports the 1,503 million barrels of proved undeveloped reserves for Equity Companies and 1,315 million for consolidated subsidiaries, it incorrectly states the net acreage for Equity Companies as 171 thousand (152k developed + 19k undeveloped), whereas the ground truth specifies only 19 thousand net acres for Equity Companies. This is a major error, as the LLM conflates total net acreage with a breakdown that includes developed acres, which are not relevant to the reserves-to-acre ratio for undeveloped reserves. Similarly, it reports 654 thousand net acres for consolidated subsidiaries instead of the correct 640 thousand. (2) The calculation of the reserves-to-acre ratio is therefore flawed: the LLM implies a ratio for Equity Companies of ~8.8 million per thousand acres (1,503 / 171), but the correct ratio is ~79.1 million per thousand acres (1,503 / 19), which is dramatically higher. For consolidated subsidiaries, the LLM does not compute the ratio but implies inefficiency; however, its acreage figure (654k vs 640k) is slightly off. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that higher reserves per acre suggest greater development potential and compares efficiency between equity companies and consolidated subsidiaries. However, due to incorrect acreage figures, the core quantitative comparison is invalid. The conclusion about relative efficiency is directionally correct (equity companies more efficient), but the magnitude is misrepresented. (4) Contextual relevance is high—the answer addresses both parts of the question and attempts the correct comparison. However, the quantitative inaccuracies severely undermine factual correctness, warranting a mid-range score of 5. The qualitative reasoning is reasonable but based on flawed data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 511,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee means it is directly and fully liable for the securities issued by Morgan Stanley Finance LLC, giving those securities senior credit support that is backed by the Parent’s balance‑sheet assets. In a resolution scenario, this guarantee dovetails with the Firm’s amended and restated support agreement, which obligates the Parent to contribute all of its contributable assets to its supported entities (including the Funding IHC) and to provide senior‑secured collateral, while the Funding IHC supplies capital and liquidity to those entities. Thus, the guarantee is a key component of the broader commitment to backstop the Firm’s subsidiaries under the resolution plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities is properly described as providing full liability and credit support. The connection to the amended and restated support agreement is accurately presented, including the obligation to contribute contributable assets to supported entities and the Funding IHC, which in turn provides capital and liquidity. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the relationship between the guarantee (a financial commitment) and the broader resolution framework under the support agreement, recognizing that the guarantee is one component of the Firm's systemic backstop strategy. (4) The only minor shortcoming is that the LLM adds detail not in the original—specifically, 'senior-secured collateral'—which, while plausible and contextually reasonable, does not appear in the ground truth and slightly extends beyond the provided information. However, this does not introduce inaccuracy but adds interpretive depth. Overall, the answer is semantically equivalent, contextually appropriate, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 383,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The 2015 Bipartisan Budget Act moved partnership‑audit adjustments to the partnership level, so if the IRS audits any partnership in which SPG is a direct or indirect partner—including the Operating Partnership, its joint‑venture properties and the equity‑method investments it holds in third‑party‑managed entities such as Klépierre and The Taubman Realty Group, LLC—any resulting tax, interest or penalty can be assessed against the partnership and then passed through to SPG as a partner. As a result, SPG could be required to pay those additional tax liabilities, increasing its cash outlays and overall financial obligations on its joint‑venture investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial and legal implications of the Bipartisan Budget Act of 2015 on Simon Property Group's (SPG) joint venture investments. (1) All factual elements are correct: the Act moved audit adjustments to the partnership level, and taxes, interest, or penalties can be assessed at that level and passed through to partners like SPG. The mention of SPG's joint ventures, the Operating Partnership, and specific third-party-managed entities (Klépierre and The Taubman Realty Group, LLC) aligns with the ground truth. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., dollar amounts) are present in either answer, the reference to '84 joint venture properties' in the ground truth is the only missing quantitative detail; however, the LLM answer does not misstate any numbers and the absence does not impair correctness. (3) Multi-hop reasoning is sound: the LLM correctly links the Act's rules to SPG's structure, its use of equity-method accounting, and the resulting financial exposure—even though SPG is not directly managing all entities. It correctly identifies that SPG cannot opt out and may face increased cash outlays. (4) Semantic equivalence is strong: the LLM captures the essence that SPG could bear economic burden due to partnership-level assessments, which is the central point. The only minor shortcoming is the lack of explicit mention of SPG's REIT status and the contrast between direct ownership (typically not subject to corporate tax) versus indirect exposure via partnerships, which adds nuance to the financial risk. This omission slightly reduces qualitative completeness but does not undermine the overall correctness. Contextual relevance is excellent—the response directly addresses the question’s focus on financial obligations through joint ventures and third-party entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 507,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "The $128 million non‑cash impairment on Lockheed Martin’s AMMROC investment recorded in Q2 2020 reduced net earnings from continuing operations by $96 million, contributing to a diluted earnings‑per‑share result of $24.50 for 2020【page_43】.  By contrast, the $36 million severance‑and‑restructuring charge in the RMS segment in 2021 (about $28 million after‑tax, or $0.10 per share) trimmed net earnings that year and helped bring diluted earnings per share down to $22.76【page_88】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $128 million non-cash impairment in 2020 and the $36 million restructuring charge in 2021, as well as their after-tax impacts of $96 million and $28 million, and per-share effects of $0.34 and $0.10, respectively. These core financial figures match the ground truth and are quantitatively accurate. However, the LLM introduces two values not present in the original answer: the diluted EPS figures of $24.50 for 2020 and $22.76 for 2021. These specific EPS totals are not supported by the ground truth, which only states the per-share impact of the charges, not the overall EPS for the years. This misrepresents the scope of the original data and implies a level of precision not warranted by the source. (2) Number verification: The $96M and $28M after-tax impacts and $0.34 and $0.10 per-share effects are correctly stated and align with the ground truth. The timing (2020 and 2021) and entity details (AMMROC investment, RMS restructuring) are accurate. The addition of overall diluted EPS figures, while possibly derived from other parts of the filing, goes beyond what the original answer provides and introduces extraneous, unverified information. (3) Multi-hop reasoning is partially sound: the model correctly links the impairment and restructuring charges to their respective after-tax impacts on net earnings and per-share results. However, it fails to limit its response to the specific impacts of the two events, instead conflating them with total annual EPS results, which requires additional data not referenced in the question or original answer. (4) The correctness score is 6 due to significant factual accuracy on the key impacts but penalized for introducing unsupported aggregate EPS figures. Quantitative accuracy is 6 because while the core numbers are right, the inclusion of unverified EPS totals reduces precision. Qualitative accuracy is 7 as reasoning is logical but overreaches in interpretation. Contextual relevance is 9 because the answer addresses the question’s focus on financial impacts, despite the extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 564,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The balance of channel‑partner financing subject to Cisco’s guarantees fell from **$1.7 billion** at July 29 2023 to **$1.2 billion** at July 27 2024 – a **$0.5 billion (≈29 %) decline** year‑over‑year【page_93】.  This reduction lowers the maximum potential future payments Cisco could be called on to make, thereby easing cash‑flow pressure and supporting the MD&A’s view that its cash, cash equivalents, operating cash generation and access to capital markets will be sufficient to meet its liquidity and capital‑resource needs for the next 12 months【page_52】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.7 billion (fiscal 2023) and $1.2 billion (fiscal 2024) are accurate, and the year-over-year decrease of $0.5 billion is correctly calculated. The approximate percentage decline of 29% (0.5 / 1.7 ≈ 29.4%) is a reasonable addition and not contradicted by the original answer. Dates (July 29, 2023, and July 27, 2024) align with Cisco's fiscal year-ends and are consistent with SEC filing conventions. (2) The answer addresses both parts of the multi-part question: the quantitative change in financing balance and its relation to Cisco’s liquidity and capital resource requirements as stated in the MD&A. (3) Entities are correct: 'channel-partner financing subject to guarantees' is accurately referenced, and Cisco is the correct company. Fiscal years are properly interpreted as 2023 and 2024. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the decrease in guaranteed financing to reduced contingent liability risk, which supports Cisco’s MD&A assertion about sufficient liquidity from cash, investments, and operating cash flow. The citation of page 52 for the MD&A liquidity statement and page 93 for the financing balance adds verifiability. The semantic meaning fully aligns with the ground truth, with slightly enhanced clarity regarding cash-flow implications. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 403,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The pension‑plan assets include $4,432 million measured at NAV, whereas the other post‑retirement benefit plans include only $5 million measured at NAV【page_94†L31-L33】. The gap between the two categories is therefore about $4,427 million, with the pension‑plan category having the substantially higher value【page_95†L31-L33】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states the two values are $2,656 million and $3 million, resulting in a difference of $2,653 million. The LLM reports $4,432 million and $5 million, with a difference of $4,427 million—these numbers do not match the ground truth and are factually wrong. (2) Completeness: While the LLM attempts to answer both parts of the question (difference and which category is higher), it does so using incorrect data. (3) Entity Accuracy: The LLM refers to 'pension-plan assets' and 'other post-retirement benefit plans', which may be the actual categories in the filing, but this cannot compensate for the gross numerical inaccuracies. (4) Reasoning: The multi-hop reasoning fails because the model uses incorrect source data, leading to an incorrect comparison and difference calculation. Even if the structure mirrors the correct approach, the factual foundation is invalid. (5) Semantic Equivalence: The answer is not semantically equivalent to the ground truth due to the large discrepancy in values. The correct difference is $2,653 million, not $4,427 million. Therefore, the answer is mostly incorrect, with major factual and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 354,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott’s 2024 10‑K notes that the company is concentrating production on its Diabetes Care devices—especially its continuous‑glucose‑monitoring (CGM) systems—and that this focus “drove higher Diabetes Care sales” 【page_31】.  The result was an 18.1 % increase in Diabetes Care revenue, rising to $6.805 billion in 2024 from $5.761 billion in 2023 【page_29】.  The revenue is recognized under Abbott’s revenue‑recognition policy, which records product sales when control transfers to the customer (generally at shipment or delivery) 【page_49】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 18.1% revenue increase, $6.805 billion 2024 revenue, and implied 2023 revenue of $5.761 billion (calculated as $6.805B / 1.181 ≈ $5.761B) are correct. The percentage and dollar amounts align with the original answer. (2) The answer addresses all parts of the multi-hop question: it links Abbott's production focus on Diabetes Care Devices (specifically CGMs) to the 18.1% revenue increase, provides the exact revenue figure, and correctly identifies the accounting policy—revenue recognition upon transfer of control at shipment or delivery—as stated in the 10-K. (3) Entity accuracy is perfect: Abbott, Diabetes Care business, 2024 fiscal year, and correct financial metrics are all properly identified. (4) The reasoning is sound and synthesizes information across multiple sections of the 10-K (pages 29, 31, 49), demonstrating correct multi-hop logic: production focus → increased sales → revenue growth → accounting policy supporting recognition. (5) Semantic equivalence is maintained: while the LLM adds minor contextual detail (e.g., mention of CGMs and page references), the core factual content matches the ground truth exactly. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 364,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "Home Depot’s strategy explicitly builds project‑planning tools into its Pro‑focused offering because Pros say they “look for … project planning tools” along with dedicated support, competitive credit, pricing and job‑lot quantities for complex purchases (page 14). By delivering those tools through a customized online experience, an enhanced order‑management system and a broader Pro‑centric assortment, Home Depot differentiates itself from rivals and strengthens its competitive position in the professional‑customer market (page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies The Home Depot's emphasis on project planning tools as a strategic response to Pro customer expectations, citing specific needs such as dedicated support, job-lot quantities, and complex purchase requirements (matching the 2024 10-K content). The reference to page 14 and page 6 supports the multi-hop requirement across sections of the filing. All entities (The Home Depot, Pros, project planning tools) and their relationships are accurately represented. There are no numeric values requiring verification, so quantitative accuracy is not applicable but assumed correct. The reasoning is sound: the LLM correctly links tool development to competitive differentiation in the Pro market. The only minor shortcoming is that it does not explicitly mention 'interconnected shopping experience' or 'product depth' from the original answer, which are part of the 10-K's outlined expectations. However, these are implied in 'enhanced order-management system' and 'Pro-centric assortment.' Thus, the answer is semantically equivalent with high completeness and strong contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 332,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "As of December 31 2024 the company had 47,088,821 shares available under the 2003 Incentive Program, 238,700 shares under the 2004 Non‑Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer Natural Resources 2006 Long‑Term Incentive Plan – a combined total of 56,689,904 shares available for award【page_32】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 for the 2006 Long-Term Incentive Plan. The total sum is correctly calculated as 56,689,904 shares. (2) The date 'December 31, 2024' aligns with 'end of 2024' in the question. (3) All entity names are correctly identified, with only minor but acceptable wording differences (e.g., 'Pioneer Natural Resources 2006 Long-Term Incentive Plan' vs. 'Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan' — semantically equivalent). (4) The multi-hop reasoning is sound: the model correctly synthesized share availability across three distinct plans and summed them accurately. (5) The answer is contextually complete and directly addresses the total number of shares available, including the breakdown and total. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 297,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The 2023 re‑classification of Customer receivables (and other items) caused the Institutional Securities segment to record a $4,432 million reduction in interest income and an identical $4,432 million reduction in interest expense, leaving net interest unchanged. The adjustment explicitly tied to this change is a $4,432 million decrease to both interest‑income and interest‑expense line items.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $4,432 million decrease in both interest income and interest expense in the Institutional Securities segment due to the 2023 reclassification of Customer receivables is correctly stated. (2) Quantitative accuracy is perfect: the amount $4,432 million is consistently and correctly reported for both line items, matching the original answer exactly; format variations (e.g., use of 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—the answer correctly identifies the financial impact on two metrics (interest income and expense), notes the absence of effect on net interest income, and ties the adjustment explicitly to the reclassification, all within the correct business segment and year. (4) The answer is contextually relevant, complete, and directly addresses all parts of the question: impact on interest income, impact on interest expense, and the specific adjustment amount tied to the change. No factual or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 318,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The amounts excluded from hedge effectiveness for net‑investment‑hedge derivative contracts were $75 million for 2021 and $133 million for 2019, totaling $208 million combined.  According to the footnote, net‑investment‑hedge contracts consist of cross‑currency interest‑rate swaps and forward contracts (with certain non‑U.S.‑dollar debt also designated for the same purpose).【page_110】【page_111】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the amounts excluded from hedge effectiveness are accurately reported as $133 million in 2019 and $75 million in 2021, with a correct combined total of $208 million. The calculation is accurate and matches the original answer. (2) The types of contracts included in net investment hedge derivatives—cross-currency interest rate swaps and forward contracts—are correctly identified. The additional detail about non-U.S. dollar debt being designated is consistent with disclosures and adds context without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesized data across years (2019 and 2021) and linked the contract types to the correct derivative category using appropriate source references (page_110, page_111). (4) The answer is semantically equivalent to the original, with clear, precise wording and proper formatting of numbers. All evaluation criteria are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 299,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "After the 2021 amendments, the Credit Facility was expanded to a $5.0 billion aggregate size and the Supplemental Facility to $4.5 billion, giving the two facilities a combined borrowing capacity of **$9.5 billion**【page_124】.  The most the facilities were ever drawn during the year ended December 31 2021 was **$2.1 billion** of outstanding balances, meaning only about one‑fifth of the total $9.5 billion capacity was used (leaving roughly $7.4 billion unused, with $5.8 billion still available at year‑end)【page_124】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.0 billion for the Credit Facility, $4.5 billion for the Supplemental Facility, and a combined capacity of $9.5 billion. The maximum aggregate outstanding balance of $2.1 billion is correctly reported. The implied calculation ($5.0B + $4.5B = $9.5B) is accurate, and the observation about usage (about one-fifth used) is a valid interpretation. (2) The answer is complete, addressing both parts of the question: total borrowing capacity post-amendment and its relation to the maximum outstanding balance in 2021. (3) Entities are correct—Simon Property Group, Credit Facility, Supplemental Facility, and the year 2021 are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes the amended capacities and compares them to actual usage, concluding conservative leverage, which aligns with the ground truth's implication. (5) Semantic equivalence is strong—though the LLM adds minor elaboration (e.g., 'about one-fifth used', 'roughly $7.4 billion unused'), these are reasonable inferences and do not distort facts. All claims are supported by the source (cited page 124). No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 353,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "In 2021 RMS’ operating profit rose $183 million, and the bulk of that gain came from higher risk‑retirements on its Sikorsky helicopter line. The Black Hawk and CH‑53K programs alone added about **$140 million** to RMS’ operating profit, accounting for most of the year‑over‑year increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the dollar amounts are correct: $140 million from risk retirements on Black Hawk and CH-53K programs and the $183 million total increase in RMS' operating profit are both accurately reported, with acceptable formatting ($140 million vs $140 million). (2) The answer correctly identifies the entities: RMS, Black Hawk, CH-53K, and Sikorsky (which produces these helicopters), and the year 2021 is properly referenced. (3) The reasoning is sound—attributing the majority of the operating profit increase to higher risk retirements on these programs aligns with the original answer. (4) While the LLM omits mention of 'lower charges on the CRH program' as an additional contributing factor, this does not detract from the core focus of the question, which specifically asks about the contribution from Black Hawk and CH-53K risk retirements. The omission is minor and does not affect the correctness of the specific dollar amount or the primary causal link. Therefore, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 328,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "In 2021 the energy‑related derivatives reduced natural‑gas revenue by $117 million and added $27 million to natural‑gas cost, creating a net pre‑tax loss of $144 million (see page 327). By contrast, in 2019 they boosted natural‑gas revenue by $223 million and added $10 million to cost, yielding a net pre‑tax gain of $233 million (see page 327).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financial impact in 2021 as a $144 million loss and in 2019 as a $233 million gain, matching the ground truth. The breakdown of revenue and cost impacts in both years is accurate: $117M reduction in revenue and $27M increase in cost in 2021 (summing to $144M loss); $223M revenue increase and $10M cost increase in 2019 (net $233M gain). All dollar amounts and years are correct. (2) Calculations are accurate: $117M + $27M = $144M loss; $223M - $10M = $233M gain (though phrased as 'added $10M to cost', the net gain implies correct netting). The comparison to 2019 is correctly represented, though the LLM does not explicitly compute the $377M difference mentioned in the ground truth. This is a minor omission. (3) Multi-hop reasoning is sound: the model synthesizes derivative impacts on both revenues and costs across two different years for Southern Company, correctly aggregating them into net impacts. Entities (SO, 2021, 2019, natural gas revenues and costs, energy-related derivatives) are accurately identified and linked. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail. The only reason for not scoring 10 is the absence of the explicit $377M year-over-year difference, which was part of the original answer. However, the components to derive it are present, so the core information is correct. Quantitative accuracy is perfect. Contextual relevance is full. Qualitative reasoning is strong but not fully complete due to missing explicit comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 432,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "Cisco’s loss on privately‑held investments narrowed by **$29 million**, falling from a **$193 million loss in 2023** to a **$164 million loss in 2024**.  This reduction helped improve the overall investment result, cutting the **net loss on investments by $11 million** (from **$177 million loss** in 2023 to **$166 million loss** in 2024).【page_46】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the loss on privately held investments decreased from $193 million in 2023 to $164 million in 2024, a $29 million improvement, and the overall net losses on investments improved from $177 million to $166 million, a $11 million positive shift. These values match the original answer exactly, with acceptable formatting (e.g., $29 million). (2) The answer is complete, addressing both parts of the question: the change in losses from privately held investments and its impact on overall net gains (losses). (3) Entity accuracy is correct—Cisco is the subject, the years 2023 and 2024 are properly referenced, and the financial metrics (losses from privately held investments, net gains/losses on investments) are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the $29 million improvement in privately held investment losses contributed to the smaller overall investment loss, even though other investment components may have offset part of the gain, resulting in only an $11 million net improvement. The inclusion of a citation (page_46) adds contextual support. (5) The semantic meaning is equivalent to the original answer, with clear, concise rewording that preserves all factual content. No errors in logic, calculation, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 396,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "VZ repaid **$4.5 billion** of principal in 2024 for anticipated redemptions of ABS Notes (page 79).  As of December 31 2024, the 2021 ABS Financing Facility had an outstanding balance of **$8.0 billion** and the 2022 facility **$5.0 billion**, for a combined **$13.0 billion** (page 79).  Thus the 2024 repayment was roughly one‑third of the total outstanding balance of the two facilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $4.5 billion principal repayment in 2024, $8.0 billion outstanding balance for the 2021 facility, $5.0 billion for the 2022 facility, and a total of $13.0 billion—correctly summed. The comparison stating the repayment was roughly one-third of the total outstanding balance is logically sound (4.5 / 13.0 ≈ 34.6%, which is approximately one-third). (2) The answer addresses both parts of the multi-part question: the 2024 principal repayment amount and the comparison to the aggregate outstanding balance as of December 31, 2024. (3) All entities—VZ, ABS Notes, 2021 and 2022 ABS Financing Facilities—are correctly identified with accurate time references (2024). (4) The reasoning is sound: it synthesizes data from the same source (page 79, as cited) across multiple financial instruments and performs a valid comparative analysis. The semantic meaning is equivalent to the original answer, with slightly more concise phrasing and an added interpretive comparison ('roughly one-third') that enhances clarity without introducing error. No factual, numerical, or logical inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 341,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL transition adjustments are built into the leverage‑ratio denominator – “adjusted average assets” are reduced for the CECL‑related deductions (goodwill, intangibles and the CECL benefit), which lifts the Tier 1 leverage ratio (7.2 % at year‑end). At the same time, the transition provisions let JPMorgan apply the Basel III Standardized approach to the First Republic assets, adding an incremental allowance for credit losses of $541 million in 2024 (and $655 million in 2023) and including those assets in the Standardized‑RWA calculation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$541 million in 2024 and $655 million in 2023 for incremental allowance for credit losses—that are not present in the original answer (ground truth). Since the ground truth does not mention any dollar amounts or specific percentages like '7.2% at year-end', these figures cannot be verified as correct and appear to be hallucinated. This significantly undermines quantitative accuracy. (2) The original answer states that CECL transition provisions affect Tier 1 leverage ratio by adjusting average assets for deductions like goodwill and intangible assets, and allows use of the Standardized approach on First Republic assets. The LLM captures this qualitatively but adds unverified specifics: the 'CECL benefit' as a deduction, the exact percentage (7.2%), and the two-year ACL figures. These are not supported by the ground truth and introduce factual risk. (3) The multi-hop reasoning is partially sound—the model correctly links CECL transition provisions to both the Tier 1 leverage ratio calculation and the application of the Standardized approach to First Republic assets at JPMorgan Chase. This shows appropriate synthesis across regulatory concepts and entities. (4) While the core conceptual explanation aligns with the original (thus high contextual relevance and decent qualitative accuracy), the inclusion of unsupported numbers reduces correctness. The answer goes beyond the ground truth with precise figures that may be plausible but are not confirmed, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 434,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon has adopted formal governance principles, written charters for each standing committee and a Code of Business Conduct and Ethics that applies to all officers, directors, employees and subsidiaries.  The company requires that at least a majority of its directors – and for certain actions, such as approving Operating‑Partnership property sales, three‑quarters of the directors – be independent under NYSE standards and have no affiliation with the Simon family, and its Audit, Compensation and Human‑Capital committees are composed entirely of independent directors who also satisfy NYSE’s financial‑expert requirements.  These policies directly meet NYSE listing rules, which mandate a majority of independent directors, fully independent key committees and a corporate code of conduct to ensure ethical conduct.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Simon has governance principles, written committee charters, and a Code of Business Conduct and Ethics applying to all officers, directors, employees, and subsidiaries. The Board maintains a majority of independent directors with no Simon family affiliation, and the Audit and Compensation and Human Capital Committees are fully independent, meeting NYSE independence and financial expert requirements. (2) Quantitative accuracy is perfect: the LLM correctly states that a majority of directors must be independent, and adds a specific detail (three-quarters for certain actions like approving Operating-Partnership property sales) that is not in the original answer but does not contradict it and may reflect additional context from filings. Since this detail is plausible and does not conflict with the ground truth, it does not reduce accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes governance policies with NYSE alignment, correctly linking Simon’s practices to NYSE requirements on board independence, committee composition, and ethical conduct. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor gap is that the original emphasizes that the governance principles cover 'function, conduct, selection, orientation, and duties' of the Board and subsidiaries, which the LLM omits, but this is a detail rather than a core omission. Overall, the answer is complete, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 432,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "Lockheed Martin’s percentage‑of‑completion cost‑to‑cost method ties the profit‑booking rate to the estimated total cost to finish a contract, so a downward revision to those cost estimates raises the profit‑booking rate (a “risk retirement”) while an upward revision lowers the rate. Any increase or decrease in the profit‑booking rate is recorded in the period the new estimate is made, producing an immediate, inception‑to‑date effect on segment operating profit and margin for that period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly explains that Lockheed Martin's use of the percentage-of-completion cost-to-cost method links profit booking rates to changes in cost estimates: downward revisions (risk retirements) increase the rate, upward revisions decrease it. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—only conceptual financial mechanics are discussed, and they are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes how cost estimate changes affect profit recognition timing and magnitude, and that adjustments are made cumulatively from inception in the period the change is determined. (4) The answer fully addresses both parts of the question: the impact on profit booking rates and the financial effect of recognizing changes in the period determined. All entities (Lockheed Martin, percentage-of-completion method, segment operating profit and margin) are accurately referenced. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 326,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The APJC Services Revenue increased by **$89 million** (from $2,160 million in 2023 to $2,249 million in 2024)【page_42】, and the APJC goodwill balance rose by **$2.826 billion** (from $5.382 billion to $8.208 billion)【page_76】. Together, these represent a **combined increase of roughly $2.915 billion**. That absolute gain is far larger than the modest **4 % year‑over‑year growth** in Services Revenue for the APJC region【page_42】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numerical values. While the $89 million increase in Services Revenue and the 4% growth rate are correct and match the ground truth, the Total Balance increase is severely miscalculated. The LLM reports a $2.826 billion ($2,826 million) increase in goodwill balance (from $5.382B to $8.208B), but this is unrelated to 'Total Balance' as referenced in the question and original answer. The ground truth states an $8,358 million increase in Total Balance, which the LLM completely misses. The combined increase is therefore wrong: LLM reports ~$2.915 billion ($2,915 million), but the correct value is $8,447 million. (2) Calculations: The Services Revenue increase is accurate ($2,249M - $2,160M = $89M), and the 4% growth is correctly cited. However, the goodwill change calculation is incorrect: $8.208B - $5.382B = $2.826B, but this metric (goodwill) is not 'Total Balance'—a critical entity confusion. The LLM fails to identify the correct Total Balance figures for APJC, leading to a major quantitative error. (3) Multi-hop reasoning: The model identifies Services Revenue correctly across years (2023 to 2024) and cites appropriate pages, showing partial multi-hop capability. However, it substitutes 'Total Balance' with 'goodwill balance'—a different financial metric—indicating a failure in entity alignment and cross-metric synthesis. This breaks the multi-hop logic required to sum the correct two components. (4) Scores justified: Correctness is low (3/10) due to major factual and metric substitution errors. Quantitative accuracy is poor (3/10) because the core sum is off by over $5.5 billion. Qualitative accuracy is slightly higher (4/10) as some reasoning and citation are sound, but entity confusion undermines validity. Contextual relevance is fair (7/10) as the answer addresses the right region, time frame, and general intent, despite incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 524,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "As of December 31 2024, Abbott reported interest‑rate hedge contracts with a notional amount of **$2.2 billion** and foreign‑currency forward exchange contracts with a total notional amount of **about $23.2 billion** (the $7.0 billion for intercompany purchases plus $16.2 billion for intercompany loans and trade payables/receivables) – a combined exposure of roughly **$25.4 billion**【page_40】. This sizable, diversified hedge program shows Abbott’s strategy of using derivatives to convert fixed‑rate debt to variable‑rate exposure and to lock in FX rates for anticipated intercompany and trade transactions, thereby reducing the volatility of cash flows and earnings from interest‑rate and currency movements【page_40】【page_41】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.2 billion for interest rate hedges, $23.2 billion for foreign currency forwards (broken down into $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables), and a total combined exposure of $25.4 billion. The calculations are correct (2.2 + 23.2 = 25.4). (2) The answer is complete, addressing both the total notional value and Abbott's risk management strategy. (3) Entity accuracy is correct—'Abbott' is the right company, 'December 31, 2024' is the correct date, and the financial instruments (interest rate hedges, foreign currency forwards) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly links the use of interest rate hedges to converting fixed-rate debt to variable-rate debt and explains that foreign exchange contracts are used to hedge both anticipated transactions and existing obligations, thereby reducing earnings and cash flow volatility. The semantic meaning is equivalent to the original answer, with only minor rephrasing for clarity. All citations (page_40, page_41) support the claims. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 361,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "McDonald’s treats its franchisee relationships as non‑consolidated entities. Under a scope‑exception for variable‑interest entities, franchisee restaurants are excluded from the consolidated balance sheet and income statement, with only franchise fees, royalties and related rent recognized as revenue 【page 45】. The company also notes that the results of any restaurant purchases or sales with franchisees are “not material either individually or in the aggregate” to the consolidated financial statements, so franchisee operations have no material effect on the consolidated results 【page 45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: McDonald's does not consolidate franchisee operations due to immateriality and a scope exception under variable interest entity (VIE) guidance. The answer correctly identifies that only franchise fees, royalties, and rent are recognized as revenue, which matches the accounting treatment described. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information about consolidation policy, immateriality of transactions with franchisees, and the application of the VIE scope exception, all of which are required to fully address the question. The reference to page 45 adds credibility and specificity. (4) The only minor shortcoming is that the LLM does not explicitly name 'joint ventures' and 'licensees' as other non-consolidated entities mentioned in the original, slightly reducing completeness in entity coverage. However, the core reasoning and all key points regarding franchisees and consolidation policy are accurately conveyed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 363,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The SLR is calculated as Tier 1 capital divided by total leverage exposure, where total leverage exposure equals the Firm’s **adjusted average assets** (total average assets less regulatory‑capital deductions such as goodwill and CECL adjustments) **plus off‑balance‑sheet exposures** – the latter are added to the adjusted asset base (page 106). Thus, off‑balance‑sheet items increase the denominator and push the ratio lower, while the adjustments that reduce average assets raise the ratio (page 106 footnotes). If the SLR falls below the regulatory floor (the 3 % minimum plus the Firm’s extra 2 % buffer, i.e., ≈ 5 %), the Firm would face limits on capital distributions (dividends, common‑share repurchases) and on discretionary bonus payments for certain executive officers (page 103).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and thresholds are accurate: the 3.0% minimum SLR requirement and 2.0% buffer are correctly cited, totaling the 5.0% threshold. The explanation of Tier 1 capital divided by total leverage exposure, which includes adjusted average assets and off-balance sheet exposures, aligns precisely with the original. (2) The answer is complete, addressing both parts of the question: how off-balance sheet exposures and adjusted average assets impact the SLR (by increasing or decreasing the denominator), and the consequences of falling below the threshold (restrictions on dividends, share repurchases, and discretionary bonuses). (3) Entity accuracy is correct—JPMorgan Chase is the subject, and all financial terms (Tier 1 capital, off-balance sheet exposures, adjusted average assets, SLR) are used appropriately. (4) The reasoning is sound and reflects proper multi-hop synthesis: it explains the mechanical impact of each component on the ratio (off-balance sheet items increase denominator, reducing ratio; adjustments to assets can increase ratio) and links the regulatory consequence to the combined 5% threshold. Minor wording differences (e.g., '≈ 5 %' vs 'totaling 5.0%') do not affect semantic equivalence. The inclusion of page references (106, 103) suggests grounding in source material, further supporting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 394,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31 2021 the Operating Partnership had $125 million outstanding under the Credit Facility and $1.05 billion under the Supplemental Facility – a combined $1.175 billion of borrowings【page_9】.  Under the amended terms, the Supplemental Facility can be drawn up to $4.5 billion (up from its original $3.5 billion)【page_6】, so the current borrowings are well below that limit – roughly one‑quarter of the facility’s maximum capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: $125 million under the Credit Facility, $1.05 billion under the Supplemental Facility, and the total of $1.175 billion as of December 31, 2021. It also accurately reports the maximum borrowing capacity of the Supplemental Facility as $4.5 billion under amended terms, noting the increase from $3.5 billion. These values match the ground truth exactly. (2) Quantitative accuracy is perfect: the sum ($125M + $1.05B = $1.175B) is correct, and the reference to $4.5 billion as the increased limit aligns with the original answer. The statement that borrowings are 'roughly one-quarter' of the facility’s capacity is a reasonable approximation ($1.175B / $4.5B ≈ 26%), though not explicitly asked, adds context without error. (3) The multi-hop reasoning is sound—information from two facilities is combined, and the comparison to the Supplemental Facility’s amended capacity is correctly drawn. The only minor omission is that the original answer specifies the $3.5 billion as the base maximum that could be increased to $4.5 billion, while the LLM implies the $4.5 billion is the current cap without clarifying it's an expandable limit. This nuance is present in the source but slightly simplified in the LLM response. (4) Despite this small simplification, the core facts, calculations, and synthesis are accurate and relevant. The answer fully addresses both parts of the question: total borrowings and comparison to capacity. Hence, correctness is scored 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to the slight lack of precision on the tiered capacity structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 463,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "Lockheed Martin reported that the aggregate notional amount of its outstanding interest‑rate swaps was **$500 million at December 31 2021**.  This was lower than the **$572 million** reported at the end of 2020, representing a **≈12.5% decrease** in notional amount year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the notional amounts for both years: $500 million in 2021 and $572 million in 2020, matching the ground truth. The percentage decrease is calculated as approximately 12.5%, while the ground truth states 12.6%. This minor discrepancy is likely due to rounding differences in intermediate steps (exact calculation: (572 - 500) / 572 = 72 / 572 ≈ 0.12587, which rounds to 12.6% when reported to one decimal place). The LLM's ≈12.5% is a reasonable approximation and does not constitute a material error. All entities (Lockheed Martin, interest rate swaps, years 2020 and 2021) are accurate. The answer fully addresses both parts of the question: the 2021 amount and the year-over-year percentage change. The reasoning and synthesis across the two years are sound, and the response is semantically equivalent to the original answer. The slight difference in percentage rounding does not affect the overall correctness significantly, hence a score of 9/10 on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 293,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The dispute over the starting dollar amount and COVID‑19 cost treatment means Georgia Power could be on the hook for cost‑sharing and tender‑provision charges that it cannot recover from customers, expanding its unrecoverable exposure.  This is reflected in the $440 million pre‑tax charge (≈ $328 million after‑tax) recorded in Q4 2021 for those provisions and the possibility of up to an additional $460 million of similar charges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key facts are correct: the $440 million pre-tax charge in Q4 2021 and the potential additional $460 million in charges are accurately reported, matching the original answer. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—both dollar amounts and the time period (Q4 2021) are correct. The after-tax conversion ($328 million) is a reasonable estimate and does not detract from accuracy. (3) The reasoning correctly links the dispute over cost-sharing provisions to Georgia Power's unrecoverable financial exposure. The mention of 'dispute over the starting dollar amount' aligns with the core disagreement in the ground truth, though it omits the specific threshold figures ($18.38 billion) and the detail that other owners claim the tender provisions have already been triggered. This is a minor omission affecting completeness but not the overall correctness. (4) The answer is fully relevant, directly addressing both parts of the question: the impact on financial exposure and the specific charges illustrating it. The synthesis across the dispute and its financial consequences is sound. The only reason for not scoring a 10 is the omission of the specific threshold amount and the other owners' position, which adds context but does not undermine the factual correctness of the financial impact described.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 397,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of **$12.24 billion** at the end of fiscal 2021【page_43】. The Experience Cloud solution that is built to manage customer journeys and deliver intelligence—while strengthening Adobe’s competitive advantage—is the **Adobe Experience Platform**【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the Digital Media ARR of $12.24 billion is accurately reported, with correct fiscal year (2021) and metric (ARR). The format ($12.24 billion) is equivalent to the ground truth. (2) The entity 'Adobe Experience Platform' is correctly identified as the specific Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: linking Adobe's financial reporting (Digital Media ARR) with its strategic product offerings (Experience Platform within Experience Cloud) to address both parts of the question. (4) The answer is contextually precise, directly addressing both sub-questions without extraneous information. Minor formatting differences (bold, page citation) do not affect factual accuracy. Semantic equivalence is maintained, and all key facts are present and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 280,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "Abbott reported that its interest‑rate‑hedge contracts had a fair‑value receivable of **$1 million** and a payable of **$51 million** at 12/31/2024, giving a net fair‑value liability of **$‑50 million**. In 2023 the contracts showed **no receivable** and a payable of **$95 million**, for a net fair‑value liability of **$‑95 million** – a reduction of about **$45 million** in net fair‑value from 2023 to 2024【page_65】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1 million receivable and $51 million payable in 2024 yield a net fair value of -$50 million, correctly calculated. For 2023, $0 receivable and $95 million payable result in a net fair value of -$95 million, also correct. The year-over-year improvement (reduction in liability) of $45 million is accurately computed as the difference between -$50 million and -$95 million. (2) The answer is complete, addressing both the 2024 fair value, the 2023 fair value, and the comparison between them, including both receivable and (payable) positions. (3) Entities are correct—Abbott, interest rate hedge contracts, and the correct fiscal years (2024 and 2023) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines data from two different years, computes net fair values, and correctly interprets the change over time. (5) The semantic meaning is equivalent to the original answer, with clear and precise wording. Minor phrasing differences (e.g., 'reduction in net fair-value' vs 'improvement') do not affect factual accuracy. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 343,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "ExxonMobil’s 2024 filing shows that equity‑company assets in Asia have discounted future net cash flows of **$31.8 billion** (page 135) and equity‑company proved reserves in Asia total **1,276 million barrels (developed) + 1,512 million barrels (undeveloped) = 2,788 million barrels oil‑equivalent** (page 10). Dividing $31,803 million by 2,788 million barrels gives about **11.4 times**, or roughly **1,140 %** of the oil‑equivalent reserves.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The ground truth states that the discounted future net cash flows from equity companies in Asia are $60,780 million, but the LLM incorrectly reports $31.8 billion, which is less than half the correct value. Additionally, the LLM incorrectly calculates total proved reserves (oil-equivalent) as the sum of developed (1,276 million barrels) and undeveloped (1,512 million barrels) reserves, totaling 2,788 million barrels. However, the ground truth explicitly uses 1,276 million barrels as the total proved reserves, indicating that this figure already represents the full oil-equivalent proved reserves. Therefore, the LLM’s denominator is wrong, leading to an incorrect cash flow per barrel ratio. (2) The calculation in the LLM answer divides $31,803 million by 2,788 million barrels to get ~$11.40 per barrel (or 1,140%), but the correct calculation is $60,780,000,000 / 1,276,000,000 = ~$47.63 per barrel. The LLM’s result is off by more than a factor of four. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the total proved reserves figure and incorrectly assumes it must sum developed and undeveloped reserves, when the original answer treats 1,276 million barrels as the total. It also cites a cash flow figure ($31.8B) that does not match the ground truth ($60.78B), suggesting either misreading of the document or referencing the wrong line item. (4) The contextual relevance is moderate because the LLM attempts the right type of analysis—calculating a ratio of cash flows to reserves—but the severe quantitative inaccuracies and incorrect entity values undermine the entire response. Due to major factual and computational errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 485,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan’s equity‑allocation framework uses Basel III Standardized RWA and the GSIB surcharge to size the capital assigned to each line‑of‑business, with any excess retained in the Corporate pool. Because this methodology leaves the firm with a reported supplementary leverage ratio of 6.1 percent—well above the 3.0 percent minimum and the 5.0 percent total (3 % + 2 % buffer)—the LOB and Corporate allocations clearly keep the firm in compliance with the leverage‑based capital requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JPMorgan Chase uses Basel III Standardized RWA and the GSIB surcharge to allocate capital across Lines of Business (LOB) and Corporate, and that this affects compliance with leverage-based capital requirements including the 3.0% minimum supplementary leverage ratio (SLR) and 2.0% buffer (totaling 5.0%). However, it introduces a specific SLR value of 6.1% which is not present in the original answer (ground truth). This figure may be factually accurate in reality, but since it was not included in the ground truth derived from the knowledge graph, its inclusion constitutes a factual addition not supported by the provided data, reducing quantitative accuracy. (2) The calculation of the 5.0% combined threshold (3% + 2% buffer) is correctly implied in both answers, and the interpretation of the buffer’s impact on capital distributions is logically consistent, though the LLM does not explicitly mention the consequence of failing to meet the threshold (e.g., restrictions on dividends/repurchases), which is a minor omission affecting completeness. (3) The multi-hop reasoning is sound: the model connects capital allocation methodology (Basel III, GSIB surcharge) to SLR compliance and interprets the regulatory thresholds appropriately. It correctly synthesizes how capital allocation supports adherence to leverage requirements. (4) Despite the unsupported 6.1% figure, the overall reasoning, entity identification (JPMorgan Chase, Basel III, GSIB, SLR), and regulatory context are accurate and relevant. The answer conveys a meaning close to the ground truth but with an unverified quantitative claim, warranting a correctness score of 7 and lower quantitative accuracy due to the unsupported percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 481,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "After the 2021 amendments, the Credit Facility can be expanded to a $5.0 billion aggregate commitment and the Supplemental Facility can be expanded to $4.5 billion, giving Simon Property Group a combined potential borrowing capacity of **$9.5 billion**. For both facilities, Daily SOFR Loans are priced at the **Adjusted Floating Overnight Daily SOFR Rate plus a margin of 0.65 %–1.40 %** (based on the company’s credit rating), meaning the Daily SOFR rate structure is identical for the Credit and Supplemental Facilities【page_124】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total potential borrowing capacity as $9.5 billion, which matches the ground truth and is derived accurately from the sum of the $5.0 billion Credit Facility and $4.5 billion Supplemental Facility. This part is factually correct. However, the interest rate structure is partially incorrect. The ground truth states that Daily SOFR Loans are priced at SOFR plus 72.5 basis points (i.e., 0.725%) plus a spread adjustment. In contrast, the LLM states a range of 0.65%–1.40% based on credit rating, which contradicts the specific 72.5 bps margin. While the LLM correctly notes that the rate structure is identical across both facilities, the actual margin is misrepresented. (2) The dollar amounts ($5.0B, $4.5B, $9.5B) are accurate and correctly summed. The interest rate percentage is the key quantitative error—72.5 bps is not equivalent to a 65–140 bps range, even if rating-dependent. (3) The multi-hop reasoning is sound: the model correctly synthesizes capacity from two facilities and compares their rate structures. It identifies that both facilities have the same pricing framework, which aligns with the ground truth. However, the incorrect margin undermines the accuracy of the interest rate comparison. (4) The contextual relevance is perfect—the answer addresses both parts of the question directly. Qualitative accuracy is high due to correct structure and synthesis, but quantitative accuracy is reduced due to the incorrect basis points. Correctness score is 7 because the core financial capacity is correct, but a significant detail in the interest rate is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 446,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The higher production volume on Sikorsky helicopter programs added roughly **$540 million** to RMS net sales in 2021, and it drove RMS product‑costs up by about **$560 million** (the portion of product‑cost growth attributed to the increased helicopter production).【page_50†L1-L5】【page_43†L1-L4】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $540 million increase in net sales and $560 million increase in product costs are accurately reported, with no calculation or numerical errors. Format variations (e.g., 'million' vs 'M') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the impact on net sales and product costs, along with the exact dollar amounts. (3) Entity accuracy is correct—RMS, Sikorsky helicopter programs, and the year 2021 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis, correctly attributing the cost and sales increases specifically to the production volume growth. The cited document references (page_50, page_43) further support the accuracy. (5) Semantic equivalence is maintained—the LLM conveys the same core information as the original answer, with slightly more concise wording but no loss of meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 300,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "McDonald’s treats purchases and sales of restaurant businesses with franchisees as recurring transactions, so any gain or loss on those sales is recorded in operating income (shown in the “Other operating (income) expense, net” line)【page_56】. Nevertheless, the company’s consolidation policy notes that the results of these franchise‑related purchases and sales are not material to the consolidated financial statements, so the effect on overall reporting is minimal【page_45】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that gains and losses from McDonald's recurring transactions with franchisees are recorded in operating income, specifically citing the correct financial statement line (‘Other operating (income) expense, net’) and referencing the appropriate page (56), which aligns with the ground truth. This reflects accurate qualitative understanding of the income statement treatment and is semantically equivalent to the original answer on that point. However, the LLM introduces a claim not present in the ground truth: that these transactions are 'not material to the consolidated financial statements' and therefore have 'minimal effect on overall reporting' (citing page 45). The original answer does not mention materiality or minimal impact; instead, it explains the structural reason for non-consolidation—franchisee entities are evaluated under variable interest entity (VIE) guidelines and generally excluded from consolidation. This is a significant omission and misdirection in reasoning. The LLM fails to explain the actual consolidation policy based on VIE criteria, which is a core part of the multi-hop reasoning required (linking recurring transactions → income recognition → non-consolidation due to VIE rules). While the financial statement impact (gains/losses at point of sale) is implied, it is not explicitly tied to the lack of consolidation as in the original. There are no numerical inaccuracies (hence full quantitative accuracy), but the qualitative reasoning is partially flawed due to the substitution of a 'materiality' rationale for the correct 'VIE-based consolidation policy.' Contextual relevance remains high because the answer addresses the core issue of financial reporting impact, albeit with incorrect justification for the consolidation aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 488,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "Chevron’s derivative commodity instruments produced only a modest net liability in 2023 (≈ $247 million of liabilities versus $148 million of assets, a net ≈ $99 million) and the change in their fair value was “not material” to the company’s financial position, results of operations or cash flows【page_78】.  The exposures are monitored daily by an internal Risk Control group under Chevron’s risk‑management policies, with fair‑value measurements based on observable market quotes (Level 1/2) recorded on the balance sheet and reflected in earnings, and the Audit Committee reviews compliance【page_53】【page_76】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the impact of derivative commodity instruments was 'not material' to Chevron's financial position, results of operations, or cash flows in 2023, which matches the original answer's core conclusion. (2) The LLM provides specific quantitative details not present in the ground truth but consistent with typical 10-K disclosures: a net liability of approximately $99 million ($247M liabilities - $148M assets), which is a correct calculation and supports the 'not material' assessment. These figures are plausible and likely drawn from the cited pages of the filing, though the ground truth does not include them—this is an enhancement, not an error. (3) The answer accurately identifies the role of the internal Risk Control group in daily monitoring and the Audit Committee’s oversight, correctly linking these to risk management and compliance, fulfilling the multi-hop requirement across risk practices, fair value, and governance. (4) It references fair value measurements based on Level 1/2 inputs, which adds detail about valuation hierarchy and reinforces the reliability of the reported values. While the ground truth does not mention Level 1/2, this is consistent with standard accounting practice and enhances accuracy. The only minor gap is that the LLM mentions 'cash flows' instead of 'liquidity'—a slight wording difference, but 'cash flows' is contextually acceptable. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth with added beneficial detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 441,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "As of December 31 2024 the CECL capital‑transition provision contributed a **$720 million net benefit to Basel III CET1 capital** through the AOCI adjustment. The same transition is reflected in the **$20.992 billion qualifying allowance for credit losses that is included in Tier 2 capital**, so the combined impact of the CECL transition on JPMorgan’s regulatory capital (CET1 + Tier 2) is roughly **$21.7 billion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the total impact on CET1 capital is $1.261 billion, composed of a $720 million AOCI benefit and a $541 million impact from the allowance for credit losses related to First Republic included in Tier 2. The LLM incorrectly reports the Tier 2 allowance as $20.992 billion — a figure that appears to be the total allowance for credit losses, not the CECL-related incremental amount — and incorrectly frames the 'combined impact' on CET1 + Tier 2 as $21.7 billion, which misrepresents the question. The question asks for the total impact *on CET1 capital*, not total regulatory capital. (2) The $720 million AOCI benefit is correctly identified, but the $541 million incremental allowance (critical to the correct total of $1.261 billion) is entirely missing and replaced with an irrelevant total allowance figure. The calculation of $21.7 billion is unsupported and incorrect. (3) The multi-hop reasoning fails: the model does not synthesize the two correct components ($720M + $541M) that affect CET1 through different mechanisms. Instead, it conflates total allowances with CECL transition impacts and misapplies the concept of regulatory capital layers. (4) Scores are low due to major quantitative and qualitative errors, though the mention of AOCI and Tier 2 shows partial relevance to the topic, warranting a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 399,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "In 2023 GE’s equity‑method investment in AerCap contributed **$2.525 billion of net income** to the company (the footnote on page 66 notes AerCap’s net‑income attributable amount of $2,525 million for 2023). The AerCap note generated a **net realized/unrealized gain of $195 million** on the investment‑securities portfolio that year (see the net realized/unrealized gains line on page 70). Combined, the AerCap‑related transactions added roughly **$2.72 billion** to GE’s earnings in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. While it correctly identifies the net income contribution from AerCap as $2,525 million ($2.525 billion), it incorrectly states the realized/unrealized gain as $195 million instead of the ground truth $129 million. This leads to an incorrect total financial impact of $2.72 billion instead of the correct $2,654 million ($2.654 billion). (2) The calculation error is material: $2,525M + $195M = $2,720M (as stated) vs. the correct sum of $2,525M + $129M = $2,654M. The individual component of $195 million does not match the ground truth and appears to be misextracted from the source (possibly from a different line or context on page 70). (3) The multi-hop reasoning structure is sound—the model correctly identifies that the total impact requires combining net income and gains from investment securities—and it references appropriate pages and concepts (equity-method investment, net income attribution, realized/unrealized gains). However, the failure to extract the correct gain value undermines the synthesis. (4) Contextual relevance is high, as the answer addresses both components of the question and cites specific document locations. Due to the major quantitative error in a core financial figure and the resulting incorrect total, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning framework is correct, but entity/metric extraction is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 418,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Merck paid a total cash consideration of **$301 million** for Immune Design.  The excess of the purchase price over the fair‑value of the net assets acquired was **$20 million**, which was recorded as goodwill (allocated to the Pharmaceutical segment)【page_101】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the total consideration of $301 million and the $20 million allocated to goodwill are correctly reported. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, with acceptable formatting variations (e.g., 'million' vs 'M'). (3) The reasoning is sound: the LLM correctly identifies that goodwill represents the excess of consideration over the fair value of net assets acquired, which demonstrates proper multi-hop synthesis of financial acquisition accounting principles. (4) The answer is contextually relevant, directly addressing both parts of the question—total consideration and goodwill allocation—and even adds a minor but accurate detail (allocation to the Pharmaceutical segment) supported by the source. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 264,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald’s revenue primarily through rent (both minimum and sales‑based rent), royalties based on a percentage of their sales, and initial franchise fees (along with ancillary technology‑platform and brand‑licensing fees). When McDonald’s co‑invests in restaurant improvements, it capitalizes its share of the upgrade costs as property and equipment, which are then depreciated – the resulting adjustments to depreciation expense are generally immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies franchisee contributions to McDonald's revenue: rent (minimum and sales-based), royalties based on sales percentage, and initial franchise fees. It adds 'ancillary technology-platform and brand-licensing fees,' which are plausible but not explicitly mentioned in the ground truth; however, they do not contradict it and may fall under broader fee categories. (2) On co-investment, the LLM correctly states that McDonald's capitalizes its share of improvement costs as property and equipment, which are then depreciated. It accurately notes that the resulting adjustments to depreciation expense are generally immaterial—this aligns with the ground truth's mention of 'immaterial adjustments to balances and associated depreciation expense.' (3) The multi-hop reasoning is sound: it connects co-investment → capitalization → depreciation → financial statement impact, even if slightly less detailed than the original about cost allocation during the project (e.g., Accounts Receivable treatment). (4) No numeric values are incorrect (quantitative accuracy is perfect), and all entities (McDonald's, franchisees, depreciation, property and equipment) are correctly used. The answer is contextually fully relevant. The minor omission of the interim cost allocation process (between Property and equipment and Accounts Receivable) prevents a perfect 10, but the overall meaning and financial impact are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 419,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "Goldman Sachs’ securities backed by real estate fell from **$689 million at 12/31/2023 to $569 million at 12/31/2024**, a decrease of **$120 million**【page_174】.  The 2023 unrealized losses on Level 3 investments in this category were attributed **primarily to ongoing weakness in the commercial real‑estate market**【page_158】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $689 million (December 2023) and $569 million (December 2024) are accurate, and the calculated decrease of $120 million is correct. (2) The answer addresses both parts of the multi-hop question: the dollar decrease in value and the primary cause of unrealized losses on Level 3 investments in 2023. (3) Entity accuracy is perfect—Goldman Sachs, 'securities backed by real estate', 'Level 3 investments', and the correct time periods (2023 to 2024) are all properly identified. (4) The reasoning is sound: the model correctly synthesizes data across time points and attributes the unrealized losses to 'ongoing weakness in the commercial real-estate market', which is semantically equivalent to the ground truth's 'weakness in the commercial real estate market'. Minor wording differences (e.g., 'ongoing') do not affect factual accuracy. All citations (page references) align with expected sourcing. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 294,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "American Tower paid an aggregate redemption price of $962.9 million to retire the CoreSite Debt, which included $80.1 million of pre‑payment consideration and $7.8 million of accrued interest – a total of about $87.9 million in costs beyond the principal amount 【page_120】.  The CoreSite Debt carried a principal balance of $955.1 million as of December 31 2021 【page_121】, so the extra cost was roughly a 9 % premium to the year‑end outstanding balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the additional costs beyond principal ($87.9 million), broken into $80.1 million prepayment consideration and $7.8 million accrued interest, and correctly states the total redemption price of $962.9 million. However, it incorrectly reports the principal amount outstanding as of December 31, 2021, as $955.1 million (from page 121), which contradicts the ground truth of $875 million. This error leads to an incorrect comparison and a flawed 9% premium calculation. (2) The calculation of additional costs ($80.1M + $7.8M = $87.9M) is accurate, but the use of $955.1M as the principal balance is factually wrong per the ground truth. The correct principal was $875M, which when added to $87.9M equals the $962.9M redemption price. The LLM’s 9% premium is based on the incorrect base and is therefore invalid. (3) The multi-hop reasoning is partially sound—linking repayment cost, additional components, and prior balance—but fails at the critical step of retrieving the correct prior balance. The model cites a conflicting figure from a different context (possibly another debt tranche), indicating a failure in entity and metric alignment. (4) Scores reflect that core cost figures are correct (supporting partial credit), but the key comparison hinges on an incorrect principal amount, undermining the answer’s factual foundation. Contextual relevance is high as the response addresses both parts of the question and cites appropriate document locations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 415,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "GE reported a $0.9 billion decline in cash from current receivables in 2024, a drop that was partially offset by higher collections from CFM International. CFM International is a non‑consolidated joint‑venture equity‑method investee (co‑owned with Safran Aircraft Engines) to which GE makes substantial sales of parts and services, generating those collections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that GE reported a $0.9 billion negative impact from current receivables in 2024, which was partially offset by increased collections from CFM International—this matches the ground truth exactly in both direction and magnitude. The use of '$0.9 billion decline' is semantically equivalent to 'a $(0.9) billion impact', so the quantitative information is accurate. (2) All numbers and dates are correct: the $0.9 billion figure and the year 2024 are accurately reported. No calculations are required beyond correct interpretation of the negative cash impact, which the model captures properly. (3) The multi-hop reasoning is sound: the model correctly identifies CFM International as a non-consolidated joint venture (equity-method investee) co-owned by GE and Safran Aircraft Engines, and explains that GE’s sales of parts and services to CFM generate the receivables and subsequent collections. This establishes the financial relationship that supports the cash flow impact. (4) The only minor shortcoming is that the LLM does not explicitly state that CFM is 'jointly owned by GE and Safran Aircraft Engines' using the exact phrasing of shared ownership, though 'co-owned' conveys the same meaning. Also, while it mentions 'substantial sales', it could have slightly more clearly linked this to the origin of receivables, though the implication is clear. Overall, the answer is factually complete, contextually precise, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction for minor phrasing imprecision in describing the ownership structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 451,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The combined effect on 2023 operating revenues was roughly **$151 million** – a $6 million increase from Ohio tax‑reform deferrals (a prior‑year deferral) plus a $145 million boost from the Duke Energy Ohio electric rate case (current‑year pricing adjustments)【page_49†L31-L38】【page_57†L1-L5】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total financial impact, stating $151 million instead of the ground truth $276 million. The breakdown provided—$6 million from Ohio tax-reform deferrals and $145 million from the rate case—does not align with the actual figures from the source. (2) Quantitative accuracy is severely lacking: the sum of $6M + $145M = $151M is mathematically correct, but both input values and the total are wrong. The ground truth states a total impact of $276 million without specifying exact components, but the LLM’s decomposition is inconsistent with the reported total. There is no indication in the original answer that the two components were $6M and $145M, so these appear to be fabricated or misread figures. (3) The reasoning is partially sound in structure—attempting to combine prior-year deferrals and current-year pricing adjustments as required by the multi-hop question—but fails in execution due to reliance on incorrect data. The model cites page references (page_49, page_57), suggesting it accessed relevant sections, but misinterpreted or extracted incorrect numbers. (4) Contextual relevance is high because the answer addresses the correct entities (Duke Energy, Ohio tax reform, electric rate case), time period (2023), and metric (operating revenues), and attempts the correct synthesis. However, the severe numerical inaccuracy drastically undermines the correctness score. Minor formatting flexibility (e.g., $151 million vs $151M) is allowed, but the magnitude of error here (~45% lower than actual) is unacceptable. Thus, the answer is mostly incorrect despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 450,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe’s Digital Media segment recorded **$11.52 billion** of revenue in fiscal 2021.  Of that total, **Creative Cloud generated $9.55 billion**, which is roughly **83 %** of Digital Media revenue, and **Document Cloud generated $1.97 billion**, or about **17 %** of the segment’s revenue【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $11.52 billion total Digital Media revenue, $9.55 billion from Creative Cloud, and $1.97 billion from Document Cloud. The percentages (83% and 17%) are correctly calculated and reported. (2) The answer is complete, addressing both parts of the question: total revenue and the individual contributions from Creative Cloud and Document Cloud with exact figures and percentages. (3) Entity accuracy is perfect: Adobe, Digital Media segment, fiscal 2021, Creative Cloud, and Document Cloud are all correctly identified. (4) The reasoning is sound—no flawed logic or incorrect synthesis; the model correctly attributes the revenue breakdown as disclosed. (5) Semantic equivalence is maintained: minor wording differences (e.g., 'recorded' vs 'generated') do not affect factual meaning. The citation to page_43 adds contextual support. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 285,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "In 2021 Netflix’s advertising spend rose by $222 million, and headcount‑related personnel costs increased by $116 million in marketing and $384 million in technology, producing a combined increase of roughly $722 million【page_26】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $222 million increase in advertising expenses, $116 million in marketing personnel costs, and $384 million in technology personnel costs are correctly reported. The total combined increase of $722 million is accurate ($222M + $116M + $384M = $722M). (2) Quantitative accuracy is perfect—each dollar amount matches the original answer, and the sum is correctly calculated. Format variations (e.g., 'roughly $722 million') are acceptable and do not affect factual correctness. (3) The reasoning is sound: the model correctly synthesizes multi-hop information across cost categories (advertising and personnel) and departments (marketing and technology), attributing the correct increases to each. (4) The answer is contextually relevant, directly addressing the total increase and its components as asked. All entities—NFLX, 2021, advertising expenses, headcount growth, marketing, and technology—are correctly identified and used. No factual or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 306,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "GM reports the equity earnings from its 50 %‑owned Ultium Cells Holdings LLC (‑ $975 million in 2024, $293 million in 2023) as part of “Automotive and other cost of sales,” so the positive earnings offset the automotive cost‑of‑goods‑sold line. By presenting the joint‑venture results within cost of sales rather than as separate investment income, GM treats its Ultium Cells stake as an integral, cost‑related element of its EV‑production supply chain, reflecting the strategic importance of the battery‑cell partnership to its electric‑vehicle strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Motors reports equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales,' which matches the original answer's key point about financial treatment. The inclusion of specific figures (-$975 million in 2024, $293 million in 2023) adds quantitative detail not present in the original answer but does not contradict it—these numbers are plausible and contextually appropriate, though the ground truth does not specify them, so their accuracy cannot be fully verified. However, their presence does not detract from correctness. (2) The quantitative accuracy is high: the dollar amounts and years are consistently presented, and the negative value in 2024 indicating a loss is logically handled. Since the ground truth does not provide numbers, the LLM likely inferred or pulled from extended data; as there's no contradiction, this is acceptable under semantic equivalence. (3) The reasoning is sound: the LLM correctly infers that reporting within cost of sales (rather than as investment income) signifies operational integration, linking this to GM’s EV production strategy. This reflects proper multi-hop synthesis between accounting treatment and strategic intent. (4) The answer is contextually excellent—addressing both parts of the question: the influence on cost of sales (offsetting COGS when positive) and the strategic implication. The only reason for not scoring a 10 is the introduction of unverified specific financial figures not present in the ground truth, which, while plausible, introduce a small risk of overprecision. Otherwise, the semantic meaning, logic, and completeness are equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 481,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average U.S. Henry Hub price fell from $6.36 per MCF in 2022 to $2.56 per MCF in 2023 – a decline of roughly 60 percent. Chevron’s international natural‑gas realizations dropped from $9.75 to $7.69 per MCF, a decrease of about 21 percent, so the domestic price fell far more sharply than the international price trend. (Source: page 39)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: U.S. Henry Hub prices decreased from $6.36 to $2.56 per MCF, and Chevron's international realizations fell from $9.75 to $7.69 per MCF. The percentage declines are accurately approximated as 'roughly 60 percent' and 'about 21 percent', which align with the ground truth calculations of 59.8% and 21.1%, respectively. Minor rounding is acceptable and does not affect factual accuracy. (2) Calculations verification: (6.36 - 2.56) / 6.36 ≈ 59.8%, and (9.75 - 7.69) / 9.75 ≈ 21.1% — both match ground truth. The LLM uses rounded percentages but retains semantic equivalence. (3) Multi-hop reasoning is sound: the model correctly compares U.S. benchmark price trends to Chevron’s international gas realizations, noting the steeper domestic decline. It synthesizes data across different sources (market data and company-specific figures) appropriately. (4) The answer is contextually complete and relevant, addressing both parts of the question — the percentage decrease in Henry Hub prices and the comparative trend with Chevron’s international realizations. The only minor shortcoming is the lack of explicit mention that international prices are 'often linked to crude oil benchmarks', a contextual detail present in the original answer that adds explanatory depth. However, this omission does not detract from core factual correctness. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 423,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs says that the fair‑value of purchased credit protection moves positively with credit‑spread changes – a widening of spreads (or higher upfront points) raises the fair value, while a tightening lowers it, and lower recovery rates also increase value. Because its level‑3 credit derivatives are priced using unobservable inputs that range from roughly 8 bps to 1,328 bps (2024) – 3 bps to 1,750 bps (2023) – for credit spreads and 20 % to 70 % for recovery rates, any shift within these wide ranges can materially affect the valuation of those level‑3 credit positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the directional sensitivity of Goldman Sachs' level 3 credit derivatives: fair value of purchased credit protection increases with wider credit spreads (or higher upfront points) and lower recovery rates. This matches the original answer's explanation. (2) The LLM provides specific numeric ranges for credit spreads (8 bps to 1,328 bps in 2024; 3 bps to 1,750 bps in 2023) and recovery rates (20% to 70%), which are precise unobservable inputs not mentioned in the original answer but consistent with the concept of 'wide ranges' and variability. These numbers are plausible and enhance the answer without contradicting the ground truth. (3) The reasoning is sound: it connects the sensitivity of fair value to changes in unobservable inputs and emphasizes how shifts within these broad ranges can materially affect valuations—this reflects correct multi-hop synthesis of valuation principles and input variability. (4) The only reason for not scoring a 10 is that the original answer emphasizes the compounding effect of underlying risk factors (leverage, volatility, industry, etc.) contributing to input variability, which the LLM omits. However, the core financial logic, entities (Goldman Sachs, level 3 credit derivatives), and directional sensitivities are all correct. Quantitative accuracy is high—ranges are clearly stated and formatted consistently. Contextual relevance is perfect: the response directly addresses the impact of credit spread and recovery rate changes on level 3 valuations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 437,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The January 7 2022 redemption removed the $955.1 million of CoreSite senior unsecured notes from AMT’s balance sheet, cutting the amount of senior long‑term debt and shifting that financing to the 2021 Multicurrency Credit Facility (a revolving loan) and cash on hand, thereby changing the composition of the company’s capital structure【page_110†L13-L20】【page_111†L13-L20】.  Because the redemption price of $962.9 million (which consists of the principal, a modest pre‑payment premium and accrued interest) is essentially equal to the $955.1 million carrying value, the CoreSite Debt was recorded at near‑fair‑value, resulting in little or no gain/loss on retirement【page_120†L9-L15】【page_121†L1-L8】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the redemption price was $962.9 million, which includes a prepayment premium and accrued interest, while the original answer and ground truth clearly state that the repayment amount was $955.1 million — matching the carrying value. This discrepancy undermines the quantitative accuracy. The date 'January 7, 2022' is more specific than the ground truth's 'January 2022', which may be correct but is not confirmed in the original answer. (2) The $962.9 million figure for redemption price contradicts the ground truth that repayment amount equals carrying value ($955.1 million), suggesting either a misinterpretation of the filing or confusion between principal and total cash outflow (including interest). This leads to an incorrect implication that the debt was retired near fair value due to minimal gain/loss — while the reasoning is sound, it's based on wrong numbers. The correct inference (from matching repayment and carrying value) is that there were minimal unamortized discounts/premiums, but this is undermined by the incorrect redemption amount. (3) The multi-hop reasoning is partially sound: the model correctly links the repayment to balance sheet impact and infers valuation implications from the closeness of repayment and carrying values. However, because the key numbers do not align (962.9M vs 955.1M), the synthesis fails on factual grounding. It also introduces the 2021 Multicurrency Credit Facility and cash as funding sources, which adds detail beyond the ground truth but is not contradicted — though it shifts focus. (4) Correctness score is 6 due to major quantitative error but correct qualitative direction and relevance. Quantitative accuracy is low (4) due to the significant dollar amount mismatch. Qualitative accuracy is 7 because logic and entity identification (CoreSite Debt, AMT, carrying value implications) are sound. Contextual relevance is high (9) as the response directly addresses both parts of the question with appropriate financial reasoning and sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 560,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The company’s ongoing tax audits – which are expected to target its R&D credits and inter‑company transfer‑pricing – could cut its unrecognized tax‑benefit balance by as much as $5 million (the range disclosed is $0‑$5 million)【page_85】.  Adobe already carries sizable tax reserves, including a $335 million valuation allowance for deferred tax assets and an ending unrecognized‑tax‑benefits balance of $289 million【page_85】, so any adjustment would be absorbed by those reserves and would have only a modest effect on its overall financial position.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5 million upper bound of potential decrease in unrecognized tax benefits, which matches the ground truth. It also accurately cites Adobe's $289 million unrecognized tax benefits and $335 million valuation allowance, though these specific reserves are not directly tied to transfer pricing in the ground truth. However, the key discrepancy lies in the conclusion: the LLM asserts that any adjustment would be 'absorbed by those reserves' and have only a 'modest effect,' which contradicts the original answer's emphasis on potential adverse effects and the risk that actual adjustments could exceed reserves due to uncertainty. (2) Quantitatively, all numbers ($5M range, $289M, $335M) are accurately reported with correct formatting and sourcing from page 85. There are no calculation errors. (3) The multi-hop reasoning is partially flawed: while the model correctly retrieves relevant financial figures, it fails to synthesize the risk implications correctly. The original answer stresses uncertainty and potential for significant balance sheet fluctuations, whereas the LLM downplays the impact based on reserve levels, ignoring the explicit caveat in the ground truth about possible reserve shortfalls. (4) The contextual relevance is high as it addresses tax examinations, transfer pricing, unrecognized tax benefits, and reserves. However, the qualitative inaccuracy in reasoning and conclusion reduces overall correctness, warranting a mid-range score of 5 for correctness despite strong quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 432,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The alliance revenue for Lenvima rose 21 % in 2021 and 44 % in 2020 – together representing roughly a 65 % increase across the two years【page_56】. This strong growth reflects Merck’s broader oncology strategy of expanding through collaborative, combination‑therapy approaches, as illustrated by Keytruda’s many approved combos—including its pairing with Lenvima for endometrial cancer and renal‑cell carcinoma—designed to broaden the company’s cancer portfolio and drive sales【page_5】【page_57】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the alliance revenue growth for Lenvima was 21% in 2021 and 44% in 2020, and the combined growth over the two years is correctly stated as 65% (21 + 44 = 65), which matches the ground truth calculation. (2) The quantitative accuracy is perfect—percentages and the resulting combined growth are correct, with no calculation errors. (3) The qualitative reasoning is sound: the answer correctly links the revenue growth to Merck’s broader oncology strategy centered on combination therapies, specifically citing Keytruda’s combination with Lenvima for endometrial carcinoma and renal cell carcinoma, which aligns exactly with the knowledge graph. (4) The answer is contextually relevant, addressing both parts of the multi-hop question: the financial performance of Lenvima alliance revenue and its strategic connection to Merck’s oncology portfolio via Keytruda. The inclusion of citation markers (e.g., 【page_56】) suggests grounding in source material, further supporting accuracy. Minor wording differences (e.g., 'endometrial cancer' vs 'endometrial carcinoma') do not affect factual equivalence, as both are acceptable references to the same indication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 356,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM’s $0.7 billion equity earnings from its investment in Ultium Cells Holdings LLC were recorded as a direct boost to EBIT‑adjusted in 2024, adding $0.7 billion to that metric【page_34】. This contribution helped offset other cost pressures and improve the company’s EBIT‑adjusted performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GM's investment in Ultium Cells Holdings LLC generated $0.7 billion in equity earnings in 2024, which directly increased EBIT-adjusted performance—matching the original answer exactly in both amount and impact. (2) The quantitative value '$0.7 billion' is correctly reported with no calculation or formatting issues. (3) The reasoning is sound: the model correctly links the equity earnings from a specific joint venture to its direct positive impact on EBIT-adjusted, demonstrating proper multi-hop synthesis between investment, earnings, and financial performance metric. (4) All entities—GM, Ultium Cells Holdings LLC, EBIT-adjusted, and the year 2024—are accurately identified and contextually used. The addition of contextual insight about offsetting cost pressures is a reasonable interpretation and does not introduce error. All aspects of the question are addressed with factual precision and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 294,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new rule obligates Goldman Sachs’ investment‑management affiliates that meet the thresholds to file monthly short‑position data for equities beginning in January 2025 (see page 25). Because Goldman Sachs is also a registered security‑based swap dealer, it must already maintain detailed record‑keeping and publicly report large security‑based swap positions under SEC rules (see page 25). The overlap forces the firm to integrate short‑position data into its existing swap‑dealer reporting infrastructure, tightening its overall derivatives reporting and control processes to satisfy both the monthly equity‑short disclosures and its swap‑dealer reporting obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the January 2025 effective date is properly cited, Goldman Sachs' status as a registered security-based swap dealer is accurately noted, and the new SEC monthly short position reporting requirement is correctly described. There are no numeric values requiring calculation, but the temporal and regulatory details are precise. (2) The LLM correctly identifies that the rule applies to institutional investment managers meeting thresholds, and clarifies that it is likely the investment-management affiliates of Goldman Sachs that are directly subject—this nuance is consistent with the original answer’s implication and adds precision without contradiction. (3) The multi-hop reasoning is sound: the answer synthesizes the new short-position reporting obligation with Goldman Sachs’ pre-existing swap dealer duties (record-keeping, trade reporting), and correctly infers that the firm must integrate these data streams, leading to tighter reporting controls. This goes a step beyond the original by specifying integration into 'existing swap-dealer reporting infrastructure,' which is a reasonable and logical extension supported by the context. (4) Semantic equivalence is maintained: while the LLM answer uses slightly more operational language (e.g., 'tightening control processes'), the core meaning and factual content match the original. The only minor gap is that the original emphasizes 'transparency and accountability' and 'broader SEC oversight goals,' which the LLM omits—but this is contextual framing, not a factual error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 476,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The remeasurement of PepsiCo’s 39 % non‑controlling interest in Tropicana Brands Group (TBG) produced a **$520 million gain** that was recorded in the PBNA and Europe divisions 【page_111】.  This gain reflects the transaction’s structure: PepsiCo sold its Tropicana, Naked and other juice brands for roughly $3.5 billion in cash while retaining a 39 % equity stake in the newly‑formed TBG joint venture, which was subsequently measured at fair value, generating the $520 million uplift.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $520 million gain and the 39% retained noncontrolling interest in TBG, as well as the $3.5 billion cash proceeds from the sale of Tropicana, Naked, and other juice brands to PAI Partners. All key financial figures and percentages match the ground truth. (2) Quantitative accuracy is perfect: $520 million gain and $3.5 billion cash are correctly reported with acceptable formatting (e.g., '3.5 billion' = 'approximately $3.5 billion'). The percentage (39%) is accurate. (3) The reasoning correctly captures the multi-hop structure: PepsiCo sold assets for cash but retained a minority stake, which was remeasured at fair value, triggering the gain. The mention of fair value measurement and the dual outcome (cash + retained equity) aligns with the ground truth. However, the LLM omits specific detail about the valuation methodology (use of discounted cash flows and option pricing model) and does not name PAI Partners as the buyer, which slightly weakens the qualitative completeness. (4) Despite minor omissions in methodological detail, the core facts, numbers, and logic are correct, and the answer fully addresses the financial impact and transaction structure. Hence, correctness is scored 9/10, with full marks for quantitative accuracy and contextual relevance, and only a slight deduction in qualitative accuracy for missing valuation techniques and counterparty name.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 397,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2023, gains from GE’s retained ownership interests – the $5.778 billion recorded under “Gains (losses) on retained and sold ownership interests” plus the $10 million realized on its Baker Hughes stake – amounted to **$5.788 billion**, representing the bulk of the $6.718 billion total other income for the year【page_68】. By contrast, in 2024 those gains fell to **$518 million** (with no Baker Hughes gain), a sharp decline from the prior year【page_68】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical quantitative error: it incorrectly sums $5,778 million and $10 million to arrive at $5.788 billion, when the original answer states that the $10 million gain from Baker Hughes is already included in the $5,778 million total. Therefore, the LLM double-counts the Baker Hughes gain, leading to an overstated total. The correct contribution in 2023 is $5,778 million, not $5,788 million. The 2024 figure of $518 million is correctly reported. (2) The calculation of year-over-year change is implied but not explicitly stated; however, the drop from ~$5.78B to $518M is described as a 'sharp decline,' which is contextually accurate. The missing explicit comparison (a $5,260 million decrease) reduces completeness. (3) The multi-hop reasoning is mostly sound—LLM correctly identifies GE, its retained ownership interests, Baker Hughes, and the relevant income line items across years. It also correctly notes the absence of a Baker Hughes gain in 2024. However, the failure to recognize that the $10M is part of, not in addition to, the $5,778M indicates a flaw in synthesis. (4) Despite the significant numerical error, the answer addresses all parts of the question, uses correct entities (GE, Baker Hughes, 2023 vs 2024), and draws a qualitatively correct conclusion about the large decline. Wording and structure are clear and relevant, with citation to supporting document pages. The primary failure is in quantitative precision, which heavily impacts the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 420,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The 10‑K shows Mortgage‑Backed Obligations with a fair value of **$236 million** as of January 31 2024 (the marketable‑securities table and the fair‑value hierarchy table each report $236 million). That $236 million equals about **$236 ÷ $12,079 ≈ 1.95 %**, i.e., roughly **2 % of the company’s total assets measured at fair value**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both total fair value and percentage calculation. It reports only $236 million as the fair value of Mortgage-Backed Obligations, missing the second disclosure of $122 million. The correct total is $358 million ($236M + $122M), per the ground truth. (2) The calculation for percentage is also wrong: the LLM uses $236M ÷ $12,079M ≈ 1.95%, but the correct denominator is the average or combined total assets from both disclosures—$12,079M and $12,010M—leading to a total assets base of approximately $12,044.5M (average) or treated as $12,079M and $12,010M separately in synthesis. The correct percentage is ~2.97% ($358M ÷ ~$12,044.5M). The LLM fails to incorporate the second data point entirely. (3) Multi-hop reasoning is fundamentally flawed: the question requires aggregating two separate disclosures of both the Mortgage-Backed Obligations and the total assets. The LLM incorrectly assumes both tables report the same $236M value and does not recognize that two distinct disclosures must be summed. This breaks the multi-hop logic. (4) Contextual relevance is moderate—it addresses the right metric (fair value of Mortgage-Backed Obligations) and time period (January 31, 2024), and attempts a percentage calculation, but due to missing data and incorrect synthesis, the factual core is unsound. Hence, low scores on correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 397,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix’s global pricing strategy—offering a range of membership plans whose prices differ by country (from roughly $2 to $27 per month) and adjusting those prices in 2021—lifted average monthly revenue per paying member by 7% (the rise is attributed to price changes and favorable FX 【page_23】; the plan‑by‑country pricing is described in the “variety of streaming membership plans” section 【page_24】). That higher per‑member revenue, together with an 11% increase in the number of paying memberships, drove total revenues up 19% year‑over‑year (19% revenue growth is explained as the result of both the 11% membership growth and the 7% per‑member revenue increase 【page_23】).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 7% increase in average monthly revenue per paying membership, the 11% growth in paying memberships, and the resulting 19% total revenue growth are all correctly stated and consistent with the original answer. The mention of price ranges ($2 to $27) adds contextual detail without contradicting the source. (2) The answer addresses both parts of the multi-part question: it explains how varied membership plans enabled pricing flexibility that contributed to the 7% per-member revenue increase, and it correctly links this with membership growth to explain the 19% overall revenue growth. (3) Entity accuracy is perfect: Netflix is correctly identified, all financial metrics (average monthly revenue per paying membership, paying memberships, revenue growth) are properly named and contextualized, and the year 2021 is consistently referenced. (4) The multi-hop reasoning is sound: the model synthesizes information about pricing strategy, regional plan variation, price changes, foreign exchange effects, and membership growth to explain the overall revenue outcome. It correctly identifies that both higher per-member revenue and volume growth drove total revenue, demonstrating strong logical and financial reasoning. The inclusion of citation markers (e.g., 【page_23】) suggests grounding in source material. Overall, the answer is factually equivalent to the ground truth, with slightly more granular detail, and fully satisfies all evaluation criteria.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 433,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck’s partnership with Eisai on Lenvima is accounted for as “alliance revenue” – Merck’s share of the net profit from Lenvima sales (product sales less cost of sales and commercialization costs) – and it contributed $704 million to the pharmaceutical segment in 2021 (up from $580 million in 2020)【page_5】. The collaboration is being advanced through the LEAP (Lenvatinib + Pembrolizumab) program, which includes 17 Phase 3 studies; only the LEAP‑002 trial in advanced HCC remains active (fully enrolled), while LEAP‑007 (NSCLC) and LEAP‑011 (urothelial) were stopped for futility, so future pharmaceutical‑segment revenue from the alliance will depend on the outcome of the remaining trial(s) and the sales of currently approved Lenvima indications【page_23】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core aspects of the question, but has minor issues in quantitative accuracy and completeness. (1) Quantitatively, the LLM states that alliance revenue from the Merck-Eisai collaboration was $704 million in 2021 and $580 million in 2020. However, the original answer (ground truth) does not include these specific dollar amounts or years, so their inclusion introduces unverified data not present in the source knowledge graph. This risks hallucination or reliance on external data not in the provided context. While such figures may be accurate in reality, they are not supported by the ground truth, which focuses on the structural and forward-looking impact of the collaboration rather than historical revenue figures. (2) The LLM correctly identifies the LEAP program structure, the discontinuation of LEAP-007 and LEAP-011 due to futility, and the ongoing nature of LEAP-002 in advanced HCC, aligning with the original answer’s emphasis on the impact of trial outcomes on future revenue potential. (3) The explanation of the alliance revenue model — Merck receiving a share of net profits after costs — is consistent with the ground truth and correctly ties this to the pharmaceutical segment. (4) The LLM omits mention of the FDA’s CRL for first-line unresectable HCC based on KEYNOTE-524/Study 116, which is a key regulatory event in the original answer and relevant to revenue prospects. It also omits the approved indications (endometrial carcinoma and RCC) where the combination already contributes to revenue, reducing completeness. (5) Despite these omissions, the reasoning is sound: it correctly links trial outcomes to future revenue implications and understands the profit-sharing model. The contextual relevance is high, as it directly addresses how the collaboration influences Merck’s pharmaceutical revenue through both current sales and pipeline risk. Overall, the answer is factually coherent and logically structured but introduces unsupported numerical data and misses a few key elements from the ground truth, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 567,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Chevron reported that its total cost incurred by consolidated companies in 2023 was **$24.6 billion**【page_103】.  The same table shows expensed exploration costs of **$0.5 billion** and the PDC Energy, Inc. acquisition cost of **$10.5 billion**, together totaling **$11.0 billion**.  Therefore, the total cost incurred exceeded the combined amount by roughly **$13.6 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Chevron's total cost incurred by consolidated companies in 2023 is correctly stated as $24.6 billion, expensed exploration costs as $0.5 billion, and the PDC Energy, Inc. acquisition cost as $10.5 billion. The combined total ($11.0 billion) and the difference ($13.6 billion) are both correctly calculated. (2) The quantitative accuracy is perfect—calculations are sound: $0.5B + $10.5B = $11.0B; $24.6B - $11.0B = $13.6B. (3) The multi-hop reasoning is correct: the model identifies and retrieves three distinct financial figures from the same source (implied by citation), combines two of them, and computes the excess—exactly as required. (4) Entities are accurate: 'Chevron', 'PDC Energy, Inc.', '2023', and financial metrics ('total cost incurred', 'expensed exploration costs', 'acquisition cost') are all correctly referenced. (5) The answer is semantically equivalent to the original, with only minor wording differences (e.g., 'roughly' is used but still reports the exact figure). The citation [page_103] adds contextual support. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 340,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower values the market‑condition portion of its 2024 performance‑based RSUs by running a Monte Carlo simulation that incorporates assumptions such as the expected term, risk‑free rate and stock‑price volatility to estimate the probability of meeting the condition (grant‑date fair value ≈ $216.11)【page_127】. The market condition itself is measured by the company’s relative total shareholder return compared with the REIT constituents of the S&P 500 Index【page_126】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 PSUs with market conditions, which matches the original answer. The market metric—relative total shareholder return compared to REIT constituents in the S&P 500 Index—is accurately stated. (2) The dollar amount ($216.11) is an additional detail not present in the ground truth, but since it is cited with a page reference and does not contradict the original answer, it can be considered supplementary rather than incorrect. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the valuation method (Monte Carlo) with the specific market condition (relative TSR vs. S&P 500 REITs), demonstrating proper understanding across financial modeling and performance metrics. (4) Semantic equivalence is maintained; wording differs slightly (e.g., 'performance-based RSUs' vs. 'PSUs') but refers to the same instrument. The only minor point is that 'RSUs' might be slightly less precise than 'PSUs' (performance-based restricted stock units), but in context, it's acceptable. All key elements are present and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 350,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "Four amendments to the Caterpillar Inc. Supplemental Employees’ Investment Plan are listed in the filings (First Amendment – July 24 2017; Second Amendment – December 14 2018; Third Amendment – January 1 2022; Fourth Amendment – July 1 2022)【page_129】. The fourth amendment became effective on **July 1 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees’ Investment Plan, addressing the first part of the question. (2) The effective date of the fourth amendment is correctly identified as July 1, 2022, which aligns with the ground truth. All dates listed for the amendments are consistent with the disclosed filings, and no incorrect numbers or dates are present. (3) The multi-hop reasoning is sound—though the answer lists all amendment dates, it correctly isolates the fourth amendment’s effective date as required. The synthesis across the sequence of amendments is accurate. (4) The answer is semantically equivalent to the original, providing the same core information with added detail (listing all amendment dates), which enhances completeness without introducing error. All entities (Caterpillar Inc., the plan name, and the amendment dates) are correctly identified. Minor formatting differences (e.g., use of em dash) do not affect accuracy. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 313,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "In fiscal 2024 the Company recorded corporate notes and obligations at an amortized‑cost of **$3,014 million**, while their fair value was **$2,978 million** – a **$36 million** difference (fair value lower than cost)【page_75】. That $2,978 million fair value is reported entirely as a **Level 2** input in the fair‑value hierarchy (Level 2 = $2,978 million, Level 1 = $0)【page_77】, so the $36 million gap reflects the shortfall between amortized cost and the Level 2 fair‑value amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the amortized cost ($3,014 million), fair value ($2,978 million), and the $36 million unrealized loss, which matches the ground truth. These numbers are accurate and properly calculated. However, the LLM makes a critical error in stating that the entire $2,978 million fair value is categorized as Level 2, directly contradicting the ground truth, which states that only $2,557 million of the fair value is classified under Level 2 inputs, with a $421 million difference between total fair value and Level 2 value. This misrepresentation undermines the core of the second part of the question. (2) Quantitative accuracy is high for the first part—$3,014M cost, $2,978M fair value, and $36M difference are all correct and properly computed. However, the Level 2 value is wrong: LLM says $2,978M vs. ground truth $2,557M, a significant $421M discrepancy. (3) The multi-hop reasoning fails: the question requires comparing the total fair value to the subset categorized under Level 2 inputs in active markets. The LLM incorrectly asserts full alignment with Level 2, failing to recognize that Level 2 is only a portion, thus breaking the synthesis across sources. This suggests a misreading of the source material (e.g., confusing total Level 2 with a subset). (4) Correctness score is 4 due to major factual error in a key comparison despite correct initial numbers. Quantitative accuracy is 8 because most numbers are right, but one critical value is wrong. Qualitative accuracy is 4 due to flawed reasoning and failure in entity/metric segmentation (Level 2 vs. total fair value). Contextual relevance is 7 because the answer addresses the right concepts and structure but draws an incorrect conclusion on a central point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 480,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has arranged $1.1 billion of financing for the Disney Treasure and a second $1.1 billion facility that can be used for the Disney Destiny, for a total of $2.2 billion. The Treasure loan bears a fixed rate of 3.80%, whereas the Destiny loan would carry a slightly lower fixed rate of 3.74%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: total financing of $2.2 billion, split into two $1.1 billion facilities for the Disney Treasure and Disney Destiny. (2) Quantitative accuracy is perfect: $1.1 billion + $1.1 billion = $2.2 billion is correctly implied, and the interest rates of 3.80% (Treasure) and 3.74% (Destiny) match the original exactly. Minor formatting differences (e.g., using ' ' as a thousands separator) do not affect correctness. (3) The multi-hop reasoning is sound—information about two separate financing facilities is correctly synthesized into a total amount and comparative interest rate analysis. (4) The answer addresses both parts of the question: total financing amount and comparison of interest rates. Wording differs slightly (e.g., 'would carry' vs 'available at') but meaning is preserved. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 276,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron’s equity‑method investment in Tengizchevroil was $27.4 billion at year‑end 2024, which is roughly 58 % of its total equity‑method investments of $46.6 billion (27,368 ÷ 46,618 ≈ 0.587).  The Kazakhstan joint venture contributed about 45 thousand barrels per day of oil‑equivalent production (≈ 26 k bbl/d of crude) in 2024, making it the single largest source of Chevron’s equity‑method earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's Tengizchevroil investment ($27.4 billion vs. $27,368 million) and total equity-method investments ($46.6 billion vs. $46,618 million), with accurate percentage calculation (58.7%, rounded to 58% — acceptable approximation). However, the production volume figures (45 thousand barrels per day, 26k bbl/d crude) are not present in the original answer and introduce new, unverified data. The ground truth states Tengizchevroil is a 'key international affiliate' contributing to production but does not quantify it. (2) Quantitatively, the dollar amounts and percentage are accurate within reasonable rounding; $27,368 ÷ $46,618 = 0.587 (58.7%), correctly computed. The addition of specific production volumes (45k, 26k) lacks support in the original and represents an overreach. (3) The multi-hop reasoning is partially sound: the model links investment size to earnings contribution, which is logical, but goes beyond the source by asserting production volumes and ranking it as the 'single largest source' of equity-method earnings — a claim not present or verifiable from the original. (4) Scores reflect high factual accuracy in core financials, minor deduction for unsupported production numbers, and strong contextual relevance as the answer addresses both parts of the question, albeit with some extraneous claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 381,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A rise in credit spreads or in the upfront credit‑points input pushes the fair‑value of purchased credit‑protection (the firm’s level 3 credit derivatives) higher, while a decline in those inputs lowers the fair‑value (the opposite effect applies to sold protection).  Goldman Sachs values its credit‑derivative positions with a mix of option‑pricing models, correlation inputs and discounted‑cash‑flow models—often applying more than one technique together to arrive at the fair value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that an increase in credit spreads or upfront credit points increases the fair value of purchased credit protection for Goldman Sachs' level 3 credit derivatives, which matches the original answer. It also correctly notes the inverse effect for sold protection, adding a detail not in the ground truth but consistent with financial principles and not contradicting it. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the qualitative financial relationships are correctly described. (3) The valuation techniques—option pricing models, correlation inputs, and discounted cash flow models—are accurately reported and match the original answer. The LLM correctly conveys that multiple techniques are often used together, reflecting proper synthesis of the valuation approach. (4) All entities (Goldman Sachs, level 3 credit derivatives, fair value measurement) are correctly identified and contextually applied. The response fully addresses both parts of the question: the impact of credit spread changes and the valuation techniques used. The reasoning is sound, complete, and contextually appropriate, warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 362,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "A breach of the Minimum DSCR (set at 1.15 ×) would trigger an “amortization period” in which all excess cash flow is automatically applied to repay the Series 2015‑2 notes or the related loan – no cash would be released to AMT (Page 58). Because the excess‑cash distributions are then unavailable, AMT could be unable to fund its capital‑expenditure program, including the planned construction of roughly 1,950‑2,550 communications sites worldwide (and associated data‑center spend) (Pages 57‑58, 52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the Minimum DSCR is accurately stated as 1.15x, the consequence of a breach (amortization period) is correctly described, and the impact on AMT's cash flow and ability to fund capital expenditures is properly explained. The range of 1,950–2,550 communications sites is correctly cited. (2) Quantitative accuracy is perfect: all numbers (DSCR threshold, site construction range) match the original answer and are presented accurately, with acceptable formatting (e.g., '1,950‑2,550' vs '1,950 to 2,550'). (3) The multi-hop reasoning is sound: the model correctly links the DSCR covenant breach to the cash trap mechanism, the diversion of excess cash flow to debt repayment, and the resulting inability to fund capital projects. It appropriately references the use of the Cash Trap Reserve Account and the impact on distributions to AMT, though it does not explicitly name the reserve account, which is a minor omission. (4) The answer is fully contextually relevant, directly addressing how the DSCR failure impacts AMT’s global construction plans. The only reason for not awarding a 10 is the slight omission of the explicit mention of the 'Cash Trap Reserve Account' being used to repay principal, though the concept is implied through 'all excess cash flow'. Wording differences are semantically equivalent and do not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 404,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar’s warranty liability is calculated by applying historical claim‑rate experience to the current field population and dealer inventory—a judgment‑heavy assumption that PwC identified as the core of its critical audit matter because it requires extensive auditor evaluation of management’s estimate. Using that methodology, the company reported a product‑warranty liability of **$1.7 billion** as of December 31, 2024【page_59】【page_115】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Caterpillar uses historical claim rates applied to current field population and dealer inventory to estimate warranty liability, a method involving significant management judgment. PricewaterhouseCoopers LLP (PwC) identified this as a critical audit matter due to the high degree of auditor judgment and subjectivity required. (2) The financial estimate of $1.7 billion as of December 31, 2024, matches the ground truth of $1,700 million—equivalent in value with acceptable format variation (billion vs. million). (3) The multi-hop reasoning is sound: the answer correctly links Caterpillar’s estimation methodology to the audit complexity and identifies the resulting financial figure from the correct time period. (4) Entity accuracy is perfect: company (Caterpillar), auditor (PwC), metric (product warranty liability), and date (December 31, 2024) are all correct. The inclusion of citation markers 【page_59】【page_115】 suggests grounding in source material. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 322,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "Disney’s Asia Theme Parks borrowings carry a **stated rate of 7.93%** (page 99), while its senior unsecured U.S.‑dollar notes have an **effective rate of 4.71%** (page 99). The roughly 3.2‑percentage‑point spread shows that capital for the Asia Theme Parks is materially more expensive, reflecting higher financing costs or risk for that segment compared with the cheaper, lower‑cost senior unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the stated interest rate on Asia Theme Parks borrowings (7.93%) and the effective interest rate on Disney's senior unsecured notes (4.71%), both matching the ground truth. The calculated difference of approximately 3.2 percentage points is accurate (7.93 - 4.71 = 3.22), and the rounding to 'roughly 3.2' is acceptable. 2) All numeric values are correct and properly cited to page 99, aligning with the source. Calculations are accurate and semantically equivalent to the ground truth's 3.22 percentage point difference. 3) The reasoning correctly interprets the higher rate on Asia Theme Parks debt as reflecting a higher cost of capital, linking it to potential risk or financing conditions. It synthesizes the two debt instruments appropriately to compare cost of capital across categories, fulfilling the multi-hop requirement. 4) The answer is contextually relevant and directly addresses how the rate difference reflects relative cost of capital. The only minor shortcoming is the omission of specific factors mentioned in the original answer (e.g., collateralization or market conditions at issuance), which slightly reduces qualitative completeness but does not affect factual correctness. Overall, the answer is factually accurate, well-reasoned, and conveys the same core information as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 374,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron capitalized $10,487 million for the PDC acquisition in 2023【page_91】, and that acquisition was primarily responsible for the 2.2 TCF of natural‑gas purchases in the DJ (Denver‑Julesburg) basin【page_115】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual components are accurate: the capitalized cost of $10,487 million for the PDC acquisition in 2023 and the attribution of 2.2 TCF of natural gas purchases to the DJ Basin are correctly stated. (2) Quantitative accuracy is perfect: the dollar amount ($10,487 million) and volume (2.2 TCF) match the ground truth exactly, with acceptable formatting (e.g., use of 'million' and 'TCF'). (3) Qualitative accuracy and multi-hop reasoning are sound—the model correctly identifies Chevron as the acquiring company, links the PDC acquisition to both the financial cost and the resource contribution, and correctly identifies the DJ (Denver-Julesburg) Basin as the location, demonstrating synthesis across financial and operational data. (4) Contextual relevance is complete, as the answer directly addresses both parts of the question with precise, relevant information and includes citation markers indicating source pages. Minor enhancements like spelling out 'Denver-Julesburg' are acceptable and do not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 315,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to its consolidated statements of comprehensive income, balance sheet, statement of operations (income statement), statements of equity and statements of cash flows. The tables show that this restatement materially altered prior‑period figures—net income rose by $2.7 billion, unrealized investment losses were restated, assets such as deferred acquisition costs were reduced by $3.3 billion, future policy‑benefit liabilities were lowered by $17 billion, equity components (retained earnings and AOCI) were adjusted, and operating cash‑flow line items changed by hundreds of millions—demonstrating the guidance’s significant impact on MetLife’s consolidated financial reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that undermine its correctness. (1) The original answer states that MetLife retrospectively adjusted the consolidated statement of operations and consolidated statements of comprehensive income. The LLM answer expands this to include the balance sheet, statement of cash flows, and statements of equity, which are not mentioned in the ground truth. While it's plausible that LDTI could affect these statements, the ground truth only confirms adjustments to the statement of operations and comprehensive income, so the inclusion of additional statements is unsupported. (2) The LLM introduces specific quantitative figures such as a $2.7 billion increase in net income, $3.3 billion reduction in deferred acquisition costs, $17 billion decrease in future policy-benefit liabilities, and changes in cash flows—none of which appear in the original answer. These numbers, while potentially accurate in context, are not present in the verified ground truth and thus represent unverified additions. (3) The reasoning about the material impact of LDTI on financial reporting is sound and aligns with the original answer’s conclusion that the guidance had a material effect. The multi-hop synthesis is reasonable in intent but flawed due to reliance on unsupported data. (4) The contextual relevance is high because the response addresses the retrospective application and its implications. However, the quantitative accuracy is low due to the inclusion of unverified dollar amounts. The qualitative accuracy is moderate because the core idea—material restatement due to LDTI—is correct, but the specific financial statements adjusted go beyond what is confirmed. Thus, the overall correctness score is reduced to 4 due to major factual overreach despite correct directional logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 499,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The 2024 Form 10‑K lists **two amendments** to the Solar Turbines Incorporated Managerial Retirement Objective Plan – a First Amendment dated December 10 2014 and a **Second Amendment** that is the most recent change. The Second Amendment became **effective on January 1 2022**【page_130†L13-L16】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan, which aligns with the original answer. (2) The effective date of the most recent amendment, the Second Amendment, is correctly identified as January 1, 2022. The mention of the First Amendment's date (December 10, 2014) adds contextual detail not required by the question but does not detract from accuracy. (3) The multi-hop reasoning is sound—information about the number of amendments and the effective date of the latest one is correctly synthesized from the Caterpillar Inc. 2024 10-K filing, as required. (4) The answer is semantically equivalent to the ground truth, with no factual, numerical, or entity errors. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 248,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate‑Case Order cut “Impairment of assets and other charges” by $13 million at Duke Energy Carolinas (31 vs 44 million)【page_51】and by $13 million at Duke Energy Progress – the portion of the impairment decline that the company attributes directly to the prior‑year North Carolina rate case order【page_52】.  Together the order produced a $26 million reduction in those charges, which shows up in the consolidated statements of operations as a $22 million decrease in the “Impairment of assets and other charges” line, lowering total operating expenses and boosting operating income【page_53】.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of the financial impact. The ground truth states that the North Carolina Rate Case Order resulted in a total *increase* of $68 million in Impairment of Assets and Other Charges ($35M for Duke Energy Carolinas and $33M for Duke Energy Progress). In contrast, the LLM claims a $13M reduction at each subsidiary, totaling a $26M *decrease*, which is the opposite of the correct impact. This misrepresents the nature of the event. (2) The numbers cited—$13M reductions and a $22M consolidated decrease—are not supported by the ground truth and appear to be misinterpretations of year-over-year changes possibly unrelated to the rate case order’s direct impact. The correct total impact is $68M, not $26M or $22M. Calculations and values are entirely inconsistent with the original answer. (3) The multi-hop reasoning fails: the model incorrectly synthesizes information by interpreting a decline in impairment charges as being *caused by* the rate case order, whereas the ground truth indicates the order *led to* new impairment charges. This reflects a critical logical error in causality and financial interpretation. (4) Due to major factual, numerical, and directional errors, the answer receives a correctness score of 1. Quantitative accuracy is very low (2) because all key numbers are wrong. Qualitative accuracy is also poor (2) due to flawed reasoning and entity/metric misattribution. Contextual relevance is slightly higher (3) because the answer discusses the right companies and financial line item, but with incorrect implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 446,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "Licensed stores generated 12 % of Starbucks’ total net revenue in fiscal 2024. Because the company only receives a margin on the branded products and supplies it sells to the licensee, plus royalties on the licensee’s retail sales and any license fees, licensed locations have a lower gross margin but a higher operating margin than company‑operated stores—licensees absorb the operating costs and capital investments, so the modest 12 % revenue share translates into a relatively profitable contribution to Starbucks’ overall earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that licensed stores accounted for 12% of Starbucks’ total net revenues in fiscal 2024, matching the ground truth. It accurately describes the structure of payments: margins on branded products and supplies, royalties on retail sales, and license fees. The conclusion that the licensed model shifts operating costs and capital investments to licensees—resulting in higher operating margins despite lower gross margins—is consistent with the original answer.\n\n2) Quantitatively, the 12% figure is correct and properly attributed to fiscal 2024. No calculations are required beyond this percentage, and it is used appropriately in context.\n\n3) The multi-hop reasoning is sound: the model connects the revenue contribution (12%) with the financial structure (product margins, royalties, fees) and infers the profitability impact based on cost-shifting. It correctly contrasts licensed and company-operated stores in terms of margin profile and cost structure, which requires synthesis across financial and operational dimensions.\n\n4) The only minor shortcoming is that the LLM answer mentions 'lower gross margin' for licensed stores—a detail not explicitly confirmed in the ground truth—though this is a reasonable inference given the business model. The original answer emphasizes higher operating margins and cost-shifting but does not discuss gross margins. This slight addition does not contradict the truth but introduces a nuance not present in the source. Otherwise, the semantic meaning and factual content are equivalent.\n\nOverall, the answer is factually accurate, complete, and contextually appropriate, with only a minor deviation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 461,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "If Target cannot successfully develop, source and market its owned‑and‑exclusive brands—products that make up roughly one‑third of sales and carry higher margins—its operating results could be materially harmed.  Longer lead times and greater responsible‑sourcing risk increase exposure to supply‑chain disruptions, reputational damage and margin erosion, which would adversely affect its results of operations and overall financial condition.【page_11】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, the statement that owned and exclusive brands represent 'roughly one-third of sales' matches the original answer's 'approximately one-third of its overall sales'—this is semantically equivalent and correctly reported. No other numerical values (e.g., margins, lead times) are specified in exact terms in either answer, so no discrepancies exist. (2) The LLM correctly identifies the financial risk: material harm to operating results due to failure in developing, sourcing, and marketing these higher-margin brands. It also correctly notes the increased responsible-sourcing risks and longer lead times, linking them to supply-chain disruptions and margin erosion. (3) The multi-hop reasoning is sound—connecting the strategic importance of the brands (one-third of sales, higher margins) with operational risks (longer lead times, forecasting challenges, sourcing risks) and their potential financial impact. The only minor omission is that the LLM does not explicitly mention 'longer-term forecasting of consumer demand' or 'exposure to misjudging rapidly changing consumer preferences,' which are key elements in the ground truth related to longer lead times. However, the implication of forecasting risk is partially covered under supply-chain disruption. (4) The answer is contextually relevant, directly addressing the financial risk posed by failure in this area. The citation '[page_11]' suggests proper grounding. Overall, the answer is factually correct and well-reasoned, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 465,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "The 2024 Form 10‑K incorporates **four** amendments to the Caterpillar Inc. Deferred Employees’ Investment Plan (First, Second, Third, and Fourth Amendments)【page_129】. The two most recent amendments are:\n\n* **Third Amendment** – incorporated by reference to the Company’s **Annual Report on Form 10‑K for the year ended December 31 2021**【page_129】.  \n* **Fourth Amendment** – incorporated by reference to the Company’s **Quarterly Report on Form 10‑Q for the quarter ended September 30 2022**【page_129】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that there were four amendments incorporated into the 2024 10-K, which aligns with the original answer. (2) The two most recent amendments are correctly identified as the Third and Fourth Amendments, with accurate details: the Third Amendment effective January 1, 2022, incorporated from the 2021 Form 10-K (Exhibit 10.28), and the Fourth Amendment effective July 1, 2022, incorporated from the Q3 2022 Form 10-Q (Exhibit 10.6). While the LLM answer does not explicitly mention exhibit numbers or exact amendment effective dates, it correctly identifies the filing types, reporting periods, and references the correct SEC filings by form and date, which is sufficient for accurate sourcing by reference. (3) The multi-hop reasoning is sound—information is synthesized across multiple filings (2021 10-K and 2022 10-Q) and correctly linked to the 2024 10-K incorporation by reference. (4) The answer is semantically equivalent to the ground truth, with no factual inaccuracies, omissions affecting correctness, or misidentifications. All scores are maximized due to full factual alignment, precise quantitative and entity accuracy, and appropriate contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 354,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "The 2013 Equity Incentive Plan had **73 million shares** still available for future grant or issuance. Under the plan the company had **8 million stock options** outstanding and **26 million restricted‑stock awards and performance‑based stock units** outstanding【page_87】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is severely incorrect in its quantitative claims. The ground truth states that 73 shares (not million) remain available, whereas the LLM incorrectly reports '73 million shares', which is off by a factor of one million. This is a critical factual error. Additionally, the LLM introduces specific numbers for outstanding awards—8 million stock options and 26 million restricted-stock awards and performance-based units—that are not present in the original answer and are likely fabricated or misextracted. (2) The original answer does not provide any breakdown of outstanding awards by quantity, only the types: options, restricted stock awards/units, and performance-based stock units. Thus, the LLM invents numerical details that are unsupported by the source. The share availability number is catastrophically wrong due to the 'million' modifier. (3) The reasoning fails on multi-hop synthesis: while the LLM identifies the correct plan and types of awards (partially), it corrupts the data with false quantities and misrepresents availability. It appears to confuse absolute numbers or misread the document, possibly interpreting a total pool or outstanding figure as availability. (4) Despite the severe quantitative inaccuracy, the LLM correctly identifies the plan name and broadly references the right types of equity awards (options, restricted stock, performance-based units), which supports partial contextual relevance. However, the introduction of false numerical precision undermines the entire response. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is low due to flawed reasoning; contextual relevance is moderate due to correct entity and category naming.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 472,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Starbucks says that “most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance” (Item 1 Business, p. 6). Thus, more than half—i.e., over 50 %—of the $1.77 billion Channel Development revenue in fiscal 2024 comes from that partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that 'most' of Channel Development revenues come from the Global Coffee Alliance with Nestlé, interpreting 'most' as 'over 50%', which is semantically equivalent to the original answer's 'greater than 50%'. (2) The dollar amount of $1.77 billion for Channel Development revenue in fiscal 2024 is factually correct and consistent with the knowledge base, though the original answer does not include this figure. Including it adds precision and is acceptable as long as it's accurate, which it is. (3) The reasoning correctly synthesizes the qualitative statement from the 10-K about revenue sources with the quantitative total, concluding that over half comes from Nestlé—this is sound multi-hop logic. (4) The only minor limitation is that the original answer explicitly acknowledges that the exact percentage is not disclosed, while the LLM implies a precise majority without reiterating the lack of an exact figure. However, this does not constitute a factual error, just a slight difference in emphasis. All entities (Starbucks, Nestlé, Global Coffee Alliance), metric (Channel Development revenues), and fiscal year (2024) are correct. Overall, the answer is factually sound, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 365,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to its consolidated statements of comprehensive income (statement of comprehensive income), balance sheet, statement of operations (income statement), cash‑flow statement and statements of equity. The tables shown for December 31 (2022 and 2021) – in the 10‑K – display the adoption adjustments and post‑adoption amounts for items such as net income, unrealized investment gains/losses, future policy‑benefits discount‑rate remeasurement gains, market‑risk benefit remeasurement gains/losses, foreign‑currency translation adjustments, other comprehensive income (pre‑ and post‑tax) and comprehensive income; retained earnings, accumulated OCI and equity balances; and cash‑flow line items including amortization of premiums, gains/losses on investments and derivatives, interest credited, changes in premiums receivable, market‑risk benefits, deferred policy acquisition costs, income‑tax, other assets, insurance‑related liabilities and net cash from operating and financing activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but includes significant overreach in scope compared to the ground truth. (1) Correct elements: The mention of the consolidated statement of operations and cash flows aligns with the original answer, and the reference to tables as of December 31 in the 2023 10-K is accurate. The detailed list of affected line items (e.g., net income, retained earnings, cash-flow items) adds context that may be present in the filing and is not contradicted by the ground truth. (2) Quantitative accuracy: There are no specific numbers, dates, or dollar amounts in the question or ground truth, so no numeric inaccuracies exist—this aspect is flawless by default. (3) Multi-hop reasoning assessment: The LLM incorrectly expands the set of adjusted financial statements beyond what the ground truth confirms. The original answer specifies only the consolidated statement of operations and consolidated statements of cash flows were retrospectively adjusted. However, the LLM includes the balance sheet, statement of comprehensive income, and statements of equity, which are not mentioned in the ground truth. This represents a significant factual overstatement. (4) Justification for scores: The correctness score is 6 because core parts of the answer (operations and cash flows) are correct, but the inclusion of additional financial statements reduces factual accuracy. Qualitative accuracy is low due to incorrect entity identification (extra financial statements). Quantitative accuracy is 10 as no numbers are wrong. Contextual relevance is high because the response addresses the question’s focus on adjustments and tables as of December 31, even if with excess detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 460,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "In 2022 MDLZ’s equity‑method investment contracts were recorded at a fair‑value liability of only **$3 million**, whereas the fair‑value of all of its asset‑derivative positions was roughly **$790 million** (the “Total fair value” of asset derivatives)【page_95】. The $3 million amount is well under 1 % of the total asset‑derivative exposure, showing that equity‑method investment contracts are a negligible, essentially immaterial, part of MDLZ’s overall derivative portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total value of asset derivatives. The ground truth states $393 million, but the LLM reports $790 million, which is nearly double the correct amount. This significantly undermines the quantitative accuracy. The $3 million value for equity method investment contracts is correct. (2) The calculation of relative significance (less than 1%) is conceptually correct, but based on incorrect input data. With the correct numbers, $3M is indeed less than 1% of $393M (~0.76%), but the LLM’s $3M vs $790M would be ~0.38%, still under 1%—so the qualitative conclusion survives despite the error. However, the source of the $790M figure is unclear and contradicts the ground truth, suggesting a misreading of the document or confusion with another line item (possibly including liability derivatives or misreading a gross amount). (3) The multi-hop reasoning—comparing the specific derivative category to the total asset derivatives and interpreting relative significance—is sound in structure and logic. The model correctly identifies the entities (MDLZ, equity method investment contracts, asset derivatives) and the year (2022). (4) Despite correct reasoning and conclusion, the major factual error in a core financial figure severely impacts correctness. The answer is semantically close but factually inaccurate on a key metric. Hence, correctness is scored low (4), quantitative accuracy very low (3), qualitative reasoning moderate (6) due to correct logic, and contextual relevance high (8) as the response directly addresses the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 441,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The 2019 freeze eliminated the “rate of compensation increase” from the actuarial model for U.S. pension plans – the assumption is now set to zero (shown as “‑ %”) and is noted as “no longer applicable.” Consequently, CAT’s U.S. pension benefit calculations no longer project any future salary growth, while the other assumptions (discount rate, expected return on assets, etc.) remain unchanged.【page_46】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that the freezing of U.S. pension benefits as of December 31, 2019, led to the discontinuation of the 'rate of compensation increase' assumption in CAT's actuarial model. (2) The quantitative and temporal details are correct: the freeze date (2019) aligns with the original answer, and the assumption being set to zero or marked as 'no longer applicable' ('‑ %') is consistent with factual reporting. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model connects the structural change (benefit freeze) to its direct accounting consequence (removal of salary growth projections), while correctly noting that other assumptions remain unaffected. (4) All entities—CAT, U.S. pension plans, actuarial assumptions—are accurately referenced. The inclusion of a citation ('【page_46】') further supports contextual fidelity. Minor wording differences (e.g., 'expected rate of compensation increase' vs. 'rate of compensation increase') do not affect meaning. The answer is complete, factually precise, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 324,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle has concentrated its hardware revenue on the higher‑margin Oracle Engineered Systems and other strategic products while de‑emphasizing lower‑margin commodity hardware, giving it a more profitable hardware mix (page 23). Nevertheless, because those engineered systems still rely on third‑party manufacturers and single‑source components, supply‑chain shortages and logistics delays—exacerbated by COVID‑19—can raise production costs, delay shipments and compress margins, limiting the profitability advantage of this focus (page 23).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the original answer in terms of key points: Oracle's strategic focus on higher-margin Oracle Engineered Systems improves profitability, but reliance on third-party suppliers and single-source components exposes it to supply chain disruptions. The LLM correctly identifies that supply chain shortages and logistics delays (including those exacerbated by COVID-19) increase production costs, delay shipments, and compress margins—directly impacting profitability. It also correctly references page 23 of the 10-K, supporting its claims. However, the LLM omits some critical elements from the ground truth: (1) the increased inventory purchases to secure manufacturing capacity, (2) the resulting risk of inventory excess and obsolescence, and (3) the negative impact on operating cash flows. Additionally, the original answer notes that Oracle cannot always pass on increased costs to customers and may face lost sales and delayed revenue recognition—important nuances not captured in the LLM response. While the core reasoning and entity identification (Oracle, Engineered Systems, third-party suppliers, supply chain risks) are correct and logically synthesized, these omissions reduce completeness and slightly weaken the qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 394,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The 2023 worldwide sales for the two Pulmonary Hypertension drugs were $1,582 million for UPTRAVI and $1,973 million for OPSUMIT, for a combined total of **about $3.6 billion**【page_31】.  Together they grew from $3,105 million in 2022 to $3,555 million in 2023 – a **≈14.5 %** increase, which is roughly **3 percentage points higher** than the overall Pulmonary Hypertension category’s 2023 growth rate of **11.6 %**【page_31】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual 2023 sales figures for UPTRAVI ($1,582 million) and OPSUMIT ($1,973 million), which match the ground truth. The combined total of $3,555 million is accurate, though the LLM rounds it to 'about $3.6 billion', which is acceptable. However, the LLM calculates a combined growth rate of ≈14.5%, which is incorrect. The ground truth does not provide a combined growth rate for the two drugs, but rather individual growth rates (10.6% for OPSUMIT, 19.7% for UPTRAVI), and states that both are higher than the category’s 11.6% growth rate. The LLM incorrectly computes an aggregate growth rate from total sales (from $3,105M to $3,555M), implying a 14.5% increase, and then compares this to the category’s 11.6% growth, stating it is '3 percentage points higher'. This reasoning is flawed because the question asks how the total (sales) compares in percentage growth — but the correct interpretation is to report the individual drug growth rates and compare them to the category, not to create a synthetic combined growth rate. (2) Number verification: $1,582M + $1,973M = $3,555M — correct. 2022 total inferred as $3,105M is plausible, but not requested in the question. The 14.5% growth calculation is mathematically correct (3,555 / 3,105 ≈ 1.145), but conceptually wrong because the question does not ask for a blended growth rate. (3) Multi-hop reasoning: The LLM correctly pulls sales figures for both drugs and the category growth rate, but fails to report the individual growth rates for the two drugs as required by the ground truth. Instead, it invents a new metric (combined growth rate) not supported by the original answer. (4) Scores justified: Correctness is 6 due to accurate sales numbers but incorrect growth interpretation. Quantitative accuracy is 6 because while raw numbers are correct, the derived growth rate is not what was asked. Qualitative accuracy is 7 — reasoning is logical but misaligned with the required comparison. Contextual relevance is 10 — all information is on-topic and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 557,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The legacy PDC Energy assets added roughly **$2.2 billion** of higher sales volume to U.S. upstream earnings in 2024, driving the segment’s earnings increase of $3.5 billion. That full‑year of PDC production also lifted net oil‑equivalent output by about **250,000 barrels per day** (≈ 19 % higher).【page_44】【page_44】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers match: $2.2 billion increase in U.S. upstream earnings and a 250,000 barrels per day increase in net oil-equivalent production, which corresponds to a 19% increase—both values are correctly reported, with acceptable formatting variations (e.g., '≈ 19 % higher' vs 19%). (2) The answer addresses both parts of the question: the earnings impact and the production impact. (3) Entities are correct—CVX (Chevron), legacy PDC Energy assets, 2024 time frame, U.S. upstream segment, and relevant metrics. (4) The reasoning is sound and reflects multi-hop synthesis: the full-year contribution is tied to both financial and operational impacts. One minor issue: the LLM adds extra information not in the original ('driving the segment’s earnings increase of $3.5 billion'), which, while potentially contextually relevant, is not part of the ground truth and could imply a causal claim not verified in the original answer. However, this does not contradict the requested information and doesn't affect the correctness of the directly asked values. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 352,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "MetLife restated its consolidated statement of comprehensive income, statement of operations (income statement), balance sheet, statement of equity, and statement of cash flows to reflect the retrospective application of the new LDTI guidance. This indicates that the guidance affected virtually every primary financial statement—assets, liabilities, equity, earnings, comprehensive income and cash‑flow items—showing a broad, company‑wide impact on its reporting.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity identification and completeness of financial statements affected. (1) The original answer states that MetLife adjusted only the consolidated statements of equity and comprehensive income. However, the LLM claims that MetLife restated *all* primary financial statements—including the income statement, balance sheet, and statement of cash flows—which is not supported by the ground truth. This overstatement undermines the factual accuracy of the response. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the absence of incorrect numbers allows a score of 10 by default. (3) The multi-hop reasoning is flawed: while the implication about broad impact is reasonable, the LLM infers a company-wide effect across all statements without evidence from the ground truth, which specifies only two statements were adjusted. This misrepresents the scope of the LDTI guidance’s retrospective application. (4) Contextually, the answer addresses the question’s intent—identifying affected statements and interpreting the impact—but does so with excessive overreach. The conclusion about 'broad, company-wide impact' may be defensible in spirit, but it is based on incorrect premises. Thus, while the reasoning attempt is relevant, it lacks fidelity to the source facts. Overall, the answer gets core elements wrong (which statements were adjusted), warranting a mid-range correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 425,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "As of December 31 2022, the equity‑method investment contracts were shown with a fair‑value liability of **$3 million** (no asset amount) in the derivatives fair‑value table【page_95†L31-L33】. The same table lists net‑investment‑hedge derivative contracts with a fair‑value asset of **$265 million** and a liability of **$241 million**, for a combined total fair value of **$506 million**【page_95†L24-L27】. Thus, net‑investment‑hedge contracts were roughly **$503 million** larger in fair‑value than the equity‑method investment contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key financial figures. The ground truth states the fair value of equity method investment contracts was $(3) million (a $3 million liability), which the LLM correctly identifies as a $3 million liability. However, the LLM incorrectly reports the total fair value of net investment hedge contracts as $506 million (calculated as $265M asset - $241M liability, or possibly summing both), whereas the ground truth states it was $24 million. This is a critical error. The correct value likely reflects the net amount ($265M - $241M = $24M), which the LLM fails to compute correctly and instead appears to sum or misinterpret the gross values. (2) Calculations are flawed: the LLM claims a difference of $503 million, which stems from using incorrect totals. The actual difference should be $24M - (-$3M) = $27M, not $503M. (3) Multi-hop reasoning is partially sound in that the model attempts to extract and compare values from the same table and time period, but fails in synthesizing the correct net value for net investment hedges, indicating a misunderstanding of how fair value is reported (net vs. gross). (4) While the entity (equity method vs. net investment hedge contracts), date (December 31, 2022), and document source (derivatives fair value table) are correct, the severe quantitative inaccuracies in the core financial figures—especially the $506M vs. $24M—undermine the answer’s validity. The comparison conclusion is therefore completely incorrect. Hence, low scores for correctness and quantitative accuracy; moderate for qualitative due to correct identification of concepts; high for contextual relevance as the answer addresses the right question structure and sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 476,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "Universal Beijing Resort’s net assets fell from roughly $600 million at 12/31/2023 (assets $7.8 bn – liabilities $7.2 bn) to about $300 million at 12/31/2024 (assets $7.3 bn – liabilities $7.0 bn), a decline of roughly $300 million. This $0.3 bn reduction is reflected in Comcast’s consolidated balance sheets, where UBR’s reported assets dropped $0.5 bn and its liabilities fell $0.2 bn, producing the net‑asset decrease.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. While it correctly identifies the starting net assets ($0.6 billion on 12/31/2023) and ending net assets ($0.3 billion on 12/31/2024), it incorrectly states the change as a $300 million (or $0.3 billion) decrease. The correct change is a $0.5 billion decrease (from $0.6B to $0.3B implies a $0.3B drop, but the ground truth explicitly states the change is $0.5B, which contradicts the provided arithmetic). However, the ground truth itself appears internally inconsistent: $7.8B - $7.2B = $0.6B (correct), $7.3B - $7.0B = $0.3B (correct), but the difference between $0.6B and $0.3B is $0.3B, not $0.5B as claimed in the original answer. This suggests a possible error in the ground truth. Despite this, the LLM should have computed the correct delta ($0.3B) and not repeated a $0.3B decline while also referencing a $0.5B asset drop. (2) The LLM claims Comcast’s consolidated balance sheets show UBR’s assets dropped $0.5B (from $7.8B to $7.3B — correct) and liabilities fell $0.2B (from $7.2B to $7.0B — correct), leading to a net asset decrease of $0.3B — which is logically sound. However, it mislabels this net change as $0.3B while the original answer incorrectly calls it $0.5B. The LLM’s calculation is mathematically accurate based on the inputs, but fails to reconcile why the net asset change isn’t equal to the net of asset and liability changes. (3) The multi-hop reasoning is partially sound — it pulls asset and liability figures for two years and computes net assets and changes. It also links UBR’s financials to Comcast’s consolidated reporting, satisfying the synthesis requirement. However, it does not notice or resolve the inconsistency between the computed net asset change ($0.3B) and the original answer’s claim of $0.5B. (4) Due to the conflicting ground truth, the LLM’s answer is more arithmetically correct than the original, but it still misstates the net asset change as $0.3B while the original insists it is $0.5B. Given that the original answer is authoritative, and the LLM does not match it, correctness is penalized. Quantitative accuracy is low due to mismatched change amount. Qualitative reasoning is moderate — logic is coherent but misses deeper reconciliation. Contextual relevance is high — directly addresses the question with appropriate entities and timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 633,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "Starbucks’ two Japanese yen‑denominated facilities – ¥5 billion ($34.5 million) and ¥10 billion ($69.1 million) – total about **$103.6 million** of available credit as of September 29 2024.  The 2021 five‑year $3 billion unsecured revolving credit facility expressly backs the commercial‑paper program: the program may issue up to $3 billion of CP and the outstanding CP must be “backstopped” by the available commitments under the revolving facility, which can be used for working‑capital, capital‑expenditure and other corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two Japanese yen-denominated credit facilities: ¥5.0 billion ($34.5 million) and ¥10.0 billion ($69.1 million), and accurately calculates the total as $103.6 million, matching the ground truth. All dollar amounts and yen values are correct, and the date (September 29, 2024) is properly referenced. (2) Quantitative accuracy is perfect: $34.5M + $69.1M = $103.6M, and the formatting variations (e.g., $3 billion vs $3.0 billion) are acceptable. (3) The reasoning is sound: the LLM correctly explains that the 2021 Revolving Credit Agreement supports the commercial paper (CP) program by backstopping outstanding CP with available commitments under the $3 billion revolving facility. It accurately notes the $3 billion CP issuance limit and the backstop mechanism. However, it omits specific mention of the permitted uses of CP proceeds (working capital, capital expenditures, business expansion, dividends, share repurchases), which is part of the original answer and relevant to the question’s second part. This is a minor omission, not a factual error. (4) The answer is contextually fully relevant, addresses both sub-questions, and synthesizes information correctly across facilities and agreements. The only reason for not scoring 10 is the slight incompleteness regarding the use of proceeds from the CP program, which was explicitly asked in the question. Thus, correctness is 9 due to high accuracy with a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 411,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle’s emphasis on Oracle Engineered Systems concentrates its hardware portfolio on higher‑margin, integrated infrastructure products, which lifts the share of revenue generated by its infrastructure‑technologies business (Engineered Systems are a core component of the hardware‑derived infrastructure‑technologies offering)【page_10】. At the same time, because these systems rely on complex, often single‑source components and outsourced manufacturing, the focus heightens Oracle’s exposure to supply‑chain disruptions, component shortages and cost pressures that can erode margins and affect overall infrastructure‑technologies revenue【page_23】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Oracle's focus on Oracle Engineered Systems boosts infrastructure technologies revenue and increases supply chain risks, which aligns with the ground truth. It accurately notes the systems are part of the hardware business and contribute to higher-margin offerings. However, it omits key quantitative and contextual details from the original answer, such as the specific revenue breakdown (infrastructure cloud services and license support made up 58% of total cloud services and license support revenues in fiscal 2022), and specific examples like the Oracle Exadata Database Machine. (2) There are no numerical inaccuracies because the LLM answer does not include specific numbers, percentages, or dates—thus, no quantitative errors, but also no verification of critical metrics. This absence prevents a higher score despite no direct mistakes. (3) The multi-hop reasoning is partially sound: it connects Engineered Systems to revenue impact and supply chain exposure, but fails to incorporate evidence of actual disruptions (e.g., manufacturing delays in fiscal 2022 due to the pandemic) or downstream financial impacts (increased inventory purchases, obsolescence risk, negative effect on operating cash flows). These omissions weaken the completeness of the synthesis. (4) The answer is contextually relevant and well-structured, using accurate terminology and logical flow. The qualitative accuracy is reduced due to missing concrete evidence and examples that are central to the original answer’s depth. While semantically aligned in direction, it lacks the full factual richness and multi-hop support required for a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 461,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "Universal Beijing Resort’s debt slipped from $3.5 billion in 2023 to $3.4 billion in 2024 – a $0.1 billion decline.  That reduction helped shrink the overall “Debt Not Guaranteed” pool from $5.0 billion to $4.8 billion, a $0.2 billion drop【page_53】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in Universal Beijing Resort's debt from $3.5 billion in 2023 to $3.4 billion in 2024, a $0.1 billion decrease, which matches the ground truth. It also correctly states that this contributed to the 'Debt Not Guaranteed' category decreasing from $5.0 billion to $4.8 billion, a $0.2 billion drop. However, the LLM omits the additional detail from the original answer that the overall decrease in 'Debt Not Guaranteed' was also due to a reduction in 'Other' debt from $1.5 billion to $1.4 billion. This missing context slightly weakens the completeness and qualitative accuracy. (2) All numeric values and calculations are accurate: $3.5B to $3.4B is indeed a $0.1B decline, and $5.0B to $4.8B is a $0.2B drop. (3) The multi-hop reasoning is mostly sound—the model correctly links Universal Beijing Resort's debt reduction to the broader category change—but fails to fully synthesize the second contributing factor ('Other' debt), which is required for full completeness. (4) The answer is contextually relevant and conveys the core facts accurately, but the omission of the 'Other' debt component prevents a perfect score. Thus, correctness is rated 8/10, with high marks for quantitative and contextual accuracy, and slightly lower for qualitative due to incomplete synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 371,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell measures progress on long‑term contracts with the cost‑to‑cost input method—comparing costs incurred to the total estimated cost of completion (see page 46). Because the total contract cost must be forecast using many subjective inputs (inflation, technical and schedule risk, subcontractor performance, etc.), auditors must devote extensive judgment: they test the effectiveness of internal controls over cost‑estimation, evaluate the reasonableness and consistency of management’s assumptions, and perform analytical procedures, detailed contract testing and profiling of loss‑or‑margin‑sensitive contracts to verify that revenue is recognized correctly over time (see page 118).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Honeywell uses the cost-to-cost input method for long-term contracts, which relies on estimating total contract costs and recognizing revenue based on costs incurred to date versus total estimated costs. The factors affecting cost estimation—such as inflation, technical and schedule risk, and subcontractor performance—are correctly identified. The audit procedures mentioned (testing internal controls, evaluating assumptions, analytical procedures, contract testing, and profiling margin-sensitive contracts) align with the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; the response correctly avoids inventing any. (3) The multi-hop reasoning is sound: the model correctly links the use of the cost-to-cost method to the need for management estimates, which in turn increases audit complexity due to subjectivity, requiring auditors to perform enhanced procedures. The synthesis across concepts (revenue recognition, estimation uncertainty, audit response) is logically coherent. (4) Minor deduction in qualitative accuracy due to slightly less emphasis on the potential for material adjustments from changes in estimates over time—a key point in the original about why this creates ongoing audit complexity. However, this is implied in the reference to testing consistency and reasonableness. Wording differs but semantic equivalence is strong. Contextual relevance is perfect—the answer directly addresses how the cost-to-cost method impacts audit complexity, focusing on estimation challenges and auditor procedures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 473,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The 2023 results show a $1,729 million non‑qualifying hedge gain in NEER’s net income versus roughly $300 million of such gains in FPL’s net income – a magnitude gap of about $1.429 billion. This gap reflects the distinct accounting treatment: NEER’s non‑qualifying hedges are marked‑to‑market and recognized directly in earnings, while FPL defers virtually all changes in the fair value of its energy‑derivative contracts as regulatory assets or liabilities (recorded through the fuel‑clause) and therefore only a small portion appears in net income (page 37).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEER's $1,729 million and FPL's $300 million non-qualifying hedge gains in 2023, and calculates the difference as $1.429 billion (equivalent to $1,429 million), which matches the ground truth. Minor formatting variation ($1.429 billion vs $1,429 million) is semantically equivalent and acceptable. (2) Quantitative accuracy is perfect: both input values are correct, and the difference is accurately computed. (3) The reasoning correctly captures the multi-hop synthesis: it contrasts NEER’s market-based accounting (mark-to-market gains directly impacting net income) with FPL’s regulated model (deferral of most derivative fair value changes as regulatory assets/liabilities), citing the fuel clause and referencing page 37 of the 10-K for support. This aligns precisely with the disclosed treatment in the original answer. (4) The answer is fully contextually relevant, addressing both the quantitative difference and the underlying accounting rationale as required by the question. All entities (NEER, FPL, 2023, non-qualifying hedges, net income) are accurately identified and correctly related. No factual or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 343,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast’s 30 % ownership of Universal Beijing Resort causes the resort’s balance‑sheet items to be fully consolidated – the December 31 2024 consolidated statements therefore include about **$7.3 billion of assets** and **$7.0 billion of liabilities** that belong to the resort (primarily property‑and‑equipment, operating‑lease assets and the resort’s debt)【page_86】. Because Comcast’s exposure is limited to its 30 % equity interest, its **maximum risk of financial loss equals 30 % of the resort’s debt**, which is roughly $1.0 billion of the $3.4 billion debt outstanding (i.e., 30 % of the total debt financing)【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Comcast owns 30% of Universal Beijing Resort, consolidates it due to VIE status (implied by consolidation), and as of December 31, 2024, the resort contributes $7.3 billion in assets and $7.0 billion in liabilities to Comcast’s consolidated balance sheet. The total debt is correctly stated as $3.4 billion, and Comcast’s maximum risk of loss is tied to its 30% equity interest. (2) Quantitatively, the numbers match exactly: $7.3B assets, $7.0B liabilities, $3.4B debt. The calculation of 30% of $3.4B = $1.02B is accurate, and the LLM rounds this to '$1.0 billion', which is acceptable for reporting purposes and does not constitute a material error. (3) The reasoning is sound: the LLM correctly explains that despite only a 30% ownership stake, full consolidation occurs, and exposure is limited to equity interest—this reflects proper understanding of VIE consolidation and risk limitation. The multi-hop logic—connecting ownership percentage, consolidation accounting, VIE rules, and risk exposure—is well executed. (4) The only minor shortcoming is that the LLM does not explicitly state *why* Comcast consolidates the entity (i.e., identifying it as a VIE and having power over major activities), though the implication is present through the consolidation treatment. This slight omission in qualitative detail prevents a perfect 10, but the core answer remains factually and logically robust. Overall, the answer is contextually relevant, complete, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 438,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The 2020 goodwill impairment for the OpenTable reporting unit totaled $489 million (interim) + $573 million (annual) = about **$1.06 billion**. In 2021, OpenTable’s revenue was only a component of Booking Holdings’ “advertising and other” segment – a modest share of that segment’s total – and therefore **the $1.06 billion impairment far exceeds OpenTable’s 2021 revenue contribution**.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2020 goodwill impairment charges for OpenTable as $489 million (interim) + $573 million (annual) = $1.062 billion, which matches the ground truth ($1,062 million). This is quantitatively accurate with acceptable rounding to $1.06 billion. (2) However, the key error lies in the qualitative assessment of OpenTable’s 2021 revenue contribution. The LLM claims that OpenTable’s revenue was 'a modest share' of the 'advertising and other' segment and concludes that the impairment 'far exceeds' OpenTable’s 2021 revenue. This contradicts the ground truth, which states that the 'advertising and other' segment totaled $1.1 billion in 2021 and that this amount represented OpenTable’s full revenue contribution. Therefore, the impairment ($1.062B) was nearly equivalent to, not far exceeding, OpenTable’s 2021 revenue. (3) The multi-hop reasoning fails in synthesis: while the model correctly retrieves the impairment charge, it incorrectly infers the proportionality of OpenTable’s contribution within the segment, despite the ground truth explicitly stating that the $1.1B was OpenTable’s contribution. This mischaracterization leads to an incorrect conclusion. (4) Quantitative accuracy is high due to correct numbers and calculation. Correctness and qualitative accuracy are low because the core comparison — the relationship between impairment and revenue — is factually wrong. Contextual relevance is moderate as the answer addresses the right entities and question structure but draws an incorrect inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 428,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil’s recoverability tests use the cash‑flow assumptions from its Corporate Plan, which explicitly include projected greenhouse‑gas emission costs (including any emission‑price assumptions) in the development‑ and operating‑cost inputs. The plan also factors in the estimated expenses needed to meet its 2030 emission‑reduction target – a net‑zero Scope 1 and 2 greenhouse‑gas emissions goal for its unconventional operated assets in the Permian Basin.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that ExxonMobil incorporates projected greenhouse gas emission costs into its Corporate Plan's cash-flow assumptions for recoverability assessments of asset groups, including in jurisdictions without current carbon pricing—this matches the original answer's claim. (2) The specific future emission-reduction goal is accurately identified: achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin by 2030. The year '2030' and the scope (Scope 1 and 2), asset type (unconventional operated), and location (Permian Basin) are all correct. (3) The multi-hop reasoning is sound—linking emission cost assumptions in financial planning to asset recoverability tests and tying them to a specific corporate emissions target demonstrates proper synthesis across environmental and financial domains. (4) Wording differs slightly (e.g., 'projected greenhouse-gas emission costs' vs 'estimated greenhouse gas emission costs'), but the meaning is preserved. No factual, numerical, or conceptual errors are present. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 340,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "Capital One still has **$1.2 billion** of the $2.4 billion CECL‑related regulatory‑capital add‑back to be phased in after December 31 2023 (the remaining $600 million will be added in each of 2024 and 2025)【page_80】. For the stress‑test period October 1 2023 – September 30 2024, the company’s minimum‑capital‑requirement‑plus‑capital‑conservation‑buffer targets are **9.3 % CET1, 10.8 % Tier 1 and 12.8 % total capital**【page_80】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that $1.2 billion of Capital One's $2.4 billion CECL-related regulatory capital addition remains to be phased in after December 31, 2023, and that $600 million will be added in each of 2024 and 2025 — this part is factually accurate and matches the ground truth. However, the LLM incorrectly states the capital conservation buffer requirements as 9.3% CET1, 10.8% Tier 1, and 12.8% total capital for the period October 1, 2023 – September 30, 2024. The original answer clarifies that the capital conservation buffer is 2.5% across CET1, Tier 1, and total capital, and that the 4.8% stress capital buffer is separate. The LLM appears to conflate the stress capital buffer with the capital conservation buffer, leading to incorrect composite percentages. These percentages (e.g., 9.3%) likely represent the sum of minimum requirements + stress capital buffer + conservation buffer, but the question specifically asks about conservation buffer requirements, which are 2.5%, not 9.3%. (2) Quantitative accuracy is partially correct: the $1.2 billion and $600 million figures are accurate, but the percentages are misattributed and do not reflect the actual conservation buffer. (3) Multi-hop reasoning is partially sound — the model correctly retrieves the phase-in schedule but fails to distinguish between different regulatory buffer frameworks (conservation vs. stress capital buffer), indicating a misunderstanding of regulatory capital structure. (4) Contextual relevance is high as the answer addresses both parts of the question and cites relevant data points, but the misinterpretation of buffer requirements significantly undermines factual correctness. Thus, the correctness score is 6 due to core factual error in a key component of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 487,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "MDLZ’s U.S. dollar notes and term loans fell from **$11,275 million** at the end of 2022 to **$9,562 million** at the end of 2023 – a **decrease of $1,713 million**. By contrast, its Euro notes rose from **$7,666 million** to **$7,916 million**, a **gain of $250 million**, so the drop in U.S. dollar debt was roughly **$1.96 billion larger** than the change in Euro notes【page_92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key financial figures: U.S. dollar notes and term loans decreased from $11,275 million to $9,562 million, resulting in a $1,713 million decrease. Euro notes increased from $7,666 million to $7,916 million, a $250 million increase. These values match the ground truth exactly. (2) All calculations are accurate: the difference of $1,713 million and $250 million are correct, and the comparison stating the drop in U.S. dollar debt was roughly $1.96 billion larger ($1,713M - $250M = $1,463M; the LLM says $1.96B which is incorrect) contains a minor error. $1,713M reduction minus $250M increase = $1,463M net difference, not $1.96B. The LLM incorrectly calculated the size of the reduction relative to the Euro change. (3) The multi-hop reasoning is mostly sound—correctly pulling data from two different debt categories across two years and comparing trends. However, the final comparative statement contains a miscalculation, which affects the qualitative accuracy slightly. (4) Despite this, the core facts, numbers, and direction of change are all correct, and the answer addresses both parts of the question. The error is in the magnitude of the comparative claim, not in the primary data. Hence, correctness is high but not perfect due to the arithmetic misstatement in the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 373,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The Resideo subsidiary’s indemnification obligation is capped at **$140 million per year**.  Under the agreement the subsidiary must pay Honeywell an amount equal to **90 % of Honeywell’s annual net spending on environmental matters at the specified sites**, but the payment cannot exceed the $140 million cap.【page_97】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states the $140 million annual cap, which matches the ground truth. (2) It correctly identifies that the payment is 90% of Honeywell’s annual net spending on environmental matters at specified sites, aligning with the original answer. (3) The multi-hop reasoning is sound: the answer synthesizes the relationship between the cap and the percentage of spending, correctly framing the $140 million as a maximum on a variable payment tied to 90% of costs. (4) All entities (Resideo subsidiary, Honeywell, environmental spending) and financial terms are accurate. Minor wording differences (e.g., 'capped at' vs 'maximum obligation') do not affect factual equivalence. The citation to page_97 adds contextual support. No errors in numbers, logic, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 251,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "Between Dec 31 2022 and Dec 31 2023, the fair‑value of Non‑Qualifying Hedges rose by about $2.178 billion, which primarily bolstered the NEER (non‑regulated) segment’s financial position. During the same period, the fair‑value of hedges in FPL Cost‑Recovery Clauses increased by roughly $5 million, giving the FPL (regulated) segment a modest uplift, together adding approximately $2.183 billion to NEE’s overall financial position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude. The ground truth states that the financial position for FPL and NEER segments related to Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased by $1 million (FPL) and $34 million (NEER), totaling a $35 million decline. Instead, the LLM claims a massive increase of $2.183 billion, with $2.178 billion from NEER and $5 million from FPL—this is the opposite of the actual trend. (2) Quantitative accuracy is extremely low: the reported values ($2.178B, $5M, $2.183B) are orders of magnitude off and not supported by the ground truth. The correct values are $3M to $2M for FPL (a $1M decrease) and $148M to $114M for NEER (a $34M decrease). No part of the numerical analysis aligns with the truth. (3) The multi-hop reasoning is completely flawed. The model fails to correctly identify the change direction (increase vs decrease), misidentifies the magnitude by billions of dollars, and incorrectly attributes gains rather than losses. It does not synthesize the correct data points across entities (FPL, NEER) or time (2022 to 2023). (4) Contextual relevance is low but not zero—the answer addresses the right segments (FPL and NEER) and the correct time frame (Dec 2022 to Dec 2023), and references the correct types of hedges, so some topical alignment exists. However, the factual and quantitative errors render the response highly misleading. Correctness and accuracy scores are near minimum due to complete inversion of results and grossly inaccurate figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 431,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "Universal Beijing Resort’s net assets fell from $7.8 billion of assets less $7.2 billion of liabilities ($0.6 billion) in 2023 to $7.3 billion of assets less $7.0 billion of liabilities ($0.3 billion) in 2024 – a decline of roughly $0.3 billion (≈$300 million)【page_86】.  Its debt obligations slipped from $3.5 billion at year‑end 2023 to $3.4 billion at year‑end 2024 – a reduction of about $0.1 billion (≈$100 million)【page_86】【page_53】.  Thus the drop in net assets (~$300 million) was three times larger than the decrease in debt (~$100 million).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures, particularly in the calculation of net assets and debt obligations. According to the ground truth, net assets decreased from $0.6 billion in 2023 to -$0.3 billion in 2024, which is a decrease of $0.9 billion, not $0.3 billion as stated by the LLM. The LLM incorrectly calculates the 2024 net assets as $0.3 billion instead of -$0.3 billion (i.e., liabilities exceeding assets), leading to a fundamentally wrong conclusion about the magnitude and direction of change. Additionally, the LLM claims debt obligations decreased from $3.5 billion to $3.4 billion, but the ground truth states total liabilities were $7.2 billion in 2023 and $7.0 billion in 2024 — a $0.2 billion reduction, not $0.1 billion from a base of $3.5 billion. These are major quantitative inaccuracies. (2) Calculations are flawed: the LLM computes a $0.3 billion decline in net assets based on $0.6B → $0.3B, but the correct change is $0.6B → -$0.3B = $0.9B decrease. Debt reduction is reported as $0.1B, but actual reduction is $0.2B; the LLM also uses incorrect base liability figures. (3) Multi-hop reasoning is partially sound — the model attempts to compute net assets from assets and liabilities and compares changes — but it relies on incorrect underlying data, undermining the logic. It also introduces unverified figures (e.g., $3.5B debt) not present in the ground truth, suggesting hallucination or misattribution. (4) Despite these serious errors, the answer is contextually relevant and structured appropriately, addressing both parts of the question and attempting comparative analysis. However, due to major factual and computational inaccuracies affecting the core conclusions, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 485,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "According to the 2023 10‑K, EDURANT (rilpivirine) was newly indicated for **pediatric patients aged 2‑12 years with HIV**. The company pursued regulatory filings for this indication in both the **United States and the European Union**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the new patient population as 'pediatric patients aged 2-12 years with HIV', matching the original answer exactly in both age range and condition. (2) The regulatory regions—United States and European Union (EU)—are correctly stated, with 'European Union' being a valid equivalent to 'EU'. (3) The reasoning is sound and reflects proper synthesis from JNJ's 2023 10-K filing, correctly linking the expanded indication to the targeted regulatory filings. (4) All entities (EDURANT, rilpivirine, JNJ, 2023 10-K, US, EU) are accurate, and the answer addresses both parts of the multi-hop question: the new patient population and the regulatory regions for filing. No factual, quantitative, or qualitative errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 244,
        "total_tokens": 1373
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com’s move to process an increasing share of reservations on a merchant‑basis means it now incurs higher payment‑processing, fraud‑detection and personnel costs, which “negatively impacts our operating margins despite increases in incremental revenues” (see p. 36). At the same time, ongoing regulatory probes—such as the Swiss Price Surveillance Office investigation into Booking.com’s commission levels and EU competition/Digital Markets Act inquiries—could force commission reductions, fines or new compliance requirements that further compress margins and push the company to focus its strategy on the integrated “Connected Trip” payment platform while absorbing additional compliance costs (see p. 34 and p. 50). Together, the merchant‑model cost pressures and the potential regulatory penalties/requirements are weighing on operating margins and shaping a strategy that balances growth‑driven payment expansion with heightened regulatory compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: the merchant-based model increases costs (payment processing, fraud detection, personnel), negatively impacting operating margins despite incremental revenues like credit card rebates. Regulatory investigations in Switzerland (Swiss Price Surveillance Office) and the EU (Digital Markets Act) are correctly identified, with accurate implications: potential commission reductions, compliance costs, and constraints on competitive practices like parity clauses. The strategic pivot toward the 'Connected Trip' platform is properly noted. (2) There are no numeric values in the question or answer requiring verification; thus, quantitative accuracy is perfect by default. (3) Multi-hop reasoning is sound—correctly linking Booking.com’s transaction model (financial impact) with regulatory pressures (strategic impact) to infer combined effects on margins and business strategy. The only minor shortcoming is that the LLM does not explicitly mention 'gatekeeper' classification or restrictions on data usage and service bundling under the DMA, though 'compliance requirements' and 'reduced competitive flexibility' are implied. (4) Contextual relevance is excellent—the response directly addresses both parts of the multi-faceted question: impact on operating margins and influence on business strategy in 2022. Overall, this is a precise, well-synthesized answer with only slight omission of specific regulatory restrictions, not affecting core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 430,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The Oil and Gas Act allows a petroleum retention licence in Papua New Guinea to run for an initial five‑year term and, at the Minister’s discretion, be extended twice – with total extensions limited to ten years – giving a maximum overall duration of 15 years【page_34】.  ExxonMobil’s 2022 10‑K lists PNG as one of its “most notable” LNG developments【page_59】, so the 15‑year retention window provides a defined horizon for securing gas rights and planning a LNG project, encouraging the company to bring the resource to commercial viability within that period and shaping its long‑term LNG investment and risk‑management strategy in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the initial 5-year term, up to 10 years in extensions (two at the Minister’s discretion), and a maximum total duration of 15 years are accurately reported. The format variations (e.g., 'ten years' vs '10 years') are acceptable and semantically equivalent. (2) The answer correctly cites ExxonMobil’s 2022 10-K and references PNG as a 'notable' LNG development (page 59), which supports the strategic relevance. (3) The multi-hop reasoning is sound: it connects the 15-year license framework to ExxonMobil’s long-term LNG strategy by explaining how the retention period allows time to achieve commercial viability, which matches the ground truth’s logic about developing non-viable resources over time. (4) The only minor shortcoming is that the LLM does not explicitly mention 'selective development of attractive natural gas resources'—a key phrase from the original answer—though the idea is implicitly conveyed through 'planning a LNG project' and 'bringing the resource to commercial viability.' This slight omission in nuance prevents a perfect 10 but does not detract from overall correctness. All entities (Papua New Guinea, ExxonMobil, 2022 10-K, petroleum retention license) are accurate and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 371,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "Coca‑Cola’s Level 2 holdings of mutual, pooled and commingled funds rose from **$202 million** at year‑end 2022 to **$257 million** at year‑end 2023 – an increase of **$55 million**【page_115】. In the same period, its hedge‑fund/limited‑partnership investments grew from **$936 million** to **$1,057 million**, a **$121 million** increase, which is roughly double the gain seen in the Level 2 mutual‑fund category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in terms of factual content. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds under Level 2 assets decreased from $83 million in 2022 to $37 million in 2023 (a $46 million decrease), whereas the LLM claims an increase from $202 million to $257 million ($55 million increase). Similarly, for Hedge funds/limited partnerships, the ground truth shows a minor increase from $14 million to $18 million ($4 million), but the LLM reports a massive increase from $936 million to $1,057 million ($121 million). These numbers are entirely inconsistent with the original data. (2) All calculations are wrong because they are based on incorrect input values. The LLM's reported changes ($55M and $121M) and starting/ending values do not match the ground truth. Even allowing for format variations, the magnitudes are off by orders of magnitude. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the relevant asset categories and their values across years, and thus cannot accurately compare the shifts between Level 2 pooled funds and hedge fund investments. Instead, it fabricates large increases in both categories, leading to a false conclusion about reallocation patterns. (4) The contextual relevance is low but not zero because the answer addresses the right types of assets and time frame (2022–2023), and attempts a comparison between two investment categories. However, due to total factual inaccuracy in numbers, entities, and direction of change, the qualitative and quantitative accuracy scores are near zero. The correctness score is 1 because the structure of the response matches the question format, but no substantive information is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 481,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The regulatory disallowances at Nicor Gas reduced Southern Company Gas’s 2023 net income by $29 million at the gas‑distribution segment and produced a further $24 million earnings offset, for a combined negative effect of about $53 million on net income【page_86†L1-L4】【page_86†L5-L7】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $29 million reduction in net income at gas distribution operations, an additional $24 million earnings adjustment (referred to as an 'earnings offset'), and a total impact of $53 million. The sum ($29M + $24M = $53M) is correct. (2) The answer is complete, addressing both components of the financial impact as required by the question: the reduction at gas distribution operations and the additional earnings adjustment. (3) Entity accuracy is correct—Nicor Gas, Southern Company Gas, and the year 2023 are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly combines two separate financial impacts from the same regulatory event into a total effect on net income. The use of 'about $53 million' is acceptable as it reflects rounding and does not detract from factual accuracy. Semantic equivalence is maintained, and the citations (page_86†L1-L4, page_86†L5-L7) support the claims. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 314,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T said that, besides WarnerMedia, the discontinued‑operations group also includes its Vrio satellite TV business, the Xandr advertising‑technology platform and the gaming‑studio Playdemic (see Note 24 – “Discontinued Operations” pages 23 and 97).  Classifying these units as discontinued operations signals AT&T’s strategic shift to shed non‑core media and entertainment assets and to present only its core communications businesses in the continuing‑operations results, underscoring the broader restructuring and refocusing of the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all businesses classified as discontinued operations by AT&T in addition to WarnerMedia: Vrio, Xandr, and Playdemic—matching the ground truth exactly. There are no numeric values (e.g., dollar amounts, dates) in the question or original answer, so quantitative accuracy is not applicable in a numerical sense, but the LLM accurately references 'Note 24 – Discontinued Operations' and page numbers (23 and 97), which aligns with typical SEC filing disclosures and adds contextual precision. The explanation of the significance—AT&T’s strategic shift to divest non-core media and entertainment assets and refocus on its core communications business—is semantically equivalent to the original answer. The only minor shortcoming is that the LLM does not explicitly mention the key conceptual point that these divestitures were treated as a *single strategic shift* despite some units not meeting materiality thresholds individually—a nuance present in the ground truth that strengthens the reasoning behind the accounting classification. However, the LLM captures the broader intent and effect of the classification. Multi-hop reasoning is sound: it synthesizes the list of businesses and interprets the accounting significance correctly. The answer is fully contextually relevant and conveys the same factual and conceptual content as the original, with only slight omission of technical accounting rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 397,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair‑value of the Level 3 auction‑rate securities was unchanged – it was $33 million at both April 30 2021 and April 29 2022 (no change). During the same period the fair value of all available‑for‑sale debt securities fell from $7,257 million to $6,893 million, a decline of about $364 million.【page_70】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022, which matches the ground truth. It also accurately reports the decline in total available-for-sale debt securities from $7,257 million to $6,893 million, calculating the $364 million decrease correctly. (2) All numeric values—$33 million (auction rate securities), $7,257 million, $6,893 million, and the $364 million difference—are factually correct and consistent with the original answer. Number formats are acceptable variations (e.g., $33 million vs $33M). (3) The multi-hop reasoning is sound: the model correctly identifies that while auction rate securities did not change, the broader category of available-for-sale debt securities declined, implying other components drove the drop. However, the LLM omits the qualitative interpretation present in the original answer—that other components experienced 'significant unrealized losses'—which slightly weakens the completeness of the reasoning synthesis. (4) Despite this minor omission, the answer is factually accurate, contextually relevant, and quantitatively precise, warranting a high correctness score of 9. The qualitative accuracy is 9 due to the missing explanatory insight, but all other dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 381,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The $489 million goodwill impairment recorded in the March 31, 2020 interim test reduced the OpenTable‑KAYAK goodwill to an adjusted $1.5 billion, and a second $573 million impairment recognized in the September 30, 2020 annual test further lowered the adjusted carrying value to $1.0 billion as of that date. Together, the two 2020 impairment charges total roughly $1.06 billion. (Source: 2020 Interim and Annual Goodwill Impairment Test discussion, page 55)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both goodwill impairment charges ($489 million in March 2020 and $573 million in September 2020), the final adjusted carrying value of $1.0 billion as of September 30, 2020, and the total cumulative impairment of $1,062 million (rounded to $1.06 billion, which is acceptable). All key facts from the ground truth are present and accurate. (2) Quantitative verification: $489M + $573M = $1,062M, which matches the ground truth total. The adjusted carrying value is correctly stated as $1.0 billion after both impairments. The LLM also correctly references the March 31 and September 30, 2020 tests, aligning with the timing in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the two impairment events, applies them sequentially to reduce the carrying value, and computes the cumulative impact. The only minor limitation is that the initial carrying value before impairments is not explicitly stated, and the intermediate $1.5 billion figure is introduced without being in the original answer—though it is logically consistent ($1.0B + $573M = $1.573B ≈ $1.5B, likely rounded). This does not contradict the ground truth but adds a minor inference. (4) Scores are high because all critical financial data and reasoning are correct; the answer is fully relevant and semantically equivalent to the original, with only slight rounding and formatting differences that do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 408,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Regulatory disallowances at Nicor Gas generated an $88 million pre‑tax loss (shown as “estimated loss on regulatory disallowance”) that reduced Southern Company Gas’s net income by roughly $29 million in 2023. Those disallowances also helped drive the $1.3 billion (≈21 %) decline in the segment’s operating revenues for the year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the $29 million decrease in net income due to Nicor Gas's regulatory disallowances in 2023, which matches the ground truth. This is the key quantitative point and is accurate. However, the LLM introduces an $88 million pre-tax loss figure not present in the original answer, which, while potentially factual, is not supported by the provided ground truth and adds unverified detail. Additionally, the claim that the disallowances contributed to a $1.3 billion (≈21%) decline in operating revenues is a significant overreach: the original answer only states that disallowances 'reduced revenues' in conjunction with lower volumes sold, but does not quantify the revenue impact or attribute a specific dollar amount or percentage decline to them. This introduces a precise figure unsupported by the ground truth, undermining quantitative accuracy. The reasoning correctly links Nicor's disallowances to Southern Company Gas's financial performance (multi-hop synthesis across entities), and the overall structure addresses both net income and revenue impacts as required. The entities (Nicor Gas, Southern Company Gas, 2023) and financial metrics (net income, revenue) are correctly identified. While the qualitative reasoning is sound and contextually relevant, the inclusion of unsupported quantitative claims reduces confidence in the numerical precision. Semantic equivalence is partially maintained, but the added specificity on revenue decline exceeds the original information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 415,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "The 2010 ESPP authorizes up to 90 million Class A ordinary shares, and by August 31 2022 the company had issued 73,808,772 shares under the plan【page_92】. Therefore, 90,000,000 – 73,808,772 = **16,191,228 shares** remained available, which is roughly **18 %** of the plan’s total authorized shares (16,191,228 ÷ 90,000,000 ≈ 0.1799 ≈ 18 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified that 16,191,228 shares remained available for issuance under the 2010 ESPP as of August 31, 2022, matching the ground truth exactly. The calculation (90,000,000 - 73,808,772 = 16,191,228) is accurate and properly sourced. (2) The percentage is reported as 'roughly 18%' and the exact calculation (16,191,228 ÷ 90,000,000 ≈ 0.1799 ≈ 18%) is correct and aligns with the ground truth value of 17.99%. The rounding to '18%' is a minor simplification but semantically acceptable and common in reporting. (3) The multi-hop reasoning is sound: the model correctly inferred the remaining shares by subtracting issued shares from authorized shares, then computed the percentage — a valid synthesis across numerical data. (4) All entities (Accenture plc, 2010 ESPP, Class A ordinary shares, correct date) are accurate. The only reason for not scoring a 10 is the slight rounding of 17.99% to 'roughly 18%', which, while reasonable, omits the precision in the original answer. Otherwise, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 313,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T says its December 2023 agreement with Ericsson to launch commercial‑scale Open RAN will increase short‑term spending – the 2024 outlook calls out “deployment of Open RAN, and associated accelerated depreciation” as a key driver of expense trends for the year. The Open RAN rollout is meant to create a more open, multi‑vendor ecosystem that lowers network‑related costs and improves capital efficiency, so while 2024 expenses rise, the initiative is expected to deliver lower operating costs and greater operational efficiency over the longer term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment is correctly tied to increased 2024 expenses due to deployment costs and accelerated depreciation. The longer-term benefits of lower network-related costs, improved capital efficiency, and operational efficiencies through a multi-vendor ecosystem are accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the mention of 'December 2023 agreement' is consistent with the 2023 10-K context. (3) Multi-hop reasoning is sound: the model correctly synthesizes that short-term expense pressure (2024) stems from Open RAN deployment and depreciation, while linking this initiative to long-term efficiency goals via software-defined 5G benefits and supplier ecosystem diversification. (4) Semantic equivalence is strong—though the LLM uses slightly different phrasing (e.g., 'more open, multi-vendor ecosystem' instead of 'robust ecosystem of network infrastructure providers'), the meaning is preserved. One minor point preventing a perfect 10 is the absence of explicit mention of 'software benefits of 5G wireless technology' as a mechanism enabling efficiency, which is present in the original and adds technical specificity. However, this does not detract significantly from overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 411,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The excerpts you provided do not include a table of oil‑and‑gas reserves, and they contain no figures for “proved developed bitumen reserves” or for the “discounted future net cash flows” for the Canada/Other Americas region. Consequently, those specific numbers cannot be determined from the pages shown.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The original answer (ground truth) provides specific, quantifiable data: 2,635 million barrels of proved developed bitumen reserves and $28,710 million in discounted future net cash flows for XOM's consolidated subsidiaries in Canada/Other Americas as of December 31, 2021. The LLM falsely claims that no such data is available in the provided excerpts, which contradicts the premise of the task—evaluating an answer against known ground truth from SEC filings. There is no attempt to report the correct numbers or perform any synthesis, despite the information being available in the knowledge base. The response fails on all dimensions: it omits all quantitative facts, misrepresents data availability, and provides no multi-hop reasoning. It is not contextually relevant because it denies the existence of information that is, by task design, present. Hence, the correctness score is 0.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 276,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022‑02 (effective Jan 1 2023) produced a cumulative accounting effect that reduced Capital One’s allowance for credit losses by roughly $63 million at the start of 2023 (Table 27), even as the total allowance grew to $15.3 billion by Dec 31 2023. The update also eliminated the troubled‑debt‑restructuring (TDR) guidance, so loan modifications for borrowers in financial difficulty are now reported as “Financial‑Difficulty Modifications” (FDMs) with new disclosure requirements and are fully incorporated into the allowance‑for‑credit‑losses estimation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative claim about the impact on the allowance for credit losses. The ground truth states that the adoption of ASU No. 2022-02 led to a $2.1 billion *increase* in the allowance, bringing it to $15.3 billion. However, the LLM claims a $63 million *reduction* at the start of 2023, which directly contradicts the ground truth. While the final allowance amount of $15.3 billion is correct, the explanation of the change is incorrect. (2) The date of adoption (effective January 1, 2023) is plausible and consistent with ASU implementation timelines, but the $63 million reduction is not supported by the ground truth and appears to misinterpret or misrepresent the data (possibly confusing it with a different adjustment or table). (3) On qualitative aspects, the LLM correctly identifies that ASU No. 2022-02 eliminated TDR classification and introduced new reporting for loan modifications, now referred to as Financial-Difficulty Modifications (FDMs), which aligns with the updated disclosure framework. This shows accurate multi-hop reasoning regarding the change in reporting practices. (4) Contextually, the answer is highly relevant and addresses both parts of the question—impact on allowance and changes in loan modification reporting. However, the major error in the direction and magnitude of the allowance adjustment severely undermines factual correctness. The final allowance figure is correct, but the path to it is wrong. Thus, while the qualitative and contextual elements are mostly sound, the quantitative inaccuracy results in a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 452,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "GE’s 2023 filing warns that the Bank BPH mortgage‑portfolio litigation in Poland could generate additional contingent liabilities that may have to be recognized as payable. Those future outflows “could materially and adversely affect GE’s business, financial position, cash flows, results of operations or capacity to provide financing,” and the run‑off insurance and banking operations—including Bank BPH—“could cause funding or liquidity stress,” meaning any increase in those liabilities would pressure GE’s overall liquidity position.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the risk posed by Bank BPH's litigation in Poland to GE's liquidity, aligning with the original answer's core message. It accurately reflects that potential contingent liabilities could adversely affect GE’s financial position, cash flows, and liquidity, particularly within the context of run-off operations. However, it omits all quantitative details present in the ground truth, including GE’s total cash of $17.0 billion, the $14.2 billion held outside the U.S., and the $1.7 billion in countries with currency controls. These figures are critical to assessing the actual liquidity constraints and were explicitly part of the original answer. (2) No numeric values are mentioned in the LLM response, so there are no incorrect numbers, but the absence of key financial data significantly reduces quantitative accuracy. The original answer hinges on these figures to substantiate the liquidity risk, which the LLM fails to include. (3) The multi-hop reasoning is partially sound: the model connects Bank BPH litigation → contingent liabilities → potential cash outflows → liquidity stress. This logical chain is valid and reflects synthesis across entities (GE, Bank BPH) and financial concepts. However, it does not incorporate the geographic and regulatory constraints on cash access, which are essential for a complete multi-hop analysis involving international liquidity. (4) The contextual relevance is high because the answer directly addresses the question’s focus on litigation impact on liquidity. Qualitative accuracy is strong due to correct entity identification (Bank BPH, GE, 2023 filing) and appropriate use of financial terminology. The correctness score is 7 because while the central claim is accurate and well-reasoned, the omission of key quantitative data from the 10-K limits completeness and precision, which are crucial in financial evaluations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 519,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "The 2022 10‑K shows that the Amended and Restated 2010 Share Incentive Plan had **14,830,623 shares** slated to be issued upon exercise of outstanding options and **27,381,461 shares** still available for future issuance, which together equal **42,212,084 shares** in total【page_49】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: 14,830,623 shares issued upon exercise of outstanding options, 27,381,461 shares available for future issuance, and a total of 42,212,084 shares — all match the original answer exactly. (2) The calculation (14,830,623 + 27,381,461 = 42,212,084) is correct and explicitly stated. (3) The multi-hop reasoning is sound — the model correctly synthesized two pieces of information from the same plan (shares issued upon exercise and shares available) and summed them to answer the total. (4) The entities are accurate: 'Amended and Restated 2010 Share Incentive Plan' and the 2022 10-K are correctly identified. The answer is semantically equivalent to the ground truth, with only minor wording differences (e.g., 'slated to be issued' vs 'issued upon exercise') that do not affect factual meaning. The citation to page 49 adds contextual support. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 285,
        "total_tokens": 1423
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "AT&T repaid the entire $2,500 million (≈ $2.5 billion) 2025 Term Loan in 2023 【page_71†L31-L38】, and the loan was formally paid off and terminated on March 30, 2023 【page_39†L7-L10】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the amount of the loan ($2,500 million, also expressed as ≈$2.5 billion) and the termination date (March 30, 2023) are accurate. Minor formatting variations in number presentation are acceptable and do not affect correctness. (2) Quantitative accuracy is perfect: the dollar amount and date are exactly as in the original answer, with no calculation errors. (3) The multi-hop reasoning is sound—information about repayment and termination is correctly synthesized, and the citations (page_71†L31-L38 and page_39†L7-L10) indicate proper grounding in the source documents. (4) The answer is contextually relevant, directly addressing both parts of the question (amount paid off and termination date) with precise, complete information. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1068,
        "completion_tokens": 255,
        "total_tokens": 1324
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "KO’s investment in mutual, pooled and commingled funds rose from $767 million at year‑end 2022 to $778 million at year‑end 2023 – an increase of $11 million. Of the 2023 total, $257 million was measured using Level 2 fair‑value inputs【page_115】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The ground truth states that KO's investment decreased by $47 million from 2022 to 2023, with a 2023 total of $39 million, of which $37 million was Level 2. The LLM claims an increase of $11 million (from $767M to $778M), and states $257 million of the 2023 investment was Level 2—both figures are wildly off. These are not formatting differences but fundamental factual errors. (2) Calculations: The LLM’s claimed increase of $11M is incorrect; the actual change was a $47M decrease. The Level 2 portion in 2023 was $37M (of $39M), not $257M. (3) Multi-hop reasoning: The model fails to correctly identify the values for mutual, pooled, and commingled funds for both years and misreports the Level 2 valuation amount. It appears to have pulled data from an unrelated context (possibly another company or asset class). (4) Entity and metric accuracy: While the company (KO) and metric category (mutual, pooled, commingled funds) are correctly targeted, the years (2022–2023) and all associated numbers are wrong. (5) Contextual relevance: The answer addresses the right type of investment and valuation levels, so it is thematically relevant, but factually baseless. Hence, very low scores for correctness, quantitative, and qualitative accuracy; minimal credit for attempting the right question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 378,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The pre‑tax charge for the ongoing borrower litigation in the year ended December 31 2023 was **$1.189 billion**. During the same period, GE paid **$203 million of net cash** to AerCap for its continuing involvement. (Source: GE 10‑K 2023, page 51).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the pre-tax charge of $1,189 million is correctly reported as $1.189 billion (equivalent value, acceptable format variation). The net cash payment of $203 million to AerCap is also exactly matched. (2) Quantitative accuracy is perfect: both figures are correct, with proper unit conversions and no calculation errors. $1.189 billion = $1,189 million is mathematically and contextually accurate. (3) The reasoning is sound and reflects proper multi-hop synthesis—linking GE’s litigation charge and its continuing involvement cash flow with AerCap in the same fiscal period (year ended December 31, 2023). (4) Entity accuracy is correct: GE and AerCap are properly identified, and the financial metrics (pre-tax charge, net cash paid) align with the original context. The answer is complete, addressing both parts of the question, and includes a relevant source citation. All criteria for correctness, precision, reasoning, and relevance are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 306,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture’s $1.1 billion annual R&D spend—backed by more than 8,300 patents and a network of labs, research, venture and innovation centers—creates proprietary tools, platforms and repeatable industry solutions that few rivals can match. By pairing that innovation engine with its “360° value” model, which ties financial outcomes to sustainability, reskilling, inclusion and holistic client experiences, Accenture can deliver a uniquely broad, end‑to‑end suite of services at scale, positioning it as a trusted, full‑service partner that out‑performs competitors that offer narrower or less integrated offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.1 billion R&D investment for fiscal 2022 is correct as per the original answer. However, the LLM introduces additional details—'8,300 patents' and 'network of labs, research, venture and innovation centers'—that are not present in the ground truth. While these may be factually correct, they are not verifiable from the provided knowledge graph and represent unconfirmed additions. (2) The core financial figure ($1.1 billion) is accurate and correctly attributed to R&D in the relevant fiscal year, satisfying the primary quantitative requirement. (3) Qualitatively, the LLM correctly captures the concept of 360° value, linking it to sustainability, reskilling, inclusion, and client outcomes, which matches the ground truth's definition. It also correctly frames Accenture’s competitive differentiation as stemming from the combination of R&D-driven innovation and broad, integrated service delivery. The reasoning correctly synthesizes the connection between R&D investment and competitive positioning, and the comparison to narrower competitors is logically sound and consistent with the original. (4) Contextually, the answer fully addresses the question about how R&D and 360° value contribute to competitive positioning, including the multi-hop element of comparing Accenture to competitors. The only minor deviation is the inclusion of unverified specifics (e.g., patent count), which do not contradict the ground truth but add unsupported detail. Overall, the semantic meaning, factual core, and logical structure are equivalent to the original answer, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 461,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T said that, besides WarnerMedia, the businesses it treated as discontinued operations were **Vrio, Xandr and Playdemic** (see page 23 & page 97). Because they are classified as discontinued, their revenues, expenses and net loss are shown in a separate “discontinued operations” section of the consolidated income statement (and detailed in Note 24) and are excluded from the MD&A discussion of continuing‑operations results (see page 22).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Entity accuracy: The LLM correctly identifies Vrio, Xandr, and Playdemic as the additional entities classified as discontinued operations alongside WarnerMedia in 2023. (2) Qualitative reasoning: The explanation of how the classification affects financial reporting is accurate — it correctly states that the financial results (revenues, expenses, net loss) are separated in the income statement under 'discontinued operations', excluded from continuing operations in MD&A, and detailed in Note 24. This aligns with the ground truth's description of separate reporting and exclusion from ongoing results. (3) Multi-hop synthesis: The answer integrates information about multiple entities and their financial treatment across time, demonstrating correct understanding of the accounting implications. (4) No numeric values are in dispute, so quantitative accuracy is not applicable in a problematic sense; the answer correctly avoids introducing incorrect figures. (5) Contextual relevance is high, as all information provided directly addresses the two parts of the question: which entities and how the classification affects financial presentation. Minor additions (e.g., page references, Note 24) enhance precision without introducing error. Semantic equivalence is maintained, and the LLM provides even more contextual detail (e.g., MD&A exclusion, note reference) than the original, without inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 408,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "Medtronic reported an unrealized loss of **$3 million** on its Auction‑rate securities as of April 29 2022. All of that loss is in the “more than 12‑month” maturity bucket (fair value $33 million); the company held no Auction‑rate securities with maturities of less than 12 months, so the loss is not allocated to that category【page_71】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total unrealized loss of $3 million is accurately reported, along with the correct date (April 29, 2022). The answer correctly states that the entire loss is attributed to securities with maturities of more than 12 months, and explicitly notes that no securities (and thus no loss) are held in the less than 12-month category. The additional detail about fair value ($33 million) is consistent with typical 10-K disclosures and does not contradict the ground truth. (2) The numbers are precise and correctly formatted; minor variations like 'million' vs 'M' are acceptable and do not affect accuracy. (3) The reasoning is sound: the answer correctly synthesizes that because no Auction Rate Securities are held with maturities under 12 months, the loss cannot be distributed to that bucket—this reflects proper multi-hop logic from holdings to unrealized loss allocation. (4) All entities—Medtronic (MDT), Auction Rate Securities, and the correct fiscal date—are accurately identified. The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 351,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "The May 2024 exchange offer resulted in Visa issuing about **120 million shares of Class B‑2 common stock** (the offer also issued roughly 48 million Class C shares)【page_40】. Those 120 million B‑2 shares represent **≈71 % of the total shares issued** (120 million ÷ (120 million + 48 million) ≈ 0.714, or 71 %) in the exchange.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that 120 million shares of Class B-2 common stock were issued in May 2024, and correctly identifies the total shares issued as 168 million (120 million Class B-2 + 48 million Class C). (2) The percentage calculation is correct: 120 / (120 + 48) = 0.714, or approximately 71.4%, which the LLM reports as '≈71 %', a semantically acceptable rounding. (3) The multi-hop reasoning—linking the exchange offer to the issuance of two share classes and computing the proportion of Class B-2 shares—is sound and properly synthesized. (4) All entities (Class B-2, Class C, May 2024) are correctly identified, and the answer addresses both parts of the question: the number of Class B-2 shares issued and their percentage of the total. Wording differs slightly but conveys the same factual content. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 266,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "GE’s wind‑turbine capacity fell from 11.7 GW in 2021 to 8.5 GW in 2023 – a total decrease of 3.2 GW.  That drop in capacity was accompanied by a decline in units sold, from 3,590 turbines in 2021 to 2,225 in 2023, a reduction of 1,365 wind turbines【page_11】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 11.7 GW in 2021 and 8.5 GW in 2023 yield a correct decrease of 3.2 GW; turbine units sold decreased from 3,590 to 2,225, correctly calculated as a reduction of 1,365 units. (2) The answer is complete, addressing both parts of the question: the change in GW capacity and the change in number of turbines sold. (3) Entities are accurate—GE is correctly identified, and the years 2021 and 2023 are properly referenced. (4) The reasoning is sound: the LLM correctly infers a decline in both capacity and unit volume, reflecting a consistent trend without overinterpretation. The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'fell' vs 'decrease'). All criteria for correctness, completeness, and accuracy are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 258,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "AT&T’s total cash outlay for the C‑Band spectrum—including the $23.406 billion purchase price, $955 million of Phase I incentive payments, $2.112 billion of Phase II incentive payments, and the relocation costs of $650 million (2021), $98 million (2022) and $109 million (2023)—equals roughly **$27.33 billion**【page_64†L1-L9】【page_64†L10-L13】.  All of these cash payments are reported in the cash‑flow statement under **“Acquisitions, net of cash acquired.”**【page_64†L14-L16】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. While it correctly identifies the $23.406 billion in auction payments, $955 million for Phase I, and $2.112 billion for Phase II, it incorrectly sums the total to $27.33 billion. The correct total from the ground truth is $26,477 million ($26.477 billion), not $27.33 billion. The LLM also double-counts or misrepresents the relocation costs: it includes $650M (2021), $98M (2022), and $109M (2023), which sum to $857M, but the ground truth states total compensable relocation costs are $1.1 billion over several years, with $857M paid through 2023. However, the ground truth explicitly states the total incentive and relocation costs are $3,067 million, not the ~$4.01 billion implied by the LLM's sum of $955M + $2.112B + $857M. The LLM incorrectly treats all listed payments as additive without recognizing that the $3,067 million is the total for incentives and relocation, not a sum of those components. (2) Calculation verification: Ground truth total = $23,406M + $3,067M = $26,473M (rounded to $26,477M, acceptable). LLM calculates ~$23.406B + $0.955B + $2.112B + $0.857B = ~$27.33B — this is $853 million over the correct total, a material error. (3) Multi-hop reasoning is partially sound: the model identifies relevant components and their cash flow classification correctly, showing synthesis across time and cost categories. However, it fails to correctly aggregate the components as defined in the ground truth, indicating flawed reasoning in how the pieces fit together. (4) The cash flow classification 'Acquisitions, net of cash acquired' is correct and matches the ground truth. Despite the numerical inaccuracies, the answer addresses both parts of the question and uses semantically appropriate terms. Thus, contextual relevance is high, qualitative accuracy is moderate due to correct structure but flawed execution, and quantitative accuracy is low due to the significant miscalculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 534,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic’s June 2021 decision to stop distribution and sale of the HVAD System eliminated its revenue stream (the HVAD generated $141 million in FY 2021) and caused a decline in HVAD net sales that partially offset the overall cardiovascular (Cardiac Rhythm & Heart Failure) net‑sales growth in fiscal 2022. In FY 2022 the company instead highlighted growth from a suite of other products—including the Micra transcatheter pacing system (and Micra AV), the CoreValve Evolut TAVR platform (and Evolut PRO), Arctic Front cryo‑ablation, VenaSeal and Abre venous‑stent systems, as well as other pacing, ICD/CRT‑D and TYRX envelope offerings (and, across neuroscience, Midas Rex instruments and StealthStation navigation).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly identifies the HVAD discontinuation in June 2021 and accurately reports its $141 million in FY 2021 net sales, which matches the ground truth. However, it incorrectly implies that HVAD sales continued into FY 2022 and partially offset growth in the Cardiac Rhythm & Heart Failure segment, whereas the original answer states the discontinuation allowed Medtronic to focus on other growth drivers in FY 2022—without indicating ongoing HVAD revenue or negative impact in that year. This misrepresents the financial impact. 2) Quantitatively, the $141 million figure and June 2021 date are correct. The LLM does not provide the key FY 2022 Medical Surgical net sales figure of $9.1 billion or the 5% growth rate, which are central to the original answer’s assessment of financial performance. These omissions reduce quantitative completeness. 3) The LLM lists several correct product lines but diverges significantly from the original answer: it highlights Micra, CoreValve Evolut, Arctic Front, VenaSeal, and others, while the ground truth emphasizes Symplicity Spyral, Pulse Field Ablation, Aurora ICD, and Intrepid transcatheter mitral/tricuspid systems. These are different product portfolios, and the mismatch indicates a failure in multi-hop synthesis—likely confusing growth drivers from different segments or time periods. 4) Contextually, the answer addresses the question’s two parts (impact of HVAD discontinuation and growth drivers), but with inaccurate reasoning and incorrect product examples. While it maintains relevance, the factual errors in key financial outcomes and product lines reduce overall correctness. The conclusion that HVAD decline 'partially offset' growth contradicts the original narrative of overall segment growth driven by recovery and other innovations despite the HVAD loss.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 493,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid **$3.5 billion** in cash during fiscal 2024 to buy additional shares from Flipkart non‑controlling‑interest holders and to settle the liability to former non‑controlling‑interest holders of PhonePe. The transaction lifted Walmart’s ownership of Flipkart from **about 75 %** at the start of the year to **about 85 %** by January 31, 2024 – roughly a **10‑percentage‑point increase**【page_66】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3.5 billion cash payment is accurately reported, and the ownership increase from about 75% to about 85% is correct, with the 10-percentage-point increase being a valid calculation. Minor formatting differences (e.g., 'about 75%' vs 'approximately 75%') are semantically equivalent. (2) The answer addresses both parts of the multi-part question: the total cash paid and the impact on Walmart's ownership percentage in Flipkart. (3) All entities—Walmart, Flipkart, PhonePe, noncontrolling interest holders—are correctly identified and contextually accurate. The fiscal year 2024 and date (January 31, 2024) align with the ground truth. (4) The reasoning is sound: the answer correctly synthesizes the two transactions (acquiring additional Flipkart shares and settling PhonePe liability) into a single cash outflow and links it to the ownership change, demonstrating proper multi-hop understanding. The citation of 'page_66' indicates source support. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 320,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft records the cash it receives for volume‑licensing programs (including SA and cloud services) as a liability – “unearned revenue” – and invoices customers at the beginning of each annual coverage period, but it recognizes the revenue ratably over the contract term, creating a timing difference between invoicing and revenue recognition (​page 63​). Because many of the bundled items are not sold separately, Microsoft must estimate their standalone selling prices using judgment, market data and customer‑size factors, which makes the allocation of the transaction price to distinct performance obligations complex and results in a large unearned‑revenue balance disclosed in Note 13 (​page 62​; page 95​). Accordingly, auditors treat revenue recognition as a critical audit matter, performing extensive testing of SSP estimates, contract terms and related controls to ensure the amount and timing of recognized revenue are reliable (​page 94​; page 95​).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Microsoft invoices annually at the beginning of the contract period, recognizes revenue ratably, records unearned revenue as a liability, and faces complexity in estimating standalone selling prices (SSP) due to bundled offerings like Software Assurance and cloud services. The use of judgment, customer size, and market data in SSP estimation is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the LLM correctly references disclosure locations (e.g., Note 13, page numbers), which supports traceability and auditability. (3) The multi-hop reasoning is sound: the LLM connects invoicing timing → unearned revenue → SSP estimation challenges → impact on revenue allocation → auditor focus on revenue recognition as a critical audit matter. It correctly identifies that auditors perform extensive testing on SSP estimates, contract terms, and controls, which matches the original answer’s claim about auditor focus on transfer of control and variable consideration. (4) The only minor shortcoming is that the LLM does not explicitly mention 'variable consideration' or 'transfer of control'—key technical aspects highlighted in the original answer and relevant to audit focus—but it does convey the equivalent idea through 'extensive testing of SSP estimates, contract terms and related controls.' This omission slightly affects qualitative accuracy but does not undermine the core correctness. Overall, the answer is semantically equivalent, contextually precise, and fully relevant to the question about financial statement presentation and auditability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 484,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "Nike’s company contributions to its qualified 401(k) Savings and Profit Sharing Plan were $126 million for FY 2022, $110 million for FY 2021 and $107 million for FY 2020 – a three‑year total of $343 million. No profit‑sharing amounts are included because the company made **zero** discretionary profit‑sharing contributions in any of those years, even though the plan permits them.【page_81】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual contributions for each fiscal year—$126 million in 2022, $110 million in 2021, and $107 million in 2020—are accurate, and their sum ($343 million) is correctly calculated. (2) The answer completely addresses both parts of the question: it provides the total contributions over the three years and explains why no profit sharing amounts were included. (3) The entities—Nike, the 401(k) Savings and Profit Sharing Plan, and the fiscal years 2020–2022—are correctly identified. (4) The reasoning is sound: the answer correctly states that no discretionary profit-sharing contributions were made in any of the three years, aligning with the plan terms, even though the plan allows for such contributions. The explanation is semantically equivalent to the original answer, with only minor wording differences (e.g., 'zero discretionary' vs 'did not make any'). The citation of 'page_81' indicates proper sourcing. All criteria for correctness, completeness, and clarity are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 308,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "Chevron’s (COP) consolidated natural‑gas reserves in the Asia Pacific/Middle East region fell by **16 billion cubic feet**, dropping from **312 BCF at the end of 2023 to 296 BCF at the end of 2024**【page_145】.  \nIn the same period, Africa’s consolidated reserves **rose by 296 BCF**, increasing from **172 BCF to 468 BCF**【page_145】.  \nThus, while Asia Pacific/Middle East saw a modest decline, Africa experienced a large net increase in reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in Chevron's natural gas reserves in the Asia Pacific/Middle East region as a decrease of 16 billion cubic feet (from 312 to 296 BCF), which matches the ground truth. However, there is a minor error in the reported change for Africa: the LLM states a 296 BCF increase (from 172 to 468), but the correct change is 297 BCF (468 - 172 = 296 is incorrect; 468 - 172 = 296 is a calculation error—actual difference is 296 → 297). Despite this, the numbers cited (172 to 468) are factually correct as per the source, so the error is in the derived delta. (2) The quantitative values for starting and ending reserves are accurate for both regions. The calculation for Asia Pacific/Middle East is correct (312 - 296 = 16). For Africa, while the input values are correct, the output difference is off by 1 BCF (should be 297, not 296). This is a minor arithmetic inaccuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across regions and time periods, compares trends, and draws a valid qualitative conclusion about the contrast between regional reserve changes. (4) The answer is contextually complete and relevant, addressing both parts of the question. Due to the small calculation error in the Africa delta, full marks are not warranted for quantitative accuracy, but all other aspects—including entity identification (Chevron/COP), years (2023–2024), and metrics (natural gas reserves in BCF)—are correct. Hence, a 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 416,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received **$0.7 billion** in cash from new equity‑funding rounds for its majority‑owned PhonePe subsidiary in fiscal 2024【page_66】. In the same year it **paid $3.5 billion** to acquire shares from non‑controlling interest holders (including settling the liability to former PhonePe non‑controlling owners)【page_66】—an outflow roughly five times larger than the cash it received.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the amounts $0.7 billion received from equity funding and $3.5 billion paid to acquire shares from noncontrolling interest holders are accurately reported, with correct numerical values and units. The comparison (five times larger outflow) is logically sound and mathematically accurate (3.5 / 0.7 = 5). (2) The answer addresses both parts of the multi-part question: cash received from equity funding and cash paid for share acquisitions during fiscal 2024. (3) Entities are correctly identified: Walmart, PhonePe, noncontrolling interest holders, and fiscal 2024 are all accurately referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis—linking two distinct cash flows related to PhonePe’s equity transactions and implicitly conveying the net outflow (though not explicitly stating $2.8 billion, the comparison 'five times larger' conveys the same relative magnitude). The answer is semantically equivalent to the ground truth, with no factual errors, omissions, or misstatements. Minor wording differences (e.g., 'settling the liability') add context without altering meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 338,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a combined pre‑tax charge of **$918 million** in 2024 to resolve the SEC Administrative Order and the related deferred‑prosecution, FCA and consent‑agreement matters. An independent compliance monitor will oversee RTX’s obligations under these agreements **for three years from the date the monitor is engaged**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax charge of $918 million in 2024 is accurately reported, with acceptable formatting (bold and thin space). (2) The duration of the compliance monitor's oversight is correctly stated as 'three years from the date the monitor is engaged,' which semantically matches the original answer's 'a period ending three years from the date on which the monitor is engaged.' (3) The answer addresses both parts of the multi-hop question: the financial impact (charge amount and year) and the compliance timeline. (4) Entity accuracy is correct—RTX, SEC Administrative Order, 2024, and related legal matters are properly identified. (5) The reasoning is sound, synthesizing the total charge across multiple legal resolutions and correctly interpreting the monitoring period. The wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 285,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft’s “Microsoft Cloud” revenue was $111.6 billion in fiscal 2023.  The amount aggregates revenue from Azure and other cloud services, Office 365 Commercial (Office products and cloud services), the commercial portion of LinkedIn, Dynamics 365 (Dynamics products and cloud services), and other commercial cloud properties【page_93】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $111.6 billion for fiscal year 2023 is accurate and matches the original answer exactly. (2) The answer is complete, addressing both parts of the question: the total Microsoft Cloud revenue and the specific offerings that contributed to it, including Dynamics 365. (3) All entities are correctly identified: Azure and other cloud services, Office 365 Commercial, commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties. The inclusion of 'Office products and cloud services' and 'Dynamics products and cloud services' adds slight elaboration but does not distort meaning. (4) The reasoning is sound and reflects proper synthesis of multi-hop information from the source material, correctly aggregating the various components of Microsoft Cloud revenue. (5) The semantic meaning is equivalent to the original answer, with only minor rewording and formatting differences (e.g., use of em dashes, parentheses). The citation [page_93] indicates proper grounding. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 326,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort’s $3.5 billion of debt is the amount of financing it obtained directly from a syndicate of Chinese banks – a term loan of about $3.1 billion that is secured by the resort’s assets and the equity interests of its investors, with no liquidity arrangements, guarantees or other financial commitments from Comcast (see page 86). In Comcast’s consolidated balance sheet this debt is included in the total $97.1 billion of debt but is listed under “Debt Not Guaranteed,” showing that it is part of the company’s overall debt load yet not covered by Comcast’s cross‑ or one‑way guarantees (see page 56).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitatively, all numbers are correct: the $3.5 billion total debt and $3.1 billion term loan are accurately reported, and the reference to Comcast’s consolidated debt of $97.1 billion (implied from context) aligns with typical reporting scales. The conversion from ¥29.7 billion RMB to ~$4.2 billion maximum facility is omitted but not contradicted. (2) The answer correctly identifies that the debt was sourced from Chinese banks via a syndicated loan, secured by assets and investor equity, and that Comcast provides no guarantees or liquidity support—matching the ground truth. (3) It accurately reflects the accounting treatment: Universal Beijing Resort’s debt is included in Comcast’s consolidated financials but classified under 'Debt Not Guaranteed,' indicating it is not backed by Comcast’s broader credit or cross-guarantee structures. This demonstrates sound multi-hop reasoning linking the resort’s direct financing to its treatment in Comcast’s consolidated debt disclosures. (4) The only minor gap is the lack of explicit mention that Comcast consolidates the resort as a VIE due to governance control, which is part of the original explanation for why the debt appears in consolidation at all. However, the answer still correctly implies consolidation occurs. Wording differences are semantically equivalent and do not detract from accuracy. Overall, the response is factually correct, contextually appropriate, and synthesizes across entities and disclosures effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 439,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "Nike’s short‑term holding of commercial paper and bonds fell from $691 million at May 31 2021 to $623 million at May 31 2022 – a decline of about $68 million (see Note 6, page 72). Because total short‑term investments grew to $4.423 billion from $3.587 billion, the drop in commercial paper and bonds reduced its proportion in the portfolio, leaving Treasury securities and other cash‑equivalents a larger share of Nike’s short‑term investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Nike's investment in commercial paper and bonds was $748 million on May 31, 2021, and $660 million on May 31, 2022, a decline of $88 million. The LLM incorrectly reports these figures as $691 million and $623 million, respectively, with a decline of $68 million—both values and the difference are wrong. Additionally, the LLM claims total short-term investments grew from $3.587 billion to $4.423 billion, which contradicts the ground truth indicating a drop in Level 2 short-term investments from $695 million to $630 million. These figures are not only inconsistent in magnitude but also misrepresent the overall investment trend. (2) Calculations are internally consistent within the LLM’s incorrect numbers (e.g., $691M - $623M = $68M), but since the base values are factually wrong, the results are invalid. The ground truth shows a reallocation away from commercial paper and bonds amid a decline in total Level 2 investments, not growth in total short-term investments as claimed. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that a decline in commercial paper and bonds would reduce their portfolio share if other investments grow, and it identifies Treasury securities and cash equivalents as alternative instruments. However, this logic is applied to incorrect financial data, undermining the validity of the conclusion. It fails to reflect the actual strategic shift in the context of declining overall Level 2 investments. (4) Despite incorrect quantitative data, the answer addresses both parts of the question—change in investment and impact on composition—and uses appropriate financial terminology. The reasoning structure is relevant and follows a logical flow, earning moderate scores for qualitative accuracy and high relevance. However, the factual errors in core financial figures severely limit correctness, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 540,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The diluted‑EPS for fiscal 2023 is computed without any Class B‑2 shares because none existed before the Class B‑1 exchange offer. Both the diluted‑EPS table for 2023 (page 59) and the accompanying footnote (also repeated on page 91) state that “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer,” so the B‑2 class is excluded from the weighted‑average share count and does not affect the 2023 diluted EPS numbers (e.g., $8.28 for Class A, $13.24 for Class B‑1, $33.13 for Class C). The B‑2 shares only begin to appear in the diluted‑EPS calculation in fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. The original answer (ground truth) states that the introduction of Class B-2 common stock impacts diluted EPS by increasing the as-converted weighted-average Class A share count, as the conversion is assumed in diluted EPS calculations. However, the LLM incorrectly asserts that Class B-2 shares are excluded from the 2023 diluted EPS calculation because they were not outstanding prior to the exchange offer. This contradicts the principle of diluted EPS, which includes potential dilution from convertible securities even if not yet issued, provided the conversion is part of the capital structure changes during or before the reporting period. The LLM cites specific EPS numbers ($8.28, $13.24, $33.13) and pages (59, 91), but these are not present in the ground truth and appear fabricated or misapplied, failing quantitative accuracy. The reasoning fails the multi-hop logic: the key point is that the *assumed conversion* of Class B-2 into Class A affects the as-converted share count in diluted EPS for 2023, not whether shares were outstanding at the beginning. The LLM incorrectly defers the impact to 2024, which is unsupported by the ground truth. While the answer addresses the question's context (Class B-2 introduction post-exchange), its factual and conceptual errors severely undermine correctness. The mention of specific pages and numbers without corroboration suggests overfitting to non-existent document details, reducing reliability. Thus, the answer is mostly wrong with significant factual and logical flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 434,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "Raytheon’s pension and PRB costs are accounted for under U.S. government Cost Accounting Standards (CAS), which spreads the expense over the life of its government contracts and is shown as a separate “FAS/CAS operating adjustment” (e.g., $833 million in 2024) that adds to Raytheon’s reported operating profit. Collins Aerospace and Pratt & Whitney record pension and PRB expense on a U.S. GAAP (FAS) basis, recognizing the cost in the period incurred and therefore have no comparable adjustment, resulting in a different timing of expense recognition and profit reporting for Raytheon versus the other two segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction in pension cost recognition between Raytheon (under CAS) and Collins/Pratt & Whitney (under FAS/GAAP). It correctly explains that Raytheon uses CAS, which results in a timing difference in expense recognition and leads to a 'FAS/CAS operating adjustment' that increases reported operating profit—illustrated with a specific dollar amount ($833 million in 2024). This quantitative detail is plausible and contextually appropriate, though the original ground truth does not specify this number or year, so its inclusion cannot be fully verified and slightly reduces confidence in quantitative accuracy. However, such figures are consistent with public filings and do not contradict the ground truth. The answer correctly identifies the key qualitative difference: CAS spreads costs over contract life while FAS recognizes them when incurred, leading to different profit reporting patterns. It also implicitly conveys that Raytheon expects recovery through government pricing, though this point is not explicitly stated. All entities (Raytheon, Collins Aerospace, Pratt & Whitney) and accounting standards (CAS vs. FAS/GAAP) are correctly identified. The reasoning is sound and synthesizes multi-hop concepts: accounting standards → expense timing → financial statement impact → segment-level differences. The answer is semantically equivalent to the ground truth, with slightly more operational detail on the adjustment mechanism. Minor deduction in quantitative accuracy due to unverifiable $833M figure; otherwise, fully correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 438,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Two separate Supplemental Indentures reference the 1.850% Notes due 2020: the Ninth Supplemental Indenture (Exhibit 4.12) and the Twelfth Supplemental Indenture (Exhibit 4.15)【page_105】【page_106】. The Ninth was issued with U.S. Bank National Association as trustee, and the Twelfth was issued with The Bank of New York Mellon Trust Company, N.A. as trustee.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies two Supplemental Indentures related to the 1.850% Notes due 2020, matching the ground truth in both quantity and details. (2) The Ninth Supplemental Indenture is correctly dated February 12, 2015 (implied by exhibit reference and context), with U.S. Bank National Association as Trustee; the Twelfth Supplemental Indenture is correctly dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee—both entities and roles are accurately reported. (3) The multi-hop reasoning is sound: the model correctly associates the specific notes with the correct supplemental indentures and extracts the corresponding trustees from different documents or sections, demonstrating proper synthesis. (4) Minor wording differences (e.g., 'reference' vs 'related to', inclusion of exhibit numbers) do not affect factual accuracy and actually add contextual support. All key facts—number of agreements, indenture numbers, trustees—are correct. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 310,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "Nike recorded a **$40 million net gain** in income from foreign‑exchange forwards and options for fiscal 2022【page_84】.  The fair‑value of those forward and option assets on the balance sheet was **$92 million** as of May 31 2021【page_73】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net gain of $40 million in fiscal year 2022 and the fair value of $92 million as of May 31, 2021 are accurately reported, with correct fiscal years and dollar amounts. Minor formatting differences ($40 million vs $40 million) are acceptable and do not affect meaning. (2) The answer addresses both parts of the multi-part question: the net gain in income for fiscal 2022 and the fair value of assets as of May 31, 2021. (3) Entity accuracy is correct—Nike is the implied subject (consistent with context), and the financial instruments (foreign exchange forwards and options) and time periods are correctly identified. (4) The reasoning is sound, though the LLM does not explicitly compare the two figures as the original answer does; however, it provides both correct values, enabling the reader to make the comparison. The inclusion of page references adds contextual support. The answer is semantically equivalent to the ground truth and conveys the necessary information accurately and completely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 312,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "AIG reserves U.S. Property short‑tail lines by applying a mix of frequency‑severity, loss‑development and IBNR‑factor methods (page 273), while U.S. Personal Insurance combines those same techniques with expected‑loss‑ratio methods for the most recent accident year and relies on subrogation recoveries for auto and personal lines (page 276). In 2021 the Personal‑Insurance segment recorded a $412 million favorable prior‑year development, whereas the filing does not disclose any material prior‑year development impact for the U.S. Property segment (page 273).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $412 million favorable prior year development for U.S. Personal Insurance in 2021, which matches the ground truth exactly. It also correctly states that no material prior year development is disclosed for U.S. Property in 2021, aligning with the original answer's note that no specific figure is provided. However, the LLM misattributes the use of expected loss ratio methods to U.S. Personal Insurance for the latest accident year, while the ground truth assigns this method to U.S. Property. This is a key methodological mix-up. (2) All numeric values are accurate: $412 million is correctly cited, and there is no incorrect calculation. Format is consistent and acceptable. (3) The multi-hop reasoning is mostly sound—information is synthesized across segments and years, and the distinction in disclosure (specific number vs. no disclosed impact) is appropriately handled. However, the reserving approach comparison contains a factual error in assigning expected loss ratio methods to the wrong segment, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses both parts of the question: reserving approaches and prior year developments. Despite the methodological mix-up, the core facts—especially the quantitative result—are correct, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 378,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart’s 2018 purchase of a majority stake in Flipkart has drawn a show‑cause notice from India’s Directorate of Enforcement that could result in monetary or non‑monetary relief and uncertain indemnification, creating a potential material financial risk for the company (see page 32). This risk is a direct outgrowth of Walmart’s broader international investment strategy of growing its e‑commerce and digital presence through majority‑ownership stakes in foreign platforms such as Flipkart and PhonePe, as described in its 2023 10‑K (see page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Walmart acquired a majority stake in Flipkart in 2018; India's Directorate of Enforcement has initiated proceedings that could result in monetary or non-monetary penalties; the issue stems from alleged FDI rule violations prior to Walmart's acquisition; and Walmart cannot predict the outcome. The LLM correctly identifies the risk exposure and ties it to Walmart's broader international investment strategy. (2) Quantitative accuracy is perfect: the year 2018 is correct, and no numerical figures (e.g., dollar amounts, percentages) are misstated. The reference to 'page 32' and 'page 6' of the 10-K adds specificity and matches typical disclosure locations, though page numbers are not part of the ground truth and do not affect scoring as long as they are plausible. (3) Multi-hop reasoning is sound: the model correctly links Walmart's acquisition of Flipkart, the subsequent regulatory risk from pre-acquisition conduct, and how this fits into Walmart's broader strategy of expanding global e-commerce via majority stakes. The mention of PhonePe (a subsidiary of Flipkart) adds contextual detail consistent with the 10-K. (4) The only minor shortcoming is that the LLM does not explicitly state that the FDI violations under investigation occurred between 2009–2015, prior to Walmart’s ownership, which slightly weakens the causal clarity. However, it correctly frames the risk as stemming from Flipkart’s past conduct. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 446,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "In FY 2023 Accenture issued Class A ordinary shares that generated $8.9 million of par‑value and $2.15 billion of additional paid‑in capital – roughly $2.16 billion in total【page_71】.  This issuance helped lift Accenture plc’s total shareholders’ equity to $28.29 billion as of August 31 2024, an increase of about $2.6 billion from the prior year【page_67】【page_72】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key numbers. The total dollar value of Class A ordinary shares issued in FY2023 is stated as approximately $2.16 billion, but the ground truth is $7,970. This is off by over three orders of magnitude. The breakdown into $8.9 million par value and $2.15 billion paid-in capital does not align with the ground truth value of $7,970 total, suggesting a fundamental misinterpretation of the data. (2) The ending shareholders' equity of $28.29 billion is close to the correct value of $28,288,646 (~$28.29 billion), so this number is approximately correct. The increase of about $2.6 billion is also close to the actual increase of $2,595,807 (~$2.6 billion), so this part is reasonably accurate in magnitude. However, the LLM attributes this entire increase to share issuance, which is incorrect—the original answer notes that issuance was only one of several contributing factors. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the total value of shares issued (a core fact), misrepresents the financial scale of the transaction, and oversimplifies the causal relationship between share issuance and equity growth. It does, however, correctly link share issuance to an increase in shareholders' equity and uses approximately correct end-of-period equity figures, showing some level of synthesis. (4) The contextual relevance is fair because the answer addresses both parts of the question—share issuance value and its impact on equity—with relevant financial concepts and citations. However, the severe quantitative errors and incorrect causal attribution drastically reduce factual correctness. The qualitative accuracy is low due to incorrect entity values and reasoning, though the general directionality (increase in equity) is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 497,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG first applies traditional loss‑development techniques to excess‑casualty losses capped at $10 million and then uses the resulting development pattern to infer the ultimate loss for the higher‑attachment layers (> $10 million), recognizing that those layers mature much later and can be highly variable (see page 263).  That same development‑driven framework underpins its U.S. Property reserving—combined with frequency‑severity and IBNR‑factor methods for short‑tail lines—and its aerospace reserving, where loss development is blended with expected‑loss‑ratio projections to capture severity, trend and inflation (see page 273).  Expected loss ratios are therefore applied both to the most recent accident years and to translate the $10 million‑capped development results into the final reserve for the high‑attachment excess and aerospace exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AIG uses traditional loss development methods for losses capped at $10 million and leverages that to estimate higher layers (> $10 million), which aligns with the layered reserving approach described in the original answer. The role of expected loss ratios in both excess casualty and aerospace/U.S. Property lines is correctly identified, especially for recent accident years with insufficient data. (2) Quantitative accuracy is perfect: the $10 million attachment point is correctly cited, and no numerical errors are present. Format variations (e.g., $10 million) are acceptable. (3) Multi-hop reasoning is sound—LLM correctly synthesizes how the lower-layer analysis informs higher-layer estimates and connects this methodology to U.S. Property and aerospace lines, noting the use of loss development and expected loss ratios in both. It also correctly references severity, inflation, and trend adjustments, particularly in aerospace. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on 'expected relationships between layers' and 'adjustments for rate changes and market conditions' mentioned in the original, though these are partially captured in 'trend and inflation'. The LLM cites specific pages (263, 273), which may reflect source fidelity, but since the evaluation is based on factual correctness rather than source citation, this does not affect scoring. Overall, the answer is complete, factually correct, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 435,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "The Consolidated Shareholders’ Equity statement shows that for the fiscal year ended August 31 2022 Accenture repurchased Class A ordinary shares for **$4,111,266** (the “Purchases of Class A shares” line)【page_70】.  \n\nAs of August 31 2024 the company’s remaining authorization for its open‑market and related share‑purchase programs was **$2,694,281**【page_100】.  \n\nThus, the remaining authorization in 2024 is roughly $1.4 million lower than the amount repurchased in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total dollar value of Accenture plc Class A ordinary shares repurchased during the fiscal year ending August 31, 2022, as $4,111,266, matching the ground truth. It also accurately reported the remaining share purchase authorization as of August 31, 2024, at $2,694,281. These figures are factually correct and properly attributed to the relevant financial statements with page references. (2) Quantitatively, all numbers are accurate and correctly formatted. However, the LLM states that the remaining authorization in 2024 is 'roughly $1.4 million lower' than the 2022 repurchase amount. This is incorrect: the difference is $4,111,266 - $2,694,281 = $1,416,985, so the remaining authorization is actually about $1.42 million *lower*, but more importantly, this comparison is logically flawed — the remaining authorization in 2024 is not directly comparable to a single year’s repurchase amount from 2022, as the authorization is cumulative and may have been replenished or used over time. The ground truth correctly interprets this as indicating significant prior usage, not a direct numerical comparison. (3) The multi-hop reasoning is mostly sound — the model synthesizes data from two different time points (2022 repurchases and 2024 remaining authorization) correctly. However, the flawed comparison slightly undermines the qualitative reasoning. (4) Despite the minor misinterpretation in the comparison, the core facts are correct, and the answer addresses both parts of the question with precise data and proper context. Hence, correctness is scored 9 for minor reasoning flaw, quantitative accuracy is 10, qualitative accuracy 9, and contextual relevance 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 468,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "Meta’s decision to replace the “legitimate‑interests” legal basis with a consent‑based model in the EU/EEA/Switzerland – and to add a “subscription‑for‑no‑ads” tier and a “less‑personalized‑ads” option – limits the data signals it can use for behavioral targeting, making ads less relevant and effective【page_20】. That reduced targeting efficiency is expected to lower ad pricing and overall advertising revenue, and the ability for users to opt‑out or receive less‑personalized ads can also dampen user engagement and the volume of ad‑supported impressions【page_62】【page_18】【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies Meta's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe (specifically EU/EEA/Switzerland), the introduction of the 'subscription for no ads' option and 'less personalized ads', and the resulting reduction in ad relevance and effectiveness. The answer accurately links these policy changes to lower ad pricing, reduced advertising revenue, and dampened user engagement—particularly in high-monetization features like Feed and Stories—due to fewer data signals for targeting and increased user opt-outs. All entities (Meta, EU regulatory context, ad targeting model change) are correct. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor shortcoming is that the LLM answer does not explicitly mention that reduced user engagement affects revenue *because* those features (Feed, Stories) monetize at higher rates—though it implies it by linking engagement to ad-supported impressions. This slight omission in causal detail prevents a perfect 10 on qualitative accuracy, but the reasoning is otherwise sound and complete. The answer is highly contextually relevant and synthesizes the multi-hop logic correctly: regulatory change → policy adaptation → reduced targeting → lower engagement and revenue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 390,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "Accenture plc can redeem any Class X ordinary share at its par value, and it will do so whenever an Accenture Canada Holdings Inc. exchangeable share is redeemed or exchanged – a rule that caps the total Class X shares outstanding so they never exceed the number of exchangeable shares outstanding. The alignment is enforced by a contractual provision that ties each Class X redemption to the redemption or exchange of the corresponding exchangeable share and prevents a holder’s Class X balance from falling below the number of exchangeable shares they own (see Class X Ordinary Shares description, page 100).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately describes the redemption mechanism of Accenture plc Class X ordinary shares and how it ensures the number of Class X shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. The key mechanism—a one-for-one redemption upon exchange or redemption of the exchangeable shares—is correctly identified. The answer adds a detail not in the original (about preventing a holder’s Class X balance from falling below their exchangeable share ownership), which is contextually relevant and plausible based on typical structural protections in such share arrangements, though not explicitly stated in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Accenture plc, Accenture Canada Holdings Inc., Class X ordinary shares, exchangeable shares) are correctly named and logically connected. The reasoning is sound and reflects proper multi-hop understanding between corporate structure and share alignment mechanisms. The slight deduction in qualitative accuracy is due to the addition of a minor detail (holder-level balance protection) that, while reasonable, goes slightly beyond the scope of the original answer. Overall, the answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 376,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalized for Jardiance fell from $156.2 million at year‑end 2020 to $136.1 million at year‑end 2021 – a decrease of about $20.1 million. This decline reflects the filing’s amortization policy, which requires that milestone payments be recorded as intangible assets and then amortized to cost of sales over the collaboration term (based on launch date, patent life, etc.), so the deferred balance shrinks as the amortization expense is recognized.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the net milestone capitalization decreased from $156.2 million in 2020 to $136.1 million in 2021, a difference of $20.1 million, which matches the ground truth exactly. (2) The calculation of the decline ($156.2M - $136.1M = $20.1M) is accurate. (3) The reasoning correctly explains that the decrease reflects amortization practices described in the filing—capitalized milestones are treated as intangible assets and amortized to cost of sales over time based on factors like launch date and patent life. (4) The answer addresses both parts of the multi-hop question: the quantitative change and the link to amortization policy. Wording differs slightly but conveys the same meaning with no omissions or inaccuracies. All entities (Jardiance, years 2020–2021, net milestone capitalization) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 275,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "Both regions apply IBNR‑factor techniques to lines where losses are “low‑frequency/high‑severity,” but the underlying claim profile differs. U.S. Property notes that a growing share of non‑admitted coverages has softened the aggregate severity, so its IBNR factors are continually re‑calibrated and used together with frequency‑severity and loss‑development methods to capture the evolving risk (page 273). UK/Europe Property, by contrast, retains a more classic low‑frequency/high‑severity pattern, so IBNR factors—combined with loss‑development and expected‑loss‑ratio methods—provide a relatively stable reserve estimate with fewer adjustments (page 280).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both regions use IBNR factor methods for low-frequency/high-severity lines; UK/Europe maintains a classic profile leading to stable reserve estimates with fewer adjustments; U.S. Property has seen reduced aggregate severity due to growth in non-admitted coverages, necessitating ongoing recalibration of IBNR factors. The mention of supplementary methods (frequency-severity, loss-development, expected-loss-ratio) adds contextual detail consistent with a nuanced reserving process. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in claim characteristics (frequency/severity) and links them to regional reserving practices, including how IBNR factors are adapted (re-calibrated in the U.S. vs. more stable in UK/Europe). The reference to specific pages (273, 280) suggests grounding in source material, though not required for correctness. (4) Semantic equivalence is strong—while the LLM uses slightly more detailed methodological language (e.g., naming specific supplementary methods), it does not contradict or misrepresent the original. The only minor gap is that the original emphasizes IBNR factors being applied to earned premium in UK/Europe and adjusted for cost levels/emergence patterns, which the LLM omits. This is a small but relevant detail in the reserving mechanics, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is complete, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 471,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Procter & Gamble’s Grooming segment holds **more than 60% of the global blades‑and‑razors market**, while it captures **just over 25% of the male electric‑shaver market**. Thus, its blades‑and‑razors share is roughly double the share it has in male electric shavers【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Procter & Gamble's market shares as 'more than 60%' in blades and razors and 'just over 25%' in male electric shavers, which aligns with the ground truth of 'over 25%' and 'more than 60%'. These phrasings are semantically equivalent and factually accurate. (2) All quantitative values match the original answer; no calculations (e.g., the 35-percentage-point difference) are incorrect, though the LLM does not explicitly state the numerical difference. Instead, it offers a qualitative comparison—'roughly double'—which is reasonable given that 60% is about 2.4 times 25%, so 'roughly double' is a slight understatement but not factually inaccurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct market share figures across product categories and draws a valid comparative conclusion. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only minor shortcoming is the lack of explicit mention of the >35 percentage point difference, which slightly reduces qualitative accuracy, but the core facts and synthesis remain correct. Hence, high scores across all dimensions with a 9 in correctness due to the slightly imprecise comparative framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 356,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "In 2023 General Dynamics reported $510 million of company‑sponsored research and development expenses, which include its Aerospace product‑development costs【page_60】.  The company offsets a portion of those costs through cost‑sharing arrangements with certain suppliers—milestone‑based agreements in which suppliers reimburse the company for development expenses, and the contributions are recorded as a reduction of R&D expense【page_60】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $510 million investment in Aerospace segment product development in 2023, matching the ground truth exactly. The mechanism—cost-sharing arrangements with suppliers—is accurately described, including that supplier reimbursements are recorded as a reduction of R&D expenses. (2) The numeric value ($510 million) and year (2023) are correct, with acceptable phrasing as 'company-sponsored research and development expenses' which encompasses Aerospace product development. No calculations are required, and all figures match. (3) The multi-hop reasoning is sound: the model correctly links General Dynamics, 2023, Aerospace R&D investment, and the supplier cost-sharing mechanism, synthesizing the information appropriately. (4) The answer is semantically equivalent to the ground truth, with slightly different wording but full factual alignment. All evaluation dimensions are satisfied at the highest level, warranting perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 286,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent **$4.509 billion** on Class A Ordinary Share purchases in fiscal 2024 (13.9 million shares)【page_101】.  The purchases were recorded as a reduction in equity and increased the treasury‑share balance by the same amount – the treasury‑share line shows a $4.509 billion (13,913‑share) increase, thereby raising the total value of treasury shares held by that amount【page_72】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the key numeric value. The ground truth states Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM reports $4.509 billion—a difference of over 1,000x. This is a major quantitative error that fundamentally undermines the answer. (2) The LLM cites specific pages (101 and 72) and includes share counts (13.9 million), which are not present in the ground truth and appear to be hallucinated or drawn from a different source. The calculation logic—purchases increasing treasury shares by the same amount—is correct and aligns with accounting principles and the original answer. However, the numbers themselves are grossly inaccurate. (3) The multi-hop reasoning is structurally sound: the model correctly infers that share repurchases increase the value of treasury shares held, and it connects the purchase amount to the change in treasury balance. But due to incorrect input data, the synthesis fails on factual grounding. (4) Contextual relevance is high because the answer addresses both parts of the question (amount spent and effect on treasury shares) and uses appropriate financial terminology. However, the massive numerical discrepancy results in a low correctness and quantitative accuracy score. Minor note: $4.509 billion = $4,509,000,000 vs. ground truth $4,111,266—this is not a formatting difference but a clear factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 401,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "META’s “Servers and network assets” rose from $46.8 billion at 12/31/23 to $68.4 billion at 12/31/24 – an increase of roughly **$21.6 billion**【page_107】.  The company depreciates these assets on a **straight‑line basis over their estimated useful lives of four to five years (extended to 5.5 years for certain assets beginning January 2025)**, i.e., over the shorter of the asset’s useful life or its lease term【page_97】.  Consequently, the larger asset base will be allocated as depreciation expense over that 4‑5‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the year-over-year increase in META's Servers and Network Assets: from $46.8 billion to $68.4 billion, resulting in an increase of approximately $21.6 billion. This aligns with the ground truth value of $21.559 billion (rounded appropriately). All numeric values are accurate within acceptable rounding tolerance ($46.838B → $46.8B, $68.397B → $68.4B, difference $21.559B → $21.6B).\n\n2) The LLM accurately describes META's depreciation policy, citing straight-line depreciation over 4–5 years, extended to 5.5 years for certain assets starting January 2025, and notes that depreciation applies over the shorter of useful life or lease term. This matches the policy details in the source.\n\n3) While the LLM correctly explains how assets are depreciated once placed in service, it does not explicitly mention the key multi-hop insight from the ground truth: that the large increase in depreciable assets likely reflects the transition of construction-in-progress (CIP) assets into service during 2024. This omission slightly weakens the qualitative reasoning, though the conclusion about the larger asset base being depreciated over 4–5 years is logically sound.\n\n4) The answer is contextually complete and highly relevant, addressing both the quantitative change and the depreciation policy. The minor omission of the CIP-to-service transition explanation prevents a perfect qualitative score, but all stated facts are correct and semantically equivalent to the original answer. Quantitative accuracy is flawless within reporting precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 432,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "Eli Lilly has **two** FDA Breakthrough‑Therapy‑designated indications that are listed as **Submitted** in the 2022 filing: Empagliflozin (Jardiance) for heart‑failure with preserved ejection fraction (cardiovascular/heart‑failure) and Baricitinib (Olumiant) for alopecia areata (dermatology)【page_39】. No Breakthrough‑Therapy‑designated indication is shown as **Discontinued** in the 2022 report.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of drug indications (two) in the submitted status and zero in discontinued status are accurate. (2) The specific compounds—Empagliflozin (Jardiance®) and Baricitinib (Olumiant®)—and their associated therapeutic areas—heart failure with preserved ejection fraction (cardiovascular) and alopecia areata (dermatology)—are correctly identified. (3) The reasoning is sound: the model correctly synthesized information across drug, indication, regulatory status, and year, fulfilling the multi-hop requirement. (4) The answer addresses all parts of the question: it distinguishes between submitted and discontinued statuses, provides counts, and lists the relevant compounds and therapeutic areas. Minor formatting differences (e.g., 'heart‑failure' vs 'heart failure', use of em dashes) do not affect semantic accuracy. The citation reference 【page_39】 adds contextual support without introducing error. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 309,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG’s U.S. Other Casualty reserving relies on a blend of loss‑development, frequency‑severity and expected‑loss‑ratio techniques, giving loss‑development the most weight for older accident years while leaning on expected‑loss‑ratio methods for the most recent years and for smaller or volatile subsets (see page 266). In contrast, U.S. Property reserves are set primarily with loss‑development methods combined with frequency‑severity and IBNR‑factor approaches for short‑tail and low‑frequency/high‑severity lines (see page 273). For U.S. Personal Insurance, AIG recorded a $412 million favorable prior‑year development adjustment in 2021—essentially a reserve reduction driven by favorable emergence and sub‑rogation recoveries from the 2017‑2018 catastrophe years (see page 273).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $412 million favorable prior year development in 2021 for U.S. Personal Insurance is accurately reported, and the attribution to subrogation recoveries from 2017–2018 catastrophes matches the original. (2) The description of reserving methods is substantively correct: for U.S. Other Casualty, the use of loss development, frequency/severity, and expected loss ratio methods is accurate, with appropriate emphasis on expected loss ratio for recent years due to long-tail characteristics. For U.S. Property lines, the reliance on frequency/severity, loss development, and IBNR factor methods for short-tail, low-frequency/high-severity lines is correctly stated. (3) Multi-hop reasoning is sound—information is synthesized correctly across different lines of business and time periods. (4) Minor wording differences exist (e.g., 'favorable emergence' is added in the LLM answer but not in the original), but this does not introduce inaccuracy and may reflect additional context from the source. The reference to specific pages (266, 273) suggests fidelity to source material. No calculation errors. The answer fully addresses both parts of the question. Only a minor deduction in qualitative accuracy due to slight rephrasing that slightly extends beyond the original with 'favorable emergence', but this is contextually reasonable. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 423,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounted for **about 24 % of P&G’s FY 2024 net sales**【page_18】.  Because the family‑care portion of this segment is a largely North‑American business and Charmin holds **over 25 % of the U.S. toilet‑paper market**, Charmin can be estimated to generate roughly **one‑quarter of the segment’s sales** – roughly **6 % of total net sales** (≈25 % of the 24 % segment share).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Baby, Feminine & Family Care segment contributed 24% of P&G's FY 2024 net sales, matching the ground truth. It accurately notes Charmin's market share as 'over 25%' in the U.S. toilet paper market, which is consistent with the ground truth's 'approximately 25%'—a reasonable semantic variation. The LLM then estimates that Charmin generates roughly one-quarter of the segment’s sales, leading to ~6% of total net sales (25% of 24%), which is a logical inference supported by the data. (2) All numbers are correct: 24% segment contribution, 25% market share, and the calculation (0.25 × 0.24 = 0.06 or 6%) is mathematically accurate. (3) The multi-hop reasoning is sound: the model connects Charmin’s brand strength in the North American toilet paper market to the Family Care sub-segment, and then estimates its proportional contribution within the larger segment and overall sales. The only minor limitation is the slight overstatement of 'over 25%' versus 'approximately 25%', but this does not materially distort the conclusion. (4) The answer is highly relevant, complete, and factually aligned with the ground truth. The small wording difference does not affect correctness, warranting a 9/10 on qualitative accuracy and 9/10 overall due to the near-perfect synthesis and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 373,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "The Combat Systems segment channels a portion of the $510 million 2023 R&D budget into research, engineering and prototype work that fuels the next‑generation upgrades of the Abrams tank family—including the SEPv3 enhancements and the new M1E3 Abrams, which incorporate modern communications, power‑generation, fuel‑efficiency, optics and armor to lower sustainment costs and increase tactical mobility【page_10】.  By investing in these innovations, GD creates long‑term value and a market‑leading position for Combat Systems, a strategy reflected in the company’s strong financial results – $3.3 billion of net earnings and $4.7 billion of operating cash flow in 2023 – and that positions the business to capture future tank‑modernization contracts and sustain revenue growth【page_58】【page_60】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $510 million R&D investment in 2023 is accurately cited, and the financial outcomes—$3.3 billion net earnings and $4.7 billion operating cash flow—are factually consistent with the source data. These figures, while not directly caused by the Combat Systems R&D spend alone, are appropriately framed as part of the company’s overall strong financial performance in 2023, which supports the strategic context. (2) The answer correctly identifies the M1E3 Abrams development focus, including modern communications, power generation, fuel efficiency, optics, and armor—matching the ground truth. It also correctly notes reduced sustainment costs and increased tactical mobility, which are aligned with the 'reduced sustainment footprint' and 'increased tactical mobility' mentioned in the original. (3) The multi-hop reasoning is sound: the model connects R&D spending to platform modernization (M1E3), links that to strategic outcomes (market leadership, future contracts), and supports it with company-wide financial health as an indicator of successful execution. (4) Minor deduction in qualitative accuracy because the LLM attributes the financial results (net earnings, cash flow) more directly to the Combat Systems R&D investment than the original does; the ground truth ties outcomes to contract security and revenue sustainability without citing overall corporate earnings. However, the LLM does not claim causation outright and uses the financials as contextual support, so this is a nuance rather than an error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 468,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "Accenture’s total cash outlay for Class A ordinary‑share purchases in fiscal 2024 was **$4.111 billion**.  The Consolidated Shareholders’ Equity Statements for the year ended August 31 2024 show a $4,111,266‑million (‑) treasury‑share entry under “Purchases of Class A shares,” which aggregates both the publicly announced open‑market repurchase program and the purchases unrelated to that program.【page_70】",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claim. It states that Accenture's total cash outlay for Class A ordinary-share purchases in fiscal 2024 was $4.111 billion, citing a '4,111,266-million' treasury-share entry, which is a severe misreading of the number (4,111,266 million = ~$4.1 trillion, an impossible figure). The ground truth is $609.1 million, with $605 million from the open-market program and $4.1 million from unrelated purchases. The LLM's number is off by more than an order of magnitude. While the answer attempts to address both components of the question (purchases under and unrelated to the program), it fails to correctly extract or interpret the actual data. The reference to 'page_70' and the Consolidated Shareholders’ Equity Statements suggests an attempt at grounding, but the numerical misinterpretation invalidates the response. Multi-hop synthesis is not required here as the total is directly reported in the ground truth, but the model fails at basic numerical accuracy. The entity (Accenture), metric (Class A share purchases), and time period (fiscal 2024) are correctly identified, but this does not compensate for the catastrophic quantitative error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 337,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T paid Crown Castle **$253 million** in 2021 under the sub‑lease arrangement (page 133). In the original 2013 tower deal, AT&T received **$4,827 million** in cash from Crown Castle (page 132). Thus, the 2021 payment is only a small fraction—roughly 5 %—of the cash proceeds received in 2013.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $253 million in 2021 payments and $4,827 million in initial 2013 proceeds, which aligns with the ground truth values (with acceptable formatting variation using 'million'). The implied ratio (~5%) is a correct approximation (253 / 4827 ≈ 0.0524 or 5.24%). (2) The answer is complete, addressing both parts of the comparison: the 2021 payment and the 2013 cash proceeds. (3) Entities are correctly identified: AT&T and Crown Castle, with correct years (2021 and 2013) and financial arrangements (sublease payments vs. initial transaction proceeds). (4) The reasoning is sound and demonstrates proper multi-hop synthesis across time and financial events—linking the 2013 sale proceeds to the 2021 payment under a related arrangement. The conclusion that the 2021 payment is a small fraction of the original amount is logically and quantitatively supported. (5) Semantic equivalence is maintained: the LLM adds minor clarification (percentage estimate) but does not distort or misrepresent the facts. All elements meet the highest standard for correctness and fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 339,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "GM values its Stellantis warrants with a Black‑Scholes option‑pricing model, using the Stellantis share price and dividend yield as the key inputs【page_66】.  In its equity‑price‑risk sensitivity analysis, GM notes that a 10 % adverse change in Stellantis’s quoted stock price would have had an “insignificant” effect on the $1.5 billion of equity‑price‑risk exposures at December 31 2021【page_50】.  Consequently, a 10 % drop in Stellantis’s share price would have a negligible financial impact on GM’s equity investments in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: GM uses the Black-Scholes model to value Stellantis warrants, with Stellantis stock price and dividend yield as key inputs. The fair value of the investment at the end of 2021 was $1.5 billion. A 10% adverse change in Stellantis’s stock price would have had an 'insignificant' effect on GM’s financial statements. (2) Quantitative accuracy is perfect: the dollar amount ($1.5 billion), percentage (10%), and year (2021) all match the original. The term 'insignificant' is directly quoted and correctly interpreted as 'negligible financial impact'. (3) Multi-hop reasoning is sound: the answer connects GM’s valuation methodology (Black-Scholes) to sensitivity analysis and concludes the lack of materiality, synthesizing information from both the methodology and risk disclosure. (4) The answer is highly relevant, directly addressing how the valuation methodology and sensitivity analysis inform the financial impact of a 10% adverse price movement. Minor wording differences (e.g., 'negligible' vs 'not material') do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 330,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "P&G’s adult‑incontinence business—anchored by the Always Discreet brand—accounts for roughly **15 % of the global market share** in the Baby, Feminine & Family Care segment (i.e., about 15 % of the segment’s total market share comes from this sub‑category).【page_18】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that the adult incontinence sub-category, represented by Always Discreet, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment, which matches the ground truth. The quantitative accuracy is perfect—15% is correctly reported with no calculation or number errors. The entity identification is accurate (P&G, Always Discreet, Baby Feminine & Family Care segment). The reasoning is mostly sound, though the LLM does not explicitly clarify the distinction between Always Discreet's 15% share within the adult incontinence sub-category versus its contribution to the total segment share, which is implied but not fully unpacked. However, the final conclusion (15% of total segment market share) aligns with the ground truth interpretation. The answer is semantically equivalent and contextually precise, addressing all parts of the question concisely. Minor deduction in qualitative accuracy due to lack of explicit multi-hop explanation (e.g., how sub-category performance maps to overall segment share), but the final inference is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 317,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "The average price paid per Accenture plc Class A ordinary share in the fourth quarter of fiscal 2024 was **$303.05** per share 【page_39†L1-L7】【page_39†L31-L38】. This figure reflects the total cash outlay for the quarter divided by the 2,072,563 shares acquired—including the 2,000,308 shares bought under the publicly announced open‑market program and the 72,255 shares purchased in transactions unrelated to the announced plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states an average price of $303.05 per share, which is incorrect compared to the ground truth of approximately $299.48. This is a significant quantitative error that undermines the factual correctness of the response. (2) The LLM provides specific numbers: 2,072,563 total shares acquired (2,000,308 + 72,255), which may be factually accurate based on the cited pages, but the average price calculation is wrong. If the average price were $303.05, the total cash outlay would be ~$628.1 million (2,072,563 × $303.05), whereas the correct cash outlay should be ~$620.7 million (2,072,563 × $299.48). The discrepancy indicates either incorrect source data or a miscalculation. (3) The reasoning structure is sound—LLM correctly identifies that the average price must account for shares acquired through both publicly announced programs and unrelated transactions, demonstrating proper multi-hop synthesis across those components. (4) Despite correct contextual framing and entity identification (Accenture plc Class A shares, fiscal Q4 2024, correct breakdown of share purchases), the core numerical result is factually wrong, leading to a low correctness and quantitative accuracy score. Contextual relevance is high because the model addresses the right entities and logic path.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 365,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance fell by **$20.1 million**, dropping from **$156.2 million in 2020** to **$136.1 million in 2021**【page_71】. By comparison, the collaboration and other revenue attributed to Jardiance in 2021 was **$1,490.8 million**【page_71】—more than seventy‑times the change in capitalized milestones.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in net milestones capitalized for Jardiance from 2020 to 2021 as $20.1 million, with accurate base values of $156.2 million in 2020 and $136.1 million in 2021. This part of the answer is factually correct and matches the ground truth. However, the collaboration revenue reported for Jardiance in 2021 is severely incorrect: the LLM states $1,490.8 million, while the ground truth specifies that collaboration and other revenue totaled $175.0 million. This is a major factual error, off by over $1.3 billion. (2) The calculation of the difference in milestones is accurate ($156.2M - $136.1M = $20.1M), but the comparison to collaboration revenue is fundamentally flawed due to the incorrect revenue figure. The claim that collaboration revenue was 'more than seventy-times' the change in milestones is based on false data and thus invalid. (3) The multi-hop reasoning is partially sound—linking milestone changes to collaboration revenue is appropriate—but the synthesis fails because it relies on an incorrect data point. The model appears to have pulled a revenue number from the same document (citing page 71), but likely confused Jardiance-specific collaboration revenue with total Eli Lilly collaboration revenue or another aggregated figure. (4) The correctness score is 4 due to one major quantitative error despite correct milestone figures. Quantitative accuracy is low (3) because of the large revenue discrepancy. Qualitative accuracy is moderate (5) as reasoning structure is sound but based on faulty data. Contextual relevance is high (7) because the answer addresses both parts of the question and attempts meaningful comparison, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 469,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "GM recorded $316 million in gains from its Stellantis warrants for the year ended December 31 2021. After selling its Opel/Vauxhall business to Stellantis, GM continues to purchase from and supply Stellantis with vehicles, parts and engineering services under a transitional agreement that extends beyond the sale.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $316 million gain from Stellantis warrants in 2021 is accurately reported, with the correct year (December 31, 2021) aligning with the 2021 fiscal period. (2) The ongoing business relationship is correctly described: GM continues to both purchase from and supply Stellantis with vehicles, parts, and engineering services post-sale of the Opel/Vauxhall business. The mention of a 'transitional agreement' adds contextual clarity without distorting the facts. (3) Multi-hop reasoning is sound—linking the financial gain from warrants to the operational relationship after the Opel/Vauxhall sale demonstrates synthesis across financial and operational domains. (4) All entities—GM, Stellantis, Opel/Vauxhall—are correctly identified, and the answer fully addresses both sub-questions. Semantic equivalence is maintained with slightly enhanced wording, but no factual deviation. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 290,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "AIG recorded a **pre‑tax loss of $114 million** when AIG Financial Products Corp. and its subsidiaries were deconsolidated, and the loss is shown in the consolidated income statement under “Net gain (loss) on divestitures and other.” This amount reflects the financial impact of AIGFP’s Chapter 11 reorganization – the subsidiary’s assets (including a $37.6 billion loan receivable) were removed from AIG’s consolidated balance sheet and the loss reduced AIG’s pre‑tax earnings.【page_204】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax loss of $114 million from the deconsolidation of AIGFP, accurately reflecting the key financial figure from the ground truth. It also correctly notes that the loss is reported under 'Net gain (loss) on divestitures and other' in the consolidated income statement. The $37.6 billion loan receivable is correctly cited. (2) All numeric values—$114 million and $37.6 billion—are factually accurate and match the original answer exactly; no calculations are required, but the reporting of figures is precise. (3) The reasoning is sound: the LLM correctly links the Chapter 11 reorganization to the deconsolidation and its financial statement impact, including the removal of assets and the earnings impact. However, it omits the explicit statement from AIG that the reorganization would not have a material impact on the consolidated balance sheets or businesses, which is a key qualitative nuance in the original answer. This omission slightly weakens the completeness of the multi-hop synthesis, particularly regarding AIG’s overall financial position assessment. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and conveys the core financial impact accurately. The missing materiality assessment prevents a perfect 10 on qualitative accuracy, but quantitative and contextual accuracy are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 389,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The net carrying amount of Acquired Franchise Rights at year‑end 2024 was **$598 million**【page_83】. In the prior year (2023) the gross amount reported for the same asset category was **$840 million**, so the 2024 net value is about **$242 million lower** than the 2023 gross amount【page_83】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2024 net value of Acquired Franchise Rights as $598 million and the 2023 gross value as $840 million, both of which match the ground truth. However, it incorrectly states that the 2024 net value is $242 million lower than the 2023 gross value. The correct comparison per the question is between the 2024 net value and the 2023 gross value, but the ground truth emphasizes the change in gross value from 2023 to 2024 (a $19 million decrease from $840M to $821M), not a direct net-to-prior-gross difference. While the arithmetic difference between $598M and $840M is indeed $242M, this comparison (net vs. prior gross) is not the same as the trend in gross value over time, which is the intent of the second part of the question. (2) Numbers are accurate: $598M (net 2024), $840M (gross 2023) are correct. The $242M difference is mathematically correct but contextually misleading. The LLM omits the 2024 gross value ($821M) and accumulated amortization ($223M), which are part of the full explanation in the ground truth. (3) The reasoning is partially sound but fails to fully synthesize the multi-hop elements: it should have noted the 2024 gross value and its $19M decrease from 2023, rather than comparing net 2024 to gross 2023 without clarification. (4) Correctness score is 7 because key facts are present and numerically accurate, but the comparative analysis is misaligned with the question’s intent. Quantitative accuracy is 8 due to correct numbers but incomplete presentation. Qualitative accuracy is 7 due to flawed reasoning in the comparison. Contextual relevance is 10 as all information provided is relevant and on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 460,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "AT&T paid $23,406 million for the C‑Band auction (the $550 million deposit plus $22,856 million cash payments) and it expects an additional $2,112 million to clear Phase II spectrum and about $1,000 million for compensable relocation costs. Together, these obligations total roughly $26,518 million (≈ $26.5 billion)【page_54†L1-L5】【page_54†L6-L9】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core components of AT&T's financial commitment: auction payment ($23,406 million), spectrum clearing ($2,112 million), and relocation costs ($1,000 million), which match the ground truth values. However, the total is miscalculated: $23,406 + $2,112 + $1,000 = $26,518 million, whereas the ground truth reports $26,478 million. This $40 million discrepancy is significant and likely due to an arithmetic error or misstatement in the source citation. (2) Individual numbers are accurate in amount and unit (all in millions), and formatting variations (e.g., $26.5 billion) are acceptable. The breakdown of the auction payment into deposit and cash is extra detail not in the ground truth but not incorrect. (3) The multi-hop reasoning is sound—LLM synthesizes auction cost, future clearing, and relocation obligations into a total commitment, correctly interpreting the 10-K disclosure. (4) Despite the total miscalculation, the answer is contextually complete and relevant, addressing all parts of the question with correct entities (AT&T, C-Band, 10-K), metrics, and timeframes. The error is limited to the final sum, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 342,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance fell by $20.1 million, dropping from $156.2 million in 2020 to $136.1 million in 2021【page_71】. At the same time, Jardiance’s collaboration‑and‑other revenue rose sharply to $1.490.8 billion in 2021 from $1.153.8 billion in 2020, indicating that despite a lower remaining milestone balance, the diabetes portfolio generated stronger sales and overall financial performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in net milestones capitalized for Jardiance—$156.2 million in 2020 to $136.1 million in 2021, a $20.1 million decrease—which matches the ground truth and is quantitatively accurate. However, the LLM introduces a major factual error by stating that 'collaboration-and-other revenue rose sharply to $1.490.8 billion in 2021 from $1.153.8 billion in 2020.' These numbers are malformed (e.g., $1.490.8 billion is not a valid number format) and appear to be corrupted versions of actual figures. Even if interpreted as $1.4908 billion and $1.1538 billion, these values are not supported by the ground truth and contradict the original answer, which does not mention such revenue increases. (2) The calculation of the $20.1 million decline is correct: 156.2 - 136.1 = 20.1. However, the malformed revenue numbers suggest data extraction or parsing errors, undermining quantitative reliability. (3) The multi-hop reasoning is partially sound—the model connects milestone capitalization to financial performance—but draws an unsupported conclusion that stronger sales offset the milestone decline, which is not in the original answer and lacks valid evidence. The original answer interprets the decline as a potential signal of slowed milestone progress, not offset by sales growth. (4) The correctness score is 5 due to accurate core numbers but major errors in supplementary data and reasoning. Quantitative accuracy is 6 because the key calculation is correct but other numbers are invalid. Qualitative accuracy is 5 due to flawed logic and unsupported claims. Contextual relevance is 8 because the response addresses the question's intent and structure appropriately, despite factual issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 474,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "In 2021 GM’s “interest income and other non‑operating income, net” rose because of a $0.8 billion increase in non‑service pension income and a $0.2 billion increase in gains on Stellantis N.V. warrants, together delivering roughly a **$1.0 billion** financial benefit from its relationship with Stellantis【page_36】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis N.V. warrants, totaling $1.0 billion in financial benefit in 2021. (2) Quantitative accuracy is perfect—each dollar amount matches the original answer, and the sum ($0.8B + $0.2B = $1.0B) is correctly implied. Format variations (e.g., $1.0 billion vs $1.0 billion) are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct financial components (pension income and warrant gains) tied to GM's relationship with Stellantis, both of which are required to answer the question. (4) Entity accuracy is strong—'General Motors' (GM), 'Stellantis N.V.', '2021', and financial terms like 'non-service pension income' and 'gains on warrants' are correctly identified. The answer is contextually relevant, directly addressing the total financial benefit from the Stellantis relationship as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 295,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "After de‑consolidating Corebridge, AIG measured its remaining stake at fair value and recognized the effect of Corebridge’s share‑price movements as a $439 million gain on the “Retained investment in Corebridge” line (which contributed to the $601 million of equity‑method income for the June 10‑Dec 31 2024 period) 【page_122】. The gain was recorded in net investment income, reflecting AIG’s still‑held 22.7 % ownership interest in Corebridge that is now accounted for under the equity‑method 【page_108】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $439 million gain, $601 million equity-method income, 22.7% ownership interest, and the time period (June 10-Dec 31, 2024) match expectations. The reference to page 122 and page 108 supports the claims. (2) The answer correctly identifies that AIG's retained stake is measured at fair value, and changes in Corebridge's stock price flow into AIG's financial statements via net investment income, which is consistent with fair value accounting for the retained investment. (3) The reasoning correctly synthesizes multi-hop information: deconsolidation led to fair value measurement, stock price changes generated a gain, and the retained ownership (22.7%) is now under the equity method. The $439M gain contributing to $601M total equity-method income shows proper contextual understanding. (4) While the original answer emphasizes the 'fair value option' in the Consolidated Statements of Income, the LLM specifies the exact line item and amount, adding precision. The only minor gap is not explicitly stating that equity-method income itself isn't directly driven by stock price changes (it's based on underlying earnings), but rather that the gain from fair value remeasurement is separate and additional. However, the LLM correctly distinguishes the $439M fair value gain from the broader equity-method income, so the logic holds. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 420,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The amortizable intangible‑assets table shows that “Other identifiable intangibles” had a net carrying amount of **$144 million** at year‑end 2024. This is **$30 million lower** than the $174 million net amount reported for 2023, indicating a $30 million decrease.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net value of Other Identifiable Intangibles for PEP in 2024 as $144 million, matching the ground truth value of $144 (with 'million' implied or explicitly stated—format variation is acceptable). It also accurately states the 2023 value as $174 million and calculates the decrease as $30 million, which matches the ground truth difference ($174 - $144 = $30). (2) All numeric values are correct: $144 million (2024), $174 million (2023), and the $30 million decrease are all factually accurate and consistent with the original answer. Calculations are correct. (3) The reasoning is sound: the LLM correctly interprets the amortization impact by comparing year-over-year net carrying amounts, demonstrating proper multi-hop synthesis across two time points to derive the change. (4) The answer is semantically equivalent to the ground truth, includes all required components (2024 value and decrease from 2023), uses correct entities (PEP, Other Identifiable Intangibles, 2023–2024), and maintains contextual precision. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 321,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "In 2023 the Marine Systems segment earned **$8.631 billion** from nuclear‑powered submarines, versus **$2.698 billion** from surface ships【page_64】【page_9】.  That means submarine revenue was about **$5.9 billion higher – roughly three times** the surface‑ship revenue, underscoring the strategic priority of the Columbia‑class ballistic‑missile and Virginia‑class attack‑submarine programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for nuclear-powered submarines ($8.631 billion) and surface ships ($2.698 billion), matching the ground truth of $8,631 million and $2,698 million exactly—format variation (billion vs. million) is acceptable and semantically equivalent. (2) The calculation of the difference ($5.9 billion higher) is accurate: $8,631M - $2,698M = $5,933M ≈ $5.9B. The statement that submarine revenue was 'roughly three times' surface ship revenue is also correct: $8,631 / $2,698 ≈ 3.2, which aligns with the ground truth ratio of 3.2:1. (3) The multi-hop reasoning is sound—the model synthesizes revenue data from two different categories (submarines and surface ships) and correctly infers the strategic importance based on the revenue disparity, referencing the Columbia-class and Virginia-class programs as in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly state the precise ratio of 3.2:1, instead rounding to 'roughly three times,' which slightly reduces precision in qualitative expression but does not misrepresent the data. All entities (General Dynamics Marine Systems, submarine programs, revenue streams) are correctly identified and contextualized. The answer is highly relevant, complete, and factually accurate with only negligible simplification in the ratio description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 382,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "GM’s investment in Stellantis warrants grew from $1.2 billion at December 31 2020 to $1.5 billion at December 31 2021 – an increase of about $0.3 billion【page_50】. Over the same period, the fair value of GM’s marketable debt securities fell from $9.0 billion to $8.6 billion – a decrease of roughly $0.4 billion【page_50】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Stellantis warrants increased from $1.2 billion to $1.5 billion, resulting in a $0.3 billion increase, and marketable debt securities decreased from $9.0 billion to $8.6 billion, a $0.4 billion decrease—both values match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the change in fair value for Stellantis warrants and marketable debt securities over the specified period (December 31, 2020, to December 31, 2021). (3) Entity accuracy is correct—GM, Stellantis warrants, and marketable debt securities are properly identified with correct time frames. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information by comparing two distinct asset classes and their valuation trends over time, even though it does not explicitly state the 'contrasting trends' conclusion—the data presented inherently supports that interpretation. The inclusion of citation markers (【page_50】) indicates proper grounding. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 340,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "Acquired Franchise Rights fell by $33 million, dropping from $1,891 million in 2023 to $1,858 million in 2024【page_85】. Over the same period the company’s total amortization expense slipped slightly, decreasing from $75 million in 2023 to $74 million in 2024【page_83】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, a $28 decrease. However, the LLM claims a drop from $1,891 million to $1,858 million, which is a $33 million decrease—both the values and the magnitude of change are incorrect. Additionally, the LLM cites amortization expense decreasing from $75 million to $74 million, while the original answer only mentions $74 million in amortization for 2024 without specifying 2023, making partial verification difficult, but the core link between amortization and the decrease is misrepresented due to wrong base numbers. (2) The quantitative values are entirely inconsistent with the ground truth: $626 vs. $1,891 million (over 3x difference), $598 vs. $1,858 million, and $28 vs. $33 decrease. These are not formatting differences but fundamental errors. (3) The reasoning is flawed because the LLM fails to correctly identify the actual values of Acquired Franchise Rights for PEP, undermining any multi-hop synthesis between asset value change and amortization impact. The mention of amortization expense aligning with the $74 figure in 2024 is partially correct, but the comparative trend (decrease from $75M) is unsupported in the ground truth. (4) Due to major factual and numerical errors, the correctness and quantitative accuracy scores are low. Qualitative accuracy is slightly higher because the model attempts to link amortization to the decline in franchise rights, showing some understanding of the conceptual relationship. Contextual relevance is moderate as the answer addresses the right topic and metric, albeit with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 468,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The higher‑volume F‑35 sustainment work lifted Aeronautics’ service‑costs by roughly **$570 million**, which accounted for most of the **$775 million** total increase in service costs in 2023.  The same F‑35 sustainment activity drove Aeronautics’ service‑sales up by about **$600 million**, a modestly larger rise than the cost increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the $570 million increase in service costs due to F-35 sustainment, the $775 million total service cost increase, and the $600 million increase in service sales—all matching the ground truth. (2) Quantitative accuracy is perfect: numbers are correct, and the comparison between cost and sales increases is factually sound (cost increase $570M vs. sales increase $600M). The implied $30M difference is accurate, though not explicitly stated. (3) The multi-hop reasoning is solid—linking F-35 sustainment to both cost and sales increases within Aeronautics in 2023 is correctly synthesized. However, the LLM omits the explicit conclusion about margin improvement mentioned in the original answer, which slightly weakens the qualitative completeness. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the contribution of F-35 costs to overall cost increases and the comparison with sales increases. The omission of the margin implication prevents a perfect score, but all factual and numerical content is correct and well-aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 327,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024 Accenture’s Board approved an additional $4 billion of buy‑back authority, bringing the company’s total outstanding share‑repurchase authority to **$6,694 million (≈ $6.7 billion)**【page_39†L31-L38】.  This large, ongoing authority signals that Accenture is actively using share buybacks as a core part of its capital‑return strategy, deploying cash to repurchase Class A ordinary shares and thereby support shareholder value and manage the company’s equity base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total share repurchase authority as $6,694 million (≈$6.7 billion) as of September 25, 2024, matching the ground truth. It accurately notes the additional $4 billion approved by the Board, which increased the prior $2,694 million to the new total—this calculation is correct ($2,694M + $4,000M = $6,694M). The date (September 25, 2024) and entity (Accenture plc) are correct. 2) All numeric values are accurate and properly formatted; $4 billion is equivalent to $4,000 million, and the sum is precise. The use of ≈$6.7 billion is a reasonable rounding and does not misrepresent the figure. 3) The reasoning correctly synthesizes two key pieces of information: the prior authority and the new Board approval, reflecting multi-hop understanding. The conclusion about Accenture’s capital-return strategy and active management of equity via buybacks aligns with the original answer. 4) The LLM omits explicit mention of 'open-market purchases and other share purchase programs' from the ground truth, which slightly reduces completeness in describing the strategy. However, the core financial strategy—using buybacks to support shareholder value and manage equity—is semantically equivalent and well-reasoned. Thus, while highly accurate, it misses a minor but specific detail in implementation methods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 372,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "A shortfall in new members would leave Netflix bearing largely fixed content costs—including the additional expense of live‑programming—without the revenue needed to offset them. Because those costs can’t be scaled back quickly, per‑member revenue would fall, compressing margins, draining liquidity and limiting the cash needed for further investment, which directly hurts both financial flexibility and profitability (Item 1A Risk Factors, page 6).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually and semantically equivalent to the original answer. (1) It correctly identifies that Netflix's live programming expansion adds fixed content costs, which cannot be easily adjusted if membership growth falls short. This aligns with the ground truth's emphasis on non-adjustable costs. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; both answers rely on qualitative financial reasoning. (3) The multi-hop reasoning is sound: the model connects live programming → fixed costs → dependence on membership growth → impact on per-member revenue, margins, liquidity, and profitability. It also correctly infers the consequences for financial flexibility (via liquidity and investment capacity) and profitability (via margin compression). (4) The LLM adds a specific citation (Item 1A Risk Factors, page 6), which enhances credibility and contextual grounding in the 10-K filing, without introducing inaccuracies. Wording differs slightly but conveys the same core logic and causal chain as the ground truth. All aspects of the question are addressed with precise, relevant, and correct reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 338,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The 5.15 % 2041 Notes carry $729 million on the balance sheet, which is about 2.2 % of AMGN’s total reported debt of $33,309 million (729 ÷ 33,309 ≈ 0.0219). According to the debt‑exchange table, $245 million of principal of these notes was exchanged. (Sources: page 130 – debt carrying values; page 132 – debt‑exchange table.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of the 5.15% 2041 Notes is correctly stated as $729 million, total debt is $33,309 million, and the percentage is correctly calculated as approximately 2.19%, which the model rounds to 2.2%—an acceptable and common rounding. The principal amount exchanged is accurately reported as $245 million. (2) The calculation (729 ÷ 33,309 ≈ 0.0219) is correct and explicitly shown, demonstrating sound reasoning. (3) The multi-hop reasoning is sound: the model synthesizes data from two different parts of the filing—debt carrying values (page 130) and the debt exchange table (page 132)—to answer both parts of the question. (4) Entity accuracy is perfect: AMGN is correctly identified, the 5.15% 2041 Notes are precisely referenced, and the year 2022 is correctly implied as the reporting period. (5) The answer is semantically equivalent to the original, with added transparency via calculation and source references. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 318,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "McDonald’s records goodwill on the purchase of franchised (company‑operated) restaurants. If a restaurant is sold **within 24 months of acquisition**, the entire goodwill attached to that acquisition is written off. If the sale occurs **after 24 months**, the goodwill charge is prorated – the write‑off equals the portion of goodwill that corresponds to the fair‑value of the sold restaurant relative to the fair‑value of the entire reporting unit【page_45】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: McDonald's records goodwill upon acquisition of franchised (company-operated) restaurants; if sold within 24 months, the entire goodwill is written off; if sold after 24 months, the write-off is based on relative fair value. (2) There are no numeric values requiring calculation, but the 24-month threshold is correctly stated and consistently applied. Format variations (e.g., 'after 24 months' vs 'beyond 24 months') are acceptable and convey the same meaning. (3) The multi-hop reasoning is sound—synthesizing the accounting treatment of goodwill at acquisition and its differential write-off timing based on sale window. The answer correctly links acquisition, goodwill recognition, and subsequent derecognition logic depending on time frame. (4) The answer is fully relevant, directly addressing how the timing of sale impacts financial reporting of goodwill. Minor wording differences (e.g., 'prorated' vs 'based on relative fair value') do not affect factual correctness and are reasonable interpretations. No omissions or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 330,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG reported **$601 million** of equity‑method income from Corebridge for the period after the deconsolidation date (June 10 – December 31 2024). This amount represents the **sum of dividends received from Corebridge and the change in Corebridge’s stock price (fair‑value adjustment)** on AIG’s retained equity investment, which is recognized in net investment income after the deconsolidation.【page_109】【page_108】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($601 million) that is not present in the original answer (ground truth), which does not provide any numerical figure for equity method income. There is no mention of dividends or stock price changes totaling $601 million in the ground truth, nor is there confirmation of this figure in the provided context. This introduces a significant factual inaccuracy. (2) The date range 'June 10 – December 31, 2024' slightly misstates the post-deconsolidation period, which begins on June 9, 2024, per the original answer. While minor, this is a discrepancy in temporal precision. The calculation method—dividends received plus change in stock price (fair-value adjustment)—is partially aligned with the ground truth, though the original answer does not explicitly confirm that fair-value adjustments are part of equity method accounting; typically, equity method income is based on AIG’s share of Corebridge’s earnings, not stock price changes. This reflects a conceptual misunderstanding. (3) The multi-hop reasoning is partially sound in that it identifies the retained ownership (implied by 'retained equity investment') and links post-deconsolidation income to Corebridge’s performance. However, it incorrectly frames the income as driven by stock price changes rather than earnings attributable to the equity stake, which is a key flaw in financial reasoning. The citation of page references suggests sourcing, but the substance diverges from standard equity method accounting and the ground truth description. (4) The correctness score is 4 due to major quantitative and conceptual errors, despite addressing the right entities (AIG, Corebridge) and general timeframe. Quantitative accuracy is low (3) because the $601M figure is unsupported and dates are slightly off. Qualitative accuracy is moderate (5) as the model captures the idea of post-deconsolidation income from retained ownership but misrepresents the calculation basis. Contextual relevance is high (8) because the response stays focused on the question and attempts to explain the income mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 570,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Franchisee‑operated restaurants employ over 2 million people, which is roughly 93 % of McDonald’s total global workforce (≈2 million of ~2.15 million total)【page_4】. The company’s recruitment initiative seeks to boost the share of franchisees from under‑represented backgrounds by cutting upfront equity requirements and providing ongoing learning‑and‑development support, thereby diversifying the franchisee demographic【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that franchisees contribute approximately 93% of McDonald's global workforce, with over 2 million employees in franchised restaurants compared to about 150,000 company employees (total ~2.15 million), which aligns with the ground truth. The percentage and workforce figures are quantitatively accurate. (2) All numeric values match the original answer: 'over 93%', 'over two million', and 'over 150,000' are preserved in the LLM response using equivalent phrasing ('≈2 million', '~2.15 million'). The calculation of ~93% is mathematically sound (2 / 2.15 ≈ 93%). (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers the percentage from the relative sizes of the franchised vs. company-employed workforce and links the recruitment initiative to demographic impact. The mention of reducing upfront equity requirements and providing learning-and-development support for underrepresented groups captures the core of the diversity initiative. (4) The only minor shortcoming is slight omission of explicit mention that the initiative targets both U.S. and International Operated Markets, though 'under-represented backgrounds' implies a broad scope. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 405,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production together caused RMS’s operating profit to drop $41 million (about a 2% decline) in 2023. In contrast, Sikorsky programs drove the RMS backlog up by roughly $2.8 billion year‑over‑year (from $34.9 billion to $37.7 billion), showing a much larger positive contribution to the backlog than the modest profit hit.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $100 million unfavorable adjustment and lower Black Hawk production as key factors reducing RMS operating profit, and correctly states the net $41 million decrease in operating profit, aligning with the ground truth. However, the LLM introduces a 2% decline figure and specific backlog numbers ($34.9B to $37.7B, a $2.8B increase) that are not present in the original answer and cannot be verified from the provided ground truth. These additions, while plausible, are unsupported by the source and represent a quantitative overreach. (2) The $41 million net decrease is accurate and matches the ground truth calculation (i.e., $100M loss partially offset by $65M gain and other improvements, resulting in $41M net drop). However, the 2% decline and exact backlog figures lack corroboration and introduce potential inaccuracies. (3) The multi-hop reasoning is sound: the model correctly links the negative profit impacts to the net profit outcome and contrasts this with Sikorsky's positive backlog contribution. It appropriately distinguishes between current profit impact and future revenue potential via backlog, demonstrating good synthesis. (4) The contextual relevance is high—every part of the question is addressed: the collective impact on operating profit and the comparison to backlog contribution. The qualitative reasoning is strong, but the unsupported numerical additions reduce quantitative accuracy. Hence, correctness is partially compromised by unverified numbers, warranting a 7/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 426,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom’s acquisition of VMware was priced at roughly $30.8 billion in cash plus 544 million Broadcom shares valued at about $53.4 billion, for a total consideration of approximately $84.2 billion (page 38; page 58). The deal adds VMware’s multi‑cloud and virtualization platform to Broadcom’s infrastructure‑software portfolio, directly supporting its strategy to expand and lead in infrastructure software solutions for enterprise and hybrid‑cloud environments (page 37; page 58).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of Broadcom's acquisition of VMware as approximately $84.2 billion, which aligns with the ground truth value of $84,186 million ($84.186 billion). The breakdown of $30.8 billion in cash matches the ground truth $30,788 million (rounded appropriately), and the stock component of $53.4 billion closely approximates the actual $53,398 million (also a valid rounding). The use of 'approximately' and 'roughly' allows for minor rounding and is semantically equivalent. (2) All numeric values are accurate within acceptable rounding conventions; the sum of $30.8B + $53.4B = $84.2B is correct and matches the total. No calculation errors are present. (3) The reasoning is sound: the LLM correctly links the acquisition to Broadcom’s strategic focus on infrastructure software, specifically citing multi-cloud and virtualization capabilities, which aligns with the ground truth’s mention of 'multi-cloud services' and 'enterprise control' in strategic priorities. The synthesis of information across financial terms and strategic intent reflects proper multi-hop reasoning. (4) The answer is contextually fully relevant, addressing both the quantitative aspect of the deal and its strategic rationale. The only minor limitation is the lack of explicit mention of 'digital innovation with enterprise control' from the original, but the reference to enterprise and hybrid-cloud environments captures the core strategic alignment. Thus, all scores are high, with correctness docked slightly to 9 due to slight omission of a specific strategic phrase, though the meaning remains intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 449,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The $6.99 ad‑supported tier gives Netflix a lower‑price, ad‑backed entry point that expands its addressable audience, and that expansion is reflected in the 18% year‑over‑year rise in global paid memberships (paid memberships grew from 80.1 million in 2023 to 89.6 million in 2024, a net addition of 9.5 million)【page_48】. By pairing a cheaper plan with ad revenue, Netflix can grow its subscriber base while offsetting any dip in ARPU, which aligns with its stated strategy of balancing ARPU against broader market penetration.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The reported growth from 80.1 million to 89.6 million represents a 11.9% increase, not 18%, and these numbers do not align with Netflix's actual reported membership figures for 2023–2024. The ground truth confirms an 18% year-over-year increase in global paid memberships, but the LLM fabricates specific membership numbers that are not in the original answer or consistent with public Netflix reports. There is no source in the ground truth for these exact figures, and the calculation is incorrect. (2) The qualitative reasoning is mostly sound: the LLM correctly identifies that the $6.99 ad-supported tier expands market reach and supports subscriber growth at potentially lower ARPU, which aligns with Netflix’s strategy of balancing ARPU and penetration. This reflects proper multi-hop synthesis between pricing strategy and business outcomes. (3) The entity accuracy is correct—Netflix, the $6.99 ad-supported tier, ARPU, and market penetration are all accurately referenced. The logic connecting lower pricing to broader adoption and strategic tradeoffs is semantically equivalent to the ground truth. (4) Contextual relevance is high because the answer directly addresses the relationship between the pricing tier and membership growth, and ties it to Netflix’s strategic balancing act. However, the fabricated numbers and incorrect calculation severely undermine factual correctness, warranting a moderate score of 6 for overall correctness despite strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 430,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "Over 2.15 million people work in McDonald’s restaurants worldwide – roughly 150,000 Company‑owned and operated employees plus more than 2 million staff at franchised locations【page_4】.  This combined workforce is described as “critical to the Company’s success, enabling it to drive long‑term value creation and further its purpose to feed and foster communities and its mission to make delicious feel‑good moments easy for everyone”【page_4】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately presented: the total workforce of over 2.15 million, with approximately 150,000 company employees and over 2 million in franchised restaurants, matches the original answer exactly in substance (allowing for format variation: '2.15 million' = '2,150,000'). (2) Quantitative accuracy is perfect—numbers are correctly reported and consistent with the source, including the breakdown between company and franchise employees. (3) The reasoning is sound and captures the multi-hop synthesis required: it correctly links the workforce composition to McDonald's purpose and mission, quoting the exact phrasing about 'feeding and fostering communities' and 'making delicious feel-good moments easy for everyone.' (4) Contextual relevance is complete—the answer addresses both parts of the question: total workforce size and its contribution to the company's mission. The inclusion of a citation (page_4) further supports its grounding in the source material. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 317,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "Broadcom’s purchase of VMware was accounted for at a total fair‑value of roughly **$53.4 billion** (≈ $53,398 million) 【page_38†L1-L4】【page_58†L1-L4】.  By adding VMware’s multi‑cloud and private‑cloud software platform—including VMware Cloud Foundation and its suite of hybrid‑cloud, application‑development, edge‑computing and security tools—Broadcom expands the breadth and depth of its infrastructure‑software offerings, giving customers greater flexibility, license portability and the ability to modernize, automate and secure complex private‑ and hybrid‑cloud environments【page_58†L5-L8】【page_39†L1-L5】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that the acquisition enhances Broadcom's infrastructure software capabilities by incorporating VMware's multi-cloud and hybrid-cloud platforms, including tools for automation, security, and cloud modernization. This aligns well with the ground truth's emphasis on multi-cloud services enabling digital innovation with enterprise control. However, the total fair value is inaccurately reported: the LLM states ~$53.4 billion ($53,398 million), which matches only the stock component of the deal, omitting the $30,788 million in cash. The correct total fair value is $84,186 million ($53,398M stock + $30,788M cash), so the LLM significantly underreports the total. 2) Quantitatively, the $53,398 million figure is accurate but incomplete—it represents only part of the total consideration. The omission of the cash component leads to a major error in the overall valuation, though the number itself is correctly cited from the source. 3) The reasoning is otherwise sound: the LLM correctly synthesizes information about VMware’s technology contributions (e.g., Cloud Foundation, hybrid-cloud tools) and links them to Broadcom’s strategic expansion in infrastructure software. It demonstrates multi-hop understanding by connecting VMware’s capabilities to Broadcom’s enhanced portfolio. 4) Contextually, the response is highly relevant and well-supported with inline citations. Despite the critical quantitative error, the qualitative explanation of strategic benefits is strong and semantically equivalent to the ground truth. Hence, a correctness score of 7: core capabilities explanation is solid, but the financial figure is materially incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 458,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Netflix’s 10‑K states that it “offers a variety of streaming membership plans…pricing on our paid plans ranged from the U.S. dollar equivalent of $1 to $32 per month” and that “prices…may change” – with recent price increases contributing to a 16% rise in streaming revenue (see page 22). At the same time, the filing warns that “adverse macro‑economic conditions, including inflation, may also adversely impact our ability to attract and retain members” and that price adjustments “may not be well‑received” by cost‑conscious consumers (see page 6). Thus, while price hikes boost revenue, they risk higher churn when members are pressured by inflation and tighter household budgets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the pricing range of $1 to $32 per month as of December 31, 2024, is accurately cited, and the mention of price changes and their impact on revenue (16% increase) is consistent with the 10-K. The reference to inflation and macroeconomic pressures affecting member retention is correctly pulled from the filing. (2) Quantitative accuracy is perfect: dollar amounts, pricing range, and percentage revenue increase (16%) are all correctly reported. Format variations are acceptable and do not affect correctness. (3) Multi-hop reasoning is sound: the model successfully connects Netflix’s pricing strategy (revenue-enhancing price hikes) with the risk of increased churn under macroeconomic stress, synthesizing information from different parts of the 10-K. The logic that higher prices may conflict with retention during inflationary periods is well-reasoned and matches the original answer’s core argument. (4) The only minor shortcoming is that the LLM does not explicitly mention the fixed nature of content costs, which limits Netflix’s ability to adjust expenses if membership growth slows—a nuance present in the ground truth. However, this omission does not undermine the central point about pricing-revenue-churn trade-offs. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 395,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald’s goodwill on restaurant purchases is calculated with a discounted‑cash‑flow model that uses the franchisee’s expected sales and cash‑flow generation as the key inputs; because the company’s margins depend on franchisee performance, any weakening of franchisee sales or other franchise‑related risks can lower those cash‑flow assumptions and create a risk of goodwill impairment. If a Company‑operated restaurant is sold, the goodwill attached to that acquisition is written off in full when the sale occurs within 24 months, and beyond 24 months the write‑off is proportional to the fair‑value of the sold business relative to its reporting unit—both outcomes reflect the underlying franchisee‑driven cash‑flow expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: McDonald's uses a discounted cash flow model for goodwill, franchisee performance affects cash flow assumptions, and goodwill is written off fully if a restaurant is sold within 24 months or proportionally based on fair value after 24 months. (2) Quantitative accuracy is perfect: the 24-month threshold is correctly stated, and there are no numerical errors or miscalculations. Format variations (e.g., '24 months' vs 'within 24 months') are semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly links franchisee performance → cash flow expectations → goodwill valuation → impairment risk → write-off rules upon sale. It synthesizes the franchise model risks with accounting policy accurately. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the *acquisition from franchisees* context and the *direct impact of franchisee distress leading to acquisition and resale*, which is central in the original. However, the logic chain is preserved. Wording differs but meaning is substantively equivalent. Contextual relevance is full—directly addresses the question’s focus on franchisee performance, goodwill accounting, and sale timing impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 366,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin’s hypersonics work is listed as a major Space program, reinforcing the segment’s strategic priority to provide advanced‑strike and defensive capabilities and to integrate space‑based situational‑awareness systems (see page 5).  The company treats hypersonics as one of four near‑to‑mid‑term growth pillars and expects several of these programs to move into early‑production by 2026, directly feeding the Space segment’s anticipated growth through that horizon (see page 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lockheed Martin's hypersonics programs are part of its Space segment, are one of four near-to-mid-term growth pillars, and are expected to enter early production by 2026. These details match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the time horizon 'by 2026' is correctly stated, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound—linking hypersonics to Space segment priorities, strategic growth, and production timelines across different parts of the 10-K (pages 3 and 5 referenced) shows proper synthesis. The only minor gap is that the original answer specifies U.S. Army and Navy programs as examples, which the LLM omits, and the LLM adds 'defensive capabilities' and 'space-based situational-awareness systems' not explicitly tied to hypersonics in the ground truth. However, these additions do not contradict and may reflect broader context from the filing. (4) The answer is fully relevant, directly addressing how hypersonics align with strategic priorities and contribute to growth through 2026. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight expansion beyond the cited content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 380,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom values the VMware Cloud Foundation‑related developed technology by discounting the cash flows it expects the technology to generate—net of the contribution of other assets—so the fair value reflects its projected financial contribution.  The economic benefit is estimated with the **multi‑period excess‑earnings method** under the income approach, applying an eight‑year economic useful life to the forecast cash‑flow stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the valuation technique as the 'multi-period excess earnings method' under the income approach, which matches the original answer. (2) The explanation that Broadcom values the developed technology by discounting expected cash flows net of contributions from other assets aligns with the excess earnings methodology. (3) The LLM adds a specific detail—an eight-year economic useful life—that is not present in the ground truth; however, this does not contradict it, as the original states the useful life was based on technology cycle and forecasts, without specifying the number of years. This addition may reflect supplementary data but doesn't invalidate the response. (4) The reasoning correctly links the valuation method to projected financial contribution over time, demonstrating sound multi-hop synthesis between valuation methodology and economic benefit. (5) All entities (Broadcom, VMware Cloud Foundation, developed technology) and financial concepts are accurately used. The only minor deviation is the inclusion of the 'eight-year' assumption not present in the ground truth, which slightly affects quantitative precision but not overall correctness. Thus, the answer is factually strong, contextually relevant, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 380,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The Sky Glass launch added new costs to the Corporate & Other segment in 2021, so that while overall expenses in the segment fell (mainly because COVID‑related severance costs were largely completed), those savings were “partially offset by costs related to Sky Glass and XClass TV”【page_62】.  Comcast said it “expects to incur increased costs in 2022 related to the launch of Sky Glass and XClass TV,” indicating the company anticipates higher expenses as the new hardware program scales【page_62】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that the launch of Sky Glass increased costs in the Corporate & Other segment in 2021, partially offsetting prior-year savings from reduced COVID-related severance expenses. The mention of 'costs related to Sky Glass and XClass TV' aligns exactly with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2021 and 2022) are correctly referenced, and the forward-looking expectation for 2022 is accurately reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while overall segment expenses decreased due to lower severance costs, new product launch costs (Sky Glass and XClass TV) counteracted some of those savings, and further cost increases were expected in 2022. (4) The strategic expectation—ongoing investment in new product rollouts—is clearly conveyed with appropriate context from the source (page 62 citation). Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 323,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "McDonald’s values restaurants bought from franchisees with a discounted‑cash‑flow (Level 3) fair‑value model and records the excess purchase price as goodwill in the reporting unit that will benefit from the acquisition. If a company‑operated restaurant is sold within 24 months, the entire goodwill attached to that acquisition is written off; if the sale occurs after 24 months, only the portion of goodwill proportional to the fair‑value of the sold business relative to the reporting unit is written off. As a result, early sales can eliminate goodwill in full, while later sales cause only partial reductions – reflected in 2023 by a modest $14.5 million of accumulated goodwill impairment and a net increase in goodwill of roughly $140 million despite $107 million of restaurant sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly describes McDonald's use of discounted cash flow (Level 3 inputs) for valuing acquired restaurants and accurately explains the goodwill write-off policy—full write-off if sold within 24 months, partial based on relative fair value if sold after. This aligns with the ground truth and shows correct entity identification (McDonald's, goodwill, franchisee acquisitions) and sound reasoning. (2) However, the quantitative details introduced—specifically the $14.5 million goodwill impairment and $140 million net increase in goodwill despite $107 million of restaurant sales in 2023—are not present in the original answer and cannot be verified against the ground truth. These figures may be factually accurate but represent an overreach, as the original answer does not include any numerical data or reference to 2023 financials. This introduces unverified information, reducing quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly links valuation methodology → goodwill treatment → timing of sale → financial impact on write-offs. It synthesizes the cause-effect relationship well, even extending it to implied financial outcomes. (4) While the core qualitative and contextual elements are accurate and complete, the addition of unsupported numbers lowers confidence in factual precision. Hence, correctness is reduced to 7 due to unverified quantitative claims, though the conceptual explanation remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 409,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "Boeing disclosed that the COVID‑19‑driven collapse in airline revenues and cash flows has already produced defaults in its $1.8 billion customer‑financing portfolio (Item 1A, page 11). Because that portfolio is heavily weighted toward a few aircraft types—most notably the 717 and 747‑8 (Item 1A, page 23)—any additional financial distress or value decline for those models would hit a disproportionate share of the portfolio, further eroding cash‑flows, limiting redeployment of the aircraft and magnifying the pandemic‑related financial vulnerability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the $1.8 billion portfolio defaults due to COVID-19 are accurately cited, and the concentration risk in the 717 and 747-8 aircraft types is correctly identified. The reference to Item 1A, pages 11 and 23, supports the sourcing from Boeing's 10-K filing, enhancing credibility. (2) Quantitative accuracy is perfect: the $1.8 billion figure is correctly stated, with no calculations required beyond what is provided in the original. Format is consistent and precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes two key risks—pandemic-driven defaults and portfolio concentration—linking them to amplified financial vulnerability. It logically explains how concentration in less liquid aircraft types (717, 747-8) limits redeployment and magnifies losses, which is consistent with the original's emphasis on material adverse effects. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'fewer customers' aspect of concentration risk (i.e., counterparty concentration), focusing more on aircraft type than customer base. While implied in 'heavily weighted,' the explicit connection to customer-level exposure is slightly weaker than in the original. Otherwise, semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 384,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The fourth‑quarter launch of Sky Glass helped lift the Corporate & Other segment’s top line – revenue jumped 86.1% to $461 million in 2021, “primarily due to … sales of Sky Glass televisions” (CMCSA 10‑K 2022, p. 62).  At the same time, operating costs fell 10.5% to $1.819 billion, “partially offset by costs related to Sky Glass and XClass TV” (p. 62), reflecting the new hardware‑sale expenses tied to the product introduction.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Sky Glass increased revenue but also increased expenses in the Corporate and Other segment. However, the LLM claims that operating costs *fell* by 10.5% to $1.819 billion, which contradicts the expected increase in expenses due to the product launch. This misrepresents a key financial effect. (2) The quantitative claims are unsupported by the ground truth: the original answer does not mention an 86.1% revenue increase, $461 million in revenue, or a 10.5% cost decrease. These specific numbers and percentages are absent from the ground truth and cannot be verified as correct. While the LLM cites a source (CMCSA 10-K 2022, p. 62), the evaluation is based on alignment with the provided ground truth, which lacks these figures. Thus, the numerical assertions appear fabricated or misaligned. (3) The reasoning is partially sound in linking Sky Glass to revenue and costs, showing multi-hop awareness—tying a product launch to segment performance. However, the conclusion that costs decreased overall while being partially offset by Sky Glass expenses contradicts the ground truth’s assertion of *higher* expenses due to the launch. This indicates flawed synthesis. (4) Contextual relevance is moderate—the answer addresses the right segment, company (implied), product, and time frame, and attempts to discuss both revenue and cost impacts. But due to major quantitative errors and a critical qualitative misstatement about cost trends, the overall correctness score is low. The answer conveys the *direction* of revenue impact and mentions cost effects but gets the net cost impact wrong, undermining its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 469,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "CVS reported that its commercial mortgage‑backed securities were valued at **$975 million** as of December 31 2023, and they carried a **gross unrealized loss of $100 million**【page_147】. That loss represents roughly **12 % of the total $836 million unrealized loss** on the company’s **$21.7 billion debt‑securities portfolio** (about 0.5 % of the portfolio’s fair value)【page_149】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the fair value of commercial mortgage-backed securities. The ground truth states $675 million, but the LLM reports $975 million, which is a significant overstatement of $300 million. However, the unrealized loss of $100 million is correct, as is the total unrealized loss across the debt securities portfolio ($836 million), and the 12% proportion is accurately calculated and reported. (2) Quantitative accuracy is compromised due to the incorrect fair value figure, despite correct values for unrealized loss and total portfolio unrealized loss. The additional detail about the $21.7 billion debt securities portfolio and 0.5% of fair value is contextually relevant but not requested in the question and does not compensate for the core error. (3) The multi-hop reasoning is partially sound: the model correctly identifies the unrealized loss and its percentage of the total, showing synthesis between categories. However, the incorrect fair value undermines the foundation of the response, suggesting a possible misreading of the source document or data extraction error. (4) The contextual relevance is high because the answer addresses both parts of the question and adds relevant context. However, the major numerical inaccuracy in the primary metric (fair value) severely impacts correctness, warranting a low-to-mid score. Qualitative accuracy is moderate due to correct use of percentages and proper identification of entities and relationships, despite the key number error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 426,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "Amazon’s net sales rose 12% in 2023 to $574.8 billion, and the company says the increase “primarily reflects increased unit sales, primarily by third‑party sellers” in both North America (12% growth) and International (11% growth) – making third‑party seller volume the main driver of the overall sales gain【page_24】. A key international risk is that regulatory, trade‑restriction or licensing changes—especially in China (and India) where many third‑party sellers are based—could curtail those sellers’ ability to operate and therefore hinder Amazon’s international expansion strategy【page_8】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12% overall sales increase in 2023 and attributes it primarily to third-party seller unit sales, aligning with the ground truth. The dollar amount of $574.8 billion is accurate and consistent with Amazon's reported net sales for 2023. The breakdown of 12% growth in North America and 11% in International is factually correct and supports the claim that third-party sales were a key driver. (2) All numbers, percentages, and financial figures are accurate. The 12% overall growth is correctly cited, and the regional growth rates match public filings. There are no calculation errors. Format variations (e.g., $574.8 billion) are acceptable and standard. (3) The multi-hop reasoning is sound: the model correctly links third-party seller growth to Amazon’s overall sales increase across regions. On the risk side, it correctly identifies regulatory risks in India and adds China as a relevant jurisdiction—while the ground truth specifically highlights India’s foreign ownership rules, mentioning China as an additional risk (where many third-party sellers operate) is contextually reasonable and supported by Amazon’s risk factors in its 10-K. However, the ground truth emphasizes India’s ownership rules as a structural barrier to Amazon’s control over third-party sellers, which the LLM slightly generalizes as 'regulatory, trade-restriction or licensing changes.' This is not incorrect but less precise on the nature of the Indian regulatory issue. (4) The answer is highly relevant, complete, and factually aligned with the original. The minor deduction in qualitative accuracy is due to the slightly broader framing of the international risk, though it remains within reasonable interpretation. Overall, the answer demonstrates strong synthesis, quantitative precision, and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 503,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "In 2023 the Deferred Compensation Plan had **1,853,363** shares remaining available for future issuance, while the Non‑Qualified Deferred Compensation Plan for Independent Contractors had **140,553** such shares. The difference between the two plans is **1,712,810 shares** (1,853,363 – 140,553).【page_11】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Deferred Compensation Plan had 1,853,363 shares remaining, and the Non-Qualified Deferred Compensation Plan for Independent Contractors had 140,553 shares, both of which are correct per the source. (2) The calculation of the difference (1,853,363 – 140,553 = 1,712,810) is accurate and matches the ground truth exactly. (3) The multi-hop reasoning is sound—LLM correctly identified two distinct plans, retrieved the correct share numbers for each, and computed the difference. (4) The entities (plan names, year 2023, Wells Fargo context) are correctly referenced, and the answer is semantically equivalent to the original, with added clarity by showing the calculation. All aspects of the question are addressed completely and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 248,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "PMI defines its reduced‑risk product line as the sale of **heated‑tobacco units (HTUs) and related consumables, heat‑not‑burn devices and accessories, e‑vapor (vape) products and oral‑nicotine products**【page_33】. Heated‑tobacco units – the consumables sold under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, Marlboro HeatSticks, Parliament HeatSticks, TEREA and the KT&G‑licensed Fiit and Miix brands – are specifically identified as HTUs and their shipments are counted within the reduced‑risk product revenue, making them a core component of that classification【page_34】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately lists all product categories in PMI's reduced-risk product line: heated tobacco units, heat-not-burn devices and accessories, e-vapor, and oral nicotine products. The inclusion of specific brand names (e.g., HEETS, Marlboro HeatSticks) adds detail beyond the ground truth but remains factually consistent. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, shipment volumes), so quantitative accuracy is not compromised. (3) The reasoning is sound: the LLM correctly identifies heated tobacco units as a core component of the reduced-risk category and supports this with a reference to page 34 of the 10-K, where HTUs are explicitly classified under reduced-risk product revenue. (4) The answer demonstrates strong multi-hop synthesis by connecting the definition of the product line with the specific role and classification of heated tobacco units. All entities (PMI, HTUs, product types) are correctly identified and contextualized. The answer is semantically equivalent to the original, with enhanced specificity that improves clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 337,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "DirectCustomer A accounted for **12 % of NVIDIA’s total revenue in fiscal 2025**. In the prior year (fiscal 2024), its share was **below the 10 % threshold** (i.e., less than 10 %). Thus, DirectCustomer A’s contribution rose from under 10 % in FY 2024 to 12 % in FY 2025【page_80】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in a critical aspect: it claims that DirectCustomerA's share in fiscal year 2024 was 'below the 10% threshold' (i.e., less than 10%), but the ground truth states that the contribution was 'not disclosed' and marked as '*', meaning no data was reported. This is a significant error because 'not disclosed' does not imply 'below 10%'—it means the information is unavailable or redacted, which could be due to various reporting policies, not necessarily because it was below the threshold. The LLM incorrectly infers a specific quantitative value where none exists, leading to a false comparison. While the 12% figure for FY2025 is correct, the comparison to FY2024 is unsupported by the data. The model fails in multi-hop reasoning by fabricating a data point instead of acknowledging the absence of information. This undermines the correctness of the conclusion that the contribution 'rose from under 10% to 12%'. The contextual relevance is fair because the answer addresses the right entities and time periods, but the reasoning and factual accuracy are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 311,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "The filing lists only one Restricted Share Rights Award Agreement for each grant period – a single version incorporated by reference for grants on or after January 24 2023, and a single version filed herewith for grants on or after January 23 2024【page_13】. In other words, there is one distinct version for each of those dates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same information as the ground truth. It correctly identifies two distinct versions of the Restricted Share Rights Award Agreement: one incorporated by reference for grants on or after January 24, 2023, and another filed herewith for grants on or after January 23, 2024. The quantitative accuracy is perfect—dates and the count of one version per period are accurate. The answer addresses both parts of the question (grants on or after the two dates) and correctly synthesizes the filing status (incorporated by reference vs. filed herewith), demonstrating sound multi-hop reasoning. The only minor limitation is that it does not explicitly state the total number 'two' upfront, instead phrasing it as 'one distinct version for each of those dates,' which is semantically equivalent but slightly less direct. This does not affect factual correctness. Contextual relevance is excellent, as all information pertains precisely to the question and source document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 289,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The lingering uncertainty over when the FAA will clear the 787 to resume deliveries forced Boeing to record a reach‑forward loss on the program, which was a key factor behind the $4.6 billion drop in cost of sales and the lower cost‑of‑sales‑as‑a‑percentage‑of‑revenue in 2021 (see page 34). That same uncertainty – especially the chance that delayed aircraft could hit contractual termination rights – made margin forecasting highly uncertain, because any shift in the delivery schedule could generate additional customer consideration and further erode margins or create new reach‑forward losses (see page 136).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $4.6 billion decrease in cost of sales is correctly reported (matches $4,574 million in original answer, with acceptable rounding). The reference to 2021 cost of sales decreasing compared to 2020 is accurate and correctly attributed to the reach-forward loss on the 787 program. (2) The answer correctly identifies the causal chain: FAA approval uncertainty → delivery delays → risk of contractual termination → increased estimation uncertainty in revenue forecasts → potential customer considerations → margin erosion or additional reach-forward losses. (3) Multi-hop reasoning is sound: it connects regulatory delays (FAA) to contractual risks, financial impacts (cost of sales), and forecasting challenges (margin uncertainty), synthesizing implications across operational and financial domains. (4) Minor deduction in qualitative accuracy because the original answer emphasizes that the uncertainty impacted *2022* forecasting but the financial impact was reflected in *2021* cost of sales, a nuance slightly underemphasized in the LLM response. However, the core logic and facts are preserved. Wording differs but semantic equivalence is strong. All entities (Boeing, 787 Program, FAA, reach-forward loss, cost of sales, margin forecasting) are correct and appropriately contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 383,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "Third‑party sellers were the main driver of the higher unit‑sales that lifted North America revenue 12% and International revenue 11% in 2023. Foreign‑exchange movements had a mixed impact – they trimmed overall net sales by $71 million, but added $88 million to International sales, partially offsetting the negative FX effect.【page_24】",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that third-party sellers were a key driver of unit sales growth in both North America and International segments, with North America sales growing by 12% and International by 11%, which matches the ground truth. It also correctly states the foreign exchange impacts: a $71 million reduction in North America and an $88 million increase in International. However, it fails to explicitly state the net positive impact of $17 million on total sales growth, which is a required part of the original answer. Instead, it says FX 'trimmed overall net sales by $71 million', which is factually incorrect — the $71 million reduction was specific to North America, not overall. The net effect should have been calculated as +$17 million ($88M - $71M). (2) Quantitatively, all individual numbers (12%, 11%, $71M, $88M) are accurate and correctly attributed, but the mischaracterization of the $71M as an overall reduction rather than a regional one leads to a flawed interpretation of the net FX impact. (3) The reasoning is mostly sound in linking third-party seller activity to sales growth and recognizing mixed FX effects, but the synthesis of the net FX effect across regions is incomplete or incorrect. The model does not perform the final multi-hop calculation to determine the net $17M positive impact. (4) Scores reflect high accuracy in data recall and relevance, with a moderate deduction for missing the net FX effect and misrepresenting the scope of the $71M reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 419,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Because the USA PATRIOT Act obliges Wells Fargo to maintain an effective anti‑money‑laundering (AML) program, any shortcomings in that program would be viewed by regulators as a failure to combat money‑laundering and could cause them to deny or impose conditions on a proposed bank purchase. These AML deficiencies are evaluated by the federal banking regulators – principally the Board of Governors of the Federal Reserve System (the FRB) – during the acquisition‑approval process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly identifies that deficiencies in Wells Fargo's AML program, required under the USA PATRIOT Act, could constrain its ability to pursue bank acquisitions due to regulatory scrutiny. The regulatory body responsible—the Board of Governors of the Federal Reserve System (FRB)—is accurately named. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the absence of any numerical errors supports a score of 10. (3) The reasoning is sound: the LLM correctly links AML deficiencies to regulatory risk in the acquisition approval process, acknowledging the FRB's role in evaluating compliance. The only minor shortcoming is that the answer does not explicitly mention 'national security' or 'financial integrity' as grounds for denial under the PATRIOT Act, which slightly weakens the completeness of the multi-hop synthesis compared to the original. (4) The response is highly contextually relevant, directly addressing both parts of the question—how AML deficiencies constrain acquisitions and which regulator assesses them. Overall, the answer is semantically equivalent with only slight omission of nuance, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 369,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "PMI’s estimated total international industry cigarette + heated‑tobacco unit volume grew **2.4 %** in 2021 versus 2020【page_35】. In its financial reporting, heated‑tobacco units are recorded under the **“Reduced‑Risk Products”** category【page_33】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021 is accurately reported as 2.4%, which aligns with the original answer. (2) The heated tobacco units are correctly categorized under 'Reduced-Risk Products' in PMI's financial reporting, as confirmed in the source. (3) The multi-hop reasoning is sound: the model correctly synthesized information across time periods (2020 vs 2021) and product categories (cigarettes and heated tobacco), and accurately linked the product type to its reporting category. (4) All entities—PMI, 2021 vs 2020 comparison, 'reduced-risk products'—are correctly identified. Minor formatting differences (e.g., 'Reduced‑Risk Products' vs 'reduced-risk products') do not affect semantic equivalence. The inclusion of page references adds contextual support without altering factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 275,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Boeing’s financing portfolio contains about **$445 million** of CCC‑rated receivables (the “CCC” line in the rating table) 【page_94】.  At the 24.2 % default rate the company currently expects a loss of roughly **$108 million** on that segment, but if every CCC‑rated receivable were to default the loss would rise to the full **$445 million**—an increase of roughly **$337 million (≈$338 million)** in potential losses 【page_11】【page_94】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The ground truth states that potential losses could increase by $435.6 million if all CCC-rated receivables default, but the LLM claims an increase of only $337 million. This is a major quantitative discrepancy. Additionally, the LLM incorrectly calculates the value of CCC-rated receivables as $445 million (24.2% of $1.8 billion is actually $435.6 million), which undermines the entire analysis. (2) The calculation in the original answer is straightforward: 24.2% of $1.8 billion = $435.6 million, representing the full potential loss if all CCC-rated receivables default. The LLM instead treats the 24.2% as an expected default rate on a separate $445 million base, then claims the increase in losses would be $337 million (i.e., $445M - $108M), which misrepresents the scenario. The question asks for the total potential loss increase if *all* CCC-rated receivables default, not the incremental loss beyond expected defaults. (3) The multi-hop reasoning is flawed. The LLM appears to misinterpret the 24.2% default rate as an expected loss rate on a subset, rather than understanding that the $1.8 billion portfolio includes CCC-rated receivables whose full default at a 24.2% weighting implies a $435.6 million exposure. It introduces a distinction between current expected loss ($108M) and full default loss ($445M) not supported by the ground truth or typical interpretation of such risk metrics. (4) While the LLM attempts to use document references and shows awareness of relevant concepts (ratings, default rates, portfolio segments), the core financial calculation is incorrect, leading to a substantially wrong conclusion. Contextual relevance is high because it addresses the right topic and cites plausible document locations, but factual accuracy is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 506,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "DirectCustomerC accounted for **11 % of NVIDIA’s total revenue in fiscal 2025 (year ended Jan 26, 2025)**. In the prior year (fiscal 2024, year ended Jan 28, 2024), its share was **below the 10 % reporting threshold (i.e., < 10 %)**【page_80】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that DirectCustomerC's share in fiscal 2024 was below 10%, while the ground truth confirms it was exactly 11% in both fiscal years. This contradicts the original answer and introduces a significant error. The fiscal 2025 percentage (11%) is correct, but the prior year comparison is wrong. (2) Quantitative accuracy is partially correct for the 2025 figure (11%), but the claim of '<10%' for 2024 is false—this is a critical error in financial disclosure context where the 10% threshold determines whether a customer is reportable. The dates (Jan 26, 2025, and Jan 28, 2024) are correctly identified. (3) The multi-hop reasoning fails because the model incorrectly infers that DirectCustomerC was not a reportable customer in 2024, when in fact it was (at 11%), and thus fails to correctly synthesize the year-over-year stability. The model may have misread or misinterpreted the source footnote, leading to flawed logic. (4) Contextual relevance is high—the answer addresses the right company (NVDA), customer (DirectCustomerC), and fiscal years—but due to the major factual error in the comparative analysis, the correctness score is low. The answer would have been strong if not for the incorrect prior-year data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 358,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "CVS Health’s commercial mortgage‑backed securities were reported at a total fair value of **$975 million** as of December 31 2023【page_147】.  The investment‑maturity breakdown shows that the CMBS in a loss position incurred **$100 million of unrealized losses**【page_150】—about one‑tenth of their fair‑value amount.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total fair value of CMBS: it reports $975 million, whereas the ground truth is $675 million. This is a significant factual inaccuracy that affects the core of the question. However, the unrealized losses amount of $100 million is correct and properly cited. (2) The calculation of the proportion of unrealized losses is partially misrepresented: the LLM states that $100 million is 'about one-tenth' of the fair value, which would imply a fair value near $1 billion, reinforcing the inaccuracy. In reality, $100 million unrealized losses on $675 million fair value is approximately 14.8%, as correctly stated in the original answer. The LLM’s comparison is therefore quantitatively flawed. (3) The multi-hop reasoning is partially sound—the model correctly identifies the unrealized losses from the investment maturity breakdown and links them to CMBS, showing synthesis across data points. However, the incorrect fair value undermines the comparative analysis. (4) Despite the major numerical error in fair value, the answer addresses both parts of the question (fair value and comparison to unrealized losses), uses correct entities (CVS Health, CMBS, December 31, 2023), and cites relevant sections, warranting moderate scores in qualitative accuracy and high contextual relevance. The correctness score is limited primarily by the incorrect fair value figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 395,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "MetLife’s footnote to the Level‑3 roll‑forward explains that the fair‑value changes of its Unit‑linked (and FVO) securities are **recorded in net investment income**. By contrast, **net derivative gains (losses) reflect the fair‑value changes of embedded derivatives (including lapses)** and do not include the Unit‑linked securities. Thus, Unit‑linked fair‑value movements affect net investment income, while derivative‑related movements affect net derivative gains (losses).【page_252】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that changes in the fair value of Unit-linked securities are recorded in net investment income, which matches the original answer. It also correctly distinguishes that net derivative gains (losses) reflect fair-value changes of embedded derivatives, including lapses, and explicitly notes that Unit-linked securities are not included in this line item. This captures the core accounting distinction described in the ground truth. The mention of the Level-3 roll-forward footnote and page reference adds contextual support. The only minor shortcoming is that it does not explicitly use the term 'net embedded derivatives' or clarify that lapses are tied to those derivatives—though it does mention 'embedded derivatives (including lapses)', which is semantically close. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the reasoning correctly synthesizes the accounting treatment across different financial statement components. The answer is highly relevant and addresses all aspects of the question with strong qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 339,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a **$3.5 billion loss** on the 787 program in the fourth quarter of 2021. Under the program‑accounting methodology, revenue is estimated based on the timing of FAA approval to resume deliveries; uncertainty or further delays in that approval push delivery dates out, lower the forecasted revenue (and increase customer compensation), which can generate additional reach‑forward losses and thus reduce future revenue estimates for the 787 program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss Boeing recorded on the 787 program in Q4 2021, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) All numbers, dates, and dollar amounts are correct—$3.5 billion and Q4 2021 are accurately reported. Format variations (e.g., spacing in '$3.5 billion') do not affect correctness. (3) The reasoning around program accounting and the impact of FAA approval delays is sound and aligns with the ground truth. The LLM correctly explains that uncertainty in FAA approval affects delivery timing, which under program accounting influences revenue estimates, customer compensation, and potential reach-forward losses. It captures the core cause-effect relationship: delayed approvals → delayed deliveries → lower revenue forecasts and higher costs → reduced margins and additional losses. (4) The only minor shortcoming is that the LLM does not explicitly mention 'contractual termination rights' or 'which aircraft will reach those rights,' a nuance present in the original answer that adds depth to the risk of customer considerations. While the concept of customer compensation is mentioned, the contractual mechanism behind it is slightly underdeveloped. However, the overall synthesis across accounting methodology, regulatory uncertainty, and financial impact is accurate and contextually appropriate. Thus, the answer is factually complete and semantically equivalent with only a slight omission in technical detail, warranting a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 432,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "In fiscal 2025 (year ended Jan 26, 2025) NVIDIA reported that DirectCustomer A accounted for **12 % of total revenue**. For the prior fiscal year (ended Jan 28, 2024), the filing does not give a specific percentage – it is marked with an asterisk indicating the customer contributed **less than 10 % of revenue** and therefore was not disclosed as a 10 %‑plus customer.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 12% revenue contribution from DirectCustomerA in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly interprets the asterisk (*) in the prior fiscal year (ended January 28, 2024) as indicating that the customer contributed less than 10% of revenue. The ground truth states that the data is simply 'unavailable' and marked with '*', not that it was below 10% or withheld due to being a non-10% customer. This is a significant factual misinterpretation. (2) The date and percentage for the 2025 fiscal year are accurate. The error lies in the qualitative interpretation of the prior year's disclosure, not the number itself (since no number is given). (3) The multi-hop reasoning fails in the second part: while the model recognizes that no specific percentage is given for the prior year, it infers a reason (sub-10% contribution) that is not supported by the source data. The original answer makes no such claim and explicitly states the data is unavailable. (4) The correctness score is 4 due to one major factual error in interpretation despite one correct data point. Quantitative accuracy is 5 because the only number provided (12%) is correct, but the handling of missing data is quantitatively misleading. Qualitative accuracy is 4 due to flawed reasoning about disclosure rules. Contextual relevance is 8 because the answer addresses both parts of the question and stays on topic, even if incorrectly reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 416,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "Amgen’s equity stake in BeiGene was valued at $4.514 billion as of December 31 2023 (the “Equity securities” line in the fair‑value table)【page_147】.  In 2023 the collaboration generated $109 million of net cost recoveries, $125 million of product‑sale revenue and $40 million of profit‑and‑loss‑share expense – a total of $274 million【page_131】.  Adding the fair‑value of the investment to those collaboration cash‑flows yields a combined financial impact of roughly $4.79 billion for the year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The fair value of Amgen's equity investment is stated as $4.514 billion, but the ground truth is $4.2 billion. This discrepancy is critical and materially affects the final total. The collaboration components (net cost recoveries: $109M, product sales: $125M, profit/loss sharing: $40M) are correctly reported, totaling $274M, which matches the ground truth sum of these elements. However, the final combined financial impact is calculated as $4.79 billion, which is incorrect due to the wrong investment valuation. The correct total should be $4.374 billion. (2) Calculation verification: $109M + $125M + $40M = $274M is correct. But $4.514B + $0.274B = $4.788B ≈ $4.79B uses an incorrect base investment value. Correct calculation: $4.2B + $0.274B = $4.474B — still does not match the ground truth of $4.374B, suggesting either a typo in the original answer or an error in the LLM’s source data. However, the original answer explicitly states $4.374B as the total, so the LLM’s $4.79B is definitively wrong. (3) Multi-hop reasoning is partially sound — the model correctly identifies that the total impact combines the fair value of the investment and the collaboration cash flows. However, it uses an incorrect value for the investment, undermining the synthesis. (4) Scores justified: Correctness is low (4) due to major numerical errors in the core component (equity value) and final total. Quantitative accuracy is poor (3) because only the collaboration sub-components are correct. Qualitative accuracy is moderate (5) — reasoning structure is sound but based on faulty data. Contextual relevance is high (9) — the answer addresses the right entities, time frame, and financial concepts, citing appropriate pages.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 490,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "MetLife applies a two‑year economic‑forecast horizon to most commercial and agricultural mortgage loans (with a one‑year horizon for some loans in certain markets) and, after that period, it phases the loss rates back to its historical loss experience on a straight‑line basis over **two years** (page 216). For residential mortgage loans it also uses a two‑year forecast, but once that horizon ends the company reverts to historical loss experience on a straight‑line basis over **one year** (page 217). Thus, the estimated lifetime loss rates remain in effect longer for commercial/agricultural loans (two‑year reversion) than for residential loans (one‑year reversion).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: two-year forecast period for both commercial/agricultural and residential loans, with a two-year reversion to historical loss experience for commercial/agricultural loans and a one-year reversion for residential loans. These durations match the original answer exactly. (2) The calculation of total duration (forecast + reversion) is implied but not explicitly stated in the LLM answer — the ground truth explicitly notes 4 years total for commercial/agricultural (2+2) and 3 years for residential (2+1), which the LLM omits. This minor omission prevents a perfect 10 on correctness and qualitative accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly distinguishes between the two loan types, identifies both the forecast and reversion periods, and draws the correct conclusion that loss rates remain in effect longer for commercial/agricultural loans. (4) Contextual relevance is excellent — the response directly addresses how forecast and reversion periods affect the duration of estimated lifetime loss rates. The only shortcoming is the lack of explicit total duration comparison (4 vs 3 years), which was part of the original answer’s key insight. Overall, the answer is factually correct and well-reasoned, with only a minor gap in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 391,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco funds employee health‑care benefits largely through self‑insurance and estimates the related liability using historical claims experience, demographic and severity factors and other actuarial assumptions (see page 30). Because those claim costs are “highly unpredictable” and can rise sharply with inflation, regulatory or legal changes, or other unforeseen developments, any material increase—especially when combined with labor‑related risks such as higher wages or difficulty attracting and retaining staff (page 13)—could raise cash outflows and strain the company’s financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Costco uses self-insurance for employee health care, relies on actuarial assumptions including historical claims, demographics, and severity factors, and faces unpredictable cost fluctuations due to inflation, regulatory changes, and unforeseen developments. The mention of labor-related risks (e.g., higher wages, staffing challenges) ties directly to the financial condition impact. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and consistent in that regard, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly links self-insurance funding methods to actuarial estimation practices, then connects potential cost volatility to broader financial and operational risks, including labor pressures. The citation of page 30 for actuarial assumptions and page 13 for labor risks suggests proper synthesis across document sections. (4) The only minor shortcoming is that the LLM omits the explicit statement that liabilities are 'not discounted,' a small but technically relevant detail in accounting terms. However, this does not materially alter the overall correctness. The answer remains semantically equivalent and contextually precise, fully addressing the question’s focus on financial condition impact under uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 404,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "3M recorded a $4.2 billion pre‑tax charge for the CAE Settlement and $437 million of restructuring pre‑tax charges in 2023, totaling roughly $4.637 billion. The reconsolidation of the former de‑consolidated Aearo Entities removed the $0.7 billion equity‑investment asset and the $0.6 billion net intercompany liability (previously reflected as $0.9 billion of other liabilities and $0.3 billion of other assets) from the consolidated balance sheet as of December 31 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $4.2 billion for the CAE Settlement, $437 million in restructuring charges, totaling $4.637 billion—calculation is correct. The balance sheet impacts—$0.7 billion asset removal in equity and other investments, and $0.6 billion net liability from former intercompany amounts—are precisely reported. The additional detail about the $0.9 billion other liabilities and $0.3 billion other assets being netted into the $0.6 billion liability provides extra clarity and is consistent with the reconsolidation accounting. (2) The answer is complete, addressing both parts of the multi-part question: total pre-tax charges in 2023 and the balance sheet impact of the Aearo Entities' reconsolidation. (3) Entities are correctly identified: 'Aearo Entities' as formerly de-consolidated, 'CAE Settlement', and correct time frame (as of December 31, 2023). (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the CAE charge, restructuring costs, and reconsolidation impact across different financial statements. (5) Semantic equivalence is maintained; wording differs slightly but conveys identical factual content with enhanced precision. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 366,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "By embedding Gemini 2.0 in Vertex AI, Google gives Cloud developers a multimodal, generative model they can train, fine‑tune, augment, test and deploy straight on the platform, and also supplies ready‑made AI agents that can write, document, test, operate code and aid cybersecurity. This adds richer multimodal capabilities and turnkey tools—such as vector search, grounding and model distillation—to the Google Cloud developer suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. It correctly identifies the integration of Gemini 2.0 into Vertex AI and accurately describes the expanded capabilities for developers on Google Cloud Platform, including training, fine-tuning, augmenting, testing, and deploying generative AI models. The mention of multimodal capabilities and specific tools like vector search, grounding, and model distillation aligns with the enhanced development environment described in the original answer. The addition of 'ready-made AI agents' that can write, document, test, and operate code and aid cybersecurity is a plausible extension of the platform's capabilities and does not contradict the ground truth, though it is not explicitly mentioned in the original. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced due to the introduction of specific agent functionalities not present in the original, but the overall reasoning and entity identification (Gemini 2.0, Vertex AI, Google Cloud Platform, multimodal generative models) are correct. The answer is fully contextually relevant and directly addresses how the integration expands developer capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 362,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "In 2024 MetLife’s yield table treats its FVO securities as part of the fixed‑maturity portfolio, so the $205 million of investment income (and the associated carrying amount) from FVO securities is included in the $13,089 million of fixed‑maturity securities and therefore contributes to the reported 4.44 % yield. Because FVO securities are classified as Level 3 assets, they are valued using matrix, market and consensus pricing with significant unobservable inputs (offered quotes, quoted prices, swap‑yield curves, etc.); any change in those inputs would shift the fair‑value of the FVO securities and thus directly affect both the investment‑income amount and the sensitivity of the fixed‑maturity yield to fair‑value changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million investment income from FVO securities in 2024, matching the ground truth. It also accurately references the total fixed-maturity securities amount of $13,089 million and the resulting 4.44% yield, which are consistent with the source data. These figures are critical quantitative elements and are reported with full accuracy, earning a perfect score on quantitative accuracy. (2) The explanation of Level 3 classification and valuation techniques is mostly accurate, mentioning matrix pricing, swap-yield curves, and unobservable inputs. However, the ground truth emphasizes specific unobservable inputs such as nonperformance risk spreads and long-term equity volatilities, which the LLM omits, instead listing 'offered quotes' and 'quoted prices'—some of which are observable. This slight mischaracterization of inputs slightly weakens the qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly links the inclusion of FVO securities in yield calculations to their fair value sensitivity due to Level 3 classification, recognizing the dual impact on investment income and yield volatility. This demonstrates strong synthesis across valuation, income recognition, and sensitivity concepts. (4) The answer is fully contextually relevant, addressing both the income impact and sensitivity to fair value changes as required by the question. Overall, the response is factually correct, well-reasoned, and only minor in precision regarding the specific unobservable inputs, justifying a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 438,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The filings note that the 2022 de‑consolidation of the Aearo Entities “resulted in a charge that was **not material** to 3M” and that the 2023 re‑consolidation “resulted in an **immaterial** income‑statement impact”【page_100】. In other words, the combined pre‑tax effect of both moves was essentially zero (i.e., immaterial). Both actions were tied to the Combat Arms Earplugs litigation – the de‑consolidation occurred as part of the Aearo Entities’ Chapter 11 filing that sought to stay the ear‑plug claims, and the later re‑consolidation followed the bankruptcy dismissal that lifted that stay and set the stage for the CAE Settlement of the Combat Arms Earplugs lawsuits【page_100】【page_101】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states the total pre-tax financial impact was $1.2 billion, comprising a $1.0 billion funding commitment and $0.2 billion for projected case expenses. However, the LLM claims the combined pre-tax effect was 'immaterial' or 'essentially zero,' directly contradicting the $1.2 billion figure. This is a major factual error. (2) The LLM incorrectly interprets the term 'immaterial' as applying to the entire financial impact, when in context it refers only to the accounting impact on the income statement due to the timing and structure of the charge, not the actual cash or economic impact. The $1.2 billion obligation remains real and material, even if the income statement charge was structured to be immaterial. The LLM fails to report any dollar amounts, missing the key financial data entirely. (3) While the LLM correctly identifies the causal relationship between the Combat Arms Earplugs litigation and both the deconsolidation and reconsolidation events—showing accurate multi-hop reasoning regarding timing and legal context—it fails to integrate the financial magnitude of the events. The synthesis of litigation → bankruptcy → deconsolidation → dismissal → reconsolidation is logically sound and contextually accurate. (4) The contextual relevance is high because the answer addresses the right events and their legal/strategic motivations. However, the quantitative accuracy is extremely low due to the omission and mischaracterization of the $1.2 billion impact. The qualitative accuracy is partially correct due to sound reasoning about the sequence and motivation of events, but flawed in financial interpretation. The correctness score is low because the primary question asks for the total pre-tax financial impact, which the LLM fundamentally misrepresents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 508,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "Adobe wove its Firefly generative‑AI models into the core of Creative Cloud—embedding them in Photoshop, Illustrator, Premiere Pro, Express and the web‑based Photoshop experience—and paired those capabilities with AI‑enhanced Document Cloud tools such as Liquid Mode and AI‑driven PDF features, creating a unified AI “co‑pilot” across its subscription suite.  This AI infusion raises the value of existing subscriptions, draws novice creators, communicators and enterprise users (via free and premium Firefly tiers and Generative Credits), and translates into higher‑value plans and stronger renewal rates, which helped lift Creative Cloud ARR to $12.37 billion and Document Cloud ARR to $2.81 billion in fiscal 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the integration of Adobe Firefly into Creative Cloud apps (Photoshop, Express, etc.) and Document Cloud enhancements, aligning with Adobe's strategy to increase recurring revenue and expand the customer base. It accurately captures the multi-hop reasoning by linking AI features to subscription value, user acquisition (including novice creators), and retention. The mention of free and premium tiers, Generative Credits, and impact on renewal rates reflects sound strategic understanding.\n\n2) However, the quantitative accuracy is low. The LLM introduces specific ARR figures—$12.37 billion for Creative Cloud and $2.81 billion for Document Cloud in fiscal 2023—that are not present in the ground truth. While these numbers may be factually correct in external sources, they were not included in the original answer derived from the knowledge graph, making their inclusion unsupported in this evaluation context. Since the question does not ask for financial figures and the ground truth does not provide them, introducing unverified metrics reduces factual fidelity.\n\n3) The qualitative reasoning is strong: the LLM correctly synthesizes Firefly’s role across Creative Cloud and Document Cloud, connects AI capabilities to strategic outcomes (recurring revenue, customer expansion), and references relevant product offerings (Express, Generative Credits). It goes beyond the original answer by naming additional apps (Illustrator, Premiere Pro, Liquid Mode), which are plausible but not confirmed in the ground truth. This expansion is reasonable but slightly exceeds the evidence provided.\n\n4) Contextual relevance is perfect—the answer directly addresses how Firefly integration supports Adobe’s strategy through specific product integrations and AI-driven capabilities in fiscal 2023. Despite the unsupported numbers, the core logic and entity mapping (Adobe, Firefly, Creative Cloud, Document Cloud, AI features, subscription model) are accurate and well-synthesized. The score is reduced primarily due to the introduction of unverified quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 562,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "As of December 31 2022, Amgen’s U.S. Treasury bills were valued at $1,676 million and its money‑market mutual funds at $2,659 million, giving a combined fair‑value total of $4,335 million. That combined amount is exactly the same as the total fair value of all of Amgen’s available‑for‑sale investments, which was also $4,335 million【page_133】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: U.S. Treasury bills valued at $1,676 million and money market mutual funds at $2,659 million are correctly reported. The sum ($1,676M + $2,659M = $4,335M) is accurate and matches the total fair value of available-for-sale investments. (2) Quantitative accuracy is perfect—numbers are correct, properly formatted, and the calculation is sound. (3) The multi-hop reasoning is correct: the model identifies two distinct asset categories, sums their values, and correctly infers that this sum equals the total available-for-sale investments, demonstrating proper synthesis across financial line items. (4) The answer is semantically equivalent to the original, with clear, precise language and proper contextual framing. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 257,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The 10‑K says that Unit‑linked and FVO securities are valued with the same Level‑3 techniques used for other assets—option‑pricing (e.g., Black‑Scholes) and present‑value methods that incorporate a risk‑margin and non‑performance risk assumptions (page 250). Because those techniques rely on the unobservable inputs shown in the Level‑3 sensitivity table, a rise in the assumed long‑term equity volatility lifts the estimated fair value, whereas a higher non‑performance risk spread pulls the fair value down (page 249).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Unit-linked securities are valued using Level-3 techniques involving option-pricing (e.g., Black-Scholes) and present-value methods, which rely on unobservable inputs like long-term equity volatility and nonperformance risk spreads—consistent with the original answer. (2) There are no numeric values in the question or answers that conflict; the LLM references page numbers (249, 250), which are plausible and contextually appropriate, though not verifiable without the document. No calculations are required, so quantitative accuracy is intact. (3) The multi-hop reasoning is sound: the LLM correctly infers the directional impact—higher long-term equity volatility increases fair value, while higher nonperformance risk spreads decrease it—demonstrating proper synthesis of how these inputs affect valuation. This causal relationship is implied in the original answer and explicitly stated in the LLM response, adding clarity. (4) The only minor gap is that the LLM does not explicitly mention 'market risk benefits (MRBs)' or the variation of nonperformance risk by duration and currency, which are part of the full context in the original. However, the core mechanisms and sensitivity effects are accurately conveyed. Wording differs but semantic meaning matches. Thus, the answer is factually correct, complete in substance, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 400,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe has built “Generative Credits” into Creative Cloud paid plans as a monthly token allowance that lets subscribers use Firefly’s generative‑AI features to create images, text effects and other content on demand (page 10).  By turning AI‑generated output into a subscription‑driven utility, the credits raise the perceived value of Creative Cloud, encourage more frequent product use and upsell, and—through free and premium tiers and AI‑powered tools in Photoshop, Illustrator, Premiere Pro and Express—extend the appeal of the platform beyond professional creators to marketers, communicators and other non‑creative stakeholders, thereby expanding engagement and recurring revenue (page 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original answer in both factual content and reasoning. (1) All key facts are correct: Generative Credits are part of Creative Cloud paid plans, function as a monthly token allowance for AI-generated content via Firefly, and are used across tools like Photoshop, Illustrator, Premiere Pro, and Express. The answer correctly identifies the strategy of tiered access (free and premium) and the expansion to non-creative stakeholders such as marketers and communicators. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly links Generative Credits to increased engagement, product-led growth, AI integration, broader market reach, and recurring revenue. The only minor omission is not explicitly stating that users can hit a usage limit and then pay for more credits (implied by 'monthly token allowance' and 'upsell'), which slightly reduces completeness in qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing how Generative Credits support Adobe’s strategy around engagement and subscription revenue. Wording differs but semantic meaning matches the ground truth. Minor lack of explicit mention of 'conversion and retention' or 'workflows more efficient' slightly reduces qualitative score to 9, but core strategic logic is intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 407,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "Gemini 2.0 now powers AI features in all seven of Google’s two‑billion‑user products—Android, Chrome, Gmail, Maps, Play Store, Search and YouTube—so billions of users are consuming Gemini‑driven capabilities every day (page 6).  That broad adoption creates demand for the AI‑optimized compute, networking and storage that Google Cloud sells (including TPUs) and for the Vertex AI developer platform, which lets customers train, tune, test and deploy Gemini‑based models; the resulting consumption‑based fees and subscriptions from this infrastructure and developer service drive Google Cloud’s AI‑related revenue (page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini 2.0 powers AI features across Google's seven two-billion-user products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube), which is consistent with the original answer. The mention of 'two-billion-user products' correctly reflects the scale, and while the phrasing 'billions of users' is slightly looser, it is semantically acceptable. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures; the reference to consumption-based fees and subscriptions matches the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly links Gemini 2.0's integration into consumer products to increased demand for Google Cloud's AI-optimized infrastructure (e.g., TPUs) and Vertex AI platform, showing how this drives revenue—this demonstrates proper synthesis across product, platform, and monetization layers. (4) The only minor shortcoming is that the LLM answer does not explicitly state that Vertex AI enables developers to 'deploy applications using advanced generative AI models' in the same conceptual breadth as the original, though it does mention training, tuning, testing, and deploying Gemini-based models, which covers most of the functionality. Wording differences (e.g., 'test' is added, not in original) are negligible. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission in completeness of developer capabilities, justifying a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 436,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "MetLife explains that the income it records on FVO securities is driven by the cash‑flow assumptions embedded in those securities, so a change in pre‑payment speeds or default rates alters the projected cash flows and therefore the amount of income recognized (see page 209). The fair‑value of the FVO securities is further determined using Level 3 unobservable inputs – the same inputs used for other Level 3 assets – such as offered quotes, market and consensus pricing, swap‑yield curves, and actuarial assumptions (mortality, lapse, utilization and withdrawal rates), long‑term equity volatility and non‑performance risk spreads (see page 249 and the note on page 251).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that changes in prepayment and default rates affect income recognition on FVO securities by altering projected cash flows, which matches the original answer's assertion of direct impact on income. (2) The unobservable inputs listed—long-term equity volatility and non-performance risk spreads—are explicitly mentioned in both answers and are key Level 3 inputs affecting fair value. The LLM adds additional detail (e.g., offered quotes, swap-yield curves, actuarial assumptions), which are not in the original but are contextually appropriate and do not contradict it; they likely come from the cited pages (249, 251) and enhance completeness without introducing error. (3) The reasoning is sound and reflects multi-hop synthesis: linking cash flow assumptions to income recognition, and Level 3 inputs to fair value determination. (4) All entities (MetLife, FVO securities, unobservable inputs) are correct, and the citations to specific pages suggest grounding in source material. The only minor deviation is the inclusion of extra inputs not in the concise ground truth, but since the question asks what 'further influence' valuation, including additional valid inputs does not reduce accuracy. No numeric values are incorrect, and no calculations are required. Thus, the answer earns a 9/10 for correctness due to slight over-elaboration without factual error, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 419,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco’s sizable investment in its private‑label Kirkland Signature line lifts gross‑margin performance because Kirkland items are positioned as high‑quality, lower‑priced alternatives that “generally earn higher margins” and help drive member loyalty and sales mix. However, the company cautions that the margin benefit depends on “maintaining consistent product quality, competitive pricing, and availability” – a loss of member acceptance or any production, distribution or supply‑chain disruption to Kirkland products could reduce sales and erode those higher margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Kirkland Signature products contribute positively to gross margin due to higher margins versus national brands, they enhance member loyalty, and the benefit is contingent on quality, pricing, and availability. Risks related to production, supply chain, and member acceptance are correctly identified. (2) There are no numeric values, percentages, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between private-label strategy, margin performance, member loyalty, and operational risks. The only minor shortcoming is that the LLM slightly condenses the risk impact by not explicitly mentioning 'out-of-stock situations' as a consequence of disruptions, though 'availability' and 'supply-chain disruption' imply it. (4) Contextual relevance is perfect—the response directly addresses all parts of the question with appropriate depth and focus. The wording differs slightly but preserves full meaning, including direct quotes from the source language (e.g., 'consistent product quality, competitive pricing, and availability'). Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 393,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair‑value of “Other short‑term interest‑bearing securities” went from **$0 million at 12/31/2022 to $138 million at 12/31/2023**, a $138 million increase【page_148†L13-L16】【page_147†L13-L16】.  That addition helped lift the overall available‑for‑sale investment portfolio from **$4,335 million in 2022 to $10,404 million in 2023**【page_133†L31-L38】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the fair value of 'Other short-term interest-bearing securities' correctly increases from $0 million on December 31, 2022, to $138 million on December 31, 2023. The total available-for-sale investments are correctly reported as $4,335 million in 2022 and $10,404 million in 2023. The implied increase of $6,069 million in total AFS investments is accurate (10,404 - 4,335 = 6,069), though not explicitly stated, the LLM correctly attributes the rise to the addition of the $138 million in securities. (2) The answer addresses both parts of the question: the change in fair value of the specific security and its reflection in total available-for-sale investments. (3) Entities are correct—'Other short-term interest-bearing securities' and 'available-for-sale investments' are properly identified with correct time periods (December 31, 2022, and December 31, 2023). (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the increase in the specific security category contributed to the overall growth in the total portfolio, which is supported by the cited pages. Wording differs slightly from the original answer (e.g., 'helped lift' vs 'contributed to'), but the semantic meaning and factual content are equivalent. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 395,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The objection by RBH on January 24 2025 – together with the unresolved allocation of the CAD 32.5 billion settlement under the Proposed Plan – narrowed the range of possible outcomes and was judged an impairment indicator for PMI’s equity investment in RBH. As a result, PMI performed a quantitative valuation of the RBH investment as of December 31 2024, estimating its fair value at $714 million and recording a non‑cash impairment charge of $2,316 million in the consolidated statement of earnings for the year ended December 31 2024【page_99†L13-L22】【page_147†L5-L12】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: RBH's objection on January 24, 2025, the CAD 32.5 billion settlement, the narrowing of possible outcomes as an impairment indicator, the quantitative valuation as of December 31, 2024, the fair value of $714 million, and the non-cash impairment charge of $2,316 million. (2) Quantitative accuracy is perfect: dates (January 24, 2025; December 31, 2024), dollar amounts ($714 million, $2,316 million), and currency (CAD 32.5 billion) match the original. The impairment charge is correctly derived as the difference between carrying value and fair value, consistent with the ground truth. (3) Multi-hop reasoning is sound: the model correctly links RBH’s objection to increased uncertainty resolution, which triggered an impairment review, leading to a DCF-based valuation and ultimately the charge. Though the LLM omits some details about valuation assumptions (e.g., discount rate, tax deductibility), it captures the essential causal chain and outcome required by the question. (4) Contextual relevance is high—the answer directly addresses both parts of the question: the influence of developments on the valuation and the resulting impairment charge. Minor omission of methodological details does not detract from factual correctness or completeness at the required level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 386,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "If Google Network advertising revenue rose by $10 billion, the amount paid to Google Network partners under the traffic‑acquisition‑cost (TAC) would rise by 22% × $10 billion = approximately **$2.2 billion**.  The filing notes that TAC paid to Google Network partners “will increase as our revenues grow” and that the TAC rate is expressed as a percentage of advertising revenue (22% in this case)【page_30】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of $10 billion is correctly computed as $2.2 billion, with no errors in numbers or formatting. (2) The answer addresses all parts of the question, including the $10 billion revenue increase, the constant TAC rate of 22%, and the resulting increase in TAC payments. (3) Entities are correctly identified—Google Network properties, TAC (traffic acquisition cost), and the relevant financial relationship are all accurately referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that if TAC is a fixed percentage of revenue (22%), then an increase in revenue directly translates to a proportional increase in TAC, which is explicitly supported by the filing citation (page 30). The answer is semantically equivalent to the ground truth and provides additional context from the source, enhancing clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 282,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "UnitedHealth’s long‑term debt and other financing obligations rose from $61,449 million at year‑end 2023 to $75,604 million at year‑end 2024 – an increase of about **$14.2 billion**.  Over the same period the fair‑value of those obligations grew from $59,851 million to $70,565 million – an increase of roughly **$10.7 billion**.  Thus, the carrying‑value increase exceeded the fair‑value increase by about **$3.5 billion**【page_55】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value increased from $61,449 million to $75,604 million, a difference of $14,155 million, which the model correctly rounds to $14.2 billion (equivalent). The fair value increased from $59,851 million to $70,565 million, a $10,714 million increase, correctly rounded to $10.7 billion. The comparison stating that the carrying value increase exceeded the fair value increase by about $3.5 billion is accurate ($14,155M - $10,714M = $3,441M ≈ $3.5B). (2) The answer is complete, addressing both the change in carrying value and fair value, and includes a correct comparative analysis. (3) Entities are accurate: UnitedHealth Group, long-term debt and other financing obligations, correct years (2023 to 2024), and proper financial metrics. (4) The multi-hop reasoning is sound—information from two different valuation bases (carrying value and fair value) across two years is correctly synthesized and compared. (5) The semantic meaning is equivalent to the original answer, with only minor, acceptable rewording and rounding. The citation [page_55] adds contextual support. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 349,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant‑accommodation reservation services at Booking.com added about **$573 million** to merchant transaction costs in 2022.  That same year merchant revenues jumped **94.6 %** to $7.2 billion, far outpacing agency revenues, which grew **35.1 %** to $9.0 billion.  In other words, the rise in merchant transaction costs coincided with merchant revenue growth that was roughly three times the pace of agency‑revenue growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation reservation services at Booking.com in 2022, which matches the ground truth. However, the LLM introduces specific revenue figures and growth percentages—94.6% growth in merchant revenues to $7.2 billion and 35.1% growth in agency revenues to $9.0 billion—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be factually accurate but are not supported by the knowledge graph answer, making their inclusion problematic. (2) The quantitative accuracy is reduced because while the $573 million figure is correct, the additional percentages and dollar amounts (e.g., $7.2B, $9.0B, 94.6%, 35.1%) are not in the original answer and introduce unverified data. There is no indication in the ground truth that merchant revenue growth was 'three times' that of agency growth, so this derived comparison, while possibly logical, is not substantiated by the provided truth. (3) The reasoning is sound in linking increased transaction costs to stronger merchant revenue growth relative to agency revenues, which aligns with the original answer’s logic. The multi-hop synthesis—connecting service expansion to cost increases and then to revenue model performance—is appropriate and reflects understanding. However, the unsupported numerical precision undermines the qualitative accuracy. (4) The contextual relevance is perfect: the answer directly addresses both parts of the question—contribution to transaction costs and the relationship to merchant vs. agency revenue growth—using relevant financial reasoning and framing. Despite the overreach in numbers, the core insight matches the ground truth. Correctness score is 7 due to accurate core facts but significant addition of unverified quantitative details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 516,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD’s Zynq UltraScale+ RFSoCs extend its Adaptive SoC line by embedding high‑performance RF data converters directly into the chip—making it the industry’s first “RFSoC” architecture and adding a new capability to the existing FPGA and MPSoC families【page_11†L9-L13】【page_10†L13-L16】.  By offering integrated RF‑ADC/DAC alongside programmable logic and processing, the RFSoCs let customers target wireless, radar, cable‑access and other RF‑intensive markets with a single, differentiated device, which fits AMD’s broader strategy of serving high‑performance RF data‑conversion applications across its embedded and data‑center segments【page_10†L13-L16】【page_11†L9-L13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the significance of AMD's Zynq UltraScale+ RFSoCs: expanding the Adaptive SoC line with integrated RF data converters, targeting markets like wireless, radar, and cable access. The answer notes the industry-first 'RFSoC' architecture, which aligns with the product's innovation status. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM connects the product introduction (RFSoCs) to AMD’s broader strategy of serving high-performance RF markets by integrating ADC/DAC with programmable logic, thus enabling single-chip solutions for complex applications. This reflects correct synthesis across technical capability and strategic intent. (4) The LLM answer is semantically equivalent to the original, though slightly less detailed in mentioning 'aerospace, defense, and communication infrastructure' or 'real-time control, sensor fusion, and analytics'—minor omissions that do not detract from the core correctness. The reference to 'embedded and data-center segments' slightly overreaches, as the ground truth emphasizes embedded and high-growth industrial sectors, not data-center use for RFSoCs. This minor overgeneralization prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 407,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "UnitedHealth’s debt securities‑held‑to‑maturity had a carrying (amortized‑cost) amount of **$512 million in 2024** and **$603 million in 2023**, for a combined **$1,115 million**.  Their fair values were **$508 million in 2024** and **$596 million in 2023**, totaling **$1,104 million**.  Thus, the combined fair value is about **$11 million (≈1 %) lower** than the combined carrying value【page_55】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $603 million (2023 carrying value), $512 million (2024 carrying value), summing to $1,115 million; fair values of $596 million (2023) and $508 million (2024), totaling $1,104 million. The $11 million difference (unrealized loss) is correctly calculated. Minor formatting variations (e.g., $512 million vs $512 million) are acceptable. (2) Calculations are precise: 603 + 512 = 1,115 and 596 + 508 = 1,104; difference is 1,115 - 1,104 = $11 million. The ≈1% note is a reasonable addition and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model correctly aggregated data across two years and two financial metrics (carrying value and fair value), then compared them. (4) Entities are accurate: UnitedHealth Group, debt securities - held-to-maturity, correct years (2023 and 2024), and proper financial terminology (carrying value, fair value, unrealized loss). (5) The answer is semantically equivalent to the original, with clear, concise presentation and correct sourcing (page_55). All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 328,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant‑accommodation reservation services at Booking.com drove about **$573 million** of the rise in Sales and Other Expenses in 2022 (the bulk of the $1.0 billion jump from $979 million in 2021 to $1,986 million in 2022)【page_52】.  That same expansion helped merchant gross bookings more than double – up **108.4 %**, or roughly **$28 billion** (from $25.8 billion in 2021 to $53.9 billion in 2022)【page_50】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in expenses due to the expansion of merchant accommodation services, which matches the ground truth. However, it introduces additional quantitative claims not present in the original answer: specifically, the total jump in sales and other expenses from $979M to $1,986M and the breakdown of merchant gross bookings increasing by 108.4% ($28B, from $25.8B to $53.9B). While these figures may be factually accurate based on the source documents, they go beyond the information provided in the ground truth answer, which only states that merchant gross bookings grew more than agency bookings without citing specific percentages or dollar amounts. (2) The calculation of the $1.0 billion increase in expenses is numerically correct ($1,986M - $979M ≈ $1,007M), but this level of detail was not in the original answer and risks overprecision. The 108.4% growth in merchant gross bookings and the $28B increase are potentially accurate but not mentioned in the ground truth, making them extraneous and unsupported in the context of evaluating fidelity to the provided answer. (3) The multi-hop reasoning is sound—the model connects the expansion of services to both increased expenses and higher gross bookings, aligning with the causal relationship described in the ground truth. However, the original answer does not quantify the gross booking growth, so adding such detail reduces fidelity despite possible accuracy. (4) The correctness score is 7 because the core fact ($573M expense increase linked to merchant expansion) is correct and central, but the added numerical details reduce quantitative accuracy relative to the ground truth. Qualitative accuracy is high due to proper entity and relationship identification. Contextual relevance is perfect as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 506,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "As of December 31 2023 PayPal reported a crypto‑asset safeguarding **asset of $1.241 billion** and a matching **crypto‑asset safeguarding liability of $1.241 billion**【page_91†L31-L38】【page_92†L31-L38】—together amounting to roughly **$2.48 billion**. The equal‑sized asset and liability show that PayPal is holding crypto assets on behalf of its users and carries a corresponding obligation to return them, underscoring its active role in crypto‑related custodial and financial services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the crypto asset safeguarding asset and liability as $1.241 billion each, which matches the ground truth of $1,241 million (equivalent values, different units). The total combined value of $2.48 billion is an accurate sum of the two equal components. (2) All numeric values are correct: $1.241 billion = $1,241 million, and the date 'December 31, 2023' is accurately referenced. The calculation of the total ($1.241B + $1.241B = $2.482B, rounded to $2.48B) is precise. (3) The reasoning is sound: the model correctly infers that equal asset and liability amounts indicate PayPal is holding crypto assets on behalf of customers, reflecting its role in custodial and financial crypto services. This demonstrates proper multi-hop synthesis between the balance sheet items and their business implications. (4) The only minor shortcoming is that the original answer emphasizes the equality reflects an obligation to safeguard assets, while the LLM slightly reframes it as 'return them'—a small nuance in wording that doesn't distort meaning but slightly reduces qualitative precision. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 343,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The aircraft impairment charges arise from FedEx’s decision to retire older Boeing MD‑11F, 757‑200 and Airbus A300‑600 planes and their engines so it can modernize the fleet, improve the global network and better match air‑network capacity to current and forecast shipment volumes—key objectives of the Network 2.0 optimization effort embedded in the DRIVE transformation (page 55). The non‑cash impairment recorded was $70 million in 2023 and $157 million in 2024, for a cumulative impact of $227 million on the DRIVE program through 2024 (page 55).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the aircraft impairment charges of $70 million in 2023 and $157 million in 2024, and accurately calculates the cumulative impairment impact as $227 million, which aligns with the ground truth. The retired aircraft models (Boeing MD-11F, 757-200, Airbus A300-600) are correctly listed, and the connection to Network 2.0 and the DRIVE program is accurately explained. However, the LLM answer omits the additional $582 million in business optimization costs incurred in 2024, which the ground truth includes in the total cumulative optimization-related costs of $839 million. This omission means the LLM underrepresents the full financial impact on the DRIVE program through 2024. (2) Quantitatively, all provided numbers are correct: $70M (2023), $157M (2024), and their sum $227M are accurate. The error lies not in calculation but in incompleteness—failing to incorporate the $582M business optimization cost into the total cumulative impact. (3) The multi-hop reasoning is sound in linking impairment charges to fleet modernization and Network 2.0, and correctly situating this within the DRIVE program. However, it fails to fully synthesize the second financial component (business optimization costs), which is required to answer the full scope of the question about cumulative financial impact. (4) The answer is contextually relevant and well-structured, with accurate terminology and proper citation (page 55). The correctness score is 8 because while the core facts and calculations are correct, the answer is incomplete on a key part of the multi-hop synthesis—total financial impact—thus missing a significant portion of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 463,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "As of December 31 2024, UnitedHealth’s U.S. government and agency obligations were valued at a total of **$4.769 billion** (‑ $4.327 billion for the available‑for‑sale portion and $442 million for the held‑to‑maturity portion)【page_52】.  The gross unrealized losses on these obligations grew from **$240 million** at year‑end 2023 to **$276 million** at year‑end 2024, an increase of **$36 million**【page_52】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The total fair value is reported as $4.769 billion, whereas the ground truth is $3,627 million ($3.627 billion), a difference of over $1.1 billion. This major discrepancy suggests incorrect sourcing or misinterpretation of the data. Additionally, the gross unrealized losses are stated as increasing from $240 million in 2023 to $276 million in 2024 (an increase of $36 million), but the correct values are $234 million in 2023 and $274 million in 2024, resulting in a $40 million increase. Both the starting and ending values are off, and the calculated difference is incorrect. (2) Calculations: The LLM computes a $36 million increase ($276M - $240M), which is mathematically correct based on its numbers, but since the inputs are wrong, the result is factually inaccurate. The correct calculation is $274M - $234M = $40M, which the LLM fails to match. (3) Multi-hop reasoning: The model attempts to synthesize information across time periods and categories (available-for-sale and held-to-maturity), indicating an understanding of the required structure. However, the synthesis is based on incorrect underlying data, undermining the reasoning. It correctly identifies the need to report total fair value and changes in unrealized losses over time, showing appropriate qualitative logic. (4) Contextual relevance is high—the answer addresses both parts of the question, cites a relevant page, and uses proper financial terminology. However, due to severe quantitative errors in core financial figures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the framework of the response is sound, but it fails in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 479,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "Booking.com’s merchant‑basis mix rose to 54 % of gross bookings in 2023 (up from 44 % in 2022) 【page_37】. Because a larger share of transactions is processed on a merchant basis, the company incurred higher merchant‑related costs – chiefly additional personnel spending to support payment operations, higher payment‑processing fees, chargebacks (including fraud‑related losses) and other merchant‑related expenses recorded in “Personnel” and “Sales and other expenses” 【page_37】. These added costs compressed operating margins in 2023 relative to 2022, offsetting the incremental merchant‑revenue gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative facts: the merchant basis transaction mix increased from 44% in 2022 to 54% in 2023, which matches the ground truth exactly. All percentages and years are accurate. (2) The answer accurately reflects that this shift led to higher merchant-related expenses, which negatively impacted operating margins despite incremental revenues—this aligns with the original answer’s conclusion. The key cost components are correctly identified as personnel expenses, payment processing fees, and chargebacks (including fraud-related losses), and are properly attributed to 'Personnel' and 'Sales and other expenses' as per the Consolidated Statements of Operations. (3) The multi-hop reasoning is sound: the model correctly synthesizes the cause (increased merchant mix), effect (higher costs), and outcome (margin compression), even noting that the costs outweighed revenue gains. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'payment card rebates' as part of the incremental revenues that were offset—this detail is present in the ground truth and adds slight nuance to the revenue side of the trade-off. However, the core logic and factual content are preserved, so this does not significantly detract from accuracy. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 388,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "The eligible consumer‑installment portfolio was moved out of ordinary loans into “Loans and interest receivable, held for sale,” which eliminated the credit‑loss allowance that had been recorded and therefore reduced transaction‑and‑credit‑loss expense on the income statement.  Beginning in Q1 2024 PayPal switched the fair‑value measurement of those held‑for‑sale loans from a price‑based (Level 3) model to an observable‑input (Level 2) model, so the portfolio is now reported at $541 million (versus $563 million in 2023) and any changes in fair value are recognized in the “restructuring and other” line of the consolidated statement of income, affecting earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key aspects of the original answer with only minor omissions. (1) Correctly identifies the reclassification of consumer installment receivables to 'Loans and Interest Receivable, Held for Sale', the elimination of the allowance for credit losses (reducing transaction and credit loss expense), the shift in fair value methodology from Level 3 (unobservable) to Level 2 (observable inputs), and the impact on income recognition via the 'restructuring and other' line item. (2) Quantitatively, the LLM provides specific dollar amounts: $541 million in 2024 versus $563 million in 2023. While the original answer does not include these exact figures, they are plausible and consistent with the revaluation narrative; their inclusion does not contradict the ground truth, which focuses on methodology and classification impact rather than specific balances. The dates (Q1 2024) are correct. (3) Multi-hop reasoning is sound: the model connects reclassification → valuation methodology change → fair value hierarchy shift (Level 3 to Level 2) → income statement impact, synthesizing cause and effect across accounting policies and financial statement line items. (4) The only minor omission is that the reversal of the allowance occurred in 2023 (as stated in the original), which the LLM implies but does not explicitly date. Otherwise, semantic equivalence is strong, terminology is accurate, and the response directly addresses both asset valuation and income recognition as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 423,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "As of December 31 2024, PMI’s new €1.5 billion revolving credit facility (≈ $1.6 billion) together with its short‑term credit arrangements of about $2.1 billion gives a total borrowing capacity of roughly **$3.7 billion**【page_105】.  By comparison, the short‑term credit capacity alone was about **$2.7 billion** at December 31 2023, so the 2024 combined capacity is roughly **$1.0 billion higher** than the 2023 short‑term amount【page_105】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the €1.5 billion credit facility and converts it to approximately $1.6 billion, and correctly states the 2024 short-term credit arrangements as $2.1 billion, leading to a total combined capacity of $3.7 billion — all of which matches the ground truth. However, the key error lies in the comparison: the LLM states that the 2024 combined capacity is '$1.0 billion higher' than the 2023 short-term amount of $2.7 billion, which is incorrect. The ground truth states that the $3.7 billion 2024 total represents a *decrease* compared to the $2.7 billion in 2023 — but this is logically impossible since $3.7B > $2.7B, indicating a contradiction in the original answer. Upon closer inspection, the original answer likely contains a factual error: it claims $3.7B total in 2024 is a 'decrease' vs $2.7B in 2023, which is numerically incorrect. However, the LLM contradicts this by correctly computing the difference ($3.7B - $2.7B = +$1.0B) but then mischaracterizes the trend as an increase, which is actually consistent with the numbers. The core issue is that the ground truth contains an illogical statement (claiming a decrease when numbers show an increase). The LLM follows the math correctly but fails to align with the ground truth's erroneous conclusion. (2) All numbers are accurately cited: €1.5B ≈ $1.6B, $2.1B short-term in 2024, $2.7B in 2023 — all correct. The sum $1.6B + $2.1B = $3.7B is accurate. The difference of +$1.0B is also correct. (3) The multi-hop reasoning — combining new and existing facilities across years — is sound and properly synthesized. (4) Despite correct calculations, the LLM contradicts the ground truth's flawed conclusion, which expects a 'decrease'. Since evaluation must follow the ground truth even if it appears factually inconsistent, the LLM is penalized for stating an increase instead of a decrease. However, the numbers themselves are right, so partial credit is given. Final scores reflect correct data but incorrect interpretation relative to the (possibly flawed) ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 556,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "The two customers tied to the Compute & Networking segment together accounted for 13 % + 19 % = 32 % of NVIDIA’s FY 2024 revenue. Applying that share to the assumed total revenue of $27 billion yields roughly $27 billion × 0.32 ≈ $8.64 billion contributed by the Compute & Networking segment.【page_40】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Compute & Networking segment's revenue contribution is derived from the combined 13% (direct) and 19% (indirect) customer shares, totaling 32%. It then correctly applies this percentage to the $27 billion total revenue. The calculation $27 billion × 0.32 = $8.64 billion matches the ground truth exactly. (2) All numeric values—13%, 19%, 32%, $27 billion, and $8.64 billion—are accurate and correctly used. The arithmetic is sound and precisely matches the required computation. (3) The multi-hop reasoning is correct: the model synthesizes the two customer revenue contributions (direct and indirect) tied to the Compute & Networking segment and links them to the total company revenue to derive segment-level revenue. This reflects proper understanding of the indirect attribution logic based on customer revenue shares. (4) The answer is semantically equivalent to the ground truth, includes correct entities (NVIDIA, Compute & Networking segment, FY2024, $27 billion total revenue), and provides a clear, logically sound derivation. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 325,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG’s internal capital framework quantifies the firm’s aggregate economic risk at a specified confidence level and explicitly incorporates diversification benefits across risk factors and business lines. The framework’s output is fed into the company’s stress‑testing program, which gauges exposure to its most material financial and insurance risks, and together they are used to determine the capital the AIG parent must allocate to its subsidiaries to keep the consolidated target capitalization level in place.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AIG's Internal Capital Framework quantifies aggregate economic risk at a specified confidence level, incorporates diversification benefits across risk factors and business lines, and informs capital allocation from AIG Parent to subsidiaries to maintain consolidated target capitalization levels. The integration with the stress testing framework is correctly described as evaluating exposure to material financial and insurance risks. (2) There are no numeric values, dates, or percentages in the question or answers, so quantitative accuracy is not applicable beyond correct use of qualitative financial concepts—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links the Internal Capital Framework to diversification, capital assessment, stress testing, and capital allocation decisions. The only minor omission is that the original answer explicitly states the frameworks 'complement' each other in guiding capital decisions and ensuring financial resilience—the LLM implies this but doesn't use the term 'complement' or mention 'financial resilience,' slightly reducing qualitative completeness. (4) Contextual relevance is perfect: every part of the LLM response directly addresses the question about how the framework supports capital assessment in relation to stress testing and diversification. Wording differs slightly but meaning is semantically equivalent. No incorrect entities or concepts are introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 431,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Target’s owned‑brand portfolio—about one‑third of total merchandise sales—requires longer lead times and more direct involvement in sourcing, so any supply‑chain disruption or mis‑judgment of consumer demand can leave the retailer with either stockouts or excess inventory. Both outcomes force Target to incur higher transportation, storage and labor costs, increase inventory markdowns and shrinkage, and compress the higher margins that owned brands normally deliver, thereby hurting its profitability and overall results of operations【page_12†L1-L9】【page_12†L10-L15】【page_10†L13-L20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Quantitatively, the statement that Target's owned brands represent 'about one-third of total merchandise sales' matches the ground truth exactly—this key percentage is correct. No other numerical values (e.g., dates, dollar amounts) are present in either answer, so no calculation errors exist. (2) The LLM correctly identifies the higher operational risks: longer lead times, early ownership in the supply chain, and the consequences of demand misforecasting—specifically stockouts and excess inventory. It accurately links these to increased costs (transportation, storage, labor), higher markdowns, and shrinkage, all of which are mentioned or implied in the original. (3) The reasoning is sound and reflects multi-hop synthesis: it connects owned-brand characteristics (longer lead times, higher margins) to supply chain vulnerabilities, then to inventory and profitability impacts. The only minor omission is the explicit mention that owned brands have higher margins *that are compressed* when markdowns or shrink occur—though the phrase 'compress the higher margins that owned brands normally deliver' effectively captures this. Also, while the original emphasizes the holiday period (November–December) as a critical time when these risks are magnified, the LLM answer does not mention this seasonal aspect, which is a small but relevant contextual detail. (4) Despite this omission, the LLM answer remains semantically equivalent in substance and fully addresses the core of the question. All entities (Target, owned brands, inventory, profitability) are correct. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 489,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "In 2024 NVIDIA’s 3.50% Notes due 2050 carried a balance of **$2 billion**, while the 3.50% Notes due 2040 carried **$1 billion** (both shown in the long‑term debt table)【page_72】. The 2050 notes therefore have a **$1 billion higher** carrying value than the 2040 notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values. According to the ground truth, the difference is $397 million, but the LLM claims a $1 billion difference, which is more than double the correct amount. The stated carrying values of $2 billion (2050 notes) and $1 billion (2040 notes) are not aligned with the ground truth data, though the entities (NVDA, 3.50% Notes Due 2050 and 2040, 2024) are correctly identified. (2) The calculation of the difference ($2B - $1B = $1B) is mathematically correct based on the LLM's numbers, but the input values themselves are wrong, leading to an incorrect final answer. The correct difference is $397 million, not $1 billion. (3) The reasoning structure is sound—comparing two carrying values from the same year and calculating the difference—but the underlying data is inaccurate, indicating a failure in retrieving the correct figures from the source document. This breaks the multi-hop synthesis despite correct logical flow. (4) The contextual relevance is high because the answer addresses the right companies, notes, and time period, and performs the correct type of comparison. However, due to major quantitative errors, the correctness and accuracy scores are low. Minor formatting differences are acceptable, but a $603 million discrepancy is not.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1060,
        "completion_tokens": 374,
        "total_tokens": 1434
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2024 UnitedHealth Group had **48 million shares** available for future issuance under the 2020 Stock Incentive Plan and **16 million shares** available under the 1993 Employee Stock Purchase Plan, for a combined **64 million shares** that could be issued. The 2020 Stock Incentive Plan permits the grant of **stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only a minor discrepancy in plan name. (1) Quantitatively, all numbers are correct: 48 million shares under the 2020 Stock Incentive Plan, 16 million under the ESPP, totaling 64 million shares available for future issuance as of December 31, 2024 — all match the original answer. (2) The types of awards under the 2020 Stock Incentive Plan — stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards — are fully and correctly listed. (3) The only issue is that the LLM refers to the '1993 Employee Stock Purchase Plan' instead of the 'ESPP', which, while technically possibly correct (if ESPP was originally established in 1993), introduces unnecessary specificity not in the question and slightly deviates from the more general and accurate reference to 'ESPP' used in the ground truth. However, this does not affect factual correctness. (4) Multi-hop reasoning is sound: the model correctly synthesized total shares by combining two separate figures from the same filing and accurately described award types. The answer is contextually complete and relevant. A score of 9 is justified due to full factual and quantitative accuracy with only a minor, non-material wording choice affecting precision of entity naming.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 382,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG reserves for U.S. Workers’ Compensation are built with a mix of loss‑development and expected‑loss‑ratio techniques because the line has an extremely long‑tail loss‑emergence pattern (page 53). The Bornhuetter‑Ferguson approach combines the premium‑based expected loss ratio with paid‑loss development, weighting each by the reciprocal of the development factor (page 200), and “recognizes large losses without extrapolating unusual large activity onto the unreported portion of the losses” (page 51). By blending prior expectations with actual loss experience, this method dampens the impact of early‑stage volatility and produces more stable reserve estimates for the long‑tail Workers’ Compensation business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AIG's use of the Bornhuetter-Ferguson method within Expected Loss Ratio Methods to address loss emergence volatility in U.S. Workers' Compensation, a long-tail line. The explanation that this method blends expected loss ratios with actual loss experience to avoid overreacting to early anomalies matches the original answer's intent. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model connects the long-tail nature of Workers' Compensation, the instability of early loss data, and the stabilizing role of the Bornhuetter-Ferguson method by blending prior expectations with emerging data. The citation of 'large losses without extrapolating unusual large activity' directly reflects the ground truth's point about avoiding distortion. (4) Minor deduction in qualitative accuracy due to omission of the specific note about 'increasing proportion of large deductible business' slowing reporting patterns—a contextual detail present in the original that adds depth. However, this does not undermine the core correctness. The LLM answer remains semantically equivalent and contextually appropriate, hence high scores in all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 388,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "The 10‑K lists three amendments to the original Credit Card Program Agreement – a First Amendment (Feb 24 2015), a Second Amendment (Nov 19 2019) and a Third Amendment (Nov 1 2022)【page_74†L21-L24】【page_75†L1-L3】. The succession of amendments shows that Target and TDBank USA have continually refined the program, indicating a maturing and increasingly customized financial partnership over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states there are 3 amendments, while the ground truth confirms only 2 amendments (2015 and 2019). The 2022 Third Amendment is not part of the documented amendments in the ground truth, making the quantitative claim factually incorrect. (2) The dates mentioned—Feb 24, 2015, and Nov 19, 2019—align with the correct amendment dates in the ground truth, but the inclusion of a Nov 1, 2022 amendment introduces a false data point, undermining the accuracy. The number of amendments (3 vs. 2) is a critical factual error. (3) The reasoning about the evolution of the financial partnership being indicative of a maturing relationship is logically sound and semantically consistent with the ground truth’s interpretation. However, the multi-hop synthesis fails because it draws on an extra, unverified amendment not recognized in the knowledge graph, suggesting either a misreading of the source or inclusion of non-referenced data. (4) The contextual relevance is high because the answer addresses both parts of the question—number of amendments and interpretation of partnership evolution—and uses appropriate reasoning. However, the core factual error in the count of amendments severely reduces correctness and quantitative accuracy. The qualitative accuracy is moderate because the logic is sound but based on incorrect input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 381,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "FedEx incurred $273 million in 2023 and $582 million in 2024 on business‑optimization activities tied to Network 2.0 – a total of about $855 million.  The spending was part of the DRIVE transformation program, intended to consolidate facilities, cut pickup‑and‑delivery routes and create an end‑to‑end optimized network that lowers overhead and support costs while improving the efficiency of package pickup, transport and delivery in the U.S. and Canada.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dollar amounts spent by FedEx on Network 2.0 business optimization activities: $273 million in 2023 and $582 million in 2024, with a correct total of $855 million. These figures match the ground truth exactly, and formatting variations (e.g., 'about $855 million') are acceptable. 2) Quantitatively, all numbers and the sum are accurate. The calculation of $273M + $582M = $855M is correct and properly reported. 3) The primary purpose is described with high fidelity: improving efficiency in package pickup, transport, and delivery in the U.S. and Canada. While the original answer emphasizes 'professional services and severance' as the use of funds, the LLM answer frames the expenditures within the broader DRIVE transformation program, mentioning facility consolidation, route reduction, and network optimization. This is contextually accurate and aligns with the strategic goals of Network 2.0, though it omits the specific mention of 'professional services and severance' as the direct use of funds. This is a minor omission in qualitative detail but does not misrepresent the purpose. 4) The reasoning is sound and reflects multi-hop synthesis—linking expenditures to Network 2.0, identifying the correct years and amounts, and connecting them to operational efficiency improvements. The mention of the DRIVE program adds contextual depth consistent with public disclosures. Overall, the answer is factually correct, highly relevant, and semantically equivalent to the ground truth, with only slight variation in emphasis on fund usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 433,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The 10‑K warns that the new, lower‑priced ad‑supported subscription tier is a new pricing model with little operating history, so forecasting consumer uptake and the resulting advertising revenue is “inherently difficult.” That uncertainty raises the risk that Netflix’s revenue, margin and earnings projections could differ materially from actual results, which could cause missed guidance and a decline in its stock price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the introduction of the ad-supported subscription plan increases financial forecasting risks due to the difficulty in predicting consumer adoption and advertising revenue, which aligns with the original answer. The core financial risks—material discrepancies in revenue, net income, and other metrics—are accurately conveyed, though the LLM adds a plausible consequence (stock price decline) not explicitly stated in the ground truth. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a full score. (3) The multi-hop reasoning is sound: the model connects Netflix’s new pricing model (from competitive strategy context) to the uncertainty in forecasting mentioned in the 10-K, correctly synthesizing the cause-effect relationship between new business models and financial risk. (4) The answer is semantically equivalent to the original, with slightly expanded implications (e.g., 'missed guidance' and 'stock price decline') that are reasonable but not present in the ground truth. This justifies a 9 instead of 10 for qualitative accuracy. Contextual relevance is perfect as it directly addresses the question’s focus on financial forecasting risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 370,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "Pfizer’s 2024 10‑K shows that Prevnar 13’s basic U.S. patent runs until 2026, its Japanese patent until 2029, and the key European patent covering the 13‑serotype conjugate has already been revoked (with only other European patents remaining)【page_13】【page_14】. Because those exclusivity periods are ending – especially the U.S. 2026 expiry and the loss of the Europe combination patent – Pfizer recorded a $964 million impairment of Prevnar 13’s developed‑technology rights in 2023 to reflect the reduced cash‑flow outlook once the product’s patent protection expires【page_76】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $964 million impairment charge in 2023 and links it to the patent expiration timeline for Prevnar 13, which matches the ground truth. The U.S. patent expiration in 2026 and European patent status (revoked combination patent, with other patents remaining) are accurately described, though the ground truth specifies the major European patent expires in 2029, while the LLM notes Japan's patent until 2029 but not Europe's 2029 expiry explicitly. This is a minor discrepancy in regional emphasis but does not contradict facts. (2) All numeric values—$964 million, 2023 impairment, 2026 U.S. patent expiry, 2029 Japanese patent—are factually correct and consistent with the original answer and expected data. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes patent expiration timelines from Pfizer’s 10-K with the impairment charge, logically connecting reduced exclusivity to lower cash flow expectations and thus the need for impairment. It correctly infers that waning patent protection impacts commercial viability, prompting the charge. (4) The answer is contextually precise, directly addressing how patent expirations relate to the impairment. The only minor shortcoming is slightly less clarity on the European 2029 expiry being a key remaining patent, instead focusing on revocation of the combination patent. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 409,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald’s growth and profitability are driven largely by its franchisees, who must execute system‑wide initiatives that shape the customer experience; however, because franchisees are independent parties that the Company does not control, it treats them as scope‑exception entities and does not consolidate their businesses in the financial statements (Consolidation policy – page 43). Consequently, if franchisees fail to invest in or properly implement key customer‑experience programs—such as digital, delivery or drive‑thru upgrades—the brand’s reputation, system‑wide sales and overall financial results could be harmed, and McDonald’s has limited ability to intervene (Franchise business‑model risks – page 30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: McDonald's does not consolidate franchisee-related entities due to a scope exception under consolidation guidance, and this is tied to franchisees being independent operators. The answer correctly identifies that despite lack of consolidation, McDonald's success depends on franchisee execution of key customer experience initiatives like digital, delivery, and drive-thru improvements. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly connects the accounting treatment (non-consolidation) with the business model reliance on franchisees and the associated risk if they underperform. It references appropriate risk factors, including reputational harm and impact on system-wide sales, which are logical consequences even without financial consolidation. (4) The LLM adds contextual detail not in the original—specific page references (e.g., 'page 43', 'page 30') and slightly more granular risk language (e.g., 'limited ability to intervene')—but this does not introduce inaccuracies; rather, it enhances precision. The only minor gap is that the original explicitly names 'mobile ordering' and 'guest counts' as affected metrics, while the LLM uses broader terms like 'system-wide sales'. This slight omission prevents a perfect 10 but does not undermine correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 448,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG’s adoption of the new long‑duration contracts (LDTI) standard cut its beginning total equity by **$1.264 billion as of January 1, 2021**.  To restate the prior periods, the company **reduced net income for 2022 by $2 million, increased net income for 2021 by $983 million, and raised total equity at December 31, 2022 by $1.219 billion**【page_129】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $1,264 million decrease in beginning equity as of January 1, 2021, the $2 million decrease in net income for 2022, the $983 million increase in net income for 2021, and the $1,219 million increase in total equity as of December 31, 2022. Number formats are consistent in meaning ($1.264 billion = $1,264 million). (2) Quantitative accuracy is perfect: all dollar amounts and years match the original answer exactly in value and direction (increase/decrease). (3) The qualitative reasoning is sound—LLM correctly identifies the impact of LDTI adoption on equity and income across multiple periods, demonstrating proper multi-hop synthesis of restatement effects. (4) The answer is contextually relevant, directly addressing both parts of the question: the equity impact as of January 1, 2021, and the specific adjustments to financial statements for 2022 and 2021. The mention of restating prior periods aligns with the nature of accounting standard adoptions. No critical information is missing, and no extraneous or incorrect details are added.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 330,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The rise in Gulfstream aircraft orders lifted customer‑deposit balances, which helped boost cash provided by operating activities to $4.3 billion in 2021【page_45】.  That operating cash flow was equal to roughly 131 % of net earnings【page_34】【page_46】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the increase in Gulfstream aircraft orders led to higher customer deposits, which boosted cash flow from operating activities—a direct causal link stated in the ground truth. The key figures—$4.3 billion in cash provided by operating activities and 131% of net earnings—are both accurately reported. (2) Quantitatively, the dollar amount ($4.3 billion) and percentage (131%) match the ground truth exactly, with acceptable formatting (use of 'billion' and spacing around %). No calculations are required beyond what is provided, and the values are correctly attributed to 2021. (3) The multi-hop reasoning is sound: the model connects Gulfstream orders → customer deposits → impact on operating cash flow → comparison to net earnings, synthesizing information across financial statements and narrative disclosures (as indicated by page references). (4) The answer is semantically equivalent to the original, with slightly rephrased wording but full preservation of meaning and precision. All evaluation dimensions are satisfied at the highest level, warranting perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 322,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG’s integrated bottom‑up risk‑identification and assessment process captures material risks at the product‑line level and feeds that granular data into the company’s risk‑analytics engine. Those analytics are a core input to the internal capital framework, which then quantifies the firm’s aggregate economic risk at a specified confidence interval while accounting for diversification benefits across risk factors and business lines【page_115】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: AIG's bottom-up risk identification at the product-line level feeds into the internal capital framework, which quantifies aggregate economic risk at a given confidence interval. The answer correctly notes that diversification benefits across risk factors and business lines are accounted for. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly links granular risk identification to input for risk analytics, then to the internal capital framework and its purpose in quantifying aggregate risk with diversification. The only minor omission is the explicit mention of 'risk identification and measurement framework' as the broader context, though the process is accurately described. (4) The answer is highly relevant, directly addressing how the bottom-up process supports the capital framework. Wording differs slightly (e.g., 'risk-analytics engine' not in original), but this does not affect factual correctness. Overall, the response captures the core logic and factual chain accurately—justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 368,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The RTX 4080 launch is a new‑architecture GPU that falls within NVDA’s “product transitions,” which the filing says increase supply‑chain complexity and the risk of mismatches between supply and demand (see pages 16‑17). Because NVDA must secure wafer and component capacity from third‑party foundries with long lead times and pre‑pay for inventory, any error in forecasting RTX 4080 demand could create excess inventory or shortages, higher component costs, warranty or inventory provisions, and thus pressure gross margins and earnings (see pages 16‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the original answer. (1) It correctly identifies the RTX 4080 as part of NVDA's product transitions, links this to supply chain complexity, demand forecasting risks, and financial impacts such as inventory provisions, warranty costs, and margin pressure. All key qualitative points—long lead times, prepayment for inventory, third-party foundry dependence, and consequences of demand misforecasting (excess inventory or shortages)—are present and factually aligned with the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect numbers. (3) The multi-hop reasoning is sound: it connects product transition risks → supply chain constraints → demand forecasting challenges → financial consequences. The only minor omission is the lack of explicit mention of 'geopolitical tensions' and 'low manufacturing yields,' which are part of the broader supply chain risks in the original. Also, the original emphasizes potential damage to customer relationships and market share loss, which the LLM answer omits. These are secondary but relevant points. (4) Despite these small gaps, the LLM answer conveys the essential causal chain and financial implications with high fidelity, using semantically equivalent language and correct entity references (NVDA, RTX 4080, third-party foundries). Thus, the answer is contextually fully relevant and qualitatively very strong, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 439,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "Starbucks defers revenue for the estimated value of Stars earned under the Starbucks Rewards program, recording a liability in deferred revenue; the revenue is then recognized only when a member redeems the reward (or when breakage is realized). Advertising expense for fiscal 2022 was $416.7 million.【page_62】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the revenue recognition impact of the Starbucks Rewards program: revenue is deferred based on the estimated value of earned Stars and recognized upon redemption or breakage, which matches the original answer's explanation. (2) The quantitative figure for advertising expense in fiscal 2022 is exactly correct at $416.7 million, with no calculation required. (3) The reasoning is sound and reflects proper multi-hop synthesis—linking the loyalty program mechanics to revenue deferral and correctly identifying the separate financial metric (advertising expense) from the same fiscal year. (4) All entities (Starbucks, Starbucks Rewards, fiscal 2022) are accurate, and the response addresses both parts of the question completely and concisely. Minor wording differences (e.g., 'defers revenue for the estimated value of Stars earned' vs. 'defers revenue based on the estimated value of the product') do not affect factual accuracy. The citation '[page_62]' indicates source support, further validating the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 317,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The notional amount of intercompany loans and forecasted interest payments grew from $2.86 billion at year‑end 2023 to $4.406 billion at year‑end 2024 – an increase of $1.546 billion【page_96】.  In 2024, $75 million of interest payments on those loans was recorded in earnings (interest and other expense, net)【page_97】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the notional amount increased from $2,860 million (stated as $2.86 billion) in 2023 to $4,406 million (stated as $4.406 billion) in 2024, resulting in a $1,546 million increase—calculation is accurate and format variations are acceptable. (2) The interest payments recognized in earnings in 2024 are correctly stated as $75 million, consistent with the original answer. (3) Multi-hop reasoning is sound: the model correctly synthesized data across years (2023 to 2024) and linked the interest recognition to the correct financial statement line item ('Interest and other expense, net'). (4) Entities, metrics, and time periods are accurate. The inclusion of page references adds contextual support. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 256,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "Total Marine Systems revenue rose from $9,979 million in 2020 to $10,526 million in 2021 – an increase of **$547 million**【page_10】.  Revenue from nuclear‑powered submarines grew from $6,938 million to $7,117 million, a **$179 million** rise【page_10】, so the overall Marine Systems growth was about **$368 million larger** (roughly three times) than the increase in nuclear‑powered submarine revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: Total Marine Systems revenue increased from $9,979 million in 2020 to $10,526 million in 2021, resulting in a $547 million increase. Nuclear-powered submarines revenue rose from $6,938 million to $7,117 million, a $179 million increase. These values match the ground truth exactly. (2) All calculations are accurate: $10,526M - $9,979M = $547M; $7,117M - $6,938M = $179M; and the difference in growth ($547M - $179M = $368M) is correctly implied. The qualitative comparison stating the Marine Systems growth was 'about $368 million larger' and 'roughly three times' is semantically equivalent and factually sound. (3) The multi-hop reasoning is correct—information from two different revenue segments (Total Marine Systems and Nuclear-powered submarines) across two years is properly synthesized to compute and compare growth. (4) All entities (Total Marine Systems, Nuclear-powered submarines), time periods (2020 to 2021), and financial metrics (revenue increases in dollar amounts) are accurately identified and used. The answer is fully complete, contextually relevant, and conveys the same information as the original with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 342,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "Apple’s Mac net sales grew from $29.357 billion in 2023 to $29.984 billion in 2024 – an increase of about $627 million【page_38†L31-L35】. In contrast, iPad net sales fell from $28.300 billion in 2023 to $26.694 billion in 2024 – a decline of roughly $1.606 billion【page_38†L31-L35】. Thus, while Mac sales rose modestly, iPad sales dropped by more than twice that amount (about $2.2 billion larger in the opposite direction).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all key figures: Mac sales increased from $29.357 billion to $29.984 billion, a $627 million increase, and iPad sales decreased from $28.300 billion to $26.694 billion, a $1.606 billion decline—matching the ground truth exactly. Number formats vary slightly ($29.357 billion vs $29,357 million) but are semantically equivalent. (2) All calculations are accurate: the differences are correctly computed, and the direction of change (increase vs decrease) is properly identified. (3) The multi-hop reasoning is sound—information from two product lines across two years is correctly synthesized and compared. The conclusion that Mac sales increased modestly while iPad sales declined significantly is valid. (4) The only minor issue is a small error in the comparative statement: the LLM says iPad sales dropped by 'more than twice that amount (about $2.2 billion larger in the opposite direction)', which is incorrect—the difference between a $627M increase and a $1,606M decrease is $2,233M, but describing it as 'more than twice that amount' is misleading because $1,606M is roughly 2.56 times $627M, not 'more than twice the amount in the opposite direction' in clear terms. This imprecise phrasing slightly affects qualitative accuracy but does not invalidate the core facts. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 384,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The Europe segment’s net revenues rose $452 million in 2024, mainly from higher net pricing, but that gain was partially eroded by an unfavorable volume/mix that was driven by declines in chocolate (a 2.1‑percentage‑point drag) (page 53). By contrast, in the prior year chocolate enjoyed a favorable volume/mix that helped lift growth (page 53). Thus, the 2024 chocolate volume‑mix weakness acted as a head‑wind, offsetting part of the $452 million revenue increase that otherwise would have been larger.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the unfavorable volume/mix in chocolate in 2024 acted as a drag on Mondelēz's revenue growth and that this contrasted with the prior year's favorable performance. It correctly notes the $452 million overall revenue increase and attributes part of the limitation in growth to chocolate's decline. However, it incorrectly narrows the $452 million increase to the 'Europe segment,' while the original answer states this is the company's *total* net revenue increase. This is a significant error in scope. (2) The LLM introduces a specific figure of '2.1-percentage-point drag' from chocolate volume/mix, which is not present in the ground truth and cannot be verified against it—this introduces unverified quantitative data. The ground truth provides absolute dollar figures: chocolate revenues were $10.619 billion in 2023 and contributed $1,437 million to prior-year growth, none of which are mentioned in the LLM answer. These omissions reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly contrasts 2024's unfavorable volume/mix with 2023's favorable trend and links it to net revenue impact. However, it fails to incorporate key data points from the original answer (e.g., chocolate's $10.619B 2023 revenue, the $1.437B prior-year growth contribution), weakening the synthesis. (4) Despite the misattribution to Europe and the unverified 2.1-point drag, the core qualitative insight—that chocolate's 2024 performance dragged on growth despite overall revenue increase—is correct and contextually relevant. The answer captures the directional impact and comparative dynamic, just not with full factual fidelity. Hence, correctness is reduced to 7 due to significant but not fundamental errors in entity scope and unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 497,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Apple’s custom‑made parts are frequently obtained from a single supplier, and when a new technology is introduced those parts often have “initial capacity constraints” until the supplier’s yields and production capacity mature. Because Apple depends heavily on single‑source suppliers and outsourcing partners—most of them in Asia—for component fabrication and final assembly, those early‑stage constraints magnify supply‑chain risk and can lead to shortages or delayed product launches, limiting Apple’s ability to keep products available on schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that Apple relies on single-source suppliers for custom components and that initial capacity constraints occur with new technologies until supplier yields and production capacities mature—this aligns exactly with the 10-K filing content. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data earns a perfect score. (3) The multi-hop reasoning is sound: the model connects custom components → single-source suppliers → capacity/yield ramp-up delays → supply chain risk → impact on product availability, and correctly situates outsourcing partners in Asia as a compounding factor. The only minor omission is that the LLM does not explicitly mention suppliers potentially prioritizing more common components over Apple’s custom ones, which is a nuance present in the original. This slightly reduces completeness but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing how capacity constraints interact with supplier concentration and geographic outsourcing to affect supply chain resilience and product availability. Wording differs but semantic meaning matches the ground truth closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 384,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported **$3.429 billion** of TV/SVOD distribution‑licensing revenue in fiscal 2022 after accounting for the $1.023 billion content‑license early‑termination reduction. In the prior year, FY 2021 TV/SVOD distribution‑licensing revenue was **$5.266 billion**, so the 2022 amount was about **$1.8 billion lower** than the previous year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Disney's 2022 TV/SVOD distribution licensing revenue after the early termination fee is correctly stated as $3.429 billion (equal to $3,429 million), the fee itself is $1.023 billion ($1,023 million), and 2021 revenue is $5.266 billion ($5,266 million). (2) The year-over-year decrease is accurately implied as approximately $1.8 billion, which aligns with the exact $1,837 million difference in the ground truth (rounding to nearest $100M is acceptable and common). (3) The multi-hop reasoning—synthesizing revenue figures across two years and adjusting for a one-time fee—is sound and correctly executed. (4) All entities (Disney, TV/SVOD distribution licensing, fiscal years 2021 and 2022, content license early termination fee) are correctly identified and contextualized. The answer addresses both parts of the question: the adjusted 2022 revenue and the comparison to the prior year. Minor formatting differences (billion vs million, decimal vs comma) do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 315,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Starbucks links its Mobile App directly to the Starbucks Rewards program, automatically enrolling cardholders and letting them earn “Stars” for purchases made with the app, mobile wallets, cash or credit/debit cards, while also enabling Mobile Order & Pay for advance pickup. That seamless digital experience makes payment and ordering more convenient, incentivizes repeat purchases to accrue rewards, and therefore drives higher customer engagement and more frequent store visits.【page_11】【page_10】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Starbucks integrates the Mobile App with Starbucks Rewards, enables earning Stars across multiple payment methods (app, mobile wallets, cash, credit/debit cards), and offers Mobile Order & Pay for advance pickup. These features drive customer engagement and store visit frequency through convenience and reward incentives. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes how app integration with Rewards drives behavior via digital convenience and loyalty incentives. (4) The LLM omits minor contextual details present in the original—such as explicit mention of access to card balances and loyalty benefits or the alignment with contactless trends—but captures the essential mechanisms and outcomes. Wording differs slightly but maintains semantic equivalence. The inclusion of citation placeholders 【page_11】【page_10】 suggests proper grounding in the document. Overall, the answer is factually correct, relevant, and complete in substance, warranting a high correctness score with only a minor deduction for slight incompleteness in contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 375,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "PayPal’s October 2021 acquisition of Paidy, Inc. meant that Paidy was excluded from both management’s assessment and the auditor’s scope of internal‑control‑over‑financial‑reporting testing for 2021. The subsidiary’s total assets and revenues accounted for **less than 1 %** of PayPal’s consolidated assets and revenues, so its amounts fell short of the audit inclusion threshold by under 1 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly states that Paidy was excluded from PayPal's internal control over financial reporting audit in 2021 due to the October 2021 acquisition, which aligns with SEC guidance for first-year acquisitions. (2) The quantitative claim that Paidy's total assets and revenues represented 'less than 1%' of PayPal's consolidated totals is accurate and matches the ground truth; the phrasing 'fell short of the audit inclusion threshold by under 1%' is slightly imprecise but semantically acceptable since the threshold is 1%, and being below it means the shortfall is less than 1 percentage point. (3) The multi-hop reasoning is sound: the model correctly links the timing of the acquisition (October 2021) to the exclusion from the year-end audit and connects the size of Paidy relative to PayPal to the SEC's 1% inclusion threshold. (4) All entities—PayPal, Paidy, Inc., internal control over financial reporting, 2021 audit scope—are correctly identified and contextualized. The only minor issue is the slightly awkward phrasing of 'fell short... by under 1%', which could imply a calculation error but in context clearly means 'was below the 1% threshold'. This does not affect factual correctness. Overall, the answer is complete, accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 380,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "In 2024 the Latin America segment lifted net pricing by about 7 percentage points and cut manufacturing costs through productivity gains, but those advantages were largely erased by a 2.4‑point hit to volume/mix caused by weaker sales of chocolate and refreshment‑beverage categories (along with candy and cheese & grocery). The unfavorable mix offset the pricing and cost‑control benefits, leaving segment operating income up only $3 million – a 0.6 % increase (page 51).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 7.0 percentage point increase in net pricing, the $3 million (0.6%) increase in operating income, and the negative impact of volume/mix — all of which align with the ground truth. It also accurately notes productivity-driven manufacturing cost reductions. However, it introduces a '2.4-point hit to volume/mix' that is not present in the original answer; while this may be a valid inference, it is not explicitly supported by the provided ground truth and adds specificity not warranted. Additionally, the LLM broadens the categories affected to include 'candy and cheese & grocery,' which were not mentioned in the original answer (only chocolate and refreshment beverages were cited). (2) Quantitatively, all key numbers — 7.0 percentage points pricing gain, $3 million, 0.6% growth — are accurate and match the ground truth. The 2.4-point volume/mix decline, while plausible, is not verifiable from the original and thus represents an unsupported addition. (3) The multi-hop reasoning is sound: the model correctly synthesizes that pricing and cost controls were offset by volume/mix declines, leading to minimal income growth. However, it slightly overreaches by specifying the magnitude of volume/mix impact and expanding the product categories without basis. (4) Despite minor over-specification, the core explanation is factually aligned, contextually appropriate, and directly addresses the question. The answer captures the essential trade-off and outcome, warranting a high correctness score with a slight deduction for unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 440,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream’s current product line holds **more than 270 city‑pair speed records**, the most of any business‑jet manufacturer, and this achievement is **led by the G650ER** (which also holds the National Aeronautic Association’s polar and westbound around‑the‑world speed records).【page_6】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, 'more than 270 city-pair speed records' matches the original answer exactly, and the mention of the G650ER's specific records (polar and westbound around-the-world) is accurate. (2) The answer addresses both parts of the question: the total number of records and the specific model (G650ER) credited with leading the achievement. (3) Entity accuracy is perfect: Gulfstream, G650ER, and the National Aeronautic Association are all correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis—linking the overall record count to Gulfstream’s product line and attributing leadership to the G650ER based on its specific accomplishments. Minor wording differences (e.g., 'led by' vs 'explicitly credited with') do not affect factual equivalence. All information is relevant and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 269,
        "total_tokens": 1434
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded $105 million of contingent‑consideration in fiscal 2024 and $704 million in fiscal 2022, for a combined total of $809 million. The Abiomed acquisition alone contributed $704 million of that total (​page 71​).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $704 million in 2022 (Abiomed) and $105 million in 2024 (Proteologix), with a correct total of $809 million. The format variations ($704 million vs $704M) are acceptable. (2) The answer addresses both parts of the multi-part question: the total contingent consideration over 2024 and 2022, and the specific contribution of Abiomed. (3) Entity accuracy is correct—Johnson & Johnson, Abiomed, and the fiscal years 2022 and 2024 are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes information across years and acquisitions, correctly attributing the $704 million to Abiomed and noting the total. The citation to page 71 adds contextual support. The answer is semantically equivalent to the ground truth, with no factual or logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 260,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal treats the portion of PPWC and PPBL merchant receivables that it sells to WebBank as a sale, derecognizing that participation interest and reporting the remaining receivable **net of the sold interest and a pro‑rata allowance for current expected credit losses** (see page 72). After adopting CECL on 1 Jan 2020, the allowance is measured using expected‑loss models that incorporate historical loss data, macro‑economic forecasts and qualitative adjustments, whereas before CECL it was based on roll‑rate and vintage‑based delinquency forecasts (see pages 43‑44 and 74). Thus, credit‑loss expense is now recognized on the **net** PPWC/PPBL balance using the CECL methodology rather than on the gross balance under the older roll‑rate approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal sells participation interests in merchant receivables under PPWC and PPBL to WebBank, accounts for them as sales, and derecognizes the sold portion—this matches the original answer. It accurately states that PayPal retains servicing rights and remains exposed to credit losses on the retained interest. The key shift from the incurred loss model to CECL in 2020 is correctly noted, including the effective date of January 1, 2020. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2020 adoption) are correct. (3) The multi-hop reasoning is sound: the model connects the sale of receivables, derecognition, retained exposure, and the impact of CECL adoption on allowance measurement. It correctly emphasizes that the allowance is now applied on a pro-rata basis to the net retained balance under CECL, versus the prior roll-rate and vintage-based delinquency methods. The mention of page references (72, 43–44, 74) suggests grounding in source material, though not required for correctness. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the change made provisioning more forward-looking and sensitive to economic forecasts—though it does mention macro-economic forecasts as part of CECL, which implies this. This slight omission in elaborating the broader implications on provisioning behavior prevents a perfect 10, but the core facts, entities, timing, and reasoning are all correct. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 463,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese & grocery category posted a volume decline, which was a key component of the overall “unfavourable volume/mix” that helped drive a $80 million (‑1.6 %) drop in Latin America net revenues in 2024【page_51】.  Even with that revenue hit, the segment’s operating income still edged higher, rising $3 million (‑0.6 %) to $532 million for the year【page_51】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key quantitative metrics. It incorrectly states that the unfavorable volume/mix caused a $80 million (-1.6%) drop in Latin America net revenues, while the ground truth indicates the impact was an unfavorable 2.4 percentage points on net revenues—not an absolute dollar or percentage decline in total revenues. This misrepresents the nature of the impact. Additionally, the LLM claims operating income rose $3 million to $532 million, but the original answer only states the increase was $3 million (0.6%), with no absolute value provided. The sign on the percentage change is also wrong: the LLM writes '-0.6%' increase, which contradicts itself—either a decrease of 0.6% or an increase of 0.6%, but not both. (2) The calculation and interpretation of financial impacts are incorrect. The 2.4 percentage point unfavorable volume/mix impact is a relative drag on revenue growth, not a direct revenue decline. The LLM misinterprets this as an actual revenue drop of 1.6%, which is not supported by the original answer. The $3 million increase in operating income is correctly cited in amount but incorrectly framed with a negative percentage. (3) The multi-hop reasoning is partially sound in linking cheese & grocery volume declines to the broader unfavorable volume/mix and then to operating income, but it fails to mention other contributing categories (chocolate, candy, refreshment beverages) and the offsetting gains in biscuits & baked snacks and gum, which are key to the full context. (4) Due to significant quantitative inaccuracies and misrepresentation of financial metrics, the correctness score is low at 3. Quantitative accuracy is severely compromised (score 2). Qualitative accuracy is partially correct in identifying the direction of impact but flawed in detail (score 4). Contextual relevance is moderate as the answer addresses the right topic and segment but distorts the data (score 6).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 531,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The filing shows that the new Telco Class A‑4 preferred interests represent a $2,250 million redemption liability (they can be called at issue price beginning Nov 1 2028) and the two‑million Mobility II non‑controlling interests will accrete to a $2,000 per‑interest redemption value – a total of $4,000 million (the redemption price is $1,000 per interest plus accrued distributions, and the interests become redeemable starting March 15 2028)【page 88】. Together, these obligations amount to roughly $6.25 billion, meaning AT&T must have that amount of cash available in 2028 when both the Telco Class A‑4 and Mobility interests become payable, creating a material cash‑flow commitment for that year.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies the $2,250 million redemption value of the Telco Class A-4 preferred interests, it incorrectly calculates the total redemption value of the Mobility noncontrolling interests. It states that two million interests will accrete to a $2,000 per-interest redemption value, implying a total of $4,000 million (2 million × $2,000), but the ground truth specifies the total redemption value is $2,000 million, not per interest. This results in a major error: the LLM claims a combined obligation of 'roughly $6.25 billion' ($2.25B + $4B), whereas the correct total is $4,250 million ($2.25B + $2B). The redemption timing is mostly correct—March 15, 2028, for Mobility and Nov 1, 2028, for Telco—but the LLM omits that Mobility interests can be put by holders on June 15, 2028, and mischaracterizes the redemption mechanism. (2) Calculations are flawed: the sum of $2,250 million and $4,000 million is $6,250 million, but the actual sum should be $4,250 million. The LLM incorrectly multiplies the number of shares by a per-share value that is not supported by the ground truth, which states a total redemption value of $2,000 million, not per interest. (3) The multi-hop reasoning is partially sound—linking both redemption obligations and their impact on 2028 cash flows—but fails due to incorrect financial synthesis. The model identifies that both obligations become payable in 2028 and affect liquidity, which aligns with the ground truth, but the magnitude is wrong. (4) Correctness score is 5 due to major numerical errors despite correct identification of some facts and the general timing and impact on cash flow. Quantitative accuracy is 5 because half the numbers are correct (Telco value), but the Mobility total and combined sum are wrong. Qualitative accuracy is 6 because the reasoning structure is logical and entities are mostly correct, but the financial interpretation is flawed. Contextual relevance is 9 because the answer directly addresses the question’s focus on redemption values and cash flow impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 570,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The Orthopaedics franchise generated **$9.158 billion** in 2024.  Within that franchise, Hips ($1.638 billion) and Knees ($1.545 billion) together contributed **$3.183 billion**, which is roughly one‑third of the total Orthopaedics revenue (about $5.975 billion less)【page_34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values are correct and accurately presented. The LLM correctly reports Orthopaedics revenue as $9.158 billion (equivalent to $9,158 million), Hips as $1.638 billion, Knees as $1.545 billion, and their sum as $3.183 billion. These match the ground truth exactly, with acceptable format variation (billion vs million). (2) The calculation of the combined Hips and Knees revenue ($1.638B + $1.545B = $3.183B) is accurate. However, the LLM does not explicitly compute or report the percentage (34.76%) of total Orthopaedics revenue represented by Hips and Knees, instead stating it is 'roughly one-third'—which is a reasonable approximation but omits the precise figure. It also mentions '$5.975 billion less', which is correct ($9.158B - $3.183B = $5.975B) but was not asked for, so it adds extra detail without error. (3) The multi-hop reasoning is sound: the model correctly identifies that Hips and Knees are subcomponents of the Orthopaedics segment and aggregates their revenues appropriately. (4) The answer is semantically equivalent in terms of core facts and calculations. The only minor shortcoming is the lack of the exact percentage (34.76%), which reduces qualitative accuracy slightly. However, all entities, years, and metrics are correct, and the response is fully contextually relevant. Thus, correctness is high but not perfect due to the missing precise percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 391,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan required a proportional adjustment after the 2024 special dividend, which increased the pool of shares that could be granted under the plan by roughly 128,000 RSU shares (in addition to the ~52,000 shares added to the outstanding RSU balance). This adjustment is formally set out in the 2019 Incentive Plan filing (Exhibit 10.2* – DEF 14A filed December 17 2019) and the related RSU award agreements (Exhibits 10.3.1*‑10.3.4* filed as Form 10‑Q on December 23 2019).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 128,000 increase in available RSU shares and the ~52,000 increase in outstanding RSUs match the original answer. The dates (December 17, 2019, for the DEF 14A filing) are accurate. (2) The explanation of the proportional adjustment mechanism under the 2019 Incentive Plan is correct, and the impact on both outstanding and available shares is properly described. (3) The filing references are mostly accurate: Exhibit 10.2 in the DEF 14A filing on December 17, 2019, is correctly cited as the source of the adjustment mechanism. However, the LLM adds that the RSU award agreements (Exhibits 10.3.1–10.3.4 filed on December 23, 2019, as part of a Form 10-Q) also formally document the adjustment. The ground truth does not support this—only the 2019 Incentive Plan (Exhibit 10.2) is cited as formally documenting the adjustment requirement. This is a minor overstatement but does not contradict facts. (4) The reasoning is sound and reflects proper multi-hop synthesis: linking the plan’s adjustment clause to the dividend event and its effect on share counts. Wording differs but meaning is semantically equivalent. The only reason for not giving a 10 is the slight over-attribution of documentation to additional exhibits not cited in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 385,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "Intel 4’s shift to high‑volume manufacturing in Ireland in 2024 will grow its share of the 2025 processor mix, delivering roughly a 20% performance‑per‑watt gain over Intel 7 and supporting higher‑margin, higher‑value products while the “Smart Capital” strategy and government incentives help contain the capital outlay and protect cash flow. The same Irish fabs will move Intel 3 to high‑volume in 2025—adding up to an 18% performance‑per‑watt improvement over Intel 4—and will host the first high‑volume run of Intel 18A in 2025, which is expected to further boost performance‑per‑watt and density scaling beyond Intel 3.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial and technological impacts of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio. (1) All key facts are correct: Intel 4 delivers a 20% performance-per-watt improvement over Intel 7, Intel 3 offers up to 18% improvement over Intel 4, and Intel 18A is set for high-volume production in 2025. The timeline (2024 for Intel 4 ramp, 2025 for Intel 3 and 18A) matches the ground truth. (2) Quantitative accuracy is perfect: percentages (20%, 18%) and years (2024, 2025) are correctly stated with no calculation errors. (3) Multi-hop reasoning is sound: the answer correctly links the manufacturing transitions of Intel 4, Intel 3, and Intel 18A in Ireland, showing how the ramp of one enables the next. It also appropriately references the strategic context (Smart Capital, government incentives), which, while not in the original answer, adds relevant qualitative depth without contradicting facts. (4) The only minor omission is the lack of specific product names like 'Intel Core Ultra', 'Xeon 6 Scalable', and 'Panther Lake', which are mentioned in the ground truth and help concretely anchor the technology transitions. Additionally, the explanation of Intel 18A's technological breakthroughs (RibbonFET, PowerVia) is absent, which slightly reduces completeness. However, the answer still conveys the essential performance-per-watt and density scaling improvements. Overall, the answer is semantically equivalent in intent and fact, with only minor contextual omissions preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 439,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "AT&T’s DIRECTV investment fell from a book value of **$877 million at December 31 2023 to $0 at December 31 2024**, a decline of **$877 million**. This reduction was recorded in 2024, **after** AT&T had already deconsolidated Gigapower—an action that took effect on **May 12 2023 (following the May 11 2023 transaction closure)**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: the book value of AT&T's investment in DIRECTV decreased from $877 million on December 31, 2023, to $0 on December 31, 2024, resulting in a $877 million decrease. These figures match the ground truth exactly. The date of Gigapower's deconsolidation is accurately cited as May 12, 2023, with a reference to the May 11, 2023 transaction closure, which aligns with the original answer’s timeline. (2) All calculations are correct: the difference of $877 million is accurate, and the temporal comparison (DIRECTV reduction occurring after Gigapower deconsolidation) is properly sequenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two distinct events (DIRECTV investment write-down and Gigapower deconsolidation), compares their timing, and contextualizes them as separate equity investment changes. However, the LLM omits the explanation that the DIRECTV investment was reduced to zero due to cumulative cash receipts exceeding the initial investment and equity earnings—a key qualitative detail in the ground truth that explains *why* the book value hit zero. This minor omission prevents a perfect qualitative score. (4) Despite this, the answer remains factually accurate, contextually relevant, and semantically equivalent in conveying the core facts and timeline. The omission affects depth but not correctness, justifying a 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 413,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed $564 million of sales to the Cardiovascular franchise in fiscal 2024. In Johnson & Johnson’s human‑capital reporting, the company notes that the Shockwave acquisition is already included in the FY 2024 employee headcount (and full‑time‑equivalent) figures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the revenue contribution of $564 million in 2024 is accurately reported, with acceptable phrasing as 'sales' and correct fiscal year reference (fiscal 2024). (2) The human capital reporting is correctly described: Shockwave is included in the FY 2024 employee headcount and full-time-equivalent figures, which aligns with the ground truth stating its employees are incorporated into overall human capital metrics. (3) The multi-hop reasoning is sound—linking Shockwave's financial contribution to Johnson & Johnson's Cardiovascular segment and connecting the acquisition to human capital reporting across two domains (financial and workforce reporting). (4) All entities—Shockwave, Johnson & Johnson, Cardiovascular segment, 2024 time frame—are correctly identified and contextualized. Minor wording differences (e.g., 'sales' vs 'revenue', 'employee headcount' vs 'headcount reporting') do not affect factual accuracy. The answer is complete, precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 307,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The 11% rise in the Optimized Application Experiences category was driven by growth in Cisco’s ThousandEyes and Intersight offerings, which offset a decline in AppDynamics.  The category’s revenue grew by about $75 million in fiscal 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the 11% growth in the Optimized Application Experiences category, the $75 million increase in dollar terms, and the specific offerings (ThousandEyes and Intersight) driving the growth despite AppDynamics' decline. (2) Quantitative accuracy is perfect: the 11% growth rate and $75 million increase match the original answer exactly; format variations (e.g., 'about $75 million') are acceptable and do not affect factual precision. (3) Multi-hop reasoning is sound—the model correctly synthesizes that while AppDynamics declined, other offerings compensated and led to overall category growth, demonstrating understanding of offsetting dynamics across different product lines. (4) Entity accuracy is complete: Cisco, AppDynamics, ThousandEyes, Intersight, and fiscal 2022 are all correctly referenced. The answer is concise, relevant, and fully addresses both sub-questions: which offerings drove growth and the dollar increase. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 308,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T repurchased the 213 million Mobility preferred interests in April 2023 for a total purchase price of **$5,414 million**, which included accrued and unpaid distributions【page_87】.  The redemption eliminated those interests from the “Redeemable Noncontrolling Interest” line on the consolidated balance sheets—thereby reducing non‑controlling interest—and the difference between the carrying and settlement values was recorded as an adjustment to additional paid‑in capital【page_87】【page_88】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that AT&T paid $5,414 million in April 2023 to repurchase the Mobility preferred interests, including accrued and unpaid distributions, which matches the ground truth exactly. The date (April 2023) and entity (AT&T) are accurate. 2) Quantitatively, the $5,414 million figure is correct and properly formatted. There are no calculation errors. 3) The reasoning is sound: the redemption did remove the preferred interests from the noncontrolling interest classification. The LLM adds more precise detail by specifying 'Redeemable Noncontrolling Interest' and noting the accounting treatment (adjustment to additional paid-in capital), which is consistent with the source (pages 87–88) and enhances accuracy. 4) The answer fully addresses both parts of the question: the total payment amount and the impact on noncontrolling interest. While the ground truth uses the broader term 'Noncontrolling interest', the LLM’s use of 'Redeemable Noncontrolling Interest' is more specific and technically accurate, reflecting a nuanced understanding. The only minor difference is that the LLM does not explicitly say the interests were 'no longer outstanding', but the elimination from the balance sheet conveys the same outcome. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 365,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit posted a **14.5 % year‑over‑year revenue increase** (14.9 % on an operations‑only basis) after its 2022 acquisition【page_34】.  By contrast, the **overall Cardiovascular segment grew about 21.4 % YoY** (22.8 % on an operations basis) in the same period【page_35】【page_34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year revenue growth for Abiomed as 14.5%, matching the ground truth. It also accurately reports the Cardiovascular segment's growth as 21.4%, which aligns with the original answer. The dollar amounts ($1.306B to $1.496B for Abiomed and $6.350B to $7.707B for Cardiovascular) are not explicitly mentioned in the LLM answer, but the percentages are calculated correctly and match the ground truth. The LLM additionally provides 'operations-only' figures (14.9% for Abiomed and 22.8% for Cardiovascular), which are not in the original answer but are likely from the source document and do not contradict the ground truth; they add supplementary detail. (2) All key numerical values (14.5% and 21.4%) are accurate and correctly attributed. The growth percentages match the ground truth calculations: (1.496 - 1.306)/1.306 ≈ 14.5%, and (7.707 - 6.350)/6.350 ≈ 21.4%. (3) The multi-hop reasoning is sound: the LLM correctly isolates Abiomed's performance post-acquisition and compares it to the broader Cardiovascular segment, fulfilling the comparative aspect of the question. (4) The answer is semantically equivalent to the ground truth in terms of core facts and intent, though slightly more concise and enhanced with operational metrics. The omission of exact revenue figures is a minor completeness gap but does not detract from the correctness of the growth percentages or the comparison. Hence, the answer is highly accurate with only minor omissions of contextual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 424,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The exhibit list includes three separate amendments to the Lowe’s Companies Benefit Restoration Plan, and the most recent amendment is dated March 31, 2022. (See the Benefit Restoration Plan entries in the exhibit schedule on page 79.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on both key points. The original answer states there are seven amendments to the Lowe's Companies Benefit Restoration Plan, but the LLM claims only three. Additionally, the most recent amendment date is stated as April 4, 2017 (Amendment No. 7) in the ground truth, whereas the LLM incorrectly reports March 31, 2022. These errors directly contradict the verified data from the knowledge graph derived from actual SEC filings. (2) Quantitative accuracy is severely lacking: the number of amendments (3 vs 7) and the date (March 31, 2022 vs April 4, 2017) are both wrong. There is no acceptable variation that reconciles these discrepancies—these are clear factual errors. (3) The multi-hop reasoning failed completely. The question requires identifying all amendments listed in the exhibits and determining the latest date among them. The LLM not only undercounted the amendments but also cited a date that does not correspond to the correct amendment (and may reflect confusion with the filing year of the 10-K itself). (4) Contextual relevance is low but not zero—the response attempts to address the right document (2022 10-K) and refers to the exhibit list, so it is not entirely off-topic. However, due to major factual and quantitative errors, the answer is substantially incorrect and misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 377,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "Capital One phased in 75 % of the $2.4 billion CECL transition amount—approximately $1.8 billion—by January 1 2024【page_85】.  Under the Stress Capital Buffer framework effective October 1 2024, the company must maintain a CET1 capital ratio of 10.0 % (the minimum CET1 requirement plus the buffer)【page_85】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One phased in 75% of the $2.4 billion CECL transition amount, which is accurately calculated as $1.8 billion. It also correctly states that under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of 10.0%. All factual elements match the ground truth. (2) Quantitative verification: 75% of $2.4 billion = $1.8 billion — calculation is correct. Dates (January 1, 2024, and October 1, 2024) and percentages (75%, 10.0%) are exact matches. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer combines information about regulatory capital phase-in and future capital requirements from different parts of the filing, correctly attributing both to Capital One. (4) The answer is semantically equivalent to the original, with no omissions or distortions. Wording differences (e.g., 'minimum CET1 requirement plus the buffer') add clarity without altering meaning. All scores are maximized due to full factual accuracy, correct calculations, proper entity identification, and contextual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 324,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney’s filing shows that it uses both plain‑vanilla, time‑based RSU awards (e.g., the “Form of Restricted Stock Unit Award Agreement (Time‑Based Vesting)” in Exhibit 10.43, 10.49 and 10.54) that simply vest over a set period to retain executives, and a suite of performance‑based RSU awards (e.g., the “Form of Performance‑Based Stock Unit Award Agreement” in Exhibit 10.44 and the various “Performance‑Based Restricted Stock Unit Award Agreements” in Exhibits 10.45‑10.48, 10.55) whose vesting is tied to metrics such as Total Shareholder Return, ROIC and Section 162(m) requirements. The time‑based awards provide predictable, retention‑focused compensation, while the performance‑based awards align executive pay directly with long‑term shareholder value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All entities are correct: Disney, time-based and performance-based RSU agreements, correct exhibit numbers (10.43, 10.49, 10.54 for time-based; 10.44-10.48, 10.55 for performance-based), and performance metrics (TSR, ROIC) are correctly identified. (2) Quantitative accuracy is perfect: exhibit references are accurate, and no numerical claims are made that contradict the ground truth. The LLM omits mention of Exhibits 10.57–10.59, which are included in the ground truth as additional performance-based agreements, representing a minor omission. (3) Reasoning is sound: the distinction between retention-focused time-based vesting and performance alignment through metrics-linked vesting is logically and correctly explained. The multi-hop synthesis—linking vesting types to exhibits and then to strategic compensation goals—is well executed. (4) Semantic equivalence is strong; the LLM conveys the same core message: time-based for retention, performance-based for shareholder value alignment. The only shortfall is the incomplete listing of performance-based exhibits, but this does not undermine the central conclusion. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to near-complete entity coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 383,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Orthopaedics franchise grew 2.4% year‑over‑year, rising to $9.158 bn in 2024 from $8.942 bn in 2023. Within that franchise, Hips sales rose 5.0% to $1.638 bn and Knees sales rose 6.1% to $1.545 bn, and the faster growth of these two product lines supplied a key boost that helped lift the overall Orthopaedics segment to its modest 2.4% increase.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall Orthopaedics segment growth as 2.4%, matching the ground truth, and accurately reports the Hips (5.0%) and Knees (6.1%) growth rates. However, it does not explicitly state the dollar-amount growth for Hips ($78M) and Knees ($89M), nor the combined $167M contribution. Instead, it provides absolute revenue figures for 2024 (Hips: $1.638B, Knees: $1.545B), which are not in the ground truth and cannot be verified as correct without additional data. The total segment revenue implied ($8.942B in 2023 to $9.158B in 2024) implies a $216M increase, which matches the ground truth and supports quantitative accuracy on that point. (2) The calculation of total segment growth ($9.158B - $8.942B = $216M) is correct and aligns with the ground truth. However, the LLM does not calculate or mention that Hips and Knees together contributed $167M, or that this represents ~77% of total growth—this omission is significant for a multi-hop question focused on contribution. (3) The reasoning is sound in noting that faster-growing Hips and Knees helped drive overall growth, but it fails to quantify their relative contribution to segment growth, which is the core of the question. The answer describes directional influence but misses the precise synthesis required. (4) Scores reflect high contextual relevance and mostly accurate data, but the lack of explicit contribution analysis and unverifiable absolute revenue figures reduce quantitative and overall correctness. The answer is factually plausible and well-structured but incomplete on key multi-hop metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 443,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Capital One added back a total of $2.4 billion to regulatory capital under the CECL Transition Rule and, as the company notes, “we have phased in 75 % of this amount as of January 1 2024” – i.e., about $1.8 billion, with the remaining $600 million slated for the January 1 2025 phase‑in【page_85】.  \n\nThe CECL Transition Rule gives banks an optional five‑year election: they may defer the CECL capital impact through December 31 2021 and then phase in the cumulative after‑tax “day 1” impact plus the ongoing “day 2” increase (estimated with a 25 % scaling factor) at 25 % per year – 25 % in 2022, 50 % in 2023, 75 % in 2024 and fully phased in by 2025【page_85】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.4 billion total capital addition, 75% phased in by January 1, 2024 ($1.8 billion), and the remaining $600 million in 2025. These values are correctly calculated and reported. (2) The explanation of the CECL Transition Rule is complete and accurate, correctly describing the optional five-year transition, the deferral through 2021, and the annual phase-in schedule (25% per year starting in 2022, reaching 75% by 2024 and 100% by 2025). The mention of the 25% scaling factor for ongoing 'day 2' impacts adds detail consistent with regulatory guidance. (3) Multi-hop reasoning is sound: the answer synthesizes Capital One's specific implementation with the general rule structure from the regulatory framework. (4) Entities (Capital One, CECL Transition Rule, dates, financial amounts) are correctly identified and contextualized. The answer addresses both sub-questions fully—how much was phased in by January 1, 2024, and how the rule works—demonstrating strong qualitative and contextual accuracy. Minor formatting differences (e.g., spacing in dates) do not affect meaning or correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 341,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The November 2023 issuance of four Guaranteed Senior Notes by Costco’s Japan subsidiary added roughly $500 million to “Other long‑term debt” (raising it from $484 million in 2023 to $919 million in 2024) and was reflected in the $5.738 billion fair‑value of total long‑term debt at year‑end 2023. The July 2024 repayment of $77 million reduced the outstanding notes, yet the overall fair‑value of long‑term debt still fell to $5.412 billion at year‑end 2024, showing a net decline despite the issuance. The issuance generated cash inflows in financing activities in 2024, while the repayment contributed to cash outflows, together with other debt repayments and dividend payments, resulting in a much larger net cash outflow from financing activities in 2024 versus 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 million issuance in November 2023 and the $77 million repayment in July 2024, aligning with the ground truth. It accurately states the fair value of long-term debt decreased from $5,738 million at the end of 2023 to $5,412 million at the end of 2024. However, the LLM introduces a detail not present in the original answer—specifically, the increase in 'Other long-term debt' from $484 million to $919 million—which, while plausible, is not supported by the ground truth and adds unverified granularity. (2) All key numbers—$500 million issuance, $77 million repayment, $5,738 billion and $5,412 billion fair values—are correct in magnitude and context (format variations like $5.738 billion = $5,738 million are acceptable). The net cash used in financing activities is mentioned qualitatively but lacks the specific $10,764 million figure from the ground truth, which is a notable omission. (3) The multi-hop reasoning is sound: the model correctly links the issuance and repayment to changes in long-term debt fair value and financing activities. It correctly infers that despite the issuance, overall debt fair value declined, and that both issuance (inflow) and repayment (outflow) affected financing activities. However, it omits the specific mention of the $1,000 repayment on the 2.750% Senior Notes, which is a key component of the net cash outflow in 2024 per the original answer. (4) The answer is contextually relevant and well-structured, addressing both the fair value impact and financing activities. The scores reflect high accuracy with minor deductions for unverified details and missing specific figures in the financing activities breakdown.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 469,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "Caterpillar states that the environmental‑remediation liability it accrues for all of its sites is “not material” and is simply rolled into the accrued‑expenses line item – no separate dollar amount is disclosed. For each individual site the company bases its estimate on the best‑available data, technologies, applicable laws and prior remediation experience, accruing the minimum of any range when no single amount is more likely; when multiple potentially responsible parties are involved, it accrues only its proportionate share of the probable costs. 【page_130】【page_13】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the answer correctly states that Caterpillar's total environmental remediation liability is 'not material' (synonymous with 'immaterial' in the original) and is included in 'Accrued expenses,' with no specific dollar amount disclosed—this matches the ground truth exactly. (2) The methodology for individual sites is accurately described: estimates are based on best-available data, technologies, laws, and experience, with the minimum accrued when no amount is more likely—this aligns precisely with the original. (3) For multi-party sites, the LLM correctly notes that Caterpillar accrues only its proportionate share of the probable costs, reflecting the multi-hop synthesis of the company's accounting policy across different site types. (4) All entities (Caterpillar, environmental remediation liability, accrued expenses) and concepts are correctly identified and explained. The answer is complete, factually accurate, and contextually appropriate, with no omissions or errors. Minor wording differences (e.g., 'not material' vs. 'immaterial') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 341,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "Cisco’s Other Products revenue fell 29% year‑over‑year, dropping from $15 million in FY 2021 to $11 million in FY 2022【page_44】.  In FY 2022 the company revamped its reporting to group product revenue into seven strategic categories—including a distinct “Other Products” line—so that under‑performing segments are more visible and can be managed in line with Cisco’s overall strategic priorities【page_106】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 29% year-over-year decline in revenue for Cisco's 'Other Products' category, with accurate figures of $15 million in FY 2021 and $11 million in FY 2022. These numbers match the ground truth exactly, and the percentage change is accurate (approx. 26.67% actual drop, which rounds to 29% as reported—likely reflecting rounding or disclosed rate in source). (2) All numeric values and fiscal years are correct; format variations (e.g., $15 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model connects the revenue decline with the structural reporting change in FY 2022, correctly interpreting that the new categorization—including 'Other Products' as a distinct line—increases visibility into underperforming segments. (4) The LLM slightly rephrases the strategic rationale: instead of explicitly stating that including underperforming segments reflects their continued strategic relevance, it emphasizes visibility and management alignment, which is a valid interpretation but slightly less precise in capturing the 'still considered relevant' nuance from the original. However, the core message about strategic alignment is preserved. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only minor room for refinement in qualitative emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 388,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The Ron Vachris executive employment agreement appears as a single amendment (Exhibit 10.9) filed on December 20 2023 and slated to become effective on January 1 2024【page_68】. In contrast, W. Craig Jelinek’s agreement has been renewed each year – extensions filed in December and effective on January 1 of the next year (Exhibits 10.5.1‑10.5.5 covering 2019‑2023) – reflecting an annual renewal pattern over the past six years【page_67】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) Quantitatively, all dates and timing are correct: Ron Vachris's agreement was filed on December 20, 2023, effective January 1, 2024, matching the source. W. Craig Jelinek’s renewals are correctly described as annual, with extensions filed in December and effective January 1 from 2019–2023, consistent with the six-year pattern (filings from 2017–2022 covering renewals through 2023). The mention of Exhibits 10.5.1–10.5.5 and Exhibit 10.9 adds document-level precision. (2) The answer correctly identifies both executives and the annual renewal pattern, confirming entity accuracy. (3) The reasoning is sound: it compares the timing and frequency of amendments, recognizes the annual renewal practice, and implicitly confirms that Vachris’s agreement continues Jelinek’s established pattern. (4) While the LLM does not explicitly state 'this indicates a continuation of Costco’s executive employment practices' (a minor omission in synthesis), it provides all necessary facts for that conclusion, making the answer semantically equivalent. Wording differs slightly but meaning is preserved. No calculation errors. One point deducted from correctness and qualitative accuracy for not fully articulating the comparative implication, though the data supports it.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 372,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net carrying amount of Customer Relationships fell from $893 million at 12/31/2020 to $712 million at 12/31/2021—a decrease of $181 million. Intellectual Property declined from $366 million to $280 million over the same period, a drop of $86 million, so the fall in Customer Relationships was roughly twice as large as the decline in Intellectual Property.【page_103】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: Customer Relationships decreased from $893 million to $712 million, a difference of $181 million; Intellectual Property decreased from $366 million to $280 million, a difference of $86 million. These values match the original answer exactly. (2) Calculations are correct—the decreases are accurately computed, and the qualitative comparison stating that the fall in Customer Relationships was roughly twice as large as the decline in Intellectual Property is a reasonable interpretation (181 / 86 ≈ 2.1). (3) Multi-hop reasoning is sound: the model correctly synthesized data across two different intangible asset categories (Customer Relationships and Intellectual Property) over the same time period (2020 to 2021), which requires pulling and comparing values from separate parts of the financial statements. (4) The terminology used—'net carrying amount'—is an appropriate synonym for 'net value' in the context of balance sheet assets, and the dates (12/31/2020 and 12/31/2021) are correctly specified. The inclusion of a citation (【page_103】) adds contextual support. The answer fully addresses both parts of the question: the change in each asset and the comparison between them. All evaluation dimensions—factual accuracy, completeness, entity precision, and reasoning—are flawless.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 386,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "In fiscal 2022 the Secure, Agile Networks product category contributed **$23,829 million** in revenue【page_106】.  Within this category, **hardware (and perpetual software) is a distinct performance obligation and revenue is recognized upfront when control transfers to the customer**, while **SaaS arrangements are a single performance obligation satisfied over time, so revenue is recognized ratably over the contract term**【page_74】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23,829 million for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original ground truth answer. The ground truth does not provide any quantitative revenue amount—only a qualitative description of the revenue recognition model. Therefore, the inclusion of this number is unsupported by the provided truth and likely hallucinated or extracted from a source not aligned with the ground truth. This significantly undermines factual accuracy. (2) There are no calculations in the question or answer, but the LLM introduces a precise dollar amount without corroboration in the original answer, making the quantitative accuracy low. (3) The qualitative reasoning about revenue recognition models is correct and aligns with the ground truth: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS revenue is recognized ratably over time as a performance obligation satisfied over time. This reflects accurate multi-hop understanding of accounting treatment across product types. (4) Contextually, the answer is highly relevant and addresses both parts of the question—revenue contribution and differences in revenue recognition—though the revenue figure is incorrect or unsubstantiated. The explanation of accounting models is semantically equivalent and accurate. Thus, while the conceptual reasoning and relevance are strong, the introduction of an unsupported numeric value results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 428,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "The excerpts from Amazon’s 2022 Form 10‑K do not break out a separate line for “third‑party seller fees,” so the exact 2022 amount cannot be identified from the pages provided. Amazon explains that third‑party seller services generate commissions and related fulfillment/shipping fees when sellers list and sell on its marketplace, which directly reflects its stated business model of enabling sellers to grow their businesses through its platform【page_42】【page_41】.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the exact amount for third-party seller fees cannot be identified from the 10-K, which contradicts the ground truth that Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This is a major factual error. The actual 2022 10-K does report this figure within the 'North America' and 'International' segment disclosures under 'Third-party seller services' as part of the broader 'Services' revenue category, which can be isolated with proper parsing. (2) Quantitative accuracy is severely lacking—the correct number ($117,757 million) is not provided, and no attempt is made to extract or approximate it from disclosed line items, despite the data being available. (3) Qualitatively, the reasoning about how third-party seller fees align with Amazon’s business model is sound and consistent with the company’s stated strategy: enabling sellers through platform access, fulfillment, and customer reach. The use of citations (page_41, page_42) suggests correct contextual understanding of where this information resides. (4) Contextual relevance is high—the response addresses both parts of the question and correctly identifies the nature of the revenue stream and its strategic role. However, the failure to provide the correct quantitative figure—despite it being extractable from the 10-K—results in a low correctness score, as the primary factual component of the multi-hop query is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 405,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "Capital One’s Common Equity Tier 1 (CET1) capital ratio was **13.5 %** at December 31 2024, while the regulatory minimum CET1 requirement is **4.5 %**. Thus, the CET1 ratio exceeds the minimum by **about 9 percentage points**【page_86】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio as 13.5% and the regulatory minimum requirement as 4.5% as of December 31, 2024, which aligns with the ground truth. The calculated difference is 13.5% - 4.5% = 9 percentage points, matching the original answer exactly. (2) All numeric values are accurate: 13.5%, 4.5%, and the resulting 9 percentage point difference are correct. The calculation is sound and properly presented. (3) The reasoning is logically sound and demonstrates correct multi-hop synthesis: it retrieves the company-specific CET1 ratio, identifies the applicable regulatory minimum, and computes the difference—exactly what the question requires. (4) The answer is semantically equivalent to the ground truth, conveying the same core fact (a 9 percentage point excess over the minimum) with additional helpful context (specific values). All entities—Capital One Financial Corp, CET1 ratio, minimum capital adequacy requirement, and date—are correctly identified and used. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 320,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Regulatory risks to Altria’s $1.7 billion JUUL stake include an FTC antitrust challenge to the 35 % investment (which could force divestiture or rescission), and FDA‑related actions that could block, withdraw approval for or even ban JUUL’s e‑vapor products in the United States (including denial of pending PMTA applications or a federal prohibition on sales). If any of these actions succeed, Altria could lose its governance and non‑competition rights, be compelled to sell or write down the investment, incur impairment charges and earnings volatility, and thereby undermine its strategic objective of diversifying into reduced‑risk products and achieving its long‑term Vision.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.7 billion investment amount and the 35% stake, both of which match the ground truth. It accurately references the FTC antitrust challenge and the potential remedies (divestiture or rescission), which are factually correct. However, the LLM introduces additional regulatory risk from the FDA—specifically, the possibility of product bans or PMTA denials—which, while plausible, is not mentioned in the original ground truth answer derived from the 2022 10-K. This addition, though contextually relevant, goes beyond the documented risk in the source material. (2) Quantitatively, all numbers (dollar amount, percentage) are accurate and correctly formatted. There are no calculations required, so no errors arise there. (3) The multi-hop reasoning is largely sound: the model connects the FTC action to potential financial consequences (impairment charges, earnings volatility) and links this to Altria’s strategic objectives (diversification into reduced-risk products). This aligns with the original answer’s logic about strategic and financial objectives being hindered. However, the original answer emphasizes credit rating impacts and financing costs, which the LLM omits. Instead, it adds governance and non-competition rights, which are not in the ground truth. (4) The answer is highly contextually relevant and captures the core regulatory and financial risks. The correctness score is 8 because the key facts and numbers are correct, but there is a partial mismatch in completeness—some risks are added that aren’t in the source, and some from the source (credit ratings, financing costs) are missing. Still, the semantic core of the threat to the investment and strategic impact is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 479,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million 2060 note is one of the $11 billion of senior notes NVIDIA carries (see the list of outstanding notes on page 54).  Because it will not mature until 2060, the company must continue to allocate cash to interest and eventual principal repayment, and—like all of its senior notes—must either be repaid or refinanced as it comes due (page 40).  If refinancing must occur on less‑favorable terms or cannot be obtained, the cash‑flow burden and covenant restrictions tied to the 2060 note would limit NVIDIA’s ability to fund operations, acquisitions, dividends or share‑repurchases, thereby reducing its financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million Notes Due 2060 and $11 billion total senior notes match the original answer. The maturity year 2060 is correctly cited. (2) The answer correctly identifies that the 2060 note is part of a larger $11 billion debt structure and acknowledges the long-term nature of the obligation, which necessitates ongoing cash flow allocation for interest and principal. (3) The reasoning is sound: it explains that refinancing risk (on less favorable terms or not at all) could constrain financial flexibility, and it links this to impacts on funding operations, acquisitions, dividends, and share repurchases—consistent with the original answer’s emphasis on limited flexibility and increased vulnerability. (4) While the LLM answer omits explicit mention of 'covenant restrictions' and slightly less detail on 'vulnerability to general economic conditions,' it captures the core multi-hop logic: long-term debt → cash flow commitments → refinancing risk → reduced financial flexibility. The reference to page 54 and 40 suggests document-based support, enhancing credibility. Wording differs but semantic meaning is equivalent. One point deducted from qualitative accuracy for minor omission of broader economic vulnerability; otherwise, fully correct and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 387,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The FDA’s expansion of Vemlidy to treat chronic HBV in children ≥ 6 years (weighing ≥ 25 kg) adds a younger pediatric cohort to Gilead’s HBV franchise, which already includes Vemlidy for adults and Viread for children ≥ 2 years (page 5). Combined with its broader liver‑disease portfolio (Epclusa, Harvoni, Livdelzi) and Vemlidy’s U.S. patent protection through 2031 (page 9), the new indication substantially enlarges Gilead’s market potential in chronic HBV. (page 8)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: the expanded FDA approval for Vemlidy applies to pediatric patients aged 6 years and older weighing at least 25 kg, which is consistent with the original answer. The mention of Viread’s approval for children ≥2 years and the inclusion of Epclusa and Harvoni in Gilead’s portfolio aligns with the ground truth. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or metrics are presented. The reference to Vemlidy’s U.S. patent protection through 2031 is an additional detail not in the original answer but does not contradict it and may reflect updated or supplementary knowledge; it does not detract from correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information about Vemlidy’s expanded indication, its position within Gilead’s existing HBV and liver disease portfolio, and the resulting market expansion. (4) The only minor shortcoming is that the original answer emphasizes how the expansion bridges a gap between Viread (for younger children) and prior Vemlidy use (12+ years), which the LLM mentions implicitly but could have articulated more clearly. However, the omission is not material. The LLM also adds Livdelzi, which is not mentioned in the original answer—this is contextually relevant to Gilead’s liver disease portfolio but not directly tied to HBV, so it slightly extends beyond the scope without introducing error. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 432,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "About 5 % of Lowe’s total fiscal‑2023 sales came from installed sales, and those installed‑sales categories overlap with the product lines covered by its extended protection plans. One product category that is explicitly mentioned in both the installed‑sales description and the protection‑plan list is **Appliances**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that approximately 5% of Lowe's total sales in fiscal 2023 came from installed sales categories covered by extended protection plans, matching the ground truth. The specific product category 'Appliances' is accurately identified as being explicitly mentioned in both contexts. (2) The percentage (5%) is factually correct and matches the original answer; no calculations are required beyond this, and the fiscal year (2023) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information about installed sales, overlap with protection plan coverage, and identifies Appliances as the common category mentioned in both contexts. The only minor shortcoming is that the LLM slightly rephrases the connection (e.g., 'overlap with product lines') rather than explicitly stating that these are 'installed sales categories that are also covered'—but the semantic meaning remains intact. (4) Scores reflect near-perfect factual accuracy, with full quantitative correctness and high qualitative accuracy due to correct entity and context linkage. Contextual relevance is perfect as all parts of the question are addressed directly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 342,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "Capital One added back $2.4 billion (after‑tax) to its regulatory capital under the CECL Transition Election as of December 31 2021【page_206】.  Because the after‑tax “day 1” impact and the 25 %‑scaled “day 2” ongoing impact are phased in at 25 % per year from 2022‑2024【page_86】【page_204】, the cumulative offset from 2020‑2024 equals $2.4 billion × (1 + 0.75 + 0.5 + 0.25) ≈ $6.0 billion, meaning that 75 % of the CECL impact will have been recognized by the end of 2024 with the remaining 25 % deferred to 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual and calculation errors, despite correctly identifying some elements of the CECL Transition Election phase-in framework. (1) The 'day 1' after-tax impact of $2.4 billion is correctly cited from the filing (page 206), and the 25% scaling of the 'day 2' ongoing impact for 2020–2021 is consistent with the ground truth. However, the cumulative calculation is fundamentally flawed: the LLM computes a cumulative offset of $2.4 billion × (1 + 0.75 + 0.5 + 0.25) ≈ $6.0 billion, which misrepresents the phase-in mechanics. The 25% annual phase-in from 2022–2024 applies to both the 'day 1' impact and the scaled 'day 2' impact, meaning that by 2024, 100% of the 'day 1' impact and the scaled 'day 2' impact would have been phased in—there is no basis for applying multipliers of 1, 0.75, 0.5, and 0.25 to the $2.4 billion. These multipliers suggest a declining credit, but the phase-in is additive (25% per year), not subtractive. (2) The claim that '75% of the CECL impact will have been recognized by the end of 2024 with the remaining 25% deferred to 2025' is incorrect: the full amount should be recognized by 2024 under a 25% annual phase-in over three years (2022–2024), which would total 75 percentage points added cumulatively, but starting from the base already included in 2021. The model fails to correctly model the transition from the initial 2020–2021 treatment to the 2022–2024 phase-in. (3) While the LLM correctly references the 25% scaling and phase-in schedule, it misapplies the logic, indicating flawed multi-hop reasoning. The answer introduces a calculation not supported by the original structure. (4) Contextually, the response is relevant and attempts to quantify the cumulative impact, but the numerical inaccuracy and incorrect synthesis reduce its correctness significantly. The original answer emphasizes the structure of the transition without asserting a specific dollar total, while the LLM fabricates a cumulative figure unsupported by the ground truth. Thus, while entities (Capital One, CECL, years 2020–2024) and general regulatory framework are accurate, the quantitative output is invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 577,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "Altria’s 2021 cost of sales included about $4.6 billion of charges for the State Settlement Agreements and FDA user‑fees 【page_28】.  Those charges were partially offset by NPM‑adjustment recoveries – $1.03 billion from the multi‑state settlement, $373 million from the New York settlement, $21 million recorded in Q3 2021 for the 2004 adjustment, and $32 million recorded in Q1 2021 from escrow‑funds 【page_103】【page_104】 – which together total roughly $1.456 billion.  Consequently, the net impact on cost of sales was an increase of about $3.1 billion for the year 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. While it correctly identifies the $4.6 billion in charges to cost of sales related to State Settlement Agreements and FDA user fees (matching the ground truth), it introduces incorrect NPM adjustment recoveries totaling $1.456 billion, including $1.03 billion from a multi-state settlement, $373 million from New York, and $32 million from escrow funds—none of which are mentioned in the original answer or supported by the ground truth. The only correct recovery amount is the $21 million from the 2004 NPM adjustment. (2) The calculation is therefore fundamentally flawed: the LLM computes a net impact of $3.1 billion ($4.6B - $1.456B), whereas the correct net cost is $4.579 billion ($4.6B - $0.021B). This represents a massive discrepancy in both inputs and outputs. (3) The multi-hop reasoning fails—the model incorrectly synthesizes information by pulling in unrelated or fabricated recovery amounts not present in the ground truth, suggesting confusion between different types of settlements or adjustments. It does not correctly isolate the specific 2021 impact of the 2004 NPM adjustment as specified. (4) Despite the severe quantitative and qualitative inaccuracies, the answer is contextually relevant—it addresses the right company (Altria), time period (2021), financial statement line (cost of sales), and general topic (tobacco settlement obligations and NPM adjustments). However, the inclusion of unsupported figures and incorrect net impact renders the answer mostly incorrect. Correctness and quantitative accuracy are severely penalized due to the magnitude of the error in both individual values and final calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 468,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "After the 2019 U.S. pension‑benefit freeze, Caterpillar’s non‑qualified deferred‑compensation liability rose from $63 million in 2020 to $67 million in 2021, while its other post‑employment‑benefit liability grew from $491 million to $538 million. Together, the two liabilities increased by $51 million from 2020 to 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly swaps the values for 'non-qualified deferred compensation' and 'other postemployment benefits' between 2020 and 2021. According to the ground truth, in 2020, non-qualified deferred compensation was $491 million (not $63 million), and other postemployment benefits were $63 million (not $491 million). The same swap error occurs in 2021: non-qualified deferred compensation was $538 million (not $67 million), and other postemployment benefits were $67 million (not $538 million). (2) Due to this swap, the calculated increase is wrong: the LLM reports a $51 million increase ($67M - $63M = $4M; $538M - $491M = $47M; $4M + $47M = $51M), but the correct total increase is $91 million ($645M - $554M = $91M). The correct calculation is: ($538M - $491M) + ($67M - $63M) = $47M + $4M = $51M — wait, this would be $51M, but the ground truth states $91M total increase. However, rechecking: $554M (2020: $491M + $63M) to $645M (2021: $538M + $67M) is indeed a $91M increase ($645M - $554M = $91M). The LLM’s component values are swapped, leading to incorrect interpretation, but their sum increase calculation ($51M) is mathematically consistent with their wrong assignment. However, the actual increase is $91M, so the LLM’s $51M is factually incorrect. (3) The multi-hop reasoning is flawed because the model misattributes which liability corresponds to which amount, indicating a failure to correctly extract and align entities and figures from the source data. This undermines the synthesis across years and categories. (4) Despite the severe quantitative and qualitative inaccuracies, the answer is contextually relevant—it addresses the right company, time frame, benefit types, and the pension freeze context. Hence, contextual relevance is moderate. However, the correctness score is low due to major factual and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 517,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The finite‑lived intangible assets acquired with Mellanox (developed technology $1,640 m, customer relationships $440 m, trade names $70 m) are amortized over 5‑, 3‑ and 5‑year lives respectively, which works out to roughly $489 m in FY 2023 and $342 m in each of FY 2024 and FY 2025, with no further amortization thereafter – a total of about $1.2 billion of amortization expense for FY 2023‑2028【page_80】.  The $630 million indefinite‑lived IPR&D asset recorded for Mellanox’s in‑process R&D is not amortized at all; it is instead tested for impairment each year, so it does not affect the amortization total【page_80】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states the total estimated amortization expense from fiscal years 2023 to 2028 is $1.889 billion, but the LLM estimates only about $1.2 billion, which is substantially lower. The LLM provides annual figures of $489 million in 2023 and $342 million in each of 2024 and 2025, totaling $1.173 billion, with no amortization thereafter. However, the correct figures are $585M (2023), $461M (2024), $405M (2025), $121M (2026), $16M (2027), and $121M (2028+), summing to $1.889B. These numbers do not match either annually or cumulatively. (2) The LLM incorrectly attributes all amortization to Mellanox acquisition assets only, breaking down developed technology, customer relationships, and trade names with specific amortization lives and amounts. However, the original answer refers to 'acquisition-related intangible assets' broadly (not limited to Mellanox), suggesting a broader scope that may include other acquisitions. The LLM narrows the scope incorrectly, leading to miscalculations. (3) On qualitative reasoning, the LLM correctly explains that the $630 million indefinite-lived IPR&D asset is not amortized and is instead subject to annual impairment testing—this aligns with the ground truth and shows sound multi-hop understanding of accounting treatment for indefinite-lived intangibles. (4) Contextually, the answer is relevant and addresses both parts of the question: total amortization and the relationship to the $630M IPR&D asset. While the explanation of non-amortization due to indefinite life and impairment testing is accurate, the core financial figures are wrong, severely undermining factual correctness. The model appears to pull data from a plausible source (page 80) but reports incorrect numbers or misinterprets the amortization schedule. Thus, despite correct logic on IPR&D treatment, the major quantitative error in the total and yearly amortization expenses results in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 543,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "Biktarvy’s primary compound patents are scheduled to expire in 2033 both in the United States and in the European Union (page 9). The FDA’s expanded approval for people with HIV who have M184V/I resistance adds a new indication, which can generate additional regulatory exclusivity and therefore may prolong its market‑protection period even though the underlying patent expiry remains 2033 (page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. 2) The LLM accurately notes that the FDA's expanded approval for patients with M184V/I resistance broadens the indication, which aligns with the original answer’s point about reinforcing market exclusivity by expanding therapeutic application. However, the LLM slightly overreaches by suggesting the new indication 'may prolong its market-protection period' due to 'additional regulatory exclusivity,' whereas the ground truth emphasizes that the expanded approval supports continued revenue generation *within* the existing 2033 patent framework, not extending it. This distinction is important: regulatory exclusivity can sometimes extend protection, but the ground truth does not confirm such an extension occurred—only that the broader use strengthens commercial viability up to 2033. 3) The multi-hop reasoning is mostly sound: the model connects patent expiry (2033 in both regions) with the impact of FDA approval on market dynamics. However, the inference about prolonged market protection introduces a nuance not supported in the original answer, slightly weakening qualitative accuracy. 4) Despite this, the core facts, dates, and synthesis are correct, and the answer remains highly relevant and factually aligned. The minor overstatement prevents a perfect 10, but the answer is substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 412,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve’s supervisory stress‑testing models can project a smaller capital cushion than Capital One’s internal estimates, and that lower‑capacity assessment can trigger restrictions on the company’s ability to pay dividends or repurchase stock【page_33】. This constraint is reinforced by the Dodd‑Frank Act’s enhanced prudential standards—specifically the Stress Capital Buffer Rule, which requires a stress‑capital buffer and imposes automatic limits on capital distributions【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the Federal Reserve's stress testing may limit Capital One's ability to return capital via dividends and share repurchases due to a more conservative capital cushion assessment, which aligns with the ground truth. It also correctly references the Dodd-Frank Act as reinforcing these limitations, satisfying contextual relevance and qualitative intent. However, there is a critical factual discrepancy in the regulatory mechanism cited: the LLM attributes the restriction to the 'Stress Capital Buffer Rule' under Dodd-Frank’s enhanced prudential standards, while the ground truth specifies the 'source of strength doctrine' codified by the Dodd-Frank Act. The Stress Capital Buffer Rule, while real, is a post-Dodd-Frank regulatory development (finalized by the Fed in 2019) and not the specific statutory requirement emphasized in the original answer. This misidentification of the core regulatory requirement undermines the qualitative accuracy, especially in a multi-hop context requiring precise linkage between the Fed's stress tests, capital distribution limits, and the statutory basis. No numerical data are present, so quantitative accuracy is scored as 10 by default. The answer is semantically close and contextually appropriate but fails on precise entity and regulatory accuracy, which is central to the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 380,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "PM USA recorded State Settlement Agreement payments of roughly $4.2 billion for 2019, $4.4 billion for 2020 and $4.3 billion for 2021 – a combined total of about **$12.9 billion**【page_103】.  The independent auditor’s estimate of PM USA’s **maximum potential NPM Adjustment for 2020** was **$572 million**【page_103】, which is only a small fraction of the $12.9 billion combined payment (about $12.3 billion less, or roughly one‑twentieth of the total).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All individual payment amounts are correct: $4.2B (2019), $4.4B (2020), and $4.3B (2021). However, the total sum is stated as $12.9B, while the ground truth calculates $12.8B. The correct sum of the three values is $12.9B (4.2 + 4.4 + 4.3 = 12.9), so the LLM's total is actually mathematically accurate, suggesting the ground truth may have a minor error or rounding difference. (2) The maximum potential NPM Adjustment for 2020 is correctly cited as $572 million. (3) The comparison reasoning is sound: the LLM correctly notes that the $572M adjustment is a small fraction of the total payments, and even provides additional context (about $12.3B less, roughly one-twentieth), which enhances understanding. (4) All entities (PM USA, State Settlement Agreements, NPM Adjustment, correct years) are accurately identified. (5) The multi-hop synthesis—aggregating payments across three years and comparing to a single-year adjustment—is correctly executed. The minor discrepancy in the total (if any) does not affect the overall correctness, especially since the LLM's sum is mathematically precise. Thus, the answer deserves a high score, with only a potential tie to the ground truth's total amount preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 366,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The first table shows the 2.85 % Notes Due 2030 valued at **$5.0 billion** (fair value), and the second table lists the same notes with a **net carrying amount of $5.0 billion**. Therefore, the difference between the fair value and the net carrying amount is **$0 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and conclusion. The ground truth states the fair value is $1,542 million and the net carrying amount is $1,500 million, resulting in a $42 million difference. The LLM incorrectly reports both values as $5.0 billion, leading to a difference of $0 million. These numbers do not match the source data and are off by over $3.4 billion in total. (2) Quantitative accuracy is extremely low: the correct fair value is $1,542 million (not $5.0 billion), and the net carrying amount is $1,500 million (not $5.0 billion). The calculated difference should be $42 million, not $0 million. Even allowing for format variations, $5.0 billion is not equivalent to $1.542 billion. (3) The multi-hop reasoning structure is sound—comparing fair value from one table to carrying amount from another for the same debt instrument—but the model used entirely wrong data points, indicating a failure in information retrieval or synthesis. (4) Contextual relevance is high because the answer addresses the right fiscal year, the correct note (2.85% Notes Due 2030), and attempts the correct comparison. However, due to severe factual and numerical errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 352,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "Because the Tailoring Rules place Capital One in Category III, the firm is exempt from the Basel III Advanced‑Approaches framework and can elect to exclude certain accumulated‑other‑comprehensive‑income (AOCI) items from its regulatory capital calculation. At the same time, the Stress Capital Buffer Rule replaces the fixed 2.5 % capital‑conservation buffer with an institution‑specific stress‑capital buffer (e.g., 5.6 % for 2020‑21 and 2.5 % for 2021‑22) that is added to the minimum CET1, Tier 1 and total‑capital ratios, while the counter‑cyclical buffer remains at 0 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that as a Category III institution under the Tailoring Rules, Capital One (COF) is exempt from the Basel III Advanced Approaches framework and can elect to exclude certain AOCI items from regulatory capital—this matches the original answer. (2) The Stress Capital Buffer Rule is accurately described: it replaces the fixed 2.5% capital conservation buffer with an institution-specific buffer, and the LLM provides correct examples (5.6% for 2020-21 and 2.5% for 2021-22), which are factually consistent with public regulatory data. These percentages are not in the ground truth but are accurate and add useful context without contradicting it. (3) The multi-hop reasoning is sound—linking Category III status to reduced regulatory burden via exclusion of AOCI and recalibrated stress buffer requirements. (4) Minor deduction in quantitative accuracy due to inclusion of specific percentages not in the original answer (though they are correct); however, since they enhance rather than distort, the overall correctness remains high. The answer is fully contextually relevant, addressing all aspects of the question: Tailoring Rules, Category III status, AOCI exclusion, and Stress Capital Buffer implications. Wording differs but semantic meaning aligns closely with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 387,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "Altria’s JUUL investment was carried at $1.705 billion at both December 31 2020 and December 31 2021, so the net change in fair value over the year was $0. The $100 million decline recorded in 2020 appears as a loss in the “(income) losses from equity investments” line of the consolidated statement of earnings, while 2021 shows no loss or gain for JUUL and the balance‑sheet carrying amount remains $1.705 billion.【page_67】【page_68】",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Altria's JUUL investment had a carrying value of $1.705 billion in both 2020 and 2021, which aligns with the ground truth that the fair value remained unchanged at $1,705 million. This supports a $0 change in fair value from 2020 to 2021, which the LLM correctly infers. However, the LLM introduces a '100 million decline recorded in 2020' that is not part of the question or the ground truth answer, which only concerns the 2020–2021 period. This extraneous detail suggests a misinterpretation of the timeline and risks implying a change occurred during the period in question when it did not. (2) The numbers themselves ($1.705 billion = $1,705 million) are quantitatively accurate and correctly formatted. However, the mention of a $100 million decline in 2020, while possibly factually correct in broader context, is not relevant to the 2020–2021 comparison and introduces a factual distraction that undermines the precision of the response. The core calculation of $0 change is correct. (3) The reasoning is partially sound: the LLM correctly identifies that no change occurred between 2020 and 2021 and that the amount is reflected in the balance sheet and earnings statement. However, it fails to mention that changes in fair value are measured quarterly using level 3 inputs and does not explicitly state that the investment is accounted for under the fair value option post-Share Conversion in Q4 2020—key qualitative details from the ground truth. (4) The answer is contextually relevant and addresses both parts of the question—change in fair value and financial statement reflection—but omits critical accounting methodology and includes an irrelevant prior-year loss, reducing its qualitative and quantitative accuracy. The score reflects partial correctness with significant omissions and a distracting inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 507,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Union Pacific had 1,037 leased locomotives out of a total of 7,154, meaning roughly 14.5 % of its locomotive fleet is leased rather than owned (see page 19). In contrast, the company’s fleet includes 132 switching locomotives, all of which are owned (see page 19).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers 1,037 leased locomotives, 7,154 total locomotives, and 132 switching locomotives are all accurate. The percentage calculation (1,037 / 7,154 ≈ 14.5%) is correct. (2) The answer addresses both parts of the question: the percentage of leased locomotives and the comparison to the number of switching locomotives. (3) Entity accuracy is correct—Union Pacific is the subject, and all metrics (leased, total, switching locomotives) are properly identified. (4) The reasoning is sound: it correctly synthesizes that the number of leased locomotives (1,037) is significantly higher than the number of switching locomotives (132), even adding the detail that switching locomotives are all owned, which is consistent with the context. The inclusion of page references adds credibility. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 274,
        "total_tokens": 1396
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The 2.20 % senior notes that were due in 2021 were carried at a fair value of about **$1.5 billion on January 31 2021** and **$0 on January 30 2022**, a **decline of roughly $1.5 billion** as the notes were fully repaid when they matured in 2021. This reduction is shown in the fair‑value of debt table (the line for the 2.20 % notes drops from $1.5 bn to $0) and is reflected in the debt‑maturity/interest‑rate schedule, where the note is either listed with a $0 fair‑value or omitted entirely, indicating it is no longer outstanding.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. The ground truth states the fair value on January 31, 2021, was $1,011 million, but the LLM incorrectly reports it as $1.5 billion. This is a material error in magnitude (~48% overstatement). The final value of $0 on January 30, 2022, is correct and logically explained as the result of maturity. The calculated decline of $1.5 billion is therefore also incorrect; the actual decline is $1,011 million. (2) The dates (January 31, 2021, and January 30, 2022) and the note description (2.20% Notes Due 2021) are accurate. The effective interest rate (2.38%) and remaining term (0 years) mentioned in the ground truth are missing from the LLM response, which omits a key cross-verification point from the debt-specific maturity table. (3) The reasoning is partially sound: the LLM correctly infers that the drop to $0 reflects maturity and repayment, and it appropriately links this to both the fair value disclosures and the maturity/interest rate table. However, it fails to mention the specific interest rate or term data that would confirm the multi-hop synthesis between the two tables. (4) Despite incorrect numbers, the answer is contextually relevant and structured well, addressing both parts of the question—change in fair value and reflection in disclosures. The conclusion that the note is omitted or shown with $0 value in the maturity table is reasonable. However, the significant quantitative error in the starting fair value severely undermines factual correctness, warranting a low correctness score. Minor formatting variations like $1.5 billion vs $1,500 million would be acceptable, but $1,011M vs $1,500M is beyond acceptable variance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 475,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion removes U.S. Treasury securities and deposits held at the Federal Reserve Banks from the denominator (total leverage exposure) of the supplementary leverage ratio, which shrinks the exposure base and therefore lifts the ratio. The change was made under the Federal Reserve’s interim‑final rule (issued in April 2020 as a COVID‑19 response) that temporarily allowed bank‑holding companies to omit those assets from the supplementary leverage‑ratio calculation under the Basel III framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately explains that the exclusion of U.S. Treasury securities and deposits with the Federal Reserve reduces the denominator (total leverage exposure) of the supplementary leverage ratio, thereby increasing the ratio. (2) It correctly identifies the regulatory mechanism: an interim final rule issued by the Federal Reserve in April 2020 (contextually accurate as part of the COVID-19 response), which aligns with the ground truth's reference to the rule without specifying the exact date—this level of detail is acceptable as the original answer does not include the date either. (3) The multi-hop reasoning is sound: it connects the regulatory action (exclusion of assets) to its impact on the leverage ratio and correctly situates this within the Basel III framework, which governs capital requirements. (4) All entities—Federal Reserve, U.S. Treasury securities, Federal Reserve deposits, Basel III—are accurately named and logically linked. The explanation is complete, factually precise, and contextually appropriate, addressing both the 'how' and 'what regulatory framework' parts of the question. Minor wording differences do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 351,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "Union Pacific’s pension plan held **$3,209 million** of assets classified as Level 2 investments at December 31 2023. These Level 2 assets – which include federal government securities, corporate bonds and debentures, and certain preferred stock – were **valued using a bid‑evaluation process that incorporates bid data from independent pricing sources** (i.e., significant other observable inputs).【page_58】【page_57】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total value of Union Pacific's Level 2 pension plan assets in 2023 as $3,209 million, matching the ground truth. It also accurately describes the valuation method as a bid-evaluation process using bid data from independent pricing sources, which aligns with the ground truth's 'bid evaluation process with bid data provided by independent pricing sources.' (2) Quantitatively, the $3,209 million figure is correct. While the original answer breaks down the components (Federal Government Securities: $1,508 million; Bonds and Debentures: $1,696 million), the LLM does not include these sub-components. However, their sum ($1,508 + $1,696 = $3,204 million) is close to $3,209 million—this minor discrepancy may reflect rounding or inclusion of other small items (e.g., 'certain preferred stock' mentioned in LLM answer), which is acceptable and does not constitute an error given the overall total matches exactly. (3) The reasoning is sound: the LLM correctly attributes the valuation method and links it to observable inputs, demonstrating proper synthesis of the valuation approach. It references the correct entity (Union Pacific), metric (Level 2 pension assets), and year (2023). (4) The answer is semantically equivalent and contextually complete. The only minor omission is the absence of the specific breakdown of the $3,209 million into its two main components, but since the question only asks for the total value and valuation method, this does not detract significantly from correctness. The inclusion of 'certain preferred stock' adds detail not in the original but does not contradict it. Overall, the answer is factually accurate, well-supported, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 471,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "The filing notes that NVIDIA Omniverse is being used for virtual car showrooms and that its Omniverse Avatar software provides real‑time conversational AI for in‑vehicle experiences via the DRIVE Concierge suite [page_9]. By embedding Omniverse Avatar into the DRIVE software platform—alongside DRIVE Chauffeur and the DRIVE Hyperion AGX hardware—NVIDIA extends its unified AI computing architecture that trains deep‑neural‑network models on GPUs in the data center, simulates them with DRIVE Constellation, and runs them on‑vehicle, delivering a complete end‑to‑end AI solution from cloud to car [page_9].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the specific automotive applications of NVIDIA Omniverse mentioned in the 10-K: real-time conversational AI via Omniverse Avatar in DRIVE Concierge and references DRIVE Chauffeur. It adds 'virtual car showrooms,' which is not explicitly mentioned in the ground truth but may be a reasonable inference from Omniverse's broader use cases; however, since it's not in the original answer, this is a minor overreach. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links Omniverse Avatar to the DRIVE platform, explains integration with DRIVE Chauffeur and hardware (Hyperion AGX), and situates this within NVIDIA’s end-to-end AI strategy from data center training to in-vehicle deployment. The explanation of simulation via DRIVE Constellation and over-the-air updates is implied in the strategy and consistent with the knowledge graph. (4) The answer is contextually excellent—directly addresses both parts of the question, uses correct entities (Omniverse, DRIVE Concierge, DRIVE Chauffeur, GPUs, data center, in-vehicle), and accurately describes the end-to-end AI computing narrative. The only minor gap is the omission of explicit mention of 'DRIVE Chauffeur' being tied to conversational AI (it's more related to autonomous driving), but the integration into the broader platform is correctly framed. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth with only slight over-specification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 464,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "Converse’s share of NIKE’s total revenue fell from about 5.0 % in FY 2022 ( $2,346 m ÷ $46,710 m ) to roughly 4.7 % in FY 2023 ( $2,427 m ÷ $51,217 m ), a decline of roughly 5‑6 % year‑over‑year【page_90】.  In contrast, Converse’s operating income (EBIT) rose from $669 million in FY 2022 to $676 million in FY 2023, an increase of about 1 %【page_90】.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key metrics. The ground truth states that Converse's contribution to NIKE's total revenues *increased* by 3.4% from 2022 to 2023, while the LLM claims it *decreased* by 5–6%. Similarly, the ground truth reports a 30.0% *decrease* in Converse's operating income, but the LLM incorrectly states a 1% *increase*. These are direct contradictions of the correct answer. (2) The LLM provides specific dollar figures: $2,346M and $2,427M for Converse revenue in 2022 and 2023, and $46,710M and $51,217M for total NIKE revenue. While these raw numbers may align with the filings (and thus the page citations may be accurate), the percentage calculations are flawed. The correct revenue contribution percentages are ~5.02% in 2022 ($2,346/$46,710) and ~4.74% in 2023 ($2,427/$51,217), which represents a *decline* in share — but the question asks for the *percentage change in Converse's contribution to total revenues*, which refers to the growth rate of Converse's revenue (i.e., (2,427 - 2,346)/2,346 ≈ 3.4%), not the change in its revenue share. The LLM misinterpreted the metric. However, the operating income figures ($669M to $676M) cited by the LLM contradict the ground truth, which implies a 30% drop — meaning the actual operating income must have fallen significantly (e.g., from $669M to ~$468M). Thus, the LLM’s operating income numbers are likely wrong or misattributed. (3) The multi-hop reasoning fails: the model incorrectly interprets 'contribution to total revenues' as revenue share rather than revenue growth, and it uses incorrect or misaligned operating income data. It does cite a single page (90) for both claims, suggesting an attempt at sourcing, but the synthesis is invalid. (4) The contextual relevance is moderate because the answer addresses the right entities (Converse, NIKE, revenue, operating income) and time frame (FY2022–2023), but the core quantitative conclusions are inverted. Due to major factual and interpretive errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 551,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The new guidance removed the “reasonably‑expected” and concession‑assessment thresholds, so loans in trial modification were no longer treated as full‑debt modifications (FDMs) but were recorded as troubled‑debt restructurings (TDRs). As a result, for 2023 the firm classified $69 million of residential‑real‑estate trial‑modification loans and $27 million of credit‑card trial‑modification loans as TDRs rather than FDMs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the removal of the 'reasonably expected' and 'concession' criteria is accurately described, and the resulting classification of trial modifications as TDRs but not FDMs is correctly stated for both residential real estate and credit card portfolios. (2) Quantitative accuracy is perfect: the $69 million for residential real estate and $27 million for credit card loans under trial modification classified as TDRs are exactly correct, with acceptable formatting (e.g., $69 million vs $69 million). (3) The multi-hop reasoning is sound—linking the change in accounting guidance to its impact on classification across two loan types and providing dollar amounts for each. (4) The only minor shortcoming is slight omission of the explicit phrase 'not FDMs' in the final classification summary, though the meaning is preserved by stating they were 'classified as TDRs rather than FDMs'. Wording differs slightly (e.g., 'no longer treated as FDMs') but semantic equivalence is maintained. No factual or calculation errors. Contextual relevance is complete and precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 333,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "Union Pacific had 954,405 retention shares plus 366,046 retention units outstanding as of December 31 2023 – a combined total of 1,320,451 retention awards【page_75†L1-L4】. By contrast, the Directors Plan had only 16,000 restricted shares outstanding on that date【page_51†L9-L11】, meaning the retention awards were roughly 80‑plus times the number of restricted shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 954,405 retention shares and 366,046 retention units are correctly reported, and their sum (1,320,451) is correct. The 16,000 restricted shares under the Directors Plan are also accurately stated. (2) The calculation of the total retention awards (sum) is correct, and the comparative statement that retention awards were 'roughly 80-plus times' the restricted shares is reasonable (1,320,451 ÷ 16,000 ≈ 82.5), adding useful context without distorting facts. (3) The multi-hop reasoning is sound—information is correctly synthesized from two different plans (stock incentive plans vs. Directors Plan) as of the same date (December 31, 2023), demonstrating proper cross-document/entity synthesis. (4) All entities (Union Pacific, stock incentive plans, Directors Plan, retention shares/units, restricted shares) and the date are correctly identified. (5) The answer is semantically equivalent to the original, with slightly enhanced phrasing (e.g., '80-plus times') that improves clarity without introducing error. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 332,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "AMD’s equity‑method investment in the ATMP joint venture was recorded at about **$149 million** as of December 28 2024【page_75】. In addition, AMD entered into a **$100 million** secured term loan to the JV on October 9 2024, which is reflected in receivables from related parties【page_73】. Together, these two components represent a total investment of roughly **$249 million** in the ATMP JV.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $149 million carrying value of the equity investment and the $100 million secured loan are correctly reported, and their sum of $249 million is accurate. Minor formatting differences (e.g., 'about $149 million' vs. exact $149 million) are acceptable under semantic equivalence. (2) The answer is complete, addressing both components of AMD's total investment as required by the question—equity investment and secured loan—and provides the correct total. (3) Entity accuracy is perfect: AMD, ATMP JV, and the correct date (December 28, 2024) are all correctly identified. The loan date (October 9, 2024) is an additional detail not contradicted by the ground truth. (4) The multi-hop reasoning is sound: the model correctly synthesizes information from two different parts of the filing (equity investment from page 75, loan from page 73) and combines them logically to compute the total investment. (5) The semantic meaning is equivalent to the original answer, with clear, well-structured explanation and proper contextualization of each component. All scoring criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 341,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The Envista disposition generated a $451 million gain, a $109 million foreign‑currency translation‑adjustment loss, and $69 million of IPO and separation‑related costs, leaving a net impact of $451 m – $109 m – $69 m = $273 million (positive)【page_86】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual components: $451 million gain on disposition, $109 million foreign currency translation adjustment loss, and $69 million in IPO and Separation-related costs — all of which match the ground truth. However, the final net impact is incorrectly calculated as $273 million ($451M - $109M - $69M), whereas the original answer states the total financial impact was $387 million. This indicates a critical error in reasoning or calculation. (2) Quantitative accuracy is partially correct — all input numbers are accurate, but the arithmetic is wrong. $451M - $109M - $69M = $273M, but the ground truth reports $387M as the total impact, which suggests either a different interpretation (e.g., net of only certain items) or an error in the original synthesis. However, the LLM’s calculation contradicts the stated correct total. (3) The multi-hop reasoning fails because the model assumes the total impact is the net of all three items, while the ground truth implies the $387M may reflect a different aggregation (e.g., gain minus only one cost component, or inclusive of tax effects). But given that $451M - $109M - $69M ≠ $387M, and no explanation for $387M is provided in the LLM answer, the reasoning is flawed. (4) Contextual relevance is high — the answer addresses all elements of the question and cites a source page. However, the incorrect final figure severely undermines factual correctness. The model should have either matched the stated total or reconciled the discrepancy. Thus, correctness and quantitative accuracy are low despite correct inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 442,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15 % currency‑neutral drop in Converse revenue (driven by weaker North‑America and Western‑Europe sales) translated into a roughly 30 % fall in the segment’s EBIT – EBIT fell to $474 million in FY 2024 from $676 million in FY 2023.  That EBIT decline was amplified by a 130‑basis‑point contraction in gross margin caused by unfavorable foreign‑currency exchange rates【page_46†L19-L27】【page_90†L15-L22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 15% currency-neutral revenue decline, 30% EBIT decline, and 130 basis point gross margin contraction are accurately reported. The dollar amounts—$474 million EBIT in FY2024 and $676 million in FY2023—are factually correct and support the 30% decline (verified: (676 - 474) / 676 ≈ 29.9%, rounds to 30%). These figures match the expected impact and are cited with document references. (2) The answer is complete, addressing both the revenue decline’s impact on EBIT and the amplifying effect of the gross margin contraction due to foreign exchange rates. (3) Entities—Converse segment, EBIT, gross margin, foreign currency impact, North America, Western Europe—are correctly identified and contextualized. (4) The reasoning is sound: it correctly links the revenue drop to EBIT performance and acknowledges the additional margin pressure, demonstrating proper multi-hop synthesis across financial metrics and geographic segments. The only minor shortcoming is that the original answer emphasizes the 'reported EBIT' decline, while the LLM specifies dollar values not present in the ground truth; however, these values are accurate and enhance clarity. Thus, the answer exceeds expectations in quantitative and contextual accuracy, with near-perfect qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 384,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 reduced JPMorgan Chase’s allowance for loan losses by **$587 million** in 2023 (the “cumulative effect of a change in accounting principle” line in the allowance‑for‑credit‑losses table).  By re‑classifying the **$69 million of trial‑modification loans and $9 million of Chapter 7 bankruptcies** as TDRs rather than fully‑drawn modifications, the firm lowered its overall credit‑loss reserve, which in turn decreased credit‑loss expense and improved its balance‑sheet/earnings position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the $587 million reduction in allowance, the $69 million in trial modifications, and the $9 million in Chapter 7 loans, which match the ground truth exactly. Dates (January 1, 2023) and the company (JPMorgan Chase) are accurate. (2) Quantitative accuracy is perfect—dollar amounts and their roles in the accounting change are correctly reported, with no calculation errors. (3) However, there is a critical qualitative error in reasoning: the LLM states that the loans were reclassified 'as TDRs rather than fully-drawn modifications', which misrepresents the actual change. According to the ground truth, these loans were reclassified as *non-FDMs* (Financial Disincentive Modifications), even though they remained TDRs. The LLM incorrectly frames the reclassification as being 'as TDRs', when in fact the key point is that they were no longer treated as FDMs, which reduced reserve requirements. This reflects a misunderstanding of the accounting mechanism. (4) Despite this misstatement, the overall impact—lower reserves, improved financial position—is correctly conveyed, and all numbers are accurate. Hence, the correctness score is 8 (core facts right, minor but important conceptual error), quantitative accuracy is 10, qualitative accuracy is 7 due to the mischaracterization of the reclassification logic, and contextual relevance is 10 as the answer directly addresses all parts of the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 415,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "UNP’s pension plan reports $3,209 million of Level 2 assets (the $1,508 million in Federal Government securities, $1,696 million in bonds and debentures, and $5 million in other Level 2 holdings). The categories that use a bid‑evaluation process with independent pricing sources are Federal Government securities, Bonds and debentures, and Preferred stock (the preferred‑share component of Corporate stock).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the total Level 2 assets and the composition of those assets. The ground truth states the total Level 2 assets are $1,111 million, but the LLM claims $3,209 million, which is more than double the correct amount. The LLM breaks this down into $1,508 million (Federal Government Securities), $1,696 million (Bonds and Debentures), and $5 million (other), but these numbers do not sum to the correct total and are not supported by the ground truth. (2) The quantitative inaccuracies are severe: the sum of the LLM's components is $3,259 million, not $3,209 million, indicating a calculation error as well. More critically, none of the individual values match the ground truth, which does not provide exact dollar amounts per category but does state the total is $1,111 million across the three categories. (3) The qualitative reasoning is partially sound in identifying that bid evaluation with independent pricing sources applies to certain categories, but it incorrectly adds 'Preferred stock' as a separate category and misrepresents 'Preferred stock' as the 'preferred-share component of Corporate stock', which is not stated or implied in the ground truth. The ground truth lists Corporate Stock, Federal Government Securities, and Bonds and Debentures as the categories using this methodology—Corporate Stock is listed as a whole, not broken into preferred/common components. (4) The contextual relevance is moderate because the answer addresses the right topic (Level 2 assets, valuation methodology) and attempts to break down categories and valuation methods, but the factual foundation is flawed. Due to major quantitative and entity-level errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 476,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The research‑and‑medical products line grew from $13.5 billion in 2019 to $24.8 billion in 2021 – an increase of roughly **84 %** (24,802 – 13,512 ÷ 13,512)【page_92】, while DHR’s total sales rose from $17.9 billion to $29.5 billion, a **≈ 65 %** gain【page_91】. Because the segment’s growth rate exceeded the company‑wide rate, it was a primary driver of DHR’s overall revenue expansion and underscores the segment’s outsized contribution to the firm’s financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: research and medical products segment revenue of $13,512 million in 2019 and $24,802 million in 2021, and total DHR revenue of $17,911 million in 2019 and $29,453 million in 2021. The growth rates are accurately approximated as 84% and 65%, respectively, which are correct when rounded from the exact values of 83.5% and 64.4%. Minor rounding is acceptable and does not affect factual accuracy. (2) All calculations are sound: (24,802 - 13,512) / 13,512 ≈ 0.835 (83.5%), and (29,453 - 17,911) / 17,911 ≈ 0.644 (64.4%). The LLM correctly computes and compares these, with only negligible rounding differences. (3) The multi-hop reasoning is solid: the model synthesizes segment and total revenue data across two years, compares growth rates, and draws the correct conclusion that the segment outpaced overall company growth and was a primary driver. (4) The answer is semantically equivalent to the ground truth, with slightly more concise wording and the use of '≈' and rounded percentages, which is acceptable. The only minor shortcoming is the lack of explicit mention of the two-year period (though implied), and the use of 'sales' instead of 'revenue'—a negligible terminology difference. Overall, the answer is factually precise, logically sound, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 376,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The change to the TDR accounting guidance on January 1 2023 produced a **$587 million reduction** in JPMorgan’s allowance for loan losses (the cumulative effect of the accounting‑principle change shown in the allowance‑for‑credit‑losses table). For credit‑card loans, the new guidance meant that **$27 million of loans under trial modification were treated as TDRs rather than as full‑debt modifications**, because trial modifications were now classified as TDRs under the revised rules.【page_134†L31-L38】【page_121†L12-L19】",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key quantitative aspects: the $587 million reduction in the allowance for credit losses and the $27 million in loans under trial modifications are accurately reported. The date of adoption (January 1, 2023) and the impact on TDR classification are also correctly stated. However, the LLM answer omits several important details present in the original answer: (1) it does not mention the elimination of the 'TDR reasonably expected' and 'concession assessment' criteria, which is a key part of the guidance change; (2) it fails to report the prior year's credit card TDRs ($418 million), which provides context for the change; and (3) it does not state that trial modifications are now considered TDRs but not FDMs, nor does it include the $648 million in credit card FDMs for 2023. While the core financial figures and directional impacts are correct, these omissions reduce completeness and weaken the multi-hop synthesis. The reasoning is sound where present, and all cited numbers match the ground truth exactly. The answer is highly relevant and focused on the question, but lacks full qualitative depth due to missing comparative and definitional context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 343,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "Beginning in the first quarter of 2021, 3M switched from a calculated‑value to a fair‑value method for the fixed‑income portion of its pension and post‑retirement plan assets and applied the change retrospectively to all periods (page 65). The new method re‑measured the expected return on plan assets and the amortization of unamortized actuarial gains/losses, which restated the pension‑related expense previously shown in non‑operating other expense (income) (e.g., other expense (net) fell from $450 million to $366 million in 2020 and from $462 million to $531 million in 2019) and adjusted the defined‑benefit pension and post‑retirement adjustment in other comprehensive income (e.g., $171 million to $106 million in 2020 and a loss of $560 million to $507 million in 2019), as well as retained earnings, accumulated other comprehensive loss and the “Company pension and post‑retirement expense” line (page 66). These restatements altered the presentation of pension‑related metrics across the 2019‑2021 reporting periods but did not affect operating income or cash flow from operations (page 91).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key change: 3M's adoption of a fair-value method for fixed-income securities in pension and postretirement plans in Q1 2021, replacing the calculated-value approach with a three-year deferral. The retrospective application is accurately noted. (2) Quantitatively, the LLM provides specific restated figures: other expense (net) adjusted from $450M to $366M in 2020 and $462M to $531M in 2019; other comprehensive income adjustments from $171M to $106M (2020) and $560M loss to $507M loss (2019). These numbers are plausible and consistent with the type of impact described in the original answer, though the ground truth does not specify exact dollar amounts. Since the original answer does not include these figures, the LLM likely pulled them from the actual 10-K (e.g., page 65/66 references), so their inclusion enhances accuracy rather than detracting, assuming they are correctly cited. (3) The reasoning is sound: the LLM correctly links the accounting change to restatements in net periodic benefit cost, non-operating expenses, other comprehensive income, retained earnings, and accumulated other comprehensive loss—matching the multi-hop synthesis required. It also correctly notes that operating income and cash flow from operations were unaffected, a detail not in the ground truth but factually correct and contextually valuable. (4) The answer is semantically equivalent and even exceeds the original in specificity, with no factual errors. The only reason for not scoring a 10 is that the original ground truth emphasizes the alignment with liability-driven investment strategy and funded status, a qualitative rationale slightly underemphasized in the LLM response. However, this is a minor omission. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 512,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 lowered JPMorgan’s allowance for credit losses. The change produced a $587 million reduction to the allowance for credit losses in 2023【page_134】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses, which matches the ground truth in both amount and timing. All factual elements—date, dollar amount, direction of impact (reduction), and affected metric (allowance for credit losses)—are accurate. (2) The quantitative accuracy is perfect: $587 million is correctly reported, and the date (January 1, 2023) aligns with the original answer. No calculation errors or number mismatches. (3) The reasoning is sound but slightly less detailed than the original answer. While the LLM correctly reports the impact, it omits the explanation of *why* the change led to the reduction—specifically, the elimination of the 'reasonably expected' and 'concession' criteria and the reclassification of trial modifications not being considered FDMs. This missing context slightly weakens the qualitative depth but does not affect factual correctness. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the impact (reduction) and the dollar amount ($587 million). The minor omission of explanatory detail prevents a perfect 10, but the core multi-hop synthesis (linking accounting change to financial impact) is correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 379,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "In 2023 the Africa/Eurasia segment’s goodwill fell by $19 million (no impairments or acquisitions, only a foreign‑currency translation loss) and it earned $254 million of operating profit, together amounting to roughly $235 million of net effect【page_88】. By contrast, capital expenditures in Africa/Eurasia were just $10 million for the year【page_117】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $19 million decrease in goodwill due to foreign currency translation and the $254 million operating profit in the Africa/Eurasia region for 2023, which matches the ground truth. It also correctly states that capital expenditures were $10 million. However, the LLM makes a critical error in calculating the 'combined impact' as roughly $235 million, which incorrectly subtracts the $19 million goodwill decrease from the operating profit. The original answer interprets 'combined impact' as the sum of the goodwill decrease ($19M) and capital expenditures ($10M), totaling $29M, which is then compared to operating profit. The LLM instead appears to net the goodwill change against operating profit, which misrepresents the intended synthesis. (2) All individual numbers are accurate: $19M goodwill decrease, $254M operating profit, $10M capex — these are factually correct and match the ground truth. The calculation error lies in the interpretation of 'combined impact' — it should be $19M + $10M = $29M, not $254M - $19M = $235M. (3) The multi-hop reasoning is partially sound: the model pulls correct data from different parts (goodwill change, operating profit, capex), but fails to synthesize them correctly. It compares capex to operating profit appropriately but mischaracterizes the combined effect of goodwill and capex. The original answer emphasizes that the $29M total outflow/decline is much smaller than the $254M profit; the LLM’s $235M figure distorts this relationship. (4) Scores reflect that core data is correct (hence not low), but the incorrect calculation and flawed logic in combining the impacts significantly reduce correctness and qualitative accuracy. Contextual relevance is high because the answer addresses all relevant entities and regions with proper sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 499,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The first‑quarter 2021 change in business‑segment reporting required 3M to re‑allocate goodwill to the newly defined reporting units, applying the relative‑fair‑value method – an adjustment that proved immaterial. 3M then incorporated the change into its routine fourth‑quarter goodwill‑impairment test (and a specific assessment of the reporting‑unit changes) and determined that no goodwill impairment existed, indicating no heightened impairment risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2021 business segment reporting change required reallocation of goodwill using the relative fair value method, the adjustment was immaterial, and no impairment was found in the fourth quarter of 2021. (2) Quantitative accuracy is perfect—dates (first-quarter and fourth-quarter 2021), methods (relative-fair-value), and outcomes (no impairment, immaterial change) match the original answer. Format variations (e.g., 'relative‑fair‑value method') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly links the segment change to goodwill reallocation, explains the method used, and connects it to the impairment test outcome, concluding no heightened risk. The only minor shortcoming is that the original answer explicitly states that the change was evaluated both in terms of allocation and as part of the annual test, while the LLM slightly compresses this by implying the routine test covered the change assessment—still accurate in substance but slightly less explicit. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: impact on goodwill reporting structure and evaluation of impairment risk. Overall, this is a semantically equivalent, factually correct, and well-reasoned answer with only negligible differences in nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 399,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD bought Silo AI to bring its Finnish AI‑lab talent and expertise in‑house so it can speed the creation and rollout of AI models and software that run on AMD’s chips, especially its Data‑Center hardware. The goodwill from the deal is attributed to Silo AI’s workforce, which AMD expects will accelerate both AI model deployment and the development of AI‑focused software solutions—key pillars of AMD’s broader AI strategy.【page_71】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies AMD's strategic rationale for investing in Silo AI: leveraging Silo AI's workforce and expertise to accelerate AI model deployment and software development on AMD hardware, particularly in the Data Center segment. The mention of 'goodwill from the deal' and attribution to Silo AI’s workforce aligns with the original answer's emphasis on human capital as a key asset. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor deviation is the use of 'bought' and 'acquisition' language, which implies a full acquisition, while the original answer refers to an 'investment,' which could be partial. However, given the context and the focus on integrating talent, this does not materially misrepresent the strategic intent. Multi-hop reasoning is sound—connecting Silo AI's expertise to AMD's AI strategy and hardware goals. The answer is fully contextually relevant and addresses both parts of the question: rationale and connection to AI goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 324,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Six amendments – the First, Second, Third, Fourth, Fifth and Sixth Amendments – were executed with effective dates from October 31 2014 through September 1 2015, which falls within the September 2 2014 – September 1 2015 period【page_108†L1-L2】【page_109†L1-L6】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It correctly identifies that 6 amendments were made to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015. (2) The quantitative accuracy is perfect: the number '6' is correct, and the listed amendments (First through Sixth) with effective dates from October 31, 2014, to September 1, 2015, fall entirely within the specified date range. The dates and count align with the ground truth. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying each amendment and verifying their effective dates fall within the required period. (4) The answer is contextually relevant, directly addressing the question with precise information and citation of supporting document pages. Minor wording differences (e.g., spelling out 'Six' instead of '6') do not affect semantic equivalence. All criteria are met with high accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1090,
        "completion_tokens": 288,
        "total_tokens": 1378
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "Because PMI only obtained a majority stake in Swedish Match on Nov. 11 2022, the 2023 10‑K includes Swedish Match results only from that date forward and presents the business as a separate operating segment, distinct from the geographic segments. The filing also provides a stand‑alone shipment‑volume table and commentary that rely on Swedish Match’s own disclosures and note that the figures are shown for comparability, indicating that the volume data are still being reported separately and that full integration of Swedish Match’s shipment volumes into PMI’s consolidated reporting is being phased in.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the acquisition date of November 11, 2022, is correctly stated, and the implication that Swedish Match’s results were included from that date forward in the 2023 10-K is factually sound. There are no numerical inaccuracies. (2) The LLM correctly identifies that Swedish Match was presented as a separate operating segment, distinct from PMI’s geographic segments, which matches the original answer’s point about being 'managed and evaluated separately.' (3) The mention of a stand-alone shipment volume table and commentary relying on Swedish Match’s own disclosures accurately reflects the separate reporting, supporting the conclusion of a phased integration. This demonstrates correct multi-hop reasoning: linking the late 2022 acquisition date to limited reporting scope, segment presentation, and ongoing integration signaled by separate metrics. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2022 inclusion period (Nov–Dec) was too short to enable full integration by 2023, which slightly weakens the causal explanation. However, the implication of phased integration is clearly conveyed. Wording differs but semantic meaning and factual content are equivalent. All entities (PMI, Swedish Match, 2023 10-K, shipment volumes) are correct, and the reasoning is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 389,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "In 2021 3M entered into interest‑rate swaps with an aggregate notional amount of **$800 million**【page_106】. The swaps were used to convert $500 million of a $1.0 billion note and $300 million of a $650 million note due in 2049 and 2050, respectively – a combined principal of **$1.65 billion** – so the swap notional covers roughly half (about 48 %) of the total principal of those fixed‑rate notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the notional amount of $800 million and the combined principal of $1.65 billion are accurately reported, with correct formatting variations (e.g., $800 million = $800 million). The percentage coverage is correctly approximated as 'about 48%' (exact calculation: 800 / 1650 ≈ 48.48%), which aligns with the ground truth's 'approximately 48.5%'. (2) The answer is complete, addressing both parts of the question: the total notional amount of swaps in 2021 and the comparison to the hedged notes' principal. (3) Entities are accurate: 3M, 2021 (year of swap), notes due in 2049 and 2050, and correct financial terms (notional amount, principal, fixed-rate notes, interest rate swaps). (4) The multi-hop reasoning is sound—the model correctly synthesizes that the $800 million in swaps was applied across two separate notes ($500M + $300M) with a total principal of $1.65B, and computes the coverage ratio accurately. The explanation adds contextual clarity by specifying how the notional was allocated, which enhances understanding without introducing error. (5) Semantic equivalence is maintained: despite slightly different phrasing (e.g., 'roughly half' vs 'approximately 48.5%'), the factual content and precision match the ground truth. No errors in logic, numbers, or entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 384,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "AbbVie transferred a combined total consideration of about **$64.6 billion** – $64.084 billion for the Allergan acquisition and $0.535 billion for the Soliton acquisition【page_91】.  Cash payments made up roughly **$40.2 billion** of that amount – $39.675 billion in cash for Allergan plus $0.535 billion cash for Soliton【page_91】【page_94】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in substance and conveys the same information as the ground truth. The total consideration is reported as $64.6 billion, which matches the ground truth of $64,619 million when rounded. The cash portion is given as $40.2 billion, aligning with the ground truth of $40,210 million when rounded. Minor discrepancies are due to rounding and are acceptable under semantic equivalence. (2) The breakdown of Allergan at $64.084 billion and Soliton at $0.535 billion sums to $64.619 billion, which is exactly $64,619 million. Similarly, cash payments of $39.675 billion (Allergan) + $0.535 billion (Soliton) = $40.210 billion ($40,210 million), matching the ground truth. The LLM correctly performs and implies this multi-hop summation. (3) The reasoning is sound: the model synthesizes data from two separate acquisitions, correctly attributes values to each, and aggregates both total consideration and cash components. Citations to page_91 and page_94 support the sourcing. (4) The correctness score is 9 because while all key facts and calculations are accurate, the LLM uses rounded figures (e.g., $64.6 billion instead of $64,619 million), which slightly reduces precision but does not affect semantic accuracy. Quantitative accuracy is 9 for the same reason—values are correct when accounting for rounding. Qualitative accuracy is 9 due to strong reasoning and entity identification. Contextual relevance is 10 as the answer directly and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 418,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America’s Basel 3 compliance gives it ample head‑room to fund the $25 billion share‑repurchase.  As of 31 Dec 2024 its CET1 ratio was 11.9 % (Standardized) and 13.5 % (Advanced) versus the 10.7 %/10.0 % minimum, its Tier 1 ratio was 13.2 %/15.0 % versus a 12.2 %/11.0 % floor, and its leverage ratio was 6.9 %/5.9 % versus a 4.0 % floor (Table 10, p. 52).  Because these ratios and the required capital‑conservation and G‑SIB buffers are comfortably above the regulatory minima, the bank can allocate capital to the $25 billion repurchase without breaching Basel 3 requirements (Board‑authorized repurchase discussion, p. 51).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bank of America's Basel 3 compliance enables its stock repurchase program and notes the key CET1 ratio of 11.9% under the Standardized approach, which matches the ground truth. However, it introduces additional data not present in the original answer—specifically the Advanced approach CET1 ratio (13.5%), Tier 1 ratios under both approaches, and leverage ratios—without confirmation from the ground truth. These values may be accurate in context but are not part of the verified knowledge graph answer, introducing unverified quantitative claims. (2) The ground truth states the bank repurchased $13.1 billion of stock in 2024 under the $25 billion authorized program, implying the full $25 billion was not executed in that year. The LLM answer incorrectly implies the entire $25 billion repurchase is being funded and proceeds without noting the actual $13.1 billion execution, missing a key factual nuance. (3) The reasoning is logically sound—linking capital adequacy to distribution capacity—and correctly references the capital conservation buffer and G-SIB surcharge as constraints. It synthesizes the relationship between regulatory thresholds and repurchase authority appropriately, though with overreach in including unverified metrics. (4) Contextual relevance is strong: the answer directly addresses the influence of Basel 3 on the repurchase program. However, the quantitative accuracy is reduced due to inclusion of unsupported figures and omission of the actual repurchase amount executed ($13.1 billion). The correctness score is 7 because core facts (CET1 ratio, regulatory threshold, and general conclusion) are correct, but significant details are either added or omitted, affecting precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 481,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The 2023 $650 million medium‑term note carries $649 million, and the 2048 $650 million medium‑term note carries $638 million, giving a combined carrying value of **$1,287 million**【page_87†L31-L34】【page_87†L73-L75】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the carrying value of the 2023 medium-term note is $649 million and the 2048 note is $638 million, both correctly extracted. The sum, $1,287 million, is accurate and matches the ground truth exactly. (2) Quantitative accuracy is perfect: individual values and the total are correct, with proper formatting ($649 million + $638 million = $1,287 million). Minor format variation (using 'million' vs 'M') is acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly identified two separate medium-term notes of $650 million each with different maturity dates (2023 and 2048), retrieved their respective carrying values from the MMM 2022 10-K, and summed them appropriately. (4) Entity accuracy is correct: MMM (3M Company), 2022 10-K filing, correct years (2023, 2048), and correct financial term 'carrying value' are all properly used. The answer is contextually relevant, complete, and supported by cited page references (page_87).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 304,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "IBM’s 2.900% Notes due 2030 have a coupon of 2.9%【page_1】. The highest‑yielding debt listed in the filing is the 7.125% Debentures due 2096【page_1】, so the rate spread is about 7.125% – 2.900% ≈ 4.225 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the 2.900% Notes due 2030 and the 7.125% Debentures due 2096 are correctly identified as the relevant instruments. (2) The calculation of the interest rate difference (7.125% - 2.900% = 4.225 percentage points) is precise and correctly formatted. Minor wording differences (e.g., 'rate spread' vs 'difference in interest rates') do not affect semantic equivalence. (3) The multi-hop reasoning—identifying the highest-yielding debt instrument across IBM's debt portfolio and computing the spread—is sound and complete. (4) All entities (IBM, correct debt instruments, years, and percentages) are accurately referenced. The answer is contextually relevant, complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 234,
        "total_tokens": 1345
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "AbbVie’s acquisition of Allergan was a $64.084 billion transaction (cash $39.675 bn + AbbVie stock $23.979 bn + equity awards $0.430 bn).  In assuming Allergan’s lease obligations, AbbVie acquired roughly $453 million of right‑of‑use assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the total financial value of AbbVie's acquisition of Allergan is correctly stated as $64.084 billion (equivalent to $64,084 million in the original answer), and the right-of-use assets acquired are accurately reported as $453 million. The breakdown of the transaction value (cash, stock, equity awards) adds up to $64.084 billion ($39.675 + $23.979 + $0.430 = $64.084), which aligns with the total value. (2) Quantitative accuracy is perfect: numbers match exactly when adjusted for format ($64.084 billion = $64,084 million; $453 million is consistent). (3) The multi-hop reasoning is sound—LLM correctly identifies both the total acquisition value and the specific component of right-of-use assets from lease obligations, which requires synthesizing information across different parts of the filing. (4) Entities (AbbVie, Allergan, right-of-use assets, lease obligations) and the context (acquisition details as of year-end 2020, implied by source data) are correctly referenced. The answer is concise, relevant, and complete, addressing both sub-questions in the multi-part query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 336,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "The 2024 Form 10‑K shows that the Norwest Corporation Directors’ Formula Stock Award Plan had **391 shares of common stock issuable upon distribution** (see the footnote that “...391 shares issuable upon distribution related to the Norwest Corporation Directors’ Formula Stock Award Plan”【page_14】).  The plan’s material features state that **no future stock awards or deferrals may be made under this plan**, meaning the plan is closed to any new grants or additional deferrals by design【page_15】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares—391—is accurately reported, with no calculation required. The format matches exactly and aligns with the original answer. (2) The answer addresses both parts of the multi-part question: it correctly states the number of shares issuable upon distribution and explains that no future awards or deferrals are possible because the plan is closed, which is consistent with the 2024 10-K filing. (3) Entity accuracy is correct: the plan name 'Norwest Corporation Directors’ Formula Stock Award Plan' and the reference to the 2024 10-K are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the quantitative figure to the plan’s status and interpreting the closure of the plan as preventing future activity. The inclusion of page references (【page_14】, 【page_15】) further supports contextual fidelity. (5) Semantic equivalence is strong: the LLM conveys the same meaning as the original answer using slightly different but equivalent phrasing (e.g., 'closed to any new grants or additional deferrals by design' = 'has been closed to new deferrals and awards'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 351,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The 2021 gross‑margin increase was partially offset by higher amortization of intangible assets related to the Allergan acquisition, which reduced gross margin even as other factors lifted it 【page_65】.  The total amortization expense for definite‑lived intangible assets in 2021 was $7.7 billion 【page_100】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that the amortization of intangible assets from the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, which aligns with the original answer's claim that it 'partially offset' margin gains from other factors. (2) The total amortization expense for definite-lived intangible assets is correctly reported as $7.7 billion, matching the ground truth exactly. Number format is consistent and precise. (3) The reasoning correctly synthesizes multi-hop information: it identifies the impact on gross margin (qualitative effect) while also providing the total expense figure (quantitative), both of which are required to fully answer the question. (4) All entities—AbbVie, Allergan acquisition, 2021 fiscal year, definite-lived intangible assets—are accurately referenced. The answer is concise but complete, with appropriate contextual relevance and no factual or logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 286,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Home Depot’s Restoration Plans exist to give eligible associates the deferred compensation they would have earned as a matching contribution under the defined‑contribution Benefit Plans if it weren’t for the Internal Revenue Code’s contribution caps. The company funds the Restoration Plans by making cash contributions to grantor trusts, which then use the money to buy Home Depot common‑stock in the open market for plan participants【page_69】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the purpose of the Restoration Plans: providing deferred compensation in the form of matching contributions that would have been made under the Benefit Plans but for the IRS compensation limits. (2) It correctly explains the funding mechanism: The Home Depot makes cash contributions to grantor trusts, which then purchase the company's common stock in the open market. (3) There are no numerical values in the question or answer that require calculation or verification, so quantitative accuracy is not applicable beyond factual consistency, which is maintained. (4) The multi-hop reasoning is sound—linking the IRS limits to the need for Restoration Plans and explaining how they are funded through trusts and stock purchases. (5) All entities (The Home Depot, Restoration Plans, Benefit Plans, Internal Revenue Code, grantor trusts, common stock) are correctly identified and logically connected. The inclusion of the citation [page_69] adds contextual support. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 323,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes were $22 million at both year‑ends, meaning a 0 % change (22 → 22).  In contrast, total borrowings rose from $20.4 billion in 2023 to $31.1 billion in 2024 – an increase of about $10.7 billion, or roughly 52 % – indicating that the overall borrowing growth was driven by other debt instruments (fixed‑rate notes, commercial paper, term loan, etc.) rather than any change in the Variable Rate Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Variable Rate Notes remained at $22 million, resulting in a 0% change, which matches the ground truth. Total borrowings are reported as $20.4 billion in 2023 and $31.1 billion in 2024, which are accurate rounded versions of $20,443 million and $31,099 million. The implied increase of $10.7 billion is a properly rounded version of $10,656 million. The overall percentage increase is stated as 'roughly 52%', which aligns with the exact 52.1% in the ground truth—this minor rounding is acceptable. (2) All calculations are quantitatively accurate within reasonable rounding: (31.1 - 20.4) / 20.4 ≈ 52.45%, which rounds to 52%, and the model correctly identifies no change in Variable Rate Notes. (3) The multi-hop reasoning is sound: the model correctly contrasts the unchanged Variable Rate Notes with the significant increase in total borrowings, and logically infers that other debt instruments drove the growth—this synthesis across two financial metrics and time points is valid. (4) The answer is contextually complete and relevant, addressing both parts of the question: percentage change in Variable Rate Notes and its reflection in total borrowings. The only minor limitation is the use of rounded figures without specifying exact values, but this does not affect factual correctness. Hence, the answer earns a 9/10 for correctness and qualitative accuracy due to slight imprecision in decimal presentation, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 418,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "The 4.95 % senior notes due September 2026 have a net carrying amount of **$744 million** and the 4.95 % senior notes due September 2052 have a net carrying amount of **$980 million** as of January 28 2024, for a combined total of **$1.724 billion**【page_59】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net carrying amounts of HD's 4.95% Senior Notes due in September 2026 ($744 million) and September 2052 ($980 million) as of January 28, 2024, which aligns with the ground truth data. The combined total is calculated as $1.724 billion, which is numerically equivalent to $1,724 million. The ground truth states $1,726 million, indicating a $2 million discrepancy. This minor difference could stem from rounding in intermediate steps or presentation format but does not suggest a fundamental error. (2) Quantitative accuracy is high: individual components ($744M and $980M) are correct, and their sum is accurately computed within reasonable rounding tolerance. The use of '$1.724 billion' is an acceptable format variation of $1,724 million. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying two separate notes, extracting their respective carrying amounts, and summing them—exactly what the question requires. (4) Contextual relevance and qualitative accuracy are perfect: all entities (HD, 4.95% Senior Notes, maturities in 2026 and 2052, correct date) are accurately referenced, and the answer directly addresses the question. The minor $2M difference prevents a perfect 10, but the answer is substantively correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 364,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "PM’s net derivative‑asset balance fell from $186 million at the end of 2022 to $101 million at the end of 2023 – a drop of about $85 million, or roughly a 46 % decrease【page_128】. In the same period the total gross notional amount of its derivative contracts rose from $40.4 billion to $43.3 billion, an increase of about $2.9 billion (≈7 %)【page_128】. Thus, despite a modest rise in overall contract volume, the net asset value of those derivatives declined sharply.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly states PM's net derivative asset decrease from $186 million in 2022 to $101 million in 2023 and approximates the percentage decrease as 46% (actual is 45.7%, which is acceptable), it completely misrepresents the total gross amount of derivative contracts. The LLM claims the gross notional increased from $40.4 billion to $43.3 billion, but the ground truth states a decrease from $873 million to $584 million — a reduction, not an increase, and in the hundreds of millions, not tens of billions. This is a critical factual error. (2) The quantitative accuracy is low: the net asset figures are correct, but the gross derivative amounts are off by an order of magnitude (billions vs. millions), and the direction of change (increase vs. decrease) is wrong. The calculation of the net decrease is approximately correct (45.7% vs. 46%), but the gross contract change is entirely inaccurate. (3) The multi-hop reasoning fails: the LLM incorrectly infers that rising gross contracts with falling net assets suggest a divergence, but the ground truth shows both net and gross positions declined, indicating a coordinated reduction in exposure. The LLM’s reasoning is based on false data and thus invalid. (4) The contextual relevance is partially maintained as it addresses the right company (PM), time frame (2022–2023), and metrics (net derivative asset, gross derivative contracts), but the core financial data is incorrect, undermining the answer’s validity. Due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 444,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024 the 2016 Stock Incentive Plan had 27.1 million shares and the 2016 Stock Plan for Non‑Employee Directors had 0.8 million shares available for future grants – a combined pool of roughly 27.9 million shares of common stock [page_90]. By contrast, those same plans already have about 12,767,488 shares of common stock that will be issued upon exercise of outstanding options and settlement of RSUs [page_120], so the remaining grant capacity is roughly twice the amount already slated for option‑ and RSU‑related issuances.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total shares available for future issuance (27.1 million + 0.8 million = 27.9 million), which matches the ground truth. However, the number of shares to be issued for options and RSUs is inaccurately summarized as a single figure of 12,767,488, whereas the ground truth specifies 10,221,113 (options) + 2,005,555 (RSUs) under the 2016 Stock Incentive Plan and 129,854 (options) under the Non-Employee Directors plan, totaling 12,356,522. The LLM's figure of 12,767,488 is incorrect and not supported by the provided data. (2) The calculation of the total committed shares (options + RSUs) is therefore flawed: 10,221,113 + 2,005,555 + 129,854 = 12,356,522, not 12,767,488. This is a significant quantitative error. The comparison stating that the remaining grant capacity is 'roughly twice' the amount already slated is based on incorrect totals and thus misleading. (3) The multi-hop reasoning is sound in structure—correctly separating available shares from committed shares and comparing them—but fails due to incorrect aggregation of the committed shares. (4) Despite the numerical inaccuracy in the committed shares total, the LLM captures the correct plans, correct time frame (December 31, 2024), and correct individual plan availability, and attempts a relevant comparison. Hence, the correctness score is 7 due to core factual accuracy on available shares but significant error in the committed shares total; quantitative accuracy is penalized more heavily (6) due to the incorrect sum; qualitative and contextual scores remain high as the reasoning framework and relevance are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 449,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "In fiscal 2022, Microsoft’s Dynamics 365 revenue grew about 39% year‑over‑year. That rapid expansion was the primary driver behind the broader Dynamics products and cloud services segment, which posted a 25% increase overall【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dynamics 365 revenue grew by 39% in fiscal year 2022, matching the ground truth exactly. It also accurately notes that this contributed to the overall Dynamics products and cloud services revenue growth of 25%, which is factually correct. (2) All numeric values—39% and 25%—are accurate and correctly attributed to the right fiscal year (2022) and business segments. No calculations are required beyond these percentages, and they are reported with precision. Format variations are not an issue here as percentages are standard. (3) The multi-hop reasoning is sound: the model correctly infers that the strong growth in Dynamics 365 (39%) drove the broader Dynamics segment’s 25% growth, which aligns with the causal relationship implied in the original answer. The LLM refers to Dynamics 365 as the 'primary driver,' which is semantically equivalent to the ground truth's 'key driver' characterization. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'strong adoption and demand for Microsoft's integrated business applications platform,' which adds contextual interpretation in the original. However, this omission does not detract from factual correctness or completeness of the core query. All key parts of the question are addressed: the growth figure for Dynamics 365 and its contribution to the overall 25% growth. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for missing minor interpretive context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 439,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla’s Energy Generation and Storage revenue rose by **$795 million (a 40 % increase)** in 2021 versus 2020, a gain that the filing attributes “primarily to an increase in deployments of Megapack” among other products【page_39】.  Megapack is Tesla’s utility‑scale lithium‑ion battery system – a large‑capacity storage solution for commercial, industrial, utility and energy‑generation customers that can be combined into gigawatt‑hour installations, complementing the smaller‑scale Powerwall and replacing the phased‑out Powerpack in its energy‑storage portfolio【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $795 million increase and 40% growth in Tesla's Energy Generation and Storage revenue from 2020 to 2021, matching the ground truth exactly. These figures are accurately cited and properly attributed to Megapack deployments as a primary driver, along with mention of other contributing factors indirectly through the phrase 'among other products,' which aligns with the original answer's inclusion of solar, Powerwall, and Solar Roof. (2) Quantitatively, all numbers are correct: the dollar amount ($795 million) and percentage (40%) are precise and consistent with the ground truth. There are no calculation errors. (3) The multi-hop reasoning is sound— the model correctly links Megapack deployment to the revenue increase and contextualizes Megapack within Tesla’s broader energy storage portfolio. It accurately describes Megapack as a utility-scale product for commercial and industrial customers and notes its role in forming large-scale (gigawatt-hour) installations. It adds valuable context not in the original but factually correct—namely that Megapack replaces the phased-out Powerpack and complements Powerwall—demonstrating strong synthesis from the filings. (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer explicitly lists all contributing factors (solar cash/loan, Powerwall, Solar Roof), while the LLM answer only implies them. However, this does not make the answer incorrect—just slightly less complete in detailing all contributors—hence a 9 in qualitative accuracy. Overall, the answer is factually accurate, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 454,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recorded a $5.5 billion estimated pre‑tax loss on the Asda divestiture in the fourth quarter of fiscal 2021 and an additional $0.2 billion incremental loss in the first quarter of fiscal 2022, for a combined pre‑tax loss of roughly $5.7 billion. The 2021 loss included $2.3 billion of accumulated pension components from the Asda pension plan, showing that pension‑related obligations accounted for a substantial portion of the overall loss tied to the disposal group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.5 billion pre-tax loss in fiscal 2021, the additional $0.2 billion in fiscal 2022, and the total $5.7 billion loss are all accurately reported. The $2.3 billion pension component is correctly identified as part of the 2021 loss. (2) Quantitative accuracy is perfect: the sum of $5.5B + $0.2B = $5.7B is correct, and all figures match the original answer in value and context. Format variations (e.g., using 'billion' vs 'B') are acceptable and do not affect clarity. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across fiscal years and events (initial estimate and closing adjustments) and links pension obligations to the disposal group's financial impact. (4) The only minor shortcoming is that the LLM omits some detail about the reasons for the $0.2 billion adjustment (e.g., changes in net assets, currency fluctuations, purchase price adjustments), which are included in the original answer and add context to the closing adjustment. However, this does not detract significantly from the core accuracy. The answer remains semantically equivalent in conveying the total loss and the significant role of pension liabilities. Thus, the answer is excellent but not fully complete in qualitative depth, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 388,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "Windows OEM licensing accounts for 42 % of the More Personal Computing segment’s FY 2022 revenue of $56.5 billion, i.e., about $23.7 billion.  Adding the Devices line‑item revenue (which includes Surface devices) of $6.991 billion【page_96】gives a combined total of roughly $30.7 billion.  That amount represents about 54 % of the segment’s $56.5 billion revenue (30.7 ÷ 56.5 ≈ 0.54).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies Windows OEM's 42% contribution ($23.7 billion, close to the ground truth $23.73 billion), it uses an incorrect Devices (Surface) revenue figure of $6.991 billion, whereas the ground truth states $9.04 billion (16% of $56.5 billion). This leads to an incorrect combined total of $30.7 billion instead of $32.77 billion, and thus a wrong percentage of 54% instead of 58%. (2) Calculations: The LLM’s math is internally consistent (23.7 + 6.991 ≈ 30.7; 30.7 / 56.5 ≈ 54%), but based on incorrect input data. The ground truth explicitly states Devices contributed 16% ($9.04 billion), which the LLM fails to use. (3) Multi-hop reasoning: The model correctly identifies that the answer requires summing two revenue components (Windows OEM and Devices) and expressing them as a percentage of total segment revenue. However, it fails in entity alignment—despite citing a source (page_96), it uses a figure that contradicts the known 16% Devices contribution. This suggests either misreading of data or failure to reconcile percentages with dollar amounts. (4) Scores justified: Correctness is low (4) due to major factual error in a core number; Quantitative accuracy is poor due to wrong dollar amounts and resulting percentage; Qualitative reasoning is partially sound (correct approach) but flawed in execution; Contextual relevance is high as the answer addresses the right entities and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 414,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "Walmart recorded a $1.0 billion cash contribution by Asda to the U.K. defined‑benefit pension plan in fiscal 2020, and when Asda was sold the disposal group included $2.3 billion of accumulated pension components that were recognized as a loss. Together, these two items represent a total $3.3 billion impact on Walmart’s pension‑related obligations and gains/losses【page_78】【page_79】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key components of the financial impact: the $1.0 billion cash contribution by Asda to its pension plan in fiscal 2020 and the $2.3 billion in accumulated pension components included in the disposal group upon sale. The total impact is accurately calculated as $3.3 billion, matching the ground truth. (2) All numeric values are correct and properly formatted; the sum of $1.0 billion + $2.3 billion = $3.3 billion is accurate. Fiscal year (2020) is correctly cited. (3) The multi-hop reasoning is sound—information from two distinct events (pension contribution and sale disposal) is correctly synthesized into a total pension-related financial impact. The only minor issue is the characterization of the $2.3 billion as 'recognized as a loss,' which is not explicitly stated in the ground truth and slightly overinterprets the nature of the accounting impact, though it may be contextually reasonable. (4) Despite this small interpretive addition, the answer remains factually aligned with the original, conveys the same core information, and fully addresses the question with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 330,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The pre‑owned aircraft inventory grew from $15 million on December 31 2023 to $23 million on December 31 2024 – an increase of $8 million【page_70】.  The company values these aircraft at the lower of the trade‑in value or the estimated net realizable value (i.e., the lower‑of‑cost‑or‑NRV method)【page_70】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for pre-owned aircraft inventories on December 31, 2023 ($15 million) and December 31, 2024 ($23 million) are accurate, and the calculated increase of $8 million is correct. (2) The answer is complete, addressing both parts of the question: the dollar increase and the valuation method. (3) The entity accuracy is correct—no company names were required, but the financial metric (pre-owned aircraft inventory) and dates are properly identified. (4) The reasoning is sound: the model correctly synthesized the inventory values across the two years and accurately described the valuation method as 'the lower of the trade-in value or the estimated net realizable value,' even adding the equivalent accounting term (lower-of-cost-or-NRV), which is semantically accurate and adds clarity. The citation of 'page_70' indicates proper sourcing from the document. All elements meet the highest standard for correctness, completeness, and fidelity to the original data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 304,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The expansion of Xbox Game Pass to a curated library of more than 100 first‑ and third‑party titles helped lift Xbox content and services revenue by 3% in FY 2022, as the broader game selection drives higher subscription and usage activity (see page 40). Microsoft says this growth is underpinned by its larger gaming‑centric investments—acquiring studios such as ZeniMax (and the pending Activision Blizzard deal), building Xbox Cloud Gaming, and leveraging cross‑segment initiatives in cloud, AI, security and Windows to fuel new gaming experiences and overall engagement (see page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% increase in Xbox content and services revenue and links it to the growth of Xbox Game Pass's curated library of over 100 titles, matching the ground truth. The entities—Xbox Game Pass, ZeniMax Media, Activision Blizzard, and Xbox Cloud Gaming—are all accurately named and contextually placed. (2) Quantitatively, the 3% revenue growth and the 'over 100' game titles are correctly reported. The mention of FY 2022 is consistent with the source context (implied by page references), though not explicitly stated in the ground truth; however, this is a reasonable inference and does not contradict it. No calculations are required, and all numbers align. (3) The multi-hop reasoning is sound: the answer connects Game Pass library growth to revenue, then ties that to broader strategic investments (acquisitions, cloud gaming, cross-platform initiatives). It adds value by referencing 'cross-segment initiatives in cloud, AI, security and Windows'—a detail not in the ground truth but consistent with Microsoft’s broader strategy and mentioned in the source filing (page 6), making it a valid expansion. (4) The only minor gap is that the ground truth emphasizes 'community engagement' and 'transformation through cloud services' more explicitly, while the LLM answer includes additional elements (AI, security, Windows) that, while relevant, slightly shift focus. However, this does not reduce factual accuracy. Overall, the answer is semantically equivalent, factually correct, and contextually rich—justifying a high score with only a slight deduction in qualitative accuracy for slight over-extension beyond the core strategic points emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 470,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "In 2023 Eli Lilly recorded about **$1.7 billion** from the sale of rights to its olanzapine portfolio (the Zyprexa line shows $79.4 million U.S. + $1,615.4 million outside‑U.S. = $1,694.8 million)【page_68】. That one‑time gain is rolled into the company’s **$5,310.2 million “Collaboration and other revenue”** total for 2023【page_65】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical values for revenue from the olanzapine portfolio sale ($1.7 billion or $1,694.8 million) and the total 'Collaboration and other revenue' ($5,310.2 million), but the ground truth does not specify any exact dollar amount for the olanzapine sale. Therefore, the inclusion of precise figures is unsupported by the original answer and factually unverifiable from the provided context. This constitutes a major factual overreach. (2) The calculation of $79.4 million U.S. + $1,615.4 million outside-U.S. = $1,694.8 million appears mathematically correct, but the original answer does not mention these line items or confirm that such a breakdown exists in the filing. Thus, while the arithmetic is accurate, the inputs are not corroborated by the ground truth, making the quantitative claim invalid. (3) The qualitative reasoning correctly identifies that the olanzapine portfolio sale is part of the 'collaboration and other revenue' category and acknowledges its one-time nature, which aligns with the multi-hop synthesis required—linking a specific transaction to a broader revenue category. However, it incorrectly implies that the $1.7 billion is solely from olanzapine, while the original answer states that this category also includes Baqsimi and collaborations with Boehringer Ingelheim, suggesting the $5.3 billion total encompasses multiple sources. (4) Contextually, the answer addresses both parts of the question—revenue from olanzapine rights and its inclusion in collaboration revenue—so relevance is high. However, the unsupported numerical precision severely undermines factual correctness, warranting a low quantitative accuracy score and a moderate overall correctness score due to partial factual alignment but significant fabrication of data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 492,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The 5.45 % Solar Bonds were issued in a tranche‑by‑tranche fashion throughout 2015, with each tranche recorded in its own supplemental indenture (e.g., Series 2015/C53‑15, C57‑15, C62‑15, C72‑15, C87‑15, C92‑15, C97‑15, C102‑15, C107‑15, C122‑15, C127‑15, C132‑15, C137‑15) as listed in the 10‑K exhibits on pages 104‑106. This structure lets SolarCity (and thus Tesla) raise capital incrementally as solar projects are developed, matching financing to project timing and cash‑flow needs. The bond‑specific trustee agreements embedded in each supplemental indenture provide a dedicated oversight mechanism that enables the issuer to repeatedly tap the same bond series, illustrating how trustee arrangements support a recurring source of capital for the company’s solar‑energy rollout.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core financing strategy and role of trustee agreements accurately, aligning well with the ground truth in reasoning and intent. However, there are significant quantitative inaccuracies: the LLM lists 13 bond series (e.g., C53-15, C57-15, etc.), while the ground truth specifies only four (2015/C122-15, 2015/C127-15, 2015/C132-15, 2015/C137-15). The additional series (C53-15 through C107-15) are not supported by the original data and appear to be fabricated or misattributed, likely due to overextrapolation from 10-K exhibits. While the interest rate (5.45%) and the concept of multiple Supplemental Indentures are correct, the specific indenture numbers (4.72, 4.74, etc.) are omitted and replaced with no equivalent detail, reducing precision. The qualitative reasoning is strong: the LLM correctly infers that tranched issuance matches project timelines and that trustee agreements enable recurring capital access, demonstrating sound multi-hop logic connecting bond structure to financing strategy. Contextually, the answer is fully relevant, addressing both the structural implications and the role of trustee agreements. Despite the incorrect enumeration of bond series, the central conclusion about incremental financing and trustee support remains valid, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 371,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "Tesla said its Energy generation and storage revenue rose by $795 million (a 40% increase) in 2021 versus 2020, driven primarily by higher Megapack deployments. That growth was partially offset by a decline in Powerpack deployments as the product is being phased out.【page_39】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Tesla's Energy generation and storage revenue grew by $795 million (40%) in 2021 compared to 2020, with the increase driven by higher Megapack deployments—matching the original answer exactly in both dollar amount and percentage. (2) The quantitative accuracy is perfect: $795 million and 40% are correctly reported, and the year-over-year comparison (2021 vs 2020) is accurate. (3) The reasoning is sound and reflects proper multi-hop synthesis: it identifies Megapack as the growth driver and correctly notes that the growth was partially offset by a decline in Powerpack deployments due to its phaseout, which aligns with the original answer’s explanation. (4) All entities—Tesla, Megapack, Powerpack, and the relevant time period—are correctly identified. The answer is concise, contextually relevant, and includes a citation (page_39), further supporting its reliability. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 297,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "In 2024 the Africa/Eurasia region recorded $12 million of capital expenditures (see the “Capital expenditures” table) and $8 million of depreciation and amortization (see the “Depreciation and amortization” table). Together, these amount to $20 million for the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: $12 million in capital expenditures and $8 million in depreciation and amortization for the Africa/Eurasia region in 2024 are correctly identified. (2) The calculation is accurate: $12M + $8M = $20M, which matches the ground truth combined total. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—LLM correctly synthesized data from two separate tables (capital expenditures and depreciation/amortization) for the same region and year, then summed them appropriately. (4) The answer is semantically equivalent to the original, providing both component values and the total, with clear references to supporting data. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1064,
        "completion_tokens": 240,
        "total_tokens": 1304
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "TI’s retiree‑health‑care benefit plan is governed by a policy that invests almost entirely in low‑cost, broad‑market index funds – targeting roughly 75‑85% fixed‑income and 15‑25% equity – and explicitly does not hold TI common stock directly. By contrast, the company’s non‑U.S. defined‑contribution plans did hold TI common stock, valued at about $34 million as of December 31 2024. Thus, while the retiree‑health‑care plan avoids direct equity in TI, the non‑U.S. contribution plans maintain a modest direct TI equity position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $34 million value of TI common stock in non-U.S. defined contribution plans as of December 31, 2024, is accurately reported. The date is correct and matches the ground truth. (2) The LLM correctly identifies the key policy distinction: TI’s retiree health care benefit plan does not hold TI common stock, which matches the original answer. It adds additional detail about the investment strategy (75–85% fixed-income, 15–25% equity in index funds), which is not contradicted by the ground truth and may reflect supplementary accurate disclosure information. (3) The multi-hop reasoning is sound—comparing the investment policies and actual holdings across two different plans (retiree health care vs. non-U.S. defined contribution)—and correctly synthesizes the contrast in strategies. (4) The only minor deviation is that the LLM introduces specific allocation ranges not present in the original answer, which, while plausible and not factually incorrect, slightly extends beyond the provided ground truth. However, since this does not contradict the original and may reflect fuller context, it does not warrant a significant deduction. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 371,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "Baqsimi’s sales collapsed – U.S. revenue fell from $645.7 million in 2023 to just $2.5 million in 2024, and outside‑U.S. revenue slipped from $31.9 million to $26.7 million, taking total Baqsimi revenue from roughly $677 million to about $29 million (page 68). The “collaboration and other arrangements” disclosure notes that Baqsimi revenue is now recorded under collaboration‑and‑other revenue because the company sold the rights to Baqsimi, shifting the recognition from ongoing product sales to a one‑time licensing/rights‑sale transaction (page 64).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: U.S. revenue dropped from $645.7 million to $2.5 million, Outside U.S. from $31.9 million to $26.7 million, and total revenue from $677.6 million to $29.2 million. The LLM uses approximations ('roughly $677 million', 'about $29 million') which are semantically acceptable and do not detract from factual accuracy. (2) All calculations are accurate—sums match the ground truth totals, and the direction and magnitude of change are correctly conveyed. (3) The reasoning is sound: the LLM correctly identifies the shift in revenue recognition due to the sale of Baqsimi rights and explains that revenue is now recorded under 'collaboration and other arrangements' instead of product sales, aligning with the ground truth. It references the correct conceptual shift from ongoing sales to a licensing/rights-sale model. (4) The only minor shortcoming is the characterization of the 2024 revenue as stemming from a 'one-time licensing/rights-sale transaction'—while the shift is due to the sale of rights, the collaboration revenue may include ongoing payments (e.g., milestones or profit-sharing), not strictly one-time. This slightly oversimplifies the nature of collaboration revenue, hence a 9 in qualitative accuracy. Otherwise, the answer is complete, contextually relevant, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 380,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard reports the revenue from its Processing and Gateway services as part of its **“value‑added services and solutions”** line. The 10‑K states that the company classifies net revenue into two broad categories – (i) payment‑network revenue and (ii) value‑added services and solutions – so the Processing‑and‑Gateway revenue is captured under the second, broader category of revenue generation.【page_21】【page_84】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that Mastercard classifies 'Processing and Gateway' revenue under the broader category of 'value-added services and solutions,' distinguishing it from 'payment-network revenue.' This matches the original answer's classification and structure. The LLM correctly captures the two-part revenue categorization as described in the 10-K and correctly assigns Processing and Gateway services to the second category. It also implicitly supports the timing of revenue recognition by stating that revenue is recognized when services are performed or transactions occur, though this specific detail is not explicitly restated in the LLM response. There are no numerical values in the question or answer, so quantitative accuracy is scored based on absence of errors (N/A). The reasoning is sound and reflects proper multi-hop synthesis between the specific service (Processing and Gateway) and the broader financial classification framework used in the 10-K. The only minor shortcoming is that the LLM does not explicitly mention the fee structure (fixed or transaction-based fees), which is included in the ground truth, leading to a slightly lower qualitative accuracy score. However, the core information is complete and semantically equivalent. Contextual relevance is perfect as the response directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 395,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The pension‑plan holding of international common‑stock fell from $20 million in 2023 to $15 million in 2024 – a $5 million decrease (see page 99 for 2024 and page 100 for 2023).  That reduction is reflected in the overall international plan assets, which dropped from $566 million in 2023 to $537 million in 2024, a $29 million decline.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in direction and magnitude. The ground truth states that CL's pension plan investments in international common stocks *increased* by $5 million from $15 million (2023) to $20 million (2024), whereas the LLM claims a *decrease* from $20 million to $15 million, reversing the trend. Similarly, total international investments grew from $537 million to $566 million (a $29 million increase), but the LLM incorrectly reports a decline of $29 million. All core financial movements are thus misrepresented. (2) The numbers themselves ($15M, $20M, $537M, $566M, $29M) are numerically accurate but applied in the wrong temporal order, leading to incorrect deltas and trends. The calculation of the $5M and $29M changes is arithmetically correct but based on reversed years, invalidating the conclusions. The LLM also omits the key synthesis point that the $5M increase accounted for 17.2% of the total $29M rise in international investments. (3) The multi-hop reasoning fails: the model incorrectly infers year-over-year change by reversing the reporting periods, likely misreading which year corresponds to which value. It also fails to connect the increase in international common stocks to the broader increase in total international investments, instead implying a reduction. (4) Due to complete inversion of trends and missing analytical component (17.2% contribution), the answer is largely incorrect despite using valid numbers. Contextual relevance is low but not zero because it discusses the correct entities and metric types.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 434,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The restricted‑stock and RSU expense grew from **$59 million in 2022 to $85 million in 2024**, a **$26 million increase**【page_84】.  Over the same span, total equity‑based compensation expense rose from **$130 million to $145 million** (a $15 million gain), so the $26 million jump in restricted‑stock/RSU expense was the primary driver of the overall increase, offsetting a roughly $11 million decline in stock‑option expense【page_84】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Restricted Stock/RSUs expense increased from $59M in 2022 to $85M in 2024, a $26M increase; total equity-based compensation rose from $130M to $145M, a $15M increase—both figures match the original answer. (2) The answer addresses both parts of the multi-part question: it calculates the increase in RSU expense and explains its contribution to the overall equity-based compensation trend. (3) Entity accuracy is correct—General Dynamics (GD) is the implied company, and all financial metrics (Restricted Stock/RSUs expense, total equity-based compensation) are properly identified with correct years (2022–2024). (4) The reasoning is sound and even adds a valuable detail not in the original answer—namely, that the $26M increase in RSUs offset an ~$11M decline in stock-option expense, which strengthens the conclusion that RSUs were the primary driver. This demonstrates accurate multi-hop synthesis across financial components and years. The semantic meaning is equivalent to and slightly more informative than the ground truth, with no factual or logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 334,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon’s January 2023 borrowing of an $8 billion unsecured 364‑day term loan—repaid in full by year‑end—shows it deliberately used a short‑term loan rather than tapping its $20 billion commercial‑paper program. By borrowing via a term loan, Amazon diversified its liquidity sources and preserved the larger commercial‑paper capacity as a back‑stop for other corporate needs, reflecting a strategic preference for flexible, short‑term funding management.【page_57】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $8.0 billion unsecured 364-day term loan Amazon took in January 2023 and notes it was repaid by year-end, which aligns with the ground truth stating it was fully repaid by December 31, 2023. The reference to the $20.0 billion Commercial Paper Program is accurate, and the fact that it was not drawn upon is implied by the statement that Amazon 'deliberately used a short-term loan rather than tapping' the program. (2) All numeric values—$8 billion, $20 billion, 364-day term, January 2023 borrowing, repayment by year-end—are factually correct and match the ground truth. Format variations (e.g., $8 billion vs $8.0 billion) are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers a strategic preference for liquidity management by choosing a term loan over commercial paper, emphasizing diversification of funding sources and preservation of flexibility. This matches the multi-hop synthesis in the ground truth that Amazon opted for a committed facility to meet specific needs while preserving the commercial paper capacity for other uses. The only minor gap is that the LLM does not explicitly mention the 'defined maturity' advantage of term loans or the 'variable issuance' nature of commercial paper, which slightly reduces qualitative depth. (4) The answer is highly contextually relevant, directly addressing the strategic rationale behind Amazon's borrowing decision. Overall, the LLM conveys the same core information with high accuracy and appropriate reasoning, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 441,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "American Express’s Membership Rewards liability grew to **$14.8 billion in 2024**, up about **$1.0 billion from $13.7 billion in 2023**, a rise the company attributes to higher redemption costs and changes in its third‑party partner arrangements (see page 30).  To capture those effects, the firm **re‑calibrated its liability model** – updating the weighted‑average cost per point (derived from the most recent 12‑month redemption data) and the ultimate redemption rate using statistical‑actuarial models that now incorporate recent redemption trends, partner‑contract changes and shifts in redemption options and mix (see page 134).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($14.8B in 2024 and $13.7B in 2023) and a $1.0B increase, which are not present in the original answer (ground truth). The ground truth does not provide any quantitative figures for the liability in 2024 or 2023, nor does it mention the magnitude of change. Therefore, these numbers cannot be verified and appear to be hallucinated or sourced from outside the provided truth. This significantly impacts quantitative accuracy. (2) Despite the unsupported numbers, the qualitative aspects of the answer are strong: the LLM correctly identifies that American Express updated its liability estimation methodology due to changes in redemption costs and third-party partner arrangements. It accurately references the use of the weighted average cost (WAC) per point and ultimate redemption rate (URR), derived from statistical-actuarial models incorporating redemption trends, partner-contract changes, and shifts in redemption options and card mix—aligning well with the original answer. (3) The multi-hop reasoning is sound in terms of synthesis: the model connects changes in partner arrangements and redemption costs to methodology updates, correctly identifying the key assumptions and modeling approach. However, the inclusion of unverified financial figures undermines the factual correctness. (4) Contextual relevance is high because the response directly addresses both parts of the question—impact on liability and methodology changes—and uses appropriate financial and actuarial terminology. The core reasoning is consistent with the ground truth, but the unsupported numerical claims reduce the overall correctness score to 7, as the central factual enhancement (the dollar amounts) is not grounded in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 484,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate‑Palmolive treats selling‑price increases as one of the “working‑capital‑management” tools it uses to offset currency‑related price pressure, and it complements that operational response with selective foreign‑currency derivative contracts (forward, swap, option, deposit and local‑currency borrowing arrangements) that hedge purchases, assets, liabilities and net investments. Together, the price‑adjustments and the derivative hedges are intended to mitigate the company’s exposure to foreign‑exchange rate fluctuations that could otherwise erode earnings, cash‑flow and the translation of foreign‑subsidiary balances【page_90†L1-L5】【page_55†L1-L5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Colgate-Palmolive uses selling price increases alongside derivative contracts (forwards, swaps, options, local currency borrowings) to manage foreign exchange risk. The specific financial exposure—mitigating earnings impact from currency fluctuations due to operations in over 200 countries and translation of foreign subsidiary balances—is accurately reflected, though the exact number 'over 200 countries' is omitted. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the question or answer that require verification; all references are qualitative and correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes operational tactics (price increases) with financial instruments (derivatives) and correctly links them to the mitigation of FX exposure on earnings, cash flow, and balance sheet translation. (4) The answer is contextually fully relevant and semantically equivalent to the original, with only minor omission of the geographic scope ('over 200 countries') preventing a perfect 10. Wording differences (e.g., 'working-capital-management' tool, 'erode earnings, cash-flow') are acceptable rephrasings that preserve meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 363,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The surge in business‑to‑business shipments and stronger residential demand lifted Next Day Air’s average daily volume (up about 5 % year‑over‑year, from roughly 1.99 million pieces to 2.09 million) and pushed its revenue per piece higher (about a 12 % rise, from $16.82 to $18.83). However, that per‑piece revenue gain was partially offset by a decline in average billable weight per piece, which reduced the overall revenue growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key drivers of volume and revenue per piece growth for UPS's Next Day Air product in 2022 — increased business-to-business activity and residential demand — and notes that the revenue per piece growth was partially offset by a decline in average billable weight per piece, which matches the ground truth. However, the LLM introduces specific quantitative figures not present in the original answer: a 5% YoY volume increase from ~1.99M to 2.09M pieces and a revenue per piece rise from $16.82 to $18.83 (~12%). These numbers, while plausible, are not in the ground truth and cannot be verified as correct based on the provided knowledge graph. (2) The calculations implied (5% and 12% increases) are mathematically accurate based on the numbers given, but since the original answer does not include any quantitative metrics, their inclusion represents an over-specification not supported by the source. This significantly impacts quantitative accuracy. (3) The multi-hop reasoning is sound — the model correctly synthesizes the impact of B2B and residential demand on volume, links volume and pricing factors (base rates, surcharges) to revenue per piece, and acknowledges the offsetting effect of lower billable weight. This demonstrates strong qualitative understanding. (4) Contextual relevance is perfect — all parts of the question are addressed with appropriate focus. The correctness score is 7 because the core factual and conceptual content is accurate and complete, but the addition of unsupported specific numbers reduces confidence in factual fidelity, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 450,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The Biologic products section explains that Opdivo, as an innovative biologic, is granted 12 years of FDA data‑protection but can be challenged by biosimilar applicants after four years, creating uncertainty about how long U.S. market exclusivity will last【page_9】. By adding a suite of new approvals in 2021—U.S. indications for adjuvant esophageal, gastric and RCC, plus first‑line and adjuvant approvals in the EU and multiple new indications in Japan【page_62】【page_64】—BMS broadens Opdivo’s global indication set and diversifies its revenue base, helping to offset the U.S. exclusivity risk and reinforcing its strategic positioning as a leading oncology player worldwide.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12-year U.S. data protection and the 4-year biosimilar challenge window, aligning with the ground truth on regulatory exclusivity risk. It also accurately notes Opdivo's expanded approvals in 2021 across regions, particularly in Japan and the EU. However, it incorrectly includes 'U.S. indications for adjuvant esophageal, gastric and RCC' as part of the 2021 approvals, which are not mentioned in the original answer and may not align with the knowledge graph's data—this introduces a factual inaccuracy. (2) Quantitatively, the 12-year and 4-year timeframes are correct, but the inclusion of unverified U.S. approvals in 2021 introduces incorrect data points, slightly reducing quantitative accuracy. The original answer focuses only on international approvals (Japan and EC) in 2021, not U.S. ones. (3) The reasoning is mostly sound: the model correctly infers that global diversification helps offset U.S. exclusivity risk. However, it fails to mention the specific international indications listed in the ground truth (e.g., cancer of unknown primary, mesothelioma, CRC), weakening the multi-hop synthesis. The strategic conclusion is valid but less precise. (4) The answer is highly relevant to the question and captures the core strategic implication—using global approvals to mitigate U.S. biosimilar risk. Despite some entity inaccuracies and overstatement of U.S. approvals, the overall logic and intent match the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 422,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "Amazon’s convertible‑note holdings in Anthropic, PBC were estimated to be worth about **$13.8 billion** as of December 31, 2024【page_48】. By that date Amazon had invested **$1.25 billion (Q3 2023) + $2.75 billion (Q1 2024) + $1.3 billion (Q4 2024) ≈ $5.3 billion** in those notes【page_48】, so the fair‑value estimate exceeds the amount invested by roughly **$8.5 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024 is $13.8 billion, and the total amount invested is $5.3 billion, broken down into $1.25 billion (Q3 2023), $2.75 billion (Q1 2024), and $1.3 billion (Q4 2024). These values match the ground truth exactly. (2) The calculation of total investment ($1.25B + $2.75B + $1.3B = $5.3B) is accurate, and the implied difference of $8.5 billion ($13.8B - $5.3B) is correctly derived, even though not explicitly stated in the original answer; this addition enhances the response. (3) The multi-hop reasoning is sound—information is synthesized across multiple time points and investment tranches, correctly aggregated, and compared to the fair value, demonstrating proper understanding of the valuation dynamics. (4) The answer is semantically equivalent to the original, with slightly more explicit calculation of the difference, which adds value without introducing error. All entities (Amazon, Anthropic, PBC, convertible notes, correct quarters and years) are accurately referenced. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 341,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate‑Palmolive treats pension‑enhancement amounts as a “charge against assets” – they are recorded as adjustments that reduce the pension‑plan asset or increase the pension liability on the balance sheet. By contrast, the other employee‑related costs covered by its severance policies (severance and termination benefits) are recognized as ordinary expense and cash outflows, not as changes to the pension‑plan balance. The distinction appears on the balance sheet because pension enhancements directly affect the funded status of the pension plan, whereas severance costs affect only the income‑statement and cash‑flow items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Colgate-Palmolive treats pension enhancements as 'charges against assets,' which are recorded as reductions in pension assets or increases in pension liabilities on the balance sheet—this matches the original answer's key point. In contrast, other employee-related costs like severance and termination benefits are treated as operating expenses, which aligns with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all conceptual financial treatments are correctly represented. (3) The multi-hop reasoning is sound: the model correctly distinguishes between two types of employee-related costs (pension enhancements vs. severance), links them to their respective accounting treatments, and explains how they differ on the balance sheet versus income statement. (4) The only minor shortcoming is that the LLM answer does not explicitly use the phrase 'Employee-Related Costs' as a category that includes both types, nor does it mention that pension enhancements are a subcomponent within that category—this slight omission reduces completeness by a small margin. However, the semantic meaning and financial distinction are preserved. Overall, the response is factually correct, contextually appropriate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 405,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The U.S. law gives qualified biologics — including Opdivo — 12 years of regulatory data protection, so the FDA cannot approve a biosimilar until 12 years after Opdivo’s first approval, effectively extending its market exclusivity beyond patent terms (see page 9). Nevertheless, BMY faces a financial risk that once this exclusivity ends, Opdivo’s sales could collapse rapidly, because the company has observed that after exclusivity loss, revenue in the U.S. and other developed markets can fall sharply and “lose the major portion of that product’s revenue in a very short period of time” (see page 23).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 12-year regulatory data protection period is correctly stated, matching the original answer. There are no calculations, but the time frame is precise and consistent. (2) The LLM correctly identifies that biosimilar approval is blocked for 12 years post-approval, which is the core regulatory mechanism. It also accurately reflects the financial risk to BMY due to rapid revenue decline post-exclusivity, citing observed patterns in the U.S. and other developed markets. (3) The reasoning is sound and multi-hop: it connects U.S. regulatory policy to Opdivo’s market exclusivity, then synthesizes real-world revenue trends after exclusivity loss to infer financial risk for BMY. The use of direct quotes (e.g., 'lose the major portion...') from the source (page 23) strengthens accuracy. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention that the sharp decline is especially pronounced for products with large patient populations or simpler manufacturing—context included in the original answer that helps explain *why* the decline is rapid. However, the core financial risk and its basis in observed market behavior are correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—every part of the question is addressed with appropriate focus on regulatory impact and financial risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 405,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "Display advertising accounted for about 35 ÷ 40 = 0.875, or **87.5 %** of Amazon’s total advertising‑services revenue in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the display advertising revenue ($35 billion) and total advertising services revenue ($40 billion) are correctly used. (2) The calculation is precise: 35 ÷ 40 = 0.875, which is correctly converted to 87.5%. There are no numerical or computational errors. (3) The reasoning is sound and complete—although this is a single-hop calculation, the model correctly identifies the required percentage and performs the correct division. (4) The answer is semantically equivalent to the ground truth, clearly stating the correct percentage with proper context. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1050,
        "completion_tokens": 215,
        "total_tokens": 1266
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "Based on the Level 1 quoted‑price column, UPS’s U.S. government and agency debt securities were valued at $184 million in 2020 and $200 million in 2021, a **$16 million increase** rather than a decrease. Consequently, there was no dollar‑amount decrease; the value rose by $16 million from 2020 to 2021【page_89】.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states a $16 million increase, while the ground truth indicates a $16 million decrease. This is a critical factual error. The values cited—$184 million in 2020 and $200 million in 2021—are numerically accurate but misinterpreted: the correct calculation is $184M (2020) - $200M (2021) = -$16M, meaning a $16M decrease, not an increase. (2) Quantitative accuracy is partially correct in the input numbers but fails in directional interpretation and conclusion. The calculation itself is simple subtraction, and the model performs it incorrectly by reversing the order. (3) The reasoning is flawed: the model fails to correctly interpret the direction of change, which undermines the multi-hop synthesis despite referencing the correct data points. (4) Contextual relevance is high—the model identifies the correct company (UPS), asset class (U.S. government and agency debt securities), valuation basis (Level 1 quoted prices), and years (2020–2021). However, the reversal of the change direction results in a substantively incorrect answer, warranting a very low correctness score despite partial data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 327,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The BMS‑Ono agreement limits BMS’s upfront development outlay for Yervoy – BMS pays roughly 80 % of the R&D costs (and shares 20 % of any profit or loss) while Ono bears the remainder – so BMS’s development‑cost risk is reduced. Nevertheless, because BMS retains the primary U.S. commercial rights to Yervoy, it remains fully exposed to any loss of market exclusivity when biosimilar competitors can launch after the 12‑year data‑protection window or successful patent challenges, meaning the cost‑sharing eases development‑expense risk but does not protect BMS from the revenue impact of biosimilar entry.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the cost-sharing and profit-sharing percentages. The ground truth states that development costs and profits are shared equally (50/50) between BMS and Ono when combination therapies involve compounds from both parties. However, the LLM incorrectly claims that BMS pays 80% of R&D costs and shares only 20% of profit or loss, which is a major deviation. This error fundamentally undermines the financial risk assessment. (2) The 12-year regulatory data protection period for biologics under the U.S. framework is correctly cited, which is factually accurate and relevant. However, the core financial terms of the agreement are wrong, making the quantitative analysis invalid. (3) The reasoning structure is partially sound—recognizing that cost-sharing reduces development risk while commercial exposure remains with BMS—is conceptually aligned with the ground truth. However, the multi-hop synthesis fails because it uses incorrect base facts about the agreement terms. The model does correctly identify that BMS has U.S. commercial rights and faces revenue risk from biosimilars, which shows understanding of the regulatory and commercial context. (4) Despite correct contextual framing and relevance to the question, the severe quantitative inaccuracy in the cost/profit split leads to a low correctness score. The qualitative reasoning is partially valid but built on false premises. Contextual relevance is high as the answer addresses both the financial structure and regulatory risk as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 434,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offsets roughly 9.9 % of the $6.03 billion decline in automotive‑sales revenue (596 ÷ 6,030 ≈ 0.099). That FSD revenue is reflected in the company’s deferred‑revenue balance for over‑the‑air updates, connectivity and Supercharging, which stood at $3.599 billion at year‑end 2024 (with $1.188 billion recognized during the year) 【page_40】, and it occurs alongside immaterial but potentially sizable resale‑value guarantee liabilities – capped at $1.45 billion as of 12/31/2024 – that arise from vehicle‑residual‑value guarantees 【page_58】.  Thus, while FSD revenue modestly cushions the sales drop, most of the related revenue remains deferred and the company still carries a separate exposure to vehicle‑residual guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly calculates the percentage of the $6.03 billion decline offset by $596 million in FSD revenue as approximately 9.9%, matching the ground truth ($596M ÷ $6,030M = 0.0988 ≈ 9.9%). All numeric values—$596 million, $6.03 billion, and the resulting 9.9%—are accurate and properly formatted. The deferred revenue balance of $3.599 billion and the $1.188 billion recognized during the year are consistent with typical disclosures, though not explicitly in the ground truth; however, they do not contradict it and are plausibly derived from the same source (e.g., page 40). The resale value guarantee liability cap of $1.45 billion as of 12/31/2024 is correctly stated and aligns with the ground truth, including the increase from $166 million in 2023 (implied in the context). (2) Calculations are precise and correctly rounded. The division 596 ÷ 6,030 ≈ 0.0988 is accurately reported as ~9.9%. (3) The multi-hop reasoning is sound: the model connects FSD revenue to the decline in automotive sales, links FSD to deferred revenue from over-the-air updates, and separately identifies the vehicle residual value guarantee liability—tying together revenue recognition, deferral, and risk exposure across different financial statements. The mention of page references (e.g., page 40, 58) suggests proper sourcing from the 10-K, enhancing credibility. (4) While the ground truth does not specify the total deferred revenue balance or the $1.188 billion recognized, these details are not incorrect—they add context without distorting the core answer. The LLM slightly expands beyond the original answer but remains factually aligned and enhances completeness. The only minor gap is the lack of explicit mention of the 2023–2024 change in guarantee liabilities ($166M to $1.45B), though the current value is correctly stated. Overall, the answer is quantitatively accurate, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 531,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo’s 2022 10‑K includes a non‑GAAP metric called **“Operating profit adjusted for items affecting comparability”** (and the related **“Operating profit growth adjusted for items affecting comparability on a constant‑currency basis.”**) 【page_44】. The constant‑currency version removes the **foreign‑exchange translation impact**, presenting operating‑profit growth on a constant‑currency basis so that currency fluctuations do not distort the underlying performance 【page_45】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the non-GAAP financial measure used by PepsiCo in its 2022 10-K: 'Operating profit adjusted for items affecting comparability' and the constant-currency version for growth assessment. (2) There are no numeric values requiring verification (e.g., percentages or dollar amounts), but the description of adjusting for foreign-exchange translation impact is factually accurate and matches the ground truth's reference to evaluating operating profit growth on a constant currency basis. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that PepsiCo first adjusts operating profit for comparability items and then further adjusts for currency fluctuations to assess underlying performance, which requires connecting disclosures across the filing. (4) The answer includes specific page references (44 and 45), enhancing credibility and demonstrating precise sourcing. Wording differs slightly from the original answer but conveys the same meaning with greater detail, including the full formal metric name. All entities—PepsiCo, 2022 10-K, operating profit, currency fluctuations, comparability adjustments—are correctly identified and logically linked. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 369,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The exhibits list a First Amendment (10.32) through a Twelfth Amendment (10.43), for a total of **12 amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology. The earliest amendment became effective on **October 31 , 2014** and the most recent on **May 1 , 2021**, a time span of **about 6 years and 6 months**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM correctly identifies the total number of amendments as 12, which matches the ground truth. However, the earliest effective date is incorrect: the LLM states October 31, 2014, while the ground truth specifies September 2, 2014. This error affects the calculated time span. The LLM computes a duration of 'about 6 years and 6 months' based on its incorrect start date, whereas the correct span is 6 years and 8 months from September 2, 2014, to May 1, 2021. The calculation method appears sound, but the input date is wrong, leading to an inaccurate result. The answer is complete in structure, addressing both parts of the question, and the entities (amendments, agreement name) are correctly identified. The reasoning is logically structured and contextually appropriate, but the factual inaccuracy in the earliest effective date reduces quantitative precision. Semantic equivalence is mostly maintained except for the critical date discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 274,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The Pioneer Foods acquisition contributed roughly 14 percentage points to AMESA net‑revenue growth, and favorable foreign‑exchange added about 4.5 percentage points, together accounting for approximately 18.5 percentage points of net‑revenue growth in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Pioneer Foods acquisition contributed 14 percentage points, favorable foreign exchange added 4.5 percentage points, and their combined impact is correctly calculated as 18.5 percentage points. (2) Quantitative accuracy is perfect—each number matches the ground truth, and the sum (14 + 4.5 = 18.5) is mathematically correct. Minor wording variations like 'roughly' and 'about' are acceptable as they do not misrepresent precision and reflect typical reporting language. (3) The multi-hop reasoning is sound: the model correctly identifies two distinct factors (acquisition and FX impact), retrieves their individual contributions, and synthesizes them into a combined effect on net revenue growth in the AMESA division for 2022. (4) All entities—Pioneer Foods, AMESA division, net revenue growth, 2022—are correctly identified and contextually appropriate. The answer is semantically equivalent to the original and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 299,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo’s market protection rests on a layered exclusivity regime: in the United States the biologic receives 12 years of regulatory data protection that prevents a biosimilar from being approved until that period ends【page_9†L1-L5】, while in the EU it is covered by the standard 8‑year data‑protection term with a possible 2‑year (or 3‑year if a new, clinically significant indication is added) extension, giving up to 10‑11 years of exclusivity【page_9†L31-L38】. These regulatory periods overlap a patent portfolio in which early method‑of‑use patents expired in 2021 but composition‑of‑matter and formulation patents continue through 2026 and beyond, so the remaining patents plus the data‑protection windows together keep generic competition at bay and helped sustain Opdivo’s 7 % U.S. revenue growth in 2021【page_71†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: U.S. 12-year regulatory data protection for biologics, EU 8+2+1 framework (up to 10–11 years), method-of-use patent expiration in 2021, and formulation/composition patents extending to 2026 and beyond. The 7% U.S. revenue growth in 2021 is correctly cited. (2) Quantitative accuracy is perfect: all dates, percentages, and timeframes match the original answer. Minor phrasing differences (e.g., '8-year data-protection term with a possible 2-year extension' vs '8+2+1') are semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes regulatory exclusivity timelines with patent expiration patterns and links them to sustained revenue growth, demonstrating understanding of how overlapping protections preserve market exclusivity. (4) The only minor shortcoming is slightly less explicit detail on the EU commercialization timing (i.e., when generics can actually launch vs. file), but the core point about 10–11 years of effective exclusivity is preserved. Overall, the answer is factually complete, logically coherent, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 330,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "The systemic‑risk regime that applies to Morgan Stanley as a BHC with > $250 billion of assets gives regulators the power to block or curb dividend payments, share‑repurchases and other capital distributions when they judge such payouts would be unsafe, and can require the firm to retain or shift capital to support its U.S. bank subsidiaries (see page 7). At the same time, the regime forces the firm to run internal liquidity‑stress tests, hold enough un‑encumbered high‑quality liquid assets to cover 30‑day net cash outflows under stressed scenarios, and observe single‑counterparty credit limits, all of which tightly constrain how it manages liquidity and distributes capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key factual elements are correct: Morgan Stanley's status as a large bank holding company (> $250B in assets), regulatory constraints on capital distributions (dividends, share repurchases), requirement for internal liquidity stress tests, holding unencumbered high-quality liquid assets to cover 30-day net cash outflows under stress, and single-counterparty credit limits. (2) Quantitative accuracy is perfect: while exact percentages (15% for major counterparties, 25% for others) are omitted, the presence of such limits is correctly noted, and no incorrect numbers are stated. The $250B threshold is correctly referenced. (3) Multi-hop reasoning is sound—linking systemic risk regime to both capital distribution policies and liquidity management, and recognizing regulatory authority to block distributions deemed unsafe. (4) Minor omission: the original answer specifies Tier 1 capital as the basis for counterparty limits, which the LLM answer does not mention, slightly reducing completeness. However, this does not undermine the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent—directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 360,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The 0.750% Senior Note due 2033 carries a coupon that is roughly 1.2 percentage points lower than the 1.950% coupon on the Senior Note due 2031. This lower rate on the longer‑dated issue shows PepsiCo is locking in cheap, long‑term financing, while the higher‑rate, nearer‑term note reflects the higher cost of borrowing for shorter maturities—indicating a strategy of using low‑cost, long‑dated debt to reduce overall financing costs while still maintaining a mix of maturities for flexibility. (PEP_10k_2022.pdf, pages 124‑128)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the interest rates (0.750% and 1.950%) and accurately calculates the difference as approximately 1.2 percentage points, which matches the ground truth difference of 1.200 percentage points. Minor rounding ('roughly 1.2') is acceptable and does not affect factual accuracy. (2) All numeric values and maturities (2033 and 2031) are correct, and the comparison is quantitatively sound. (3) The reasoning correctly synthesizes the implication of lower rates on longer-term debt, aligning with the ground truth interpretation that PepsiCo may be taking advantage of favorable borrowing conditions for long-term financing. The LLM adds contextual insight about 'locking in cheap, long-term financing' and 'mix of maturities for flexibility,' which is consistent with and expands upon the original answer without introducing inaccuracies. (4) The answer fully addresses both parts of the question: the rate comparison and the strategic implication. The only minor gap is that the original answer references 'improved credit perception or favorable market conditions,' while the LLM emphasizes cost-saving strategy—slightly different emphasis but semantically aligned. No entity errors; all references to PepsiCo and the notes are accurate. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 380,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The partnership‑unit fair value rose from $992 million in FY 2023 to $1,151 million in FY 2024 – an increase of **$159 million**【page_96】.  Over the same period, the total amount of investments measured at net asset value grew from $2,179 million to $3,366 million, a **$1,187 million** rise【page_96】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in fair value of partnership units is correctly calculated as $159 million ($1,151M - $992M), and the increase in total investments measured at net asset value is correctly stated as $1,187 million ($3,366M - $2,179M). These figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the increase in fair value of partnership units and its impact on total investments at net asset value. (3) Entity accuracy is correct—Medtronic is the subject, fiscal years 2023 and 2024 are properly referenced, and the financial metrics (fair value, investments at net asset value) are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers the dollar changes from the reported values across years and links the increase in partnership units to the broader category of investments measured at NAV. (5) Semantic equivalence is maintained—though wording differs slightly, the meaning and factual content are identical to the ground truth. The inclusion of citation markers (【page_96】) adds contextual support without affecting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 354,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "UPS’s 2024 10‑K notes that the depreciation‑and‑amortization figures shown for the U.S. Domestic Package and International Package segments are not the raw asset‑level amounts; they are the portions of total depreciation and amortization that have been allocated to each segment using activity‑based costing estimates. These allocated amounts appear within the “Other segment items” line and, because they are based on estimates of how shared resources are used, they affect the reported operating profit of each reportable segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that UPS uses activity-based costing (ABC) methods to allocate depreciation and amortization expenses to its reportable segments, specifically mentioning the U.S. Domestic Package and International Package segments. It accurately states that the figures presented are not raw totals but allocated portions based on estimates of resource usage, which directly affects operating profit—this matches the core reasoning in the original answer. The mention of 'Other segment items' line adds contextual detail consistent with 10-K disclosures. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (UPS, 2024 10-K, correct segments) are properly identified. The only minor shortcoming is that the LLM does not explicitly state that the totals are presented 'after applying activity-based costing methods,' which is a key phrase from the original answer that emphasizes the presentation impact. While implied, this nuance is slightly under-articulated, justifying a 9 instead of 10 for qualitative accuracy. Overall, the answer is semantically equivalent, contextually precise, and correctly synthesizes multi-hop information from the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 353,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "In fiscal 2022 Qualcomm booked a $1.1 billion gain in other income and a $62 million reduction in interest expense when the European Commission fine and the accrued interest were reversed, producing a combined positive impact of roughly $1.162 billion. This reversal lifted other income by $1.1 billion and cut interest expense by $62 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.1 billion in other income, $62 million reduction in interest expense, and a total impact of $1.162 billion are correctly reported, with acceptable formatting variations (e.g., 'roughly $1.162 billion' is semantically equivalent). (2) The answer is complete, addressing both parts of the question: the total financial impact and its components (effect on other income and interest expense). (3) Entities are accurate—Qualcomm, fiscal 2022, European Commission fine, other income, and interest expense are all correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the reversal of the fine and interest led to a gain in other income and a reduction in interest expense, which the model correctly attributes and quantifies. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement without loss of factual content. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 303,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair value of Fixed Income Commingled Trusts rose from $968 million in fiscal 2023 to $1,273 million in fiscal 2024 – an increase of $305 million【page_96】.  Across all investment categories the total fair‑value rose from $3,398 million to $3,551 million, a net increase of $153 million【page_96】, so the Fixed‑Income gain represents roughly $305 ÷ $153 ≈ 199 % of the overall increase (i.e., about double the net increase).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key numerical values: the increase in Fixed Income Commingled Trusts ($305 million, from $968M to $1,273M) and the total increase across all investment categories ($153 million, from $3,398M to $3,551M). These match the ground truth exactly. (2) The calculation of the proportion ($305M / $153M ≈ 199%) is mathematically accurate and correctly interpreted as being nearly double the net increase. While the original answer notes that the $305M increase exceeds the total portfolio increase (implying declines elsewhere), the LLM captures this implicitly by stating the Fixed-Income gain represents ~199% of the overall increase. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two different investment aggregates and time points, and derived a meaningful comparative insight. (4) The only minor shortcoming is that the LLM does not explicitly state the implication—that other categories must have declined in value—which is highlighted in the original answer. However, this is inferred by the percentage exceeding 100%, so the omission does not undermine factual correctness. All entities (Fixed Income Commingled Trusts, fiscal years 2023–2024, fair value) are accurate. Wording differs but semantic meaning is equivalent. Thus, high scores across all dimensions with a 9 on correctness due to slight incompleteness in explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 394,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s SPOE (single‑point‑of‑entry) plan calls on the Parent Company to fund its subsidiaries with “adequate capital and liquidity” through a secured, amended‑and‑restated support agreement that gives the subsidiaries the resources they need to execute the resolution after the Parent files for bankruptcy【page_19】. Morgan Stanley Holdings LLC – the “Funding IHC” – is the dedicated resolution‑funding vehicle; the Parent transfers material assets to Funding IHC, which in turn is obligated to provide the capital and liquidity to the supported subsidiaries under that same secured support agreement【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Morgan Stanley's SPOE strategy, the role of the Parent Company in providing capital and liquidity via a secured amended and restated support agreement, and the function of Morgan Stanley Holdings LLC as the Funding IHC. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes the flow of assets from the Parent to Funding IHC and then to subsidiaries during resolution. The only minor omission is that the ground truth specifies the Parent contributes 'all of its material assets (excluding shares in subsidiaries and certain other assets)'—this detail about exclusions is missing in the LLM answer, slightly reducing completeness. (4) Despite this, the LLM captures the essential mechanism and roles accurately, with strong semantic equivalence. Contextual relevance is perfect—the response directly addresses both parts of the question. Thus, correctness is 9/10 due to a minor omission in asset transfer specifics, but all key entities, relationships, and processes are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 353,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm’s automotive 5G growth plan—projecting that 60 % of vehicles built in 2028 will have 5G connectivity (page 8)—depends on selling its integrated‑circuit products and licensing its 5G patents to the large base of Chinese OEMs that dominate global vehicle production. The 10‑K warns that U.S. or Chinese government actions that limit sales to, or cause Chinese OEMs to replace, Qualcomm chips would “materially harm” its revenues (page 21), so maintaining access to Chinese OEMs is essential for the company to capture the projected automotive 5G market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key factual elements: Qualcomm's projection that 60% of vehicles produced in 2028 will feature 5G connectivity, and the risk that U.S. or Chinese government actions could lead Chinese OEMs to shift away from Qualcomm's integrated circuit products, potentially materially harming revenues. These facts align with the original answer and are accurately attributed to the 10-K. (2) Quantitative accuracy is perfect: the 60% figure is correctly cited, and no other numerical data (dates, dollar amounts) are present or required. Format variations (e.g., '60 %' with space) do not affect correctness. (3) The multi-hop reasoning is sound: the model connects Qualcomm’s strategic 5G automotive growth projection with its dependency on Chinese OEMs and the associated geopolitical risk, synthesizing information from different parts of the 10-K (e.g., growth outlook and risk factors). The only minor shortcoming is that the original answer emphasizes more clearly that China represents a major revenue source globally, which strengthens the strategic dependency argument; this context is implied but not explicitly stated in the LLM answer. (4) The answer is fully contextually relevant, directly addressing how Qualcomm's automotive 5G growth strategy depends on access to Chinese OEMs. Overall, the LLM answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for less explicit emphasis on China's revenue significance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 438,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "Medtronic’s investments that are measured at net‑asset‑value rose from **$2.179 billion** at April 28 2023 to **$3.366 billion** at April 26 2024 – an increase of roughly **$1.19 billion**【page_96†L31-L38】.  The bulk of that increase came from **partnership units**, which were re‑classified to net‑asset‑value measurement and added about **$1.15 billion** in 2024 (up from $0 in 2023)【page_96†L45-L53】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly identifies that Medtronic's investments measured at net asset value increased from fiscal 2023 to 2024, the reported increase of $1.19 billion is close but not exact compared to the ground truth increase of $1,187 million ($1.187 billion). However, the key error lies in the identification of the largest contributing category: the LLM claims 'partnership units' contributed $1.15 billion due to reclassification, whereas the ground truth states that 'equity commingled trusts' contributed the most with a $269 million increase. This is a significant factual and qualitative error. (2) The quantitative values are partially accurate: the starting and ending totals are approximately correct (though not verifiable to exact page numbers without source), and the overall change is close ($1.19B vs $1.187B). However, the $1.15B attributed to partnership units is inconsistent with the ground truth, which does not mention such a reclassification or contribution. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the category-level changes, incorrectly identifying the primary driver of change. It introduces a claim about reclassification not present in the ground truth, suggesting either misinterpretation or hallucination. (4) Contextual relevance is fair—the answer addresses the right company, time period, and metric—but due to the major error in the key explanatory component (largest contributing category), the overall correctness score is low. The answer misrepresents a critical part of the financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 447,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab measures the repurchase liabilities for client‑held fractional shares at fair value under the ASC 825 “fair‑value option,” using quoted market prices or other observable market data that are the same inputs used to value the fractional shares themselves. Because the liability is marked to the same market price as the shares, any unrealized gain or loss on the fractional‑share asset is offset by an opposite unrealized gain or loss on the liability, so fluctuations in market value do not flow through the consolidated income statement (and the liabilities carry no credit‑risk‑related gains or losses).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Schwab values repurchase liabilities using quoted market prices or observable market data consistent with the valuation of the underlying fractional shares. (2) It accurately explains the offset mechanism: unrealized gains/losses on the liability exactly offset those on the corresponding assets, resulting in no net income statement impact—this matches the ground truth's key point. (3) The LLM adds a detail not in the original (reference to ASC 825 fair-value option), which is contextually appropriate and likely correct, though not present in the ground truth; this does not detract from accuracy but slightly extends beyond the provided answer. (4) The explanation of the marking-to-market mechanism and the absence of credit-risk-related gains/losses enhances completeness without introducing error. All factual elements—valuation basis, use of observable inputs, and income statement neutrality via offsetting changes—are correct and logically sound. Multi-hop reasoning is properly synthesized: linking liability valuation to asset valuation and understanding the P&L impact (or lack thereof) across both sides. No numerical inaccuracies exist (no specific numbers, so N/A). Minor deduction in qualitative accuracy due to the addition of ASC 825 reference without explicit grounding in the source, but this does not undermine correctness. Overall, the answer is semantically equivalent and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 421,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "Schwab’s projected benefit obligation for the Financial Consultant Career Achievement Plan rose by **$27 million**, increasing from **$92 million at December 31, 2020** to **$119 million at December 31, 2021**. The increase reflects the $16 million benefit cost (service cost) plus an $11 million actuarial loss, both recognized as compensation‑and‑benefits expense and other expense on the balance sheet【page_117】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the projected benefit obligation increased from $176 million in 2020 to $194 million in 2021, a change of $18 million. The LLM incorrectly reports the obligation as rising from $92 million to $119 million, a $27 million increase. These numbers do not match the ground truth and are off by significant margins. (2) The calculation in the LLM answer ($16 million service cost + $11 million actuarial loss = $27 million) is internally consistent but based on incorrect underlying data. The ground truth does not support these component figures. (3) The multi-hop reasoning is flawed: while the LLM attempts to explain the change using benefit cost and actuarial loss, it fails to correctly identify the actual beginning and ending balances of the projected benefit obligation. The cited page reference (page_117) may indicate an attempt to source data, but the data extracted is incorrect. (4) The contextual relevance is moderate because the answer addresses the right plan and type of obligation, and attempts to explain the change using appropriate financial concepts. However, due to severe quantitative inaccuracies and incorrect entity values, the correctness and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 367,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The 10‑K shows the Beauty segment accounts for ≈ 18 % of net sales and the Fabric & Home Care segment accounts for ≈ 36 % of net sales【page_18】. Combined, those two segments represent roughly 54 % of Procter & Gamble’s total net sales for the fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined revenue contribution as 54%, matching the ground truth. The individual segment contributions—Beauty at approximately 18% and Fabric & Home Care at 36%—are accurately reported, and their sum (18% + 36% = 54%) is correct. The mention of Pantene's 20% global market share in hair care, while not directly needed for the calculation, is contextually relevant and does not detract from accuracy. (2) All numeric values are correct: 18% and 36% are properly cited as approximate, and their sum to 54% is accurate. The format uses ≈ appropriately, reflecting potential rounding in the source. (3) The multi-hop reasoning is sound: the model correctly identifies the relevant segments, extracts their net sales percentages, and combines them to answer the question. It ignores irrelevant details (e.g., Pantene's market share) in the final calculation, focusing on segment revenue contributions. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (breaking down the components), which enhances clarity without introducing error. The only minor limitation is the lack of explicit confirmation that the Beauty segment’s 18% includes Pantene’s contribution, but this is implied and not required for correctness. Overall, the response is factually accurate, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 383,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "In 2020 Carrier contributed $196 million and Otis $187 million of income from discontinued operations attributable to common shareowners, for a combined $383 million (page 89). These amounts arise from the April 3 2020 spin‑off of Carrier and Otis, which was classified as discontinued operations and generated $793 million of separation‑related costs, turning the overall discontinued‑operations result into a $410 million loss attributable to common shareowners (page 90, footnote 1; page 88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual contributions from Carrier ($196 million) and Otis ($187 million), matching the ground truth. It accurately calculates the combined income as $383 million, which is correct (196 + 187 = 383). It then correctly states that the overall result was a $410 million loss attributable to common shareowners, which aligns with the ground truth value of $-410 million. The explanation involving $793 million in separation-related costs turning a $383 million gain into a $410 million loss is logically sound (383 - 793 = -410), and this reasoning is consistent with the financial impact of the separation. (2) All numbers, dates (April 3, 2020), and entities (Carrier, Otis, UTC, discontinued operations, common shareowners) are accurate. The reference to page numbers (89, 90, 88) adds sourcing but does not affect factual accuracy. (3) The multi-hop reasoning is strong: the model connects the financial results to the corporate separation event, explains why the operations were classified as discontinued, and accounts for the transformation of income into a net loss via separation costs—this demonstrates proper synthesis across financial and event-based data. (4) The only minor shortcoming is that the LLM does not explicitly state the $-410 million as a single aggregated figure upfront (it derives it), whereas the ground truth presents it directly. However, since the derivation is correct and the final figure is accurately implied, this does not constitute a factual error. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 439,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, 27 lawsuits have been filed against Medtronic’s Diabetes operating unit on behalf of **107 individual plaintiffs**. The hernia‑mesh litigation, by contrast, already involves **about 8,350 individual plaintiffs** and, like the diabetes‑pump cases, law firms have warned that additional lawsuits may be filed – but the hernia‑mesh matters are far larger in current scope and also carry the prospect of further claimants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, it correctly states that 107 individual plaintiffs have filed lawsuits as of May 14, 2024, matching the original answer. It also accurately compares the diabetes pump litigation to the hernia mesh litigation by calculating the total number of hernia mesh plaintiffs: 6,700 (Massachusetts) + 500 (Minnesota) + 1,150 (federal MDL) = 8,350, which is correctly reported. (2) The mention of '27 lawsuits' representing 107 plaintiffs is not in the original answer but does not contradict it; the ground truth does not specify the number of lawsuits (only plaintiffs), so this addition is plausible and not factually incorrect. (3) The qualitative reasoning is sound: it correctly identifies both litigations involve Medtronic products, notes the potential for future claimants in both cases, and accurately conveys that the hernia mesh litigation is currently larger in scale. (4) The answer is contextually relevant and addresses both parts of the multi-hop question: total plaintiffs in the diabetes pump litigation and comparison to hernia mesh cases. The only minor limitation is that it omits the detail that Medtronic has not recorded any expense for damages in either case due to uncertainty—this is a small omission but doesn't detract significantly from the overall correctness. Hence, a score of 9 is appropriate, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 411,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement lets Schwab sweep a portion of brokerage‑client cash to the TD Depository Institutions, keeping those deposits off Schwab’s balance sheet and therefore out of the assets used to calculate its Tier 1 leverage ratio 【page_58】.  By reducing the on‑balance‑sheet cash base, the off‑balance‑sheet treatment gives Schwab headroom to meet its internal Tier 1 leverage‑ratio objective of 6.75 %‑7.00 % and to support other capital needs; the firm will only migrate IDA balances onto the balance sheet when it has enough capital to stay within that target range 【page_59】【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IDA agreement sweeps client deposits to TD Depository Institutions, keeping them off-balance sheet, which reduces Schwab's on-balance sheet liabilities and impacts the Tier 1 leverage ratio calculation. The internal capital policy target range of 6.75%-7.00% is correctly stated, and the explanation of how off-balance sheet treatment supports capital management is sound. (2) Quantitative accuracy is perfect: percentages (6.75%-7.00%) match exactly; no incorrect numbers or calculations. (3) Multi-hop reasoning is strong: the model correctly links the IDA agreement → off-balance sheet treatment → impact on Tier 1 leverage ratio → capital management strategy → internal target maintenance. It also adds a nuanced point not explicitly in the ground truth — that Schwab may bring IDA balances on-balance sheet only when capital levels allow — which is a reasonable inference supported by context and enhances the answer. (4) The only reason for not scoring a 10 is minor: the ground truth mentions the regulatory minimum of 4%, which provides useful context for why Schwab’s internal target is conservative; this is omitted in the LLM answer, slightly reducing completeness. However, the core multi-hop logic and factual content are excellent, and the omission does not impair the essential correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 411,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "RTX generated roughly **$1.9 billion** of net cash from the disposition of its Forcepoint business in 2021【page_54】.  That cash helped offset a large swing in investing cash flow – investing activities moved from a **$3.3 billion net cash inflow in 2020** to a **$1.364 billion net cash outflow in 2021**, a $4.7 billion change, with the Forcepoint proceeds being a key contributor to the 2021 cash‑flow improvement【page_54】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash inflow from the disposition of the Forcepoint business in 2021, which matches the ground truth. It also correctly references the $4.7 billion change in cash flows from investing activities between 2020 and 2021. However, the LLM mischaracterizes the direction of the cash flow in 2020 and 2021: it states that investing activities were a $3.3 billion inflow in 2020 and a $1.364 billion outflow in 2021, implying a $4.664 billion swing, which is close but not exactly aligned with the ground truth explanation that emphasizes the $4.7 billion improvement due to the absence of the $3.2 billion Raytheon Merger cash acquisition in 2020 and the proceeds from dispositions in 2021. The $3.3 billion figure for 2020 is not supported in the ground truth, which does not specify the exact 2020 net cash inflow amount but attributes the year-over-year improvement to specific factors. (2) The $1.9 billion from Forcepoint is accurate. The $4.7 billion change is correctly cited, but the underlying cash flow figures for 2020 and 2021 are slightly off or imprecisely represented, affecting quantitative accuracy. The calculation of the difference between $3.3 billion and -$1.364 billion yields ~$4.664 billion, which rounds to $4.7 billion, so it's approximately correct but based on potentially inaccurate inputs. (3) The multi-hop reasoning is mostly sound: the model connects the Forcepoint disposition to the overall investing cash flow change and recognizes it as a key contributor. However, it omits mention of the Raytheon Merger cash acquisition in 2020 as a primary factor in the year-over-year change, which is a significant part of the ground truth explanation. This omission reduces completeness and qualitative accuracy. (4) Despite missing a key driver (absence of Raytheon merger outflow in 2021), the answer captures the core facts—Forcepoint proceeds and the $4.7 billion improvement—and remains contextually relevant and largely accurate. The scores reflect minor factual discrepancies and incomplete synthesis of all contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 569,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle delivers its Cloud Services primarily from data‑center space that it leases from third‑party colocation providers (see page 37). Because these facilities are obtained through long‑term operating leases, Oracle is obligated to pay substantial termination fees if it must exit the contracts early, and it has no direct control over the providers’ operations—any service interruption or inability to secure space on reasonable terms could therefore impair cash flow and profitability (see page 22). This dependence on external colocation suppliers thus adds a material financial‑risk component to Oracle’s cloud business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial risks associated with Oracle's reliance on third-party colocation suppliers, aligning well with the ground truth. (1) All factual elements are correct: Oracle leases substantially all its global data centers from third-party providers under long-term operating leases with significant termination fees. The answer correctly identifies the financial risk from early termination fees and lack of operational control, which could impact cash flow and profitability. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model connects Oracle’s leasing model to financial exposure and strategic inflexibility, correctly synthesizing implications of lease commitments and operational dependency. The only minor omission is that the original mentions Oracle depreciates leased assets over useful lives, and that a shift in cloud strategy could shorten these lives and impact profitability—a nuance not included in the LLM response. This affects completeness slightly but does not undermine the core correctness. (4) The answer is fully contextually relevant, directly addressing the financial risk from lease commitments and third-party dependence. Overall, the LLM captures the essential meaning and risk factors with high fidelity, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 414,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "UnitedHealth Group had **82 million shares** available for future equity awards as of December 31 2021 – 64 million under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan【page_77†L31-L38】. This sizable pool gives the company flexibility to issue stock options, SARs, restricted stock, RSUs, performance awards and other equity awards, supporting its strategy of using share‑based compensation to attract, retain and motivate talent while aligning employee interests with shareholders and offsetting dilution from repurchases【page_67†L12-L19】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 64 million shares under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available as of December 31, 2021 — all figures match the original answer exactly. The sum (64M + 18M = 82M) is correct. (2) The answer is complete, addressing both the total number of shares and how this supports UnitedHealth Group’s share-based compensation strategy. (3) Entity accuracy is perfect: correct plan names, correct company (UnitedHealth Group), and correct date. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly links the availability of shares to the company's broader compensation strategy, including attracting and retaining talent, aligning employee-shareholder interests, and managing dilution — which goes slightly beyond the original answer but remains factually consistent and well-supported (as indicated by the cited pages). The LLM also correctly identifies the types of equity awards (stock options, SARs, RSUs, etc.), demonstrating accurate qualitative understanding. (5) Semantic equivalence is maintained — while the LLM provides slightly more detail, all added content is contextually appropriate and factually aligned with the source. No inaccuracies or hallucinations are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 387,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab treats client‑held fractional shares as assets because the derecognition criteria of ASC 860 and the off‑balance‑sheet exemption of ASC 940 are not met; the shares are recorded in “Other securities owned” (other assets) at fair value. An equal‑amount repurchase liability is also measured at fair value and is presented in the “Accrued expenses and other liabilities” line of the consolidated balance sheet【page_75】. The footnote to the balance‑sheet schedule confirms that the corresponding repurchase liabilities for these fractional shares are included in accrued expenses and other liabilities【page_97】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately identifies how Schwab accounts for client-held fractional shares under GAAP: they are recorded in 'Other securities owned' (part of other assets) at fair value when derecognition under ASC 860 or off-balance-sheet treatment under ASC 940 is not met. (2) It correctly states that corresponding repurchase liabilities are recognized and measured at fair value, and are reflected in 'Accrued expenses and other liabilities' on the consolidated balance sheet—matching the disclosure in the 2022 10-K. (3) The multi-hop reasoning is sound: the answer synthesizes accounting treatment (ASC 860/940), asset classification, fair value measurement, and liability presentation across balance sheet line items. (4) The citations to page 75 and 97 of the 10-K add contextual support and align with typical disclosure locations, though the ground truth does not require page numbers. There are no factual inaccuracies, omissions, or calculation issues. All entities (Schwab, ASC 860, ASC 940, balance sheet line items) are correct. Minor wording differences (e.g., 'equal-amount repurchase liability') do not affect meaning and are consistent with the original. Thus, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 360,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle’s Autonomous Database runs as an OCI service that automatically scales resources and is priced on a consumption‑based model, so customers pay only for what they use and avoid the labor‑intensive DBA tasks and upfront hardware costs that traditionally drive total‑cost‑of‑ownership (see page 12). Because the database is tightly integrated with OCI’s compute, storage and networking platform, its adoption accelerates migration to Oracle Cloud, lifts cloud‑services revenue (now ≈ 37 % of total revenue) and creates cross‑selling opportunities for SaaS and license‑support contracts, thereby expanding Oracle’s cloud‑and‑license business (see pages 6, 7, 8 & 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key cost-reduction mechanisms—consumption-based pricing, automatic scaling, and reduced DBA labor—and links them to Oracle's strategic cloud growth through migration incentives and cross-selling. It accurately reflects the integration of Autonomous Database with OCI and mentions broader business impacts like cloud-services revenue growth. However, it introduces a specific percentage (≈37% of total revenue) not present in the original answer, which lacks any such figure. This number cannot be verified against the ground truth and may be fabricated or misattributed, lowering quantitative accuracy. (2) No calculations are performed, but the inclusion of an unsupported percentage (37%) is a factual overreach. The original answer does not provide any revenue breakdowns, so this detail is extraneous and unverified. (3) The multi-hop reasoning is strong: the model connects automation → cost savings → customer migration → cloud revenue growth → expansion of cloud and license business. It also correctly infers strategic benefits like cross-selling SaaS and license-support contracts, which aligns with the original’s theme of ecosystem expansion. The mention of integration with OCI’s infrastructure (compute, storage, networking) adds technical depth consistent with the original’s emphasis on platform integration. (4) Despite the unsupported statistic, the answer is contextually rich, semantically aligned, and captures the core causal chain. The error is in added quantitative detail, not in reasoning or entity identification—hence a high but not top score on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 448,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "If UnitedHealth transfers the AARP Program contract, it must remit cash equal to the fair‑value of the program’s assets at the transfer date. Because those assets are classified as current assets (used to fund the RSF and related liabilities), the transfer would create a cash outflow that removes the assets from UnitedHealth’s balance sheet and offsets the associated liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core financial implication correctly: UnitedHealth must transfer cash equal to the fair value of the AARP Program assets upon contract transfer, resulting in a removal of both assets and associated liabilities from the balance sheet. The assets are correctly identified as current assets used to fund liabilities (referred to as RSF—likely 'Related Settlement Funds' or similar), which aligns with the ground truth description of funding medical costs and related liabilities. There are no numeric discrepancies (quantitative accuracy is perfect), and all entities (UnitedHealth Group, AARP Program, asset classification) are correct. The reasoning is sound and reflects proper multi-hop synthesis of asset management, classification, and contractual obligations. The only minor shortcoming is that the LLM does not explicitly mention the potential impact on short-term liquidity, which is a nuanced but relevant consequence noted in the original answer. However, this omission does not undermine the essential correctness. Wording differences (e.g., 'remit cash' vs 'transfer cash') are semantically equivalent. Overall, the answer is highly accurate, contextually appropriate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 349,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The excerpts you provided do not contain any disclosure of Card Member and Other Loans, nor any discussion of their fair‑value measurement or Level 3 hierarchy classification. Consequently, the fair value, its comparison to the carrying amount, and the Level 3 designation cannot be determined from the pages supplied.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to match the ground truth. (1) The original answer states specific and accurate figures: the fair value of Card Member and Other Loans is $113 billion and the carrying value is $110 billion, with the entire fair value classified under Level 3 of the fair value hierarchy. The LLM claims no information is available, which contradicts the provided ground truth. (2) There are no correct numbers or calculations in the LLM response — it fails to report any of the required quantitative data. (3) The multi-hop reasoning is absent; the LLM does not identify or synthesize any information about fair value, carrying value, or Level 3 classification, despite the ground truth indicating this information is available. (4) The response lacks contextual relevance because it denies the existence of the information rather than answering the question. This represents a complete failure in factual accuracy and information retrieval, warranting the lowest possible score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 289,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2021, the UnitedHealth Group 2020 Stock Incentive Plan had **64 million shares** of common stock available for future issuance. Those shares may be used for future awards such as **stock options, stock‑appreciation rights, restricted stock, restricted‑stock units, performance awards and other stock‑based awards**【page_77】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares available — 64 million — is accurate, and the date — December 31, 2021 — is correctly stated. (2) The answer completely addresses both parts of the question: it specifies the number of shares available for future issuance and lists all allowable award types (stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards), which matches the original answer verbatim in substance. (3) Entity accuracy is correct: UnitedHealth Group 2020 Stock Incentive Plan is properly identified, and the context of future issuance under that plan is maintained. (4) The reasoning is sound and reflects proper synthesis of information from the source document, as evidenced by the accurate multi-hop response combining both quantitative and qualitative elements. Minor formatting differences (e.g., en-dashes, spacing) do not affect meaning. The citation [page_77] adds contextual support. Overall, the answer is factually precise, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 327,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The company reported foreign government bonds and obligations with an estimated fair value of **$770 million** in 2023【page_119】. In 2022, the estimated fair value for foreign government bonds and obligations with maturities of **12 months or more was $0** (no amount was reported in that maturity bucket)【page_120】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the 2023 estimated fair value of foreign government bonds and obligations as $770 million, which matches the ground truth. However, it incorrectly stated that the 2022 value for maturities of 12 months or more was $0, directly contradicting the ground truth value of $549 million. This is a critical factual error. (2) The quantitative accuracy is low because while the 2023 figure is correct, the 2022 figure is entirely wrong, and the implied change (from $0 to $770M) is therefore also incorrect. The ground truth reports a $221 million increase from $549M to $770M, which the LLM answer fails to reflect. (3) The multi-hop reasoning is flawed: the model failed to correctly retrieve and synthesize the 2022 value for the same category (foreign government bonds with maturities ≥12 months), breaking the comparison. The citation to page 120 does not excuse the factual discrepancy with the ground truth, which is based on the same source data. (4) Contextual relevance is high because the answer addresses the right category, time frame, and metric, and attempts the required comparison. However, due to the major factual inaccuracy in the 2022 value, the overall correctness score is low despite partial accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 354,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The Africa/Eurasia region recorded capital expenditures of **$33 million in 2021**. This was **significantly higher than the $8 million spent in 2019**, representing an increase of about $25 million (roughly four‑times the 2019 amount)【page_117】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the capital expenditures for the Africa/Eurasia region in both 2021 ($33 million) and 2019 ($8 million), matching the ground truth exactly. (2) The calculation of the increase—$33M - $8M = $25M—is accurate, and the additional contextual comparison stating it is 'roughly four-times the 2019 amount' is a reasonable approximation (8M × 4 = 32M, close to 33M) and does not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different years for the same region and performs a valid temporal comparison. (4) All entities (region: Africa/Eurasia, metric: capital expenditure, years: 2019 and 2021) are correctly identified and used. The answer is complete, factually precise, and semantically equivalent to the ground truth, with slight enhancement in interpretive context that improves clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 270,
        "total_tokens": 1378
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "Johnson & Johnson’s worldwide Contact Lenses/Other sales rose from $2.994 billion in 2020 to $3.440 billion in 2021 – a **14.9 % increase** year‑over‑year【page_33】.  By contrast, the broader Vision franchise grew from $3.919 billion to $4.688 billion, a **19.6 % increase**【page_33】, so Contact Lenses/Other grew more slowly than the overall Vision segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts for Contact Lenses/Other sales ($2.994B in 2020 and $3.440B in 2021) are accurate, and the calculated year-over-year percentage increase of 14.9% is correct: ((3.440 - 2.994) / 2.994) ≈ 0.149 or 14.9%. Similarly, the broader Vision segment grew from $3.919B to $4.688B, and the percentage change is correctly calculated as ((4.688 - 3.919) / 3.919) ≈ 0.196 or 19.6%. (2) The answer is complete, addressing both parts of the question: the percentage change for Contact Lenses/Other and the comparison to the overall Vision segment growth. (3) Entity accuracy is perfect: Johnson & Johnson, Contact Lenses/Other, Vision segment, and the years 2020–2021 are all correctly identified. (4) The reasoning is sound and multi-hop: it correctly pulls and compares two related but distinct financial figures from the same document (page 33), computes growth rates, and draws the logical conclusion that Contact Lenses/Other underperformed relative to the broader segment—consistent with the ground truth. (5) Semantic equivalence is maintained: though the LLM uses slightly different phrasing (e.g., 'grew more slowly' vs 'underperformed'), the meaning is identical. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 365,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "The weighted‑average grant price for the Service‑and‑Performance‑Based RSUs that were outstanding at December 31 2021 – reflecting both the beginning‑balance and the grants made during the year – was **$114.22 per share**【page_130†L31-L38】. (The beginning balance had a $103.08 price and the 2021 grants a $125.02 price, resulting in a combined $114.22 weighted‑average for the total outstanding shares.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct weighted-average grant price of $114.22 per share for Service and Performance-Based RSUs outstanding as of December 31, 2021, incorporating both the beginning balance and new grants during the year. The quantitative values are correct: $114.22 (final weighted average), $103.08 (beginning balance), and $125.02 (2021 grants), matching the ground truth in both amount and context. The only minor discrepancy is in unit interpretation: the original answer states '$114.22 million' which refers to the total value, while the LLM interprets it as '$114.22 per share', which is the correct unit for a 'weighted-average grant price'. This suggests a subtle but important distinction: the ground truth answer appears to conflate total value with per-share price, whereas the LLM correctly reports the per-share price, which aligns with standard financial reporting terminology for 'weighted-average grant price'. Thus, the LLM likely corrects an ambiguity in the original answer. The reasoning is sound, entities (metric, time period, RSU type) are accurate, and the multi-hop synthesis (combining beginning balance and new grants) is properly addressed. The answer is contextually relevant and semantically equivalent in intent, with only a nuanced difference in what the dollar figure represents (total value vs. per-share price), but given standard usage, the LLM’s interpretation is more technically accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 402,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "Boeing’s 1.43 %‑2.50 % unsecured bonds due 2032 fell from **$10,135 million in 2023 to $6,159 million in 2024**, a **decrease of $3,976 million**. That tranche represented roughly **11.4 % of the company’s total 2024 debt of $53,864 million**【page_95】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2023 balance ($10,135 million), 2024 balance ($6,159 million), the decrease ($3,976 million), total 2024 debt ($53,864 million), and the percentage (11.4%) are all correct. The calculation of the decrease (10,135 - 6,159 = 3,976) is accurate. The percentage is correctly approximated (6,159 / 53,864 ≈ 11.43%, rounded to 11.4% — acceptable precision). (2) The answer is complete, addressing both parts of the question: the dollar decrease and the percentage of total debt in 2024. (3) Entities are correctly identified: Boeing, the bond tranche (1.43%-2.50% unsecured bonds due 2032), and the correct years (2023 to 2024). (4) The reasoning is sound and reflects proper multi-hop synthesis: it pulls bond balances across two years, computes the change, and contextualizes the 2024 balance within total debt. (5) Semantic equivalence is maintained — minor wording differences (e.g., 'fell from' vs 'decreased by') do not affect factual accuracy. The citation [page_95] adds contextual support. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 327,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "In 2021 the Hips franchise posted $1.485 billion of sales and the Knees franchise $1.325 billion, together amounting to roughly **$2.81 billion**. This combined figure represents **about 32.7 % (≈ 33 %)** of the Orthopaedics segment’s total revenue of $8.588 billion for the year【page_33】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Hips revenue is correctly stated as $1.485 billion ($1,485 million), Knees as $1.325 billion ($1,325 million), and their sum is accurately calculated as $2.81 billion ($2,810 million). The total Orthopaedics revenue is correctly cited as $8.588 billion ($8,588 million), and the percentage (32.7%) matches the ground truth exactly. Minor formatting differences (e.g., billion vs million, use of ≈33%) do not affect factual accuracy. (2) Quantitative verification: $1.325B + $1.485B = $2.81B; $2.81B / $8.588B ≈ 32.7% — both calculations are correct. (3) Multi-hop reasoning is sound: the model correctly identified revenues from two product lines (Knees and Hips), summed them, and computed their share of total Orthopaedics revenue — all from the same fiscal year (2021). (4) Entities (Johnson & Johnson’s Orthopaedics segment, product franchises, year 2021) are correctly identified and contextualized. The answer is complete, precise, and directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 312,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "Boeing excluded a total of **25.8 million potential common shares** from the diluted loss‑per‑share calculation (13.6 million for 2024, 6.5 million for 2023 and 5.7 million for 2022). These shares were omitted because their inclusion would have been **antidilutive** – either the strike price was above market or the performance conditions were not met, and in each year the company’s net loss made the effect of the awards antidilutive.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total number of excluded shares. The ground truth states 20.8 million total shares were excluded across the three fiscal years, but the LLM claims 25.8 million (13.6M + 6.5M + 5.7M = 25.8M), which is a significant overstatement. This quantitative error undermines the core of the answer. (2) The individual yearly breakdowns (13.6M, 6.5M, 5.7M) are not supported by the ground truth, which does not provide year-specific figures but only a total of 20.8 million. There is no verification that these component numbers are accurate, and their sum contradicts the correct total. (3) The reasoning for exclusion is partially correct: the LLM correctly identifies that shares were excluded due to antidilution, mentioning net loss and strike prices above market or unmet performance conditions. However, the ground truth emphasizes the net loss as the primary reason for antidilution across all periods, while the LLM introduces additional conditions not confirmed in the original answer, potentially conflating general accounting rules with Boeing-specific disclosures. (4) Despite the major numerical inaccuracy, the answer addresses both parts of the question—total number and reason for exclusion—and demonstrates understanding of the concept of antidilution, earning moderate scores for qualitative accuracy and contextual relevance. However, the correctness and quantitative accuracy scores are low due to the critical error in the total share count.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 416,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment lowered the projected benefit obligation by roughly **$1.8 billion** as of the January 3, 2021 measurement date. For U.S. non‑union employees hired before January 1 2015, benefits already earned under the Final Average Pay formula for service before January 1 2026 remain unchanged, but beginning January 1 2026 they will also accrue benefits under the Retirement Value formula— a change that drives the $1.8 billion reduction in the PBO.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $1.8 billion reduction in Projected Benefit Obligation (PBO) as of January 3, 2021 is correctly stated, matching the original answer exactly. The dates—January 3, 2021 (measurement date) and January 1, 2026 (effective date of formula change)—are also correct. (2) The answer correctly identifies that U.S. non-union employees hired before 2015 are affected, and it accurately explains that benefits earned before January 1, 2026 under the Final Average Pay formula are preserved, while future benefits accrue under the Retirement Value formula. (3) The multi-hop reasoning is sound: it connects the amendment to the PBO reduction and correctly links the change in benefit formula to its impact on employee groups and timing. (4) The only minor shortcoming is slight imprecision in phrasing: the original answer specifies that employees hired before 2015 are transitioning 'to the Retirement Value formula for benefits earned after January 1, 2026', while the LLM says they 'will also accrue benefits under the Retirement Value formula', which could be interpreted as in addition to Final Average Pay, rather than a switch. However, the context and the link to the PBO reduction clarify the intended meaning. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 394,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The table on page 141 shows that the “fair‑value” numbers for assets and liabilities carried at amortized cost are only point‑in‑time estimates based on management’s judgment of current market conditions and perceived risks. Because those estimates cover only a subset of the company’s balance‑sheet items, are not forward‑looking and do not reflect the full set of assets, liabilities and other value‑drivers, the filing cautions that “these figures may not be indicative of future fair values, nor can the fair value of American Express be estimated by aggregating the amounts presented.”【page_141†L1-L5】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the fair value figures for financial assets and liabilities carried at amortized cost are point-in-time estimates based on management’s judgment of market conditions and perceived risks, which matches the original answer’s emphasis on estimates as of December 31, 2021 and 2020 (the specific dates are omitted but the concept of point-in-time estimates is preserved). (2) There are no numeric values requiring calculation in this question; the reference to 'page 141' is consistent with the source context and supports the claim. (3) The reasoning is sound: the LLM correctly explains that aggregating individual fair values does not reflect the company’s overall fair value because it fails to capture non-financial factors and the holistic nature of the business, which is the core multi-hop insight from the filing. (4) The answer is contextually precise, directly addressing why aggregation is inappropriate, and includes a verbatim quote from the filing to reinforce accuracy. The only minor shortcoming is the omission of the specific years (2021 and 2020), but since the concept of 'point-in-time estimates' is clearly conveyed, this does not materially affect understanding. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 377,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index shows **one amendment** – Amendment Number One to the Benefits Plan for Members of the Board of Directors (10.13.1)【page_135】. The original plan is listed as “as amended and restated through April 14, 2004” (10.13)【page_135】, and the first amendment is dated **December 16, 2005**【page_135】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the effective date of the original plan (April 14, 2004) and the first amendment (December 16, 2005), which matches the ground truth. However, it incorrectly states that there is only one amendment explicitly listed, while the ground truth confirms there are two. This is a critical error in quantitative accuracy. (2) The dates are correct and match the original answer; however, the count of amendments is off by one, which is a factual discrepancy. The format of the dates is acceptable and semantically equivalent. (3) The reasoning appears to be based on correct document references (exhibit index, page 135), but the model failed to identify the second amendment, indicating a failure in complete information extraction or synthesis. This affects multi-hop completeness, as the question asks for the number of amendments explicitly listed. (4) Despite accurate dates and proper context referencing, the incorrect count of amendments significantly undermines the factual correctness. The answer is partially correct but contains a major omission in the quantitative aspect, warranting a moderate score. Contextual relevance is high as all provided information is on-topic and well-supported by exhibit references.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 356,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle’s hybrid deployment model—offering customers the ability to run applications on‑premise, in the cloud, or a combination of both—provides the choice and flexibility that drives demand for both cloud subscriptions and license‑support contracts【page_41】. By giving customers programs to pivot existing on‑premise licenses to Oracle Cloud Services and expand workloads across environments, the model fuels growth in the cloud and license segment, which accounted for 84 % of Oracle’s total fiscal‑2024 revenue【page_42】【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 84% figure for the cloud and license business as a share of total revenues in fiscal 2024 is correctly stated, matching the original answer exactly. No other numerical values are present, and the fiscal year is correctly identified. (2) The LLM captures the core mechanism of Oracle's hybrid deployment model—flexibility in on-premise, cloud, or mixed environments—and links it to customer demand for both cloud subscriptions and license-support contracts, which is consistent with the ground truth's emphasis on customer choice and retention. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the hybrid model to deployment flexibility, migration programs (e.g., pivoting on-premise licenses to cloud), and ultimately to revenue contribution—though it omits explicit mention of high renewal rates and the pricing mechanism of support contracts as a percentage of net fees, which are included in the original. These are minor contextual omissions rather than errors. (4) The answer remains semantically equivalent in intent and factual content, with only slight differences in emphasis. The inclusion of citation markers like 【page_41】 suggests grounding in source material. Thus, the answer is factually correct, contextually relevant, and logically coherent, warranting a high score with a minor deduction in qualitative accuracy for incomplete elaboration on recurring revenue mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 414,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "American Express reported **$2.838 billion** of deferred card fees that are attributable to Membership Rewards program participants as of December 31 2021 (the “Deferred card and other fees (a)” line)【page_129】. These deferred fees underpin the Membership Rewards liability, which the company estimates by applying a **weighted‑average cost per point** and an **Ultimate Redemption Rate**—both derived from statistical and actuarial models that consider redemption trends, enrollment tenure, card‑spend levels and credit attributes【page_129】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that $2.838 billion of deferred fees are attributable to Membership Rewards program participants as of December 31, 2021. However, the ground truth indicates that while the total deferred card and other fees were $8,737 million, it does not specify the exact dollar amount tied to Membership Rewards participants—only that such fees are 'specifically called out' within that total. Therefore, the $2.838 billion figure is factually incorrect or at least not supported by the provided ground truth. This is a major quantitative error. (2) The mention of 'page_129' suggests a source reference, but the number itself contradicts the ground truth, which does not provide a specific breakout amount. There is no indication in the original answer that the Membership Rewards portion was $2.838 billion. (3) The qualitative reasoning about the methodology—using weighted average cost per point and Ultimate Redemption Rate (URR) based on statistical models and factors like redemption trends and credit attributes—is accurate and aligns with the ground truth. The multi-hop connection between deferred fees and liability estimation methodology is correctly conceptualized. (4) Despite correct contextual framing and relevant terminology, the answer introduces a precise number that is not present in the ground truth, leading to a low correctness and quantitative accuracy score. The contextual relevance is high because the response addresses both parts of the question and uses appropriate financial language and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 427,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "The exhibit index lists **19 separate “Form of … Agreement” entries** for the 2014 Equity Plan that were adopted between February 18 2015 and February 17 2021 (10.5.1‑10.5.2 on 2/18/15; 10.5.3‑10.5.4 on 2/17/16; 10.5.5‑10.5.7 on 2/15/17; 10.5.9‑10.5.10 on 2/14/18; 10.5.11‑10.5.13 on 2/20/19; 10.5.14‑10.5.16 on 2/19/20; and 10.5.18‑10.5.21 on 2/17/21)【page_131】【page_132】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states 19 different forms of award agreements were documented, while the ground truth is 16. This is a significant factual error in the core quantitative claim. The LLM cites specific exhibit numbers and dates, but the count is incorrect. (2) The LLM lists: 2 (2015) + 2 (2016) + 3 (2017) + 2 (2018) + 3 (2019) + 3 (2020) + 4 (2021) = 19 total entries. However, the ground truth from the knowledge graph confirms only 16 such agreements were documented in that period. Either the LLM miscounted the exhibits or included some that were outside the scope (e.g., duplicates, non-award agreements, or outside the date range). For example, the entry '10.5.8' is missing from the list, and '10.5.21' may fall outside the documented set. (3) The reasoning shows multi-hop synthesis by aggregating exhibits across multiple filings and dates, which is appropriate. The model correctly identifies the relevant time frame and attempts to enumerate filings from the 10-K exhibit index. However, the final count is inaccurate, indicating a failure in either data extraction or aggregation. (4) Despite the incorrect number, the answer is contextually relevant and uses proper sourcing (exhibit numbers and dates). The qualitative reasoning is sound in approach but flawed in execution. The quantitative accuracy is low due to the 19 vs 16 discrepancy, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 389,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "In 2021 AMD purchased $1.1 billion of inventory from the ATMP joint venture and recorded a $6 million equity‑income gain, giving the relationship a combined financial impact of roughly $1.106 billion. That scale of spend—and the earnings contribution—highlights the JV’s strategic importance as a key supplier of assembly, test, marking and packaging services that is integral to AMD’s manufacturing supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $1.1 billion in purchases and $6 million in equity gain, correctly summing to $1.106 billion in total financial value. The numbers match the original answer exactly, with acceptable formatting variations (e.g., 'roughly $1.106 billion' is appropriate given the inputs). (2) Quantitative accuracy is perfect: both components are correctly stated, and the implied sum is accurate. (3) The reasoning correctly synthesizes two distinct financial flows—purchases and equity income—from AMD's relationship with the ATMP JV, demonstrating multi-hop understanding across operational and investment dimensions. (4) Entity accuracy is preserved: AMD, ATMP JV, 2021 time frame, and the nature of services (assembly, test, marking, packaging) are all correctly identified. (5) The answer addresses both parts of the question: the total financial value and the strategic importance, linking scale of spend and earnings to strategic supply chain integration. No critical information from the ground truth is missing, and the conclusion about strategic importance is logically supported. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 351,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The first patent cliff for the DARZALEX/DARZALEX FASPRO franchise could arrive in **2029**, when the U.S. composition‑of‑matter patents covering DARZALEX expire (the next European expiry is 2032 and DARZALEX FASPRO is protected by a separate Janssen portfolio). 【page_9】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies 2029 as the earliest year patent expiration could impact the combined revenue stream, aligning with the U.S. patent expiry for DARZALEX. (2) The date '2029' is accurate and matches the ground truth; the mention of 2032 for Europe and the separate patent portfolio for DARZALEX FASPRO adds contextual precision without introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while both products are part of a combined revenue stream, the earliest vulnerability is tied to DARZALEX's U.S. patents expiring in 2029, which could enable biosimilar competition in a key market. (4) The answer is concise, contextually relevant, and captures the core risk to revenue without overstatement. Minor wording differences (e.g., 'composition-of-matter patents' vs. general 'patent protections') enhance specificity and do not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 283,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The filing lists one amendment to the Excess Benefit Plan in 2015 (Exhibit 10.31) and one amendment in 2018 (Exhibit 10.37), for a combined total of **two amendments**【page_19†L7-L9】【page_20†L1-L3】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately identifies two amendments—one in 2015 and one in 2018—to The Bank of New York Company, Inc. Excess Benefit Plan, which aligns with the original answer. (2) The quantitative details are correct: one amendment in 2015 (referenced as Exhibit 10.31) and one in 2018 (Exhibit 10.37), totaling two amendments. The years and count are factually accurate, and no calculations are required beyond summation, which is correctly performed. (3) The multi-hop reasoning is sound—the model synthesizes information from two different years and confirms the total across both, as required by the question. (4) The answer is contextually relevant, directly addressing the total number of amendments documented in the 2022 10-K for the specified plan and years. Minor differences in phrasing (e.g., referencing exhibit numbers) add precision without altering the semantic meaning. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 286,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx’s Network 2.0 spending – $582 million in 2024 (and $273 million in 2023) – is a core element of the DRIVE transformation’s network‑efficiency work and is rolled into the company’s 2025 capital‑expenditure budget of roughly $5.2 billion, which explicitly calls out continued investment in Network 2.0 【page_92】. The European workforce‑reduction plan, projected to cost $250‑$375 million in cash severance and professional fees through FY 2026, is also part of DRIVE’s business‑optimization thrust to lower structural costs, but it is treated as an operating expense rather than a capital outlay 【page_92】【page_91】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM provides specific figures for Network 2.0 spending ($582M in 2024, $273M in 2023), which are not in the original answer but do not contradict it—these details add precision without error. The $5.2 billion 2025 capex figure matches exactly. The European workforce reduction cost range ($250M–$375M through FY2026) is correctly stated. (2) The LLM correctly distinguishes that Network 2.0 expenditures are part of capital expenditures (capex), while the European workforce reductions are operating expenses under the DRIVE program—this nuance is consistent with the original answer’s implication that workforce costs are 'business optimization expenses' and not capital outlays. (3) Multi-hop reasoning is sound: the LLM synthesizes the relationship between Network 2.0, DRIVE, capex, and workforce reductions across different financial categories and timeframes. (4) The answer is semantically equivalent to the ground truth, with added specificity (e.g., prior-year Network 2.0 spend) that enhances completeness without introducing errors. The only minor point preventing a perfect 10 is that the original answer emphasizes the strategic integration of both initiatives under DRIVE for long-term profitability, which the LLM implies but could have stated more explicitly. However, the core facts, synthesis, and categorizations are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 397,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD’s reliance on third‑party designers, manufacturers and AIB partners for graphics cards means that distributors and AIB partners carry inventory of AMD products, and AMD’s agreements protect those inventories from price cuts and grant limited return rights. If product prices fall sharply, AMD must honor those price‑protection obligations, which can erode revenue and gross margin and increase the company’s inventory‑related financial risk. 【page_28】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core financial risks associated with AMD's dependency on third-party suppliers and AIB partners, particularly regarding price protection obligations and inventory risk. It correctly identifies that AMD must honor price protection if prices fall sharply, which can reduce revenue and gross margins—this aligns with the ground truth. The mention of 'limited return rights' corresponds to the original answer's detail about AIB partners returning products removed from the price book within 12 months, though the LLM does not specify the 12-month timeframe, representing a minor omission. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is scored as 10 (no errors, all references accurate). The qualitative reasoning is sound: it correctly synthesizes the cause-effect relationship between price declines, price protection, and financial impact. The contextual relevance is full—the response directly addresses inventory management and price protection as financial risk factors. The only reason for not scoring a perfect 10 is the lack of explicit mention of the 12-month return window, which is a relevant detail in the ground truth and contributes to financial risk exposure. However, the omission does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 373,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie’s cost of products sold attributable to Venclexta consists of Genentech’s share of U.S. profits plus the royalties paid on Venclexta net revenues earned outside the United States.  The combined amount was **$869 million in 2023** (the figure reported as “Genentech’s share of profits, including royalties, included in cost of products sold”)【page_68】【page_69】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the two components of AbbVie's cost of products sold related to Venclexta: Genentech’s share of U.S. profits and royalties on non-U.S. net revenues. This aligns with the ground truth in terms of conceptual and qualitative accuracy. The answer also correctly references the appropriate line item from AbbVie’s financial statements and cites specific pages, demonstrating sound reasoning and contextual relevance. However, the quantitative accuracy is flawed: the LLM asserts a specific figure of $869 million for 2023, which is not present in the original answer (ground truth). The ground truth does not provide any numerical value—it only describes the composition of the cost. Since the question does not ask for a specific dollar amount and no such number was confirmed in the ground truth, introducing a precise figure like $869 million constitutes a significant factual overreach. This numerical claim cannot be verified against the provided truth and may misrepresent the data. Thus, while the reasoning and structure are strong, the inclusion of an unsupported quantitative figure reduces the overall correctness. The model fails the quantitative accuracy check despite being semantically close in description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 349,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY also makes its **Directors’ Code of Conduct** publicly available, and the code is **explicitly applicable to all directors of BNY**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It correctly identifies the additional governance document as the 'Directors’ Code of Conduct' and accurately states that it is applicable to 'all directors of BNY', matching the original answer exactly in substance. (2) There are no numerical values, dates, or calculations in this question, so quantitative accuracy is not applicable, but the absence of such elements is consistent with the ground truth. (3) The multi-hop reasoning is sound: the question asks for a specific document beyond Committee Charters and Corporate Governance Guidelines, and the LLM correctly retrieves and synthesizes the correct document and its applicability. (4) All entities (BNY, Directors’ Code of Conduct, directors) are accurately identified and correctly linked. The answer is concise, relevant, and complete, addressing both parts of the question without any factual or contextual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 277,
        "total_tokens": 1380
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "AMD’s MD&A notes that 2021 net revenue jumped 68% to $16.4 billion and gross margin rose three points to 48% (page 43).  This growth was driven by a “high‑performance products” rollout that featured the July 2021 launch of the Radeon RX 6600 XT – a RDNA 2 GPU built for high‑frame‑rate 1080p gaming (page 8) – and a broader gaming‑focused graphics strategy that added the RX 6700 XT, RX 6000M mobile GPUs and the AMD Advantage design framework (pages 6‑7).  The new, power‑efficient, higher‑margin gaming GPUs captured strong consumer demand and shifted AMD’s product mix toward higher‑margin graphics sales, directly fueling the revenue surge and margin improvement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AMD's 68% year-over-year revenue growth, increase from $9.8B to $16.4B in 2021, gross margin improvement from 45% to 48%, and the July 2021 launch of the Radeon RX 6600 XT are all accurately stated. The mention of the RX 6700 XT, RX 6000M mobile GPUs, and AMD Advantage framework aligns with the broader gaming strategy in the original answer. (2) Quantitative accuracy is perfect: revenue figures, percentage growth, and margin change are all correct and consistent with the ground truth. No calculation errors. (3) Multi-hop reasoning is sound—the LLM correctly links the product launches (especially RDNA 2-based GPUs like the 6600 XT) to increased revenue and improved margins via higher-margin product mix and strong consumer demand. It correctly infers that power efficiency and performance gains contributed to pricing power and margin expansion. (4) The answer is fully relevant, directly addressing how the RX 6600 XT and broader gaming GPU strategy contributed to the stated financial outcomes. Minor additions (e.g., mention of RX 6700 XT) are consistent with the broader strategy and do not detract from accuracy. Wording differs but meaning is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 358,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie recorded **$2.288 billion** in net revenue from Venclexta in 2023 (U.S. $1.087 bn + International $1.201 bn)【page_96】.  Under the 2007 AbbVie‑Genentech collaboration, Genentech’s share of the U.S. pre‑tax profit (including royalties) from Venclexta was **$869 million** for 2023【page_69】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports AbbVie's total net revenue from Venclexta as $2.288 billion (equivalent to $2,288 million), which matches the ground truth, it incorrectly states that Genentech received $869 million as its share of U.S. pre-tax profit. The original answer (ground truth) does not provide a specific dollar amount for Genentech’s share—only that the U.S. pre-tax profit is shared equally (50%). The $869 million figure is unsupported by the ground truth and appears to be either a hallucination or misinterpretation. (2) The quantitative accuracy is partially correct: $2.288 billion = $2,288 million is accurate and correctly sourced. However, the $869 million figure for Genentech’s share cannot be verified and contradicts the ground truth, which only specifies a 50% split without dollar amounts. (3) The reasoning is flawed in the multi-hop synthesis: the model assumes a specific dollar value for Genentech’s profit share without sufficient basis in the provided truth. It also conflates 'pre-tax profit' with 'royalties', while the ground truth makes no mention of royalties being part of the payment—only an equal split of pre-tax profit. (4) Contextual relevance is high—the answer addresses both parts of the question and cites appropriate pages. However, due to the major error in asserting an unsupported financial figure, the correctness and quantitative accuracy scores are significantly reduced. A correct answer should have stated the 50% split without assigning a dollar value unless explicitly supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 440,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "Visa’s filing shows only **10 million** Class C shares because the 48 million figure quoted for the May 2024 exchange offer is not the number of Class C shares themselves but the number of **Class A‑share equivalents** those new Class C shares represent.  The exchange‑offer description (page 89) notes that 48 million shares were issued, while the share‑class table (page 87) shows a **4‑to‑1 conversion rate** for Class C (each Class C share equals four Class A shares).  48 million Class A equivalents ÷ 4 ≈ 12 million actual Class C shares; after the timing of the issuance, rounding and other share‑adjustments, the net Class C shares outstanding at September 30 2024 were 10 million (shown in the equity section on page 58 and the weighted‑average share count on page 59).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the core facts. (1) It falsely claims that the 48 million shares issued were 'Class A-share equivalents' and that a 4-to-1 conversion rate applies, which is not supported by the ground truth. The original answer confirms that 48 million actual Class C shares were issued in the exchange offer—there is no mention of share equivalents or conversion rates in the ground truth. (2) The calculation of 48 million ÷ 4 ≈ 12 million Class C shares is therefore baseless and factually wrong. The reported 10 million shares outstanding (listed as '10' in the 10-K due to 'millions' formatting) does not result from a conversion math adjustment but from post-issuance reductions (e.g., buybacks). (3) The multi-hop reasoning fails: instead of recognizing the 'millions' unit notation in the financial table (the correct explanation), the model invents a conversion mechanism not present in the data. (4) While the answer correctly notes that 10 in the equity section means 10 million shares, it misattributes the discrepancy to conversion arithmetic rather than acknowledging the correct explanation—unit formatting and subsequent share reduction. The contextual relevance is moderate because it attempts to explain the discrepancy and references correct document sections, but the core reasoning and quantitative claims are invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 380,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "FedEx reported $582 million of costs in 2024 for its business‑optimization program, which includes the Network 2.0 rollout as part of the DRIVE transformation. The European workforce‑reduction plan announced in June 2024 is expected to generate pre‑tax cash outlays of roughly $250 million to $375 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $582 million in 2024 costs for Network 2.0 and DRIVE transformation-related business optimization activities, matching the ground truth exactly. It also accurately reports the expected future cost range of $250 million to $375 million for the European workforce reduction plan announced in June 2024. All key facts and numbers are correct. (2) Quantitative accuracy is perfect: $582 million and the $250M–$375M range are reported with correct values and timeframes. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—correctly linking Network 2.0 and DRIVE as part of the same business optimization program, and identifying the future cash outlays tied to the June 2024 European workforce reduction. The only minor omission is that the original answer specifies these future costs will occur 'through fiscal 2026,' which the LLM answer leaves implicit. This does not invalidate the response but slightly reduces completeness. (4) The answer is fully relevant, directly addressing both parts of the question with precise, semantically equivalent information. The use of 'pre-tax cash outlays' instead of 'cash expenditures' is a slight rewording but does not distort meaning. Overall, this is a highly accurate and well-reasoned response with only a minor contextual detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 392,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "AMD reported that its unbilled accounts receivable at year‑end 2021 totaled **$329 million**. These unbilled receivables “primarily represent work completed for development services and on custom products for which revenue has been recognized but not yet invoiced,” i.e., revenue recognized over time from those custom products and development services【page_62】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The quantitative value of $329 million is accurate and correctly attributed to AMD's unbilled accounts receivable for fiscal year 2021. The format ($329 million) matches the ground truth semantically, and no calculation is required beyond correct reporting. (2) The answer is complete, addressing the specific components of the question: the company (AMD), the metric (unbilled accounts receivable), the scope (custom products and development services), the revenue recognition method (over time), and the fiscal year (2021). (3) Entity accuracy is correct—AMD is the right company, fiscal year 2021 is properly referenced, and the financial term 'unbilled accounts receivable' is used appropriately. (4) The reasoning is sound and demonstrates multi-hop understanding by linking unbilled receivables to revenue recognized over time for specific services, citing the correct context from the source (page 62). The use of quotation marks and explanation confirms synthesis from the document. Overall, the answer is factually precise, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 333,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie reported total 2023 net revenues of **$2.288 billion** from Venclexta (U.S. $1.087 billion + International $1.201 billion)【page_42】. Under the 2007 collaboration, AbbVie “shares equally with Genentech all pre‑tax profits and losses from the development and commercialization of Venclexta in the United States,” meaning **50 % of the U.S. pre‑tax profit is shared with Genentech**【page_68】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the total revenue from Venclexta in 2023 is correctly stated as $2.288 billion, which is equivalent to $2,288 million in the original answer. The breakdown into U.S. ($1.087 billion) and international ($1.201 billion) sales adds up to $2.288 billion, confirming internal consistency. The percentage of pre-tax profit shared with Genentech is accurately reported as 50%, matching the ground truth. (2) The answer addresses both parts of the question completely: total revenue and profit-sharing arrangement. (3) Entities are correct—AbbVie, Genentech, Venclexta, and the 2007 collaboration agreement are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies revenue from Venclexta and links it to the collaboration agreement terms for profit sharing. The use of citations (page_42, page_68) further supports accurate sourcing from the 10-K. Semantic equivalence is maintained throughout, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 304,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The 3.650% notes due 2023 fell from a $171 million aggregate principal balance at December 31 2022 to $0 by December 15 2023 – a $171 million reduction【page_84†L31-L38】. In contrast, the 3.700% notes due 2023 still carried a $400 million balance on December 15 2023【page_84†L41-L44】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the 3.650% notes due 2023 started at $171 million on December 31, 2022, and decreased to $0 by December 15, 2023, representing a $171 million reduction. The 3.700% notes due 2023 had an aggregate principal balance of $400 million on December 15, 2023—both figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the change in principal balance for the 3.650% notes and the comparison with the 3.700% notes on the same date. (3) Entity accuracy is correct—both note tranches (3.650% and 3.700%), their maturity year (2023), and the specified dates are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly infers the change over time for one instrument and contrasts it with another as of a specific date. (5) The semantic meaning is equivalent to the ground truth, with only minor rewording (e.g., 'fell from...to' instead of 'decreased by') that does not affect factual accuracy. Citations from page 84 support the claims. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 335,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "Adverse litigation that forces Visa to lower its default interchange reimbursement rates would reduce the fee income earned on each payment and could prompt issuers and merchants to shift volume away from Visa, thereby depressing transaction volumes and net revenue. Although Visa’s U.S. and Europe retrospective responsibility plans are designed to absorb the cash impact of settlements, a shortfall in those protections—combined with any unfavorable outcomes in its ongoing U.S. and foreign tax disputes—could further strain cash flows and weaken its overall financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) It correctly identifies that adverse litigation could force Visa to lower interchange rates, leading to reduced fee income and potential volume shifts by issuers and merchants, thereby lowering transaction volumes and net revenue—this aligns with the original answer's cause-effect chain. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not applicable in a problematic way; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it connects litigation outcomes → interchange rate reductions → issuer/merchant behavior changes → lower volumes and revenue, then layers in the mitigation from U.S. and Europe retrospective responsibility plans, and finally integrates the compounding risk from tax disputes affecting cash flows and financial position. The only minor shortcoming is that the LLM does not explicitly mention the potential for issuers to reduce cardholder benefits or impose new fees—details present in the original that help explain *why* consumer usage might decline. It also omits reference to the OECD global minimum tax, which is a specific factor in the tax environment noted in the ground truth. (4) Despite these small omissions, the LLM captures the essential synthesis across litigation, financial protections, and tax risks, and remains semantically equivalent in intent and meaning. The answer is concise, relevant, and logically structured, fully addressing the multi-part, multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 438,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "The United Technologies Corporation Long‑Term Incentive Plan’s Performance Share Unit award schedule (Exhibit 10.15) was revised in **January 2016** – a change that coincided with the plan’s Amendment No. 1, which became effective on **February 5 2016** (see 10.11 and 10.15). The Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan’s Performance Share Unit award schedule (Exhibit 10.5) was updated under Amendment No. 1, which took effect on **December 6 2020** (see 10.22 and 10.25). These dates illustrate separate governance updates: United Technologies refreshed its LTIP in early 2016, while Raytheon made a later, 2020 amendment to its 2018 LTIP.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of key facts. The ground truth states the effective date for United Technologies Corporation’s Performance Share Unit award schedule is January 1, 2020, but the LLM incorrectly states January 2016 (citing Amendment No. 1 effective February 5, 2016). For Raytheon, the correct effective date is March 31, 2021, but the LLM states December 6, 2020 (citing Amendment No. 1 effective that date). These dates are factually wrong and not aligned with the disclosed governance updates. (2) Quantitative accuracy is very low: both critical dates are incorrect, and no correct calculation or timeline alignment is presented. The LLM references exhibits and amendments that may exist in filings but misaligns them with the actual effective dates of the PSUs in question. (3) The reasoning is partially sound in structure—attempting to link amendments to governance updates—but fails on multi-hop synthesis: it does not correctly associate the Raytheon update with the March 31, 2021 filing of the amended Schedule of Terms, nor the UTC update with the January 1, 2020 amendment and restatement of the LTIP Performance Share Unit Deferral Plan. Instead, it relies on earlier amendments that do not correspond to the specific award schedules queried. (4) Contextual relevance is moderate because the answer addresses the right plans and attempts to discuss governance updates, but the factual foundation is flawed, undermining the conclusion. The answer reflects a misunderstanding of which amendments govern the specific PSUs mentioned in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 439,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "Apple’s Wearables, Home and Accessories segment rose 7% to $41.2 billion in 2022, and the increase was driven primarily by higher sales of the Apple Watch and AirPods. Those two product lines posted stronger gains than the other items in the segment (Apple TV, Beats, HomePod mini and accessories), which contributed less to the overall growth【page_24】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple Watch and AirPods as the primary growth drivers in the Wearables, Home and Accessories segment for 2022, which matches the original answer. It also correctly contrasts their performance against other product categories (Apple TV, Beats, HomePod mini, and accessories), noting that these contributed less to growth—consistent with the ground truth's implication that they underperformed or remained flat. (2) The quantitative claim of a 7% increase to $41.2 billion is factually correct and matches Apple's 2022 10-K filing (though the ground truth does not include this data, the LLM adds accurate context). There are no calculation errors. (3) The multi-hop reasoning is sound: the model infers from the data that Apple Watch and AirPods outperformed other categories within the segment, correctly synthesizing relative performance. (4) The answer is contextually relevant and fully addresses both parts of the question: identifying growth drivers and comparing their performance to other categories. The only minor limitation is that it doesn't explicitly state that HomePod mini and Beats were 'not cited as growth contributors' (a nuance from the original), but the conclusion that they 'contributed less' is semantically equivalent. Wording differs slightly but meaning is preserved. No factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 391,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to see their 2025 sales dip in the first quarter because insurance reverification (along with benefit‑plan changes and higher co‑pays) suppresses demand early in the year. Each product follows the same historical pattern of lower first‑quarter sales relative to the rest of the year【page_72†L9-L13】【page_71†L13-L18】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pays, aligning with the historical trend mentioned in the original answer. (2) There are no numerical values requiring calculation, but the temporal reference (first quarter of 2025) is correctly implied and consistent. (3) The multi-hop reasoning is sound—linking insurance reverification to reduced early-year sales for both products and recognizing this as a recurring historical pattern across both entities. (4) The answer includes slightly more detail (mention of benefit-plan changes) but remains factually consistent and fully addresses all parts of the question: the comparative impact on sales expectations and the shared historical trend. Minor wording differences do not affect factual accuracy. All entities (Otezla, ENBREL, 2025 sales, insurance reverification) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 299,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "RTX’s 2023 10‑K includes one stock‑appreciation‑rights exhibit for the United Technologies Corporation 2005 Long‑Term Incentive Plan (Exhibit 10.16) and one for the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan (Exhibit 10.24)【page_119†L13-L16】【page_119†L21-L24】. Thus, the total number of distinct stock‑appreciation‑rights‑related exhibits is 2.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total number of distinct stock appreciation rights-related exhibits is correctly identified as 2, with one exhibit each for the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. The exhibit numbers (10.16 and 10.24) are specific and accurate, and the cited page references (page_119) align with the source data. (2) The answer is complete, addressing both incentive plans mentioned in the question and correctly aggregating them into a total count. (3) Entity accuracy is perfect: RTX is correctly identified as the filer, the two plan names are exact matches, and the 2023 10-K filing year is correct. (4) The reasoning is sound and demonstrates proper multi-hop synthesis—linking two separate exhibits from the same filing to two distinct incentive plans and concluding the total count. (5) The semantic meaning is equivalent to the original answer, with added detail (exhibit numbers and page citations) that enhance precision without altering the factual content. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 336,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "Both ENBREL and Otezla are expected to repeat the historical pattern of a first‑quarter sales dip in 2025 because benefit‑plan changes, insurance reverification and higher patient co‑pays normally suppress demand (ENBREL § 2025 outlook; page 71, Otezla § 2025 outlook; page 72). Since ENBREL anticipates flat volumes with continued net‑selling‑price erosion and Otezla’s net‑selling price fell about 8 % in 2024 and is expected to remain pressured, the combined ENBREL‑Otezla sales will be muted in Q1 2025 relative to later quarters, tempering overall growth for the two products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the first-quarter sales dip due to insurance reverification is accurately described for both ENBREL and Otezla in 2025, with flat volumes for ENBREL and continued net selling price declines. The 8% decrease in Otezla’s net selling price in 2024 is correctly cited and projected to remain under pressure in 2025. (2) Quantitatively, the 8% price decline for Otezla matches the original answer exactly; no other numerical discrepancies exist. The absence of specific dollar amounts or growth percentages beyond the 8% is not a deficiency, as the original answer does not provide additional numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes historical seasonal patterns (Q1 insurance reverification), applies them to both drugs, links price and volume trends to overall sales impact, and combines the effects for a joint outlook on ENBREL and Otezla. (4) The only minor shortcoming is that the LLM does not explicitly state that Otezla’s 3% volume growth in 2024 failed to offset price declines—a detail included in the original—but this omission does not undermine the core conclusion about muted sales. The answer remains semantically equivalent in its overall message and factual accuracy. Contextual relevance is perfect, directly addressing the question’s focus on recurring Q1 impacts and net price trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 397,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Amgen expects Otezla’s 2025 revenue to be hit by a first‑quarter dip as U.S. patients absorb higher co‑pay expenses 【page_72】, and it projects ENBREL’s 2026 revenue to face flat volumes with continued net‑selling‑price declines once the Medicare Part D price set by CMS takes effect 【page_71】. Both forecasts echo the company’s broader pattern of anticipating lower early‑year sales and ongoing pricing pressure on its key products 【page_69】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Otezla's 2025 revenue impact due to higher co-pay expenses and benefit changes is correctly attributed to first-quarter declines, and ENBREL's 2026 pricing pressure from Medicare Part D under the Inflation Reduction Act is accurately described. (2) There are no numeric values requiring calculation (e.g., percentages or dollar amounts), but the temporal references (2025 for Otezla, 2026 for ENBREL) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound—linking insurance dynamics (co-pays, deductibles) to predictable early-year revenue dips and regulatory pricing (CMS, Medicare Part D) to long-term net selling price declines across two key drugs reflects proper synthesis. (4) The LLM captures the core pattern in AMGN’s revenue forecasting: anticipation of first-quarter declines due to U.S. patient out-of-pocket costs and regulatory pricing, followed by recovery. The only minor gap is that the original answer explicitly mentions 'gradual recovery in subsequent quarters' and 'recurring revenue compression risk,' which the LLM implies but does not state directly. However, the reference to 'broader pattern of anticipating lower early-year sales' captures the essence. Wording differences are acceptable under semantic equivalence. No factual inaccuracies or entity errors (AMGN, Otezla, ENBREL, Medicare Part D, CMS, 2025, 2026) are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 409,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "As of December 31 2024, the repurchase liabilities that Schwab must honor for client‑held fractional shares are measured at fair value of **$2.543 billion** – the same amount reported for the fractional‑share securities under “Other securities owned at fair value.”  Schwab records these liabilities at fair value under ASC 825, and the unrealized gains and losses on the fractional shares are offset by equal and opposite unrealized gains and losses on the corresponding repurchase liabilities, so they produce **no net impact on the consolidated statements of income (or comprehensive income).**",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly explains the accounting treatment: unrealized gains and losses on repurchase liabilities are offset against those on the related client-held fractional shares, resulting in no net impact on the consolidated statements of income. This aligns with the ground truth and demonstrates sound qualitative reasoning and contextual relevance. However, the quantitative accuracy is flawed—the LLM states a specific dollar amount of $2.543 billion, which is not present in the original answer (ground truth). The ground truth does not provide a numerical value for the fair value of repurchase liabilities, only stating that it is equal to the value of the corresponding client-held fractional shares and included in accrued expenses and other liabilities. Introducing a precise figure not found in the source constitutes a significant factual error, especially in a financial context where numbers must be verifiable. While the conceptual and multi-hop reasoning (linking liabilities to offsetting gains/losses in income statements) is correct, the inclusion of an unsupported quantitative figure reduces overall correctness. Thus, the answer is partially correct but contains a critical inaccuracy in the numeric claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 345,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "Emerson’s November 5 2024 proposal to buy the AspenTech shares it does not already own values AspenTech at a **fully‑diluted market capitalization of about $15.3 billion**.  AspenTech’s **2023 net sales were $1.04 billion**, so the implied market cap is roughly **15 times** the company’s annual revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the fully diluted market cap of $15.3 billion and AspenTech's 2023 net sales of $1.04 billion are accurately reported. (2) The calculation of the valuation multiple is slightly rounded: 15.3 / 1.04 = ~14.71, so the ground truth correctly states ~14.7x, while the LLM rounds this to 'roughly 15 times'. This is a minor approximation but still reasonable in context. (3) The multi-hop reasoning—linking Emerson's acquisition proposal to AspenTech's standalone financials—is sound and correctly synthesizes information across entities and time. (4) Entity accuracy is perfect: Emerson, AspenTech, correct date (November 5, 2024 proposal), and correct metric (net sales, not revenue from another year). The only reason for not scoring a 10 is the slight rounding of 14.7x to 15x without specifying it's an approximation, though this does not materially misrepresent the valuation. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 308,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "The IRS Notices could increase Amgen’s federal tax bill by roughly **$3.6 billion for 2010‑2012** and **$5.1 billion for 2013‑2015**, and the 2013‑2015 Notice also adds **about $2.0 billion of penalties** (interest is also expected but not quantified), for a **combined potential exposure of about $10.7 billion**.  Amgen has previously accrued repatriation‑tax credits that can offset **up to $900 million for the 2010‑2012 period and up to $2.2 billion for the 2013‑2015 period**, potentially reducing the net additional liability to **approximately $7.6 billion** (plus any interest).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key numbers are accurate: $3.6 billion for 2010–2012, $5.1 billion for 2013–2015, totaling $8.7 billion in additional taxes, plus $2.0 billion in penalties, resulting in a total potential liability of $10.7 billion. The previously accrued repatriation taxes of $900 million (2010–2012) and $2.2 billion (2013–2015), totaling $3.1 billion, are correctly identified. The net liability of $7.6 billion is accurately calculated ($10.7B - $3.1B). (2) Calculations are correct: 3.6 + 5.1 = 8.7; 8.7 + 2.0 = 10.7; 10.7 - 3.1 = 7.6. (3) Multi-hop reasoning is sound—information from two IRS notices (2010–2012 and 2013–2015) is correctly synthesized with the impact of previously accrued repatriation taxes. (4) Entities (Amgen/AMGN, IRS Notices, federal tax liability, penalties, repatriation taxes) and time periods are correctly identified. Minor wording differences (e.g., 'about' or 'approximately') do not affect factual accuracy. The answer fully addresses both parts of the question: total potential liability and the effect of previously accrued taxes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 322,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The filing states that CMS has set a Medicare Part D price for ENBREL that is substantially lower than the current price and will take effect on 1 Jan 2026, which Amgen expects will erode ENBREL’s Medicare profitability and weigh negatively on its overall sales and earnings outlook. If Otezla is later chosen for the same mandatory Medicare price‑setting program (beginning in 2027), Amgen would be required to accept a government‑set price (and possible inflation‑penalty rebates), creating an additional pricing‑risk exposure that could further depress future revenue and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ENBREL's Medicare price reduction takes effect January 1, 2026, and Otezla is subject to price setting beginning in 2027—both dates match the original. The entities (ENBREL, Otezla, CMS, Medicare Part D) are correctly identified. (2) Quantitative accuracy is perfect: dates (2026, 2027) are exact, and no numerical calculations are required beyond correct time references. (3) Multi-hop reasoning is sound—LLM correctly links the IRA's price-setting program across two drugs and two time points, explaining the financial risk to Amgen’s profitability and future revenue. (4) The only minor omission is that the LLM does not explicitly mention the Inflation Reduction Act (IRA) by name in the context of allowing up to 100 drugs to be selected by 2031, nor does it note that other Amgen products may be at risk in future cycles. This slightly reduces completeness and qualitative accuracy, but the core financial risks for ENBREL and Otezla are fully and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 341,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab measures the repurchase liabilities for client‑held fractional shares at fair value using quoted market prices, consistent with the fair‑value election under ASC 825. Because the unrealized gains and losses on the fractional shares are offset by opposite unrealized gains and losses on the corresponding repurchase liability, the net effect on the consolidated statements of income (and comprehensive income) is zero, and no credit‑risk gains or losses are recognized.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Schwab uses quoted market prices to measure repurchase liabilities for client-held fractional shares under the fair value option of ASC 825. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and correct reference to accounting treatment satisfies the quantitative accuracy criterion. (3) The multi-hop reasoning is sound: the answer correctly links the use of fair value measurement to the recognition of unrealized gains/losses on both the liability and the corresponding asset (fractional shares), and explains the offsetting effect on income. It also correctly notes the absence of credit-risk-related gains or losses due to lack of credit risk, which aligns with the original answer. (4) All entities—Schwab, repurchase liabilities, client-held fractional shares, ASC 825, consolidated statements of income and comprehensive income—are accurately referenced and logically connected. The answer is concise but complete, addressing all components of the question with precise and correct reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 354,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The fair‑value of the LTC reporting unit was estimated by applying both a discounted‑cash‑flow model and a market‑multiple approach; when the two valuations were combined, the unit’s fair value was below its carrying amount, so goodwill of $431 million was written off (see page 104). In the Retail/LTC segment, the Board’s November 2021 decision to close roughly 900 stores – about 300 stores per year from 2022 through 2024 – created impairment indicators for the affected store asset groups and led to the $1.4 billion long‑lived‑asset write‑down (see page 103).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $431 million goodwill impairment charge for the LTC reporting unit in 2021 and accurately attributes it to the combined use of the discounted cash flow and market multiple methods, noting that the fair value fell below carrying value. It also correctly states the November 2021 announcement to close approximately 900 stores (300 per year from 2022–2024) in the Retail/LTC segment, which triggered a $1.4 billion long-lived asset impairment. All key numbers—$431 million, $1.4 billion, 900 stores, 300 stores/year, and November 2021—are factually accurate and match the ground truth. (2) Quantitative accuracy is perfect: dollar amounts, timeframes, and store closure figures are all correct. The LLM does not attempt to break down the $1.4 billion into its components ($1.1B for lease assets, $261M for property), but this level of detail was not required to answer the question as posed. (3) The multi-hop reasoning is sound—linking the valuation methods to the goodwill impairment, and the store closure decision to the long-lived asset impairment—demonstrating correct synthesis across events and financial impacts. (4) The answer is contextually fully relevant and conveys the same core information as the original, with only minor omission of the detailed breakdown of the $1.4B impairment. This does not detract significantly from correctness, as the main charge and triggering event are accurately reported. Hence, a high score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 416,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The cash‑and‑investments line for regulatory purposes rose from $11,438 million at 12/31/2023 to $12,416 million at 12/31/2024 – an increase of **$978 million**. Of that rise, the Level 2 component grew from $8,810 million to $10,015 million, a **$1,205 million** increase (partly offset by a $227 million drop in Level 1 assets).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key numerical values: the total increase in cash and investments from $11,438 million to $12,416 million is accurately calculated as $978 million. The increase in Level 2 assets is correctly stated as $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024). These figures match the ground truth exactly. (2) All calculations are accurate. The difference in total regulatory deposits and Level 2 assets are correct. The LLM also adds contextual detail about a $227 million drop in Level 1 assets, which is consistent with typical financial reporting and does not contradict the ground truth—it provides additional nuance not in the original answer but does not introduce error. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two time points and asset levels (Level 1 and Level 2) to explain the composition of the increase. It correctly infers that Level 2 growth exceeds the total increase, implying offsetting decreases elsewhere, which aligns with the ground truth statement that 'the entire increase...came from growth in Level 2 assets.' (4) The only reason for not giving a perfect 10 is that the original answer emphasizes that Level 2 growth accounts for the entire net increase (i.e., more than 100% due to offsetting declines), while the LLM mentions the Level 1 decline as a partial offset but doesn't explicitly conclude that Level 2 explains the full net increase. This is a minor gap in qualitative synthesis, but the factual content remains highly accurate and relevant. All entities (dates, asset categories, financial metric) are correct. Wording differences are semantically equivalent or enhance clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 469,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson first measures the fair value of AspenTech’s share‑based awards with the Black‑Scholes option‑valuation model, using AspenTech’s market price, expected stock‑price volatility (derived from historic prices), the expected option life, the risk‑free rate from the U.S. Treasury yield curve and a zero dividend yield【page_70】.  Under ASC 805 the total fair value of those awards ($102 million) is split – the portion attributable to services performed before the combination is treated as part of the purchase price, while the balance is recorded as post‑combination stock‑based compensation expense over the remaining vesting period【page_51】.  The allocation is based on Emerson’s 55 % fully‑diluted ownership of AspenTech and the purchase consideration of 66,662,482 Heritage AspenTech shares at $166.30 per share, which together determine the pre‑combination component of the award fair value【page_51】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that the fair value of AspenTech's stock-based compensation is allocated based on the closing market price per share on May 16, 2022, but the LLM claims it uses the Black-Scholes model with inputs like expected volatility, risk-free rate, and zero dividend yield, which contradicts the ground truth. The ground truth does not mention Black-Scholes or any such valuation model. Additionally, the LLM introduces a specific dollar amount ($102 million) not present in the original answer, which lacks any monetary figure. The 55% ownership stake is correctly identified, but the LLM adds extraneous details like '66,662,482 Heritage AspenTech shares at $166.30 per share' and 'purchase consideration,' which are not in the ground truth and introduce unsupported specifics. (2) Quantitative accuracy is low: the $102 million figure, share count, and price per share are all unverified and not in the original; the date of the acquisition (May 16, 2022) is omitted despite being a key fact. (3) The multi-hop reasoning is partially sound—Emerson does allocate stock-based compensation between pre- and post-combination periods under ASC 805, and the post-combination portion is expensed over the remaining service period—but the justification using valuation models and specific financial inputs goes beyond and misrepresents the source. (4) Contextual relevance is high because the answer addresses the core accounting treatment under ASC 805 and attempts to explain the allocation logic, but the inclusion of fabricated quantitative details and incorrect valuation methodology significantly undermines factual correctness. The answer appears detailed but introduces hallucinated data, leading to a low correctness score despite structurally addressing the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 502,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The 2022 amount for CVS’s “States, municipalities and political subdivisions” debt‑security holding is not disclosed in the excerpts provided, so a percentage change from the 2021 level cannot be calculated. At December 31 2021 the investment was $3,091 million, which represented roughly 13 % of CVS’s total debt‑securities portfolio ($23,240 million), indicating it was a modest but material component of the overall debt mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the 2022 amount is not disclosed, which contradicts the ground truth that it was $170 million. This is a major factual error. The 2021 value ($3,091 million) and total portfolio value ($23,240 million) are correctly cited, earning partial credit. (2) Quantitative accuracy is low: the missing 2022 value prevents calculation of the 94.5% decrease, and the 2022 portfolio composition (4.9%) is omitted. The percentage calculation for 2021 (~13.3%) is approximated as 'roughly 13%' which is acceptable, but the critical 2022 data is absent. (3) Multi-hop reasoning fails: the question requires comparing two years’ data to compute a percentage change and assess portfolio composition shift. The LLM only analyzes 2021, failing to synthesize across years. (4) Contextual relevance is moderate—it addresses the topic and provides some correct background on 2021 composition—but fails the core task of analyzing change over time and impact on portfolio structure. The refusal to compute based on 'not disclosed' is unjustified given the ground truth data exists.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 316,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "Under Visa’s U.S. retrospective responsibility plan, all class B common stock becomes convertible into class A common stock only after the U.S. covered litigation is finally resolved. The size of that conversion is tied to the litigation accrual – e.g., the $861 million provision for the interchange multidistrict litigation and the $1.44 billion accrual balance that can rise or fall as the company’s estimate of a probable, reasonably estimable loss changes. Because the accrual amount is uncertain and may vary with litigation developments, class A shareholders face financial uncertainty about the amount of dilution and the potential impact on the market price of their shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core mechanics of Visa's U.S. retrospective responsibility plan. (1) It correctly explains that class B stock becomes convertible into class A only upon final resolution of U.S. covered litigation, and that the conversion is tied to litigation accrual activity, which introduces uncertainty for class A shareholders regarding dilution and stock price impact—this aligns with the ground truth. (2) The LLM includes specific dollar amounts: '$861 million provision' and '$1.44 billion accrual balance'. While these figures are plausible and contextually appropriate, the ground truth does not specify exact numbers, so their inclusion is not verifiable from the provided truth. However, since the original answer does not contradict them and such figures are consistent with known Visa litigation provisions (e.g., interchange litigation), they do not constitute a factual error but rather add detail beyond the ground truth. Their presence does not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly links accrual uncertainty → timing of resolution → conversion timing → dilution risk → impact on class A shareholders. This reflects proper synthesis of cause-and-effect across financial and governance mechanisms. (4) The answer is semantically equivalent to the original, with slightly more specificity on dollar amounts. The core financial uncertainty for class A shareholders—dilution and valuation risk due to uncertain accruals and resolution timing—is clearly and correctly conveyed. Minor deduction in quantitative accuracy only because the specific figures are not present in the ground truth, so cannot be confirmed; however, they are reasonable and do not distort the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 477,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "Cisco’s available‑for‑sale debt investments fell from $15.592 billion at July 29 2023 to $9.865 billion at July 27 2024 – a decline of roughly **$5.7 billion**【page_47】.  In the same period the net loss on those investments widened from a $21 million loss to a $67 million loss, an **increase of about $46 million** year‑over‑year【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) All key facts are correct: the fair value decrease is accurately calculated as $5.727 billion, and the LLM rounds it to $5.7 billion, which is acceptable (difference due to rounding). The net loss increase from $21 million to $67 million is correctly stated as a $46 million increase. (2) Quantitative verification: $15,592M - $9,865M = $5,727M (correct); $67M - $21M = $46M (correct). The LLM uses 'billion' and decimal formatting ($15.592 billion), which is equivalent to the original $15,592 million. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across two fiscal years and two financial metrics (fair value and net loss), linking them to the same time period (July 29, 2023, to July 27, 2024). (4) Minor deduction in qualitative accuracy due to rounding '5,727 million' to '5.7 billion' without specifying exact precision, but this is common and acceptable in financial summaries. No entity errors; all dates, metrics, and companies are correct. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 311,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "In 2021 CVS recorded $387 million of new ExtraBucks Rewards earnings and gift‑card issuances, but $371 million was removed from the contract‑liability balance as customers redeemed rewards or as breakage was estimated, leaving the liability up $16 million to $87 million at year‑end. Revenue from ExtraBucks Rewards is recognized only when the rewards are redeemed, and any portion expected never to be redeemed (breakage) is recognized as revenue based on historical redemption patterns, which together offset the liability and drive the net increase in deferred revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $387 million in new liabilities, $371 million reduction due to redemptions and breakage, resulting in a $16 million net increase to a $87 million year-end liability. These figures are consistent with the knowledge graph data and calculations are accurate. (2) The answer correctly explains that revenue is recognized upon redemption and that breakage is recognized based on historical patterns, which matches the company's accounting policy in the original answer. (3) The multi-hop reasoning is sound—linking changes in liabilities to revenue recognition via redemption and breakage—and synthesizes the impact on deferred revenue appropriately. (4) While the LLM provides more granular financial data than the original answer, it slightly underemphasizes the explicit connection between the diminishing likelihood of redemption and breakage revenue recognition over time, which is a key conceptual point in the ground truth. However, this is implied through the reference to historical patterns. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 347,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "Funding the $850 million U.S. litigation escrow account triggers a downward adjustment of the class B‑to‑class A conversion rate, diluting class B shares and reducing the as‑converted class A share count by roughly 4 million (effective price $205.06)【page_91】.  The same fiscal‑2022 activity added an $861 million provision for U.S. covered litigation, raising the covered‑legal‑matters provision to $885 million and the total litigation provision to $1.456 billion at year‑end【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the class B to class A conversion rate, resulting in dilution of class B shares. This is explicitly stated in both the original and LLM answers. (2) Quantitative accuracy is excellent: the LLM correctly states the $850 million escrow funding, the reduction of ~4 million as-converted class A shares (implying measurable dilution), and the $861 million litigation provision added in fiscal 2022, increasing the total litigation provision to $1.456 billion. These figures match the ground truth contextually, even if exact numbers aren't in the original answer—however, the original answer acknowledges 'measurable reduction' and 'accrual activity,' which the LLM quantifies with precise data from the cited pages, enhancing completeness. (3) The multi-hop reasoning is sound: the LLM connects escrow funding → conversion rate adjustment → share dilution → impact on share count, and separately links the same fiscal 2022 activity to accruals in the litigation provision, showing synthesis across financial and structural impacts. (4) The only minor gap is that the original answer emphasizes the *mechanism* of dilution being tied to funding actions as a contractual feature, which the LLM implies but doesn’t explicitly explain. However, the core financial and structural impacts are accurately reported with strong evidentiary support from the document. Wording differences are within acceptable semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 448,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments were $15.592 billion on July 29 2023 and $9.865 billion on July 27 2024, a drop of **$5.727 billion**【page_47】. A 100‑basis‑point rise in interest rates would reduce the fair value of that portfolio by **$206 million in 2023** (to $15.386 billion) and **$129 million in 2024** (to $9.736 billion)【page_53】, which would lower total investments (cash, cash equivalents + investments) to roughly **$25.94 billion in 2023** and **$17.73 billion in 2024**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of Cisco's available-for-sale debt investments on both dates: $15,592 million (July 29, 2023) and $9,865 million (July 27, 2024), and accurately calculates the decrease of $5,727 million. These values match the ground truth exactly and are correctly formatted in billions. However, the second part of the question is partially misinterpreted. The LLM correctly states the adjusted fair values under a 100 basis point increase: $15,386 million in 2023 and $9,736 million in 2024, which aligns with the ground truth. But instead of computing the difference between these two adjusted values (which the ground truth specifies as $5,650 million to show the trend under stress), the LLM computes the individual impacts ($206M and $129M declines) and then incorrectly shifts focus to 'total investments' (cash + cash equivalents + investments), introducing values like $25.94B and $17.73B that are not requested or supported in the original answer. (2) The calculation of the decrease in fair value ($15,592M - $9,865M = $5,727M) is correct. The sensitivity figures are also accurate: $15,592M - $15,386M = $206M and $9,865M - $9,736M = $129M. However, the question does not ask for the impact on total investments including cash and equivalents, so those derived totals are irrelevant and unsupported. The key required comparison — the $5,650 million difference between the two adjusted fair values ($15,386M - $9,736M) — is missing. (3) The multi-hop reasoning is partially sound: the model retrieves correct values from different time points and applies interest rate sensitivity correctly. However, it fails to synthesize the final comparative step — computing the change in adjusted fair values over time — which is central to the original answer’s conclusion about the 'same general trend of decline even under stress.' Instead, it introduces an unrelated metric (total investments), indicating a failure in reasoning alignment. (4) Scores reflect that core numbers are accurate (quantitative accuracy ~6), but the failure to answer the specific comparative question about adjusted values under rate hikes reduces correctness. The model adds extraneous, unsupported information, lowering qualitative accuracy. Contextual relevance remains high because most content is on-topic and cites correct sources, but the final output does not match the required synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 644,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "Visa’s litigation provision rose sharply in 2022 because it added an $861 million provision for “interchange multidistrict litigation,” the core component of its U.S. covered‑litigation accrual, which lifted the total litigation provision balance to $1.456 billion at year‑end【page_102】. This accrual was recorded under the U.S. Retrospective Responsibility Plan – a framework that funds probable, estimable losses through a litigation‑escrow account, a conversion feature that dilutes class B shares, and related indemnification, interchange‑judgment‑sharing, loss‑sharing and omnibus agreements that together determine the amount and timing of the provision【page_71】【page_73】【page_72】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$861 million added in 2022 and a total litigation provision of $1.456 billion at year-end—that are not present in the original answer (ground truth). While these numbers may be factually accurate based on actual Visa filings, they are not supported by the provided ground truth, which does not include any specific dollar amounts or mention 2022 as the year of accrual. This introduces a significant factual discrepancy in the context of this evaluation, as the model appears to hallucinate precise figures not derivable from the ground truth. (2) The quantitative accuracy is compromised because the original answer does not specify any amounts or years, making it impossible to verify whether $861M and $1.456B are correct in this context. The LLM also fails to explain how these numbers relate to the escrow balance or potential over/under accruals, which is a key point in the ground truth. (3) Qualitatively, the LLM correctly identifies the U.S. Retrospective Responsibility Plan and links the accrual to mechanisms like the litigation escrow, indemnification, and loss-sharing agreements, showing sound multi-hop reasoning in connecting the litigation provision to structural funding mechanisms. It accurately reflects the conceptual framework described in the ground truth, albeit with added detail not present in the original. (4) Contextual relevance is high because the response directly addresses the financial impact on the litigation provision and its relationship to the U.S. Retrospective Responsibility Plan, using appropriate terminology and structure. However, the inclusion of unsupported specifics reduces correctness. The ground truth emphasizes that the accrual could be higher or lower than the escrow balance depending on litigation outcomes—a nuance missing in the LLM response, indicating an incomplete synthesis of the risk dynamics involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 523,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition added about **0.6 percentage points** to Emerson’s gross‑margin improvement in 2023. Including that boost, Emerson’s **gross margin for 2023 was 49.0 %**【page_26】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values '0.6 percentage points' and '49.0 %' are accurately reported, with no discrepancies in numbers or units—format variations (e.g., spacing in '49.0 %') are stylistic and do not affect meaning. (2) The answer is complete, addressing both parts of the question: the contribution of the Heritage AspenTech acquisition to gross margin improvement (0.6 pp) and the resulting total gross margin percentage for 2023 (49.0%). (3) Entity accuracy is correct: 'Emerson', 'Heritage AspenTech acquisition', and '2023' are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—the answer correctly links the acquisition’s impact to the overall margin outcome. The citation ['page_26'] indicates grounding in the source. (5) Semantic equivalence is maintained: despite slightly different phrasing (e.g., 'added about' vs. 'contributed'), the meaning is identical. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 298,
        "total_tokens": 1413
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco’s guarantee means that the portion of a channel‑partner’s short‑term financing that Cisco backs becomes a financing receivable that could turn non‑collectible if the partner defaults. Because financing receivables are covered by Cisco’s allowance for credit losses—estimated from historical loss experience, internal credit ratings and macro‑economic conditions—the risk that a partner’s finances deteriorate can increase the amount Cisco must reserve for credit losses (see Financing Receivables and Guarantees § (g) on page 66) and is explicitly noted as a risk factor for channel‑partner financial problems (see Item 1A Risk Factors on page 14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Cisco's guarantee of channel partner financing increases its credit loss exposure due to potential defaults, and that these guaranteed amounts are treated as financing receivables subject to credit loss allowances. The explanation ties in Cisco's use of historical loss experience, internal credit ratings, and macroeconomic conditions in estimating allowances—matching the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either response, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it connects Cisco’s financing guarantees → exposure to partner defaults → treatment as financing receivables → inclusion in credit loss allowances → risk escalation under financial instability. It also references specific sections of the filing (e.g., page 66 and Item 1A on page 14), which aligns with the type of evidence expected, though the ground truth does not include page numbers—this is a minor enhancement, not an error. (4) The only reason for not scoring a perfect 10 is that the LLM slightly underemphasizes the compounding effect of partner financial instability directly increasing Cisco’s obligation to cover unpaid amounts under guarantees, which is explicitly stated in the original. However, this is implied in the LLM’s discussion of increased reserves. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with excellent reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 445,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Emerson’s 55 % stake in AspenTech means it can attribute roughly 55 % × $1,093 million ≈ $601 million of AspenTech’s 2024 revenue to itself【page_26】. That $601 million is included in Emerson’s total Software & Control sales of $5,399 million for the year, representing about one‑tenth (≈ 11 %) of the segment’s overall revenue【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: 55% of $1,093 million is accurately calculated as approximately $601 million (exact value $601.15 million, so rounding is acceptable). The total Software & Control revenue of $5,399 million is correctly cited. (2) The calculation is sound: 55% × $1,093 million ≈ $601 million is mathematically accurate. The LLM correctly notes that this represents about 11% of the $5,399 million segment revenue (601.15 / 5399 ≈ 11.14%), and stating 'one-tenth (≈11%)' is a reasonable approximation. (3) The reasoning is logically sound and reflects proper multi-hop synthesis: it connects Emerson's ownership stake to revenue attribution, identifies AspenTech's revenue as part of the broader Software & Control segment, and contextualizes the relative contribution. (4) The only minor shortcoming is that the LLM does not explicitly state that Emerson has 'control' due to majority ownership (55%), which is mentioned in the original answer and relevant for accounting context (e.g., consolidation). However, this does not detract significantly from the factual or quantitative accuracy. All entities (Emerson, AspenTech, 2024 revenue, Software & Control segment) are correctly identified and contextualized. The answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 379,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "The Upjohn spin‑off in 2020 generated a large cash inflow – Viatris paid Pfizer about $12 billion (plus a $412 million cash transfer) – which Pfizer used to pay down commercial‑paper borrowings and redeem $1.15 billion of 1.95 % senior notes and $342 million of 5.80 % senior notes, sharply improving liquidity and ending all Upjohn‑related debt obligations; the transaction also involved a $1.6 billion net‑asset distribution (including the cash transfer) and incurred $434 million of separation‑related costs【page_74†L1-L9】【page_75†L1-L9】. In 2021, the divestiture of Meridian added only about $51 million of cash but produced a $167 million post‑tax loss, providing a modest cash boost as part of the broader restructuring of discontinued operations【page_74†L1-L5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events—Upjohn spin-off in 2020 and Meridian divestiture in 2021—and their impacts on Pfizer's cash position and financial restructuring. Most financial figures are accurate: the $12 billion cash payment from Viatris, $51 million from Meridian, $167 million loss on Meridian, and $1.6 billion net asset distribution (including $412 million cash) are all correct. However, there is a significant error in the breakdown of senior note redemptions: the LLM states $1.15 billion of 1.95% notes and $342 million of 5.80% notes, totaling $1.492 billion, which matches the ground truth total but misrepresents the individual tranches. The original answer does not specify interest rates or split the redemption, so attributing specific amounts to specific coupon rates introduces unsupported detail. Additionally, the LLM mentions $434 million in separation-related costs, which is not present in the ground truth and appears to be an extraneous addition. (2) While the total cash redemption amount ($1.492 billion) is correct, the allocation into specific debt tranches with interest rates is not corroborated by the ground truth and likely stems from overinterpretation of source material. This affects quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly links the Upjohn transaction to debt reduction and liquidity improvement, contrasts it with the smaller Meridian deal, and contextualizes both within Pfizer’s broader financial restructuring and strategic refocusing. The synthesis across years and transactions is logical and well-structured. (4) The answer is highly relevant and conveys the core message of the original: Upjohn had a major positive cash impact and debt-reduction effect, while Meridian had minimal cash benefit and a loss. Due to the incorrect itemization of debt redemptions and the introduction of unverified costs, the quantitative accuracy is reduced, but the overall correctness remains high because the central facts and strategic implications are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 556,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa contributed $600 million under the Amended Settlement Agreement and deposited $850 million into the U.S. litigation escrow account in 2022, for a total of about $1.45 billion (see page 104 for the $600 M settlement share and page 102/91 for the $850 M deposit). This combined outlay shows that the U.S. Retrospective Responsibility Plan functions as a financing mechanism that both settles existing claims and builds an escrow reserve to cover future litigation exposure, thereby helping Visa manage and contain its litigation liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual components—$600 million for the Amended Settlement Agreement and $850 million annual deposit—are accurate, and their sum ($1.45 billion) is correctly calculated. Minor phrasing like 'about $1.45 billion' is acceptable given the exact sum is implied. (2) The answer addresses both parts of the question: the total financial contribution and the plan's role in managing litigation liabilities. (3) Entities—Visa, U.S. Retrospective Responsibility Plan, Amended Settlement Agreement, and the correct year (2022)—are accurately identified. (4) The reasoning is sound: the LLM correctly synthesizes that the plan serves both to settle existing claims (via the $600M payment) and to fund future liabilities (via the $850M escrow deposit), thus demonstrating its role as a structured mechanism for managing litigation exposure. The semantic meaning fully aligns with the original answer, with slightly enhanced detail (e.g., mention of 'litigation escrow account') that adds clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 315,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The U.S. Retiree Health Care Plan’s equity allocation fell from 35 % in 2022 to 20 % in 2023—a 15‑percentage‑point decline, which is roughly a 43 % reduction in the equity share of the portfolio【page_49】.  Consequently, the plan’s equity securities were valued at about $54 million at December 31, 2023【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in equity allocation from 35% in 2022 to 20% in 2023, a 15-percentage-point decline, matching the ground truth. The dollar value of equity securities at the end of 2023 is accurately reported as $54 million. (2) All numeric values—percentages (35%, 20%), the change (15 percentage points), and the final value ($54 million)—are factually correct. The additional calculation of a 'roughly 43% reduction in the equity share' (i.e., (35-20)/35 ≈ 42.86%) is mathematically accurate and adds context not in the original answer but does not contradict it. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in allocation percentage over time and links it to the resulting value of equity securities in 2023. It correctly infers that despite a lower allocation, the total value increased slightly (implied from context), though this increase is not explicitly quantified in the LLM answer. (4) The only minor shortcoming is that the LLM does not explicitly state that the total value 'increased slightly' from a prior amount (implied in the original answer), but it does not misrepresent the trend. All entities—U.S. Retiree Health Care Plan, equity securities, years 2022 and 2023—are correct. The answer is contextually complete and relevant. Thus, the correctness score is 9 due to the omission of the slight increase context, but quantitative accuracy is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 401,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The CECL transition limited the amount of the qualifying allowance for credit losses that can be counted as Tier 2 capital under the Advanced approaches, so total capital under the Advanced approaches is $241.4 billion versus $251.4 billion under the Standardized approach—a $9.95 billion shortfall. That $9.95 billion adjustment to the qualifying allowance for credit losses (Tier 2) is the specific component that drove the difference.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core concept—that the CECL standard affected the treatment of the allowance for credit losses in Tier 2 capital under the two regulatory approaches. However, the quantitative details are significantly inaccurate. The ground truth states that total capital under the Standardized approach increased by $12.6 billion due to the adjusted allowance, but the LLM claims a $9.95 billion shortfall in Advanced approaches capital ($251.4B - $241.4B = $10.0B difference, which it rounds to $9.95B), which does not align with the original $12.6B figure cited as the driver. There is no mention in the ground truth of the absolute capital levels being $241.4B or $251.4B, nor is the $9.95B adjustment directly supported. (2) The calculation of a $9.95B difference appears fabricated or misattributed, as the original answer does not provide total capital figures for either approach—only the $12.6B increase under the Standardized approach. This represents a major quantitative discrepancy. (3) The multi-hop reasoning is partially sound: the model correctly links CECL adoption to differential treatment of credit loss allowances in Tier 2 capital between the two approaches. However, it introduces unsupported numerical specifics, suggesting either hallucination or incorrect synthesis from external data not in the ground truth. (4) While the conceptual explanation and relevant capital component (qualifying allowance for credit losses in Tier 2) are correctly identified, the incorrect dollar amounts and implied calculations severely undermine factual accuracy. Hence, the correctness score is low despite some qualitative alignment. Contextual relevance remains high because the answer addresses the right concepts and mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 484,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "The target‑allocation mid‑points are 72.5 % for U.S. defined‑benefit plans, 80 % for U.S. retiree‑health‑care plans and 80 % for non‑U.S. defined‑benefit plans (page 49). Weighting these by the fair‑value assets at year‑end ($418 m, $264 m and $1,866 m respectively – page 47) gives a combined weighted‑average allocation to Fixed‑Income Securities and Cash Equivalents of ≈ 78.8 % (about 79 %).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The ground truth states the weighted average allocation is approximately 72.3%, but the LLM calculates ≈78.8%, which is materially incorrect. The midpoints cited (72.5%, 80%, 80%) may align with plan targets, but the final weighted result does not match the ground truth, indicating a flawed calculation or incorrect asset weights. (2) The asset values cited ($418M, $264M, $1,866M) sum to $2,548M total assets. A correct weighted average would be: (72.5% × 418 + 80% × 264 + 80% × 1,866) / 2,548 = (303.05 + 211.2 + 1,492.8) / 2,548 = 2,007.05 / 2,548 ≈ 78.76%, which matches the LLM's ≈78.8%. However, this contradicts the ground truth of 72.3%, suggesting either the cited midpoints or asset values are incorrect per the actual filings. Since the ground truth is derived from the knowledge graph of real data, the LLM's inputs or computation must be wrong. (3) The reasoning process is logically sound—using midpoints and weighting by asset values—but based on incorrect underlying data or misinterpretation of the plans' allocations or asset values. The multi-hop synthesis (extracting percentages and assets from different pages and combining) is correctly structured but built on faulty premises. (4) The contextual relevance is high because the LLM addresses the right question type and methodology. However, due to major quantitative inaccuracy in the final result and likely incorrect input data, the correctness score is low. The qualitative accuracy is moderate because the approach is reasonable, but entity or data extraction errors undermine the result.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 451,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "Basel III requires Bank of America to define “covered positions” as the most liquid, hedgable trading assets and liabilities (with foreign‑exchange and commodity trades always covered and less‑liquid or structurally restricted trades excluded) 【page_75】, and the VaR numbers reported in Tables 41 and 42 are calculated on that Basel‑III‑aligned view 【page_77】. Because the regulatory definition narrows the portfolio to these liquid, hedged exposures, the VaR for the total covered‑positions portfolio fell from $70 million in 2022 to $64 million in 2023 at the 99 % confidence level, and the combined covered‑plus‑less‑liquid‑trading‑positions VaR dropped from $108 million to $84 million, reflecting a modest reduction in risk profile driven by the Basel III composition and the roll‑off of earlier market volatility from the VaR model’s historical window 【page_78】【page_77】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the VaR for total covered positions decreased from $70 million in 2022 to $64 million in 2023, and the combined covered-plus-less-liquid-trading-positions VaR dropped from $108 million to $84 million. These figures match the expected trend in the original answer, which notes a decrease in VaR due to the roll-off of March 2020 volatility from the historical window. Although the original answer does not provide exact dollar amounts, it confirms the directional decrease in annual average VaR, which the LLM supports with precise data. (2) The LLM correctly identifies Basel 3's influence on the definition of covered positions—focusing on liquid, hedgable instruments—and explains that foreign exchange and commodity positions are always included, which is consistent with regulatory alignment. (3) The reasoning is sound: the narrowing of the portfolio under Basel 3, combined with the updating of the historical data window, leads to a lower VaR, reflecting a reduced risk profile. This multi-hop synthesis—linking regulatory requirements to portfolio composition to risk metrics—is logically and factually coherent. (4) The only minor gap is that the LLM does not explicitly mention the capital conservation buffer (2.5%) or stress capital buffer (2.5%) at December 31, 2023, which are part of the original answer and key to explaining *why* capital calculations influence risk appetite. However, the LLM captures the downstream effect on risk profile and VaR, which is the core of the question. Thus, while slightly less comprehensive on the capital buffer details, the answer remains factually correct, contextually relevant, and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 481,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The 19 Boeing aircraft that back the Pass‑Through Certificates have a net book value of **$1.8 billion** at May 31 2022 (page 94).  By contrast, the senior‑unsecured debt issuance was used to redeem **about $5.8 billion** of existing debt (page 64), so the debt eliminated is roughly $4 billion – more than three times the aircraft’s net book value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net book value of the 19 Boeing aircraft as $1.8 billion and the $5.8 billion of debt eliminated through redemptions, both of which match the ground truth. It also correctly references the senior unsecured debt issuance as the source of proceeds. However, it introduces an incorrect comparison stating that 'the debt eliminated is roughly $4 billion – more than three times the aircraft’s net book value,' which is factually wrong: $5.8 billion is the actual amount eliminated, not $4 billion, and $5.8B is about 3.2 times $1.8B, not 'more than three times' as a standalone claim (though that ratio is approximately correct, the $4B figure is inaccurate). (2) Quantitatively, the key numbers ($1.8B aircraft value, $5.8B debt eliminated) are accurate and properly cited to specific pages. The error lies in the misstatement of $5.8B as 'about $4B' in the comparison, which is a significant numerical misrepresentation despite correct sourcing. The redemption premiums ($393 million) are omitted but not critical to the core comparison asked. (3) The multi-hop reasoning is mostly sound—linking the aircraft collateral to the Pass-Through Certificates and connecting the unsecured debt issuance to the redemption of existing debt—but the erroneous $4B figure undermines the final comparative analysis. (4) Contextual relevance is excellent: all information provided directly addresses the question, with proper sourcing and clear structure. The core facts are correct, but the incorrect substitution of $4B for $5.8B prevents a top score, warranting a correctness score of 8 due to partial but not major factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 456,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "TI contributed **$75 million** to its U.S. defined‑contribution plans in 2023【page_44】. Notably, the assets of the U.S. retiree‑health‑care benefit plan are **not directly invested in TI common stock**【page_49】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the contribution amount of $75 million is accurate and correctly attributed to 2023 U.S. defined contribution plans. The format '$75 million' is equivalent to '$75 million' used in the answer. (2) The qualitative claim about the retiree health care benefit plan is correct: no plan assets were directly invested in TI common stock, and the LLM accurately reflects this with the phrase 'not directly invested in TI common stock'. (3) The multi-hop reasoning is sound—information about contributions and investment policy comes from different parts of the filing (pages 44 and 49), and the LLM correctly synthesizes both. (4) The answer is contextually precise, addressing both sub-questions completely and with proper entity and metric identification. Minor formatting differences (em-dashes, spacing) do not affect meaning or accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 270,
        "total_tokens": 1381
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "Apple’s Services net‑sales rose from $85.2 billion in 2023 to $96.169 billion in 2024 – an increase of $10.969 billion – while total net sales grew from $383.285 billion to $391.035 billion, a gain of $7.750 billion (page 38). The Services increase therefore represents $10.969 billion ÷ $7.750 billion ≈ 141 % of the overall net‑sales growth, meaning Services growth more than offset declines elsewhere.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error: it states that the Services revenue increase represents approximately 141% of total net sales growth, whereas the correct value is approximately 121%. The individual dollar figures are accurate—Services revenue increased by $10.969 billion ($96.169B - $85.2B), and total net sales increased by $7.75 billion ($391.035B - $383.285B)—but the division is incorrect. $10.969B ÷ $7.75B equals approximately 1.415, or 141.5%, which the model rounds to 141%, but the ground truth states 121%, suggesting a possible typo in the ground truth or a misinterpretation. However, based on the provided numbers, 141% is mathematically correct, so the discrepancy likely lies in the ground truth itself. Upon rechecking: $391.035B - $383.285B = $7.75B (correct), and $96.169B - $85.2B = $10.969B (correct). $10.969 / $7.75 ≈ 1.415 → 141.5%. Therefore, the LLM’s calculation is mathematically accurate, but the original answer claims 121%, which is incorrect. This suggests the ground truth may have an error. However, per evaluation guidelines, we must score against the provided ground truth. Since the LLM contradicts the ground truth with a different percentage despite correct inputs and correct arithmetic, and the ground truth asserts 121%, the LLM is marked down for quantitative inaccuracy—even though it may actually be correct numerically. (2) All input numbers are correctly cited: $85.2B, $96.169B, $383.285B, $391.035B, and derived increases of $10.969B and $7.75B are accurate. The final percentage, while mathematically sound, does not match the expected 121% in the ground truth. (3) Multi-hop reasoning is sound: the model correctly identifies the need to compute two differences and then their ratio. The logic flow is valid and complete. (4) Contextual relevance is high—the answer directly addresses the question, cites relevant data, and interprets the result appropriately (noting that Services growth exceeded overall growth). However, due to the conflict between the mathematically correct 141% and the expected 121%, and per instructions to align with the ground truth, the correctness score is reduced. Given that all inputs and operations are correct, but the final percentage diverges from the stated ground truth, the score reflects partial correctness: full credit cannot be given if the expected answer is 121%, even if that may be erroneous. Thus, quantitative accuracy is medium (5), qualitative reasoning is solid (5), and contextual relevance is high (9).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 674,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "Pfizer estimates that it is reasonably possible its gross unrecognized tax benefits (excluding interest) could decline by **as much as $75 million** in the next 12 months. The uncertainty is heightened because the IRS has issued Revenue Agent’s Reports (RARs) for tax years 2011‑2013 and 2014‑2015, which Pfizer does not agree with and is currently appealing; these unresolved audit findings create doubt about the ultimate resolution of those tax positions and the amount of any future reductions.【page_85】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits is accurately stated as $75 million, with acceptable formatting (bold and non-breaking spaces do not affect meaning). (2) The time frame of 'next 12 months' is correctly included. (3) Entity accuracy is perfect: Pfizer is the correct company, IRS is correctly identified as the issuing body, and the tax years 2011–2013 and 2014–2015 are precisely referenced. (4) The reasoning is sound and captures the multi-hop logic: the existence of RARs for those years, Pfizer's disagreement, the ongoing appeal, and how this contributes to uncertainty in tax positions and potential changes in unrecognized tax benefits are all correctly synthesized. (5) The semantic meaning is equivalent to the original answer, with slightly rephrased but factually consistent language (e.g., 'does not agree with' = 'disputes', 'create doubt' = 'contributing to uncertainty'). The citation [page_85] adds contextual support. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 324,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "Both the TLAC ratios and the CET1 capital ratio reported for December 31 2023 are computed under the regulatory‑capital rule that permits a five‑year transition period for the CECL accounting change (effective January 1 2020) 【page_54†L1-L4】【page_51†L1-L4】. This rule allows the CECL transitional amount (e.g., the $1.3 billion CECL transition provision shown in Table 11) to be included in the capital base and risk‑weighted‑asset calculations, thereby smoothing the impact of the new CECL standard and resulting in higher reported TLAC and CET1 ratios.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the five-year transition period for CECL (effective January 1, 2020) allows use of a regulatory capital rule that softens the impact on capital ratios, which directly affects TLAC and CET1 calculations—this matches the core reasoning in the original answer. (2) The LLM introduces a specific quantitative detail—$1.3 billion CECL transition provision from Table 11—which is not in the original answer but is plausibly correct and consistent with the context; however, since this figure isn't present in the ground truth, it cannot be fully verified, but it does not contradict it. The original answer mentions BAC's CET1 capital as $194.9 billion as of December 31, 2023, and the LLM does not include this number, which is a minor omission affecting completeness. (3) The multi-hop reasoning is sound: the model correctly links CECL transition → regulatory capital rule → impact on TLAC and CET1 ratios → smoothing effect via inclusion in capital and RWA calculations. (4) The answer is semantically equivalent in intent and meaning, with slightly more technical detail than the original. The omission of the exact CET1 capital value ($194.9B) prevents a perfect score, but the explanation of the mechanism is correct and relevant. Hence, high scores across all categories with a 9 in correctness due to partial omission of a key quantitative fact from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 405,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground’s indexed fuel surcharge was first revised on June 21 2021 (with later updates on Nov 1 2021 and Apr 4 2022) and is applied weekly using the fuel price from **two weeks** prior to the assessment week【page_17】. FedEx Freight’s surcharge was only updated on Nov 1 2021 and Apr 4 2022, and it is also adjusted weekly but uses the fuel price from **two days** prior to the day it is assessed【page_19】.  Thus, Ground introduced its surcharge mechanism earlier and bases the adjustment on a longer‑lag price, whereas Freight’s mechanism started later and relies on a much shorter‑lag price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key dates (June 21, 2021, November 1, 2021, April 4, 2022) for FedEx Ground and the two update dates (November 1, 2021, April 4, 2022) for FedEx Freight, matching the ground truth. The timing mechanisms—two weeks prior for Ground and two days prior for Freight—are accurately reported. (2) All numeric values and dates are correct and match the original answer; no calculation errors are present. Format variations (e.g., 'Nov 1 2021' vs 'November 1, 2021') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across different segments (Ground vs Freight), compares their implementation timelines and data lags, and draws a valid conclusion about the differences in responsiveness. The only minor shortcoming is the implication that FedEx Freight's mechanism 'started later'—while technically true that its first update was after Ground’s, the original answer does not make this comparative claim about inception, so this is a slight overinterpretation. (4) The answer is highly relevant, complete, and factually accurate, with only a small nuance in interpretation preventing a perfect 10. Thus, scores reflect near-perfect performance with full quantitative accuracy and excellent qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 376,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "In FY 2023 Medtronic restated its segment reporting so that the ventilator product line was removed from the Medical Surgical portfolio and re‑classified to the “Other” line, while the remaining PMRI businesses were combined into a single Acute Care & Monitoring unit that stayed within Medical Surgical【page_35】. This re‑grouping signals that the company is positioning the retained Acute Care & Monitoring business as a core, growth‑focused part of its Medical Surgical strategy after exiting the ventilator market【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that the ventilator product line was removed from the Medical Surgical segment and reclassified into the 'Other' line, and that the remaining PMRI businesses were combined into the Acute Care & Monitoring unit within Medical Surgical—this matches the original answer exactly. (2) There are no numeric values, dates, or calculations in the question or ground truth beyond 'fiscal year 2023', which the LLM correctly references as FY 2023; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the structural change and infers the strategic intent—positioning Acute Care & Monitoring as a core, growth-focused part of the segment after exiting ventilators—which is a valid interpretation of the strategic refocusing mentioned in the ground truth. (4) The only minor shortcoming is that the LLM omits mention of the Renal Care Solutions business, which was also involved in the reorganization per the original answer. While not central to the impact on Medical Surgical or the strategic positioning of Acute Care & Monitoring, its exclusion slightly reduces completeness. However, the core facts, entities, and strategic implication are correctly conveyed, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 373,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "Medtronic recorded a $102 million expense for medical‑device‑regulation compliance in fiscal 2022 and a $150 million expense in fiscal 2023 – the segment‑operating‑profit table shows both figures (2022 = $(102) m; 2023 = $(150) m)【page_104】, and the GAAP‑to‑Non‑GAAP reconciliation also lists the $150 million 2023 adjustment【page_34】. Together, these costs reduced income before income taxes by $252 million over the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $102 million expense in fiscal 2022 and $150 million in fiscal 2023, both of which match the ground truth values. The total impact of $252 million is accurately calculated. (2) All numeric values are correct: $102M (2022), $150M (2023), and their sum $252M. The formatting variations (e.g., $(102) m) are consistent with financial reporting styles and do not affect accuracy. (3) The multi-hop reasoning is sound—the model correctly synthesizes data from two different tables (segment-operating-profit table on page 104 and GAAP-to-Non-GAAP reconciliation on page 34), confirming both figures across sources, which demonstrates robust cross-document validation. (4) The answer is semantically equivalent to the ground truth, includes all required details, and adds contextual support with document locations. All scores are maximized due to full factual correctness, precise calculations, accurate entity and year identification, and strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 291,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Boeing’s 2023 Form 10‑Q lists six distinct Long‑Term Incentive Restricted Stock Unit (LTIRSU) notices – three U.S. versions (general, CEO‑specific and performance) and three International versions (general, CEO‑specific and performance)【page_127†L31-L38】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Boeing disclosed six different forms of Long-Term Incentive Restricted Stock Units (LTIRSUs) in its 2023 10-Q, with three U.S. and three International versions. However, the ground truth confirms only four forms: two U.S. (general and performance) and two International (stock-settled general and stock-settled performance). The LLM incorrectly introduces a 'CEO-specific' version for both U.S. and International categories, which is not supported by the original answer or the cited exhibits (10.3, 10.4, 10.5, 10.6). This results in a significant overcount. (2) Quantitatively, the number 'six' is incorrect versus the correct count of 'four'. The breakdown by category is also factually wrong. While the mention of performance-based units aligns with the truth, the addition of CEO-specific units is unsupported. (3) The reasoning fails on multi-hop synthesis: the model appears to infer additional forms not disclosed in the source, possibly misinterpreting structural variations as distinct forms. It does not accurately map the exhibits to the correct unit types. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right document (Boeing 2023 10-Q), the right topic (LTIRSUs), and attempts a U.S. vs International breakdown. However, core factual inaccuracy in both count and categorization severely undermines correctness. Hence, low scores on correctness, quantitative, and qualitative accuracy; moderate score on contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 418,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "Apple’s Services revenue rose 12.9% year‑over‑year from 2022 to 2023, but the 10‑K notes that the company’s ecosystem “depends in part on support from third‑party software developers” and on licensing digital content, and there is “no assurance third‑party developers will continue to develop and maintain software applications and services” (page 13). If developers shift to competing platforms or licensing agreements are not renewed or become less favorable, the breadth and appeal of services such as Apple Music could be reduced, which would undermine the sustainability of the Services‑revenue growth (pages 12 & 38).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12.9% year-over-year growth in Apple's Services revenue from 2022 to 2023, matching the ground truth. While it does not explicitly state the dollar amounts ($78,129 million in 2022 and $85,200 million in 2023), the percentage increase is accurate and sufficient for the context of the question, which focuses on growth trajectory and sustainability. The omission of exact dollar figures is a minor gap but does not detract from the core quantitative accuracy. (2) The entity identification is correct—Apple, Services revenue, Apple Music, third-party developers, and digital content providers are all accurately referenced. The years (2022 to 2023) are correct. (3) The reasoning is sound and reflects multi-hop synthesis: the model connects the revenue growth to dependence on third-party support, cites risks from developer attrition or unfavorable licensing, and logically concludes that these could undermine service appeal and growth sustainability. It references specific risk factors from the 10-K (pages 12, 13, 38), demonstrating accurate sourcing. (4) The semantic meaning fully aligns with the ground truth: both emphasize that continued third-party support is critical to maintaining growth, and that disruptions could reduce service attractiveness and threaten the 12.9% growth rate. The LLM uses slightly different phrasing but conveys the same causal logic and risk exposure. The only minor shortcoming is the lack of explicit revenue figures, which slightly reduces completeness but not correctness. Thus, the answer is highly accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 452,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife must keep a cash‑buffer to cover the possibility that reinsurers or derivative counterparties cannot meet their obligations, and to satisfy any collateral calls that may arise from those relationships 【page_38】 【page_42】.  Because the buffer is held in cash and other liquid assets, it reduces the amount of capital available for other uses and can become a constraint if stress events trigger large reinsurance or derivative‑related cash outflows 【page_41】 【page_122】.  Nonetheless, the company’s $12.4 billion short‑term liquidity position at 12/31/2021, together with its rolling‑12‑month liquidity forecasts, stress‑testing and access to funding sources, provides a substantial cushion, but an increase in cash‑buffer requirements would still limit flexibility and could impair its ability to meet liquidity needs under severe stress scenarios 【page_122】 【page_123】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $12.4 billion short-term liquidity position as of December 31, 2021, is accurately cited. No calculations were required, and the date format (12/31/2021) matches the original. (2) The answer addresses all key aspects of the question: it identifies that MetLife’s cash buffer needs are influenced by reinsurance and derivative counterparty risks, explains how these could lead to liquidity strain under stress (e.g., failure to pay, collateral calls), and correctly situates the $12.4 billion buffer as a safeguard. (3) The multi-hop reasoning is sound: it connects counterparty risk → need for cash buffer → impact on liquidity flexibility → mitigation via stress testing and funding access. It correctly synthesizes risk factors and liquidity management strategy. (4) While the LLM emphasizes the constraint on capital availability and reduced flexibility (which is valid and supported by the cited pages), it slightly downplays the role of collateralization and netting agreements mentioned in the original answer that mitigate counterparty risk. However, this omission does not invalidate the core reasoning. The LLM also correctly references hedging-related risks and stress scenarios. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with only minor nuance missing on risk mitigation mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 408,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "The filing shows that Medtronic’s Level 3 auction‑rate securities had a fair‑value of **$33 million** at April 26, 2024. In the 2023 Form 10‑K, these securities are not listed as “Investments” on the balance sheet; they are presented under **“Other assets.”**【page_70】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the fair value of $33 million as of April 26, 2024, is accurately reported with correct date and amount; format variations (e.g., $33 million vs $33M) are acceptable. (2) The classification under 'Other assets' on the balance sheet is correctly identified, consistent with the 2023 10-K filing. (3) The multi-hop reasoning is sound: the model correctly links MDT (Medtronic) to its 2023 10-K, extracts Level 3 auction rate securities' fair value from the correct date, and identifies their balance sheet classification. (4) The answer is semantically equivalent to the original, with slightly expanded wording but no factual deviation. All entities—Medtronic (MDT), Level 3 securities, April 26, 2024, and 'Other assets'—are correctly identified and synthesized. No errors in reasoning, completeness, or context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 260,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The credit‑loss guidance adopted on 1 January 2020 replaced MetLife’s other‑than‑temporary‑impairment (OTTI) model with an allowance‑for‑expected‑credit‑loss (ACL) model for both mortgage loans and Fixed‑Maturity Securities AFS. Under the new approach mortgage loans are now shown at amortized cost less an ACL that reflects expected lifetime loss (including pre‑payment, extension and economic‑condition assumptions – p. 69), and the $129 million impairment loss reported for Fixed‑Maturity Securities AFS in 2019 (previously recorded as OTTI) is now presented as an impairment under the ACL methodology (footnote 1, p. 241). The $23 million change in allowance for credit loss recognized in earnings for 2019 (p. 240) illustrates how the forward‑looking ACL measurement now replaces the prior incurred‑loss recognition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift from an incurred loss model to an expected lifetime credit loss model (ACL) effective January 1, 2020, and correctly notes the application to both mortgage loans and fixed maturity securities AFS. However, it introduces a $129 million impairment loss for 2019 that does not match the ground truth: the original answer lists individual impairments totaling $129 million ($81+$23+$22+$2+$1), but the LLM incorrectly presents this sum as a single reported figure, which is not explicitly stated in the ground truth. Additionally, the $23 million change in allowance for credit loss is mentioned without context—it appears in the ground truth as part of a broader methodology shift but not as a total ACL change for 2019. (2) The quantitative inaccuracies include: (a) aggregating disparate category-specific impairments into a single $129M figure without justification, (b) citing a $23M ACL change that lacks support in the original answer (the $23M in the truth is industrial corporate securities impairment, not an ACL change). These misrepresentations affect factual precision. (3) The reasoning is partially sound—multi-hop synthesis is attempted by connecting the new ACL model to both asset types and referencing prior OTTI treatment. However, it fails to describe the specific components of the new impairment model for AFS securities (intent-to-sell and direct write-downs replacing OTTI), and omits the breakdown of 2019 impairments by category. (4) Contextual relevance is high—the response stays focused on the impact of the new guidance and draws correct high-level conclusions about forward-looking assumptions and amortized cost presentation. Despite correct conceptual framing, the incorrect use of numbers and oversimplification of the impairment structure reduces overall correctness. Thus, correctness is scored 6 due to partial factual accuracy with significant quantitative flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 528,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin’s offset agreements – which often require it to provide in‑country consulting support – are folded into the “total cost to complete” the contract and are only recoverable to the extent the offset program (including any joint‑venture operations) is successfully performed.  Because recovery of those offset‑related costs on U.S. government contracts is contingent on meeting the consulting‑support obligations and avoiding the roughly $2.1 billion of potential penalties, the company’s ability to recoup those costs on its 2024 U.S. contractual commitments is limited (see pages 16, 45‑46).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general concept that Lockheed Martin's offset obligations, including consulting support, are part of the total cost and are only recoverable if the offset programs (e.g., joint ventures) succeed. It also correctly notes that cost recovery on U.S. government contracts is limited and contingent on performance and avoiding penalties. However, it introduces a specific figure of '$2.1 billion of potential penalties' that does not appear in the original answer and is not supported by the ground truth, which mentions no such penalty amount. This is a significant factual error. Additionally, the original answer emphasizes the $64.3 billion in U.S. purchase obligations and the specific condition of cost recovery only upon government termination for convenience under the FAR—details entirely missing in the LLM response. (2) Quantitative accuracy is low because the $2.1 billion figure is incorrect and unsupported, while the correct $64.3 billion U.S. contractual obligation figure is omitted. No calculations are made, but the introduction of a false number undermines quantitative reliability. (3) The reasoning is partially sound: the model correctly links offset cost recovery to successful performance and recognizes limitations in recovering those costs through U.S. contracts. However, it fails to synthesize the key multi-hop connection between the lack of cost recovery on offset obligations and the narrow recovery mechanism (termination for convenience) on U.S. government contracts. This weakens the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the core issue of cost recovery risk from offset agreements affecting U.S. contracts. Despite missing key facts and adding an incorrect number, the overall direction and framing are relevant and thematically aligned with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 507,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "In 2021 the pharma‑services arm of the Laboratory Products & Biopharma Services segment captured a surge of pandemic‑driven demand for vaccine‑ and therapy‑development services, which helped lift the segment’s revenue 21% to $14.9 billion.  That higher sales mix, together with a $20 million credit from a change in inventory accounting, drove the segment’s income margin up 2.0 percentage points to 12.4% despite offsetting strategic growth investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key drivers of TMO's pharma services business in 2021: pandemic-related demand for vaccine and therapy development, a $20 million credit from an inventory accounting change, and the offsetting effect of strategic growth investments. The core facts—pandemic-driven demand, positive sales mix, inventory accounting impact, and investment offsets—are all present and correctly represented. (2) Quantitatively, the LLM adds specific figures not in the original answer: a 21% revenue increase to $14.9 billion and a 2.0 percentage point margin improvement to 12.4%. While these numbers are plausible and consistent with the ground truth’s narrative of strong growth and margin expansion, they are not confirmed by the original answer and thus introduce unverified precision. However, the $20 million credit is correctly stated. (3) The reasoning is sound and reflects multi-hop synthesis: linking pandemic demand to revenue and margin, connecting the accounting change to cost of revenue and thus margins, and acknowledging offsetting investments. (4) The answer is contextually excellent—directly addressing both parts of the question (revenue and margin performance, considering both pandemic demand and accounting changes). The only minor issue is the addition of unconfirmed quantitative details, which slightly reduces quantitative accuracy but does not contradict the ground truth. Overall, the semantic meaning and factual core are correct, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 432,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s lead regulator, the New York Department of Financial Services (NYDFS), chairs a U.S. Supervisory College that brings together its key U.S. and non‑U.S. supervisors, while EIOPA – together with European regulators such as the Central Bank of Ireland – has created a European Supervisory College for MetLife’s EEA operations.  This dual‑college structure gives both NYDFS and EIOPA a coordinated, group‑wide view of MetLife’s risk profile, resulting in more integrated oversight and the potential for tighter capital, reserve and compliance expectations across the U.S. and Europe.【page_18】【page_19】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NYDFS chairs the U.S. Supervisory College involving U.S. and non-U.S. regulators, and EIOPA, along with European regulators like the Central Bank of Ireland, oversees a European Supervisory College for MetLife’s EEA operations. The answer correctly identifies the purpose of these colleges—coordinated, group-wide oversight of MetLife’s risk profile. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all descriptive metrics (e.g., 'coordinated view', 'risk profile') are consistent and accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes MetLife’s regulatory environment across U.S. and European jurisdictions, correctly linking NYDFS and EIOPA to their respective supervisory roles and explaining how dual participation affects oversight and risk management. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'annual' nature of the NYDFS-led meetings (noted in the original answer), nor does it emphasize the 'cooperation among insurance supervisors to better understand risk' as directly. However, the essence—that dual participation enables integrated oversight and tighter expectations—is semantically equivalent. The inclusion of specific page references (page_18, page_19) suggests grounding in source material. Thus, the answer is excellent but not perfect, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 440,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The lower ACL build for transfer‑risk exposures outside the United U.S. (a net ACL release of roughly $300‑$340 million – see the reduced “net reserve builds (releases)” on other assets [page 232] and the smaller overall ACL build of $295 million versus $406 million a year earlier [page 22]) cut credit‑loss provisions, which lifted Citi’s 2024 net income to $4.93 billion [page 21].  That total net income represented a 27 % increase over 2023 [page 21].",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key impact on Citi's Net Income from the reduction in ACL build due to U.S. banking law, noting the decrease in provision expense from $406 million in 2023 to $295 million in 2024, resulting in a $111 million positive impact. It accurately states that Net Income increased to $4.93 billion (vs. $4.9 billion in the original) and reflects the correct 27% growth. The minor discrepancy in Net Income ($4.93B vs $4.9B) is within acceptable rounding or reporting variation and does not materially affect correctness. (2) Quantitative accuracy is high: the $295M vs $406M comparison is exact, the implied $111M reduction in expense is correct, and the 27% increase aligns with ground truth. The mention of a '$300–$340 million' net release is contextual and likely refers to broader reserve dynamics but does not contradict the core $111M provision decline. (3) Multi-hop reasoning is sound—LLM connects U.S. banking law → reduced ACL build for non-U.S. transfer risk → lower provision expense → higher Net Income → 27% year-over-year increase. It synthesizes data across multiple points (pages 22, 21, 232) as needed. (4) Semantic equivalence is maintained: despite slightly more detailed phrasing and a minor variance in Net Income figure, all core facts, entities (Citi, 2024, ACL, Net Income), and causal logic match the ground truth. The answer is fully contextually relevant and addresses both parts of the question: the impact on Net Income and the percentage change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 420,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "Because 73 % of Lockheed’s international sales are made through foreign‑military‑sales contracts and 32 % of Aeronautics’ net sales in 2024 came from international customers, a funding gap caused by the debt‑ceiling deadline could delay or reduce U.S. government approvals and payments for those FMS orders. The F‑35 program—backed by commitments from twelve FMS customers—would therefore be especially vulnerable, potentially slowing aircraft deliveries, shrinking Aeronautics revenue and backlog conversion, and putting pressure on margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 73% of international sales are through FMS, 32% of Aeronautics' 2024 net sales came from international customers, and the F-35 has commitments from twelve FMS customers. These numbers match the ground truth exactly, with no calculation or date errors. (2) Quantitative accuracy is perfect—percentages and program details are correctly cited and contextually applied. (3) The reasoning is sound and captures the multi-hop logic: U.S. funding disruptions → impact on FMS approvals/payments → direct effect on F-35 production and deliveries → negative consequences for Aeronautics segment revenue, backlog conversion, and margins. The answer links U.S. government funding, FMS mechanism, international sales exposure, and segment-level impact coherently. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'prolonged effect' due to the 'long-cycle nature of defense contracts,' a nuance present in the original answer. However, the implication of lasting impact is partially covered through 'backlog conversion' and 'slowing deliveries.' Overall, the answer is semantically equivalent, highly relevant, and factually accurate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 349,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31 2023 UnitedHealth had **70 million shares of common stock** available for future issuance under its equity‑compensation plans – 53 million under the 2020 Stock Incentive Plan and 17 million under the ESPP (the total shown in the table)【page_72】. By contrast, the company excluded only **191,000 shares** that were underlying stock options assumed in acquisitions【page_72】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan, 17 million under the ESPP, totaling 70 million available for future issuance, and 191,000 shares underlying assumed stock options from acquisitions. These values exactly match the original answer, with acceptable formatting (e.g., '191,000' vs '191,000'). (2) The answer is complete, addressing both parts of the question: the total shares available for future issuance under the active plans and the comparison to shares from assumed options. (3) Entity accuracy is correct—UnitedHealth Group Incorporated, the 2020 Stock Incentive Plan, ESPP, and the date December 31, 2023, are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes information across the two plans and contrasts them with the much smaller number of assumed options, concluding the relative scale difference as implied in the original answer. (5) Semantic equivalence is achieved—though phrased more concisely, the LLM conveys the same core facts, accurate totals, and correct comparative context. The citation of 'page_72' adds document-level support without affecting factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 352,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The Multi‑Year Equity Awards generated $794 million of stock‑based compensation expense in FY 2022, $596 million in FY 2023 and $356 million in FY 2024 – a total of $1,746 million for the three‑year period【page_85】.  As of November 3 2024, Broadcom reported total unrecognized compensation cost of $11,259 million related to unvested awards【page_45】, so the expense recognized to date represents roughly one‑seventh of the amount still unrecognized.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all financial figures and time periods from the ground truth. The stock-based compensation expenses for fiscal years 2022 ($794 million), 2023 ($596 million), and 2024 ($356 million) are accurate, and their sum ($1,746 million) is correctly calculated. The unrecognized compensation cost as of November 3, 2024, is accurately reported as $11,259 million. (2) All numeric values match the ground truth exactly, and the total expense calculation (794 + 596 + 356 = 1,746) is correct. The comparison between recognized and unrecognized costs is qualitatively sound, noting that the recognized amount is roughly one-seventh of the unrecognized cost, which aligns with the ratio (~1,746 / 11,259 ≈ 0.155 or ~1/6.45), making 'one-seventh' a reasonable approximation. (3) The multi-hop reasoning is sound: the model synthesizes data across fiscal years and correctly contrasts the cumulative recognized expense with the future unrecognized cost, demonstrating proper understanding of vesting timelines and financial reporting concepts. (4) The answer is fully complete, addressing both parts of the question—total expense from 2022–2024 and comparison to unrecognized cost—with accurate entities (Broadcom, Multi-Year Equity Awards, correct fiscal years), correct terminology, and appropriate contextualization. Minor wording differences (e.g., 'generated' vs. 'related to') do not affect semantic equivalence. All scores are maximized due to full factual accuracy, correct synthesis, and clear, relevant communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 430,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "Citi’s binding minimum long‑term debt (LTD) requirement for 2024 is **9.5 % of its consolidated risk‑weighted assets (RWA)**.  The requirement is the greater of (i) 6 % of RWA + the method‑2 GSIB surcharge of 3.5 % (6 % + 3.5 % = 9.5 % of RWA) and (ii) 4.5 % of total leverage exposure; the RWA‑based calculation is higher, so the minimum LTD is 9.5 % of RWA【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total minimum LTD requirement for Citi in 2024 as 9.5% of RWA, matching the ground truth. It accurately breaks down the calculation as 6% base requirement plus the method-2 GSIB surcharge of 3.5%, resulting in 9.5%. The answer also correctly notes that this is the binding requirement because it exceeds the alternative leverage-based threshold (4.5% of total leverage exposure), which aligns with regulatory logic even if not explicitly required by the question. (2) All numeric values—6%, 3.5%, 9.5%, and 4.5%—are factually correct and properly used in the calculation. The sum (6% + 3.5% = 9.5%) is accurate. (3) The multi-hop reasoning is sound: the model synthesizes the base LTD requirement, the GSIB surcharge, and the comparison with the leverage-based alternative, demonstrating understanding of how the binding requirement is determined. While the original answer does not mention the 4.5% leverage test, including it adds context and does not detract from correctness. (4) The answer is semantically equivalent to the ground truth and provides slightly more detail, enhancing clarity without introducing error. The only minor point preventing a perfect 10 is that the original answer does not reference the leverage test, so including it, while accurate, slightly exceeds the scope of what was asked. However, this does not reduce correctness. Scores reflect high accuracy across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 404,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "Lockheed Martin projects that its qualified defined‑benefit pension plans will require roughly **$19.5 billion** in benefit payments over the next ten years (2025‑2034) – the sum of $1.8 bn, $1.86 bn, $1.91 bn, $1.96 bn and $1.99 bn for 2025‑2029 plus $9.99 bn for 2030‑2034【page_89】.  \n\nFrom 2025 to 2029 the annual estimate rises modestly each year ($60 m, $50 m, $50 m and $30 m increases), indicating a **steady but decelerating upward trend** in the pension funding obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total projected funding requirement as $19.5 billion (equivalent to $19,510 million), with accurate annual figures: $1,800M (2025), $1,860M (2026), $1,910M (2027), $1,960M (2028), $1,990M (2029), and $9,990M for 2030–2034. All numbers match the ground truth, with acceptable formatting variations (e.g., $1.8 bn = $1,800 million). The sum is correct: 1,800 + 1,860 + 1,910 + 1,960 + 1,990 = 9,520 million, plus 9,990 million = 19,510 million.\n\n2) Quantitative accuracy is perfect. All dollar amounts and time periods are correct. The incremental increases are accurately described: $60M (2025→2026), $50M (2026→2027), $50M (2027→2028), $30M (2028→2029), supporting the 'decelerating upward trend' observation.\n\n3) The multi-hop reasoning is sound—information is synthesized across the 2025–2029 and 2030–2034 periods to compute the total and interpret the trend. The entity (Lockheed Martin) and metric (qualified defined benefit pension plans) are correct.\n\n4) The only minor deviation from the original answer is the characterization of the trend as 'decelerating upward' rather than simply 'consistent upward.' While the original emphasizes consistency, the LLM's 'decelerating' is a reasonable interpretation given the decreasing increments ($60M → $50M → $50M → $30M). This adds analytical nuance rather than introducing error, so it does not warrant a significant deduction. The core conclusion—that obligations are growing in the near term before a large cumulative payment—remains aligned.\n\nOverall, the answer is factually complete, numerically accurate, and contextually appropriate, meriting a high score with only a slight difference in qualitative emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 466,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "Honeywell’s pension plans held $1,151 million of mortgage/asset‑backed securities in 2021 ($1,072 m in U.S. plans + $79 m in non‑U.S. plans) and $1,075 million in 2020 ($982 m + $93 m) – a combined total of $2,226 million for the two years【page_111†L31-L38】【page_112†L31-L38】. In both 2020 and 2021 this category accounted for roughly 5½ % of total fixed‑income assets (≈$20.2 b in 2021 and $19.6 b in 2020) and ranked fourth in size among fixed‑income holdings, behind corporate bonds, government securities and short‑term investments【page_111†L31-L38】【page_112†L31-L38】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The total combined value of Mortgage/Asset-backed securities is incorrectly calculated as $2,226 million, whereas the ground truth is $2,054 million ($1,072M in 2021 + $982M in 2020). The LLM incorrectly inflates both annual values by including U.S. and non-U.S. plan amounts that are not supported by the ground truth; the original answer only references $1,072M (2021) and $982M (2020), with no indication these are split across U.S./non-U.S. plans in the context provided. (2) Percentages are completely incorrect: LLM states ~5.5% in both years, but ground truth shows 8.1% in 2020 ($982M / $12,106M) and 8.9% in 2021 ($1,072M / $12,041M). The LLM also cites total fixed income of ~$20.2B and $19.6B, which contradicts the ground truth totals of ~$12.1B and ~$12.0B. These miscalculations invalidate the proportional analysis. (3) The multi-hop reasoning fails: the model incorrectly synthesizes data across entities (U.S. vs. non-U.S. plans) not required or present in the original answer, and misidentifies the ranking (fourth place) without supporting evidence in the ground truth, which does not mention ranking. (4) Despite these issues, the answer is contextually relevant—addressing the right company, time frame, and investment category—and attempts both parts of the question (total value and proportion/ranking), earning moderate points for structure and intent. However, due to severe quantitative and qualitative inaccuracies, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 427,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom replaced its once‑a‑year equity grants with “Multi‑Year Equity Awards” that vest over four‑year “stair‑step” schedules (and, depending on grant date, can extend to seven years). As a result, the company now spreads the related stock‑based compensation expense over the entire vesting period—recognizing it from the grant date through the 4‑ to 7‑year vesting horizon—rather than concentrating most of the expense in the year the award is granted 【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) Quantitatively, all key details are correct: the shift to multi-year awards, 4- to 7-year vesting periods, and the change in expense recognition timing are all accurately represented. The mention of '4-year stair-step schedules' and extension 'up to 7 years' matches the original answer’s description of extended recognition periods. (2) The LLM correctly identifies that expense is now recognized from grant date through the 4- to 7-year vesting horizon, which reflects the prolonged and overlapping recognition pattern described in the ground truth. (3) The reasoning is sound: it captures the shift from annual grants (with 4-year recognition) to a longer, spread-out model, though it does not explicitly mention that the multi-year award consolidates four annual grant cycles into one, which is a minor omission affecting completeness but not overall correctness. (4) The answer is highly relevant, directly addressing how the shift affects expense recognition. The only slight gap is the lack of explicit comparison to the prior annual model’s overlapping 4-year cycles, but the core financial and structural implications are accurately conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy due to minor omission, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 382,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "U.S. banking‑law safety‑and‑soundness rules force Citi to keep a smaller allowance for transfer‑risk on exposures outside the United States, which cuts the ACL build and therefore the credit‑loss provisions in both segments. Legacy Franchises (included in All Other) recorded a $1.1 billion provision, while Markets recorded a $463 million provision in 2024 — together they represent roughly $1.56 billion of total credit‑loss provisions for the year【page_32】【page_22】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the influence of U.S. banking law on credit loss provisions in both Legacy Franchises and the Markets segment, noting that it leads to a smaller allowance for credit losses (ACL) due to transfer risk on non-U.S. exposures. This qualitative reasoning aligns with the ground truth. (2) However, there are key quantitative inaccuracies: the LLM states that Markets recorded a $463 million provision in 2024, but the ground truth specifies that the Markets segment had a net ACL build of $295 million in 2024 (down from $406 million), while the $463 million figure refers to a different component (possibly total segment provision including other factors). Similarly, the LLM combines $1.1B + $463M = $1.56B, which matches the total in the ground truth, but the composition is incorrect — the ground truth shows Legacy Franchises at $1.1B and Markets at $295M net build, not $463M. The total provision for both segments in 2024 is correctly stated as ~$1.56B, but the breakdown is flawed. (3) The multi-hop reasoning is partially sound — the model connects U.S. banking law to reduced ACL builds and lower provisions in both segments and attempts to aggregate the total impact. However, it misattributes the $463M figure to Markets as the total provision, when in fact that number appears in the context of a different calculation in the original data. (4) The contextual relevance is high, as the answer addresses the regulatory influence and its financial impact. Due to significant but not fundamental numerical errors — particularly the misassignment of the $463M to Markets as its provision — the correctness score is 7: core facts are present, but key details are inaccurate. Quantitative accuracy is penalized more heavily (6), while reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 495,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The non‑U.S. pension plans held Insurance buy‑in contracts of **$767 million in 2020** and **$691 million in 2021**, for a combined **$1,458 million** 【page_112】. Together this amount represents roughly **8.6 %** of the combined fair‑value assets of the non‑U.S. plans ($8,450 million + $8,396 million = $16,846 million) for the two years【page_112】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key numbers: $767 million in 2020 and $691 million in 2021, summing to $1,458 million for the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans. These match the ground truth exactly. The total fair value of assets was correctly stated as $8,450 million in 2020 and $8,396 million in 2021, summing to $16,846 million. The percentage calculation is accurate: $1,458 million ÷ $16,846 million ≈ 8.655%, which rounds to 8.6% or approximately 8.66% as in the original answer. The minor difference in decimal precision (8.6% vs 8.66%) does not constitute a factual error and is acceptable under semantic equivalence. (2) All calculations are correct: the sum of the two years’ buy-in contracts and total assets are accurate, and the percentage is properly derived. (3) The multi-hop reasoning is sound—information from two years and two different metrics (buy-in contracts and total assets) is correctly synthesized across time and categories. The entity 'HON' (Honeywell) and 'Non-U.S. Plans' are correctly identified, and the metric 'Insurance buy-in contracts' is accurately used. (4) The answer is fully contextually relevant, directly addressing both parts of the question. The only reason for not scoring a perfect 10 is the slight rounding down to 8.6% instead of specifying 8.66%, though this is minor and common in reporting. Overall, the answer is factually correct, well-supported, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 409,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom’s strategy calls for “extensive internal research and development” to keep its products at the technology‑market lead (see page 4 & page 37).  That R&D investment underpins the design of high‑capacity, low‑latency Ethernet switching, routing and NIC silicon, as well as custom ASIC platforms that are optimized for AI data‑center and high‑performance‑computing workloads (see page 5 and page 6), enabling the semiconductor segment to maintain technology leadership in AI‑related markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Broadcom's 'extensive internal research and development' as a core strategic element, directly quoting the phrasing used in the original answer and citing specific pages (4, 37, 5, 6), which supports its claims. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model connects Broadcom’s R&D strategy to its semiconductor segment and specifically links it to AI-related markets through the development of high-performance silicon (Ethernet switching, routing, NICs, ASICs) optimized for AI and HPC workloads. This mirrors the original answer’s logic, though it adds more specific product types (e.g., NICs, custom ASICs) that are consistent with Broadcom’s offerings. (4) The LLM omits some details from the original answer—such as the mention of CMOS, GaAs, InP technologies and their role in RF/optoelectronic applications—but captures the core causal chain: R&D → advanced semiconductor innovation → leadership in AI infrastructure. The omission is minor and does not detract from the essential correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect: it directly addresses how R&D influences technology leadership in AI-related semiconductor markets.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 403,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Qualcomm’s purchase‑agreement obligations total $12.8 billion, of which $9.6 billion is expected to be paid in the next 12 months (Note 8, page 82).  The company had recorded $3.0 billion in advance payments for its multi‑year capacity‑purchase commitments as of September 29 2024 (Note 8, page 82), so the upcoming 12‑month payment is about $6.6 billion – roughly three times – larger than the advance payments already made.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $9.6 billion expected to be paid in the next 12 months under purchase agreements and the $3.0 billion in advance payments as of September 29, 2024, both of which match the ground truth. The total obligation of $12.8 billion is also accurate. (2) However, there is a calculation error in the comparison: the LLM states the upcoming payment is 'about $6.6 billion – roughly three times – larger' than the advance payments. This is incorrect. The difference between $9.6B and $3.0B is $6.6B, but the ratio is $9.6B / $3.0B = 3.2, so it is about 3.2 times larger, not $6.6B larger. The phrasing 'larger than' should refer to the ratio or correctly describe the absolute difference. This misstatement affects quantitative accuracy. (3) The multi-hop reasoning is sound—correctly pulling data from the same note (Note 8, page 82) for both obligations and advance payments, and synthesizing them into a comparison. The entity and time period (Qualcomm, September 29, 2024) are correct. (4) The answer is highly relevant and mostly accurate, but the flawed comparison wording reduces correctness and quantitative accuracy slightly. Despite this, core facts and intent are preserved, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 354,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN‑adjustment reductions were $159 million in 2024 versus $134 million in 2023—a $25 million increase. This rise was driven by non‑U.S. revisions to clawback amounts that stemmed from VAT‑recoverable estimate adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the GTN adjustment reductions for 2024 ($159 million) and 2023 ($134 million) match the original answer, and the calculated difference of $25 million is correct. (2) The quantitative accuracy is perfect—numbers are correctly stated and the $25 million increase is accurately derived from the difference between $159M and $134M. (3) The non-U.S. factor—revisions in clawback amounts due to VAT recoverable estimate adjustments—is correctly identified and phrased with synonymous accuracy (e.g., 'VAT-recoverable estimate adjustments' = 'VAT recoverable estimates'). (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly compares two years of GTN reductions and attributes the change to a specific non-U.S. factor as required by the question. (5) The answer is contextually relevant, complete, and addresses both sub-questions directly. Minor wording differences (e.g., 'driven by' vs 'stemmed from') do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 308,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send extends Mastercard’s multi‑rail network into the disbursement and remittance space, letting consumers, businesses, governments and nonprofits send and receive money directly within digital applications and thus capturing new, non‑card payment flows. It does so by partnering with a broad ecosystem of digital‑messaging and payment platforms, central banks, fintech firms, financial‑institution partners, and government and nonprofit entities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mastercard Send enables disbursements and remittances for consumers, businesses, governments, and nonprofits, contributing to capturing new payment flows by expanding into non-card payment rails. The role in Mastercard's multi-rail strategy is correctly identified. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the answer correctly links Mastercard Send to the broader objective of capturing new payment flows and identifies the relevant partner ecosystems (central banks, fintechs, financial institutions, government and nonprofit entities), which matches the original answer. The mention of 'digital-messaging and payment platforms' adds slight nuance not explicitly in the 10-K-based ground truth but does not contradict it and may reflect broader context; however, the core ecosystems emphasized in the filing (central banks, fintechs, FIs, government/nonprofits) are all included. (4) The answer is contextually relevant, complete, and semantically equivalent to the original, with only minor rephrasing and no material omissions. One point deducted from qualitative accuracy because the emphasis on 'digital-messaging platforms' is not highlighted in the 10-K source, potentially introducing a peripheral detail not in the original filing. Otherwise, the response is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 413,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard’s rollout of Cyber and Intelligence Solutions adds a new line‑item to the “Other revenues” bucket – fees for products and services that prevent, detect and respond to fraud and secure transactions (see page 71).  Like all of its value‑added services, the cyber‑solution fees are recognized in the period the services are performed (or the related transactions occur), so the new offering both broadens the composition of Other revenues and drives its revenue to be recorded when the service is delivered in 2022 (see page 80).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Mastercard's Cyber and Intelligence Solutions contribute to the 'Other revenues' category, specifically through fees for fraud prevention and transaction security services—this matches the original answer's core claim. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the mention of '2022' is consistent and correct. (3) The reasoning is sound: the LLM correctly synthesizes that these services broaden the composition of 'Other revenues' and that revenue recognition occurs when services are performed or transactions occur—this reflects proper multi-hop understanding of both service categorization and accounting timing. (4) The LLM adds minor but accurate details (e.g., referencing page numbers 71 and 80, describing services as covering detection and response), which are plausible in a 10-K context and do not contradict the ground truth. The only reason for not scoring a 10 is that the original answer emphasizes the general principle of recognition timing as part of Mastercard’s net revenue structure, which the LLM implies but does not explicitly frame in structural terms. However, the semantic meaning and factual content are effectively equivalent. All entities—Mastercard, Cyber and Intelligence Solutions, 'Other revenues', 2022—are correct. The answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 408,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "CAT’s mortgage‑backed debt securities were valued at $452 million on 12/31/22 and $540 million on 12/31/23 – an $88 million increase in fair value【page_90】.  Over the same period the pretax unrealized loss fell from $42 million to $33 million, a $9 million improvement【page_90】, so the fair‑value gain far outpaced the modest reduction in unrealized losses.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. According to the ground truth, CAT's Mortgage-Backed Debt Securities fair value decreased from $327 million to $320 million (a $7 million decrease), whereas the LLM claims an increase from $452 million to $540 million ($88 million increase). Similarly, unrealized losses decreased from $31 million to $25 million (a $6 million improvement) in reality, but the LLM reports a drop from $42 million to $33 million (a $9 million improvement). These discrepancies indicate a complete mismatch in data. (2) Calculations are internally consistent in the LLM answer (e.g., $540M - $452M = $88M gain; $42M - $33M = $9M loss reduction), but they are based on incorrect source data, making the quantitative accuracy very low. (3) The multi-hop reasoning — comparing change in fair value to change in unrealized losses — is structurally sound in intent, but the entities and figures used are wrong, suggesting either misattribution to a different company or incorrect document extraction. The conclusion that 'fair-value gain far outpaced the reduction in unrealized losses' contradicts the ground truth where fair value declined slightly while unrealized losses improved — two opposing trends. (4) Due to pervasive factual errors in numbers, entities, and resulting logic, the correctness and accuracy scores are very low. Contextual relevance is slightly higher because the answer attempts the right comparison structure and references relevant financial concepts, albeit with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 428,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "Qualcomm’s corporate bonds and notes have a fair‑value total of **$4.634 billion**. The fair value of U.S. Treasury and government‑related securities is **$208 million**, which represents **about 3.8 %** of the total marketable securities fair value of **$5.451 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct key figures: corporate bonds and notes fair value is correctly stated as $4.634 billion (equivalent to $4,634 million in the ground truth), U.S. Treasury and government-related securities at $208 million, and total marketable securities at $5.451 billion. The percentage of 3.8% for U.S. Treasury and government-related securities is correctly reported. However, while the LLM mentions the 3.8% figure, it omits the explicit calculation or statement that corporate bonds and notes represent approximately 85% of total marketable securities, which was part of the original answer and directly addressed the comparative aspect of the question. This is a minor omission in completeness but does not undermine the core quantitative accuracy. All numbers are correct (allowing for format variation: $4.634 billion = $4,634 million), and the entities (Qualcomm, corporate bonds, U.S. Treasury securities, marketable securities) are correctly identified. The reasoning is sound, though the missing 85% weakens the multi-hop synthesis slightly. Contextual relevance is excellent as all provided information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 333,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "Merck obtains a six‑month pediatric market‑exclusivity award for Keytruda under the FDA Modernization Act, which is tacked onto the product’s compound‑patent term that otherwise ends in 2028 and onto two additional Keytruda patents that run to 2029 (see page 15, footnotes 7‑8). That extra half‑year of exclusivity (plus the 2029 patent extensions) keeps generic competition out, allowing Keytruda to continue driving Merck’s oncology sales—a multi‑billion‑dollar revenue stream—and thereby preserves that portion of oncology revenue for at least an additional six months beyond the original patent expiry (page 14‑16).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around dates and patent timelines not present in the ground truth. The original answer does not specify compound patent expiration in 2028 or additional patents running to 2029, nor does it mention the FDA Modernization Act. These specific dates and legal references are unsupported by the provided evidence sources and introduce false precision. (2) Quantitative accuracy is low because the LLM fabricates patent expiration years (2028, 2029) and implies a definite extension timeline that is not in the ground truth. The ground truth only confirms six months of pediatric exclusivity and potential for future Patent Term Extension (PTE) of up to five years, without specifying current patent expiry dates. Thus, the numerical claims about 2028 and 2029 are incorrect and not inferable from the evidence. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies pediatric exclusivity as a mechanism to delay generics and protect revenue, and links this to oncology sales impact, which aligns with the ground truth’s emphasis on delayed generic competition and revenue preservation. It also correctly infers financial significance. However, it overreaches by introducing unverified patent dates and legal mechanisms. (4) Despite the factual inaccuracies in dates, the answer captures the core concept—pediatric exclusivity extends market protection and benefits oncology revenue—and remains focused on the question. Hence, qualitative accuracy and contextual relevance are relatively high, but correctness is significantly reduced due to unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 456,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "Mastercard Installments, launched in 2022, adds an open‑loop “buy‑now‑pay‑later” product that links lenders with merchants across Mastercard’s acceptance network, giving consumers a new digital‑payment option that can be used on web, mobile and other digital touchpoints【page_8】. Because the solution expands the range of digital‑payment flows and is built on technology that “enables broader reach to scale digital payment services across multiple channels”【page_14】, it directly furthers Mastercard’s strategic priority to grow its core payments network and expand digital payments for consumers, businesses and governments across many channels【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Mastercard Installments was introduced in 2022 as an open-loop buy-now-pay-later solution connecting lenders and merchants across Mastercard’s network. It supports digital payment expansion across multiple channels, especially web and mobile, which matches the strategic goal described in the 2022 10-K. (2) Quantitative accuracy is perfect: the year 2022 is correctly cited, and no numerical values (e.g., dollar amounts) are present that could introduce error. Format and references to page numbers (e.g., page_8, page_14) suggest proper grounding in the source document. (3) Multi-hop reasoning is sound: the model correctly links the product launch (Mastercard Installments) to the broader strategic goal (expanding digital payments across channels) using supporting evidence from different parts of the filing. It references innovation, multi-channel reach, and network expansion, which reflects synthesis across sections. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the connection to 'multi-rail capabilities' or 'digital currency solutions'—components noted in the original answer as part of the broader innovation push. While the core strategic alignment is captured, this omission slightly reduces completeness in qualitative terms. However, the key mechanisms—open-loop BNPL, network integration, digital channel expansion—are all accurately conveyed. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 438,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Merck’s Cost of sales for the Lagevrio partnership was $554 million in 2024, while net sales were $964 million.  Because the partners split profits 50‑50, the profit‑sharing portion that Merck recorded as a cost to Ridgeback equals half of the $820 million total profit (net sales – Cost of sales), i.e., **$410 million** of profit‑sharing payments were included in Cost of sales for 2024【page_93】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($554 million Cost of sales, $964 million net sales, $820 million profit, $410 million payments) that are not present in the original answer or implied by the ground truth. The ground truth only states that 50% of profits were recorded in Cost of sales due to the equal profit split, with no mention of actual financial figures. These numbers appear fabricated or misattributed, as there is no support for them in the provided context. (2) The calculation of $964M - $554M = $410M is mathematically correct, but it is based on unsupported data. The LLM incorrectly assumes that half of total profit equals the amount recorded in Cost of sales, which may not align with accounting practices—profit-sharing payments could be structured differently (e.g., accrued liabilities, not direct COGS). (3) The multi-hop reasoning fails because the model invents financial data rather than relying on the known fact: the 50% profit split is the key determinant, and no numerical computation beyond that is warranted without explicit data. (4) While the LLM correctly identifies the 50-50 profit split and attempts to link it to Cost of sales, the introduction of unverified figures severely undermines factual accuracy. The contextual relevance is moderate because the general direction (profit sharing affecting COGS) is plausible, but the answer is largely incorrect due to quantitative fabrication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 402,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) gives BlackRock’s non‑UK funds – including those domiciled in its European subsidiaries – a fast‑track FCA registration so they can be marketed to UK retail investors. Under OFR, the consumer‑protection regime in the EU jurisdiction where a BlackRock fund is domiciled must be found equivalent to the UK’s consumer‑protection framework before the fund can be sold in the UK.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that under the Overseas Fund Regime (OFR), BlackRock's European-domiciled funds require an equivalence determination regarding consumer protection regimes between the EU jurisdiction of domicile and the UK in order to be marketed to UK retail investors. The mention of a 'fast-track FCA registration' adds contextual detail not in the original but aligns with the OFR's purpose and does not contradict it. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced not due to error but because the original emphasizes the potential need for structural or compliance adjustments, which the LLM omits—though this is a minor omission that doesn't undermine the core correctness. The reasoning is sound and reflects proper multi-hop synthesis between OFR rules, BlackRock’s European structures, and UK marketing implications. Contextual relevance is perfect, as the response directly addresses both parts of the question: interaction with European structures and equivalence requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 326,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom manufactures its proprietary FBAR filters in‑house (using its internal III‑V wafer fabs in the U.S. and Singapore) rather than outsourcing, which protects the unique FBAR process, speeds development and volume ramp‑up, and ensures high‑performance, low‑loss filters. Because FBAR filters are a core technology that lets cellular handsets operate more efficiently in a congested RF spectrum, this internal capability underpins Broadcom’s industry‑leading RF front‑end performance and secures a significant market share in the cellular handset market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor additional detail not present in the original. (1) All factual elements are correct: Broadcom manufactures FBAR filters in-house, which protects IP and accelerates time to market—key advantages cited in the ground truth. The LLM adds specific locations (U.S. and Singapore) and mentions III-V wafer fabs, which are plausible details consistent with public knowledge but not in the original answer; these do not contradict or distort the truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model correctly links internal manufacturing to IP protection and faster development, then connects that advantage to superior RF performance and market share in the cellular handset market. This reflects proper synthesis across technology, strategy, and market impact. (4) The answer is fully contextually relevant, directly addressing how Broadcom’s internal manufacturing strategy supports its competitive position. The only reason for not scoring a perfect 10 is that the original answer emphasizes 'protect intellectual property and accelerate time to market' as the primary mechanisms, while the LLM elaborates beyond that (e.g., 'high-performance, low-loss filters', 'industry-leading RF front-end performance')—still correct, but adds interpretive layering. Overall, the semantic meaning matches the ground truth, and the response exceeds expectations in clarity and coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 448,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck layers a patent‑term restoration (PTE) of up to five years—plus a six‑month pediatric add‑on under the FDA Modernization Act—with U.S. regulatory data/marketing exclusivity that grants biologics a twelve‑year protection period (seven years for orphan indications) from first approval【page_14】. By stacking the extended patent term with the long‑duration regulatory exclusivity, Merck can keep its biologic products off the market to competitors well beyond the normal patent life.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12-year U.S. regulatory data exclusivity for biologics and the additional 6-month pediatric exclusivity, which aligns with the ground truth. However, it introduces 'patent-term restoration (PTE) of up to five years', which is not accurate for biologics under the Hatch-Waxman Act—PTE typically applies to small molecule drugs, not biologics, and the Biologics Price Competition and Innovation Act (BPCIA) does not provide PTE in the same way. Additionally, the mention of 'seven years for orphan indications' is misleading in this context—while orphan drug exclusivity is seven years, it runs concurrently with the 12-year biologic exclusivity and does not replace it; the answer implies a shorter alternative period, which could confuse the duration. (2) Quantitative accuracy is partially correct: 12-year exclusivity and +6 months are accurate. But the 'up to five years' PTE is not applicable to biologics in the same manner as small molecules, making this a significant factual error. The seven-year orphan exclusivity is real but not a substitute for the 12-year period—so presenting it as an alternative duration is incorrect. (3) The reasoning shows good multi-hop synthesis in attempting to layer patent and regulatory mechanisms, and the concept of 'stacking' protections is valid and relevant. However, the incorrect application of PTE to biologics undermines the soundness of the reasoning. (4) Despite these issues, the core idea—that Merck combines patent extensions and regulatory exclusivity to maximize protection—is correct, and key durations (12 years + 6 months) are accurately stated. The answer is contextually relevant and well-structured, but the inclusion of inaccurate patent-term restoration details reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 491,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 UK Stewardship Code reforms – which the Financial Reporting Council is consulting on – add tailored reporting obligations for proxy advisers and investment consultants. Those new disclosure duties are expected to raise BlackRock’s UK compliance costs as it must expand reporting, monitoring and data‑collection processes, and they will also shape client engagement by requiring more granular stewardship and proxy‑voting disclosures and thus more intensive interaction with clients on those activities. (Source: 2024 10‑K, “UK Stewardship Code Review” – page 32)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2024 UK Stewardship Code reforms introduce tailored reporting requirements for proxy advisers and investment consultants, which impacts BlackRock’s compliance costs and client engagement. The mention of increased compliance costs due to expanded reporting, monitoring, and data collection is consistent with the original answer’s emphasis on heightened compliance obligations. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2024) and entities (UK Stewardship Code, BlackRock, FRC) are correctly identified. (3) The multi-hop reasoning is sound: the LLM correctly infers that new disclosure duties affect both compliance costs and client engagement through more granular stewardship reporting, which requires deeper client interaction. It also correctly identifies the source (2024 10-K, page 32) and context (FRC consultation). (4) The only minor shortcoming is that the LLM answer does not mention the regulatory risks highlighted in the ground truth—specifically, exposure to FCA sanctions, reputational risk, or client asset withdrawals due to non-compliance. While it covers the operational and engagement impacts well, this omission slightly reduces completeness in risk implications. However, the core of the question—impact on client engagement and compliance costs—is thoroughly and correctly addressed. Thus, the answer is semantically equivalent with high qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 438,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The AspenTech segment’s depreciation and amortization expense rose from $95 million in fiscal 2021 to $242 million in fiscal 2022 – an increase of $147 million (page 77). The footnote to the depreciation‑and‑amortization table notes that $148 million of the 2022 amortization of intangibles is directly related to the Heritage AspenTech acquisition, which essentially accounts for the jump in the segment’s expense (page 79).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar increase in depreciation and amortization expenses as $147 million, rising from $95 million in fiscal 2021 to $242 million in fiscal 2022, which matches the ground truth exactly. The calculation is accurate and the numbers are correctly cited. (2) The LLM adds a specific detail not present in the original answer—$148 million of the 2022 amortization is directly tied to the Heritage AspenTech acquisition—drawn from a footnote on page 79. While this figure is slightly higher than the total increase ($147M), it is plausible due to rounding or inclusion of related assets, and it supports the conclusion that the acquisition is the primary driver of the increase. This detail enhances the answer but introduces a minor discrepancy between the stated increase and the attributed amount. (3) The multi-hop reasoning is sound: the model connects the acquisition to the rise in amortization expenses via the recognition of intangible assets, consistent with the logic in the ground truth. It goes further by citing a specific dollar amount from the acquisition-related amortization, demonstrating strong synthesis across pages. (4) The answer is highly factually accurate, complete, and relevant. The slight over-attribution of $148M to an increase of $147M does not materially undermine correctness, especially given the source citation. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 422,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "The Asia Pacific region’s Subscriptions‑and‑Services revenue rose by **$24 million** year‑over‑year (from $720 million in FY 2021 to $744 million in FY 2022)【page_96†L9-L13】. This $24 million increase represents roughly **6.6 %** of the total global growth in Subscriptions and Services, which rose by $362 million (from $6,564 million to $6,926 million)【page_95†L9-L13】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the year-over-year revenue increase in the Asia Pacific region for Subscriptions and Services as $24 million, with accurate base figures ($720 million in FY2021 and $744 million in FY2022), which matches the ground truth. It also correctly states the total global segment growth of $362 million (from $6,564 million to $6,926 million). However, the critical error lies in the percentage contribution: the LLM claims the Asia Pacific increase represents 'roughly 6.6%' of global growth, whereas the ground truth states it contributed 'approximately 0.35%'. This is a major quantitative and conceptual error. The correct calculation is (24 / 362) ≈ 0.0663 or 6.63%, which suggests the LLM computed the percentage correctly but the ground truth claims 0.35%, which contradicts the math. Upon verification, 24/362 ≈ 6.6%, so the LLM's calculation is mathematically correct, but the original answer (ground truth) appears to contain an error. However, as the evaluation must be based on alignment with the provided ground truth, the LLM is marked incorrect for deviating from the stated 0.35%. (2) All numbers except the percentage contribution are accurate. The $24M increase and $362M global growth are correct. The percentage, while mathematically sound as 6.6%, does not match the ground truth’s 0.35%, which is likely a factual error in the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly pulled regional and global figures from different parts of the document and synthesized them to compute the contribution percentage. (4) Despite correct arithmetic and data extraction, the answer contradicts the ground truth on a key metric, leading to a reduced correctness score. The contextual relevance is high as all parts of the question are addressed with proper sourcing. Due to the conflict between logical calculation and provided ground truth, the score reflects partial correctness: numbers right, but final inference misaligned with expected answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 544,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The December 2023 FTC‑DOJ joint merger guidelines broaden the information and waiting‑period requirements for Hart‑Scott‑Rodino (HSR) filings, which raises antitrust scrutiny, increases pre‑merger costs and can delay or block deals—thereby limiting BlackRock’s ability to grow through strategic investments or acquisitions. The same expanded rules also tighten the constraints on any BlackRock‑managed funds that must file HSR‑reportable transactions, adding compliance burdens and restricting those funds’ ability to complete such deals.【page_16】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the 2023 joint merger guidelines by the FTC and DOJ, increased scrutiny on HSR-reportable transactions, higher costs, delays, and compliance burdens are all correctly identified. The impact on BlackRock’s acquisition strategy and managed funds is accurately described. (2) Quantitative accuracy is perfect: the date 'December 2023' aligns with the issuance of the guidelines (commonly recognized as December 2023), and no numerical figures requiring calculation are present. Format and timing are consistent with known facts. (3) Multi-hop reasoning is sound—LLM correctly links the updated merger guidelines to HSR filing requirements, then to impacts on BlackRock’s strategic growth via acquisitions, and further extends the logic to BlackRock-managed funds, demonstrating proper synthesis across regulatory and corporate entities. (4) Minor deduction in qualitative accuracy due to slightly stronger language ('can delay or block deals') compared to the more cautious 'may face delays' in the original, implying a higher certainty of deal blocking not explicitly stated in the ground truth. However, this does not constitute a factual error, as increased scrutiny can indeed result in blocked deals. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 390,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs discloses two separate award forms for its non‑employee directors – a stock‑settled RSU agreement (Exhibit 10.31) and a cash‑settled RSU agreement (Exhibit 10.32) 【page_6】.  The stock‑settled RSUs are accounted for under ASC 718 as equity‑classed compensation, with expense recognized over the vesting period and the award recorded in additional paid‑in capital, while the cash‑settled RSUs are treated as a liability under ASC 480, with expense recognized over the service period and a liability measured at fair value (re‑measured each reporting period) that appears on the balance sheet as a liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Goldman Sachs uses both stock-settled and cash-settled RSUs for non-employee directors, with different accounting treatments based on settlement type. Stock-settled RSUs are classified as equity under ASC 718 (equivalent to GAAP treatment in ground truth), while cash-settled RSUs are treated as liabilities under ASC 480, requiring fair value remeasurement each reporting period—this aligns with the original answer’s claim about liability classification and remeasurement. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all referenced exhibits and standards are correctly cited. One minor discrepancy: the LLM cites Exhibit 10.31 for stock-settled RSUs, while the ground truth references Form 10.8; however, this may reflect differences in document version or exhibit numbering across filings and does not constitute a factual error given that both refer to valid award forms. (3) The multi-hop reasoning is sound—correctly linking settlement method to accounting classification (equity vs. liability) and explaining the implications for expense recognition and balance sheet presentation. (4) The answer is contextually complete and relevant, addressing both the accounting treatment and financial statement classification as required by the question. The use of specific ASC references adds precision. The only reason for not scoring a 10 is the slight variance in exhibit number citation, but this does not affect the correctness of the underlying accounting principles described, which are fully aligned with GAAP and the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 481,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "Abbott granted **4,981,231 restricted stock units** under its 2017 Incentive Stock Program in 2023. The program documentation states that restricted stock units **vest over three years**, and when they vest the recipient receives one share of Abbott stock for each vested unit【page_60】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurate and matches the original answer exactly. (2) The vesting condition is correctly described: the units vest over three years, and each vested unit results in one share of Abbott stock, which aligns precisely with the program documentation. (3) The answer addresses both parts of the multi-hop question: the quantity of RSUs granted and the specific vesting condition. (4) The reasoning is sound, with correct entity identification (Abbott Laboratories, 2017 Incentive Stock Program, 2023 grant year), and the information is synthesized accurately from the relevant source. (5) Semantic equivalence is maintained — the wording differs slightly but conveys the same factual content. The citation to 'page_60' further supports contextual grounding. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 277,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "In 2024, 35 % of Danaher’s Life Sciences segment sales came from regions outside North America (44 %) and Western Europe (21 %) – 7 % from other developed markets plus 28 % from high‑growth markets (page_8). The segment was created in 2005 through the acquisition of Leica Microsystems, and that deal seeded a global platform that has since expanded well beyond its original NA‑Western‑Europe base, now generating a sizable share of revenue from fast‑growing international markets, illustrating the long‑term strategic payoff of the Leica acquisition (page_8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that 35% of Danaher's 2024 Life Sciences segment sales came from regions outside North America (44%) and Western Europe (21%), with 28% from high-growth markets and 7% from other developed markets—matching the ground truth exactly. All percentages are accurate and properly summed (28% + 7% = 35%). (2) Quantitative accuracy is perfect: the numbers align with the original answer, including correct segmentation and implied calculation. Format variations (e.g., using '35 %' with a space) do not affect correctness. (3) The reasoning correctly identifies the 2005 acquisition of Leica Microsystems as the foundational step for global expansion and links it to long-term strategic impact. However, while the original answer explicitly names subsequent acquisitions (Beckman Coulter, Pall, Abcam) as part of the expansion enabled by Leica, the LLM answer refers more generally to expansion without listing these key acquisitions, resulting in a minor omission in qualitative completeness. This does not invalidate the logic but slightly reduces precision in multi-hop synthesis. (4) The answer is contextually fully relevant, directly addressing both the geographic distribution and the strategic impact of the 2005 acquisition. The minor omission of specific follow-on acquisitions prevents a perfect qualitative score, but overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 408,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has completed nine acquisitions in its Life Sciences segment since the business was launched in 2005. Pall was acquired in 2015, and the most recent acquisition noted in the filing is Abcam, which was added in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Danaher has made nine acquisitions, while the ground truth confirms eight acquisitions since 2005. This is a critical factual error affecting the core of the question. However, the LLM correctly identifies the year of acquisition for Pall (2015) and the most recent acquisition, Abcam, in 2023, which are key components of the query. (2) Quantitative accuracy is partially correct: the years 2015 and 2023 are accurate, but the total count of acquisitions (9 vs. 8) is wrong. No calculations were required, but enumeration is off by one. (3) The multi-hop reasoning is mostly sound—the model correctly links Danaher’s Life Sciences segment to acquisitions over time and identifies two specific milestones (Pall and Abcam). However, it fails in complete synthesis by including an extra, unverified acquisition not listed in the ground truth, suggesting either a hallucination or miscount. (4) Contextual relevance is high as the answer directly addresses the question’s focus on acquisition count, Pall’s acquisition year, and the most recent acquisition. Despite the numerical inaccuracy, the answer remains on-topic and provides relevant entities and years. The qualitative reasoning is logical but based on incorrect data, likely due to incomplete or erroneous source information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 372,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "Abbott’s interest‑rate hedge contracts were valued at **$210 million on December 31, 2020** and **$87 million on December 31, 2021**, a **decrease of $123 million**. The receivable balance for these hedges moved from **$210 million to $87 million** over the same period, so the $123 million drop in fair value directly reflects the same reduction in the contracts’ receivable position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: fair value of $210 million on December 31, 2020, and $87 million on December 31, 2021, with a correct difference of $123 million. The receivable position is also correctly stated as decreasing from $210 million to $87 million. (2) The calculation of the $123 million decline is accurate and clearly presented. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: it correctly links the change in fair value to the change in receivable position, noting that the drop in fair value directly reflects the reduction in the receivable balance. (4) All entities—Abbott, interest rate hedge contracts, correct dates, and financial metrics—are accurately identified and used. The answer is semantically equivalent to the original, with slightly more concise wording but no loss of meaning. All parts of the question are addressed: the change in fair value and its relationship to the receivable position. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 305,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMS’s strategy emphasizes expanding its autologous CAR‑T franchise—building manufacturing capacity, adding new targets and pursuing additional Breyanzi indications such as CLL, FL and MCL (see page 43).  That focus is reflected in the market: U.S. sales of Breyanzi doubled in 2023, driven by higher demand as the product’s label and pipeline broadened (see page 52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY (Bristol Myers Squibb, referred to as BMS) expanded its autologous CAR-T franchise with a focus on new indications for Breyanzi—specifically CLL, FL, and MCL—which matches the original answer. The U.S. sales of Breyanzi doubling in 2023 is correctly stated, consistent with the ground truth. (2) Quantitative accuracy is perfect: 'doubled in 2023' correctly reflects the reported revenue growth; no calculations are required beyond this comparison, and the year 2023 is accurate. (3) Multi-hop reasoning is sound—the model connects strategic focus (pipeline expansion, new indications) to commercial outcome (doubled U.S. revenues), citing increased demand due to label and pipeline broadening, which logically explains the revenue growth. (4) Minor deduction in qualitative accuracy due to reference to 'page 43' and 'page 52', which, while possibly accurate in source documents, are not part of the ground truth and introduce extraneous detail. Also, the use of 'BMS' instead of 'BMY' is common but slightly less precise to the ticker used in the question. However, this does not impair understanding. Overall, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 363,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The Binding Site Group purchase required a cash outflow of $2.70 billion in 2023 【page_23】.  That amount made up the bulk of the company’s total acquisition cash outlays that year – $2.70 billion for The Binding Site Group plus $0.91 billion for CorEvitas, LLC, for a combined $3.61 billion of cash used for acquisitions in 2023 【page_23】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.70 billion for The Binding Site Group, $0.91 billion for CorEvitas, LLC, and a total of $3.61 billion in cash used for acquisitions in 2023. The calculations are correct (2.70 + 0.91 = 3.61). (2) The answer is complete, addressing both parts of the question: the cash outflow for The Binding Site Group and its contribution to the total acquisition spend including CorEvitas. (3) Entity accuracy is perfect: both company names are correctly identified, and the year 2023 is consistently referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by combining data from two acquisitions to compute the total cash outflow. The use of 'made up the bulk' is a reasonable qualitative interpretation and does not distort the facts. (5) The semantic meaning is equivalent to the original answer, with only minor rewording. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 288,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The company says the restructuring actions that produced roughly $0.3 billion of charges in each of 2024 and 2023 are expected to yield about $0.2 billion and $0.6 billion of annual cost savings, respectively – a combined $0.8 billion in savings. The 2023 acquisition of The Binding Site Group added specialty diagnostic assays and instruments for blood‑cancer and immune‑system disorders (especially multiple‑myeloma), expanding the Specialty Diagnostics portfolio and fueling its strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total estimated annual cost savings of $0.8 billion, with $0.2 billion from 2024 restructuring charges and $0.6 billion from 2023 charges, matching the ground truth exactly. The combined total is accurate and properly broken down. (2) All numeric values are correct and consistent with the original answer; format variations like '$0.2 billion' vs '$0.2 billion' are acceptable and do not affect accuracy. Calculations (sum of $0.2B + $0.6B = $0.8B) are accurate. (3) The multi-hop reasoning is sound: the model correctly links restructuring charges in 2023 and 2024 to their respective cost savings and synthesizes the strategic impact of The Binding Site Group acquisition on the Specialty Diagnostics segment. The acquisition's contribution—adding diagnostic assays and instruments for blood cancers, particularly multiple myeloma—is accurately described and aligned with strategic growth. (4) The only minor difference is that the LLM slightly broadens the scope by mentioning 'immune-system disorders,' which is not in the ground truth, but this does not contradict it and may reflect additional context from the source. Otherwise, the answer is factually complete, semantically equivalent, and highly relevant. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this slight over-specification, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 398,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest‑term debt instrument shown in the filing is the **1.375 % Notes due 2061**【page_1】. Its maturity in 2061 is later than all the other listed notes, which mature in 2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049 and 2051.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) The longest-term debt instrument is correctly identified as the '1.375% Notes due 2061', which aligns with the original answer. (2) The maturity year 2061 is accurately stated and correctly compared to other debt instruments. While the original answer highlights specific examples (e.g., 0.500% Notes due 2033, 1.125% Notes due 2051), the LLM provides a more comprehensive list of maturity years (2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049, 2051), all of which are earlier than 2061, reinforcing the correctness of the comparison. (3) The multi-hop reasoning is sound: the model correctly identifies the latest maturity date among multiple debt instruments and logically concludes that 2061 is the longest-term. (4) All entities (Eli Lilly, debt instrument, percentages, years) are accurate. Minor formatting differences (e.g., spacing in '1.375 %') do not affect meaning. The answer is semantically equivalent and factually precise, warranting full scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 304,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is being pursued for **two** distinct indications – early Alzheimer’s disease (submitted for regulatory review in the U.S., EU and Japan) and pre‑clinical Alzheimer’s disease (currently in a Phase III trial)【page_42】.  \nLebrikizumab is linked to **one** indication, atopic dermatitis, which has been approved in the EU and Japan and is under regulatory review in the U.S.【page_42】.  \n\nThus, Donanemab covers twice as many indications as Lebrikizumab.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Donanemab is under development or review for two indications (early and preclinical Alzheimer’s disease), and Lebrikizumab is associated with one indication (atopic dermatitis). The comparison stating Donanemab covers twice as many indications is logically sound and semantically equivalent to saying it is being developed for more indications. (2) The answer correctly identifies all entities and their associated indications, regulatory statuses, and regions (U.S., EU, Japan), aligning with the original answer. (3) Multi-hop reasoning is properly executed: the model synthesizes information across both drugs, correctly distinguishing between development status and regulatory approval/review across geographies. (4) The answer is contextually relevant, complete, and conveys the same conclusion as the ground truth—Donanemab is being developed for more indications than Lebrikizumab—while adding slightly more detail about regulatory submissions without introducing error. Minor wording differences (e.g., 'twice as many' vs 'more') do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 335,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The entry of multiple generics caused Alimta’s U.S. revenue to plunge ≈ 77 % (to $72.9 M in 2023 versus $927.7 M in 2022) and its volume to fall, which “partially offset” the overall U.S. volume increase of 11 % in 2023 【page_48】.  However, the net U.S. volume growth was still driven higher by gains from the oncology drug Verzenio, which added volume in 2023 【page_47】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims Alimta's U.S. revenue dropped from $927.7M in 2022 to $72.9M in 2023 (≈77% decline), but this is factually incorrect — a 77% decline would imply a drop to around $215M, not $72.9M. Moreover, the actual decline and specific figures are not supported by the ground truth, which does not provide exact dollar amounts or percentages. Thus, the inclusion of precise numbers without proper sourcing or accuracy undermines the answer. (2) The ground truth does not mention a specific '11% overall U.S. volume growth' or attribute it to 2023; this figure is absent from the original answer and appears to be fabricated or misattributed. (3) On qualitative accuracy, the LLM correctly identifies that Alimta’s revenue decline due to generics negatively impacted U.S. volume growth and that Verzenio contributed positively — this aligns with the ground truth. However, it omits mention of Trulicity as another contributing product, which is a notable omission in completeness. Trulicity is not an oncology drug (it’s for diabetes), so its inclusion in the original answer may be contextually questionable, but since the ground truth explicitly lists it, the LLM should have included it or clarified. (4) Contextually, the answer is relevant and addresses the core question about Alimta’s impact and offsetting products. The reasoning structure is sound — it acknowledges the negative impact and partial offset by other products — but the addition of unsupported numerical data reduces credibility. Overall, the answer gets the directional logic right but fails on key quantitative details and completeness, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 470,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Merck paid a $250 million upfront option fee for V940 (mRNA‑4157) in 2022 and, under the collaboration with Moderna, will split all future development expenses 50/50 (“share costs … equally”)【page_90】.  This investment is a cornerstone of Merck’s immuno‑oncology pillar – adding an individualized neo‑antigen vaccine to be combined with Keytruda and expanding its portfolio of next‑generation cancer‑immunotherapy combinations as outlined in the 2023 10‑K【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $250 million payment in 2022 and the 50/50 cost-sharing arrangement with Moderna for V940 (mRNA-4157), which matches the ground truth. The financial figures and timing are accurate, and the format variation ($250 million vs $250 million) is acceptable. 2) Quantitatively, all numbers and dates are correct: the $250 million upfront fee and the equal cost-sharing are explicitly stated and align with the original answer. No calculations were required, but the synthesis of financial commitment is accurate. 3) The reasoning is sound: the LLM correctly links Merck’s financial commitment to its broader immuno-oncology strategy, referencing the combination with Keytruda and the strategic intent to expand next-generation immunotherapy combinations. It cites the 2023 10-K as the source, which is contextually appropriate. However, it omits specific mention of the Phase 3 trials (INTerpath-001 and INTerpath-002) and the Breakthrough Therapy and PRIME designations, which are key elements in the ground truth that underscore the program’s strategic importance. This is a minor omission affecting completeness but not the core factual accuracy. 4) The answer is semantically equivalent in conveying Merck’s financial and strategic commitment, with only slight loss of detail. The contextual relevance is high, as it directly addresses both parts of the question—financial commitment and strategic alignment—using correct entities (Merck, Moderna, V940, Keytruda) and correct timeframes. The citation of page numbers adds precision. Final score reflects high accuracy with a minor deduction for incomplete qualitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 453,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "MK‑7962’s compound patent is listed to expire in 2027, while the granted method patents covering its use run until 2037 (absent any PTE)【page_16】. Because biologics receive a 12‑year data‑exclusivity term in the U.S.【page_14】, the ten‑year gap between 2027 and 2037 could provide up to 10 additional years of U.S. patent protection beyond that standard exclusivity period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and dates are accurate: the method patents expire in 2037, the compound patent in 2027, and the 10-year gap is correctly calculated. The 12-year U.S. biologic data exclusivity period is correctly stated. (2) The calculation of 10 additional years of patent protection beyond the exclusivity period is sound: if approval occurs in 2027, data exclusivity would last until 2039, but since method patents expire in 2037, the protection ends then—yielding 10 additional years (2027–2037) of patent coverage post-approval, which overlaps with but extends beyond exclusivity. (3) The reasoning is mostly sound and reflects multi-hop synthesis: it connects approval year (implied 2027), data exclusivity duration, and patent expiry. However, the answer slightly mischaracterizes the relationship: the additional protection is not 'beyond' the full 12-year exclusivity period if exclusivity lasts until 2039 (2027+12), but rather the patents expire *before* exclusivity ends. Still, the intended meaning—that patents add 10 years of protection from approval—is consistent with the original answer’s logic. (4) Entity accuracy is perfect: MK-7962, sotatercept, patent types, and years are correct. Wording differs slightly but maintains semantic equivalence. Minor deduction in qualitative accuracy due to slight imprecision in framing the overlap between patent term and exclusivity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 411,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "The excerpts provided (pages 108‑112) do not contain the fair‑value figures for Emerging‑Markets‑Equities holdings in Merck’s U.S. or International pension plans, nor the NAV‑based amounts for 2022 and 2023. Consequently, the total increase in those investments cannot be determined from the information shown.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide the correct information. (1) The original answer states that the total increase in Merck's fair value of Emerging Markets Equities investments from 2022 to 2023 was $106 million, with a $33 million increase in U.S. Pension Plans and a $73 million increase in International Pension Plans. The LLM claims the data is not available in the excerpts, but the ground truth implies it was present in the source documents (pages 108–112), so the LLM failed to extract or report it. (2) No numbers were reported, so there is no quantitative accuracy. The correct calculation is $740M - $707M = $33M (U.S.) and ($66M - $59M) + ($110M - $111M) = $7M - $1M = net $6M from direct holdings and funds — however, the original answer interprets the International increase as $73M, suggesting a different breakdown; regardless, the LLM did not attempt any calculation. (3) The multi-hop reasoning required — aggregating changes across U.S. and International plans, possibly across different tables or footnotes — was entirely missed. The LLM defaulted to 'not provided' instead of synthesizing. (4) The response is irrelevant because it denies the existence of data that the ground truth confirms is present. All scores are minimal due to complete factual inaccuracy and lack of synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 368,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of Gilead’s U.S. government‑agency securities rose from **$35 million at 12/31/2022 to $127 million at 12/31/2023**, a **$92 million increase**. In the same period, the estimated fair value of its U.S. Treasury securities grew from **$410 million to $426 million**, a **$16 million increase**. Thus, the gain in agency‑security value was about **$76 million larger (roughly six times) than the gain in Treasury‑security value**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, the estimated fair value of U.S. government agencies securities increased from $21 million to $127 million, a $106 million increase. However, the LLM reports a rise from $35 million to $127 million, calculating a $92 million increase—both the starting value and the change are incorrect. More critically, the LLM states that U.S. Treasury securities increased from $410 million to $426 million (a $16 million gain), whereas the ground truth shows a decrease from $379 million to $426 million—this is a contradiction: the LLM incorrectly frames a $34 million decline as a $16 million increase. This error fundamentally misrepresents the trend. (2) Calculations are internally consistent within the LLM's incorrect numbers (e.g., $127M - $35M = $92M), but the inputs are wrong, leading to false conclusions. The comparison claiming agency gains were 'six times' larger than Treasury gains is invalid because Treasuries actually declined in value. (3) The multi-hop reasoning is structurally sound—the model attempts to compare changes in two asset classes over time—but fails due to incorrect data retrieval or synthesis. It identifies the correct entities (GILD, U.S. government agencies securities, U.S. Treasury securities) and time frame (Dec 31, 2022 to Dec 31, 2023), showing awareness of required comparisons. (4) Contextual relevance is high as the answer addresses both parts of the question and attempts a comparative analysis. However, due to major quantitative inaccuracies in both input values and resulting calculations, the correctness and quantitative accuracy scores are low. The qualitative accuracy is slightly higher because the reasoning framework is appropriate, even if based on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 497,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy’s sales rose from $10.39 billion in 2022 to $11.85 billion in 2023 – a 14 % increase (U.S., Europe and other markets combined)【page_40】.  The product’s U.S. and EU patents run through 2033, and Gilead’s other key HIV drugs (e.g., Descovy, Vemlidy, Odefsey, Genvoya) are protected until 2029‑2033【page_9】.  This growth provides strong cash flow that can fund R&D, acquisitions and portfolio diversification, helping Gilead offset the revenue impact of the upcoming HIV‑product patent cliffs and sustain its long‑term financial strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Biktarvy's revenue as $11.85 billion in 2023 and $10.39 billion in 2022, matching the ground truth values (allowing for format variation: $11,850 million = $11.85 billion). The 14% growth is accurately calculated: (11.85 - 10.39) / 10.39 ≈ 0.14. (2) All numeric values, including the percentage increase and patent timelines (2029–2033 for key HIV drugs, Biktarvy patents through 2033), are factually correct and consistent with the original answer and typical 10-K disclosures. (3) The multi-hop reasoning is sound: the model correctly links Biktarvy’s revenue growth to Gilead’s long-term financial strategy, referencing patent protection timelines and the strategic use of cash flow for R&D and diversification to mitigate future patent cliffs. While the original answer emphasizes the risk of generic competition if patents expire sooner, the LLM answer complements this by highlighting proactive strategies (R&D, acquisitions), which are contextually valid and supported by typical corporate behavior. (4) The only minor gap is that the LLM answer does not explicitly state the risk to growth sustainability from potential generic competition upon patent expiration—this nuance is present in the original answer. However, the core implications for financial strategy are accurately conveyed. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 424,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "Gilead’s business is organized as a single operating segment, with the CEO acting as the chief operating decision‑maker who allocates capital across the entire company on an entity‑wide basis (see page 58).  The impending loss of U.S. patent protection for Truvada—a core HIV product listed in its portfolio (page 58)—will shave revenue from that line and therefore reduce the cash pool that can be drawn on for HIV lifecycle‑management work; at the same time, the centralized allocation model gives the CODM the flexibility to shift resources from other therapeutic areas to sustain new HIV combinations or reformulations if the company judges them strategically essential (see the broader patent‑expiration context for its HIV products in page 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Gilead's single operating segment structure, centralized capital allocation via the CEO as CODM, Truvada's role in the HIV portfolio, and the 2023 U.S. patent expiration (implied by 'impending' in context) are all correctly identified. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 based on correct handling of dates and logical consistency. (2) The answer addresses all parts of the question: it explains how the patent expiration will reduce revenue and thus constrain investment in lifecycle management, while also noting the mitigating effect of centralized resource allocation that allows strategic reallocation from other areas. (3) Multi-hop reasoning is sound: the model correctly synthesizes the structural aspect (centralized allocation) with the financial impact (revenue loss from Truvada generics) and strategic implications (potential to redirect funds if HIV initiatives are prioritized). (4) Semantic equivalence is strong—while the LLM adds detail about the CEO as CODM and cites specific pages, the core message matches the original: patent loss threatens funding for lifecycle initiatives, but centralized control provides flexibility. The only minor gap is the lack of explicit mention of 'generic competition' as the mechanism for revenue decline, though this is implied by 'shave revenue from that line' due to patent expiration. This does not detract significantly from accuracy. All scores reflect high fidelity to the ground truth, with a 9 on correctness due to this slight omission in explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 464,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement required that certain brokerage‑client deposits be swept off‑balance‑sheet to the TD Depository Institutions, so Schwab’s capital‑management plan now explicitly includes supporting the future migration of those balances and maintaining enough capital to absorb the incremental deposits 【page_59】. The buy‑down of fixed‑rate obligations under the IDA created contract assets that are amortized on a straight‑line basis, producing $85 million of amortization expense in 2023 【page_61】【page_96】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of the 2023 IDA Agreement on Schwab's capital management strategy—specifically, sweeping brokerage client deposits off-balance sheet to TD Depository Institutions and supporting future migration of balances. It also correctly notes the creation of contract assets from the buy-down of fixed-rate obligations and their amortization. The dollar amount of $85 million in amortization for 2023 matches the ground truth. However, the LLM incorrectly labels this as 'amortization expense,' while the original answer specifies it is amortized as a reduction to bank deposit account fee revenue, not an expense. This mischaracterization affects qualitative accuracy. (2) Quantitatively, the $85 million figure is accurate and correctly attributed to 2023; no calculation errors are present. Format is consistent and acceptable. (3) The multi-hop reasoning is largely sound—linking the IDA Agreement to capital management and contract asset amortization—but the failure to accurately describe the income statement treatment (revenue reduction vs. expense) indicates a partial misunderstanding of the financial mechanism. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in correctness and qualitative accuracy due to the misclassification of the amortization impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 376,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "In 2023 the long‑term incentive performance (LTIP) units added **$14.7 million** to total equity, while the “issuance of unit equivalents and other (50,658 common units)” reduced total equity by **$16.1 million**. Together those transactions produced a **net decline of roughly $1.4 million** in SPG’s total equity for the year 2023【page_95†L31-L38】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) The numbers are incorrect: the ground truth states issuance of limited partner units added $197,426 (not mentioned), LTIP units added $14,739 (LLM reports $14.7 million, off by ~1,000x), redemption of limited partner units reduced equity by $13,524, and treasury purchases reduced equity by $140,593. The LLM incorrectly states that 'issuance of unit equivalents and other' reduced equity by $16.1 million, which does not align with any single transaction in the ground truth. (2) The net effect in the ground truth is a reduction of $139,378, but the LLM reports a net decline of only $1.4 million, which is off by more than 10x. (3) The reasoning is flawed: the LLM fails to correctly identify and synthesize the multiple components (issuances, redemptions, treasury purchases) that constitute the net equity change. It incorrectly frames 'issuance of unit equivalents' as a reduction in equity, which contradicts standard accounting (issuances typically increase equity unless they represent buybacks). (4) The citation references page 95, lines 31–38, but the data there likely refers to different transactions (possibly treasury activity), and the LLM misinterprets the context. The answer is partially relevant to the question and attempts to address unit-related equity changes, but the severe numerical inaccuracies and flawed logic undermine its correctness. Minor credit is given for recognizing that LTIP units increased equity and that overall unit activities had a net negative impact, though even the direction of net change is misrepresented in magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 446,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde supplies its process gases from on‑site or adjacent cryogenic plants that are built and operated for the customer. These arrangements are “total‑requirement” contracts that usually run 10‑20 years, include minimum‑purchase commitments and price‑escalation provisions (see p. 89). Because the customer receives the gas continuously, Linde treats the obligation as satisfied over time and, under ASC 606, recognizes revenue as the product is delivered and the company has the right to invoice (using the practical expedient for measuring progress), which creates contract assets/liabilities and a large pool of future minimum‑purchase consideration (≈ $58 bn) (see p. 87‑89, 88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Linde's on-site distribution leads to 10–20 year total requirement contracts with minimum purchase commitments and price escalation clauses. Revenue is recognized over time as product is delivered, consistent with ASC 606 and the right to invoice, which matches the original answer. (2) Quantitative accuracy is excellent: the ≈$58 billion figure for future minimum-purchase consideration is correctly cited (present in the 2024 10-K, p. 88), and page references (87–89) align with the disclosed contract structure and accounting policy. Format variation (≈$58 bn) is acceptable. (3) Multi-hop reasoning is sound—LLM correctly links on-site distribution → long-term contracts → revenue recognition policy under ASC 606, demonstrating synthesis across operational and accounting disclosures. (4) The only minor shortcoming is that the original answer emphasizes the alignment of revenue recognition with 'continuous delivery through pipelines' and 'large-volume customers,' which the LLM mentions implicitly but could have stated more explicitly. However, the core reasoning and facts are fully preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses distribution model, contract structure, and revenue recognition as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 386,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The marketable‑securities table (page 77) and the fair‑value hierarchy table (page 79) both list corporate notes and obligations at $2,978 million for 2024 and $3,354 million for 2023, so the two tables are consistent – the difference between them is $0. In contrast, total marketable securities’ fair value rose from $5,492 million in 2023 to $5,722 million in 2024, an increase of $230 million, a change far larger than the zero‑difference in the corporate‑notes line.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the two tables show the same values for corporate notes and obligations ($2,978M in 2024 and $3,354M in 2023) and concludes the difference between tables is $0. However, the question asks for the difference in fair value *between the two disclosed tables*, not across time. The ground truth indicates a change over time (from $3,354M to $2,978M), not inconsistency between tables. The LLM misinterprets the question as asking whether the two tables report different values, when in fact it asks for the temporal difference in fair value for corporate notes and how that compares to the overall change in marketable securities. (2) Quantitatively, the individual numbers are accurate: $2,978M, $3,354M, $5,492M, $5,722M, and the $230M increase in total marketable securities are all correct. However, the calculation of the difference in corporate notes is misapplied — while $3,354M - $2,978M = $376M (correct in ground truth), the LLM reports a $0 difference due to misinterpretation. (3) The multi-hop reasoning fails: the model does not correctly synthesize that the question requires comparing the *change over time* in corporate notes to the *change over time* in total marketable securities. Instead, it compares two tables' consistency, which is not the question. This reflects a fundamental misunderstanding of the query. (4) Despite accurate sourcing of numbers, the incorrect interpretation of 'difference between the two disclosed tables' as cross-table inconsistency rather than longitudinal change leads to a mostly incorrect answer. The contextual relevance is moderate because it discusses the right documents and figures but answers a different question. Hence, low correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 493,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "Changing provider behavior—such as hospitals and other providers altering utilization or pricing to protect their revenues—creates volatility in health‑care cost trends, making it harder for CVS to forecast the costs that underlie its insured‑benefits premiums. Because those premiums are locked in for a fixed, generally twelve‑month period, any cost increase that exceeds the forecast cannot be recovered through higher rates, so even modest forecast errors translate into lower margins and can materially depress the Health Care Benefits segment’s operating results. 【page_41】 【page_40】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that changing provider behavior (e.g., efforts to maintain revenue) increases cost volatility and undermines forecast accuracy for CVS's premium pricing. It notes that premiums are fixed for a set period (specified as generally twelve months), preventing mid-course corrections, and that even small forecast errors can materially impact operating results due to high sensitivity of profits—this aligns with the original answer. (2) There are no explicit numbers (e.g., 94%) in the LLM answer, but the omission does not affect factual correctness; all referenced facts (fixed premiums, forecast sensitivity, provider behavior impact) are consistent with the source. The mention of a 'generally twelve-month period' is a reasonable inference and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model connects provider behavior → cost trend uncertainty → forecasting difficulty → fixed premiums preventing adjustment → profit sensitivity → adverse operating results. This synthesis across cause-effect链条 is logically coherent and matches the knowledge graph. (4) The only minor gap is the absence of the specific 94% figure for Insured Health Care Benefits' share of segment revenues, which adds precision in the original. However, the LLM still captures the essential economic mechanism and risk. Wording differs but semantic meaning is equivalent. Thus, correctness is excellent, with only a slight deduction for missing a key quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 436,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron’s October 2020 acquisition of Noble added roughly 6,000 cf/d of natural‑gas for each barrel of oil‑equivalent, raising total oil‑equivalent production (the net‑production table notes “includes production associated with the acquisition of Noble” 【page_8】) and helping generate higher operating cash flow (cash provided by operating activities rose to $29.2 billion in 2021 versus $10.6 billion in 2020) 【page_44】.  That larger, more diversified production base gives Chevron extra cash‑generating capacity and the flexibility to curtail capital spending or share‑repurchase programs, which it cites as the reason it can continue paying dividends and preserve its AA‑ (S&P) and Aa2 (Moody’s) debt ratings even during extended periods of low commodity prices 【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns well with the ground truth. It correctly identifies Chevron's acquisition of Noble in October 2020 and the 6,000 cubic feet of natural gas per barrel of oil-equivalent, which matches the conversion standard (6,000 cf = 1 barrel of oil equivalent). The mention of increased production and higher operating cash flow is supported by the cited figures: $29.2 billion in 2021 vs. $10.6 billion in 2020, which reflects a real increase and supports the narrative of enhanced cash flow post-acquisition. (2) Quantitatively, the numbers are accurate and appropriately cited from the document (pages 8, 44, 45). The only minor imprecision is the phrasing '6,000 cf/d' — it should be '6,000 cubic feet of natural gas per barrel of oil-equivalent' rather than 'per day', as the original refers to a production ratio, not a daily rate. However, this is a subtle distinction and likely a wording oversight rather than a factual error. (3) The multi-hop reasoning is sound: the model connects the acquisition → increased production → higher cash flow → ability to adjust capital spending and buybacks → maintenance of strong credit ratings (AA-/Aa2). This synthesis across financial performance, strategic flexibility, and credit rating outcomes is logically coherent and well-supported. (4) The answer is semantically equivalent to the ground truth, with slightly more specific financial data (exact cash flow numbers) and document citations, enhancing credibility. The core explanation — that expanded production enhances financial resilience and supports credit ratings during low-price environments — is fully preserved. Minor deduction in quantitative accuracy due to the 'cf/d' misstatement, but overall correctness remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 484,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab elected to buy down $5 billion of fixed‑rate obligation amounts in 2023, incurring market‑based fees of **$249 million**.  Those fees were **capitalized as contract assets** and are presented within **other assets** on the consolidated balance sheet【page_103】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement. The dollar amounts match exactly, with acceptable formatting variation ($249 million vs $249 million). (2) The classification on the balance sheet is correctly stated: the amount was capitalized as contract assets and included in other assets, matching the original answer. (3) The multi-hop reasoning is sound—information about the transaction amount, its purpose, and accounting treatment is synthesized correctly from the source. (4) The citation to page_103 adds contextual support. No factual, numerical, or conceptual errors are present. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 246,
        "total_tokens": 1373
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded a **$483 million store‑impairment charge** in 2024 tied to its enterprise‑wide restructuring plan (see page 153).  The same plan is projected to deliver **cost savings of more than $500 million in 2025** (see page 76), so the expected 2025 savings exceed the 2024 impairment charge.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $483 million store impairment charge in 2024 and the 'more than $500 million' cost savings projected for 2025 are accurately reported, with acceptable formatting variations (e.g., $483 million vs $483 million). (2) The answer addresses both parts of the multi-part question: the 2024 impairment charge and the comparison to 2025 cost savings. (3) Entities are correct—CVS, the enterprise-wide restructuring plan, and the relevant financial metrics and years are properly identified. (4) The reasoning is sound: the LLM correctly synthesizes information across time periods and financial impacts, noting that the 2025 savings exceed the 2024 charge, which aligns with the ground truth's implication of near-term cost being offset by longer-term savings. The inclusion of page references adds contextual support without detracting from accuracy. Overall, the answer demonstrates precise multi-hop reasoning and semantic equivalence to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 300,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron reported **$336 million** of equity‑in‑earnings from its investment in Angola LNG Limited for the year ended 2021【page_78】.  Because Chevron owns **36.4 %** of Angola LNG Limited, this earnings amount shows that the company is a substantial stakeholder in the Angolan liquefied natural gas (LNG) project and is generating significant profit from processing and exporting Angolan gas.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Chevron's equity in earnings from Angola LNG Limited was $336 million in 2021, when the ground truth is -$166 million (a loss). This is a major quantitative error that completely reverses the financial outcome. The ownership percentage of 36.4% is correctly stated, but the earnings figure is not. (2) The number $336 million does not match the ground truth of -$166 million; this is not a formatting or rounding issue but a fundamental factual discrepancy. There is no indication in the provided answer that Chevron incurred a loss, which is central to the correct interpretation. (3) The reasoning is flawed because it assumes profitability and uses the incorrect positive earnings figure to conclude that Chevron is 'generating significant profit,' when in fact the negative earnings indicate operational or market challenges. The multi-hop synthesis fails because the model did not correctly interpret or retrieve the financial performance data, leading to an incorrect assessment of Chevron's position in the Angolan LNG market. (4) The contextual relevance is moderate because the answer addresses the right company, project, ownership stake, and market implications, but the incorrect financial data undermines the validity of the conclusion. Due to the critical nature of the numerical error affecting both facts and interpretation, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 406,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources’ nuclear fuel supply contracts all expire by 2033, yet its Duane Arnold decommissioning is not expected to be finished until roughly 2080. This creates an operational risk that, if Duane Arnold is ever recommissioned, the company will need to secure new fuel agreements (or renegotiate existing ones) well after the current contracts end, exposing it to fuel‑procurement uncertainty and potentially higher costs; conversely, the long‑term decommissioning and spent‑fuel storage obligations must be funded and managed for decades after the fuel contracts have lapsed, adding financial and logistical exposure 【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the nuclear fuel supply contracts expire by 2033, and the Duane Arnold decommissioning is expected to continue until 2080—both dates match the original answer exactly. (2) Quantitative accuracy is perfect: no calculations are required, and the dates (2033 and 2080) are correctly cited. (3) The reasoning is sound and captures the core operational risk: the mismatch between contract expiration and long-term decommissioning obligations. The LLM correctly identifies fuel-procurement uncertainty, potential cost increases, and long-term spent fuel management as risks. It adds a reasonable speculative scenario—recommissioning—though this is not in the original answer, it does not contradict it and adds context without introducing error. (4) The answer is contextually relevant and addresses all parts of the question, including the multi-hop synthesis between fuel contracts and decommissioning timelines. The only minor shortcoming is that it does not explicitly mention the need for DOE take possession or dry storage as in the original, slightly reducing completeness in qualitative terms. However, the concept of long-term storage is implied. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 382,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s Amur GPP work is an engineering project that has been suspended since May 2022 because of sanctions and now carries a $0.7 billion contingent liability (plus a $1.0 billion liability for other terminated RCA projects) (page 84). By contrast, its on‑site industrial‑gas contracts are long‑term (10‑20 year) “total‑requirement” agreements for which revenue is recognized over time as product is delivered and the company has the right to invoice the customer (page 87). The juxtaposition shows that, although on‑site contracts generate steady, recognized revenue, they also expose Linde to substantial financial risk—any disruption, legal claim or sanction can quickly convert a long‑term supply arrangement into a large contingent liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.7 billion contingent liability related to the Amur GPP project and the May 2022 suspension due to sanctions, which aligns with the ground truth. However, it introduces an additional $1.0 billion liability for 'other terminated RCA projects' not mentioned in the original answer, which adds information not present in the ground truth and may be misleading or extraneous. This affects quantitative accuracy. (2) The revenue recognition policy for on-site industrial gas contracts is accurately described: long-term (10–20 year), total-requirement agreements with revenue recognized over time based on delivery and right to invoice. These details match the original answer. (3) The multi-hop reasoning is sound—LLM contrasts the risk profile of a large-scale international engineering project (Amur GPP) with the more stable revenue model of on-site contracts, then synthesizes this to highlight how even stable long-term agreements can carry latent financial risks under disruptions like sanctions or legal claims. This reflects the core insight of the original answer. (4) The LLM slightly overreaches by generalizing the Amur case to 'any long-term supply arrangement' becoming a liability, whereas the original answer more precisely attributes the risk to project-based involvement with multiple stakeholders and geopolitical exposure. Despite this, the overall meaning and financial insight are semantically close. The extra $1.0 billion figure, while possibly factual in context, is not in the ground truth and reduces quantitative accuracy. However, core facts, reasoning, and relevance are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 452,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "Alphabet expects TAC paid to its distribution and Google Network partners to rise as the device and geographic mix of its traffic changes (Item 7 MD&A, p. 29). Under its accounting policy, advertising on Google Network properties is recorded on a gross basis—amounts billed to advertisers are recognized as revenue, while the TAC paid to partners is recorded as a cost of revenues (Note 1 – Advertising Revenues, p. 55; Cost of Revenues, p. 56). Therefore, the higher TAC will increase the cost‑of‑revenues line and compress gross margins, but it does not change the gross amount of advertising revenue that is recognized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that TAC increases due to shifts in device and geographic mix, which directly increases cost of revenues under Google's gross revenue recognition model for ads on Google Network properties. It accurately explains that revenue is recognized gross (full amount billed), while TAC is recorded as cost of revenues, leading to higher costs and compressed gross margins—this matches the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the LLM correctly references the relevant sections (MD&A p.29, Note 1, pp.55–56), which supports factual grounding. (3) The multi-hop reasoning is sound: it connects the expected increase in TAC (from MD&A) with the accounting policy (from notes) and correctly infers the impact on cost of revenues and gross margins. (4) The only minor omission is that the LLM does not mention 'partner mix' as an additional driver of TAC (the original answer includes device, geographic, and partner mix), and it doesn't explicitly state that total advertising revenue may still grow despite margin pressure—though the point about revenue being unaffected in gross terms is made. These are minor contextual details that do not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 416,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "Duke Energy recorded a **$5.293 billion** asset‑retirement obligation for the closure of coal‑ash impoundments (see the “Closure of ash impoundments” line in the ARO table)【page_177】. That entire amount is tied to compliance with the Coal Ash Act and other state‑ and federal‑level requirements, because the chosen closure method and timetable—must meet those regulations—determine the estimated costs reflected in the ARO【page_178】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Duke Energy's asset retirement obligation (ARO) for coal ash impoundment closure is fully influenced by compliance with the Coal Ash Act and that the closure method and timetable affect the recorded ARO, which aligns with the ground truth. The qualitative reasoning and contextual relevance are strong, accurately reflecting the regulatory linkage and the impact of closure decisions on cost estimation. However, the quantitative accuracy is compromised because the original answer (ground truth) does not specify a dollar amount—$5.293 billion—while the LLM introduces this figure without support from the provided ground truth. Since the question does not ask for a specific number and the ground truth does not include one, the inclusion of a precise dollar amount represents a hallucination or unsupported addition, reducing quantitative accuracy. While the number may be factually correct in external context, within the scope of the provided ground truth, it is not verifiable and thus incorrect in this evaluation framework. The multi-hop reasoning is sound in linking regulation to ARO estimation, but the unsupported figure prevents a higher score. Semantic equivalence is mostly maintained, except for the extraneous numeric claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 356,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "Both tables list the same fair‑value amounts for Mortgage‑Backed Obligations—$236 million for January 31 2024 and $178 million for January 31 2023 (page 77 and page 79). Since the numbers are identical, the total change between the two disclosed tables is **$0 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It claims the numbers are identical in both tables, which contradicts both the ground truth and the actual calculation required. The fair value changed from $236 million to $178 million, representing a decrease of $58 million. The LLM incorrectly states the change is $0 million. (2) Quantitative accuracy is poor: while the individual values ($236M and $178M) are correctly cited, the calculation of change (difference) is entirely wrong. The correct difference is $236M - $178M = $58M decrease, not $0M. (3) The reasoning is flawed: the model fails to compute the change between two time points, instead falsely asserting no change because the values are listed separately. This reflects a failure in basic financial reasoning and multi-hop synthesis—comparing values across tables and computing change. (4) Contextual relevance is moderate because it references the correct financial instrument (Mortgage-Backed Obligations), correct filing (implied), and correct pages, but draws an incorrect conclusion due to faulty logic. The answer misses the core task: calculating the change in fair value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 322,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "In 2023, Danaher’s Diagnostics segment derived **5 % of its sales** from “other developed markets” 【page_9】. The company defines “other developed markets” as **Japan, Australia and New Zealand** 【page_78】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the percentage of sales attributed to 'other developed markets' is accurately reported as 5%, which aligns with the original answer. (2) The geographic regions classified under 'other developed markets'—Japan, Australia, and New Zealand—are correctly identified, matching the company's definition in the source. (3) The multi-hop reasoning is sound: the model correctly synthesized information from two different parts of the document (sales percentage from page 9, regional classification from page 78) to answer both sub-questions. (4) The answer is semantically equivalent to the ground truth, with no factual discrepancies, omissions, or misinterpretations. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 238,
        "total_tokens": 1352
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "In 2021 Union Pacific’s Bulk shipments generated $6.656 billion of freight revenue – calculated as 2,014 thousand carloads × $3,305 average revenue per car (2,014 × $3,305 = $6,656 million)【page_35】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key inputs and calculation. The ground truth uses 1,920,000 carloads and $3,467 average revenue per car, while the LLM reports 2,014,000 carloads and $3,305, both of which are incorrect. The final revenue figure is stated as $6.656 billion, which matches the ground truth in magnitude but is derived from wrong inputs, suggesting potential data hallucination or misattribution. (2) Calculation verification: 2,014,000 × $3,305 = $6,656,270,000 — mathematically this matches the ground truth total, but only because the incorrect inputs coincidentally multiply to the correct total. The individual numbers do not match the source data. (3) Multi-hop reasoning is partially sound in structure (revenue = volume × rate), but the model fails to retrieve the correct underlying data from the knowledge base, undermining the reasoning chain. (4) Scores reflect major factual inaccuracies in core quantitative inputs despite approximate match in final figure; contextual relevance is high as the answer addresses the right metric, company, and year, and uses the correct formulaic approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 323,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The settlement leaves the total undiscounted cost to permanently close all coal‑ash basins in North Carolina and South Carolina at roughly **$8 billion to $9 billion**.  This is about **$1.5 billion lower** than Duke Energy’s original post‑April 1, 2019 estimate of **$9.5 billion to $10.5 billion** for the same closures.【page_71】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the estimated cost range of $8 billion to $9 billion is accurately reported, as is the initial estimate of $9.5 billion to $10.5 billion. The reduction of $1.5 billion is correctly calculated as the midpoint difference (e.g., $10.5B - $9B = $1.5B or $9.5B - $8B = $1.5B), which aligns with the ground truth. (2) The answer is complete, addressing both parts of the question: the current estimated cost and the reduction from the initial estimate. (3) Entities are accurate—Duke Energy, NCDEQ, and the April 1, 2019 closure determination are correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers the cost reduction by comparing pre- and post-settlement estimates across the specified geography (NC and SC). (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content, including appropriate use of 'roughly' and bold formatting for emphasis. The citation of 'page_71' adds contextual support. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 323,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash for Dynamic Yield in 2022 and $2.7 billion in cash for Recorded Future in 2024, for a combined cash consideration of roughly $3.025 billion. This spending illustrates the company’s strategy of using sizable cash acquisitions to diversify and expand its portfolio—adding AI‑driven personalization (Dynamic Yield) and threat‑intelligence capabilities (Recorded Future) to grow beyond its core payments network and strengthen its value‑added services.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash considerations of $325 million for Dynamic Yield in 2022 and $2.7 billion for Recorded Future in 2024 are accurately reported, and the sum of $3.025 billion is correct. Minor formatting differences (e.g., thin spaces, 'roughly') do not affect accuracy. (2) The answer is complete, addressing both the total cash consideration and the strategic rationale behind the acquisitions. (3) Entities—Mastercard, Dynamic Yield LTD, Recorded Future, and the respective years—are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information across two acquisitions and links them to Mastercard's broader strategy of diversification and expansion into value-added services via specialized capabilities (AI-driven personalization and threat intelligence). The qualitative explanation aligns semantically with the original answer, using equivalent phrasing such as 'diversify and expand' and 'strengthen its value-added services.' All components of the multi-part question are addressed with factual precision and contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 328,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "The fair‑value tables show International bonds of $341 million in the pension‑plan assets (page 92) and $12 million in the other post‑retirement benefit‑plan assets (page 93), for a combined total of **$353 million**. In the pension‑plan disclosure the bonds are listed as a distinct “International bonds” line under Fixed‑income securities with a Level 1 ($3 m) / Level 2 ($338 m) split, whereas in the post‑retirement‑benefit disclosure they appear as a separate “International bonds” line under that plan’s Fixed‑income securities with a Level 1 ($10 m) / Level 2 ($2 m) split, reflecting a much smaller holding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total fair value is stated as $353 million, but the ground truth is $540 million ($12M + $528M). The LLM incorrectly reports $341M and $12M as the two components, which do not match the ground truth values. Additionally, the breakdowns by Level 1 and Level 2 are incorrect: the LLM claims $3M Level 1 and $338M Level 2 in the first table, but the correct values are $9M and $3M; for the second table, the LLM reports $10M Level 1 and $2M Level 2, but the correct values are $10M Level 1 and $518M Level 2. (2) Calculations are also wrong: $341M + $12M = $353M is mathematically correct but based on incorrect inputs, so the sum is invalid. The correct sum is $12M + $528M = $540M. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize data from two tables and compare categorizations, but it uses incorrect source data, leading to flawed conclusions. It identifies that categorization differs between disclosures, but misrepresents the magnitude and distribution across levels. (4) The contextual relevance is moderate because the structure and intent of the response align with the question—discussing two tables, fair values, and categorization differences—but the factual foundation is severely flawed, undermining correctness. Due to major quantitative and qualitative inaccuracies, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 394,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard’s real‑time account‑based payments capability builds, operates and enhances a global real‑time clearing‑and‑settlement and direct‑debit infrastructure that lets consumers, businesses, governments and merchants move money instantly from account to account, adding enhanced data‑messaging and supporting the network’s distributed, intelligent‑routing architecture that runs 24‑hours a day (see page 11). Through this infrastructure the company switches roughly 70 percent of all Mastercard and Maestro‑branded card transactions—covering both domestic purchases and, in particular, nearly all cross‑border transactions (page 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the real-time infrastructure supports instant account-to-account payments with enhanced data and messaging, operates 24/7, and handles approximately 70% of Mastercard and Maestro-branded transactions, including nearly all cross-border ones. (2) Quantitative accuracy is perfect: the 70% figure is correctly cited, and there are no calculation errors. Format and sourcing (page 11) are consistent with the original. (3) Multi-hop reasoning is sound—the answer synthesizes infrastructure functionality with transaction volume impact across domestic and cross-border contexts. (4) Minor deduction in qualitative accuracy due to slightly more verbose phrasing and inclusion of additional details (e.g., 'direct-debit infrastructure', 'distributed, intelligent-routing architecture') not present in the ground truth, which, while plausible, are not confirmed by the provided answer. However, these do not contradict the original and may reflect source document nuance. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 324,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. completed the VIZIO Holding Corp. purchase for a net cash consideration of **$1.9 billion** (see Item 7 discussion).  The deal adds a data‑privacy risk because VIZIO’s subsidiaries **collect consumer data, including television‑viewing data**, which increases Walmart’s exposure to privacy‑related breaches and regulatory compliance concerns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the cash consideration as $1.9 billion, matching the ground truth exactly. The wording 'net cash consideration' is slightly more specific but does not contradict the original answer. The data privacy risk is accurately described: VIZIO collects consumer data including television viewing data, which introduces privacy and cybersecurity risks. The LLM captures the core risk—exposure to breaches and regulatory compliance concerns—though it omits some downstream consequences mentioned in the ground truth (e.g., litigation, fines, reputational damage). (2) Quantitatively, the $1.9 billion figure is correct with no calculation required; format is standard and matches. (3) The multi-hop reasoning is sound: the model correctly links Walmart's acquisition to VIZIO's data practices and infers increased privacy risk exposure. It synthesizes information about the transaction value and risk disclosure appropriately. (4) The answer is highly accurate and relevant, with only a minor omission in the completeness of risk consequences. This does not undermine the core factual correctness, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 357,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "Higher fuel prices added $14 million to operating income via fuel‑cost recovery, but also lifted fuel‑related operating expenses by $35 million. The expense increase more than offset the recovery, leaving a net $21 million adverse effect on Duke Energy’s operating cash flows for 2022【page_55】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $14 million increase in fuel cost recovery, the $35 million rise in fuel-related operating expenses, and the resulting $21 million net adverse impact on operating cash flows are all correctly stated. (2) The calculation is accurate: $35M - $14M = $21M net cost increase, which matches the ground truth. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the impact of higher fuel prices by combining the offsetting recovery in operating income with the larger increase in operating expenses, concluding a net negative effect. (4) The answer addresses all parts of the question: impact on operating cash flows and operating expenses, and correctly identifies Duke Energy and the year 2022. The reasoning, entity identification, and contextual relevance are all excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 276,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "Intel recorded **$565 million** of additional period charges in 2021 that were “primarily associated with the ramp up of Intel 4”【page_24】. These charges stem from the rollout of the newly‑named “Intel 4” process node, which was introduced in Intel’s July 26, 2021 rebranding of its manufacturing‑process naming scheme that renamed existing nodes (e.g., 10nm Enhanced SuperFin to Intel 7, Intel 7 to Intel 7nm) and added the “Intel 4” designation【page_115】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $565 million in additional period charges for 2021 is accurately reported, and the date of the rebranding—July 26, 2021—is correctly cited. (2) The answer addresses both parts of the multi-hop question: the financial impact (charges) and its relation to the rebranding of the manufacturing node. (3) Entity accuracy is perfect: 'Intel 4' is correctly identified as the rebranded node, and the context of the naming overhaul (e.g., renaming 10nm Enhanced SuperFin to Intel 7) is accurately included, showing deep synthesis. (4) The reasoning is sound—linking the charges directly to the ramp-up of Intel 4 and explaining that the rebranding was part of a broader naming strategy announced on the specified date demonstrates correct multi-hop logic. The inclusion of source page references (24, 115) further supports fidelity to the source material. Minor wording differences (e.g., 'rebranding of its manufacturing-process naming scheme' vs. 'updated naming structure') do not affect semantic equivalence; the meaning and facts align precisely with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 329,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "Danaher’s Diagnostics segment generated 5 % of its 2023 sales from “other developed markets.” As of December 31 2023, the company employed roughly 3,000 associates in those same markets.【page_9】【page_11】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets, and Danaher had 3,000 employees in those markets as of the end of 2023. (2) Quantitative accuracy is perfect—both the percentage (5%) and employee count (3,000) are correct, with no calculation errors. Minor formatting differences (e.g., '5 %' vs '5%') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly linked Diagnostics segment sales data to employee data for the same geographic region (Other Developed Markets) and same time period (end of 2023). (4) The answer is semantically equivalent to the original, using slightly different phrasing ('generated 5% of its 2023 sales', 'employed roughly 3,000 associates') without altering factual content. Citations to page_9 and page_11 further support contextual relevance and sourcing accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 276,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "In 2021 the Industrial chemicals & plastics segment earned an average of **$3,207 per car** and shipped **606 thousand carloads**. Multiplying the two gives $3,207 × 606,000 ≈ $1,943 million, or roughly **$1.94 billion** in total revenue for that segment【page_35†L31-L38】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in unit conversion and magnitude. While it correctly identifies the average revenue per car ($3,207) and the number of carloads (606,000), the multiplication result is miscalculated in terms of scale. $3,207 × 606,000 = $1,943,442,000, which is approximately $1.94 billion. However, the ground truth states $1,943,442 (about $1.94 million), which is 1,000 times smaller. This indicates a fundamental error in either the source data interpretation or calculation logic. (2) The numbers cited—$3,207 per car and 606,000 carloads—are not consistent with the ground truth revenue of ~$1.94 million; their product yields $1.94 billion, not million. Thus, quantitative accuracy is severely compromised. (3) The reasoning process is logically structured—multiplying revenue per car by carloads is correct for deriving total revenue—and the multi-hop synthesis is conceptually sound. The model correctly identifies the relevant metrics and performs the right type of calculation, showing good qualitative reasoning. (4) Contextually, the answer is highly relevant, citing the correct segment, year, and methodology, and even providing a source reference. However, the massive discrepancy in the final figure (billion vs. million) renders the answer factually incorrect despite correct structure. Therefore, correctness and quantitative accuracy scores are low, while qualitative and contextual scores are moderate to high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1095,
        "completion_tokens": 406,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "Verizon reported $341 million of International bonds in its pension‑plan assets and $12 million in its other post‑retirement benefit‑plan assets for 2023, which together total $353 million of fair‑value International bonds【page_92†L19-L24】【page_93†L19-L24】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM reports $341 million and $12 million, summing to $353 million, which is completely inconsistent with the ground truth of $12 million in Level 1 and $12 million in Level 2, totaling $24 million. The numbers cited by the LLM do not match the disclosed values in the knowledge graph. (2) Completeness: The question specifically asks for the total fair value of International Bonds held by Verizon in 2023 across both reported asset categories (Level 1 and Level 2), but the LLM incorrectly references 'pension-plan assets' and 'other post-retirement benefit-plan assets', which are not the correct categorizations per the ground truth. (3) Entity Accuracy: While the company (Verizon) and year (2023) are correct, the financial metrics and asset classifications are misidentified. (4) Reasoning: The multi-hop synthesis is flawed — the model fails to correctly identify the two relevant bond categories (Level 1 and Level 2) and instead pulls data from unrelated benefit plans, indicating a failure in reasoning and source interpretation. (5) Semantic Equivalence: The answer does not convey the same information — it introduces different categories, incorrect figures, and an erroneous total. The citation of page 92 and 93 does not justify the discrepancy, as the ground truth clearly states the correct values are $12M in Level 1 and $12M in Level 2. Thus, the answer is factually wrong and based on a misreading of the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 423,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco’s own processing, packaging and manufacturing facilities let it produce a growing share of its private‑label merchandise (page 20).  By expanding the penetration of these lower‑cost, high‑margin private‑label items, Costco can offer attractive prices that drive comparable‑sales growth, and that higher sales base spreads SG&A costs over more revenue—reducing SG&A as a percentage of sales and boosting profitability (page 23).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Costco owns facilities that produce private-label items, which supports its strategy of driving comparable sales growth and leveraging SG&A expenses. The answer correctly identifies that private-label items are lower-cost and high-margin, enabling attractive pricing that boosts sales volume. This increased sales base allows Costco to spread SG&A costs over more revenue, reducing SG&A as a percentage of sales and enhancing profitability—this multi-hop reasoning is sound and matches the original answer. (2) There are no numeric values, percentages, dates, or financial figures in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect numbers. (3) The reasoning correctly synthesizes the causal chain: owned facilities → private-label production → increased penetration → competitive pricing → comparable sales growth → SG&A leverage → improved profitability. This reflects proper multi-hop logic across operational and financial domains. (4) The only minor shortcoming is that the LLM answer adds interpretive details not explicitly in the ground truth (e.g., 'lower-cost, high-margin')—while reasonable and likely true, they are not present in the original answer, slightly reducing qualitative precision. However, these additions do not distort meaning and are contextually justified. Overall, the answer is semantically equivalent, complete, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 418,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "RibbonFET is Intel’s first gate‑all‑around transistor introduced with the 20A node, delivering faster switching and the same drive current as multiple FinFET fins in a smaller footprint, thereby boosting performance‑per‑watt and density. By investing R&D in RibbonFET (as highlighted in the R&D investment section) Intel is accelerating its process‑technology roadmap, and the technology becomes a cornerstone of the IDM 2.0 strategy’s push to advance process and packaging capabilities, drive product leadership and differentiate its internal‑and‑foundry offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: RibbonFET is correctly identified as Intel’s first gate-all-around transistor introduced at the 20A node, delivering faster switching, improved performance-per-watt, and higher density in a smaller footprint than FinFET. The role of R&D investment and IDM 2.0 strategy is accurately described. (2) Quantitative accuracy is perfect: while no specific dollar figures (e.g., $20B investments) are mentioned in the LLM answer, none are misstated—only omitted. The ground truth includes $20B investments in Arizona and Ohio, which the LLM omits but does not contradict. Since the question does not explicitly ask for investment amounts, this is a minor completeness gap rather than a factual error. (3) Multi-hop reasoning is sound: the LLM correctly links RibbonFET to Intel's process technology roadmap, R&D investments, and the IDM 2.0 strategy, showing understanding across multiple strategic layers. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM emphasizes performance-per-watt, density, and strategic differentiation in foundry offerings, which complements the original answer. Only partial deduction is made on qualitative accuracy due to the omission of specific investment figures that ground the IDM 2.0 strategy in tangible commitments, which slightly weakens completeness. However, the core logic and synthesis remain robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 406,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In the fourth quarter of 2023 Meta said that roughly 3 % of its worldwide MAP was made up of “violating” accounts and about 4 % of its worldwide MAUs were “false” accounts【page_5】. Because these accounts are difficult to detect and the data signals used to identify them can change, Meta notes that their presence – and any loss of signal or methodological adjustments – can introduce algorithmic or technical errors that affect the stability and accuracy of its user‑metric estimates, sometimes requiring retroactive adjustments to reported MAP/MAU figures【page_4】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of Meta's worldwide MAP consisted of violating accounts and 4% of MAUs were false accounts in Q4 2023. These numbers match exactly with the original answer, satisfying quantitative accuracy. (2) All numeric values are accurate—3% and 4% are correctly attributed to MAP and MAUs respectively, with the correct time frame (Q4 2023) and entity (Meta). No calculations are required, but the model correctly reports the figures without distortion. (3) The reasoning and synthesis are sound: the LLM correctly explains that these accounts impact the stability and accuracy of user metrics due to detection challenges, changing data signals, methodological adjustments, and potential retroactive changes. This aligns with the original answer’s emphasis on fluctuations due to identification methods and data limitations. It also appropriately references reduced signal visibility (e.g., encryption in WhatsApp is implied via 'loss of signal') and notes the need for retroactive adjustments, which reflects the multi-hop understanding of both metric vulnerability and operational challenges. (4) The only minor shortcoming is that the LLM does not explicitly mention 'periodic spikes in account creation in specific countries'—a nuance included in the original answer that adds context to estimation challenges. While the core impact on stability and accuracy is well-covered, this omission slightly reduces completeness in qualitative accuracy. However, the answer remains semantically equivalent in intent and substance, with excellent contextual relevance and precise numerical reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 459,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31 2023 PayPal reported a crypto‑asset safeguarding liability of **$1.241 billion** and a matching safeguarding asset of **$1.241 billion** (see the table on page 84). Both the liability and the asset are measured at fair value using quoted market prices for the underlying crypto assets, and because the company had **no safeguarding loss events** during the period, the asset and liability were recorded at the same amount (page 83).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of both the crypto asset safeguarding liability and asset as $1.241 billion as of December 31, 2023, which aligns with the ground truth in magnitude and date. The reason provided—that both are measured at fair value using quoted market prices and that no safeguarding loss events occurred—is factually consistent with the original answer. (2) Quantitative accuracy is perfect: the dollar amounts ($1.241 billion) are correctly reported, and the date (December 31, 2023) matches. Format variation (e.g., $1.241 billion vs. $1.241B) is acceptable and does not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the equality in value arises from fair value measurement and absence of loss events, which requires connecting valuation methodology with operational outcomes. The reference to specific pages (83, 84) suggests accurate sourcing, though not required for correctness. (4) The only minor shortcoming is that the LLM does not explicitly name the 'principal market' as part of the fair value determination, a detail included in the ground truth. However, mentioning 'quoted market prices' and 'underlying crypto assets' captures the essence. Thus, while slightly less precise in terminology, the reasoning and facts remain correct. Hence, a 9/10 on qualitative accuracy and 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 389,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The table of temporary‑equity items shows that the 7.50% Cumulative Redeemable Preferred Units were valued at $15,537 thousand and “Other noncontrolling redeemable interests” at $169,192 thousand in 2024, for a combined total of $184,729 thousand (≈$184.7 million)【page_128】. In 2023 those amounts were $23,037 thousand and $172,912 thousand, respectively, totaling $195,949 thousand (≈$195.9 million)【page_128】—so the 2024 combined value is about $11.2 million lower than in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: for 2024, '7.50% Cumulative Redeemable Preferred Units' is correctly reported as $15,537 thousand and 'Other noncontrolling redeemable interests' as $169,192 thousand, summing to $184,729 thousand. For 2023, the values are $23,037 thousand and $172,912 thousand, totaling $195,949 thousand. The difference of $11,220 thousand (≈$11.2 million) is correctly implied. (2) The answer is complete, addressing both the 2024 combined total and its comparison to 2023. (3) Entities are correctly identified—specific financial instruments and years are accurate. (4) The multi-hop reasoning—aggregating two line items across two years and comparing them—is sound and clearly explained. (5) The semantic meaning fully aligns with the original answer, with added clarity in breakdown and formatting. Minor phrasing differences (e.g., '≈$11.2 million lower' vs 'decrease of $11,220 thousand') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 307,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas’ floating‑price natural‑gas purchases for Nicor Gas and SouthStar totaled roughly **$136 million** (39 mmBtu at forward‑price rates as of Dec. 31 2024)【page_103】. These purchases are covered by the utilities’ **natural‑gas cost‑recovery mechanisms**, which allow rates to be adjusted to reflect wholesale gas costs, ensuring that the $136 million of prudently incurred gas costs can be recovered through regulated tariffs【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $136 million value of floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, matching the ground truth exactly. The mention of '39 mmBtu at forward-price rates' adds contextual detail not in the original but does not contradict it and may reflect underlying calculation basis. (2) Quantitatively, the dollar amount is accurate, the date is correct, and the units (mmBtu) are plausible and consistent with industry reporting—no calculation errors present. Format variation ($136 million vs $136 million) is acceptable. (3) The reasoning is sound: the LLM correctly links the procurement strategy to natural gas cost-recovery mechanisms that allow rate adjustments to reflect wholesale costs, ensuring recovery of prudently incurred costs. It references regulated tariffs and aligns with the regulatory framework described in the ground truth. The only minor gap is that it does not explicitly mention state regulatory agency review and approval of procurement plans, which is part of the full alignment process per the original answer. (4) Despite this small omission, the core multi-hop synthesis—connecting procurement value to regulated recovery mechanism—is accurate and well-supported. Semantic equivalence is maintained. Scores reflect high accuracy with a slight deduction in qualitative accuracy for incomplete elaboration on regulatory oversight.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 401,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "In 2021 the Lower 48 segment generated **$4,932 million** of net income attributable to ConocoPhillips, while its equity‑in‑earnings of affiliates was a **$18 million loss** (‑$18 million) 【page_148】.  Thus the segment’s net income dwarfed the modest equity loss, contributing roughly $4.9 billion of profit versus a $18 million negative equity adjustment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net income of $4,932 million and equity in earnings loss of $18 million are accurately reported, with correct formatting variations (e.g., $18 million loss = $(18) million). (2) The answer addresses both parts of the question: the total net income attributable to ConocoPhillips from the Lower 48 region in 2021 and the comparison with equity in earnings (losses) for the same region and year. (3) Entity accuracy is correct—'Lower 48', 'ConocoPhillips', '2021', and financial metrics ('net income attributable', 'equity in earnings') are all properly identified. (4) The reasoning is sound: the LLM correctly interprets that the net income was substantial while the equity component was a small loss, and it appropriately contextualizes the comparison (e.g., 'dwarfed the modest equity loss'). The synthesis of both figures into a meaningful comparison demonstrates accurate multi-hop reasoning. Semantic equivalence is maintained despite rewording, and the citation to page_148 supports source grounding. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 324,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The Company disclosed that at the end of 2024 it had **$1.212 billion** of open, unsettled forward foreign‑exchange contracts.  While it also uses variable‑priced contracts for natural‑gas and electricity purchases, the filing does not provide a notional amount for those commodity contracts, indicating they are employed mainly for hedging rather than speculative purposes.  Together, the disclosed FX exposure and the (undisclosed) commodity‑price contracts show a strategy of using forward and index‑linked contracts to offset currency and energy‑price volatility on known future purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the notional value of unsettled forward foreign-exchange contracts as $1.212 billion, which matches the ground truth of $1,212 million (equivalent values, different formatting). The answer accurately notes that variable-priced commodity contracts are used for electricity, natural gas, and fuel, consistent with the original. However, the LLM states that the filing does not provide a notional amount for commodity contracts, which is correct based on the ground truth—no specific dollar figure is given. 2) Quantitatively, the $1.212 billion figure is accurate and properly converted from $1,212 million. There are no calculation errors. 3) The reasoning is sound: the LLM correctly infers that both instruments are used for hedging purposes despite the lack of derivative hedge accounting, aligning with the company's strategy to manage financial risk. It appropriately characterizes the use of index-linked contracts to mitigate price volatility. The only minor shortcoming is a slight omission in not explicitly stating that these instruments are part of a broader economic hedging strategy, though the intent is clearly conveyed. 4) The answer is contextually relevant, directly addressing both the quantitative exposure and the strategic rationale behind the company's risk management approach. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 396,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft builds Microsoft 365 through its internal “Experiences and Devices” engineering group, which is tasked with delivering end‑user experiences for Microsoft 365 and related services. Because the product is managed internally, the company revised its FY 2024 reporting to expand the Microsoft 365 Consumer subscriber metric – now counting Microsoft 365 Basic subscribers as well – so the financial metric aligns with how the internal development team tracks and manages the service.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies Microsoft's internal 'Experiences and Devices' engineering group as responsible for developing Microsoft 365, and accurately states that this internal structure influenced the change in financial reporting for FY 2024 by expanding the subscriber metric to include Microsoft 365 Basic subscribers. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or subscriber counts), so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is sound: it connects internal development ownership (Experiences and Devices) to business management practices and then to financial reporting changes, which aligns with the ground truth's logic. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the intent to provide investors with a 'more comprehensive view of consumer adoption,' which is part of the strategic rationale in the original answer. However, the explanation that the change aligns with how the internal team manages the service captures a similar idea, just with slightly less investor-focused context. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 361,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "Pfizer’s 2019 Stock Plan treats each Performance Share Award as three shares × the maximum payout. The 2023 filing shows that the maximum PSA award outstanding at year‑end was 4,734 thousand shares (the “maximum award” for PSAs)【page_99】. Multiplying by three gives 4,734 × 3 = 14,202 thousand shares, or roughly **14.2 million shares** counted toward the plan’s share limit【page_97】.  \n\nThis 14.2 million‑share exposure is only a small slice of the **248 million shares still available for award as of 12/31/2023** (including 68 million Seagen‑derived shares)【page_97】, meaning PSAs consume only about 5‑6 % of the remaining award capacity.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors despite referencing specific pages and numbers. (1) The question asks for the total number of shares counted toward the maximum available under the plan for PSAs in general, not the actual outstanding PSA awards. The original answer explains the share counting *methodology* (3 shares × maximum payout) and its *implication* for how much of the 248 million remaining shares can be consumed by PSAs. The LLM incorrectly interprets this as a request to calculate the current exposure from existing PSAs (14.2 million), which is not what the question asks. (2) The number 4,734 thousand shares is not mentioned in the ground truth and appears to be pulled from the filing but misapplied — the question is not about current outstanding PSAs but about how PSAs are accounted for under the plan. (3) The calculation (4,734 × 3 = 14,202 thousand) may be mathematically correct, but it is based on a misinterpretation of the question and thus irrelevant. (4) The conclusion that PSAs consume only 5–6% of remaining capacity is unsupported by the ground truth and introduces a false quantitative claim. The original answer makes no such calculation or percentage estimate. (5) The mention of '68 million Seagen-derived shares' is extraneous and not part of the ground truth. (6) The core concept — that PSAs count as three shares per award at maximum payout — is correctly understood, and the 248 million available shares figure is accurate. However, the failure to address the *significance* of the accounting method in terms of *future award allocation constraints* (i.e., that PSAs consume shares faster than other awards) undermines the qualitative accuracy. The answer substitutes a narrow, current snapshot for a structural explanation. Thus, while some numbers are accurate and the multiplier concept is grasped, the reasoning is misdirected, and the conclusion is factually incorrect in context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 525,
        "total_tokens": 1902
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 8.05,
    "average_quantitative_accuracy": 8.39,
    "average_qualitative_accuracy": 8.26,
    "average_contextual_relevance": 9.39,
    "score_distribution": {
      "excellent": 542,
      "good": 53,
      "fair": 72,
      "poor": 83
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 750,
    "failed": 0,
    "elapsed_seconds": 8830.53,
    "timestamp": "2026-02-02T18:07:36.274809"
  }
}